Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,DNA-dependent DNA replication (GO:0006261),0.6568206916341444,2.9154428099010903,0.0,0.0,0.0,81/128,21.72%,RFC3;PSMD14;MCM4;GINS4;RPA3;GINS1;HMGA1;PSMB2;RFC5;MCM3;DBF4;PRIM2;ORC6;SSBP1;PSMB9;PSMA5;GINS2;POLE2;RFC2;PSMB3;POLD2;PSME3;PSMA3;POLB;MCM5;BLM;PRIM1;PSMA7;MGME1;PSMD13;DDX21;MCMDC2;PSME2;PSMC2;RECQL4;PSMC4;PSMD10;TOPBP1;PSMD12;POLE3;WRNIP1;MCM7;DNA2;PSMB5;CDK2AP1;MCM6;WDHD1;ORC5;POLA1;MCM2;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;MCM10;PSME1;PSMF1;PSMD11;CDT1;UBA52;PSMD1;RPA2;POLD1;LRWD1;TEFM;ORC2;GMNN;CDC6;PSMD6;CDC7;NOC3L;CDC45;MCMBP;RFC4;ORC1;PSMD5;ORC3;BAZ1A;CDK2;PSMC1
prerank,rRNA processing (GO:0006364),0.6326221268202896,2.8119951577537394,0.0,0.0,0.0,126/167,26.84%,DKC1;DDX47;NOB1;DCAF13;WDR43;WDR12;EXOSC5;WDR3;EMG1;UTP18;IMP4;MRTO4;EBNA1BP2;BYSL;FBL;LYAR;RRP9;PES1;BOP1;EXOSC4;UTP14A;NOLC1;RPL36;RRP1;RPL8;NAT10;RRP12;RPS2;RCL1;EXOSC8;PRKDC;TFB1M;RPL37;DDX27;RSL1D1;RRP1B;EXOSC7;NOL11;EIF6;RPL18;WDR74;WDR46;WDR18;PIH1D2;RPLP0;DDX10;RPL39;SRFBP1;DDX54;EXOSC1;EXOSC3;DHX37;NOC4L;PDCD11;RPS14;RPLP2;UTP15;HEATR1;DIS3;DDX52;RPL12;RPL28;RPL27A;RRP7A;IMP3;NHP2;RPL29;RPS9;NOP14;RPL35;RPL37A;DDX49;EXOSC2;RPL7A;LSM6;UTP3;UBA52;NOP56;RPL27;NOP58;RPL32;UTP20;RPS19;POP5;POP4;RPL31;MRPL1;RPL35A;TBL3;RPS24;RPL18A;WDR36;NOL6;FCF1;XRN2;RPS16;UTP6;PIH1D1;PWP2;RPS28;RIOK1;ERI1;RPL11;RPL41;RPS15;RPL23;RPF1;MAK16;BMS1;ESF1;MPHOSPH6;RPS7;RPL23A;RPL24;RRP36;RIOK2;RPL4;RPL30;RPLP1;RPL7;RPL13;WDR75;RPL13A;RPL14;RPL15;RPL19
prerank,ribosome biogenesis (GO:0042254),0.6120245520797906,2.738833137477031,0.0,0.0,0.0,129/184,23.88%,DKC1;DDX47;NIP7;NOB1;DCAF13;RAN;WDR43;WDR12;EXOSC5;WDR3;EMG1;UTP18;IMP4;MRTO4;EBNA1BP2;BYSL;NOP16;FBL;ABCE1;LYAR;RRP9;RPL26L1;URB2;PES1;BOP1;RRS1;EXOSC4;PAK1IP1;UTP14A;NOLC1;RPL36;RRP1;RPL8;RRP12;RPS2;RCL1;EXOSC8;GTF3A;RPL37;DDX27;DDX31;RRP1B;EXOSC7;NOL11;NAF1;ZNF622;MRPL22;EIF6;NOC2L;RPL18;WDR74;WDR46;WDR18;PIH1D2;RPLP0;DDX10;RPL39;MRPL36;DDX54;EXOSC1;EXOSC3;DHX37;NOC4L;RPF2;PDCD11;RPS14;RPLP2;UTP15;HEATR1;HEATR3;DIS3;DDX52;RPL12;RPL28;RPL27A;RRP7A;IMP3;RPL29;RPS9;NOP14;RPL35;RPL37A;DDX49;EXOSC2;RPL7A;NPM1;MALSU1;UTP3;UBA52;NOP56;RPL27;NOP58;RPL32;UTP20;RPS19;POP5;POP4;RPL31;CUL4A;RPL35A;TBL3;RPS24;RPL18A;WDR36;NOL6;FCF1;XRN2;RPS16;UTP6;PIH1D1;PWP2;RPS28;RIOK1;LSG1;RPL11;RPL41;RPS15;RPL23;RPF1;SURF6;BMS1;ESF1;MPHOSPH6;RPS7;RPL23A;RPL24;RRP36;RIOK2;RPL4
prerank,rRNA metabolic process (GO:0016072),0.6145434926869257,2.7196420397533223,0.0,0.0,0.0,115/154,26.84%,DKC1;DDX47;NOB1;DCAF13;WDR43;WDR12;EXOSC5;WDR3;EMG1;UTP18;IMP4;MRTO4;EBNA1BP2;BYSL;FBL;NIFK;LYAR;RRP9;PES1;BOP1;EXOSC4;UTP14A;NOLC1;RPL36;RRP1;RPL8;RRP12;RPS2;RCL1;EXOSC8;RPL37;DDX27;RRP1B;EXOSC7;NOL11;RPL18;WDR74;WDR46;WDR18;PIH1D2;RPLP0;DDX10;RPL39;DDX54;EXOSC1;EXOSC3;DHX37;NOC4L;PDCD11;RPS14;RPLP2;UTP15;HEATR1;DIS3;DDX52;RPL12;RPL28;RPL27A;RRP7A;IMP3;RPL29;RPS9;NOP14;RPL35;RPL37A;DDX49;EXOSC2;RPL7A;UTP3;UBA52;NOP56;RPL27;NOP58;RPL32;UTP20;RPS19;POP5;POP4;RPL31;DEDD2;RPL35A;TBL3;RPS24;RPL18A;WDR36;NOL6;FCF1;XRN2;RPS16;UTP6;PIH1D1;PWP2;RPS28;RPL11;RPL41;RPS15;RPL23;RPF1;BMS1;ESF1;MPHOSPH6;RPS7;RPL23A;RPL24;RRP36;RPL4;RPL30;RPLP1;RPL7;RPL13;WDR75;RPL13A;RPL14;RPL15;RPL19
prerank,pre-replicative complex assembly (GO:0036388),0.6745230329644397,2.6673381632880298,0.0,0.0,0.0,41/64,20.25%,PSMD14;MCM4;PSMB2;MCM3;ORC6;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;MCM5;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;MCM7;PSMB5;MCM6;ORC5;MCM2;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;CDT1;UBA52;PSMD1;ORC2;GMNN;CDC6;PSMD6;ORC1;PSMD5;ORC3
prerank,cotranslational protein targeting to membrane (GO:0006613),0.615950685656567,2.650905545583621,0.0,0.0,0.0,68/93,28.55%,RPS21;SSR1;ARL6IP1;RPL36;RPL8;SRP72;RPS2;RPS18;SEC61A1;RPS3;TRAM1;RPL37;RPS4X;RPL18;RPLP0;RPL39;SRP9;RPS14;RPLP2;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;RPS24;RPL18A;SIL1;RPS16;RPS29;RPS13;RPS28;SSR2;RPL11;RPL41;RPS15;RPS8;SRP54;RPS12;RPL23;RPS7;RPL23A;RPL24;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;RPL13A;RPL14;RPS20;RPL15;RPL19;RPS3A;RPL3;RPL34;RPL10A
prerank,DNA replication initiation (GO:0006270),0.7300330610137803,2.5980771849521123,0.0,0.0,0.0,29/38,21.67%,MCM4;RPA3;MCM3;DBF4;PRIM2;ORC6;POLE2;MCM5;PRIM1;TOPBP1;POLE3;MCM7;MCM6;ORC5;POLA1;MCM2;MCM10;CDT1;RPA2;LRWD1;ORC2;GMNN;CDC6;CDC7;NOC3L;CDC45;ORC1;ORC3;CDK2
prerank,mitochondrial translation (GO:0032543),0.6369737303936214,2.5739477122617265,0.0,0.0,0.0,67/103,22.66%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;EARS2;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;FASTKD2;LARS2;MRPL50;MTIF2;MRPL16;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;TUFM;QRSL1;MRPL9;MRPS30;MRPS34;MRPL36;MRPL4;MRPL51;GFM1;MRPL45;MRPS31;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;NOA1;IARS2;GADD45GIP1;MRPS11;MRPL27;MRPL24;RARS2;MRPS26;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,tRNA transport (GO:0051031),0.7211329569558298,2.559652856257987,0.0,0.0,0.0,22/35,17.62%,NUP37;RAN;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;TOMM20;NUP43;XPOT;TOMM20L;NUP50;NUP88;NUP107;NUP205;SSB;NUP62;NUP160;NOL6;NDC1
prerank,ncRNA processing (GO:0034470),0.5618883548519513,2.5585431960581655,0.0,0.0,0.0,128/189,26.84%,DKC1;DDX47;NOB1;DCAF13;WDR43;WDR12;EXOSC5;INTS7;WDR3;EMG1;UTP18;IMP4;MRTO4;EBNA1BP2;BYSL;FBL;SMAD1;LYAR;POP1;RRP9;PES1;BOP1;EXOSC4;PUS10;UTP14A;NOLC1;RPL36;RRP1;RPL8;ADAT1;MRPL44;POP7;RRP12;RPS2;RCL1;EXOSC8;RPL37;DDX27;RRP1B;EXOSC7;NOL11;RPL18;WDR74;WDR46;WDR18;PIH1D2;RPLP0;DDX10;RPL39;DDX54;EXOSC1;EXOSC3;DHX37;NOC4L;TARBP2;PDCD11;RPS14;RPLP2;UTP15;HEATR1;DIS3;DDX52;FARS2;RPL12;RPL28;RPL27A;RRP7A;IMP3;RPL29;RPS9;NOP14;RPL35;RPL37A;SSB;DDX49;EXOSC2;RPL7A;UTP3;UBA52;NOP56;RPL27;NOP58;RPL32;UTP20;RPS19;POP5;POP4;RPL31;RPL35A;TBL3;RPS24;RPL18A;WDR36;NOL6;FCF1;XRN2;RPS16;UTP6;PIH1D1;PWP2;RPS28;INTS5;HNRNPA2B1;RPL11;RPL41;RPS15;RPL23;RPF1;BMS1;ESF1;MPHOSPH6;RPS7;RPL23A;RPL24;THG1L;RRP36;RPL4;RPL30;RPLP1;RPL7;INTS2;RPL13;WDR75;RPL13A;RPL14;LIN28A;RPL15;RPL19
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.7658411913482012,2.547973060589271,0.0,0.0,0.0,11/22,11.82%,ENC1;PSMB2;PSMB9;PSMA5;PSMB3;PSMA3;PSMA7;PSMB5;PSMB4;PSMB1;PSMA4
prerank,mitochondrial translational elongation (GO:0070125),0.6365895753702726,2.524359506737176,0.0,0.0,0.0,59/88,22.66%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;MRPL50;MRPL16;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;TUFM;MRPL9;MRPS30;MRPS34;MRPL36;MRPL4;MRPL51;GFM1;MRPL45;MRPS31;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;GADD45GIP1;MRPS11;MRPL27;MRPL24;MRPS26;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,muscle contraction (GO:0006936),-0.5946683423881512,-2.513834088932069,0.0,0.0,0.0,70/128,17.54%,TPCN2;CACNA1H;SMTN;CRYAB;MYH7;SORBS1;TACR2;MYOM1;MYL9;GNAO1;LMOD1;TPM2;TPM1;MYL2;SGCA;HRC;MYH3;TLN1;MYLK;TMOD2;ACTA1;GJC1;VCL;MYH6;DTNA;DMD;CALD1;KLHL41;MYL7;PABPN1;MYOT;ACTA2;TCAP;TNNT3;PXN;FXYD1;GALR2;ACTN2;ACTN3;MYH2;SORBS3;DES;SCN4A;CALM1;KCNIP2;RYR1;P2RX6;CASQ2;TMOD1;SNTA1;SLC8A1;ADRA1A;SSPN;MYL1;NOS1;ARHGEF11;LMOD2;DYSF;ALDOA;MYL6;SMPX;TRDN;MYBPC1;ACTC1;VIM;ROCK1;MYL3;GAMT;ANKRD2;MYOM2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5964074622935457,2.508701971369719,0.0,0.0,0.0,64/90,28.55%,RPS21;RPL36;RPL8;SEC61B;SRP72;RPS2;RPS18;SEC61A1;RPS3;RPL37;RPS4X;RPL18;RPLP0;RPL39;SRP9;RPS14;RPLP2;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;RPS24;RPL18A;RPS16;RPS29;RPS13;RPS28;RPL11;RPL41;RPS15;RPS8;SRP54;RPS12;RPL23;RPS7;RPL23A;RPL24;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;RPL13A;RPL14;RPS20;RPL15;RPL19;RPS3A;RPL3;RPL34;RPL10A
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.5154810041817659,2.5044627315878585,0.0,0.0,0.0,184/307,27.33%,POLR2F;RFC3;CHEK1;POLR2D;MCM4;FEN1;RPA3;MRPL3;E2F1;RFC5;MCM3;DBF4;CDK1;ORC6;TIPIN;MRPS16;EXO1;TOP1MT;RPS21;POLE2;RFC2;YARS2;POLD2;TIMELESS;RMI1;FARSB;INHBA;MRPL37;RHNO1;MRPL13;FAM111B;MCM5;SET;RMI2;BLM;MRPS12;RPL36;RPL8;TICRR;PTMA;RPS2;RPS18;GRWD1;RECQL4;TOP1;IGF2BP3;RPS3;RPL37;TOPBP1;RAD9B;POLE3;MRPL42;GCNT1;MRPS18B;MRPS33;MCM7;MRPL52;DRG1;DNA2;MRPL11;RPS4X;MCM6;RPL18;TUFM;MRPL9;ORC5;RPLP0;POLA1;RPL39;MRPL36;MCM2;EEF1B2;RPS14;RPLP2;RRBP1;MRPL51;GSPT1;RBBP8;RPL12;RPL28;SRBD1;MRPS18A;TAF1B;RPL27A;COPS5;MCM10;POLR2C;RPL29;RPS9;MRPL18;POLR2K;RPL35;BRCA1;RPL37A;EXT2;HUS1;RPL7A;POLR2J;RPL27;RPL32;RPS11;RPS19;ABCF1;RPA2;MRPS18C;RPL31;POLR2G;POLD1;RPL35A;RPS5;CLSPN;MRPL23;RPS24;RPL18A;ORC2;RNASEH2A;CDC6;RPS16;RPS29;RPS13;MRPS11;MRPL27;RPS28;MRPL24;RPS6KB2;CDC7;CDC45;TOP3A;RFC4;BRIP1;B4GALT5;POLR2H;ORC1;PAX8;RPL11;ALAS1;ORC3;RPL41;RPS15;RPS8;RPS12;RPL23;EEF2;POLR2I;MED20;NFKBIB;POLR2L;CDK2;MRPS15;PWP1;MRPS7;MRPS5;RPS7;POLR3A;RPL23A;RPL24;GAL3ST2;RPL4;BARD1;RNPS1;RPL30;EEFSEC;RPS26;RPLP1;RAD1;ORC4;TERT;RPL7;NKX2-8;POLR2B;RPL13;MRPL28;EXT1;RPL13A;RPL14;ATR;RPS20;PPP5C;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,translational termination (GO:0006415),0.6273082333655057,2.5036349031206404,0.0,0.0,0.0,61/95,22.66%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;ABCE1;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;MRPL50;MRPL16;MRPL42;MRPS18B;APEH;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;MRPL9;MRPS30;MRPS34;MRPL36;TRMT112;MRPL4;MRPL51;MRPL45;MRPS31;GSPT1;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;GADD45GIP1;MRPS11;MRPL27;MRPL24;MRPS26;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,regulation of cellular amine metabolic process (GO:0033238),0.6644866832334602,2.4903525977073238,0.0,0.0,0.0,28/51,14.34%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;ODC1;PSMA3;NQO1;PSMA7;AZIN1;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;OAZ3;PSME1;PSMF1;PSMD11;PSMD1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.7576199528538337,2.482348484597049,0.0,0.0,0.0,21/29,14.14%,RPN1;RPN2;STT3A;ALG8;STT3B;ALG5;MGAT5;DPM2;DDOST;UGGT1;MAGT1;OSTC;FUT8;MGAT2;DPM1;NUDT14;ST6GAL1;DAD1;ASGR1;OST4;UBE2J1
prerank,translation (GO:0006412),0.5590687969634169,2.465607006981652,0.0,0.0,0.0,125/196,27.33%,MRPL3;MRPS16;RPS21;YARS2;ABCE1;AIMP2;FARSB;MRPL37;RPL26L1;RPL22L1;DARS2;MRPL13;ZC3H15;FARSA;MRPS12;RPL36;RPL8;FTSJ1;MRPL47;MARS2;MRPL57;FASTKD2;LARS2;RPS2;RPS18;IGF2BP3;RPS3;RPL37;WARS2;MRPL16;MRPL42;MRPS18B;APEH;MRPS33;MRPL52;DRG1;MRPL11;RPS4X;RPL18;TUFM;QRSL1;MRPL9;RPLP0;MRPS34;RPL39;MRPL36;EEF1B2;PPA1;RPS14;TRMT112;RPLP2;RRBP1;MRPL51;GSPT1;PPA2;FARS2;RPL12;RPL28;SRBD1;MRPS18A;RPL27A;COPS5;RPL29;RPS9;MRPL18;RPL35;RPL37A;AIMP1;GFM2;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;ABCF1;MRPS18C;RPL31;RPL35A;RPS5;MRPS2;MRPL23;NOA1;IARS2;RPS24;RPL18A;RPS16;RPS29;RPS13;MRPS11;MRPL27;RPS28;MRPL24;RPS6KB2;RARS2;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;EEF2;MRPS15;MRPS7;MRPS5;RPS7;RPL23A;RPL24;RPL4;RPL30;EEFSEC;RPS26;RPLP1;RPL7;RPL13;MRPL28;RPL13A;RPL14;RPS20;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,regulation of cardiac conduction (GO:1903779),-0.6841171556794241,-2.4617772517847127,0.0,0.0,0.0,31/54,13.86%,RYR3;TNNI3K;DMPK;NPR2;ATP1B2;ATP2B4;ANK2;ATP1A2;NPR1;FXYD6;TRPC1;CASQ1;FXYD7;ITPR1;FXYD1;STIM1;FXYD2;SLC8A2;RYR1;NPPA;CASQ2;SLC8A1;PRKACA;ATP1A4;NOS1;ATP1A3;ABCC9;RYR2;ATP2B3;SLC8A3;TRDN
prerank,protein N-linked glycosylation (GO:0006487),0.6237516905182257,2.454416258831315,0.0,0.0,0.0,37/66,14.26%,RPN1;RPN2;STT3A;ALG1;ALG8;PMM2;STT3B;ALG5;MGAT5;DPM2;DDOST;UGGT1;MAGT1;OSTC;ALG10;FUT8;SRD5A3;MGAT2;DPM1;ALG3;ALG11;NUDT14;ALG2;GFPT1;ALG14;ST6GAL1;PGM3;SLC39A8;DAD1;DPAGT1;B4GALT7;ASGR1;TMEM165;OST4;TMEM258;UBE2J1;B4GALT1
prerank,mitochondrial translational termination (GO:0070126),0.6331416793807939,2.452037827158542,0.0,0.0,0.0,57/88,22.66%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;MRPL50;MRPL16;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;MRPL9;MRPS30;MRPS34;MRPL36;MRPL4;MRPL51;MRPL45;MRPS31;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;GADD45GIP1;MRPS11;MRPL27;MRPL24;MRPS26;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.6408369076609611,2.451490025372394,0.0,0.0,0.0,28/53,14.34%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;ODC1;PSMA3;NQO1;PSMA7;AZIN1;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;OAZ3;PSME1;PSMF1;PSMD11;PSMD1
prerank,protein targeting to ER (GO:0045047),0.5713249039606894,2.426467028212752,0.0,0.0,0.0,65/101,27.25%,SRPRB;RPS21;RPL36;RPL8;SRP72;RPS2;RPS18;SPCS1;SEC61A1;RPS3;RPL37;SEC61G;RPS4X;RPL18;RPLP0;RPL39;SRP9;RPS14;RPLP2;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;RPS24;RPL18A;RPS16;RPS29;RPS13;SPCS2;RPS28;RPL11;RPL41;RPS15;RPS8;SRP54;RPS12;RPL23;RPS7;RPL23A;RPL24;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;RPL13A;RPL14;RPS20;RPL15;RPL19;RPS3A;RPL3
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.7191740285414634,2.4183555691414766,0.0,0.0,0.0,20/32,17.62%,NUP37;RAN;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;XPOT;NUP50;NUP88;NUP107;NUP205;SSB;NUP62;NUP160;NOL6;NDC1
prerank,tRNA export from nucleus (GO:0006409),0.7191740285414634,2.4183555691414766,0.0,0.0,0.0,20/32,17.62%,NUP37;RAN;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;XPOT;NUP50;NUP88;NUP107;NUP205;SSB;NUP62;NUP160;NOL6;NDC1
prerank,protein-DNA complex assembly (GO:0065004),0.5609961818654555,2.4151633074104777,0.0,0.0,0.0,58/115,20.25%,PSMD14;MCM4;RPA3;CHAF1B;PSMB2;MCM3;ORC6;CHAF1A;PSMB9;PSMA5;CDK7;PSMB3;PSME3;PSMA3;MCM5;GTF2H3;PSMA7;PSMD13;PSME2;PSMC2;GRWD1;PSMC4;PSMD10;PSMD12;SOX9;SPTY2D1;MCM7;HMGB2;ERCC5;PSMB5;MCM6;ORC5;MCM2;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;RAD23B;DDB1;PSME1;PSMF1;NPM1;PSMD11;CDT1;UBA52;PSMD1;RPA2;CUL4A;CENPV;ORC2;GMNN;CDC6;PSMD6;ERCC2;ORC1;PSMD5;ORC3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.593487952653497,2.404735672822623,0.0,0.0,0.0,36/73,22.32%,PSMD14;CALR;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PDIA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;CYBA;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;VAMP8;PSME1;PSMF1;PSMD11;PSMD1;FCGR1A;TAP1;PSMD6;PSMD5;NCF2;PSMC1;HLA-F;CYBB
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.5772634167974695,2.4038623446683287,0.0,0.0,0.0,37/78,22.32%,PSMD14;CALR;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PDIA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;CYBA;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;VAMP8;PSME1;PSMF1;PSMD11;PSMD1;FCGR1A;TAP1;PSMD6;PSMD5;NCF2;PSMC1;HLA-F;MFSD6;CYBB
prerank,cytoplasmic translation (GO:0002181),0.5911068824977938,2.4028586402471905,0.0,0.0,0.0,66/93,28.55%,RPS21;RPL26L1;RPL22L1;ZC3H15;RPL36;RPL8;FTSJ1;EIF3I;RPS2;RPS18;EIF3M;RPS3;RPL37;DRG1;RPS4X;RPL18;RPLP0;RPL39;RPS14;GSPT1;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;RPS24;RPL18A;RPS16;RPS29;RPS13;RPS28;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;RPS7;RPL23A;RPL24;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;RPL13A;RPL14;RPS20;RPL15;RPL19;RPS3A;RPL3;RPL34;RPL10A
prerank,DNA replication (GO:0006260),0.5615438979742067,2.3914618463031654,0.0,0.0,0.0,59/106,20.25%,RFC3;CHEK1;MCM4;FEN1;RPA3;RFC5;MCM3;DBF4;CDK1;ORC6;TIPIN;EXO1;TOP1MT;POLE2;RFC2;POLD2;TIMELESS;RMI1;RHNO1;FAM111B;POLB;MCM5;SET;RMI2;BLM;TICRR;GRWD1;RECQL4;TOP1;TOPBP1;RAD9B;POLE3;WRNIP1;MCM7;DNA2;CDK2AP1;MCM6;WDHD1;ORC5;POLA1;MCM2;RBBP8;MCM10;BRCA1;HUS1;RPA2;POLD1;CLSPN;ORC2;RNASEH2A;CDC6;CDC7;CDC45;TOP3A;MCMBP;RFC4;BRIP1;ORC1;ORC3
prerank,peptidyl-asparagine modification (GO:0018196),0.7319109675717503,2.384123183471873,0.0,0.0,0.0,21/30,14.14%,RPN1;RPN2;STT3A;ALG8;STT3B;ALG5;MGAT5;DPM2;DDOST;UGGT1;MAGT1;OSTC;FUT8;MGAT2;DPM1;NUDT14;ST6GAL1;DAD1;ASGR1;OST4;UBE2J1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.5891711205864313,2.369508352504797,0.0,0.0,0.0,47/83,21.72%,PSMD14;MAD2L1;PSMB2;CDK1;FBXO5;PTTG1;PSMB9;PSMA5;SKP2;PSMB3;UBE2S;PSME3;PSMA3;BUB3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;AURKB;PSMD12;ANAPC1;PSMB5;UBE2C;AURKA;PSMD8;CDC26;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;ANAPC11;PLK1;PSMD11;UBA52;PSMD1;PSMD6;CDC20;BUB1B;UBE2D1;PSMD5;CUL3;CDK2;PSMC1
prerank,ncRNA export from nucleus (GO:0097064),0.662337721133315,2.3399118928298654,0.0,0.0,0.0,22/36,17.62%,NUP37;RAN;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;XPOT;NUP50;NUP88;NUP107;NCBP2;NUP205;SSB;NPM1;NUP62;NUP160;NOL6;NDC1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.7317168395570682,2.3223811519321815,0.0,0.0,0.0,20/24,20.20%,NARS2;YARS2;EARS2;AIMP2;FARSB;DARS2;FARSA;MARS2;LARS2;TARS2;WARS2;PARS2;PPA1;PPA2;FARS2;AIMP1;IARS2;AARS2;RARS2;CARS2
prerank,peptide biosynthetic process (GO:0043043),0.5370531810862953,2.319636338314694,0.0,0.0,0.0,94/155,27.33%,MRPL3;RHCE;MRPS16;RPS21;YARS2;FARSB;MRPL37;MRPL13;MRPS12;RPL36;RPL8;RPS2;RPS18;IGF2BP3;RPS3;RPL37;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;PCSK1;RPS4X;RPL18;MRPL9;RPLP0;RPL39;MRPL36;GGTLC2;RPS14;RPLP2;RRBP1;MRPL51;GSPT1;RPL12;RPL28;SRBD1;MRPS18A;RPL27A;COPS5;RPL29;RPS9;MRPL18;RPL35;RPL37A;RPL7A;RPL27;RPL32;RPS11;RPS19;ABCF1;MRPS18C;RPL31;RPL35A;RPS5;MRPL23;RPS24;RPL18A;RPS16;RPS29;RPS13;MRPS11;MRPL27;RPS28;MRPL24;RPS6KB2;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;MRPS15;MRPS7;MRPS5;RPS7;RPL23A;RPL24;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;MRPL28;RPL13A;RPL14;RPS20;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,regulation of heart contraction (GO:0008016),-0.5964365984180604,-2.31677327630415,0.0,0.0,0.0,49/90,17.43%,RYR3;CACNA1H;TNNI3K;DMPK;NPR2;ATP1B2;ATP2B4;TPM1;ANK2;HRC;ATP1A2;NPR1;FXYD6;TRPC1;MYH6;CASQ1;FXYD7;HSPB7;ITPR1;FXYD1;STIM1;FXYD2;DES;SLC8A2;CALM1;PDE4D;KCNIP2;PLN;RYR1;NPPA;CASQ2;SLC8A1;PRKACA;ATP1A4;NOS1;ATP1A3;ABCC9;RNF207;FOXN4;CELF2;RYR2;ATP2B3;SLC8A3;ADORA3;TRDN;TBX2;CAMK2D;ASB3;NPPC
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.7837247885033143,2.300185511852964,0.0,0.0,0.0,14/18,15.51%,RUVBL1;DKC1;CCT6A;CCT2;CCT3;RUVBL2;CCT8;CCT7;SHQ1;NAF1;NOP10;NHP2;CCT4;TCP1
prerank,maturation of SSU-rRNA (GO:0030490),0.6911708303035528,2.297889821080305,0.0,0.0,0.0,27/32,23.85%,NOB1;DCAF13;WDR3;NOL10;NAT10;NOL11;WDR46;SRFBP1;DHX37;RPS14;HEATR1;DDX52;NOP14;LSM6;UTP3;RPS19;RPS16;UTP6;MRPS11;PWP2;RPS28;RIOK1;RPS8;TSR1;BMS1;RRP36;RIOK2
prerank,regulation of cation channel activity (GO:2001257),-0.5898209652513686,-2.286494679676557,0.0,0.0,0.0,46/87,17.38%,PRRT1;VAMP2;AHNAK;NLGN2;CACNB2;ANK2;HRC;JPH2;DMD;DLG2;JPH4;PIRT;GRIA4;ACTN2;CAMK2A;ANK3;SLMAP;LRRC7;CALM1;PDE4D;DLG4;GRIA1;NLGN1;CACNB1;GSG1L;PRKACA;GRIA3;DAPK1;NOS1;KCNE2;GRIA2;FGF12;SHISA7;JPH3;STAC;MEF2C;KCNE1;CACNG7;FGF13;RELN;CAMK2B;CNIH2;NEFL;CAMK2D;CRHBP;GRIN2A
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5615379689596217,2.2811145829959245,0.0,0.0,0.0,32/71,14.34%,PSMD14;OSM;PSMB2;TP73;PUS7;PSMB9;PSMA5;CBFB;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PRKDC;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;TCF3;RUNX1;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;YTHDF2;PSMD1
prerank,myofibril assembly (GO:0030239),-0.691896781668507,-2.2792912809131955,0.0,0.0,0.0,27/42,15.02%,CSRP1;CFLAR;LMOD1;MYOZ2;PGM5;TPM1;MYL2;MYH3;TMOD2;MYH6;CASQ1;KLHL41;CAPN3;TCAP;TNNT3;ACTN2;PDGFRA;TMOD1;OBSCN;OBSL1;LMOD2;MYOZ1;CSRP2;CSRP3;FLII;ACTC1;FHOD3
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.6192394261000278,2.2765403295357065,0.0,0.0,0.0,44/58,26.26%,NIP7;WDR12;EMG1;MRTO4;EBNA1BP2;BYSL;NOP16;RPL26L1;URB2;PES1;BOP1;RRS1;TGS1;PAK1IP1;SHQ1;GTF3A;DDX31;NAF1;ZNF622;NOC2L;WDR74;MRPL36;DHX37;RPF2;HEATR3;NOP14;NPM1;MALSU1;RPS19;CUL4A;RPL35A;RPS24;RPS16;RPS28;RIOK1;RPL11;RPS15;SURF6;RPS7;RRP36;RIOK2;RPL7;NOM1;RPL14
prerank,muscle organ development (GO:0007517),-0.6529466324864144,-2.27338017894688,0.0,0.0,0.0,29/55,13.31%,POU6F1;CACNA1H;ITGA7;SPEG;FHL1;SMTN;BVES;SGCA;MYH3;MYH6;DMD;MEF2D;LAMA2;CAPN3;SGCG;ITGB1BP2;SGCE;MEF2A;CTF1;CHD2;MEF2B;TCF21;TBX1;FHL3;MSTN;CHODL;MEF2C;EVC;SGCD
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.7378971711914457,-2.262819007406867,0.0,0.0,0.0,18/23,17.79%,GSTM2;CACNA1C;ANK2;HRC;ATP1A2;AKAP6;CASQ1;DMD;CALM1;PDE4D;CASQ2;SLC8A1;PRKACA;RYR2;TRDN;CLIC2;CAMK2D;DHRS7C
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.5548706836848475,2.2623332126443856,0.0,0.0,0.0,33/75,14.34%,PSMD14;OSM;PSMB2;TP73;PUS7;PSMB9;PSMA5;CBFB;PSMB3;PSME3;PSMA3;PSMA7;PDCD2;PSMD13;PSME2;PRKDC;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;TCF3;RUNX1;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;YTHDF2;PSMD1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5470476212397288,2.26118940484169,0.0,0.000277407626756161,0.01,74/112,27.25%,RPS21;PABPC1;MAGOH;RPL36;RPL8;MAGOHB;EIF4A3;RPS2;NCBP1;RPS18;RPS3;HELZ2;RPL37;RPS4X;RPL18;RPLP0;RPL39;RPS14;RPLP2;NCBP2;GSPT1;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;EIF3E;RPS24;RPL18A;RPS16;RPS29;RPS13;SMG8;RPS28;RBM8A;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;RPS7;RPL23A;RPL24;RPL4;RNPS1;RPL30;RPS26;RPLP1;RPL7;DHX34;PPP2R2A;PPP2CA;RPL13;RPL13A;RPL14;SMG7;RPS20;RPL15;RPL19;RPS3A;PPP2R1A;RPL3
prerank,translational elongation (GO:0006414),0.5735162883044463,2.255093711546244,0.0,0.00027064158707918145,0.01,61/101,22.66%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;MRPL50;MRPL16;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;TUFM;MRPL9;MRPS30;MRPS34;MRPL36;EEF1B2;MRPL4;MRPL51;GFM1;MRPL45;MRPS31;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;GADD45GIP1;MRPS11;MRPL27;MRPL24;MRPS26;EEF2;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.7947115185525201,2.24040757339978,0.0,0.0005283954795355447,0.02,12/18,9.48%,RFC3;MCM4;GINS4;GINS1;MCM3;GINS2;POLD2;MCMDC2;LIG1;POLE3;MCM7;POLA1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.8417322050334876,2.233680646314376,0.0,0.0005161072125696018,0.02,14/15,15.51%,RUVBL1;DKC1;CCT6A;CCT2;CCT3;RUVBL2;CCT8;CCT7;SHQ1;NAF1;NOP10;NHP2;CCT4;TCP1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6636487687953625,2.2304242910670435,0.0,0.0007565662547895298,0.03,23/28,23.74%,DCAF13;RPS21;RPP40;ABT1;RRS1;NOL10;WDR46;DHX37;RPS14;HEATR1;NOP14;UTP3;UTP20;RPS19;TBL3;RPS16;UTP6;MRPS11;PWP2;RPS8;TSR1;BMS1;RRP36
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5698365062303437,2.227193416217488,0.0,0.0007397536713497625,0.03,29/64,14.34%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;ODC1;PSMA3;NQO1;PSMA7;AZIN1;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;FGFR4;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;OAZ3;PSME1;PSMF1;PSMD11;PSMD1
prerank,nucleocytoplasmic transport (GO:0006913),0.6309063696751834,2.2226991417627637,0.0,0.0007236720697986808,0.03,27/40,24.26%,SNRPF;NXT2;SNRPD1;SNRPG;SNRPB;ANP32A;NUTF2;RITA1;SNRPD2;NCBP1;SNRPE;RSRC1;NXT1;GEMIN6;NCBP2;NUP205;NPM1;HTATIP2;SMN1;LSG1;SNRPD3;HNRNPA1;RBM15B;GEMIN2;GEMIN5;RGS14;GEMIN4
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5845429832477281,2.2181995184410797,0.0,0.0007082747917178578,0.03,26/52,21.38%,CXCL5;CXCL8;CXCL3;CXCL1;CXCL11;ROMO1;CXCL2;GAPDH;DEFA6;REG1A;PF4;RPL39;CXCL9;CXCL10;CXCL6;SEMG1;RPS19;GNLY;PF4V1;PGLYRP4;REG1B;ANG;PGLYRP3;HMGN2;CXCL13;RNASE7
prerank,regulation of striated muscle contraction (GO:0006942),-0.6956051079337549,-2.206618046650756,0.0,0.0,0.0,18/26,22.99%,TNNI3K;MYL2;ANK2;ATP1A2;DMD;TNNT3;CALM1;PRKACA;NOS1;RNF207;RYR2;SLC8A3;MYL3;ASB3;MYBPC3;SMAD7;CAV3;CALM2
prerank,maturation of LSU-rRNA (GO:0000470),0.6762972109394303,2.19977812488551,0.0,0.0006935190668904025,0.03,20/25,28.93%,WDR12;NIFK;RPL7L1;PES1;BOP1;DDX18;RSL1D1;EIF6;RPF2;NHP2;RPL35;RPL7A;MRPL1;ZNHIT3;RPF1;MAK16;RPL7;URB1;RPL10A;RRP15
prerank,sarcomere organization (GO:0045214),-0.7020896854900089,-2.1997739376911514,0.0,0.0,0.0,19/27,20.37%,CSRP1;MYOZ2;TPM1;MYH3;MYH6;CASQ1;CAPN3;TCAP;TNNT3;ACTN2;OBSCN;LMOD2;MYOZ1;CSRP2;CSRP3;FHOD3;MYOM2;ANKRD1;MYLK3
prerank,DNA strand elongation (GO:0022616),0.7721878742007179,2.1994935595493113,0.0,0.0006793656165457004,0.03,11/17,9.48%,RFC3;MCM4;GINS4;GINS1;MCM3;GINS2;POLD2;DCLRE1B;MCMDC2;MCM7;POLA1
prerank,regulation of mRNA catabolic process (GO:0061013),0.5206652570680839,2.1981087703063262,0.0,0.0006657783042147863,0.03,51/122,14.34%,PSMD14;EXOSC5;PSMB2;PSMB9;PSMA5;PABPC1;PSMB3;PSME3;PSMA3;SET;YWHAB;EXOSC4;SERBP1;IGF2BP1;PSMA7;KHSRP;PSMD13;ANP32A;PNPT1;EXOSC8;PSME2;PSMC2;PSMC4;YTHDF1;PSMD10;IGF2BP3;PSMD12;EXOSC7;PSMB5;IGF2BP2;APEX1;PKP1;EXOSC1;CARHSP1;EXOSC3;PSMD8;MAPKAPK2;DIS3;PSMB4;PSMD3;PSMB1;PSMA4;ELAVL1;EXOSC2;PSME1;PSMF1;PSMD11;YTHDF2;PKP3;UBA52;PSMD1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.6260995591303272,2.1802189195212995,0.0,0.0006527238276615552,0.03,41/54,28.93%,NIP7;WDR12;MRTO4;EBNA1BP2;NOP16;BRIX1;RPL26L1;NLE1;PES1;BOP1;RRS1;PAK1IP1;GTF3A;RSL1D1;ZNF622;EIF6;NOC2L;WDR74;RPLP0;RPF2;HEATR3;NHP2;RPL7A;NPM1;MALSU1;MRPL1;RPL35A;TRAF7;RPL11;RPF1;MAK16;SURF6;RPL23A;RPL24;RPL7;RPL14;MRPL20;RPL3;SDAD1;RPL10A;RRP15
prerank,DNA metabolic process (GO:0006259),0.47165548509606575,2.1660301833352578,0.0,0.0006401714463603714,0.03,113/266,18.91%,RFC3;CHEK1;MCM4;UBE2T;FEN1;RPA3;RNASEH1;RAN;TSN;XRCC2;RFC5;MCM3;TDP1;DBF4;CDK1;PRIM2;ORC6;RAD51AP1;EXO1;TOP1MT;POLE2;RFC2;POLD2;TIMELESS;NUDT1;POLH;UBE2N;UNG;POLB;MCM5;DCLRE1B;DCTPP1;NUDT15;GLRX2;RMI2;BLM;HMGB3;NTHL1;PRIM1;XRCC5;GTF2H3;SMARCB1;TICRR;RAD18;NABP2;AXIN2;DDX21;ZRANB3;PRKDC;INIP;RECQL4;TOP1;DNMT1;NEIL3;TOPBP1;RAD9B;LIG1;MSH3;POLE3;FANCL;MCM7;HMGB2;DNA2;ERCC5;MCM6;APEX1;PARP4;UHRF1;RAD51B;WDHD1;ORC5;RAD54L;POLA1;PTGES3;MCM2;RBBP8;TOP3B;LONP1;MCM10;DDB1;MPG;BRCA1;HUS1;MSH6;NPM1;SMC1A;CDT1;UBA52;KPNA2;VCP;RPA2;POLD1;DNASE1L1;TOP2A;UBE2A;LRWD1;FANCA;SUMO1;ENDOG;ORC2;FBXO6;RNASEH2A;DNASE2;REXO4;GMNN;LIG3;CDC6;RAG1;CDC7;NOC3L;CDC45;TOP3A;FANCC
prerank,double-strand break repair via homologous recombination (GO:0000724),0.5250211393041854,2.1547701988865704,0.0,0.0006280927398252701,0.03,41/94,18.84%,RAD54B;PSMD14;RFWD3;MCM4;GINS4;FEN1;RPA3;FANCB;XRCC2;MCM3;RAD51AP1;GINS2;RMI1;UBE2N;MCM5;BLM;MMS22L;NABP2;MCMDC2;RECQL4;SFR1;PALB2;TONSL;MCM7;ERCC5;MCM6;RAD51B;RAD54L;MCM2;RBBP8;BRCA2;BRCA1;HUS1;NSMCE2;RPA2;RAD51AP2;NSMCE1;LIG3;SWSAP1;CDC7;CDC45
prerank,actomyosin structure organization (GO:0031032),-0.5542654878960733,-2.145630229354904,0.0,0.0009163486643904399,0.01,34/75,17.54%,CSRP1;SORBS1;LMOD1;MYOZ2;PGM5;TPM1;MYH3;TMOD2;MYH6;CASQ1;KLHL41;CAPN3;TCAP;TNNT3;ACTN2;CDC42BPA;TMOD1;OBSCN;EPB41L3;CDC42BPB;LMOD2;TJP1;FRMD6;MYOZ1;CSRP2;CSRP3;FLII;RHOA;ACTC1;FHOD3;PDLIM1;ROCK1;FRMD3;MYOM2
prerank,tRNA processing (GO:0008033),0.5490176318297848,2.142503742556228,0.0,0.0008219485237219586,0.03,28/56,19.41%,CSTF2;WDR4;RPP40;POP1;METTL1;TRMT10C;FTSJ1;ADAT1;DTWD2;POP7;TRUB1;TRMT6;CLP1;FARS2;TSEN54;SSB;CDKAL1;FAM98B;POP5;NSUN2;TSEN34;ANKRD16;CTU2;AARS2;CPSF4;TRNT1;URM1;RTCB
prerank,synapse organization (GO:0050808),-0.4988027788480713,-2.135655772221498,0.0,0.0008330442403549453,0.01,52/125,17.70%,NLGN2;PDZRN3;CACNB2;KIRREL3;DCTN1;MAPT;CTNND2;CNTN2;NLGN3;PTPRS;MYOT;SLITRK2;NRXN1;NLGN4X;ANK3;DNER;SLC8A2;SHANK3;SNCA;LRFN5;NLGN1;L1CAM;CACNB1;GPM6A;SNCB;LRRC4B;SDK1;ADGRL3;PSEN1;SLITRK3;OBSL1;PTEN;PPFIA4;UNC13C;LRRK2;NRXN2;NTNG1;SEMA3E;PCDHB4;SNCG;LRRC4C;CBLN2;PPFIBP1;SLC8A3;PCDHB6;CDH2;MUSK;PCDHB5;ZC4H2;SLC6A1;DSCAM;APBB2
prerank,mitochondrial gene expression (GO:0140053),0.6437945463930373,2.132695616204809,0.0,0.000807004005108832,0.03,26/40,22.50%,MRPS16;TFB2M;MRPS12;TFAM;MRPL47;MRPL57;FASTKD2;LARS2;MRPL16;MRPS18B;QRSL1;MRPS34;MRPL51;MRPS18A;GFM2;SLC25A33;MRPS2;MRPL23;NOA1;IARS2;FASTKD5;TEFM;MRPS11;RARS2;MRPS15;MRPS7
prerank,DNA replication checkpoint signaling (GO:0000076),0.7137822428287802,2.13018459648516,0.0,0.0007925932193033171,0.03,13/17,19.87%,TIPIN;TIMELESS;TICRR;TOPBP1;RAD9B;DNA2;NAE1;HUS1;CDT1;CLSPN;CDC6;CDC45;ORC1
prerank,regulation of potassium ion transport (GO:0043266),-0.6948435830273937,-2.1268700852496645,0.0,0.0007636238869920333,0.01,18/31,16.82%,FHL1;DPP6;KCNIP3;ANK2;KCNA5;KCNIP4;ACTN2;ANK3;KCNIP2;KCNH2;CASQ2;NOS1;KCNE2;KCNAB3;VIP;KCNE1;KCNIP1;CD63
prerank,tRNA aminoacylation (GO:0043039),0.7143196957810941,2.1235370207807076,0.0,0.0007786880751050133,0.03,15/20,19.84%,YARS2;AIMP2;FARSB;DARS2;FARSA;MARS2;LARS2;WARS2;QRSL1;PPA1;PPA2;FARS2;AIMP1;IARS2;RARS2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.628716854247459,2.1188746131575567,0.0,0.0007652624186376855,0.03,26/37,23.85%,NOB1;WDR3;EMG1;NOL11;SRFBP1;RPS14;DDX52;RRP7A;ERAL1;NOP14;NPM1;LSM6;RPS19;RPS5;RPS24;RPS16;MRPS11;PWP2;RPS28;RIOK1;RPS15;SURF6;MRPS7;RPS7;RRP36;RIOK2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5929308506312712,-2.1058974459542794,0.0,0.000704883587992646,0.01,27/56,17.38%,PRRT1;LYNX1;NPTX1;NLGN2;DLG2;GRIA4;ACTN2;CAMK2A;LRRC7;DLG4;DLGAP2;GRIA1;NLGN1;GSG1L;GRIA3;DAPK1;NPTXR;GRIA2;SHISA7;MEF2C;CACNG7;RELN;CAMK2B;CNIH2;NEFL;CRHBP;GRIN2A
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.7181675252104215,-2.095523014194946,0.0,0.0006545347602788855,0.01,16/26,14.21%,NLGN2;STX1B;NLGN3;NRXN1;NLGN4X;TMEM25;SLC8A2;CUX2;SHANK3;DLG4;TMEM108;NLGN1;PTEN;LRRK2;SLC8A3;RELN
prerank,neuronal action potential (GO:0019228),-0.6944006104393543,-2.0922089001779995,0.0,0.0006108991095936266,0.01,13/22,12.78%,CACNA1H;SCN7A;SCN9A;ANK3;GPER1;SCN4A;SCN11A;KCNA2;CACNA1G;KCNA1;KCNMB2;KCNMB4;SCN3A
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.7420846268704948,-2.08878190197348,0.0,0.0005727179152440249,0.01,13/17,15.81%,GSTM2;CACNA1C;ANK2;HRC;ATP1A2;DMD;CALM1;CASQ2;SLC8A1;PRKACA;RYR2;CLIC2;CAMK2D
prerank,regulation of gene silencing by RNA (GO:0060966),0.5836125679915103,2.081199971084308,0.0,0.0018493841783744063,0.09,26/49,21.64%,POLR2F;NUP37;POLR2D;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;NUP50;NUP88;NUP107;TRIM71;POLR2C;POLR2K;NUP205;POLR2J;NUP62;POLR2G;NUP160;NDC1;POLR2H;POLR2I;POLR2L
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5836125679915103,2.081199971084308,0.0,0.0018493841783744063,0.09,26/49,21.64%,POLR2F;NUP37;POLR2D;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;NUP50;NUP88;NUP107;TRIM71;POLR2C;POLR2K;NUP205;POLR2J;NUP62;POLR2G;NUP160;NDC1;POLR2H;POLR2I;POLR2L
prerank,positive regulation of cation channel activity (GO:2001259),-0.637478475021001,-2.0695994144513126,0.0,0.0005390286261120234,0.01,21/38,14.21%,GSTM2;ANK2;AKAP6;JPH2;PKD2;CASQ1;NLGN3;HAP1;PIRT;GALR2;ACTN2;ANK3;CALM1;KCNIP2;SHANK3;ADRB2;STAC2;STAC;LRRC55;TRDN;RELN
prerank,regulation of gene silencing by miRNA (GO:0060964),0.5486632019349716,2.0683536864219305,0.0,0.002000973045454276,0.1,31/60,21.64%,POLR2F;NUP37;POLR2D;NUP155;RAE1;NUP93;NUP35;AJUBA;SEH1L;SEC13;NUP210;NUP43;DHX9;NUP50;NUP88;NUP107;TRIM71;POLR2C;ELAVL1;POLR2K;NUP205;POLR2J;NUP62;POLR2G;PPARG;NUP160;TGFB1;NDC1;POLR2H;POLR2I;POLR2L
prerank,spliceosomal snRNP assembly (GO:0000387),0.5794936002968802,2.063388242600521,0.0,0.0021476719490799556,0.11,18/38,16.27%,SNRPF;CLNS1A;SNRPD1;PRPF19;LSM4;SNRPG;WDR77;TGS1;SNRPB;SNRPC;SNRPD2;SNRPE;PRPF6;LSM2;GEMIN6;STRAP;COIL;SMN1
prerank,membrane depolarization during action potential (GO:0086010),-0.6981755468276032,-2.051454944652292,0.0,0.0010181651826560443,0.02,15/26,12.78%,CACNA1H;CACNA1C;ATP1A2;SCN7A;SCN3B;SCN9A;SCN4A;KCNH2;SCN11A;SCN2B;SCN1B;SLC8A1;SCN4B;CACNA1G;SCN3A
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.5714881868082052,2.047829585531344,0.0,0.0024658455711658754,0.12,20/47,12.37%,TOMM34;RALA;HSPD1;TIMM23;GRPEL1;ROMO1;BCAP31;TOMM40;TIMM10;GRPEL2;TIMM13;TOMM22;TOMM20;TIMM50;TIMM17B;TIMM8B;TOMM20L;AIFM1;TSPO;DNAJC15
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5264710506116738,2.047395557504894,0.0,0.0024273167341164084,0.12,29/65,14.34%,PSMD14;CHEK1;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;NABP2;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;AURKB;PSMD12;CHMP4C;PSMB5;AURKA;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5296450898761883,2.046569653055642,0.0,0.0023899733997453866,0.12,25/56,14.34%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;AURKA;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.5147100425025166,2.0459412237080823,0.0,0.0025218875159650996,0.13,36/74,20.34%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PSMC2;CARD14;PSMC4;PSMD10;PSMD12;PSMB5;TNFSF15;RELA;IRAK1;PSMD8;TNFRSF10B;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;TRAF2;PSMD1;NFKB2;PSMD6;CARD10;CHI3L1;PSMD5;TNFRSF10A
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5708216694750251,-2.041522242195279,0.0,0.0014468663121954314,0.03,28/56,17.91%,PKD1;IGSF11;PALLD;PLXNB3;TRO;KIRREL3;ROBO3;CNTN2;DSCAML1;MYOT;PTPRM;NEXN;CADM3;AMIGO1;L1CAM;SDK1;OBSL1;NPTN;CADM1;TENM3;PCDHB6;CDH2;CNTN4;HMCN1;ROBO4;DSCAM;AMIGO2;CNTN6
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.4560690147761303,2.037423833503184,0.0,0.002649863897372284,0.13,93/163,27.25%,POLR2D;DCPS;EXOSC5;MRTO4;RPS21;PABPC1;MAGOH;EXOSC4;RPL36;RPL8;MAGOHB;EIF4A3;RPS2;NCBP1;RPS18;EXOSC8;CNOT11;RPS3;HELZ2;RPL37;CNOT10;EXOSC7;RPS4X;PDE12;RPL18;RPLP0;RPL39;RPS14;RPLP2;NCBP2;GSPT1;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;PATL1;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;POLR2G;CNOT1;RPL35A;RPS5;EIF3E;RPS24;RPL18A;XRN2;RPS16;RPS29;RPS13;SMG8;RPS28;RBM8A;ERI1;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;ZC3H12A;MTPAP;RPS7;RPL23A;RPL24;RPL4;RNPS1;CNOT6;RPL30;RPS26;LSM1;RPLP1;RPL7;DHX34;PPP2R2A;PPP2CA;RPL13;RPL13A;RPL14;SMG7;RPS20;RPL15;RPL19;RPS3A;PPP2R1A;RPL3
prerank,purine-containing compound biosynthetic process (GO:0072522),0.6568206235413876,2.036367957601081,0.0,0.0026108953106462208,0.13,11/26,6.42%,PAICS;PPAT;HPRT1;SHMT2;GART;MTHFD1;ADK;DCK;PNP;GMPS;APRT
prerank,cholesterol biosynthetic process (GO:0006695),0.657224357634529,2.0345578798361275,0.0,0.0025730562481730873,0.13,20/31,22.36%,CYP51A1;SQLE;NSDHL;DHCR7;SC5D;IDI2;FDPS;ACAT2;MSMO1;DHCR24;TM7SF2;ACLY;HMGCS1;G6PD;INSIG1;FDFT1;MVK;EBP;IDI1;HMGCR
prerank,regulation of cell cycle phase transition (GO:1901987),0.4935181582787083,2.02892590320052,0.0,0.0026948169456312778,0.14,45/93,20.01%,PSMD14;MAD2L1;PSMB2;TFAP4;DBF4;CDK1;FBXO5;PSMB9;PSMA5;PSMB3;UBE2S;PSME3;PSMA3;GTSE1;BUB3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;ANAPC1;PSMB5;UBE2C;PSMD8;CDC26;PSMB4;PSMD3;PSMB1;PSMA4;DDB1;PSME1;PSMF1;ANAPC11;PLK1;PSMD11;PSMD1;SIX3;PSMD6;CDC20;BUB1B;ERCC2;UBE2D1;PSMD5
prerank,ribosomal small subunit assembly (GO:0000028),0.7486471880848422,2.025885820836659,0.0,0.0028131477642878294,0.15,13/16,22.50%,ABT1;XRCC5;PRKDC;RPS14;RRP7A;ERAL1;RPS19;RPS5;MRPS11;PWP2;RPS28;RPS15;MRPS7
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.681086797439745,2.0179550779834416,0.0,0.003040083580889435,0.17,16/26,13.88%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;CENPQ;MIS18BP1;NPM1
prerank,CENP-A containing chromatin organization (GO:0061641),0.681086797439745,2.0179550779834416,0.0,0.003040083580889435,0.17,16/26,13.88%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;CENPQ;MIS18BP1;NPM1
prerank,tRNA modification (GO:0006400),0.49954665880912663,2.016542452958249,0.0,0.003148951438853719,0.18,31/60,23.69%,METTL2A;PUS7;WDR4;MOCS3;METTL1;PUS10;FTSJ1;PUS1;DTWD2;METTL6;TRUB1;THUMPD3;TRMT6;TRMT112;SSB;CDKAL1;TPRKB;TYW1;TRMT61B;NSUN2;ANKRD16;DUS2;PUSL1;CTU2;AARS2;METTL2B;URM1;TRMT5;TRMT10A;TRMT12;THG1L
prerank,protein targeting to mitochondrion (GO:0006626),0.5617972753002054,2.012311075737997,0.0,0.003106965419669003,0.18,22/53,12.37%,TOMM34;TIMM8A;HSPD1;TIMM23;MIPEP;GRPEL1;ROMO1;BCAP31;TOMM40;TIMM10;GRPEL2;TIMM13;TOMM22;TOMM20;TIMM50;TIMM17B;TIMM8B;TOMM20L;AIFM1;HSPA4;TSPO;DNAJC15
prerank,cellular amide metabolic process (GO:0043603),0.4663380083220368,2.0120283424253835,0.0,0.0030660842957259894,0.18,50/99,25.70%,NLN;SHMT2;MTHFD1;MTHFD1L;MIPEP;DHFR;SLC5A6;PDZD11;HLCS;CPZ;CPD;DNPEP;SLC19A1;MME;MCCC2;PCCB;SMPD2;ACSL6;BAAT;THEM5;ACOT7;DBI;MTHFD2;ST6GAL1;CPN1;ACOT13;ORMDL3;AASDHPPT;PLA2G4E;VNN1;FUT7;THOP1;SGPL1;ACOT4;ACOT8;OXSM;ORMDL2;BTD;FPGS;PCCA;CPXM1;PLA2G15;ASAH2;FUT6;VNN3;SHMT1;SLC46A1;ABCA12;PPP2CA;FUT3
prerank,chromatin remodeling at centromere (GO:0031055),0.6536730052311602,2.0098922028960917,0.0,0.0030262650191581197,0.18,17/28,15.70%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;CENPQ;MIS18BP1;NPM1;CENPV
prerank,cAMP-mediated signaling (GO:0019933),-0.6526272698251738,-2.00340459299878,0.0,0.00503991765414742,0.09,11/24,10.83%,PDE2A;ADCY2;CAP2;AKAP6;RAPGEF3;MAPK7;PDE4D;PDE7B;KSR1;EPHA5;PDE3A
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.4541583513219333,-1.9995986010349212,0.0,0.005236278082231085,0.1,112/240,26.63%,MPZ;NOVA1;KCNMB1;NPTX1;NLGN2;CACNB2;PLP1;PTCHD1;DTNA;SLC12A4;NLGN3;MYCBPAP;DLG2;KIF5A;HAP1;KCNK3;PMP22;GRIA4;NRXN1;NLGN4X;ATXN3;CALM1;KCNIP2;PAFAH1B1;DLG4;SYT10;AMPH;SNCA;SCN2B;GRIA1;NLGN1;CACNB1;GRIK2;SYN2;CORT;RPS6KA2;SNCB;PDE7B;RAPSN;CAMK1;PRKACA;CHRM2;GRIA3;CHRNA3;PENK;HTR3A;GRIA2;UNC13C;NTSR1;NRXN2;SNAP25;GLRB;KCNA1;PCDHB4;SLC18A3;SNCG;PRKAR2B;SLC1A2;SYT5;SYNJ2BP;CHRNB4;KCNMB4;MAPK1;NPFF;RIT2;NPY;PCDHB6;APBA1;HTR2B;PCDHB5;BSN;SLC6A1;NLGN4Y;GRIN2A;CACNA1A;HTR4;SST;GABRG1;GABRG2;CACNA1B;SYN1;CAMKK1;CHRM5;CAMKK2;KCNN1;HTR1E;CHRM3;HTR7;PCDHB3;LRP6;SYT1;DRD4;PCDHB2;CPNE6;PCDHB10;GABRA1;CHRNA10;HTR2A;CACNB3;GABARAP;GRIK1;CACNB4;PRKAR1A;CNP;HTR5A;GRM3;GABRA5;KCNC4;PCDHB14;KCNQ3;AKAP9;HTR3B
prerank,regulation of mRNA stability (GO:0043488),0.45639537859288326,1.9974868618128367,0.0,0.0029874667496817336,0.18,55/139,14.34%,PSMD14;E2F1;EXOSC5;PSMB2;PSMB9;PSMA5;PABPC1;PSMB3;PSME3;PSMA3;SET;YWHAB;EXOSC4;SERBP1;IGF2BP1;PSMA7;KHSRP;PSMD13;ANP32A;TBRG4;AXIN2;EXOSC8;PSME2;PSMC2;PSMC4;YTHDF1;PSMD10;IGF2BP3;PSMD12;EXOSC7;PSMB5;IGF2BP2;APEX1;PDE12;EXOSC1;CARHSP1;EXOSC3;PSMD8;MEX3D;MAPKAPK2;DIS3;PSMB4;PSMD3;PSMB1;PSMA4;FUS;ELAVL1;EXOSC2;PSME1;PSMF1;NPM1;PSMD11;YTHDF2;UBA52;PSMD1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.5838946032668556,1.997180641273882,0.0,0.002949650714875636,0.18,18/34,22.62%,RFC3;FEN1;RPA3;RFC5;RFC2;POLD2;UNG;POLB;NTHL1;LIG1;APEX1;MPG;RPA2;POLD1;LIG3;RFC4;SMUG1;TDG
prerank,mitotic sister chromatid segregation (GO:0000070),0.4734540734955104,1.9935985740663866,0.0,0.003190187707695851,0.19,51/96,22.30%,NCAPD3;RAN;DSN1;KIF18A;CDK1;CDCA5;SMC2;KNSTRN;CEP55;CENPE;NCAPD2;KIF23;SET;RRS1;NCAPG;SPDL1;ZWINT;NDC80;KIF14;CENPK;SMC4;SEH1L;DLGAP5;KIF22;SPAG5;PSRC1;RAB11A;CHMP4C;CSNK2A1;ZW10;NAA50;KIF2C;EML4;NSL1;NCAPG2;KPNB1;PLK1;SMC1A;TUBG1;NUP62;KIF18B;NCAPH;ESPL1;CHMP5;CHMP2B;PDS5A;WRAP73;CHMP1A;CUL3;CDCA8;KIFC1
prerank,heart contraction (GO:0060047),-0.5931112340147559,-1.9897440318141029,0.0,0.005831309682484617,0.12,27/40,23.29%,MYH7;TPM1;MYL2;ATP1A2;MYH6;DMD;TCAP;SGCG;SCN3B;KCNH2;SCN2B;SCN1B;CASQ2;SLC8A1;SCN4B;RYR2;SGCD;CSRP3;TRDN;ACTC1;MYL3;SCN5A;MYBPC3;SOD1;TTN;MYLK2;MYL4
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.6740143760977734,-1.9896937791559188,0.0,0.005577774478898329,0.12,13/22,15.81%,ANK2;HRC;ATP1A2;CASQ1;CACNA2D1;NPPA;CASQ2;CACNB1;PRNP;NOS1;TRDN;PSEN2;CAMK2D
prerank,chemical synaptic transmission (GO:0007268),-0.43908485810951203,-1.9892555634442823,0.0,0.005345367208944233,0.12,135/301,24.72%,VAMP2;MPZ;GRIK5;GRIK3;NOVA1;KCNMB1;RIC3;NPTX1;NLGN2;CACNB2;BRSK1;PLP1;PTCHD1;SLC17A7;DTNA;SLC12A4;NLGN3;MYCBPAP;DLG2;KIF5A;HAP1;KCNK3;PMP22;GRIA4;SLC5A7;NRXN1;NLGN4X;PDLIM4;ATXN3;CALM1;KCNIP2;PAFAH1B1;DLG4;SYT10;DLGAP2;AMPH;SNCA;SCN2B;GRIA1;SNPH;NLGN1;CACNB1;GRIK2;SYN2;CORT;RPS6KA2;SNCB;PDE7B;RAPSN;CAMK1;PRKACA;CHRM2;GRIA3;CHRNA3;PTEN;PENK;HTR3A;GRIA2;UNC13C;NTSR1;NAPB;NRXN2;SNAP25;GLRB;KCNA1;PCDHB4;SLC18A3;SNCG;FCHSD1;PRKAR2B;SLC1A2;CBLN2;KIF1B;SYT5;SYNJ2BP;CHRNB4;KCNMB4;MAPK1;RAB3A;NPFF;RIT2;NPY;ERC1;PCDHB6;APBA1;HTR2B;PCDHB5;BSN;SLC6A1;CRHBP;NLGN4Y;GRIN2A;CACNA1A;HTR4;SST;GABRG1;GRID1;FCHSD2;GABRG2;CACNA1B;SYN1;CAMKK1;CHRM5;CAMKK2;KCNN1;HTR1E;SNAPIN;CHRM3;RIMS1;NSG1;HTR7;CHAT;PCDHB3;SLC17A8;LRP6;CDH8;SYT1;DRD4;ERC2;PCDHB2;CPNE6;GRID2;PCDHB10;GABRA1;TBC1D24;GRIN2C;STXBP1;CHRNA10;HTR2A;CACNB3;GABARAP;GRIK1;CACNB4;PRKAR1A;CNP
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.471204389352503,1.9860607947878928,0.0,0.00342478551550816,0.2,30/83,11.63%,COPZ1;KDELR3;KIF2A;KIF18A;TMED2;KIF15;TMED3;RACGAP1;TMED9;KDELR2;CENPE;COPB2;KIF23;KDELR1;ERGIC3;LMAN2;SURF4;KIF22;ARF4;COPA;KIF3B;TMED10;COPG1;ZW10;COPG2;ARF5;GOLPH3L;KIF4B;ATP9A;KIF2C
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.7737427533851946,1.9798455731249243,0.0,0.0037889822191085397,0.21,9/15,10.08%,MCM4;HMGA1;SSBP1;BLM;MCMDC2;RECQL4;MCM7;MCM6;MCM2
prerank,negative regulation of ion transport (GO:0043271),-0.6615652703298023,-1.9764799799449866,0.0,0.006231170917854991,0.15,15/25,24.37%,GPM6B;WNK3;ACTN2;PXK;PLN;SNCA;CASQ2;SYT11;NOS1;VIP;INPP5K;PACSIN3;CAV3;WNK1;CD33
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.6582410791326798,-1.97348700105556,0.0,0.006343952291933814,0.16,16/24,15.81%,GSTM2;HRC;AKAP6;JPH2;PKD2;DMD;JPH4;CALM1;PDE4D;CASQ2;PRKACA;NOS1;JPH3;TRDN;CLIC2;CAMK2D
prerank,heart development (GO:0007507),-0.4590340666741988,-1.973484048419525,0.0,0.006108991095936265,0.16,71/157,21.11%,PKD1;POU6F1;POPDC2;RBM20;MYH7;BVES;LDB3;FOXF1;HAND2;MYL2;CACNA1C;PDLIM7;MYOCD;SMYD4;TBX19;TGFBR3;PKD2;DAND5;MYH6;MEF2D;OSR1;TCAP;KAT2B;SGCG;PDLIM4;CITED2;MEF2A;SRF;WDR11;NTRK3;CRELD1;PDLIM2;TAB2;DLC1;NDRG4;TBX1;ZFPM2;PTEN;HAND1;FGF12;MEGF8;ECE1;GLI2;SOX17;MEF2C;SCUBE1;PLCE1;SGCD;DVL2;CSRP3;HDAC9;CDKN1A;TBX2;HTR2B;PDLIM1;PDGFB;TCF25;KAT2A;PCSK5;IFT122;FLRT2;TSC2;INSR;ERBB4;SOX18;KDM6B;POPDC3;MYBPC3;HEG1;AKAP13;ALPK3
prerank,interstrand cross-link repair (GO:0036297),0.5340390889955245,1.9712629744461987,0.0,0.004545474366125047,0.25,22/52,18.91%,RFWD3;UBE2T;RPA3;FANCB;EME1;RAD51AP1;FANCF;DCLRE1C;DCLRE1B;FAAP24;NEIL3;FANCL;FANCE;MSH6;UBA52;VCP;USP1;RPA2;RAD51AP2;FANCA;FANCI;FANCC
prerank,secondary alcohol biosynthetic process (GO:1902653),0.6491904585994716,1.9712480246054915,0.0,0.00449136157605213,0.25,19/30,22.36%,CYP51A1;SQLE;NSDHL;DHCR7;IDI2;FDPS;ACAT2;MSMO1;DHCR24;TM7SF2;ACLY;HMGCS1;G6PD;INSIG1;FDFT1;MVK;EBP;IDI1;HMGCR
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.4565907439393004,1.9706132993681968,0.0,0.004438522028098576,0.25,62/122,19.51%,CENPH;RCC2;CENPN;NUP37;MAD2L1;ERCC6L;INCENP;RAN;DSN1;KIF2A;TACC3;CENPL;KIF18A;NUF2;CENPU;SPC24;RCC1;CENPE;SKA1;CENPA;NEK6;STMN1;SPDL1;ZWINT;NDC80;BUB3;CENPO;CENPK;SEH1L;WDR62;DLGAP5;SEC13;AURKB;CENPM;NUP43;GPSM2;KIF3B;CENPQ;ZW10;RANGAP1;NUP107;AURKA;KIF4B;KIF2C;EML4;NSL1;BUB1;CKAP5;KPNB1;PLK1;TUBG1;CENPF;BCCIP;NUP160;DYNLL1;ESPL1;SKA2;BIRC5;KNTC1;MAPRE1;CDC20;BUB1B
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5560430966872356,-1.9685100410967569,0.0,0.006545347602788856,0.18,27/53,15.73%,FAM107A;TSC1;GPM6B;DUSP22;VCL;FERMT2;MYOC;MACF1;PHLDB2;DUSP3;COL16A1;ARHGAP6;DLC1;CLASP1;APOD;PTEN;CLASP2;PPM1F;CORO1C;DAPK3;RAC1;EFNA5;SFRP1;PEAK1;RHOA;EPHA3;ROCK1
prerank,DNA repair (GO:0006281),0.4188942825164817,1.9684190426126613,0.0,0.004386911306841615,0.25,105/277,17.81%,RFC3;RFWD3;CHEK1;UBE2T;FEN1;RPA3;FANCB;XRCC2;TP73;BRCC3;RFC5;TDP1;CDK1;EME1;CDCA5;RAD51AP1;EXO1;FANCF;POLE2;RFC2;POLD2;TIMELESS;NUDT1;POLH;DCLRE1C;RHNO1;UBE2N;UNG;POLB;TRAIP;DCLRE1B;CHEK2;APEX2;RMI2;BLM;XRCC5;GTF2H3;FAAP24;TICRR;RAD18;NABP2;MGME1;ZRANB3;XRCC4;PRKDC;INIP;RECQL4;ASCC3;ERCC8;NEIL3;TOPBP1;RAD9B;LIG1;MSH3;ACTR8;FANCL;WRNIP1;DNA2;ERCC5;APEX1;PARP4;RAD51B;WDHD1;HMGA2;RAD54L;POLA1;TRIP13;DTX3L;APTX;TEX264;RBBP8;PRMT6;RAD23B;DDB1;BRCA2;FANCE;MPG;BRCA1;PMS2;HUS1;MSH6;CIB1;NPM1;SMC1A;UBA52;SLC30A9;KPNA2;VCP;USP1;RPA2;RAD51AP2;POLD1;COMMD1;EYA1;UBE2A;FANCA;SUMO1;SPRTN;NSMCE1;FBXO6;RNASEH2A;REXO4;LIG3;GTF2H2C;FANCI
prerank,"DNA-templated transcription, termination (GO:0006353)",0.48166928618108423,1.9661367351915273,0.0,0.004464030775386498,0.25,32/66,19.68%,POLR2F;CSTF2;POLR3K;CPSF3;SNRPF;POLR1C;CDK7;POLR1B;SNRPG;CSTF1;SLBP;SNRPB;GTF2H3;NCBP1;SNRPE;TAF1A;NUDT21;TTF2;MAZ;CLP1;POLR1A;NCBP2;TAF1B;CPSF2;POLR2K;MED18;ZNF473;SMN1;CPSF4;SNRPD3;ERCC2;POLR2H
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5881624165667511,-1.9659734091676846,0.0,0.006319645961313378,0.18,18/33,20.25%,PDE2A;ADCY2;CAP2;AKAP6;RAPGEF3;MAPK7;PDE9A;PDE4D;NPPA;PDE7B;KSR1;EPHA5;PDE3A;AQP1;HTR2B;NPPB;CD36;RAPGEF2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.6158449836666364,1.9593997944781147,0.0,0.004665491904535434,0.27,18/34,15.92%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;CENPQ;HAT1;MIS18BP1;NPM1;HIRA
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4682118512193489,1.9553773299285067,0.0,0.004737748232240053,0.28,50/116,22.48%,PSMD14;PSMB2;PSMB9;PSMA5;TNFRSF11B;PSMB3;PSME3;PSMA3;EIF5A;TNFSF11;TXNDC17;PSMA7;PSMD13;PSME2;PSMC2;TNFSF9;CARD14;PSMC4;PSMD10;PSMD12;EDAR;PSMB5;TNFSF15;RELA;PSMD8;CD70;PSMB4;STAT1;PSMD3;PSMB1;PSMA4;TNFRSF9;ACTN4;PSME1;PSMF1;PSMD11;TRAF2;TNFRSF12A;PSMD1;TMSB4X;BAG4;TNFRSF1B;PSMD6;NFKBIA;TNFSF4;PSMD5;PSMC1;TNFSF8;TNFSF18;LTB
prerank,membrane depolarization (GO:0051899),-0.6062191464369457,-1.9522986226309356,0.0,0.007330789315123519,0.21,16/29,20.07%,CACNA1H;SCN7A;SCN3B;SCN9A;SCN4A;KCNH2;SCN11A;P2RX7;SCN1B;CACNA1G;SCN3A;CACNA1A;CACNA1B;BEST2;CACNA1I;SCN5A
prerank,regulation of sodium ion transport (GO:0002028),-0.6156711639532955,-1.9509569660642119,0.0,0.00738990858379387,0.21,14/35,9.83%,PER1;ATP2B4;WNK3;SCN3B;ANK3;SLMAP;SPTBN4;P2RX7;SCN1B;CNKSR3;SNTA1;NOS1;SCN4B;FGF12
prerank,ribosome assembly (GO:0042255),0.5592077761945851,1.949612633443273,0.0,0.00493169114233175,0.3,27/47,23.45%,BRIX1;NLE1;BOP1;RRS1;C1QBP;MRPL22;EIF6;RPLP0;DHX37;RPF2;RPS14;RRP7A;ERAL1;NPM1;RPS19;RPS5;MRPS2;TRAF7;MRPS11;PWP2;RPS28;RPL11;RPS15;MTERF3;MRPS7;RPL23A;RPL24
prerank,striated muscle contraction (GO:0006941),-0.5691161779525308,-1.9483802104726407,0.0,0.007158973940550311,0.21,25/51,13.67%,MYH7;TPM1;MYH3;ATP1A2;MYH6;DTNA;DMD;KLHL41;TCAP;TNNT3;SCN3B;KCNH2;SCN2B;SCN1B;CASQ2;SLC8A1;NOS1;SCN4B;STAC2;ARHGEF11;RYR2;STAC;ALDOA;SMPX;CSRP3
prerank,synaptic vesicle endocytosis (GO:0048488),-0.6020106480156975,-1.9469817431269936,0.0,0.00694203533629121,0.21,20/38,12.21%,VAMP2;PIP5K1C;STON1;NLGN2;NLGN3;NLGN4X;SYNJ1;AMPH;SNCA;PACSIN1;ITSN2;NLGN1;ITSN1;KIAA1109;SNCB;SNAP91;SYT2;SNCG;OPHN1;SYT5
prerank,muscle filament sliding (GO:0030049),-0.5954729030203155,-1.9449636192236457,0.0,0.007330789315123519,0.24,21/38,16.46%,MYH7;TPM2;TPM1;MYL2;MYH3;ACTA1;MYH6;DMD;TCAP;TNNT3;ACTN2;ACTN3;MYH2;DES;TMOD1;MYL1;MYL6;MYBPC1;ACTC1;VIM;MYL3
prerank,actin-myosin filament sliding (GO:0033275),-0.5954729030203155,-1.9449636192236457,0.0,0.007330789315123519,0.24,21/38,16.46%,MYH7;TPM2;TPM1;MYL2;MYH3;ACTA1;MYH6;DMD;TCAP;TNNT3;ACTN2;ACTN3;MYH2;DES;TMOD1;MYL1;MYL6;MYBPC1;ACTC1;VIM;MYL3
prerank,positive regulation of immune response (GO:0050778),0.47865852776643497,1.9393636890147052,0.0,0.005609121244300397,0.33,35/71,30.60%,EREG;IL23A;SKAP1;ZP3;POLR3C;CD46;AKIRIN2;TGFB2;NMI;DHX9;POLR3B;CYBA;CD81;XBP1;GBP5;GRN;FPR2;ADAM8;IL23R;MYB;POLR3G;NOD2;PLSCR1;SLC15A4;TNFSF4;IL12B;IL12RB1;ITGB2;IFNG;IFI35;IL10;NLRP3;IFNL1;TLR8;RSAD2
prerank,base-excision repair (GO:0006284),0.5379131059840705,1.9333605583306581,0.0,0.005789376558389446,0.35,21/47,17.32%,RFC3;FEN1;RPA3;RFC5;RFC2;POLD2;UNG;POLB;APEX2;NTHL1;NEIL3;LIG1;DNA2;ERCC5;APEX1;HMGA2;PRMT6;MPG;RPA2;POLD1;LIG3
prerank,skeletal muscle tissue development (GO:0007519),-0.5828615927852506,-1.9305147457233385,0.0,0.009672569235232421,0.32,15/35,13.67%,POPDC2;BVES;CFLAR;MYOZ2;ACTA1;KLHL41;RYR1;TCF21;CAV2;KLHL40;MEF2C;SKI;MYL6;MYOZ1;CSRP3
prerank,presynaptic endocytosis (GO:0140238),-0.6413734592975241,-1.9301664020021712,0.0,0.009411148445091003,0.32,17/27,12.21%,VAMP2;PIP5K1C;STON1;NLGN2;NLGN3;NLGN4X;SYNJ1;AMPH;SNCA;PACSIN1;NLGN1;KIAA1109;SNCB;SYT2;SNCG;OPHN1;SYT5
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.6535169521508931,1.9276691189487125,0.0,0.005846440305828768,0.35,14/22,20.09%,WDR12;RPS21;RPP40;ABT1;PES1;RRS1;EXOSC8;EXOSC7;EXOSC3;NOP14;EXOSC2;UTP20;ERI1;ERI2
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.556207771602207,-1.9270562281088492,0.0,0.009163486643904399,0.32,29/46,23.65%,TTC23;PTCH2;INTU;RAB34;GLI3;IFT81;FGFR2;KIF7;WDR11;RORA;STK36;TULP3;MEGF8;EVC;SFRP1;GLIS2;BTRC;ARMC9;TXNDC15;IFT122;KCTD21;GAS1;SMO;DLG5;SUFU;FUZ;TUBD1;KCTD6;HERC4
prerank,centromere complex assembly (GO:0034508),0.6178738195094995,1.925653374487559,0.0,0.005902289930982148,0.36,20/33,15.70%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPE;CENPA;CENPO;CENPK;HJURP;DLGAP5;OIP5;CENPM;CENPQ;MIS18BP1;NPM1;CENPF;CENPV
prerank,neurotrophin signaling pathway (GO:0038179),-0.6706127821949467,-1.924025932359979,0.0,0.010103331427894593,0.35,12/21,20.25%,RAP1A;HAP1;MAGI2;KIDINS220;NGF;NGFR;NTRK1;RAPGEF1;NTF3;SOS1;CASP3;RAPGEF2
prerank,regulation of blood circulation (GO:1903522),-0.5853821597743488,-1.9235614968487662,0.0,0.00985074814219723,0.35,18/34,15.81%,CACNA1H;DMPK;TPM1;MYH6;HSPB7;FXYD1;AGTR1;DES;KCNIP2;PLN;FOXN4;CELF2;ECE1;KCNMB2;KCNMB4;ADORA3;TBX2;CAMK2D
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.7396709936781717,-1.9232239276533833,0.0,0.00961048599238754,0.35,11/17,10.70%,CACNA1C;CACNB2;ANK2;ATP1A2;SCN3B;CACNA2D1;SCN2B;SCN1B;SLC8A1;SCN4B;CACNA1G
prerank,action potential (GO:0001508),-0.5722693395030166,-1.9216615355579918,0.0,0.009599843150756989,0.36,29/43,24.89%,CACNA1H;KCNB1;AKAP6;SCN7A;DMD;SCN3B;SCN9A;ANK3;GPER1;SCN4A;KCNH2;SCN11A;KCNA2;KCNE2;CACNA1G;KCNA1;KCNMB2;KCNMB4;SCN3A;KCNE1;GNAQ;SLC4A3;KCNE4;CACNA1I;SCN5A;GNA11;KCNMB3;GNA14;CLN3
prerank,gene expression (GO:0010467),0.39673095362100513,1.9215385221743289,0.0,0.006190570197084855,0.37,187/349,27.33%,POLR2F;DKC1;NUP37;POLR2D;TESC;MRPL3;CPSF3;E2F1;ALYREF;MRPS16;HSPD1;THOC3;RPS21;HNRNPF;YARS2;NUP155;FARSB;MRPL37;MRPL13;U2AF1;MAGOH;PRPF4;RAE1;SLBP;MRPS12;RPL36;DUOXA2;RPL8;NUP93;PTMA;MRPL44;NUP35;MAGOHB;FASTKD2;EIF4A3;RPS2;NCBP1;RPS18;SEH1L;NUFIP1;DDX39A;SRSF9;SEC13;IGF2BP3;NUP210;RPS3;RPL37;SNRNP40;MRPL42;NUP43;MRPS18B;NXT1;MRPS33;MRPL52;DRG1;MRPL11;HNRNPK;RPS4X;RPL18;GLE1;MRPL9;RPLP0;NUP50;RPL39;MRPL36;DDX54;NUP88;CLP1;NUP107;EIF4E;DUSP11;RPS14;RPLP2;NCBP2;RRBP1;MRPL51;GSPT1;RPL12;RPL28;SORL1;SRBD1;MRPS18A;TAF1B;RPL27A;COPS5;CPSF2;POLR2C;RPL29;RPS9;TSPAN17;MRPL18;DHX8;POLR2K;NUP205;RPL35;RPL37A;THOC6;RPL7A;POLR2J;APOBEC1;RPL27;RPL32;RPS11;RPS19;ABCF1;NUP62;RBM3;MRPS18C;RPL31;POLR2G;DEDD2;RPL35A;NUP160;RPS5;MRPL23;SYNCRIP;RPS24;RPL18A;XRN2;NDC1;RPS16;RPS29;RPS13;MRPS11;MRPL27;RPS28;MRPL24;RPS6KB2;RBM8A;CPSF4;HNRNPA2B1;POLR2H;SRSF3;NXF3;PAX8;RPL11;RPL41;TFIP11;RPS15;RPS8;RPS12;RPL23;RBM15B;POLR2I;MED20;NFKBIB;POLR2L;MRPS15;PWP1;RNGTT;U2AF2;AGFG1;MRPS7;MRPS5;DNAJB11;RPS7;POLR3A;RPL23A;RPL24;RPL4;THOC7;RNPS1;TSPAN33;RPL30;RPS26;HNRNPD;RPLP1;TSPAN15;RPL7;NKX2-8;POLR2B;NUP98;RPL13;MRPL28;NXF2;RPL13A;RPL14;SMG7;HNRNPU;RPS20;PPP5C;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,regulation of microtubule-based process (GO:0032886),-0.5814683893140931,-1.91866118241655,0.0,0.010442112687239895,0.39,19/36,16.56%,FAM107A;MAP6;MAPT;KLHL42;PHLDB1;MACF1;PHLDB2;HDAC6;CLASP1;CLASP2;BICD2;PRKAA2;TPPP;MARK4;EFNA5;EPHA3;ROCK1;APC;MAP6D1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5678911740637984,1.9180383141818245,0.0,0.006472844624310422,0.39,17/35,16.09%,DCPS;EXOSC5;LSM7;LSM5;LSM4;EXOSC4;EXOSC8;EXOSC7;LSM2;EXOSC1;EXOSC3;DIS3;EXOSC2;LSM6;PATL1;POLR2G;LSM3
prerank,import into nucleus (GO:0051170),0.4823699000260419,1.9179569791110787,0.0,0.006406114267358768,0.39,28/75,16.27%,RAN;CSE1L;SNRPF;NXT2;SNRPD1;NUP155;SNRPG;SNRPB;E2F3;NUP62CL;NUP93;NUTF2;SYK;SNRPD2;SNRPE;SEC13;NXT1;NUP50;NUP88;NUP107;GEMIN6;TNPO3;HEATR3;KPNB1;HTATIP2;MMP12;NUP62;SMN1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.49568639308829665,1.9176774501140859,0.0,0.006340745754426536,0.39,30/73,21.64%,POLR2F;RFC3;POLR2D;RPA3;RFC5;PRPF19;CDK7;RFC2;POLD2;GTF2H3;ERCC8;HMGN1;LIG1;ERCC5;COPS5;DDB1;POLR2C;POLR2K;POLR2J;UBA52;RPA2;POLR2G;POLD1;CUL4A;LIG3;RFC4;ERCC2;POLR2H;POLR2I;POLR2L
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5077605566687321,1.9168734815720845,0.0,0.006276697817513136,0.39,30/61,21.12%,DKC1;RFC3;MYC;DSCC1;CCT6A;RFC5;CCT2;CCT3;RFC2;PDGFRB;XRCC5;CCT8;CCT7;NEK2;AURKB;FBXO4;NAF1;PTGES3;FGFR4;WRAP53;MAPK15;GRHL2;CCT4;TCP1;CHTF18;HSP90AB1;RFC4;HSP90AA1;HNRNPA1;MAPKAPK5
prerank,cellular response to chemokine (GO:1990869),0.5004347057284833,1.9161177244317469,0.0,0.006213930839338005,0.39,21/54,13.93%,SLC12A2;CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;TFF2;CCL20;CCL22;PF4;STK39;CCL4;CCL3;GPR35;DUSP1;CXCL9;CCL26;CXCL10;CXCL6
prerank,positive regulation of establishment of protein localization (GO:1904951),0.6358695648458967,1.9139385838422922,0.0,0.006591864398166202,0.42,9/19,15.51%,DKC1;CCT6A;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;TCP1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.5581548002508459,1.9137899685008444,0.0,0.006527238276615552,0.42,21/45,17.62%,NUP37;NUP155;RAE1;NUP93;NUP35;PNPT1;SEH1L;SEC13;NUP210;NUP43;EIF6;NUP50;NUP88;NUP107;NOS2;KHK;NUP205;NUP62;NUP160;NOA1;NDC1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.5617183449764998,1.9124979697828939,0.0,0.006679329265585235,0.43,19/37,19.63%,CHEK1;E2F1;INTS7;TIPIN;PRPF19;TIMELESS;RHNO1;CHEK2;RAD9B;DNA2;HUS1;CDT1;CLSPN;TIPRL;FBXO6;CDC6;CDC45;CDC5L;BRIP1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.5901622232507586,-1.9122011817552251,0.0,0.010829575124614289,0.39,18/33,17.24%,MYOCD;CDON;BOC;MEF2A;SRF;FGFR2;CDK9;RBM4;MEGF10;CAMK1;BNIP2;MEF2C;MAPK11;SUPT6H;HDAC9;CDH2;SPAG9;MAPK14
prerank,retrograde axonal transport (GO:0008090),-0.7219972520086521,-1.9119817565262216,0.0,0.01058891789962286,0.39,15/16,27.38%,DLG2;KIF5A;MAP1A;HAP1;PAFAH1B1;TMEM108;KIF1A;KIF1C;DST;MGARP;NEFL;SOD1;FBXW11;ACTR10;DYNC1H1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5614256084902054,1.9117035473994497,0.0,0.006615104945723837,0.43,13/28,19.43%,GRIN2B;USP50;PSME3;EFNA3;PSME2;APH1A;EFNA1;PRELID1;PSME1;SEMG1;NCSTN;LYN;FYN
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.46365168645210575,1.9115968816769924,0.0,0.006552103946240753,0.43,38/85,22.46%,MYC;CCND1;CDKN3;E2F1;TFDP1;DBF4;FBXO5;CDK7;CDK5;RCC1;INHBA;DHFR;KHDRBS1;EIF4EBP1;E2F3;CCNE1;CDK4;CDKN2A;USP37;POLA1;EIF4E;GSPT1;TRIM71;CDT1;CDC25A;CUL4A;CDC6;USP26;ACVR1B;CDC7;CDC45;ORC1;SPDYA;CRLF3;CDK6;CUL3;CDK2;CDK16
prerank,mRNA splice site selection (GO:0006376),-0.6225276092278581,-1.9101895484096478,0.0,0.01055793026362898,0.39,15/29,14.30%,LUC7L2;SRSF5;LUC7L3;CELF1;SFSWAP;LUC7L;CELF4;CELF6;PRPF39;SF1;CELF2;YTHDC1;ISY1;PSIP1;SRSF12
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.6804879540597099,-1.9086932294836687,0.0,0.010333293449509215,0.39,12/22,16.14%,RAP1A;MAPT;MAGI2;STMN2;NTRK3;TMEM108;KIDINS220;NGF;WASF1;NTRK1;RAPGEF1;NTF3
prerank,histone exchange (GO:0043486),0.6023806742346387,1.908654961216379,0.0,0.006594973768165336,0.44,19/34,15.49%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;SPTY2D1;CENPQ;ZNHIT1;MIS18BP1;NPM1;VPS72
prerank,positive regulation by host of viral transcription (GO:0043923),0.6503362012394265,1.907581925696183,0.0,0.006533338499303978,0.44,5/16,7.09%,TFAP4;SMARCB1;LEF1;RRP1B;SMARCA4
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.5724383873852726,-1.906514120830174,0.0,0.010308922474392449,0.4,19/40,15.94%,GABBR1;KCNMB1;FLNA;ANK2;KCNN3;AKAP6;KCNMA1;PIRT;ACTN2;ANK3;KCNH2;AMIGO1;NOS1;GNG2;STAC;KCNMB2;KCNMB4;KCNE1;KCNJ9
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.504399519748867,-1.906078112741276,0.0,0.010472556164462169,0.41,33/70,19.26%,YJEFN3;ATP2B4;NPR1;FOXJ2;MECP2;PTPRM;STAB1;PDE3B;ADGRB1;CLDN5;ADAMTS1;SEMA3E;DCN;EMILIN1;ANGPT4;FOXO4;THBS4;SYNJ2BP;PRL;DAB2IP;KRIT1;SEMA6A;HSPG2;ECSCR;ROCK1;SPINK5;COL4A2;NPPB;SERPINF1;HOXA5;COL4A3;AGO1;HHEX
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5650000234716229,1.901882865036827,0.0,0.006678331755240912,0.45,16/33,16.09%,DCPS;EXOSC5;LSM7;LSM5;LSM4;EXOSC4;EXOSC8;EXOSC7;LSM2;EXOSC1;EXOSC3;DIS3;EXOSC2;LSM6;PATL1;LSM3
prerank,mitotic spindle organization (GO:0007052),0.4318656436303828,1.9013493829983783,0.0,0.006617062656568977,0.45,77/147,22.72%,CENPH;RCC2;CENPN;NUP37;MAD2L1;ERCC6L;INCENP;RAN;DSN1;KIF2A;CENPL;MZT1;KIF18A;NUF2;CENPU;SPC24;RCC1;CENPE;SKA1;CENPA;KIF23;NEK6;STMN1;CHEK2;SPDL1;ZWINT;NDC80;BUB3;CENPO;CENPK;SEH1L;WDR62;DLGAP5;SEC13;AURKB;RAB11A;CENPM;NUP43;GPSM2;KIF3B;CENPQ;ZW10;RANGAP1;NUP107;AURKA;SPAST;TPX2;KIF4B;KIF2C;EML4;NSL1;BUB1;CKAP5;KPNB1;PLK1;SMC1A;TUBG1;VCP;CENPF;BCCIP;NUP160;DYNLL1;SKA2;BIRC5;KNTC1;MAPRE1;CDC20;BUB1B;WRAP73;KIF4A;SPC25;MISP;TTK;CDCA8;KIFC1;CENPP;ITGB3BP
prerank,regulation of ATP metabolic process (GO:1903578),0.5360741931959498,1.9007772103974696,0.0,0.006657783042147864,0.46,23/52,17.62%,NUP37;SHMT2;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;BEND3;NUP43;UQCC2;EIF6;NUP50;NUP88;NUP107;COX7A2L;NUP205;COX7A2;NUP62;SLC25A33;NUP160;NDC1
prerank,positive regulation of cell projection organization (GO:0031346),-0.49609685209968407,-1.900501456032579,0.0,0.011362723438441455,0.44,54/111,21.08%,ATP1B2;MAP6;PLXNB3;CAPRIN2;RAP1A;FZD4;PTN;MAGI2;LRRC7;ROR2;CUX2;DVL3;DLG4;STMN2;NTRK3;AMIGO1;SCN1B;NDRG4;KIDINS220;NGF;FES;DPYSL3;NGFR;CAMK1;PRKD1;OBSL1;SLIT2;NPTN;CHODL;NTRK1;ROR1;GRIP1;DAB2IP;TOX;TIAM1;TENM3;DVL2;RIT2;RAPGEF1;FUT9;RELN;CAMK2B;RHOA;EPHA3;IL1RAPL1;SCARF1;PLXNA4;PLXNB1;RET;SETX;INS;RAPGEF2;SLITRK1;FZD1
prerank,cell cycle G1/S phase transition (GO:0044843),0.493516893252825,1.9001032832846634,0.0,0.006697769727085687,0.47,28/63,21.67%,MYC;CCND1;CDKN3;E2F1;DBF4;CDK7;RCC1;INHBA;KHDRBS1;EIF4EBP1;E2F3;CCNE1;CDK4;CDKN2A;USP37;EIF4E;GSPT1;TRIM71;CDC25A;CUL4A;USP26;ACVR1B;CDC7;SPDYA;CRLF3;CDK6;CUL3;CDK2
prerank,embryonic organ development (GO:0048568),-0.5045947500305547,-1.8998413223403077,0.0,0.011139924939648485,0.44,31/64,16.86%,RNF112;TEAD3;GDNF;TPO;PBX3;BMPR1A;GLI3;FGFR2;TAL1;TEAD1;ATF4;NDRG4;RARB;KIT;KMT2A;PBX2;KITLG;RBPJ;HAND1;FLT3LG;GLI2;HEY1;RARRES2;SOX17;ERCC3;TBX2;TEAD2;HEY2;COL13A1;PCSK5;IFT122
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.6477630101298508,-1.8997789509061183,0.0,0.010925695613886014,0.44,13/21,15.81%,GSTM2;CACNA1C;ANK2;HRC;ATP1A2;DMD;CALM1;CASQ2;SLC8A1;PRKACA;RYR2;CLIC2;CAMK2D
prerank,dendrite self-avoidance (GO:0070593),-0.7147130650523682,-1.8994120830795047,0.0,0.010719550413624015,0.44,10/16,17.91%,PALLD;ROBO3;CNTN2;DSCAML1;NEXN;NPTN;CNTN4;ROBO4;DSCAM;CNTN6
prerank,mitotic metaphase plate congression (GO:0007080),0.5065342300319138,1.8968565176039425,0.0,0.00683611651649111,0.47,27/51,22.30%,KIF18A;CDCA5;NUF2;CEP55;CENPE;RRS1;SPDL1;NDC80;KIF14;SEH1L;KIF22;PSRC1;RAB11A;CHMP4C;ZW10;KIF2C;EML4;KPNB1;CDT1;NUP62;CHAMP1;CHMP5;CHMP2B;CHMP1A;CUL3;CDCA8;KIFC1
prerank,recombinational repair (GO:0000725),0.49124535699891875,1.8947352833032458,0.0,0.007070212080157022,0.49,28/76,17.32%,RAD54B;PSMD14;RFWD3;FEN1;RPA3;XRCC2;RAD51AP1;RMI1;RHNO1;UBE2N;BLM;MMS22L;NABP2;RECQL4;SFR1;PALB2;TONSL;ERCC5;RAD51B;RBBP8;BRCA2;BRCA1;HUS1;NSMCE2;RPA2;RAD51AP2;NSMCE1;LIG3
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5068363275883377,1.8942760190275783,0.0,0.007105528685333246,0.49,23/51,17.59%,CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;TFF2;CCL20;CCL22;PF4;RBM15;STK39;CCL4;CCL3;GPR35;CXCL9;CCL26;CIB1;CXCL10;CXCL6;CCL17;PF4V1
prerank,response to muscle stretch (GO:0035994),-0.6922229756562462,-1.892706199137133,0.0,0.01187859379765385,0.52,11/15,22.92%,GSN;DMD;TCAP;NPPA;SLC8A1;RYR2;CSRP3;CDH2;ANKRD1;TTN;CAV3
prerank,cytosolic calcium ion transport (GO:0060401),-0.5928129128059003,-1.8893316921043242,0.0,0.011995837061111212,0.53,12/26,11.92%,CACNA1C;JPH2;JPH4;CACNA2D1;SLC8A2;SLC25A23;MICU3;SLC8A1;ADRA1A;JPH3;RYR2;ATP2B3
prerank,sister chromatid segregation (GO:0000819),0.5752495354492356,1.883957112576465,0.0,0.007912147963132242,0.54,22/32,22.30%,RAN;DSN1;KIF18A;KNSTRN;ZWINT;NDC80;CENPK;SMC4;SPAG5;ZW10;NSL1;NCAPG2;PLK1;SMC1A;TUBG1;TOP2A;KIF18B;ESPL1;CHAMP1;WRAP73;CDCA8;KIFC1
prerank,circulatory system development (GO:0072359),-0.4524919064452514,-1.8831066557079639,0.0,0.012436160445298826,0.54,61/122,23.07%,PKD1;POU6F1;POPDC2;RBM20;BVES;LDB3;FOXF1;HAND2;MYL2;CACNA1C;PDLIM7;SMYD4;PKD2;OSR1;KAT2B;NXN;PDLIM4;CITED2;MEF2A;SRF;WDR11;NTRK3;PDLIM2;TAB2;TCF21;TBX1;ZFPM2;PTEN;HAND1;FGF12;FLT4;ECE1;GLI2;HEY1;SOX17;NOTCH4;MEF2C;PLCE1;DVL2;HDAC9;CDKN1A;HSPG2;PDLIM1;PDGFB;TCF25;HEY2;KAT2A;PCSK5;TSC2;ERBB4;FBXW7;SOX18;KDM6B;POPDC3;HEG1;AKAP13;ALPK3;CDH5;ID2;SH3PXD2B;RAMP2
prerank,regulation of neuron projection development (GO:0010975),-0.4491495604355867,-1.8826218593750899,0.0,0.01221798219187253,0.54,69/157,20.25%,CAMK2G;ATP1B2;PLXNB3;BRSK1;NCS1;LPAR1;RAP1A;STX1B;CRMP1;PTPRS;PTN;MAGI2;LRRC7;ROR2;ZDHHC15;SHANK3;STMN2;DENND5A;NTRK3;RUFY3;SCN1B;NDRG4;KIDINS220;FES;DPYSL3;CAMK1;PSEN1;PRKD1;PTEN;KIF1A;LRRK2;NTNG1;NPTN;LRRC4C;NTRK1;ROR1;NDEL1;DAB2IP;TOX;ABI2;EPHA4;EFHC2;TENM3;RIT2;MARK1;RAPGEF1;FUT9;RELN;MAG;DISC1;CAMK2B;CDH2;EPHA3;KANK1;ADCY6;IL1RAPL1;DBN1;CCDC88A;SCARF1;CAMSAP2;SEMA3A;SPOCK1;MYLIP;DCC;SIPA1L1;RET;GSK3A;SETX;RAPGEF2
prerank,regulation of stem cell differentiation (GO:2000736),0.46156953181084404,1.8758447558645952,0.0,0.009087491221322514,0.56,37/90,15.36%,PSMD14;TACSTD2;OSM;PSMB2;TP73;PUS7;PSMB9;PSMA5;CBFB;PSMB3;SLC4A11;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PRKDC;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;NUDT21;TCF3;RUNX1;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;YTHDF2;PSMD1;SMYD5;NSUN2
prerank,lysosome localization (GO:0032418),-0.5644338869476456,-1.875396609332986,0.0,0.012955274220692424,0.56,19/34,20.39%,FLCN;MAP6;RAB34;HDAC6;PLEKHM2;KIT;VPS33B;KLC2;SYTL4;NDEL1;S100A13;DEF8;RAB3A;TFEB;SPAG9;MRGPRX2;BLOC1S1;NR4A3;SNAPIN
prerank,positive regulation of type I interferon production (GO:0032481),0.47701225641591727,1.8751034992754425,0.0,0.009009820356183005,0.56,35/73,25.04%,POLR2F;POLR3K;POLR1C;HSPD1;RIPK2;G3BP1;GAPDH;XRCC5;POLR3C;PRKDC;DHX9;POLR3B;OAS2;MYD88;RELA;IRAK1;STAT1;POLR2K;NFKB2;ISG15;DDX41;POLR3G;CRCP;OAS3;POLR2H;HSP90AA1;IFI16;POLR2L;POLR3A;TRIM15;XRCC6;ZBP1;CTNNB1;CREBBP;PTPN11
prerank,RNA modification (GO:0009451),0.47404510370831515,1.8742573605841983,0.0,0.009027502430031,0.56,23/53,19.30%,PUS7;WDR4;HENMT1;METTL1;FTSJ1;NAT10;NSUN3;DTWD2;TRUB1;TFB1M;TRMT6;RBM15;NOP10;APOBEC3F;SSB;CDKAL1;NSUN2;NSUN5;ANKRD16;CTU2;PUS7L;AARS2;URM1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.46096291923480687,1.8728722372578366,0.0,0.009044887326167265,0.57,35/93,14.34%,PSMD14;IL1A;PSMB2;PSMB9;PSMA5;PSMB3;RIPK2;PSME3;PSMA3;IL1RN;UBE2N;IRAK2;PSMA7;IL1B;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;MYD88;RELA;IRAK1;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;RPS6KA4;PSME1;PSMF1;PSMD11;UBA52;PSMD1
prerank,error-free translesion synthesis (GO:0070987),0.613569662555989,1.8709942170160976,0.0,0.009339390100790752,0.58,12/21,19.37%,RFC3;RPA3;RFC5;RFC2;POLH;POLDIP2;UBA52;VCP;RPA2;POLD1;SPRTN;RFC4
prerank,nuclear membrane reassembly (GO:0031468),0.5031583110589092,1.8696279188108933,0.0,0.009629025060957653,0.6,30/54,27.42%,NUP37;RAN;CDK1;VRK1;RCC1;NUP155;NUP93;NUP35;SEH1L;SEC13;CHMP4C;NUP43;RANGAP1;NUP107;SPAST;NUP205;KPNB1;BANF1;NUP160;SUMO1;NDC1;CHMP2B;CCNB2;REEP4;PPP2R2A;PPP2CA;CHMP2A;NUP98;PPP2R1A;CCNB1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5494832227438633,1.8665485235400154,0.0,0.009822958586775534,0.6,17/40,17.62%,NUP37;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;EIF6;NUP50;NUP88;NUP107;NUP205;NUP62;NUP160;NDC1
prerank,regulation of dendritic spine development (GO:0060998),-0.6398868307710499,-1.8655879434752844,0.0,0.014133513298225429,0.61,14/21,25.81%,PTPRS;SHANK3;NLGN1;CAMK1;PSEN1;KIF1A;CPEB3;MEF2C;SRGAP2C;CAMK2B;DLG5;PPFIA2;FOXO6;TANC2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4092925650362132,1.8637868969155855,0.0,0.009923524859569986,0.6,84/185,21.72%,PSMD14;MAD2L1;CEP72;E2F1;PSMB2;TFAP4;CDK1;FBXO5;PSMB9;PSMA5;PSMB3;UBE2S;PSME3;CENPE;PSMA3;NEK6;CEP250;KIF14;BUB3;PSMA7;YWHAE;NEK2;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;TUBB4B;HAUS2;PSMD12;ANAPC1;PSMB5;MAD2L1BP;YWHAG;UBE2C;TUBA4A;HAUS8;ZW10;CEP76;AURKA;PSMD8;TPX2;CDC26;PSMB4;PSMD3;PSMB1;PSMA4;DDB1;CKAP5;ANLN;HAUS1;PSME1;HAUS6;PSMF1;ANAPC11;PLK1;PSMD11;TUBG1;UBA52;PSMD1;CEP78;CENPF;PLK4;TM4SF5;DYNLL1;CDC6;HAUS7;NPM2;PSMD6;KNTC1;MAPRE1;CDC20;BUB1B;ERCC2;UBE2D1;SSNA1;CEP41;PSMD5;HSP90AA1;CUL3;HECW2;TUBB;CDK2;PSMC1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5408395679694818,1.8622064758457069,0.0,0.009932982764494796,0.6,17/40,17.62%,NUP37;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;EIF6;NUP50;NUP88;NUP107;NUP205;NUP62;NUP160;NDC1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.608855051557359,1.862028477994382,0.0,0.009853518902378837,0.6,15/31,14.02%,HSPD1;TIMM23;PEX7;GRPEL1;ROMO1;TOMM40;GRPEL2;TOMM20;TIMM50;TIMM17B;TOMM20L;AIFM1;PEX10;DNAJC15;PEX16
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.4334027062640425,-1.8600839146724162,0.0,0.014814303407645444,0.62,44/115,20.88%,ADCY5;PTH1R;CNR1;ADRA2B;ADCY2;LPAR1;ADRB3;ADGRD1;ADCY4;ADGRB3;ADGRB1;GPER1;GPR26;ADRB2;ABCA1;ADRA1A;PTGER3;ADCY9;ADGRL3;ADRA1D;GNG2;S1PR1;RAMP1;ADGRL2;GPR161;ADORA2A;VIP;MC1R;GPR12;GNAL;S1PR3;ADGRG4;ADRB1;S1PR2;ADCY6;GNAQ;TBXA2R;CRHR1;RAMP3;ADGRL1;ADGRB2;RAPGEF2;LHCGR;PTGFR
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6449479345653764,-1.8589591993253995,0.0,0.01502210925230229,0.64,12/22,13.86%,GSTM2;ANK2;AKAP6;JPH2;PKD2;CASQ1;HAP1;CALM1;STAC2;RYR2;STAC;TRDN
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5576976511536134,-1.8556506407518165,0.0,0.01581440436931888,0.67,16/35,19.21%,ATP2B4;FGF2;MECP2;PTPRM;ADGRB1;NR2F2;SLIT2;DCN;ANGPT4;SYNJ2BP;MEF2C;DAB2IP;KRIT1;ADAMTS9;CSNK2B;AGTR2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.528794657241298,-1.8554947195882845,0.0,0.01570883424669325,0.67,22/46,20.73%,FLCN;NOVA1;ARNTL;ACTN3;TFE3;PLCL1;NR1D1;ATF4;LAMA4;RBPJ;NOVA2;NPR3;NR1H2;ALDH1A1;IP6K1;ZNF423;ADAMTS5;IL18R1;ABHD6;TLE3;LNPEP;MAP2K6
prerank,cardiac muscle cell contraction (GO:0086003),-0.6615523577278631,-1.852701409132512,0.0,0.016465640063265716,0.68,12/19,15.81%,CACNA1C;GSN;SCN3B;CACNA2D1;SCN2B;SCN1B;KCNE2;SCN4B;FGF12;CACNA1G;KCNE1;CAMK2D
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.5958146760123372,-1.8521850651108371,0.0,0.01635329924142939,0.69,14/27,10.05%,AHNAK;CACNB2;ANK2;HRC;JPH2;DMD;JPH4;CALM1;PDE4D;PLN;CACNB1;PRKACA;NOS1;JPH3
prerank,cardiac muscle contraction (GO:0060048),-0.6100160044120789,-1.8516343671560747,0.0,0.01610552198019561,0.69,23/33,23.29%,MYH7;TPM1;ATP1A2;GSN;MYH6;DMD;TCAP;SCN3B;KCNH2;SCN2B;SCN1B;CASQ2;SLC8A1;SCN4B;RYR2;CSRP3;CAMK2D;MYL3;SCN5A;MYBPC3;TTN;MYLK2;MYL4
prerank,rRNA modification (GO:0000154),0.6337449737344568,1.8515651754945603,0.0,0.011448568723270136,0.66,10/19,12.43%,DKC1;GAR1;FBL;TFB2M;NAT10;NSUN3;TFB1M;NOP10;TRMT112;NHP2
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.6545769031742755,-1.8503074962096893,0.0,0.016275446427233185,0.7,14/21,19.42%,GPM6B;VCL;MACF1;DUSP3;CLASP1;CORO1C;DAPK3;EFNA5;PEAK1;RHOA;EPHA3;ROCK1;LIMCH1;SLK
prerank,neuron cell-cell adhesion (GO:0007158),-0.6894358637519957,-1.8479282669557686,0.0,0.01684464456600073,0.73,13/16,19.37%,NLGN2;NLGN3;NRXN1;NLGN4X;NLGN1;NRXN3;NRXN2;ASTN1;ASTN2;NCAM2;CNTN4;NLGN4Y;RET
prerank,neuron projection morphogenesis (GO:0048812),-0.4525400639118746,-1.8464659743407095,0.0,0.016733323436694987,0.73,59/137,18.72%,APBB1;MAP6;S100B;BRSK1;CTNND2;DSCAML1;ZDHHC17;GAS7;MAP1A;SLITRK2;MAP1B;ANK3;NYAP1;SPTBN4;MEF2A;ADGRB1;CNTNAP1;SHANK3;FGFR2;DLG4;PACSIN1;NLGN1;DCLK1;NEFH;FLRT1;PARD3;GPM6A;NGF;DIP2A;EPB41L3;SLITRK3;SRGAP2;PTEN;MAP2;LRRK2;NTNG1;SDC2;NCKAP1L;DICER1;TAOK2;DAB2IP;SLITRK5;RAB3A;ISL2;KLF7;ZNF335;ATL1;CNTN4;DBN1;ROCK1;NTF3;TRIO;BAIAP2;NRK;PLXNB1;MYO16;ALS2;DCC;UBB
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.4171992227772932,-1.8457122055955404,0.0,0.016625182911083697,0.73,67/160,24.54%,PDE2A;GLP2R;ADCY5;GABBR1;PTH1R;GNAO1;CNR1;ADCYAP1R1;ADCY2;LPAR1;ADRB3;ADGRD1;ADCY4;ADGRB3;GNAZ;VIPR2;GALR2;AKAP12;ADGRB1;GPER1;GNAI1;GPR26;ADRB2;ABCA1;PTGER3;CORT;ADCY9;CHRM2;ADGRL3;GRK5;ADRA1D;S1PR1;RAMP1;ADGRL2;GPR161;ADORA2A;VIP;MC1R;GPR12;P2RY12;GNA12;GNAL;S1PR3;ADGRG4;AVPR2;OPRL1;S1PR2;ADCY6;GNAQ;TBXA2R;CRHR1;WASF2;RAMP3;ADGRL1;ADGRB2;GNAI2;LHCGR;HTR1E;PTGFR;CRHR2;ADGRL4;RAMP2;GNA11;ADRA1B;ADCYAP1;GNA14;RGS1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5986584645626034,1.8452543296809336,0.0,0.012494264764135754,0.69,12/24,19.37%,RFC3;RPA3;RFC5;RFC2;POLD2;POLB;LIG1;UBA52;RPA2;POLD1;LIG3;RFC4
prerank,regulation of AMPA receptor activity (GO:2000311),-0.6440198354833571,-1.8448113587249533,0.0,0.01652008859746145,0.74,12/24,15.45%,PRRT1;NLGN2;NLGN3;SHANK3;NLGN1;ADRB2;GSG1L;SHISA7;MEF2C;CACNG7;RELN;CNIH2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.5263618017225495,-1.8446339287796514,0.0,0.016417913570328714,0.74,24/48,20.44%,BVES;RADIL;TMEFF2;FERMT2;LAMA5;PXN;LAMB2;ATRNL1;PIK3R1;ILK;ITGB3;LAMC1;PARVA;SRGAP2;NTNG1;FER;LAMB1;RAC1;PEAK1;RHOA;LAMB4;MEGF9;NTN4;ITGA8
prerank,regulation of viral genome replication (GO:0045069),0.46282795843151403,1.8442702429483364,0.0,0.012570033087388544,0.7,22/66,15.83%,HACD3;IFITM3;IFITM1;PABPC1;CXCL8;PPIH;IFITM2;SRPK1;PROX1;PDE12;STAU1;SLPI;OAS2;TARBP2;APOBEC3F;DDB1;TMEM39A;BST2;OASL;MX1;ISG15;BANF1
prerank,mitotic nuclear membrane organization (GO:0101024),0.5063729518380812,1.8382923887128884,0.0,0.013486278469991826,0.74,30/51,27.42%,NUP37;RAN;CDK1;VRK1;RCC1;NUP155;NUP93;NUP35;SEH1L;SEC13;CHMP4C;NUP43;RANGAP1;NUP107;SPAST;NUP205;KPNB1;BANF1;NUP160;SUMO1;NDC1;CHMP2B;CCNB2;REEP4;PPP2R2A;PPP2CA;CHMP2A;NUP98;PPP2R1A;CCNB1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.5063729518380812,1.8382923887128884,0.0,0.013486278469991826,0.74,30/51,27.42%,NUP37;RAN;CDK1;VRK1;RCC1;NUP155;NUP93;NUP35;SEH1L;SEC13;CHMP4C;NUP43;RANGAP1;NUP107;SPAST;NUP205;KPNB1;BANF1;NUP160;SUMO1;NDC1;CHMP2B;CCNB2;REEP4;PPP2R2A;PPP2CA;CHMP2A;NUP98;PPP2R1A;CCNB1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.5322236609053396,-1.835380466717025,0.0,0.018075918859208676,0.77,18/44,13.83%,GABBR1;ATP1B2;KCNMB1;FLNA;ANK2;KCNN3;AKAP6;KCNMA1;WNK3;ACTN2;KCNIP2;KCNH2;NPPA;AMIGO1;GNG2;KCNMB2;KCNMB4;KCNE1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4630508160209998,-1.83232445789379,0.0,0.018450804188402097,0.77,60/107,26.53%,GRIK5;GRIK3;NPTX1;NLGN2;LGI1;ATP1A2;STX1B;CPLX3;NLGN3;GRM6;PXK;NLGN4X;CAMK2A;SLC8A2;NPAS4;DLG4;DLGAP2;TMEM108;NLGN1;GRIK2;NGF;NPTXR;PTEN;RIMS3;LRRK2;NRG3;LRRC4C;OPHN1;MEF2C;SLC8A3;CHRNB4;KCNMB4;RELN;CDH2;CNTNAP4;NTF3;IQSEC2;NLGN4Y;CACNA1A;GRID1;CACNA1B;SYN1;RIMS1;BEGAIN;GRM2;SYT1;GRID2;DLGAP4;CLSTN2;PSMC5;DGKI;GRIK1;DLGAP3;EIF4EBP2;CLN3;ARC;GRM3;CPLX2;CLSTN3;AKAP9
prerank,cellular protein metabolic process (GO:0044267),0.3737312067200945,1.8301995080174347,0.0,0.014653899062233846,0.76,183/384,27.33%,NOTUM;RPN1;MRPL3;RPN2;PDIA6;ERO1A;EVA1A;HM13;MRPS16;P4HB;RPS21;SERP1;YARS2;TMEM208;FARSB;UBE2S;LOXL2;MRPL37;MRPL13;ATG3;MMP1;CHEK2;MRPS12;RPL36;RPL8;TMEM132A;MSLN;FUCA2;TIMP1;AMELX;SPP1;RPS2;RPS18;PRKDC;SPCS1;IGF2BP3;RPS3;CTSH;RPL37;MRPL42;F5;STOML2;MRPS18B;MRPS33;MRPL52;SERPINA10;MRPL11;APH1A;CKAP4;RPS4X;PARP4;RPL18;SERPIND1;MRPL9;VGF;RPLP0;DNAJC3;RPL39;MRPL36;FN1;FDXR;ABL2;ADAM10;AFP;PCSK9;IGFBP2;RPS14;RPLP2;RRBP1;L2HGDH;MRPL51;MMP2;GSPT1;ADORA2B;PROC;RPL12;RPL28;SRBD1;MRPS18A;RPL27A;COPS5;SEPHS1;CCDC59;RPL29;RPS9;FDX1;B4GALT7;SHISA5;MRPL18;RPL35;LCMT1;RPL37A;PRKCSH;RPL7A;UBL5;BMP4;UBA52;GATA6;C3;IGFBP1;RPL27;RPL32;YME1L1;RPS11;RPS19;ABCF1;MRPS18C;RPL31;MANBA;RPL35A;RPS5;MRPL23;NCSTN;RPS24;RPL18A;IDE;RPS16;LGALS1;RPS29;MMP15;RPS13;RCN1;SPCS2;MRPS11;MRPL27;RPS28;MRPL24;RPS6KB2;IGFBP3;UBE2L6;SLC34A1;SEC11C;RPL11;GOLM1;RPL41;RPS15;RPS8;YES1;RPS12;RPL23;DMBT1;MCRS1;MRPS15;LGMN;LTA4H;MSRB1;MRPS7;UBE2D2;MRPS5;QSOX1;RPS7;MEN1;RPL23A;RPL24;RPL4;WWP2;UBL4A;RPL30;CSNK1G3;RPS26;ICMT;RPLP1;RPL7;SEC11A;CSF2RA;PPP4R2;SERPINA1;RPL13;MRPL28;MAGEA2;IGFALS;RPL13A;HTRA2;KNG1;RPL14;MATN3;RPS20;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,regulation of cation transmembrane transport (GO:1904062),-0.6244945353721085,-1.8291098541122357,0.0,0.0197931311508335,0.78,16/29,16.82%,DPP6;ATP2B4;KCNIP3;HRC;KCNIP4;WNK3;SLMAP;KCNIP2;KCNH2;SNTA1;KCNE2;FGF12;KCNAB3;KCNE1;KCNIP1;CD63
prerank,GPI anchor biosynthetic process (GO:0006506),0.5654254304420254,1.8285474700571376,0.0,0.01479507342699525,0.76,16/30,25.44%,PIGM;PIGU;DPM2;DPM1;PIGW;PIGT;PGAP2;PIGF;PIGO;PIGA;PIGN;PIGX;DPM3;PGAP3;GPAA1;PIGC
prerank,regulation of innate immune response (GO:0045088),0.4725663886216506,1.8271651077902942,0.0,0.014767263138598646,0.77,22/61,20.69%,ABCE1;EREG;LYAR;POLR3C;LRP8;TKFC;USP18;TNFAIP3;AKIRIN2;NMI;DHX9;POLR3B;XIAP;GBP5;FPR2;ADAM8;HSP90AB1;POLR3G;PLSCR1;SLC15A4;ERAP1;IFI16
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.6398438506166638,-1.8259300449916098,0.0,0.020014983985370136,0.8,12/20,23.42%,ADRA2B;ADRB3;PDE4D;ADRB2;ADRA1A;ADCY9;ADRA1D;ADRB1;RAPGEF2;AKAP13;ZDHHC21;ADRA1B
prerank,negative regulation of TOR signaling (GO:0032007),-0.5464554040672174,-1.8257222023849462,0.0,0.019755049128417277,0.8,15/33,20.12%,FLCN;EPM2A;TSC1;SZT2;ARNTL;TNFAIP8L1;PRKAA2;UBR2;RNF152;UBR1;TSC2;DEPDC5;KPTN;GSK3A;SIRT1
prerank,axonogenesis (GO:0007409),-0.4117114006782068,-1.8240708299234722,0.0,0.019971701659791636,0.81,92/235,18.10%,NCAM1;APBB1;GFRA1;GDNF;S100B;PALLD;PDLIM7;SEMA6C;BRSK1;LGI1;EPHA7;ULK1;ROBO3;CNTN2;NLGN3;GAB1;LAMA2;KIF5A;DSCAML1;ZDHHC17;LAMA5;MAP1A;NRP2;MAPK7;NEXN;PPP3CB;SLITRK2;GFRA3;NRXN1;MAP1B;GFRA2;ULK2;ANK3;SPTBN4;ADGRB1;KIF5C;SHANK3;PIK3R1;FGFR2;RPS6KA5;SCN1B;L1CAM;NEFH;PRKCA;PARD3;UNC5D;NRXN3;SEMA4C;EVL;SLITRK3;SLIT2;PTEN;EPHA5;NTNG1;SEMA3E;NRTN;SLIT3;NPTN;GRB10;FEZ2;GLI2;TAOK2;OPHN1;SLITRK5;MAPK1;EPHA4;MAPK3;RANBP9;RAB3A;ISL2;SEMA6D;SEMA6A;KLF7;RELN;EFNA5;SEMA3B;ATL1;EPHA3;CNTN4;VLDLR;SEMA3G;ENAH;EPHA6;NOTCH2;ROBO4;DOK6;BAIAP2;SOS1;DSCAM;SEMA3A;CNTN6;GPC1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.565471293684079,-1.8239945638096675,0.0,0.019718895309667694,0.81,16/38,15.94%,FHL1;GABBR1;KCNMB1;FLNA;ANK2;KCNN3;AKAP6;KCNMA1;ACTN2;KCNH2;AMIGO1;GNG2;KCNMB2;KCNMB4;KCNE1;KCNJ9
prerank,DNA recombination (GO:0006310),0.511127913368016,1.820991373339151,0.0,0.015071100916304864,0.79,12/37,9.40%,RAD54B;TSN;XRCC2;EXO1;RHNO1;BLM;HMGB3;HDAC10;RECQL4;MSH3;RAD51B;RAD54L
prerank,cell junction assembly (GO:0034329),-0.464617091199615,-1.8198763252454142,0.0,0.02015967061658968,0.81,36/102,15.41%,LIMS2;FLCN;NLGN2;FLNA;TLN1;GJC1;FLNC;KIRREL3;CDH19;CTNND2;NLGN3;FERMT2;CDHR3;NRXN1;DNER;SHANK3;ILK;CLDN5;MYO9A;NLGN1;DCHS1;CTNND1;GPM6A;SDK1;ADGRL3;OBSL1;PTEN;NRXN2;CDH10;PCDHB4;OPHN1;TJP1;PCDHB6;CDH2;RHOA;PCDHB5
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.631209742151779,-1.8184592821336292,0.0,0.02013704472364176,0.81,13/20,23.65%,PTCH2;GLI3;KIF7;TULP3;MEGF8;GPR161;GLIS2;BTRC;IFT122;KCTD21;SUFU;KCTD6;HERC4
prerank,cellular response to hormone stimulus (GO:0032870),-0.47346575270034397,-1.815137166244318,0.0,0.02089721954158686,0.84,35/75,20.98%,CACNA1H;KLF9;ATP1A2;SOCS2;THRB;GPER1;NCOA1;BRD8;AR;GHR;CYP11B1;SLIT2;ZFP36L1;GAS2L1;GCK;ATP1A3;RAMP1;AKR1C1;SLIT3;NR3C1;WBP2;RDX;CYP11A1;MEF2C;INPP5K;SFRP1;MGARP;AKR1C2;ARID5A;TFPI;CRHBP;RAMP3;NR4A3;LHCGR;BCAS3
prerank,embryonic organ morphogenesis (GO:0048562),-0.5467523860868827,-1.8128493615751404,0.0,0.021197463079875235,0.85,24/42,22.85%,RBPMS2;FOXF1;DSCAML1;PDGFRA;HOXD3;FGFR2;HOXA4;HOXB4;TCF21;TBX1;MEGF8;RYR2;MFAP5;SOX17;HOXB3;HOXD4;HOXD9;SOX11;EFEMP1;FUZ;OSR2;HOXC4;NIPBL;ID2
prerank,positive regulation of cytokinesis (GO:0032467),0.5297492455751751,1.809492129685919,0.0,0.016685555031555756,0.83,20/37,23.30%,KIF20B;RACGAP1;SSTR5;KIF23;KIF14;AURKB;CXCR5;ECT2;OR2A4;SPAST;DRD2;CENPV;CDC6;PKP4;CDC42;RXFP3;CUL3;GIPC1;CDC14C;CSPP1
prerank,regulation of mitochondrial translation (GO:0070129),0.6272382879095023,1.8090596496707785,0.0,0.016644457605369655,0.84,12/20,15.47%,SHMT2;TRMT10C;NSUN3;TRUB2;FASTKD2;C1QBP;RMND1;UQCC2;COA3;RPUSD4;MALSU1;MTG2
prerank,blood vessel diameter maintenance (GO:0097746),-0.5211785322620635,-1.808864093947086,0.0,0.02225418184948211,0.87,24/33,32.82%,NPR1;AGTR1;GPER1;SCPEP1;NOS1;ECE1;KCNMB2;KCNMB4;HTR2B;ADCY6;ROCK1;EDNRB;NPPB;AGTR2;INS;KLF2;ITGB1BP1;F2RL1;GCLC;EDN3;BDKRB2;PER2;KEL;NOS3
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.4303991421625273,-1.8087989052594748,0.0,0.02199236794537056,0.87,67/139,25.70%,ARHGEF26;INPP5B;FLCN;ARHGAP10;ARHGEF17;TRIP10;ARHGAP33;STARD13;ARHGEF9;SYDE1;PLEKHG2;MYO9A;FAM13B;ARHGAP6;ARHGAP20;ARHGEF6;ITSN1;DLC1;STARD8;OBSCN;RHOQ;RHOJ;MYO9B;RHOB;SRGAP2;SLIT2;ARHGAP21;ARHGAP19;ARHGEF18;ARHGEF11;SYDE2;OPHN1;ARHGAP23;FGD1;ARHGAP24;PLCE1;TIAM1;RAC1;RELN;SOS2;RHOA;ARHGEF7;ARHGAP29;ARHGAP31;MCF2;TRIO;SOS1;RHOT2;CGNL1;FGD2;ARHGAP5;SRGAP1;AKAP13;PIK3R2;ARHGEF3;ARHGDIG;ARHGAP28;RHOU;RHOC;RASGRF2;ARHGAP11B;ARHGAP35;ARHGAP15;ARHGAP1;ARHGAP17;ARAP3;CHN1
prerank,regulation of muscle contraction (GO:0006937),-0.5958734200258425,-1.8072901547122837,0.0,0.022056299247537332,0.87,14/26,16.46%,MYL9;PPP1R12B;TPM1;MYL2;ATP1A2;CNN1;TNNT3;CHRM2;CHRNA3;KCNA1;ANXA6;PLCE1;DAPK3;MYL3
prerank,sterol biosynthetic process (GO:0016126),0.5635402040333602,1.803388109039197,0.0,0.017170924634249962,0.85,20/34,22.36%,CYP51A1;SQLE;NSDHL;DHCR7;SC5D;IDI2;FDPS;ACAT2;MSMO1;DHCR24;TM7SF2;ACLY;HMGCS1;G6PD;INSIG1;FDFT1;MVK;EBP;IDI1;HMGCR
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.43674377200792475,1.8029246387690796,0.0,0.017207313659657518,0.85,27/73,19.61%,SOX4;E2F1;TFDP1;TFAP4;CDK1;TRIAP1;CHEK2;GTSE1;ARID3A;CDC25C;CNOT11;PML;CNOT10;CASP2;USP10;AURKA;BATF;PRMT1;CARM1;MYO6;FOXM1;ACER2;E2F8;CNOT1;PAXIP1;BAX;SFN
prerank,ameboidal-type cell migration (GO:0001667),-0.48361469363356974,-1.801719790819718,0.0,0.02306670775879383,0.88,25/50,22.91%,GDNF;SEMA6C;AMOTL1;RADIL;NANOS1;TBX1;SEMA4C;SRGAP2;SEMA3E;NRTN;MEGF8;CORO1C;ANXA6;SEMA6D;SEMA6A;SEMA3B;HTR2B;PDLIM1;SEMA3G;AMOTL2;SEMA3A;ERBB4;SEMA3C;PKN1;SOX8
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6863222200659573,-1.801556157187096,0.0,0.022804586079716627,0.88,10/17,14.21%,NLGN2;STX1B;NLGN3;NRXN1;CUX2;SHANK3;DLG4;NLGN1;PTEN;RELN
prerank,positive regulation of cell cycle process (GO:0090068),0.4302211909961078,1.801428016977855,0.0,0.0174826677006041,0.85,43/99,22.14%,RCC2;MAD2L1;FEN1;IL1A;KIF20B;DBF4;RANBP1;RACGAP1;EREG;SSTR5;RHNO1;PDGFRB;KIF23;NDC80;KIF14;IL1B;AURKB;CXCR5;SPAG5;ECT2;GPSM2;OR2A4;AURKA;SPAST;DRD2;E2F8;PLK4;NUP62;CENPV;DMRT1;CDC6;LRP5;NPM2;PLSCR1;CDC7;PKP4;TGFA;CDC42;RXFP3;E2F7;CUL3;GIPC1;CDC14C
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.60053872802626,-1.8012070374448108,0.016666666666666666,0.022754275823627775,0.89,12/26,17.24%,MYOCD;CDON;BOC;MEF2A;RBM4;CAMK1;BNIP2;MEF2C;MAPK11;CDH2;SPAG9;MAPK14
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.585776890419319,-1.7994950050662566,0.0,0.022806900091495393,0.9,23/35,25.15%,GRIK5;GRIK3;NLGN2;NLGN3;PXK;NLGN4X;NLGN1;GRIK2;NGF;NRG3;LRRC4C;RELN;NTF3;IQSEC2;NLGN4Y;CACNA1A;GRID1;CACNA1B;GRID2;PSMC5;GRIK1;EIF4EBP2;ARC
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.6048763552160097,-1.7990343243747222,0.0,0.022656972471192194,0.9,12/23,15.59%,ATP2B4;SNCA;ATF4;PRKACA;GNG2;LRRK2;SIRT2;RYR2;MAPK1;MAPK3;APLP1;ADCY6
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.474024855120335,-1.7974659753997138,0.0,0.022709510378371767,0.91,29/72,14.72%,BVES;RADIL;TMEFF2;FERMT2;LAMA5;PXN;LAMB2;ATRNL1;PIK3R1;ILK;ITGB3;ACTN1;METTL3;ATF4;LAMC1;PARVA;SRGAP2;NTNG1;FER;LAMB1;OPHN1;MEF2C;ABI2;UNK;RAC1;RELN;RILPL1;PEAK1;RHOA
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.5005489694364416,-1.7930790581830327,0.0,0.023746239582590967,0.91,22/54,16.82%,FHL1;DPP6;GABBR1;KCNMB1;KCNIP3;FLNA;KCNN3;AKAP6;KCNMA1;KCNIP4;KCNIP2;KCNH2;AMIGO1;GNG2;KCNE2;KCNAB3;KCNMB2;KCNMB4;KCNE1;KCNIP1;KCNJ9;CD63
prerank,regulation of calcium ion transport (GO:0051924),-0.48930768248701334,-1.790597258062806,0.0,0.02427349121629995,0.92,19/56,14.98%,CAMK2G;CACNB2;ANK2;HRC;MYLK;PKD2;CASQ1;WNK3;STIM1;CAMK2A;CACNA2D1;PLN;BCL2;NOS1;TRPC6;INPP5K;HOMER2;CAMK2B;HOMER3
prerank,regulation of endopeptidase activity (GO:0052548),0.47284237097915005,1.7896954694964087,0.0,0.019814830482582924,0.9,22/57,13.41%,SERPINB5;PSMB9;PSME3;PSMA3;GAPDH;TIMP1;SERPINB1;CRB2;PSME2;SERPINE3;SERPINA10;APH1A;ATP13A2;SERPIND1;HDAC1;SERPINA7;SERPINA4;SERPING1;PRELID1;SERPINB7;AGT;PSME1
prerank,cardiac muscle cell action potential (GO:0086001),-0.5839528385483495,-1.7881910209271188,0.0,0.024789642815615055,0.92,17/30,13.83%,CACNA1C;ANK2;ATP1A2;DMD;SCN3B;CACNA2D1;KCNIP2;KCNH2;SCN2B;SCN1B;SLC8A1;KCNE2;SCN4B;FGF12;CACNA1G;KCND3;KCNE1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.525030597105853,-1.7861212951280319,0.0,0.025104135284863095,0.92,19/37,18.20%,FAM107A;MAP6;STMN4;MAPT;PHLDB1;PHLDB2;STMN2;CLASP1;CLASP2;BICD2;GAS2L1;PRKAA2;TPPP;MAPRE3;EFNA5;EPHA3;ROCK1;MAP6D1;MAPRE2
prerank,negative regulation of angiogenesis (GO:0016525),-0.4644947440828927,-1.784538589465532,0.0,0.025412143373301888,0.92,35/78,19.26%,YJEFN3;ATP2B4;NPR1;EPN2;FOXJ2;MECP2;PTPRM;STAB1;PDE3B;ADGRB1;CLDN5;ADAMTS1;SEMA3E;DCN;EMILIN1;ANGPT4;FOXO4;THBS4;SYNJ2BP;PRL;DAB2IP;KRIT1;SEMA6A;HSPG2;ADAMTS9;ECSCR;ROCK1;SPINK5;COL4A2;NPPB;SERPINF1;HOXA5;COL4A3;AGO1;HHEX
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5460460633876135,1.7829365194513456,0.02631578947368421,0.021176751225611162,0.91,9/25,8.31%,E2F1;TFDP1;TP73;GZMB;YWHAB;YWHAE;PMAIP1;BBC3;YWHAG
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5460460633876135,1.7829365194513456,0.02631578947368421,0.021176751225611162,0.91,9/25,8.31%,E2F1;TFDP1;TP73;GZMB;YWHAB;YWHAE;PMAIP1;BBC3;YWHAG
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.46830917704851405,1.7827062425933637,0.0,0.02102866205620129,0.91,21/52,16.09%,POLR2D;DCPS;EXOSC5;LSM7;LSM5;LSM4;EXOSC4;EXOSC8;CNOT11;CNOT10;EXOSC7;PDE12;LSM2;EXOSC1;EXOSC3;DIS3;EXOSC2;LSM6;PATL1;CNOT1;LSM3
prerank,striated muscle cell differentiation (GO:0051146),-0.6673115966967649,-1.7814992124255837,0.0,0.026835925171434308,0.92,10/18,20.66%,POPDC2;BVES;MYOCD;MYEF2;MEF2C;SKI;KDM6B;CBY1;POPDC3;AKAP13
prerank,regulation of primary metabolic process (GO:0080090),0.40785902136552,1.7807527137366832,0.0,0.02119086037720674,0.92,58/125,22.36%,PSMD14;PSMB2;CYP51A1;PSMB9;PSMA5;PSMB3;PSME3;ODC1;PSMA3;ADIPOR1;TGS1;SQLE;NQO1;DHCR7;PSMA7;SC5D;AZIN1;PSMD13;SCD;PSME2;PSMC2;PSMC4;PSMD10;NFYA;HELZ2;PSMD12;PSMB5;FGFR4;PSMD8;CERS2;PSMB4;PSMD3;PSMB1;PSMA4;FDPS;OAZ3;CARM1;PSME1;PSMF1;PSMD11;PSMD1;TM7SF2;HMGCS1;PPARG;MED1;EDF1;FASN;FDFT1;MVK;PSMD6;PRKAB1;PSMD5;HNF4A;IDI1;PSMC1;LDLR;ELOVL6;HMGCR
prerank,axon guidance (GO:0007411),-0.4126685478945733,-1.7805490031231337,0.0,0.02684253663365935,0.92,79/201,18.10%,NCAM1;GFRA1;GDNF;NTN1;PALLD;PLXNB3;PDLIM7;SEMA6C;LGI1;EPHA7;ROBO3;CNTN2;GAB1;LAMA2;KIF5A;DSCAML1;LAMA5;PTPRM;NRP2;MAPK7;NEXN;GFRA3;NRXN1;GFRA2;SPTBN4;KIF5C;SHANK3;PIK3R1;RPS6KA5;SCN1B;L1CAM;PRKCA;GAP43;UNC5D;NRXN3;SEMA4C;EVL;SLIT2;EPHA5;SEMA3E;NRTN;NFIB;SLIT3;NPTN;GRB10;TMEFF1;FEZ2;GLI2;RNF165;OPHN1;MAPK1;EPHA4;MAPK3;RANBP9;SEMA6D;SEMA6A;RAC1;KLF7;NTN5;RELN;EFNA5;SEMA3B;EPHA3;CNTN4;VLDLR;SEMA3G;ENAH;EPHA6;NOTCH2;ROBO4;DOK6;SOS1;SMO;DSCAM;SEMA3A;PLXNA4;PLXNB1;CNTN6;GPC1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.5362734733469116,-1.7791163451551597,0.0,0.027123920465957022,0.92,16/30,22.87%,VAMP2;MACF1;RAB34;ANK3;VAMP4;BBS1;GGA3;OPTN;BBS2;KIF13A;GGA2;VAMP5;PREPL;GOLGA7;RAB31;GGA1
prerank,positive regulation of viral transcription (GO:0050434),0.548624027888782,1.7788328141074823,0.0,0.021656926447446496,0.94,17/26,27.56%,POLR2F;POLR2D;NELFCD;DHX9;POLR2C;GTF2F2;POLR2K;POLR2J;POLR2G;NELFE;POLR2H;POLR2I;POLR2L;NELFA;POLR2B;NELFB;GTF2F1
prerank,positive regulation of T cell proliferation (GO:0042102),0.4554510809310265,1.7787821462458688,0.0,0.021584593424314992,0.94,16/64,10.97%,IL23A;SLC7A1;ZP3;CD276;IL1B;SYK;PNP;TNFSF9;RPS3;CD46;IL27RA;IL21;CD80;IGFBP2;JAK3;CD70
prerank,GPI anchor metabolic process (GO:0006505),0.5532013789172427,1.7769431334540786,0.0,0.02173969972946241,0.94,13/26,25.44%,PIGM;PIGU;DPM2;DPM1;PIGW;PGAP2;PIGF;PIGO;PIGA;PIGN;DPM3;PGAP3;PIGC
prerank,7-methylguanosine mRNA capping (GO:0006370),0.5377466129431333,1.7731398960747438,0.0,0.022043666448274806,0.94,17/31,22.59%,POLR2F;POLR2D;CDK7;GTF2H3;NCBP1;NCBP2;POLR2C;GTF2F2;POLR2K;POLR2J;POLR2G;ERCC2;POLR2H;POLR2I;POLR2L;RNGTT;CMTR2
prerank,7-methylguanosine RNA capping (GO:0009452),0.5377466129431333,1.7731398960747438,0.0,0.022043666448274806,0.94,17/31,22.59%,POLR2F;POLR2D;CDK7;GTF2H3;NCBP1;NCBP2;POLR2C;GTF2F2;POLR2K;POLR2J;POLR2G;ERCC2;POLR2H;POLR2I;POLR2L;RNGTT;CMTR2
prerank,purine nucleotide metabolic process (GO:0006163),0.5855901268701899,1.772959260463984,0.0,0.021896708671952973,0.94,10/24,13.74%,PPAT;HPRT1;GART;MTHFD1;NUDT15;ITPA;PNP;DNPH1;GPX1;PRPS2
prerank,intracellular protein transmembrane transport (GO:0065002),0.5184352379295063,1.7720145257281688,0.017543859649122806,0.02182518282028604,0.94,18/43,14.02%,HSPD1;TIMM23;PEX7;GRPEL1;ROMO1;TOMM40;SEC61B;GRPEL2;SEC61A1;TOMM20;TIMM50;SEC61G;TIMM17B;TOMM20L;AIFM1;PEX10;DNAJC15;PEX16
prerank,nucleic acid metabolic process (GO:0090304),0.4488864815709763,1.7711134317056354,0.0,0.021754598098246303,0.94,34/71,21.64%,POLR2F;POLR2D;FEN1;RAN;HNRNPF;LSM8;NCBP1;PTBP1;TOPBP1;DNA2;HNRNPK;PDE12;WDR74;DDX54;DUSP11;NCBP2;HNRNPC;POLR2C;GTF2F2;POLR2K;HNRNPA0;POLR2J;KPNA2;POLR2G;DNASE1L1;DNASE2;XRN2;HNRNPR;HNRNPA2B1;POLR2H;HNRNPA1;POLR2I;DDX1;POLR2L
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.40385562434122935,1.7709034832786714,0.0,0.021612411182571494,0.94,68/147,21.73%,PSMD14;RCC2;CCND1;CEP72;PSMB2;CDK1;FBXO5;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;CEP250;KIF14;PSMA7;YWHAE;NEK2;PSMD13;CDC25C;PSME2;PSMC2;PSMC4;PSMD10;CDK4;TUBB4B;HAUS2;PSMD12;RAB11A;PSMB5;YWHAG;TUBA4A;RAD51B;HAUS8;CEP76;AURKA;PSMD8;TPX2;PSMB4;PSMD3;PSMB1;PSMA4;CKAP5;HAUS1;PSME1;HAUS6;PSMF1;PLK1;PSMD11;TUBG1;PSMD1;CEP78;CENPF;PLK4;CDC25A;DYNLL1;HAUS7;PSMD6;CDC7;STOX1;MAPRE1;SSNA1;CEP41;PSMD5;HSP90AA1;TUBB;CDK2;PSMC1;DTL
prerank,positive regulation of neuron projection development (GO:0010976),-0.487517655189542,-1.770840976677267,0.0,0.029123556561319923,0.94,36/84,15.70%,ATP1B2;PLXNB3;CAPRIN2;RAP1A;PTN;MAGI2;LRRC7;ROR2;CUX2;ZDHHC15;STMN2;NTRK3;PACSIN1;SCN1B;NDRG4;KIDINS220;FES;DPYSL3;CAMK1;PRKD1;ALK;BHLHB9;NPTN;NTRK1;ROR1;DAB2IP;TOX;TENM3;RIT2;RAPGEF1;FUT9;RELN;CAMK2B;EPHA3;VLDLR;DBN1
prerank,synapse assembly (GO:0007416),-0.4867671256177181,-1.7697237155646492,0.0,0.02919738391440127,0.94,39/69,28.52%,NLGN2;KIRREL3;NLGN3;NRXN1;NLGN4X;DNER;SHANK3;NPAS4;NLGN1;GPM6A;SDK1;ADGRL3;OBSL1;PTEN;NRXN2;PCDHB4;FGF13;PCDHB6;CDH2;PCDHB5;NLGN4Y;DSCAM;PLXNB1;LGI2;GABRG2;SLITRK1;FZD1;LRRTM3;PCDHB3;PCDHB2;GRID2;PCDHB10;GABRA1;SDK2;PCDHB14;DNM3;RYK;RAB29;DVL1
prerank,negative chemotaxis (GO:0050919),-0.5466237690234997,-1.769074993610555,0.0,0.029002880057406154,0.94,22/32,28.34%,NTN1;SEMA6C;EPHA7;ITGB3;SEMA4C;SLIT2;SEMA3E;SLIT3;SEMA6D;SEMA6A;SEMA3B;RHOA;SEMA3G;SEMA3A;UNC5C;LRTM2;SEMA3C;SLIT1;PDGFA;SEMA4B;SEMA3D;SEMA6B
prerank,termination of RNA polymerase I transcription (GO:0006363),0.503475483060796,1.7654554538662552,0.020833333333333332,0.022624933714658322,0.94,12/26,21.64%,POLR2F;POLR1C;CDK7;POLR1B;GTF2H3;TAF1A;POLR1A;TAF1B;POLR2K;ERCC2;POLR2H;POLR2L
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4448760555456078,1.7642868722128977,0.0,0.022836911725216864,0.95,35/73,20.84%,PNPO;SHMT2;MTHFD1;MTHFD1L;MMACHC;DHFR;TCN1;SLC5A6;PDZD11;HLCS;SLC52A2;SLC19A1;MCCC2;PCCB;MTHFD2;GSTO2;PDXK;RFK;SLC52A3;SLC25A19;AASDHPPT;GSTO1;VNN1;FLAD1;CD320;MMAA;ACP5;PRSS3;MMAB;SLC2A1;MMADHC;THTPA;BTD;FPGS;PCCA
prerank,protein glycosylation (GO:0006486),0.4221301790025277,1.760427107857692,0.0,0.023970864158160576,0.96,46/126,15.74%,POMK;RPN1;GALNT6;RPN2;STT3A;ALG1;ALG8;PMM2;STT3B;ALG5;C1GALT1C1;MGAT5;B3GNT4;SERP1;DDOST;MAGT1;ALG10;FUT8;POFUT1;MGAT2;FUT1;PLOD3;DPM1;ALG3;ALG11;ALG2;GFPT1;B3GNT2;ALG1L2;B3GALNT2;PGM3;SLC39A8;DAD1;DPAGT1;GALNT1;B4GALT7;TMEM165;ST8SIA6;GALNT7;FUT7;TMEM258;B4GALT1;FUT2;B3GNT3;B3GNT5;FUT10
prerank,synaptic vesicle exocytosis (GO:0016079),-0.5331345321799174,-1.7587821701506556,0.0,0.032600865944659885,0.96,15/39,13.14%,PRRT2;VAMP2;PIP5K1C;STX1B;CPLX3;SYT10;SNCA;SNPH;STX2;RIMS3;UNC13C;SNAP25;SYT2;SYT5;RAB3A
prerank,synaptic vesicle recycling (GO:0036465),-0.5524437017684692,-1.758290461833565,0.0,0.032464924109832725,0.96,18/34,13.14%,VAMP2;PIP5K1C;STON1;NLGN2;NLGN3;NLGN4X;SYNJ1;AMPH;SNCA;PACSIN1;NLGN1;KIAA1109;SNCB;SYT2;SNCG;OPHN1;SYT5;RAB3A
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.43986345144337946,1.7577388754555914,0.0,0.024595631620673634,0.96,27/64,21.67%,SOX4;RFWD3;CCND1;E2F1;TFDP1;CDK1;TRIAP1;CHEK2;GTSE1;ARID3A;CDC25C;PRKDC;CNOT11;PML;CNOT10;CASP2;AURKA;PRMT1;CARM1;E2F8;RPA2;CNOT1;SDE2;BAX;SFN;E2F7;CDK2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5089530144992255,-1.756995437582661,0.0,0.03233154721528533,0.96,25/52,18.72%,SNX1;GAS7;NYAP1;CNTNAP1;PACSIN1;DCLK1;GPM6A;NGF;WASF1;EPB41L3;SRGAP2;LRRK2;NCKAP1L;DICER1;TAOK2;DAB2IP;ZNF335;DBN1;NTF3;TRIO;NRK;PLXNB1;MYO16;ALS2;UBB
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.6246822667998116,-1.7558636530240017,0.0,0.03228630340889681,0.96,10/17,23.42%,ADRA2B;ADRB3;ADRB2;ADRA1A;ADCY9;ADRA1D;ADRB1;RAPGEF2;AKAP13;ADRA1B
prerank,mRNA modification (GO:0016556),0.5521407614576649,1.7548135271360568,0.022222222222222223,0.025001801297517293,0.97,10/21,15.36%,DKC1;PUS7;TRMT10C;PUS1;TRUB2;TRUB1;TRMT6;RPUSD2;TRMT61B;NSUN2
prerank,nucleotide-excision repair (GO:0006289),0.4373570526540238,1.7543494764774272,0.0,0.024914345346402383,0.97,38/105,19.68%,POLR2F;RFC3;POLR2D;RPA3;RFC5;PRPF19;CDK7;RFC2;POLD2;POLB;GTF2H3;ERCC8;HMGN1;LIG1;ERCC5;POLA1;COPS5;RAD23B;DDB1;POLR2C;BRCA2;POLR2K;HUS1;POLR2J;UBA52;SLC30A9;RPA2;POLR2G;POLD1;CUL4A;COMMD1;LIG3;GTF2H2C;FANCC;RFC4;ERCC2;BRIP1;POLR2H
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6609380178611641,-1.7540529858669163,0.0,0.032157050352220065,0.96,8/17,14.21%,NLGN2;TSHZ3;NLGN3;NRXN1;SHANK3;NLGN1;CACNG7;RELN
prerank,nervous system development (GO:0007399),-0.3772598564398145,-1.7505440871429523,0.0,0.032786787074520325,0.97,153/439,19.66%,PKD1;MAL;MAB21L2;MPZ;RBFOX3;GPM6B;HDAC4;GFRA1;GDNF;NFASC;S100B;ATN1;NR2C2;ROGDI;NPTX1;NLGN2;SZT2;LGI1;NUMBL;TMOD2;TENM1;CYP46A1;LPAR1;PKD2;PRX;GSN;KIRREL3;FGF2;DCTN1;GBA2;NLGN3;DSCAML1;CRMP1;INTU;PTN;TRIM3;HAP1;PMP22;GFRA3;NRXN1;PPP2R5D;GFRA2;WWTR1;LRCH4;DNER;ADGRB1;LY6H;ATXN3;TAGLN3;SHANK3;PHOX2B;PTPRZ1;DLG4;TRAK2;PCDHB15;MTR;MBNL1;NAV2;NLGN1;DCLK1;DCHS1;SCRG1;NRSN1;L1CAM;IRF2BPL;TEAD1;NAB2;HAPLN2;GPM6A;NGF;SNTG2;RBFOX2;SDK1;CHRM2;ADGRL3;EVL;CHRNA3;OBSL1;FAT4;DYRK1A;PTEN;ZBTB16;NRXN2;FGF12;NAV1;MBD5;ZNF358;NRTN;LSAMP;HPCAL4;ADAM23;GLRB;PCDHB4;ADORA2A;LDB2;MOBP;FEZ2;NRSN2;OPHN1;MERTK;MEF2C;ACTL6B;MYT1L;SH3GL3;NAV3;ARNT2;FGF17;SEMA6A;APLP1;DPYSL5;MARK4;NTN5;FGF13;RELN;EFNA5;CNTFR;PCDHB6;CDH2;PCDHA3;APBA1;CNTN4;VLDLR;SDHA;MOG;PCDHB5;GLIS2;SCD5;NOTCH2;APC;NTF3;DPYSL4;ZC4H2;SPINK5;EDNRB;FGF5;AHI1;ZEB2;SMO;DSCAM;PCDHB12;SPOCK1;MYLIP;CNTN6;ERBB4;CHST8;DPF2;DPYSL2;HAPLN4;POU3F3;APAF1;CDK5RAP2;ADGRB2;RBM45
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5480614355870086,1.7499469087446617,0.0,0.02586826119501201,0.98,14/25,28.65%,CBFB;IL4I1;FOXP3;CD46;MDK;SOCS1;RUNX1;FANCA;LILRB4;TNFSF4;IL2RA;IFNG;CTLA4;BCL6
prerank,cardiac muscle cell development (GO:0055013),-0.5841003372545739,-1.7480381287229285,0.0,0.0335716828863043,0.97,14/23,22.85%,MYL2;MYH6;TCAP;SORBS2;PDGFRA;SLC8A1;OBSL1;CSRP3;ACTC1;FHOD3;HEY2;MYLK3;ALPK3;TTN
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6035295952226684,-1.7464222576644737,0.017241379310344827,0.03384711282883606,0.97,12/18,24.54%,GRIK5;GRIK3;SLC17A7;GRIK2;GRIA2;UNC13C;NAPB;GRID1;SLC17A8;CDH8;GRID2;GRIK1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6357710627504151,-1.744538386533283,0.0,0.034444891759676355,0.97,10/16,18.27%,AKAP6;TGFBR3;BMPR1A;FGF2;FGFR2;ZFPM2;RBPJ;MEF2C;TBX2;ERBB4
prerank,vesicle transport along microtubule (GO:0047496),-0.5794624330937264,-1.7428933986768371,0.0,0.03478881212597334,0.98,10/21,13.99%,DYNC1I1;FYCO1;KIF5A;HAP1;PAFAH1B1;TRAK2;KIF1A;KIF1C;NDEL1;KIF13A
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4225491865089835,1.7418077105021121,0.0,0.02777522325036841,0.99,32/85,14.94%,PSMD14;CELSR1;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;CELSR3;PSMA7;PSMD13;WNT5A;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;AP2S1;ARHGEF19;PSMB4;PSMD3;PSMB1;PSMA4;CLTC;WNT11;PSME1;PSMF1;PSMD11;PSMD1;AP2B1
prerank,oxoacid metabolic process (GO:0043436),0.5107533872229133,1.7408709077241147,0.0,0.02822023264778724,0.99,10/29,17.98%,SULT2B1;LIPT2;SULT1C2;SULT1C3;MINPP1;PPA1;PPA2;BPNT1;SULT1A3;TPST2
prerank,myelination (GO:0042552),-0.5007321172487833,-1.7389285324923256,0.0,0.036171657804885786,0.98,24/47,21.54%,LGI4;MAL;MPZ;NFASC;PLP1;MYOC;PMP22;CNTNAP1;AMIGO1;PARD3;MARVELD1;ARHGEF10;EPB41L3;SIRT2;TPPP;FAM126A;SLC8A3;SKI;EIF2B4;SBF2;GPC1;ZNF24;DEGS1;ABCD1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.5936913432956574,-1.7377564649306678,0.0,0.03609616912772776,0.98,13/27,9.83%,ATP2B4;FXYD6;FXYD7;FXYD1;SCN3B;FXYD2;SLMAP;SCN2B;SCN1B;SNTA1;NOS1;SCN4B;FGF12
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.4388278241999738,1.7375545149403415,0.0,0.02886400828088644,0.99,19/41,22.29%,RFC3;RPA3;RFC5;RFC2;POLD2;POLH;WRNIP1;USP10;POLA1;UBA52;VCP;RPA2;ISG15;POLD1;SPRTN;UBE2L6;RFC4;DTL;USP43
prerank,positive regulation of translation (GO:0045727),0.4176586068878408,1.7374683675067015,0.0,0.028688008230393233,0.99,48/96,26.54%,SOX4;POLR2D;CDC123;KHDRBS1;EIF2S3;TRMT10C;EIF5A;EIF3C;NAT10;TRUB2;FASTKD2;EIF4A3;C1QBP;PRKDC;YTHDF1;RMND1;EIF5AL1;UQCC2;RPS4X;EIF6;DHX9;EIF3D;RPS9;ELAVL1;COA3;RPUSD4;NPM1;YTHDF2;LARP4B;RBM3;POLR2G;NSUN5;EIF3E;JMJD4;PKM;RPS6KB2;PASK;UHMK1;EEF2;MRPS27;LARP1;METTL5;THBS1;LARP4;HNRNPD;FASTKD3;RPUSD3;LIN28A
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.533112162635644,-1.7366677538272404,0.0,0.03594298640496984,0.98,19/35,24.16%,TNNI3K;ANK2;RGS2;CALM1;PDE4D;PLN;NPPA;SLC8A1;ADRA1A;PRKACA;NOS1;RNF207;RYR2;ASB3;SCN5A;SMAD7;CAV3;CALM2;ATP2A2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5731441465315237,1.7352297592551673,0.0,0.028984893850158875,0.99,13/24,16.16%,HSD17B12;DGAT2;TECR;ACSL6;THEM5;ACOT7;HACD2;ACSL3;ELOVL1;ACSL5;ELOVL7;FAR2;ACSF3
prerank,protein localization to cilium (GO:0061512),-0.5279036997529089,-1.7335519571507294,0.0,0.03728050976494439,0.98,21/34,28.14%,TUB;WDR19;RABEP1;BBS4;TTC21A;BBS1;TULP3;ZNF423;TTC21B;TULP1;BBS9;IFT122;CSNK1D;ARL3;TULP2;WDR35;ARL6;FSIP2;ROPN1;IFT140;RAB29
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5939145207865785,1.7334143879871482,0.02127659574468085,0.02974611901361244,1.0,9/16,30.97%,IL23A;SYK;CD55;CD81;TGFBR2;TNFSF4;IL12B;IL18;XCL1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.6444006931723738,1.7329479877931535,0.0,0.029700888421557835,1.0,12/15,31.57%,TNFSF11;IL23A;IL17A;POU4F1;ATP6AP1;IL23R;IL12B;OCSTAMP;TYROBP;IFNG;TRAF6;TNF
prerank,inner mitochondrial membrane organization (GO:0007007),0.5563544540086652,1.7318248062788608,0.0,0.02998644346364216,1.0,11/28,11.78%,TIMM8A;MTX1;ROMO1;TIMM10;APOO;TIMM13;HSPA9;UQCC3;TIMM8B;CHCHD6;CHCHD3
prerank,regulation of DNA binding (GO:0051101),0.494109061027671,1.731208090994894,0.0,0.02980900888693422,1.0,25/45,21.40%,E2F1;TFAP4;MDFI;HJURP;LEF1;HMGB2;HMGA2;CEBPG;KDM1A;NME1;CDT1;MMP9;PPARG;PLAUR;EDF1;SUMO1;GZMA;TGFB1;CPNE1;SUMO3;NFKBIA;MMP8;HES1;IFI16;HMGB1
prerank,protein import into nucleus (GO:0006606),0.4336057444330713,1.730354422865233,0.0,0.029960023689665386,1.0,23/74,15.20%,RGPD4;RAN;CSE1L;NXT2;NUP155;E2F3;NUP62CL;NUP93;NUP35;NUTF2;SYK;SEC13;NXT1;NUP50;NUP88;NUP107;TNPO3;KPNA7;HEATR3;KPNB1;KPNA2;MMP12;NUP62
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5780087901839748,1.7296385265461418,0.0,0.029784818872766756,1.0,14/23,18.79%,RCC2;CCND1;CDK1;FBXO5;CDC25C;CDK4;RAB11A;RAD51B;ATAD5;NPM1;CDC25A;DYRK3;CDC7;STOX1
prerank,peripheral nervous system development (GO:0007422),-0.5973055072147336,-1.7292401266041673,0.0,0.038517706570987985,0.98,11/24,22.91%,GDNF;NFASC;PMP22;GFRA3;ADGRB1;NGF;GSTM3;NTF3;GPC1;ADGRB2;SOX8
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4413363866494381,1.728828471119058,0.0,0.029998731730608102,1.0,27/73,14.34%,PSMD14;CA9;PSMB2;PSMB9;PSMA5;PSMB3;VHL;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;UBA52;PSMD1
prerank,negative regulation of reproductive process (GO:2000242),0.6098376762643151,1.727499926962473,0.0,0.030338452590905,1.0,8/20,14.27%,CALR;WDR77;ZP3;TIMP1;HYAL3;DUSP1;ARHGDIB;SEMG1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5458794822012821,-1.7269378361153207,0.0,0.039426093795622286,0.98,17/32,17.38%,DLG2;GRIA4;ACTN2;CAMK2A;LRRC7;DLG4;GRIA1;NLGN1;GRIA3;DAPK1;GRIA2;MEF2C;RELN;CAMK2B;NEFL;CRHBP;GRIN2A
prerank,potassium ion transport (GO:0006813),-0.4376634021970072,-1.7267701461288933,0.0,0.039326630180089715,0.98,53/120,24.96%,KCNB1;KCNMB1;KCNQ4;KCNN3;ATP1A2;KCNA5;PKD2;KCNMA1;KCNK3;SLC9A9;ABCC8;KCNIP2;SLC24A4;KCNH2;KCNA2;KCNK4;KCND1;ATP1A4;KCNE2;SLC24A3;ABCC9;KCNA1;KCNAB3;KCNMB2;KCNJ8;AQP1;LRRC55;KCNMB4;KCND3;KCNE1;TMEM175;KCNQ5;KCNA4;KCNC1;KCNJ1;KCNK2;SLC9A5;KCNS2;KCNN1;HCN3;KCNS3;KCNK7;KCNF1;KCNH5;LRRC52;KCNG1;KCNH1;KCNK6;KCNMB3;KCNJ5;KCNN2;HCN2;LRRC38
prerank,calcium ion transport (GO:0006816),-0.41695907951633765,-1.7247264858737752,0.0,0.03983466094788193,0.98,34/112,15.16%,PKD1;RYR3;CACNA1H;ATP2B4;CACNA1C;CACNB2;ANK2;TRPV1;PKD2;TRPC1;ITPR1;STIM1;CAMK2A;CACNA2D1;SLC8A2;SLC24A4;RYR1;P2RX7;ORAI3;SLC8A1;CDH23;PSEN1;TRPC6;TRPC4;SLC24A3;RAMP1;CACNA1G;RYR2;SLC8A3;MCOLN3;CACNG7;TRPV3;MCOLN1;PSEN2
prerank,protein sumoylation (GO:0016925),0.47794540518461004,1.7225370718471547,0.0,0.032141021582782786,1.0,24/53,21.58%,NUP37;NUP155;RAE1;NUP93;NUP35;SEH1L;NUP210;NUP43;NUP50;NUP88;RANGAP1;NUP107;RNF212B;UBA2;NUP205;NSMCE2;NUP62;NUP160;EYA1;SUMO1;NDC1;SUMO3;TRIM28;ZBED1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.40133114176389295,1.721879971573743,0.0,0.032337803347575335,1.0,41/116,20.61%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;NRAS;PSMD13;SYK;MUC5AC;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;CLEC6A;RELA;FFAR2;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1;PAK1;LYN;MUC20;PSMD6;MUC17;FYN;PSMD5;CLEC4C;MUC16
prerank,regulation of establishment of planar polarity (GO:0090175),0.42048652899979716,1.7207968264066225,0.0,0.03246930176805066,1.0,33/88,14.94%,PSMD14;CELSR1;PSMB2;PSMB9;PSMA5;PSMB3;SAPCD2;PSME3;PSMA3;CELSR3;PSMA7;PSMD13;WNT5A;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;AP2S1;ARHGEF19;PSMB4;PSMD3;PSMB1;PSMA4;CLTC;WNT11;PSME1;PSMF1;PSMD11;PSMD1;AP2B1
prerank,cellular response to lectin (GO:1990858),0.39789668987699145,1.7207477804705607,0.0,0.03216681694520877,1.0,40/113,20.61%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;NRAS;PSMD13;SYK;MUC5AC;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;CLEC6A;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1;PAK1;LYN;MUC20;PSMD6;MUC17;FYN;PSMD5;CLEC4C;MUC16
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.39789668987699145,1.7207477804705607,0.0,0.03216681694520877,1.0,40/113,20.61%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;NRAS;PSMD13;SYK;MUC5AC;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;CLEC6A;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1;PAK1;LYN;MUC20;PSMD6;MUC17;FYN;PSMD5;CLEC4C;MUC16
prerank,regulation of viral transcription (GO:0046782),0.4742479733139222,1.7205366524380465,0.0,0.0321110951194841,1.0,23/41,27.56%,POLR2F;POLR2D;IFITM3;NELFCD;DHX9;TRIM27;TARBP2;TRIM14;POLR2C;GTF2F2;POLR2K;POLR2J;TRIM11;POLR2G;NELFE;POLR2H;POLR2I;POLR2L;TRIM31;NELFA;POLR2B;NELFB;GTF2F1
prerank,snRNA 3'-end processing (GO:0034472),0.6041675759871434,1.718056393660845,0.02564102564102564,0.032425869260831255,1.0,10/19,25.47%,EXOSC5;INTS7;EXOSC4;EXOSC8;EXOSC7;EXOSC3;EXOSC2;INTS5;INTS2;SAGE1
prerank,extracellular matrix assembly (GO:0085029),-0.5761252778560249,-1.7162648847575177,0.03773584905660377,0.043113453554107575,0.99,13/24,19.83%,GPM6B;FBLN5;TNXB;LAMB2;MFAP4;LTBP3;NTNG1;EFEMP2;EMILIN1;LAMB1;LAMB4;PXDN;NTN4
prerank,positive regulation of heart rate (GO:0010460),-0.6295122507900628,-1.7162271885013944,0.0,0.04276293767155386,0.99,9/17,14.31%,TPM1;HRC;SCN3B;PDE4D;NPPA;ADRA1A;ADRA1D;RYR2;ADRB1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.5296060702442272,-1.7151685645950276,0.0,0.042935368871842385,0.99,16/36,15.24%,TPM1;BMPR1A;FGF2;CNN1;MEF2D;FOXJ2;GPER1;PRKG1;ADAMTS1;MFN2;PTEN;EFEMP2;MEF2C;CDKN1A;IGFBP5;PDGFB
prerank,double-strand break repair (GO:0006302),0.404611934303046,1.7141242751000618,0.0,0.03377935963373364,1.0,52/150,17.88%,RAD54B;PSMD14;RFWD3;FEN1;RPA3;XRCC2;BRCC3;TDP1;EME1;CDCA5;RAD51AP1;PRPF19;RMI1;DCLRE1C;UBE2N;POLB;DCLRE1B;CHEK2;BLM;XRCC5;MMS22L;NABP2;XRCC4;PRKDC;RECQL4;SFR1;PALB2;TONSL;ACTR8;HMGB2;DNA2;ERCC5;RAD51B;POLA1;TRIP13;DTX3L;APTX;RBBP8;BRCA2;BRCA1;HUS1;CIB1;NSMCE2;KPNA2;VCP;RPA2;RAD51AP2;EYA1;SUMO1;NSMCE1;LIG3;PAXIP1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.5400557576323901,-1.7140638327257145,0.0,0.04317834906607752,0.99,12/27,16.23%,CAMK2G;BRSK1;NCS1;PSEN1;PTEN;NTNG1;NDEL1;EFHC2;MARK1;DISC1;IL1RAPL1;CCDC88A
prerank,protein localization to cell surface (GO:0034394),-0.5325938328525011,-1.7126442431139626,0.0,0.04327202026288188,0.99,13/27,19.11%,PRRT1;JAM3;RIC3;FBLN5;FLNA;ANK2;VCL;GPIHBP1;GGA3;FGF7;FGF10;GGA2;ANGPT1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5617323379505765,1.7117865976047462,0.022727272727272728,0.03432538326675135,1.0,14/23,28.37%,OSM;IL23A;PHB;SLC7A5;IL21;MYD88;IL23R;TGFB1;NOD2;IL12B;PRKCQ;CCL1;SLAMF6;IL18
prerank,regulation of mitotic cell cycle (GO:0007346),0.3773038777807873,1.7102964875391775,0.0,0.034865439428369956,1.0,53/176,14.34%,PSMD14;MAD2L1;CKS2;CKS1B;KIF20B;PSMB2;TP73;TFAP4;CDK1;FBXO5;PSMB9;PSMA5;RCC1;PSMB3;UBE2S;PSME3;PSMA3;MCIDAS;NEK6;BUB3;EIF4EBP1;PSMA7;NEK2;PSMD13;CDC25C;RNF40;PSME2;PSMC2;DLGAP5;PSMC4;PSMD10;PSMD12;ANAPC1;PSMB5;PDXP;UBE2C;TTLL12;EIF4E;PSMD8;CDC26;PSMB4;PSMD3;PSMB1;PSMA4;DDB1;PKMYT1;PTPN3;PSME1;PSMF1;ANAPC11;PLK1;PSMD11;PSMD1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.4021506047874575,1.7101610178912072,0.0,0.03467595334452012,1.0,64/131,22.50%,POLR2D;MCTS1;SNRPF;CLNS1A;SNRPD1;PRPF19;BRIX1;LSM4;SNRPG;WDR77;NLE1;ABT1;EIF2S3;BOP1;RRS1;TGS1;SNRPB;XRCC5;SNRPC;SHQ1;EIF2S2;SNRPD2;NCBP1;SNRPE;PRKDC;SRPK1;SRSF9;DENR;NAF1;EIF6;DHX9;NUDT21;PRPF6;RPLP0;PTGES3;CLP1;RPF2;TARBP2;GEMIN6;RPS14;CRNKL1;RRP7A;ERAL1;RPS19;STRAP;USP39;PUF60;COIL;SMN1;RPS5;TRAF7;HSP90AB1;MRPS11;PWP2;RPS28;SNRPD3;RPL11;HSP90AA1;RPS15;DDX1;TXNL4A;GEMIN2;GEMIN5;MRPS7
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.4599476957997104,-1.7097160913400575,0.0,0.04430221101856142,0.99,19/54,15.31%,DDX17;RBFOX3;RBM5;NOVA1;RBM24;ZC3H10;CELF1;RBM25;RBM4;MBNL1;CELF4;FXR2;CELF6;RBFOX2;NOVA2;CELF2;YTHDC1;SRSF12;NSRP1
prerank,positive regulation of telomerase activity (GO:0051973),0.47193142027611873,1.7090139075097823,0.0,0.03466845584109428,1.0,16/34,21.12%,DKC1;MYC;CCT2;XRCC5;NEK2;AURKB;NAF1;PTGES3;WRAP53;MAPK15;GRHL2;CCT4;TCP1;HSP90AB1;HSP90AA1;MAPKAPK5
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.4019031639131917,1.7083847467586137,0.0,0.034661038955984845,1.0,39/86,29.34%,COX20;SDHAF4;UQCC2;SDHAF3;UQCC3;COX18;AIFM1;COA1;NDUFS6;SCO2;COA3;FOXRED1;NDUFB3;NDUFB11;NDUFA12;SLC25A33;NDUFAB1;NDUFA3;NDUFAF2;COX19;NUBPL;SAMM50;NDUFAF3;NDUFA1;NDUFB9;TMEM126A;NDUFB6;NDUFB5;NDUFB4;COX17;NDUFS3;FASTKD3;PET117;NDUFAF6;SMIM20;NDUFAF4;NDUFS1;TTC19;NDUFB7
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5685379201713057,-1.7058881989965278,0.01818181818181818,0.04545948452249448,0.99,16/30,13.83%,CACNA1C;ANK2;KCNA5;GJC1;SCN3B;CACNA2D1;KCNH2;SCN2B;SCN1B;SNTA1;KCNE2;SCN4B;FGF12;CACNA1G;RYR2;KCNE1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.6426030444923608,1.7049197104986236,0.0,0.03619650317032261,1.0,10/15,23.03%,CDK1;MTBP;CENPA;SPDL1;BUB3;AURKB;ZW10;CHAMP1;TTK;CTCF
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.4681489245315521,-1.7041952850106672,0.0,0.046101572340263214,1.0,30/73,15.16%,APBB1;MAP6;S100B;BRSK1;DSCAML1;ZDHHC17;MAP1A;SLITRK2;MAP1B;ANK3;SPTBN4;MEF2A;ADGRB1;FGFR2;NEFH;PARD3;SLITRK3;MAP2;NTNG1;SDC2;TAOK2;OPHN1;MEF2C;SLITRK5;RAB3A;ISL2;UNK;KLF7;ATL1;CNTN4
prerank,cytoplasmic microtubule organization (GO:0031122),-0.4729154839212449,-1.7041318123822211,0.0,0.045746944860722734,1.0,24/54,19.42%,CLIP3;FIGN;CLIP4;CCDC13;DCTN1;MAPT;TUBGCP6;CEP126;NUMA1;KATNAL1;CLIP1;CLASP1;TPPP;DST;KATNAL2;TRDN;SLAIN2;RHOA;PCM1;TUBGCP5;CCDC88A;CAMSAP2;HOOK3;SLK
prerank,histone mRNA metabolic process (GO:0008334),0.5677123605239464,1.703102269938802,0.0,0.03683028916932861,1.0,16/24,24.54%,CPSF3;SNRPF;SNRPG;EXOSC4;SLBP;SNRPB;NCBP1;SNRPE;NCBP2;CPSF2;SSB;ZNF473;SNRPD3;ERI1;MTPAP;LSM1
prerank,protein alkylation (GO:0008213),0.5780170974116986,1.7029179779502652,0.0,0.03704639417632541,1.0,10/18,14.25%,PRMT3;CAMKMT;SNRPB;EEF2KMT;FAM98A;METTL21A;GSPT1;PRMT1;LCMT1;FAM98B
prerank,regulation of interleukin-4 production (GO:0032673),0.5724640331312523,1.7021611990160317,0.0,0.03714342118250913,1.0,10/23,20.15%,CEBPB;FOXP3;ZP3;SLC7A5;SYK;LEF1;ZFPM1;PRKCZ;TNFSF4;CD86
prerank,muscle cell differentiation (GO:0042692),-0.5452533176557517,-1.7011591976032296,0.017857142857142856,0.04714648853428675,1.0,13/30,12.29%,SPEG;POPDC2;BVES;MYOCD;DMD;SYNE1;RORA;MEGF10;TBX1;SEMA4C;WNT5B;TMEM204;MEF2C
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5015057517174427,-1.6984792094590697,0.019230769230769232,0.04810830488049809,1.0,16/42,19.50%,CALCOCO1;DDX17;PGR;EGLN2;GPER1;PPARGC1B;RBFOX2;AR;RHOXF1;ZMIZ1;NR3C1;KDM3A;WBP2;ESR1;TRERF1;RNF14
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.4438064370106224,-1.6976422565699032,0.0,0.04857336905227519,1.0,28/69,18.59%,CLIP3;PLEKHH2;CRYAB;TTBK2;CLU;TUBB4A;LIMA1;SMAD4;CHADL;SHANK3;STMN2;SNCA;CLASP1;DYRK1A;SLIT2;MAP2;CLASP2;KANK3;EMILIN1;NAV3;FGF13;SSH1;KANK1;APC;MYADM;ATXN7;CAMSAP2;PFDN5
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.6256816298650051,-1.696298955671501,0.0,0.04896310773907127,1.0,12/17,26.89%,BOC;RBM24;SMYD1;MEF2C;HIF1AN;RANBP3L;MAPK14;PLCB1;AKIRIN1;MYF6;XKR8;BTG1
prerank,regulation of telomerase activity (GO:0051972),0.4309132493228547,1.6941949343119187,0.0,0.03938897820747165,1.0,22/46,25.36%,DKC1;MYC;CCT2;XRCC5;NABP2;NEK2;AURKB;NAF1;PARP4;PTGES3;WRAP53;MAPK15;GRHL2;CCT4;TCP1;HSP90AB1;HSP90AA1;MAPKAPK5;MEN1;TP53;CTNNB1;PRKCQ
prerank,lamellipodium organization (GO:0097581),-0.5196970743505659,-1.6938937536233392,0.0,0.049822216271302434,1.0,12/28,16.23%,SNX1;VCL;WHAMM;ARHGEF6;KIT;WASF1;S1PR1;ABLIM3;P2RY12;RAC1;ARHGEF7;CCDC88A
prerank,regulation of metal ion transport (GO:0010959),-0.5954207355416389,-1.6935824276940605,0.0,0.049725390758834156,1.0,7/17,14.60%,CAMK2G;ANK2;STIM1;CACNA2D1;PLN;BCL2;CAMK2B
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.6187373914735348,1.6929400388948788,0.0,0.039588380068327135,1.0,11/18,21.44%,PAICS;PPAT;HPRT1;GART;ATIC;GMPS;IMPDH2;NT5C2;IMPDH1;AMPD2;PFAS
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3850101932888981,1.6919972961084806,0.0,0.03967072797134737,1.0,40/104,21.39%,TRIB3;CEBPB;PDIA4;TMEM33;ERO1A;P4HB;CXCL8;PDIA3;RNF183;BCAP31;GORASP2;HYOU1;DERL1;ERP44;BBC3;ERP27;TMCO1;CHAC1;AIFM1;TMX1;TNFRSF10B;GSK3B;TRAF2;VCP;HSPA5;UFC1;UBQLN1;ERLEC1;OS9;AGR2;CREB3L1;MBTPS2;CCDC47;CFTR;BAX;EIF2S1;BAK1;DNAJC10;UFM1;DDRGK1
prerank,positive regulation of viral process (GO:0048524),0.44152347925971186,1.6918190666735664,0.0,0.03946623968283527,1.0,31/61,27.56%,POLR2F;POLR2D;HACD3;PABPC1;PPIH;NELFCD;SRPK1;DHX9;PDE12;STAU1;TARBP2;DDB1;POLR2C;GTF2F2;POLR2K;TMEM39A;POLR2J;KPNA2;POLR2G;RAB7A;NELFE;POLR2H;POLR2I;POLR2L;PPID;LARP1;NELFA;POLR2B;RAD23A;NELFB;GTF2F1
prerank,Golgi to plasma membrane transport (GO:0006893),-0.4847442179025831,-1.6916973070851449,0.0,0.05023195963191389,1.0,23/46,22.87%,VAMP2;RABEP1;EXOC6B;MACF1;RAB34;ANK3;VAMP4;BBS1;OSBPL5;GGA3;OPTN;BBS2;CCDC93;KIF13A;STEAP2;GGA2;VAMP5;ARL3;PREPL;GOPC;GOLGA7;RAB31;GGA1
prerank,T cell receptor signaling pathway (GO:0050852),0.3716938282462564,1.690899219615162,0.0,0.03943456109579888,1.0,38/153,14.60%,PSMD14;THY1;PSMB2;PSMB9;PSMA5;PSMB3;RIPK2;PSME3;KHDRBS1;PSMA3;UBE2N;SKAP1;PSMA7;CD276;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;STOML2;CARD11;BTN1A1;PSMB5;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;INPP5D;VTCN1;PSMD11;PSMD1;PAK1
prerank,mitochondrion localization (GO:0051646),-0.6142641623803916,-1.6891839680186618,0.03773584905660377,0.05099679523564187,1.0,7/17,13.67%,HAP1;ATCAY;MEF2A;TRAK2;MFN2;LRRK2;MARK1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.5356889142454498,-1.6880013325013095,0.0,0.05181655037488386,1.0,15/28,23.51%,PLEKHH2;LIMA1;SMAD4;SHANK3;CLASP1;SLIT2;KANK3;TJP1;SSH1;KANK1;MYADM;IQCJ-SCHIP1;ARPIN;CAV3;PRKCD
prerank,regulation of T cell proliferation (GO:0042129),0.4282319529652732,1.687911187592211,0.0,0.04008257137619632,1.0,28/74,22.40%,CEBPB;IL4I1;IL23A;SLC7A1;FOXP3;ZP3;CD276;IL1B;PNP;TNFSF9;CD46;IL21;CD80;JAK3;CD70;IDO1;PLA2G2F;VTCN1;CLC;IL23R;TNFRSF1B;LILRB4;PLA2G2D;TNFSF4;CD86;IL12B;TNFSF8;TNFSF18
prerank,dendritic cell differentiation (GO:0097028),0.519342748141897,1.6865438783654354,0.0,0.04016073865525741,1.0,9/23,20.76%,DHRS2;CSF2;TRPM2;DCSTAMP;BATF;IRF8;LYN;TGFBR2;BATF2
prerank,cellular response to nutrient levels (GO:0031669),-0.4639548387929892,-1.6865069376362178,0.0,0.052297327346282965,1.0,28/60,26.00%,FLCN;FAM107A;TSC1;KCNB1;ULK1;ZFYVE1;WDR45;RRAGC;ATG14;MAP1LC3C;GAS2L1;LRRK2;PRKAA2;RRAGB;SFRP1;CARTPT;TFEB;KLF10;PDK2;RRAGD;SIRT1;RPTOR;MAP1LC3A;MTOR;LPL;RRAGA;PDK4;FNIP1
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.5278533053237399,-1.6855576307198294,0.0,0.05283627405315089,1.0,16/31,20.77%,STX1B;CPLX3;CAMK2A;GPER1;SYT11;CHRNA3;RIMS3;LRRK2;MEF2C;CHRNB4;KCNMB4;RIMS4;SYN1;SNAPIN;PREPL;RIMS1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.5800299746055414,1.6846988255505317,0.0,0.04074249386903616,1.0,7/18,8.56%,SHMT2;MTHFD1;MTHFD1L;DHFR;GGH;SLC19A1;MTHFD2
prerank,activation of adenylate cyclase activity (GO:0007190),-0.5043690825799525,-1.683810734528768,0.0,0.05349669315349821,1.0,16/35,20.29%,ADCY5;RAF1;ADCY2;CAP2;ADRB3;ADCY4;ADRB2;ADCY9;ACR;ADORA3;AVPR2;ADRB1;ADCY6;CRHR1;P2RY11;LHCGR
prerank,response to nutrient levels (GO:0031667),-0.5844380190522043,-1.6833951709547987,0.0,0.053507072361259955,1.0,10/22,22.84%,FAM107A;KCNB1;ULK1;GH1;ATF4;PRKAA2;PRL;RPS6KB1;RPTOR;MTOR
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5376897883897829,-1.6821137598807325,0.0,0.053962754680770345,1.0,10/21,20.66%,GBA2;MAPT;MAP1A;MAP1B;MAP2;EFEMP2;MAPRE3;ARL2;CAMSAP2;AKAP13
prerank,myoblast differentiation (GO:0045445),-0.6163049208370122,-1.680180192272725,0.0196078431372549,0.05447534818652132,1.0,7/15,21.37%,DDX17;SOX15;MBNL1;PLEKHM3;HINFP;EPAS1;MAPK12
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.566826153649191,-1.6781805422981402,0.0,0.05510644707772645,1.0,6/20,12.51%,NFATC4;INPP5A;PPP3CB;NFATC1;PPP3CC;PLCE1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3982010711881113,1.6780097761108854,0.0,0.04304697243331784,1.0,32/88,15.95%,PSMD14;PSMB2;PSMB9;PSMA5;SKP2;FBXL18;PSMB3;PSME3;PSMA3;KIF14;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;FBXO4;PSMB5;CCNF;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;FBXL13;PSMD11;PSMD1;CUL4A;FBXL14
prerank,positive regulation of peptidase activity (GO:0010952),0.5698023775064494,1.677495583091981,0.0,0.043164626723258645,1.0,12/20,21.39%,PRSS22;PSME3;PSME2;CTSH;APH1A;PRELID1;PSME1;GRN;VCP;NCSTN;CLDN4;DDRGK1
prerank,cellular glucuronidation (GO:0052695),0.5646573113991666,1.6766116704301448,0.0196078431372549,0.043225904825885376,1.0,8/16,30.26%,UGT1A3;ABHD10;UGT1A6;UGT1A5;UGT2B7;UGT1A7;UGT1A9;UGT1A10
prerank,cellular response to interleukin-1 (GO:0071347),0.37188840987299615,1.6745397781214864,0.0,0.04356123723121498,1.0,46/149,14.34%,PSMD14;IL1A;PSMB2;PSMB9;PSMA5;CCL24;CXCL8;PSMB3;RIPK2;PSME3;PSMA3;IL1RN;UBE2N;IRAK2;PSMA7;IL1B;PSMD13;CCL20;PSME2;PSMC2;PSMC4;PSMD10;CCL22;PSMD12;SOX9;HYAL3;PSMB5;USP10;CCL4;CCL3;MYD88;RELA;IRAK1;PSMD8;ADAMTS12;PSMB4;PSMD3;PSMB1;PSMA4;RPS6KA4;CCL26;PSME1;PSMF1;PSMD11;UBA52;PSMD1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5917016893602555,-1.6744351158451654,0.0,0.057412048973033675,1.0,10/17,20.77%,RAP1A;NLGN1;RIMS3;LRRK2;RIMS4;RAB3GAP1;SYN1;SNAPIN;PREPL;RIMS1
prerank,positive regulation of T cell activation (GO:0050870),0.42525467948964957,1.672447985156056,0.0,0.04433055867965449,1.0,36/73,31.79%,THY1;HSPD1;TNFSF11;IL23A;SLC7A1;ZP3;CD276;IL1B;PNP;CD46;MDK;IL21;CD80;CD81;XBP1;JAK3;CD70;IL23R;IL36B;NOD2;LCK;TNFSF4;CD86;IL12B;CD47;ZAP70;PRKCQ;ANXA1;RHOH;CD3E;CD6;CCDC88B;SIRPG;CCL5;CD274;SIRPB1
prerank,neuron projection development (GO:0031175),-0.3983636564449865,-1.6723022987872072,0.0,0.05807669237825896,1.0,62/168,18.85%,GPM6B;GDNF;LGI1;PLP1;STMN4;ULK1;MAPT;CTNND2;GAS7;PTPRM;MYOC;NYAP1;ATCAY;CNTNAP1;MICALL1;SHANK3;DLG4;STMN2;TMEM108;PACSIN1;NLGN1;DCLK1;L1CAM;NEFH;FRY;GPM6A;NGF;DIP2A;EPB41L3;SRGAP2;PTEN;MAP2;MAPK8IP3;LRRK2;NRTN;NCKAP1L;LAMB1;DICER1;TAOK2;OPHN1;PPP1R9A;DAB2IP;EPHA4;NPY;ZNF335;CNTN4;DBN1;ROCK1;NTF3;NCDN;BLOC1S1;TRIO;RAB13;CAMSAP2;NRK;PLXNB1;VAPA;BTG2;MYO16;ALS2;UBB;FRYL
prerank,regulation of endocytosis (GO:0030100),-0.45815960373531317,-1.672104202955289,0.0,0.05780991574006802,1.0,30/60,29.16%,CLIP3;STON1;SNX33;CALY;SNCA;PACSIN1;SYT11;PRKD1;RAB5B;OPHN1;LGALS3;RAB4B;RIT2;PACSIN2;EPHA3;LRSAM1;ROCK1;TSC2;PACSIN3;DLL1;RUFY1;RUFY2;ZFYVE16;SMPD1;HIP1;CDH13;FLOT1;NEDD4L;MCTP1;RAB5C
prerank,mitochondrial transport (GO:0006839),0.4397972239847619,1.670303178200809,0.023809523809523808,0.04460279489020627,1.0,24/53,22.16%,TOMM34;TIMM23;BCAP31;TOMM40;TIMM10;PMAIP1;TIMM13;TOMM22;TOMM20;BCL2L1;COX18;TIMM17B;TIMM8B;PPIF;TSPO;SLC25A24;SLC25A5;MTX2;TMEM14A;HSP90AA1;BAK1;SLC25A13;SLC25A6;TIMM17A
prerank,protein methylation (GO:0006479),0.49396074257318767,1.6698330775280985,0.0,0.04460173355064909,1.0,14/32,14.25%,NTMT1;PRMT3;CAMKMT;SNRPB;EEF2KMT;FAM98A;TRMT112;METTL21A;GSPT1;PRMT1;PRMT6;CARM1;LCMT1;FAM98B
prerank,regulation of microtubule polymerization (GO:0031113),-0.48235247576681894,-1.667348689067406,0.0,0.05962375309633795,1.0,18/38,14.51%,CLIP3;DCTN1;GBA2;MAPT;TUBB4A;NUMA1;CLIP1;STMN2;SNCA;CLASP1;FES;DYRK1A;MAP2;MAPRE3;NAV3;ARL2;RAC1;SLAIN2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.43028091696408316,1.6664787155376564,0.0,0.04567799368722806,1.0,18/55,15.71%,SOX4;E2F1;TFDP1;CDK1;TRIAP1;CHEK2;GTSE1;ARID3A;CDC25C;CNOT11;PML;CNOT10;CASP2;AURKA;PRMT1;CARM1;E2F8;CNOT1
prerank,myotube differentiation (GO:0014902),-0.6102467831268233,-1.6656447365178677,0.018867924528301886,0.06044260064456146,1.0,9/18,16.53%,CACNA1H;ADGRB3;JAM2;NOS1;MYEF2;KLHL40;MEF2C;SKI;ADAMTS5
prerank,neuron development (GO:0048666),-0.39852638740680113,-1.661653568511836,0.0,0.06293868458050127,1.0,55/141,21.56%,LGI4;GPM6B;GDNF;LGI1;PLP1;STMN4;ULK1;TENM1;PBX3;GBA2;MAPT;PTPRM;MYOC;ATCAY;MICALL1;SRF;PHOX2B;STMN2;TMEM108;NLGN1;L1CAM;FRY;GPM6A;PBX2;ALK;MAP2;EPHA5;NRTN;LAMB1;ATP8A2;GLI2;OPHN1;MEF2C;ACTL6B;PPP1R9A;MYT1L;ISL2;VSX1;TENM3;UNK;NPY;CNTN4;ROCK1;NCDN;BLOC1S1;RAB13;VAPA;BTG2;FRYL;ARL3;RAPGEF2;SNAPIN;TENM2;DCX;SRRM4
prerank,neutrophil migration (GO:1990266),0.4206750557953543,1.6613586300889642,0.0,0.04776235660671293,1.0,26/68,17.59%,CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;CCL20;SYK;PPIB;CCL22;PF4;TGFB2;CXADR;CCL4;CCL3;PECAM1;CXCL9;CCL26;UMODL1;CXCL10;CXCL6;CXCR2;CCL17;PIK3CG;PF4V1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3720533926688163,1.661311494682426,0.0,0.047532729892257576,1.0,56/187,14.69%,PSMD14;TDGF1;PSMB2;PSMB9;PSMA5;TNFRSF11B;CCL24;CXCL8;PSMB3;PSME3;PSMA3;EIF5A;TNFSF11;TXNDC17;PSMA7;PSMD13;CCL20;PSME2;PSMC2;TNFSF9;CARD14;PSMC4;PSMD10;RPS3;CCL22;PSMD12;HYAL3;EDAR;PSMB5;DHX9;DCSTAMP;CCL4;CCL3;TNFSF15;RELA;PSMD8;CD70;ADAMTS12;PSMB4;STAT1;PSMD3;PSMB1;PSMA4;TNFRSF9;ACTN4;BRCA1;CCL26;PSME1;PSMF1;CIB1;PSMD11;TRAF2;TNFRSF12A;PSMD1;GBA;TMSB4X
prerank,termination of RNA polymerase II transcription (GO:0006369),0.49390649364043304,1.6604897956769573,0.0,0.047570762406415355,1.0,17/34,15.00%,CSTF2;CPSF3;SNRPF;SNRPG;CSTF1;SLBP;SNRPB;NCBP1;SNRPE;NUDT21;TTF2;MAZ;CLP1;NCBP2;CPSF2;MED18;ZNF473
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.500883518047549,-1.6603219615699534,0.0,0.06318613339424274,1.0,12/33,11.05%,MYH7;TPM1;MYL2;TGFBR3;BMPR1A;MYH6;SMAD4;FGFR2;ZFPM2;RBPJ;HAND1;RYR2
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6138961532136162,1.6602608650343045,0.02040816326530612,0.047344234966384804,1.0,7/15,12.50%,DPEP1;GGACT;ABHD12;GOT2;CHAC2;CHAC1;ALDH4A1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.57065783834985,1.6596155485009927,0.022727272727272728,0.047487978570770306,1.0,11/17,20.46%,ALG1;ALG8;SRD5A3;ALG3;ALG2;ALG14;DOLK;DPAGT1;MPDU1;ALG6;NUS1
prerank,negative regulation of DNA recombination (GO:0045910),0.4460387980727906,1.6575727418165256,0.0,0.047682707165068415,1.0,17/40,21.64%,POLR2F;POLR2D;FANCB;PARPBP;RMI2;BLM;ZRANB3;MSH3;POLR2C;POLR2K;MSH6;POLR2J;POLR2G;POLR2H;POLR2I;MSH2;POLR2L
prerank,maturation of 5.8S rRNA (GO:0000460),0.5710326218683387,1.6575327604152086,0.0,0.04745884469011505,1.0,10/16,28.93%,WDR12;PES1;EXOSC4;PRKDC;EIF6;RPF1;MAK16;MPHOSPH6;URB1;RRP15
prerank,regulation of neuron projection arborization (GO:0150011),-0.6574620251782319,-1.6573267684334807,0.0,0.06467993494755897,1.0,9/15,13.70%,FZD4;MACF1;DVL3;DLG4;MYO9A;NTNG1;GRIP1;DVL2;SPRY3
prerank,nucleotide biosynthetic process (GO:0009165),0.5827090275938296,1.6573084982753443,0.0,0.047340778173528025,1.0,5/18,5.80%,PPAT;HPRT1;GART;MTHFD1;PNP
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5757047289225417,-1.657302848842833,0.021739130434782608,0.0642626450446715,1.0,6/18,15.27%,DDX17;EGLN2;PPARGC1B;RBFOX2;AR;ESR1
prerank,establishment of protein localization to organelle (GO:0072594),0.4197540806465132,1.6564069866400415,0.0,0.0474302528351464,1.0,24/74,15.20%,RAN;RALA;CSE1L;NXT2;NUP155;LAMP3;E2F3;NUP62CL;NUP93;NUTF2;SYK;SEC13;RAB11A;LAMP2;NXT1;NUP50;NUP88;NUP107;TNPO3;HEATR3;TSPAN17;KPNB1;MMP12;NUP62
prerank,chromosome condensation (GO:0030261),0.4868997513760948,1.652820493382906,0.0,0.04895730894418915,1.0,16/32,16.90%,NCAPD3;INCENP;CDK1;CDCA5;SMC2;NCAPD2;SET;NCAPG;SMC4;CSNK2A1;AIFM1;NCAPG2;PLK1;BANF1;TOP2A;NCAPH
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6167053622244973,-1.6519175786575466,0.01639344262295082,0.0672576423542983,1.0,10/16,22.74%,CCBE1;CADM4;DCN;MYO1C;DAB2IP;SEMA6A;CD63;DLL1;ADAMTS3;IL12A
prerank,negative regulation of metabolic process (GO:0009892),-0.4641284663197498,-1.6503022208901168,0.0,0.06793820671022115,1.0,23/54,20.73%,FLCN;NOVA1;ARNTL;ACTN3;TFE3;PLCL1;NR1D1;ZDHHC7;ATF4;LAMA4;RBPJ;NOVA2;NPR3;NR1H2;ALDH1A1;IP6K1;ZNF423;ADAMTS5;IL18R1;ABHD6;TLE3;LNPEP;MAP2K6
prerank,tRNA metabolic process (GO:0006399),0.5915135039003113,1.6502496313477248,0.0,0.049600995014465646,1.0,8/15,15.02%,YARS2;POP1;DARS2;ADAT1;POP7;FARS2;SSB;POP5
prerank,protein import into mitochondrial matrix (GO:0030150),0.60846577806622,1.64951118376727,0.03571428571428571,0.04988247233413537,1.0,10/18,12.37%,TIMM23;GRPEL1;ROMO1;TOMM40;GRPEL2;TOMM20;TIMM50;TIMM17B;TOMM20L;DNAJC15
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5778163802005268,-1.6494651494286927,0.0392156862745098,0.06803018881835354,1.0,8/16,14.34%,TPM1;CNN1;GPER1;PRKG1;PTEN;EFEMP2;MEF2C;CDKN1A
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5611434748577353,1.6485156829372352,0.0196078431372549,0.05011071102499418,1.0,9/22,11.15%,WDR43;LYAR;NCL;SMARCB1;SMARCA4;NOL11;IPPK;UTP15;HEATR1
prerank,negative regulation of cell communication (GO:0010648),0.5441994306718416,1.6480854071250999,0.0,0.050235999318024784,1.0,4/20,4.70%,OSM;IL11;SRMS;IL1B
prerank,positive regulation of neurogenesis (GO:0050769),-0.4351026967529514,-1.6474996804448605,0.0,0.06921602175678732,1.0,27/71,17.85%,SMARCD3;MAP6;PLXNB3;CAPRIN2;NUMBL;GPER1;CUX2;SHANK3;AMIGO1;NGF;NGFR;OBSL1;SLIT2;BHLHB9;NPTN;CHODL;NUMB;TIAM1;ZNF335;DISC1;RHOA;IL1RAPL1;SPEN;SERPINF1;PLXNA4;SOX11;PLXNB1
prerank,basement membrane organization (GO:0071711),-0.5935605473334601,-1.6460373000362858,0.0,0.06964249849367343,1.0,11/16,27.36%,LAMB2;NID1;NTNG1;LAMB1;LAMB4;FLRT2;PXDN;NTN4;RAMP2;CTSS;CMA1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.5151676809522466,-1.6460056822296132,0.0,0.06920993639122824,1.0,14/27,22.85%,PER1;CRY2;FBXL22;PER3;RBM4;USP2;CRTC1;RBM4B;PPP1CB;FBXL8;CRY1;FBXL12;PDE6B;ID2
prerank,negative regulation of developmental growth (GO:0048640),-0.46514428586193557,-1.6458458250478274,0.018867924528301886,0.06883927929402255,1.0,18/32,20.40%,ULK1;PTPRS;ULK2;PTEN;MAP2;MSTN;WWC2;MYOZ1;BBS2;FGF13;CDKN1A;MAG;SEMA3G;WWC3;OSTN;RTN4;DCC;TRIM46
prerank,regulation of myoblast differentiation (GO:0045661),-0.5070079244263357,-1.6457457051140458,0.0,0.06852938784613166,1.0,20/33,28.23%,EID2B;BOC;KLHL41;RBM24;SMYD1;ZFP36L1;MSTN;MEF2C;HIF1AN;RANBP3L;MAPK14;ANKRD2;PLCB1;DLL1;SOX8;AKIRIN1;MYF6;XKR8;BTG1;TRIP4
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.3637101502592355,-1.644684944997458,0.0,0.06878202474784338,1.0,128/261,28.66%,TTLL3;NPHP3;PKD1;NTN1;FLNA;IFT80;WDR19;MYLK;RFX2;VCL;RAP1A;GSN;DZIP1;CNGB1;RABL2B;TTBK2;CEP126;INTU;PMP22;EHD2;ACTN2;WHAMM;IFT81;BBS4;CYS1;BBS5;DYNC2H1;WDR11;P2RX7;HDAC6;DZIP1L;ARHGEF6;INPP5E;STK36;CFAP44;CCDC66;KIT;EXOC7;BBS1;CC2D2A;FBF1;PARVA;SRGAP2;CFAP54;TEKT2;S1PR1;EMP3;NEK1;ABLIM3;RAB23;PTPDC1;CEP164;CEP162;CCDC57;EXOC3;OPHN1;FGD1;INPP5K;P2RY12;BBS2;RAC1;DISC1;TEKT3;RILPL1;CLUAP1;CFAP70;PCM1;GBF1;ARHGEF7;S1PR2;RAB11FIP3;BBS7;CEP290;EMP1;CCDC88A;ARMC9;BBS9;TXNDC15;PCNT;IFT122;AHI1;TMEM138;CDC14A;ARL3;AIF1L;FGD2;RAPGEF6;RPGR;FUZ;CCL21;RAPGEF2;RAB8B;WDR35;CNGA4;CEP89;RFX3;ANO6;UBXN10;RHO;FGD5;IFT46;KIF3A;ARL6;BBIP1;TRAF3IP1;TTC8;PIP5K1A;CDC14B;WDPCP;EXOC1;MTSS1;SPEF1;IFT43;ABCC4;GOLPH3;CDH13;DNM3;SPAG16;IFT172;ASAP1;FGD6;IFT140;OCRL;PTPN23;CEP19;CCDC28B;UNC119B;ATAT1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.5631445950903061,1.6443324776860118,0.022727272727272728,0.05181623001128653,1.0,13/18,34.47%,CEBPB;ZP3;SLC7A5;SYK;PRKCZ;TNFSF4;CD86;PRKCQ;NLRP3;GATA3;CD28;HAVCR2;FCER1G
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.5809396756357708,-1.6440303386741852,0.018867924528301886,0.0686428454052475,1.0,10/19,17.45%,NPR2;ADCY5;ADCY2;NPR1;ADCY4;NPPA;ADCY9;ADCY6;NPPC;NPPB
prerank,cytoskeleton organization (GO:0007010),-0.40245572608373664,-1.6425432736522898,0.0,0.06927816709698806,1.0,59/113,25.33%,ZNF135;MICAL3;ARHGAP10;RND2;ZMYM6;PALLD;TPM1;LRCH3;SYNE3;CNTNAP1;DES;WTIP;PACSIN1;RHOB;EPB41L3;CDC42BPB;OBSL1;WASF3;KLHL20;MAST2;MAST4;PPP2R3C;DST;FGD1;MAST1;KRT25;PLCE1;ABI2;RANBP9;MARK1;SEMA6A;RAC1;RHOA;PACSIN2;ZMYM3;RANBP10;SIPA1;PACSIN3;CAPZB;CCL11;DPYSL2;PLD2;ZRANB1;FGD2;CECR2;PHIP;CCL2;RHOBTB1;STRIP1;BRWD1;FMNL3;FMNL2;RHOU;LIMD1;FGD5;RHOC;ARC;ARAP3;WDPCP
prerank,postreplication repair (GO:0006301),0.46353115642750087,1.642503195836124,0.0,0.05273244076175672,1.0,24/45,22.29%,RFC3;RPA3;RFC5;RFC2;POLD2;POLH;UBE2N;RAD18;USP10;BRCA1;UBA52;VCP;RPA2;ISG15;POLD1;UBE2A;SPRTN;NSMCE1;UBE2L6;RFC4;UBE2NL;MSH2;DTL;USP43
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4675466589694712,1.6410435830221117,0.0,0.052943805357588386,1.0,13/28,23.82%,POLR2F;POLR1C;CDK7;POLR1B;GTF2H3;TAF1A;POLR1A;TAF1B;POLR2K;ERCC2;POLR2H;POLR2L;RRN3
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.5042009971729544,-1.6407936240371919,0.017857142857142856,0.06968639543568016,1.0,16/37,20.64%,FAM107A;KANK2;FHL1;NACC2;PKD2;JADE1;ZNF655;PTEN;CDKN1A;PRMT2;APC;CDKN2C;RBL2;MYO16;DCUN1D3;CCL2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.5743619471819428,-1.6393923675231263,0.0,0.0701443084765539,1.0,7/23,12.67%,INPP5B;MTMR9;SYNJ1;MTMR10;INPP5F;PTEN;INPP5K
prerank,ribosomal large subunit assembly (GO:0000027),0.5470831573714219,1.6393594842158967,0.0,0.05389633891262556,1.0,14/24,27.25%,BRIX1;NLE1;BOP1;RRS1;DDX28;FASTKD2;RPLP0;RPF2;TRAF7;RPL11;RPL23A;RPL24;MRPL20;RPL3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.5917528167320414,-1.6388875220325214,0.034482758620689655,0.07000036246911585,1.0,6/15,17.89%,HAP1;NGF;NGFR;NTRK1;SOS1;CASP3
prerank,neutrophil chemotaxis (GO:0030593),0.41720456559191477,1.6359379496638715,0.0,0.0549390393255757,1.0,24/63,17.59%,CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;CCL20;SYK;PPIB;CCL22;PF4;TGFB2;CXADR;CCL4;CCL3;CXCL9;CCL26;CXCL10;CXCL6;CXCR2;CCL17;PIK3CG;PF4V1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5532105845301614,1.6356953848213904,0.0,0.054695946231214744,1.0,10/19,21.85%,IL23A;SYK;PNP;SHH;CD55;HSPH1;IL23R;IHH;TNFSF4;IL12B
prerank,neutrophil activation involved in immune response (GO:0002283),0.32711503296582317,1.6344287072493828,0.0,0.05494381893813655,1.0,150/464,20.45%,PSMD14;S100A11;S100P;PRDX4;DSN1;CMTM6;ILF2;CCT2;PSMA5;DDOST;ACTR2;TCN1;CXCL1;GDI2;MAGT1;PLAU;NEU1;HEXB;GGH;GLA;GLB1;XRCC5;CCT8;DIAPH1;CNN2;NRAS;MLEC;CSTB;RAB10;ANXA3;PSMD13;SURF4;FUCA2;RAP2B;SERPINB1;TRPM2;LCN2;SYK;OLR1;CEACAM6;PNP;ERP44;PSMC2;ARPC5;CD44;APRT;CTSH;GCA;TUBB4B;SVIP;MME;PSMD12;CTSC;PAFAH1B2;APEH;LAMP2;ATP11A;OSTF1;JUP;HMOX2;CD55;CKAP4;CLEC5A;RAB3D;IMPDH2;LAMTOR2;COMMD9;SLPI;PKP1;CYBA;DNAJC3;PA2G4;ADGRE3;CPNE3;CANT1;PDXK;SELL;ADAM10;AGPAT2;ABCA13;CHIT1;OLFM4;PSMD3;CYSTM1;ORMDL3;PSMB1;PECAM1;VAMP8;CAPN1;PTGES2;VNN1;GM2A;KPNB1;FCGR3B;PSMD11;MMP9;NIT2;B4GALT1;PSMD1;TMC6;CXCR2;GRN;C3;COPB1;BST2;VCP;FPR2;COTL1;PRSS3;ADAM8;DSP;MANBA;ACLY;PTPRN2;DNASE1L1;PLAUR;HPSE;FTL;DYNLL1;RAB7A;FRK;NCSTN;PGRMC1;AGA;PDAP1;CTSZ;FAF2;NAPRT;HSP90AB1;TMEM63A;GHDC;GPR84;CPNE1;TNFRSF1B;IMPDH1;ATP6AP2;PSMD6;PKM;CTSA;DNAJC5;SLC15A4;TMEM179B;MMP8;CHI3L1;MNDA;ALDOC;RHOF;CLEC4C;HSP90AA1;DERA
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.5278341789695988,1.63369488141271,0.0,0.05514084931837376,1.0,20/30,31.79%,THY1;HSPD1;TNFSF11;SKAP1;CD44;MDK;RELA;IRAK1;FUT7;LCK;CD47;PRKCQ;ITGB2;ETS1;HAS2;TRAF6;CCDC88B;SIRPG;TNF;SIRPB1
prerank,positive regulation of T cell differentiation (GO:0045582),0.4569655632409999,1.6315112185338838,0.0,0.055917624677137075,1.0,21/42,24.93%,SOX4;IL4I1;IL23A;PNP;SHH;TNFSF9;LEF1;CD46;MDK;XBP1;SOCS1;VNN1;ADAM8;IL23R;IL36B;LILRB4;IHH;TNFSF4;IL12B;ZAP70;IL12RB1
prerank,neutrophil degranulation (GO:0043312),0.32634570288681936,1.63131435612222,0.0,0.055819238983804906,1.0,149/460,20.45%,PSMD14;S100A11;S100P;PRDX4;DSN1;CMTM6;ILF2;CCT2;PSMA5;DDOST;ACTR2;TCN1;CXCL1;GDI2;MAGT1;PLAU;NEU1;HEXB;GGH;GLA;GLB1;XRCC5;CCT8;DIAPH1;CNN2;NRAS;MLEC;CSTB;RAB10;ANXA3;PSMD13;SURF4;FUCA2;RAP2B;SERPINB1;TRPM2;LCN2;OLR1;CEACAM6;PNP;ERP44;PSMC2;ARPC5;CD44;APRT;CTSH;GCA;TUBB4B;SVIP;MME;PSMD12;CTSC;PAFAH1B2;APEH;LAMP2;ATP11A;OSTF1;JUP;HMOX2;CD55;CKAP4;CLEC5A;RAB3D;IMPDH2;LAMTOR2;COMMD9;SLPI;PKP1;CYBA;DNAJC3;PA2G4;ADGRE3;CPNE3;CANT1;PDXK;SELL;ADAM10;AGPAT2;ABCA13;CHIT1;OLFM4;PSMD3;CYSTM1;ORMDL3;PSMB1;PECAM1;VAMP8;CAPN1;PTGES2;VNN1;GM2A;KPNB1;FCGR3B;PSMD11;MMP9;NIT2;B4GALT1;PSMD1;TMC6;CXCR2;GRN;C3;COPB1;BST2;VCP;FPR2;COTL1;PRSS3;ADAM8;DSP;MANBA;ACLY;PTPRN2;DNASE1L1;PLAUR;HPSE;FTL;DYNLL1;RAB7A;FRK;NCSTN;PGRMC1;AGA;PDAP1;CTSZ;FAF2;NAPRT;HSP90AB1;TMEM63A;GHDC;GPR84;CPNE1;TNFRSF1B;IMPDH1;ATP6AP2;PSMD6;PKM;CTSA;DNAJC5;SLC15A4;TMEM179B;MMP8;CHI3L1;MNDA;ALDOC;RHOF;CLEC4C;HSP90AA1;DERA
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3705259075439495,1.6304505547954837,0.0,0.05605795678345279,1.0,71/151,27.07%,RFC3;CHEK1;RPA3;TP73;RFC5;CDK1;EXO1;CDK5;RFC2;RMI1;RHNO1;TP53RK;BOP1;RRS1;CHEK2;RMI2;PAK1IP1;BLM;HDAC2;SMYD2;PML;AURKB;RPL37;SSRP1;TOPBP1;RAD9B;DNA2;NOC2L;CSNK2A1;HDAC1;RPF2;MTA2;AURKA;TPX2;RBBP8;TAF9;POU4F1;MLST8;BRCA1;HUS1;RPA2;RNF34;CHD4;TAF4;PPP1R13L;TOP3A;TTC5;PRDM1;RFC4;BRIP1;PRKAB1;RPL11;RPS15;RPL23;MAPKAPK5;TAF15;CDK2;PRR5;TAF4B;RBBP7;TP53;BARD1;RAD1;SETD9;ING2;TAF5;TAF2;ATR;RPS20;PRMT5;CDK5R1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.6312037302015099,-1.6301407523508542,0.0,0.07464758418104576,1.0,9/16,11.29%,FAM107A;DUSP22;PHLDB2;ARHGAP6;DLC1;APOD;PTEN;CLASP2;CORO1C
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.6312037302015099,-1.6301407523508542,0.0,0.07464758418104576,1.0,9/16,11.29%,FAM107A;DUSP22;PHLDB2;ARHGAP6;DLC1;APOD;PTEN;CLASP2;CORO1C
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.46183791293246557,1.6294559575846013,0.0,0.05629461667103474,1.0,11/40,7.18%,RFWD3;ALYREF;EME1;TIPIN;TIMELESS;TRAIP;BLM;MMS22L;ZRANB3;MSH3;TONSL
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5846613152949056,1.6286372657747081,0.0,0.05633875063562891,1.0,12/17,34.60%,MYD88;IL17A;GBP5;NOD2;TICAM1;HIF1A;CLEC7A;CD6;IL17D;TNF;CARD9;TLR4
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.49863121674086786,-1.6281556138676625,0.0,0.0752791083013774,1.0,18/33,22.87%,VAMP2;MACF1;RAB34;ANK3;VAMP4;BBS1;GGA3;OPTN;GORASP1;BBS2;KIF13A;RILPL1;GGA2;VAMP5;PREPL;GOLGA7;RAB31;GGA1
prerank,placenta development (GO:0001890),0.5680720364168177,1.6276772744335084,0.02040816326530612,0.056287667172574884,1.0,8/15,21.02%,ASCL2;PHLDA2;PLAC1;E2F8;PPARG;TEX19;ANG;E2F7
prerank,DNA geometric change (GO:0032392),0.5036772066073502,1.6273720292844955,0.0,0.05623701846239791,1.0,8/25,8.43%,BLM;HMGB3;ZRANB3;RECQL4;ASCC3;HMGB2;DNA2;DHX9
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.4824993391943066,-1.6271636008359558,0.019230769230769232,0.07579739530304735,1.0,14/40,9.83%,FXYD6;DMD;FXYD7;OSR1;WNK3;FXYD1;SCN3B;ANK3;FXYD2;SLMAP;SCN2B;SCN1B;SCN4B;FGF12
prerank,negative regulation of cellular protein localization (GO:1903828),-0.5009503704364378,-1.6265509623996095,0.0,0.07541444180500632,1.0,16/33,23.11%,FLCN;GPM6B;MAPT;TTBK2;MAP1A;ACTN2;SNX33;OTUD7B;ANKRD13A;LATS2;LEPROT;SIN3A;TAX1BP3;GOPC;CAV3;LATS1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5935638056409107,1.6259702521096393,0.046511627906976744,0.056609963154986065,1.0,7/15,20.18%,HM13;DERL1;SEC61B;VCP;FAF2;OS9;AUP1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5042156156535056,1.6259064807923072,0.03571428571428571,0.05641792240357366,1.0,11/28,14.83%,SPTLC1;CYB5B;NQO1;SPTLC2;GCHFR;ASAH2B;NOS2;GCH1;SPR;GBA;ACER2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4116625346998556,1.625263293895719,0.0,0.056367364831630025,1.0,28/85,14.34%,PSMD14;CHEK1;CA9;PSMB2;PSMB9;PSMA5;PSMB3;VHL;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;UBA52;PSMD1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.4246249316408572,-1.6248929438949975,0.0,0.07613548331563998,1.0,37/85,20.66%,FLCN;KANK2;DENND3;SYNGAP1;RAF1;LZTR1;STARD13;DENND4B;DLC1;STARD8;NGF;MYO9B;MFN2;CADM4;SPRY1;ARHGEF18;NTRK1;OPHN1;RDX;PLCE1;DAB2IP;OGT;SPRY3;RAPGEF1;MMD2;EPOR;MADD;KANK1;DENND4A;MAPKAP1;NOTCH2;SGSM3;FGF10;RALGPS1;STK19;LRRD1;AKAP13
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5609580736168439,1.624401913576322,0.0,0.056595798663725556,1.0,10/19,28.37%,IL23A;TNFSF9;RPS3;IL27RA;IGFBP2;IL23R;HMGB1;IL12B;IL12RB1;IL18
prerank,anterograde axonal transport (GO:0008089),-0.4943351260374443,-1.6241596773845806,0.0,0.07596322166736658,1.0,16/37,16.35%,AP3S2;DLG2;KIF5A;MAP1A;HAP1;KIF5C;TRAK2;MAPK8IP3;KIF1A;KIF1C;KIF1B;HSPB1;AP3B2;MGARP;NEFL;BLOC1S1
prerank,regulation of exit from mitosis (GO:0007096),0.45635502094951785,1.6237493020568787,0.0,0.05696103269393171,1.0,18/39,19.76%,MAD2L1;CDCA5;UBE2S;BUB3;NEK2;ANAPC1;MAD2L1BP;UBE2C;ZW10;CDC26;ANLN;ANAPC11;UBA52;NPM2;KNTC1;CDC20;BUB1B;UBE2D1
prerank,histone methylation (GO:0016571),0.5531951596279833,1.623386482052505,0.027777777777777776,0.057046979178569865,1.0,11/24,12.32%,SUV39H2;NTMT1;FBL;SUV39H1;SMYD3;SMYD2;TRMT112;PRMT1;SETD6;PRMT6;CARM1
prerank,positive regulation of ion transport (GO:0043270),-0.469638406755768,-1.6224092158009549,0.038461538461538464,0.07662124425411587,1.0,15/50,9.51%,FHL1;GDNF;CACNB2;ANK2;MYLK;WNK3;SCN3B;ACTN2;CAMK2A;ANK3;P2RX7;SCN1B;CNKSR3;TRPC6;SCN4B
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4774887376040111,-1.622217619540489,0.0,0.07634522861185519,1.0,14/32,15.04%,TPM1;CNN1;GPER1;PRKG1;NDRG4;MFN2;APOD;PTEN;EFEMP2;OGN;VIP;MEF2C;CDKN1A;IGFBP5
prerank,positive regulation of innate immune response (GO:0045089),0.4844517400858847,1.6220943424844019,0.0,0.05731562536284317,1.0,16/33,19.09%,EREG;POLR3C;WNT5A;AKIRIN2;NMI;DHX9;POLR3B;GBP5;NLRC5;RPS19;FPR2;ADAM8;UBE2K;POLR3G;PLSCR1;SLC15A4
prerank,regulation of protein localization (GO:0032880),-0.41652567121323886,-1.6216437619042208,0.0,0.07632826025732659,1.0,32/64,27.15%,CSNK1E;ATCAY;TRIM6;DVL3;ITGB3;DZIP1L;PLEKHM2;ZDHHC7;CAMK1;MAP2;PPM1F;VIP;MMD2;MAPK8;TRIM34;CEP290;DNAJB6;VPS4A;TRIM67;FBXW7;INS;TRIM46;TESK1;SLC26A4;TRIM38;ADCYAP1;NKX3-1;USP8;MMD;WDPCP;TPR;AAK1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4991818968891991,-1.6216183479265054,0.018518518518518517,0.0759042143670081,1.0,15/27,20.48%,STMN4;GBA2;MAPT;MAP1A;MAP1B;STMN2;CLASP1;MAP2;CLASP2;GAS2L1;MAPRE3;ARL2;CAMSAP2;MAPRE2;GAS2L2
prerank,regulation of type I interferon production (GO:0032479),0.4057023624039218,1.621500944302538,0.0,0.05726241381929643,1.0,34/83,25.03%,POLR2F;POLR3K;POLR1C;G3BP1;GAPDH;XRCC5;POLR3C;PRKDC;TNFAIP3;IKBKE;DHX9;POLR3B;POLA1;MYD88;RELA;IRAK1;NLRC5;POLR2K;IRF8;NFKB2;ISG15;DDX41;POLR3G;CRCP;UBE2L6;POLR2H;IFI16;POLR2L;POLR3A;TRIM15;XRCC6;ZBP1;CTNNB1;CREBBP
prerank,neutrophil mediated immunity (GO:0002446),0.3219527879055604,1.6214457402385503,0.0,0.05702773179544685,1.0,149/466,20.45%,PSMD14;S100A11;S100P;PRDX4;DSN1;CMTM6;ILF2;CCT2;PSMA5;DDOST;ACTR2;TCN1;CXCL1;GDI2;MAGT1;PLAU;NEU1;HEXB;GGH;GLA;GLB1;XRCC5;CCT8;DIAPH1;CNN2;NRAS;MLEC;CSTB;RAB10;ANXA3;PSMD13;SURF4;FUCA2;RAP2B;SERPINB1;TRPM2;LCN2;OLR1;CEACAM6;PNP;ERP44;PSMC2;ARPC5;CD44;APRT;CTSH;GCA;TUBB4B;SVIP;MME;PSMD12;CTSC;PAFAH1B2;APEH;LAMP2;ATP11A;OSTF1;JUP;HMOX2;CD55;CKAP4;CLEC5A;RAB3D;IMPDH2;LAMTOR2;COMMD9;SLPI;PKP1;CYBA;DNAJC3;PA2G4;ADGRE3;CPNE3;CANT1;PDXK;SELL;ADAM10;AGPAT2;ABCA13;CHIT1;OLFM4;PSMD3;CYSTM1;ORMDL3;PSMB1;PECAM1;VAMP8;CAPN1;PTGES2;VNN1;GM2A;KPNB1;FCGR3B;PSMD11;MMP9;NIT2;B4GALT1;PSMD1;TMC6;CXCR2;GRN;C3;COPB1;BST2;VCP;FPR2;COTL1;PRSS3;ADAM8;DSP;MANBA;ACLY;PTPRN2;DNASE1L1;PLAUR;HPSE;FTL;DYNLL1;RAB7A;FRK;NCSTN;PGRMC1;AGA;PDAP1;CTSZ;FAF2;NAPRT;HSP90AB1;TMEM63A;GHDC;GPR84;CPNE1;TNFRSF1B;IMPDH1;ATP6AP2;PSMD6;PKM;CTSA;DNAJC5;SLC15A4;TMEM179B;MMP8;CHI3L1;MNDA;ALDOC;RHOF;CLEC4C;HSP90AA1;DERA
prerank,regulation of membrane depolarization (GO:0003254),-0.6157851781686787,-1.6207326495535408,0.017543859649122806,0.07634551303319245,1.0,11/18,22.92%,FHL1;SCN3B;SCN2B;SCN1B;LRRK2;CAMK2D;SCN5A;SMAD7;ABCD1;GPD1L;CAV3
prerank,supramolecular fiber organization (GO:0097435),-0.35467975761322396,-1.62014651259078,0.0,0.07622812515863328,1.0,120/336,21.47%,CORO6;CLIP3;FIGN;DPT;LMOD1;RND2;PGM5;FBLN5;TPM2;TPM1;COL21A1;CLIP4;STMN4;TMOD2;INPPL1;CCDC13;GSN;MYH6;DCTN1;LOXL4;COL6A1;COL28A1;MPRIP;MAPT;KLHL41;TUBGCP6;MYO15A;DDR2;CAPN3;TNXB;CEP126;KATNAL1;COL24A1;WHAMM;MFAP4;CLIP1;DES;COL6A2;LTBP3;STMN2;COL16A1;SNCA;RUFY3;ACTN1;NPPA;TMOD1;RHOB;CRTAP;MAP7D3;EVL;NCKAP5L;TRIOBP;CORO7;EFEMP2;EMILIN1;MYO5A;GGA3;P3H2;MYO1C;TPPP;CORO1C;APH1B;DST;KATNAL2;BMP1;LMOD2;BACE1;PRL;PPP1R9A;TLL1;ALDOA;COL4A5;COL5A3;COL23A1;MYOZ1;OPTC;GFAP;TRDN;FLII;ELMO2;RAC1;FGF13;HSPG2;SLAIN2;MFGE8;RHOA;PCM1;TUBGCP5;ACTC1;PLA2G1B;VIM;DBN1;NEFL;COL13A1;CCDC88A;COL27A1;COL4A6;ELMO1;COL4A2;DNAJB6;CAMSAP2;GGA2;KRT20;COL4A3;HOOK3;UBB;CD36;COL25A1;COLGALT2;CGNL1;SLK;PXDN;INS;KLHL24;COL22A1;LOXL3;RHOBTB1;COL20A1;TPPP3;ADAMTS3
prerank,granulocyte chemotaxis (GO:0071621),0.4119974304840774,1.620122965057894,0.0,0.05720258491314797,1.0,25/66,17.59%,CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;CCL20;SYK;PPIB;CCL22;PF4;TGFB2;CXADR;CCL4;CCL3;CXCL9;CCL26;ADGRE2;CXCL10;CXCL6;CXCR2;CCL17;PIK3CG;PF4V1
prerank,neural crest cell development (GO:0014032),-0.4551920676232686,-1.618805685170546,0.0,0.07641246239671098,1.0,23/44,24.28%,GDNF;SEMA6C;RADIL;TAPT1;TBX1;SEMA4C;SEMA3E;NRTN;CORO1C;ANXA6;SEMA6D;SEMA6A;SEMA3B;CDH2;HTR2B;SEMA3G;SEMA3A;SOX11;ERBB4;SEMA3C;SOX8;FAM172A;SNAI2
prerank,signal transduction in response to DNA damage (GO:0042770),0.45306734631201373,1.6178767998925119,0.0,0.058007513497304555,1.0,20/50,21.02%,CHEK1;E2F1;INTS7;PRPF19;RHNO1;TRIAP1;CHEK2;USP10;BATF;HUS1;MYO6;ACER2;CLSPN;TIPRL;FBXO6;PAXIP1;CDC5L;BID;BRIP1;E2F7
prerank,diol biosynthetic process (GO:0034312),0.5873281573173237,1.617042202712794,0.0,0.05822190838477483,1.0,10/17,22.53%,SPTLC1;DHFR;SPTLC2;ASAH2B;GCH1;SPR;GBA;ACER2;QDPR;ASAH2
prerank,cellular calcium ion homeostasis (GO:0006874),-0.3893176364675634,-1.6160482653023862,0.0,0.07808884270457661,1.0,37/128,13.99%,TPCN2;DMPK;PTH1R;ATP2B4;ANK2;HRC;TRPC1;CCL14;SCGN;STIM1;GPER1;SLC8A2;PLN;SLC24A4;MICU3;RYR1;TMEM178A;SLC8A1;CDH23;ELANE;PRKACA;BCL2;PSEN1;TRPC6;TRPC4;CAV2;SLC24A3;NPTN;CTRC;RYR2;ANXA6;ATP2B3;SLC8A3;PACS2;CSRP3;TRDN;RGN
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5716402407578736,1.615509479203192,0.018518518518518517,0.05874777644045795,1.0,10/18,20.45%,VPS35;CTSC;CD81;RNF128;PCSK9;EZR;GBA;VGLL4;MSN;HSP90AA1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.5655531103682259,-1.6148920044742825,0.016666666666666666,0.07860785569662854,1.0,12/22,17.85%,CAPRIN2;CUX2;SHANK3;NLGN1;CAMK1;PSEN1;BHLHB9;CPEB3;RELN;CAMK2B;DBN1;DLG5
prerank,cell-matrix adhesion (GO:0007160),-0.4013229174165004,-1.6145853770570417,0.0,0.0784315631026656,1.0,35/95,17.12%,PKD1;ITGA7;TSC1;ITGA10;SORBS1;FBLN5;VCL;FERMT2;LYVE1;ACTN2;SGCE;ACTN3;WHAMM;THBS3;HOXD3;ILK;ITGB3;ACTN1;CD34;L1CAM;DLC1;SIGLEC1;EMILIN1;TAOK2;TIAM1;RAC1;ADAMTS13;TMEM8B;PEAK1;ARHGEF7;ADAMTS9;THSD1;COL13A1;CD63;BCAM
prerank,response to calcium ion (GO:0051592),-0.4046757239349886,-1.614044491488745,0.0,0.07840416379811249,1.0,49/103,23.72%,RYR3;ADD1;RASGRP2;ITPKB;KCNMB1;SLC25A12;PKD2;TRPC1;KCNMA1;CAPN3;STIM1;MEF2A;CALM1;CARF;KCNIP2;SYT10;RYR1;NLGN1;CASQ2;SYT11;CLIC4;PRKAA2;SYT2;SYT9;RYR2;KCNMB2;SYT6;SYT5;MEF2C;KCNMB4;MCOLN1;BRAF;CAMK2D;CRHBP;CPNE8;CPNE4;AHCYL1;D2HGDH;SCN5A;ACER1;SYT1;TTN;TRPC3;CPNE6;CALM2;PLCG2;KCNH1;KCNMB3;SYT3
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.5797807856246106,-1.6132501519333957,0.02040816326530612,0.0786207657266904,1.0,7/15,10.65%,ST8SIA1;ST6GALNAC3;A4GALT;ST8SIA3;ST3GAL5;B4GALNT1;ST8SIA5
prerank,photoperiodism (GO:0009648),-0.5098792488197226,-1.6129899450548022,0.0,0.07825326689556454,1.0,14/28,22.85%,PER1;CRY2;FBXL22;PER3;RBM4;USP2;CRTC1;RBM4B;PPP1CB;FBXL8;CRY1;FBXL12;PDE6B;ID2
prerank,mitotic chromosome condensation (GO:0007076),0.5078690112301716,1.6124602672523518,0.04081632653061224,0.059937872769001845,1.0,11/24,13.68%,NCAPD3;CDK1;CDCA5;SMC2;NCAPD2;SET;NCAPG;SMC4;CSNK2A1;NCAPG2;PLK1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.41696993479617334,-1.612082926179654,0.0,0.0781307808585533,1.0,23/71,14.21%,VAMP2;NFATC4;MPP2;NLGN2;LGI1;TSHZ3;STX1B;NLGN3;HAP1;NRXN1;GPER1;SLC8A2;SHANK3;DLG4;NLGN1;GRIK2;ADRA1A;RIMS3;SHISA7;NPTN;SLC8A3;CACNG7;RELN
prerank,actin filament organization (GO:0007015),-0.37357484080099795,-1.6113456544795712,0.0,0.07839338835675282,1.0,43/147,16.97%,CORO6;EFS;LMOD1;RND2;TPM2;FLNA;TPM1;TMOD2;ACTA1;INPPL1;GSN;MPRIP;MYO15A;TCAP;DSTN;WHAMM;RUFY3;ACTN1;TMOD1;DPYSL3;RHOB;EVL;TRIOBP;CORO7;GAS2L1;MYO5A;MYO1C;CORO1C;LMOD2;PPP1R9A;ALDOA;ABI2;FLII;ELMO2;RAC1;RHOA;ACTC1;FHOD3;PLA2G1B;ENAH;DBN1;ELMO1;BAIAP2
prerank,actin polymerization or depolymerization (GO:0008154),-0.4484995069130435,-1.6111098847238974,0.0,0.07808054244493541,1.0,15/48,15.61%,FAM107A;MICAL3;CFL2;GSN;GAS7;DSTN;ARHGAP6;WASF1;EVL;WASF3;CORO7;ABI2;FLII;RAC1;ENAH
prerank,embryonic digestive tract development (GO:0048566),-0.522352159587976,-1.6081009185377526,0.01818181818181818,0.07962262747060972,1.0,14/20,23.93%,RBPMS2;FOXF1;GLI3;PDGFRA;FGFR2;TCF21;RARB;GLI2;RARRES2;PCSK5;SOX11;NIPBL;ID2;PKDCC
prerank,error-prone translesion synthesis (GO:0042276),0.5154958329409216,1.6079865789705434,0.021739130434782608,0.06191738229197513,1.0,6/21,2.68%,RFC3;RPA3;RFC5;POLE2;RFC2;POLH
prerank,in utero embryonic development (GO:0001701),-0.5302516441491615,-1.607916002646261,0.018867924528301886,0.07935390495752262,1.0,12/24,16.09%,PKD1;FLCN;FOXF1;EGFL8;MYH6;FGFR2;FOXD3;MBNL1;ZNF568;ARNT2;HINFP;LMX1B
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.35315146663288627,1.6067969476812478,0.0,0.06224540852154177,1.0,47/153,15.06%,CDH3;SOX4;RUVBL1;PSMD14;COL1A1;PSMB2;PSMB9;PSMA5;LGR5;PSMB3;ATP6V1C2;PSME3;PSMA3;PTK7;PSMA7;DEPDC1B;PSMD13;AXIN2;LGR6;GID8;PSME2;PSMC2;PSMC4;PSMD10;TNFAIP3;PSMD12;SMARCA4;JUP;PSMB5;CSNK2A1;BAMBI;XIAP;LBX2;PSMD8;NRARP;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;SEMA5A;PSMF1;PSMD11;PSMD1;GSKIP;VCP;TMEM9
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.47275935788735196,1.6066905960269904,0.0,0.0620864688454265,1.0,15/37,19.58%,RFC3;RPA3;RFC5;RFC2;POLD2;NTHL1;GTF2H3;ERCC5;DDB1;UBA52;RPA2;POLD1;CUL4A;RFC4;ERCC2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4529075451414755,1.6062616296871226,0.0,0.06201650343608088,1.0,13/34,21.85%,AZGP1;HSPD1;IL23A;CD1A;ZP3;IL1B;CD55;CD1B;TRAF2;IL23R;TNFSF4;HLA-F;IL12B
prerank,regulation of protein kinase A signaling (GO:0010738),-0.5613979229219663,-1.6052508129314174,0.018518518518518517,0.08096762814075527,1.0,7/19,11.60%,AKAP6;AKAP12;ADRB2;PJA2;LRRK2;PRKAR2B;MC1R
prerank,cell junction organization (GO:0034330),-0.41532895762715305,-1.6038568051565107,0.0,0.08139607268896712,1.0,26/72,13.03%,LIMS2;NLGN2;FLNA;FLNC;MAPT;CTNND2;NLGN3;FERMT2;MYOT;NLGN4X;SLC8A2;ILK;SNCA;MYO9A;L1CAM;SNCB;SDK1;PSEN1;PPFIA4;SEMA3E;SNCG;CBLN2;OPHN1;PPFIBP1;SLC8A3;TJP1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.45994739219482406,1.6037544999917135,0.02564102564102564,0.06299555870588726,1.0,17/44,16.86%,MIA2;PDIA4;CANX;RAB15;CTAGE9;RAB10;RAB8A;MTTP;RAB3D;COPG1;COPG2;CTAGE8;CTAGE4;CTAGE6;CTAGE15;STEAP3;PREB
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.46788983608099693,1.6024350126908633,0.023255813953488372,0.06348827097054727,1.0,21/33,29.88%,E2F1;TFDP1;TP73;GZMB;YWHAB;YWHAE;PMAIP1;BBC3;YWHAG;GSK3B;ZNF205;BAX;BID;SFN;BAK1;TP53;CASP8;YWHAQ;HIP1R;PPP3R1;CHCHD10
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.4717294970829448,-1.6023519911771669,0.0,0.08251789495576854,1.0,18/40,22.82%,TSC1;CORO2B;FZD4;VIT;GCNT2;ATXN3;FZD7;PPM1F;CORO1C;ARL2;RAC1;RHOA;PDGFB;MYADM;SPOCK1;FBLN2;ECM2;RSU1
prerank,DNA biosynthetic process (GO:0071897),0.544291426846238,1.6023295711298455,0.0,0.06328361485374923,1.0,6/16,15.65%,RFC3;POLD2;POLH;WRNIP1;POLA1;POLD1
prerank,intracellular lipid transport (GO:0032365),-0.5855878862168146,-1.5978542304122303,0.0196078431372549,0.0852019136940808,1.0,8/19,24.13%,ACACB;PRKAB2;PRKAG2;PRKAA2;CPT1B;ABCD4;ABCD1;ABCD2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4828359866575922,-1.597444330382795,0.0,0.0850040017318971,1.0,17/35,22.68%,TNRC6A;GNAO1;FZD4;PPP3CB;AGO4;CAMK2A;CALM1;TNRC6C;NFATC1;GNG2;AGO3;TNRC6B;AGO1;PLCB1;MAP3K7;PDE6B;PLCB2
prerank,cilium organization (GO:0044782),-0.35608525154760706,-1.596200470336796,0.0,0.08549533038762804,1.0,101/210,28.66%,TTLL3;NPHP3;PKD1;FLNA;IFT80;WDR19;RFX2;PKD2;GSN;DZIP1;CNGB1;RABL2B;TTBK2;CEP126;INTU;EHD2;IFT81;BBS4;CYS1;BBS5;DYNC2H1;WDR11;HDAC6;DZIP1L;INPP5E;STK36;CFAP44;CCDC66;EXOC7;BBS1;CC2D2A;FBF1;PARVA;CFAP54;TEKT2;NEK1;ABLIM3;RAB23;PTPDC1;CEP164;CEP162;CCDC57;EXOC3;BBS2;MARK4;DISC1;TEKT3;RILPL1;CLUAP1;CFAP70;PCM1;GBF1;RAB11FIP3;BBS7;CEP290;ARMC9;BBS9;TXNDC15;PCNT;IFT122;AHI1;TMEM138;CDC14A;ARL3;RTTN;RPGR;FUZ;FAM161B;RAB8B;WDR35;CNGA4;CEP89;RFX3;UBXN10;RHO;IFT46;KIF3A;ARL6;BBIP1;TRAF3IP1;TTC8;CDC14B;WDPCP;EXOC1;KIFAP3;IFT43;ABCC4;IQCG;SPAG16;CCP110;ROPN1;CFAP61;IFT172;ASAP1;IFT140;OCRL;PTPN23;CEP19;CCDC28B;UNC119B;ATAT1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5725700697722592,1.5937378478717472,0.06818181818181818,0.06847758693155973,1.0,11/16,26.88%,TACC3;PTTG1;CENPE;NEK6;ANAPC1;UBE2C;PLK1;CDC6;HECW2;RIOK2;CDC23
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3439362246527295,1.5937286611736614,0.0,0.06821216992794903,1.0,110/269,22.13%,POLR2F;POLR2D;CSTF2;DCPS;CPSF3;ALYREF;SNRPF;CLNS1A;SNRPD1;PRPF19;LSM7;LSM5;PABPC1;HNRNPF;PPIH;LSM4;SNRPG;SF3B3;WDR77;U2AF1;CSTF1;MAGOH;PRPF4;TGS1;PPIL1;SNRPB;RNF113A;SNRPC;EFTUD2;MAGOHB;LSM8;EIF4A3;PHF5A;SNRPD2;NCBP1;SNRPE;DDX39A;SRPK1;SRSF9;SF3B6;PTBP1;NONO;RALY;RSRC1;SNRNP40;SNRPB2;BUD31;RBM15;HNRNPK;DHX9;NUDT21;SF3B5;PRPF40A;PRPF6;LSM2;CLP1;SNRPA1;GEMIN6;NCBP2;PSPC1;HNRNPC;FUS;CRNKL1;CPSF2;POLR2C;ELAVL1;GTF2F2;DHX8;POLR2K;HNRNPA0;RBM22;POLR2J;UBL5;LSM6;CTNNBL1;STRAP;POLR2G;USP39;PUF60;DDX41;LSM3;COIL;SMN1;ELAVL2;SYNCRIP;TRA2B;SF3A3;HNRNPR;PPIL3;RBM8A;CPSF4;HNRNPA2B1;SNRPD3;CDC5L;POLR2H;SRSF3;DBR1;TFIP11;WDR83;HNRNPA1;RBM15B;POLR2I;DDX1;POLR2L;TXNL4A;RBMX2;GEMIN2;CSTF3;U2AF2;GPKOW
prerank,microtubule polymerization (GO:0046785),-0.5214678945995306,-1.5933248456467093,0.03636363636363636,0.0874862232321022,1.0,17/29,22.59%,MAPT;TUBG2;TUBGCP6;CLASP1;MAP7D3;CLASP2;TPPP;CCDC57;NDEL1;RANBP9;FGF13;SLAIN2;TUBGCP5;CSNK1D;TPPP3;GOLGA2;PIN1
prerank,positive regulation of viral genome replication (GO:0045070),0.4855869184546906,1.591421938698173,0.0,0.06893418864102904,1.0,10/29,16.07%,HACD3;PABPC1;PPIH;SRPK1;PDE12;STAU1;TARBP2;DDB1;TMEM39A;TOP2A
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.40899040464247327,1.5908346125296786,0.0,0.06896780382122401,1.0,26/63,21.64%,POLR2F;POLR2D;EAF1;CDK7;NELFCD;GTF2H3;NCBP1;CCNK;SSRP1;NCBP2;ADRM1;POLR2C;GTF2F2;POLR2K;MLLT3;POLR2J;LEO1;POLR2G;CDK12;CTR9;NELFE;ERCC2;POLR2H;ELP4;POLR2I;POLR2L
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3677654260780178,1.5906390824618089,0.0,0.06883110309857848,1.0,49/130,20.10%,CDH3;SOX4;RUVBL1;PSMD14;COL1A1;PSMB2;PSMB9;PSMA5;LGR5;PSMB3;PSME3;PSMA3;PTK7;PSMA7;PSMD13;AXIN2;LGR6;GID8;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;JUP;PSMB5;BAMBI;XIAP;PSMD8;NRARP;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;SEMA5A;PSMF1;PSMD11;PSMD1;GSKIP;VCP;TMEM9;SCEL;TGFB1;SFRP4;ATP6AP2;PSMD6;AXIN1;PSMD5;CAV1
prerank,cytoplasmic translational initiation (GO:0002183),0.5331982387210862,1.5897865173135615,0.023255813953488372,0.0691189689871839,1.0,7/18,11.69%,MCTS1;EIF2S3;EIF2S2;EIF3I;EIF3M;DENR;EIF3D
prerank,regulation of RNA metabolic process (GO:0051252),-0.4157097236907658,-1.5889108990884893,0.0,0.09041004396683895,1.0,20/63,10.07%,RBM20;CLK4;PTBP2;NOVA1;AHNAK;SNRNP70;CLK1;PRX;MITF;CLK3;PCBP3;CELF1;CLK2;MBNL1;HNRNPH3;AKAP17A;RBM38;AHNAK2;NOVA2;SON
prerank,DNA duplex unwinding (GO:0032508),0.4356447576509085,1.5880249763605563,0.025,0.06957341087770486,1.0,16/49,15.66%,MCM4;HMGA1;SSBP1;BLM;GTF2H3;MCMDC2;RECQL4;ASCC3;MCM7;MCM6;DHX9;MCM2;RAD23B;DDB1;UBA52;CUL4A
prerank,long-term memory (GO:0007616),-0.5644367484687716,-1.5877207995287985,0.061224489795918366,0.09109318249950282,1.0,7/18,15.87%,NFATC4;SLC2A4;NPAS4;PJA2;PRNP;CPEB3;KAT2A
prerank,transcription by RNA polymerase I (GO:0006360),0.4413472563706868,1.5874853536505995,0.0,0.069730189816435,1.0,9/30,12.90%,POLR2F;POLR1C;CDK7;POLR1B;GTF2H3;TAF1A;POLR1A;TAF1B;POLR2K
prerank,negative regulation of protein depolymerization (GO:1901880),-0.5071715098770571,-1.587327877328784,0.03508771929824561,0.09123059496945995,1.0,15/23,26.63%,PLEKHH2;TTBK2;LIMA1;STMN2;CLASP1;CLASP2;NAV3;FGF13;APC;ATXN7;CAMSAP2;APC2;SPEF1;TAOK1;CAMSAP1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.5290261837396708,1.5868029430124344,0.061224489795918366,0.0699276583672134,1.0,13/20,28.21%,HPRT1;ADK;POLD2;DCK;PNP;APRT;DGUOK;POLD1;AMPD2;CDA;TERT;POLD3;AMPD3
prerank,positive regulation of signal transduction (GO:0009967),-0.3678117832932781,-1.5866908677149494,0.0,0.09118786709056084,1.0,94/234,22.30%,LIMS2;SLC2A4;TRIM39;SORBS1;TTC23;NLGN2;FLNA;AGPAT1;LMO3;CCBE1;EPN2;SASH1;PKD2;STX1B;NLGN3;GKAP1;HAP1;KAT2B;MACF1;RAB34;NRXN1;CITED2;GPER1;CUX2;ARNT;SHANK3;PIK3R1;FGFR2;ILK;DLG4;GH1;KIF7;NTRK3;TMEM108;ITGB3;NLGN1;RSPO1;PRKCB;PRKCA;STK36;RWDD3;NECAB2;PTGIS;DSTYK;MN1;RBPJ;PTEN;CAV2;LRRK2;MAML1;MBD5;RSPO2;ZMIZ1;NPTN;TSLP;GRB10;MYO1C;WLS;NOTCH4;SKI;EVC;DAB2IP;ASXL1;RELN;DISC1;SFRP1;KANK1;NTF3;ARMC9;TXNDC15;FAS;CD63;GPS2;SPIN1;SMO;FGF1;DLG5;RSPO3;ZRANB1;HHEX;ENHO;DLL1;CRADD;TM2D3;INS;SIRT1;ING5;PHIP;RIMS1;LOXL3;ADAMTS3;KLF2;TRIM44;TUBD1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.330187744695722,1.584959185648434,0.0,0.07095795084394434,1.0,115/327,20.62%,RFC3;RFWD3;CHEK1;MYC;UBE2T;FEN1;CCND1;E2F1;XRCC2;CBX3;TP73;RFC5;TDP1;DCUN1D5;CDK1;RAD51AP1;EXO1;FANCF;POLE2;RFC2;TIMELESS;NUDT1;POLH;FBXO45;SUV39H1;UNG;POLB;TRAIP;CHEK2;RMI2;BLM;XRCC5;GTF2H3;TICRR;RAD18;MASTL;NABP2;ZRANB3;PRKDC;INIP;RECQL4;ERCC8;CCNK;PML;RPS3;TOPBP1;RBBP5;RAD9B;LIG1;MSH3;POLE3;FANCL;IKBKE;EPHA2;BCL2L1;MCM7;APEX1;PARP4;CASP2;BCL2A1;RAD51B;USP10;WDHD1;XIAP;RAD54L;POLA1;AATF;CHCHD6;NEK4;DTX3L;APTX;MAPKAPK2;MACROD1;BATF;RBBP8;MCM10;DDB1;TAF9;BRCA1;HUS1;MSH6;MAPK15;CIB1;NPM1;SMC1A;PAK1;ACER2;VCP;UBA1;POLD1;CUL4A;TOP2A;UBE2A;OARD1;FANCA;SUMO1;ZDHHC16;SPRTN;FBXO6;REXO4;LYN;TNFRSF1B;VAV3;FANCC;RFC4;BAX;BID;SFN;PDS5A;MNDA;VCPIP1;SPDYA;BAK1;BRAT1;TRIM28
prerank,protein import (GO:0017038),0.39113781320733326,1.5848670372141984,0.0,0.07073374992344358,1.0,26/87,15.20%,RAN;CSE1L;NXT2;NUP155;E2F3;NUP62CL;NUP93;NUTF2;SYK;PEX13;SEC13;ACBD5;TOMM22;LAMP2;NXT1;NUP50;NUP88;HSPA4;NUP107;TNPO3;HEATR3;KPNB1;SLC25A17;PEX16;MMP12;NUP62
prerank,translesion synthesis (GO:0019985),0.45175244602859593,1.583956125761558,0.0,0.07104947574829436,1.0,19/40,22.29%,RFC3;RPA3;RFC5;POLE2;RFC2;POLD2;POLH;USP10;POLDIP2;UBA52;VCP;RPA2;ISG15;POLD1;SPRTN;UBE2L6;RFC4;DTL;USP43
prerank,amino acid import (GO:0043090),0.542572601747257,1.5836738215163937,0.0,0.07095035212202183,1.0,9/22,12.88%,SLC6A20;SH3BP4;SLC6A14;SLC7A1;SLC7A5;SLC6A6;TSPO2;SFXN2;SFXN1
prerank,protein localization to nucleus (GO:0034504),0.39394112591441,1.583360045618732,0.0,0.07089306017101892,1.0,33/102,15.59%,CALR;RAN;CSE1L;COL1A1;NXT2;NUP155;RRS1;E2F3;NUP62CL;NUP93;YWHAE;NUTF2;SYK;SEC13;PML;NXT1;ARL2BP;NUP50;NUP88;NUP107;RPF2;TNPO3;SIX1;HEATR3;TOR1A;TOR1B;BMP7;KPNB1;PLK1;BMP4;MMP12;NUP62;MSX1
prerank,regulation of stress fiber assembly (GO:0051492),-0.4296039798968628,-1.5827612573931145,0.0,0.09336970128910356,1.0,41/71,27.18%,TSC1;TPM1;RAPGEF3;LPAR1;ASAP3;TMEFF2;FERMT2;MYOC;PXN;PHLDB2;SORBS3;PIK3R1;ARHGAP6;DLC1;CLASP1;ARHGEF10;EVL;CLASP2;PPM1F;ARHGEF15;ARHGEF18;INPP5K;TJP1;RAC1;SFRP1;RHOA;ROCK1;CCDC88A;WASF2;CGNL1;LIMCH1;TESK1;ARHGAP28;RHOC;TGFB3;FHOD1;SYNPO2L;RGCC;ALMS1;ITGB1BP1;PPM1E
prerank,ncRNA catabolic process (GO:0034661),0.4956753434566377,1.5819678384399605,0.021739130434782608,0.0711228114650113,1.0,11/25,18.34%,SND1;EXOSC5;POP1;EXOSC4;EXOSC8;EXOSC7;EXOSC3;DIS3;EXOSC2;DEDD2;NUDT16L1
prerank,regulation of RNA splicing (GO:0043484),-0.40485252269682653,-1.5812125799587922,0.0,0.09406960926713452,1.0,24/74,11.64%,RBM20;CLK4;PTBP2;AHNAK;SNRNP70;CLK1;PRX;PIK3R1;CLK3;CELF1;CLK2;MBNL1;HNRNPH3;AKAP17A;QKI;RBM38;AHNAK2;SF1;DYRK1A;SON;TIA1;JMJD6;HABP4;YTHDC1
prerank,positive regulation of macroautophagy (GO:0016239),-0.44332228926529105,-1.5805747183058128,0.016666666666666666,0.09445440079101457,1.0,22/50,21.15%,EPM2A;HSPB8;SLC25A4;FYCO1;GPSM1;VPS13D;CALCOCO2;ADRB2;PIP4K2B;PRKAA2;DCN;OPTN;UVRAG;WAC;BAG3;PIP4K2A;LRSAM1;TSC2;RAB3GAP1;SIRT1;BNIP3;MAP3K7
prerank,determination of heart left/right asymmetry (GO:0061371),-0.44983058628077754,-1.5800365594201407,0.01818181818181818,0.09444091019602907,1.0,20/46,19.82%,NPHP3;PKD2;DAND5;SRF;BBS4;BBS5;CCDC39;NDRG4;CCDC40;HAND1;MEGF8;FOXN4;SOX17;MEF2C;TBX2;BBS7;AHI1;SMO;SOX18;DLL1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.47238145126098186,1.5799581322478742,0.023255813953488372,0.07188121152122877,1.0,13/33,15.51%,CCT6A;CCT2;CCT3;XRCC5;CCT8;CCT7;NEK2;AURKB;FBXO4;NAF1;MAPK15;CCT4;TCP1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4049898214088205,1.5786217561423872,0.0,0.07218695166577903,1.0,23/66,17.98%,SULT2B1;ENTPD7;RAN;HPRT1;SULT1C2;SULT1C3;EPHA2;ACSL6;BAAT;THEM5;ACOT7;DBI;GNAI3;ACOT13;BPNT1;ACOT4;ACOT8;SULT1A3;ACLY;OXSM;HINT1;NT5C2;TPST2
prerank,O-glycan processing (GO:0016266),0.4148770272861778,1.5777185674451333,0.0,0.07253095759420208,1.0,21/59,20.61%,GALNT6;C1GALT1C1;B3GNT4;CHST4;C1GALT1;POFUT1;MUC5AC;B3GNT2;GCNT1;GALNT5;ST6GAL1;GALNT3;GALNT1;GALNT7;B3GNT3;B3GNT5;MUC20;MUC17;B3GNT8;B4GALT5;MUC16
prerank,negative regulation of signaling (GO:0023057),0.47615522095319607,1.5771576707881847,0.02040816326530612,0.07259001025953943,1.0,6/24,11.65%,OSM;IL11;SRMS;IL1B;PCSK9;AP1AR
prerank,cellular response to cAMP (GO:0071320),-0.4873136722434685,-1.5769638553142131,0.01694915254237288,0.09669660191853405,1.0,14/30,20.47%,PDE2A;AKAP6;RAPGEF3;PKD2;RAP1A;ZFP36L1;AQP1;INPP5K;RAPGEF1;KCNE1;IGFBP5;CRHBP;RAPGEF2;HCN3
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3663231808453723,1.5762261586884783,0.0,0.07268883901088971,1.0,53/113,28.45%,IL1A;CXCL5;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;IL1B;WNT5A;DEFA6;PF4;TNFAIP3;CARD17;HMGB2;PLAA;CD80;CCL3;XBP1;MYD88;RELA;IRAK1;CXCL9;CXCL10;CXCL6;TNIP3;TGFB1;PF4V1;LYN;IL36B;TNFRSF1B;CHMP5;NOD2;CTR9;ADAM9;SERPINE1;TNFSF4;CD86;CXCL13;GIT1;HMGB1;NFKBIB;ZC3H12A;MTDH;IL36RN;TICAM1;CARD16;GSTP1;IL36G;IL37;DEFA1;IL10;IL18;TRAF6
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.4689344588038858,1.57562173684812,0.0,0.07266677760803986,1.0,15/39,19.58%,RFC3;RPA3;RFC5;RFC2;POLD2;NTHL1;GTF2H3;ERCC5;DDB1;UBA52;RPA2;POLD1;CUL4A;RFC4;ERCC2
prerank,positive regulation of axonogenesis (GO:0050772),-0.4775322106587084,-1.5748754494610109,0.0,0.09788862035715884,1.0,17/43,17.85%,MAP6;NTN1;PLXNB3;MAPT;MACF1;RUFY3;AMIGO1;L1CAM;NGF;NGFR;SLIT2;CHODL;TIAM1;RHOA;DBN1;PLXNA4;PLXNB1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5993014479740351,-1.5734991054050445,0.02,0.09868037739638558,1.0,10/18,22.09%,DMD;PDE4D;CNKSR3;NCK1;PTEN;PPM1F;INPP5K;RASSF2;SMAD7;GPD1L
prerank,metal ion export (GO:0070839),-0.49155048141726876,-1.5711488689095408,0.014925373134328358,0.10023907925022182,1.0,13/31,13.83%,ATP1B2;ATP2B4;ATP1A2;KCNA5;FXYD2;KCNIP2;KCNH2;ATP1A4;KCNT2;KCNE2;ATP1A3;KCND3;KCNE1
prerank,amino acid transport (GO:0006865),0.44018113834082506,1.5702664234572323,0.0,0.07507967567314226,1.0,25/49,29.73%,SLC6A20;SLC1A5;SH3BP4;SLC1A4;SLC6A14;SLC7A1;SLC7A11;SLC38A5;SLC7A5;SLC6A6;SLC7A4;SLC3A2;SLC16A10;SLC43A2;SLC25A48;SLC7A7;SLC7A8;SLC6A18;SLC7A6;SLC38A8;SLC38A9;SLC38A7;SLC6A12;SLC38A10;SLC38A3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.4544669976249638,-1.570233626360238,0.017241379310344827,0.10062707295876325,1.0,15/39,16.77%,PER1;TRIM39;MAPKBP1;ZMYND11;RORA;NR1D1;CARD8;OTUD7A;OTUD7B;DAB2IP;PPM1A;PPM1B;ESR1;TLE1;NLRX1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5038017056338601,1.5699029452012032,0.05714285714285714,0.07496965970399475,1.0,9/23,21.48%,SULT2B1;SULT1C2;SLC35B2;SULT1C3;BPNT1;PAPSS1;SULT1A3;TPST2;ABHD14B
prerank,regulation of translation (GO:0006417),0.33794628462104687,1.5696737844897901,0.0,0.07478117024126796,1.0,53/168,16.77%,SOX4;ENC1;CALR;CAPRIN1;SHMT2;PUS7;GZMB;DHFR;MRPL13;EIF3C;GAPDH;NOLC1;IGF2BP1;NCL;NAT10;NSUN3;EIF4A3;NCBP1;PRKDC;YTHDF1;NANOS3;IGF2BP3;RPS3;CNOT10;MTIF2;GRB7;IGF2BP2;RPS4X;EIF6;DHX9;GLE1;TRAP1;EIF4E;EIF4E2;NCBP2;GSPT1;EIF3D;TRIM71;ELAVL1;OGFOD1;METAP1;EIF3B;EIF3H;NPM1;MALSU1;PKP3;LARP4B;RBM3;MTG2;NSUN5;CNOT1;EIF3E;SYNCRIP
prerank,folic acid metabolic process (GO:0046655),0.5420445097357486,1.5686978938823666,0.0,0.07506788590227216,1.0,6/18,8.56%,SHMT2;MTHFD1;MTHFD1L;DHFR;SLC19A1;MTHFD2
prerank,regulation of DNA metabolic process (GO:0051052),0.41812178862430144,1.5675796987989006,0.02127659574468085,0.07535256811887209,1.0,18/44,18.79%,MYC;ALYREF;POLH;UBE2N;TOM1L1;KDM1B;XRCC5;TICRR;WRNIP1;WDR18;SUB1;CDT1;GRHL2;KPNA2;USP1;IL7R;MPV17;STOX1
prerank,mitotic nuclear division (GO:0140014),0.4099238234734654,1.5674200148657123,0.0,0.07512551418583809,1.0,29/68,17.34%,RAN;DSN1;KIF2A;MZT1;KIF18A;KNSTRN;UBE2S;CHEK2;ZWINT;NDC80;CENPK;SMC4;SPAG5;RAB11A;KIF3B;UBE2C;ZW10;SPAST;TPX2;NSL1;NCAPG2;KPNB1;PLK1;SMC1A;TUBG1;NUP62;BCCIP;KIF18B;ESPL1
prerank,regulation of hydrolase activity (GO:0051336),-0.41895846158395084,-1.5672310722401415,0.03636363636363636,0.102801533884174,1.0,34/69,28.27%,BVES;PLXNB3;RABGAP1;CAMK2A;PAFAH1B1;PRKG1;NOS1;SERPINA5;EPHA5;FGD1;RDX;RASIP1;DAB2IP;EPHA4;EFNA5;EPHA3;RAB3GAP1;PLXNA4;PLXNB1;SIPA1L1;CDK5RAP3;FGD2;RAPGEF6;SOD1;FGD5;ARHGAP15;FBXW11;CHN1;ITGB1BP1;ARHGAP9;PLXNA3;FGD6;OCRL;CRK
prerank,negative regulation of autophagy (GO:0010507),-0.43251911261384857,-1.5664483575235686,0.0,0.10304680119464714,1.0,23/55,24.80%,NRBP2;TSC1;SNRNP70;MTMR9;SNCA;WDR6;TAB2;ZKSCAN3;BCL2;KLHL22;LRRK2;SIRT2;RASIP1;LEPR;HTR2B;NUPR1;EIF4G3;GOLGA2;SMG1;MTOR;HGF;PINK1;RRAGA
prerank,inositol phosphate metabolic process (GO:0043647),-0.4558336595957717,-1.5664233939347778,0.0,0.10265638724115941,1.0,15/47,14.11%,INPP5B;IP6K3;PLCD4;ITPKB;INPP5A;INPP4A;INPPL1;FGF2;SYNJ1;CALM1;NUDT10;NUDT11;PTEN;PLCE1;IP6K1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.5033185768595934,-1.5659674829177317,0.02,0.10247972677907763,1.0,16/35,20.64%,FAM107A;KANK2;FHL1;PKD2;JADE1;ZNF655;PTEN;CDKN1A;PRMT2;APC;CDKN2C;RBL2;MYO16;DCUN1D3;SUSD2;CCL2
prerank,amino acid transmembrane transport (GO:0003333),0.4531488448926451,1.565750021863679,0.0,0.07615034711940251,1.0,22/45,26.53%,LRRC8E;SLC6A20;SLC6A14;SLC7A1;SLC7A11;SLC38A5;SLC7A5;MFSD12;SLC6A6;LRRC8D;TSPO2;SLC25A22;SFXN2;SFXN1;SLC3A2;SLC7A7;SLC25A13;SLC7A8;SLC7A6;SLC38A8;SLC38A9;SLC38A7
prerank,neural crest cell migration (GO:0001755),-0.4608723957250161,-1.5657277266740408,0.0,0.1023046796545491,1.0,17/36,18.27%,GDNF;SEMA6C;RADIL;PHOX2B;TBX1;SEMA4C;SEMA3E;NRTN;CORO1C;ANXA6;SEMA6D;SEMA6A;SEMA3B;HTR2B;SEMA3G;SEMA3A;ERBB4
prerank,negative regulation of transport (GO:0051051),-0.4257722786033797,-1.5627272782594828,0.018518518518518517,0.1037973123482262,1.0,15/44,17.55%,CRYAB;PXK;SNX33;SNCA;ITGB3;SYT11;PRKD1;PTEN;PPM1F;DYSF;LGALS3;NR1H2;EPHA3;LRSAM1;PACSIN3
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.4613305917178421,-1.5625214216967047,0.0,0.10361788743491898,1.0,21/36,25.44%,FLCN;ARNTL;FERMT2;RUNX1T1;WWTR1;GPER1;RORA;ZADH2;ZFPM2;SIRT2;ASXL1;GATA2;TRIB2;GPS2;TRIO;SIRT1;ANKRD26;WNT10B;ZFP36L2;BBS12;SMAD3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.33949402011326973,1.56240754262553,0.0,0.07798561072176707,1.0,101/246,22.41%,POLR2F;POLR2D;CSTF2;CPSF3;ALYREF;SNRPF;SNRPD1;PRPF19;LSM7;LSM5;PABPC1;HNRNPF;PPIH;LSM4;SNRPG;SF3B3;U2AF1;CSTF1;MAGOH;PRPF4;PPIL1;SNRPB;RNF113A;SNRPC;EFTUD2;MAGOHB;LSM8;EIF4A3;PHF5A;SNRPD2;NCBP1;SNRPE;DDX39A;SRSF9;SF3B6;PTBP1;NONO;RALY;RSRC1;SNRNP40;SNRPB2;BUD31;RBM15;HNRNPK;DHX9;NUDT21;SF3B5;PRPF40A;PRPF6;LSM2;CLP1;SNRPA1;GEMIN6;NCBP2;PSPC1;HNRNPC;FUS;CRNKL1;CPSF2;POLR2C;ELAVL1;GTF2F2;DHX8;POLR2K;HNRNPA0;RBM22;POLR2J;UBL5;LSM6;CTNNBL1;POLR2G;USP39;PUF60;DDX41;LSM3;ELAVL2;SYNCRIP;TRA2B;SF3A3;HNRNPR;PPIL3;RBM8A;CPSF4;HNRNPA2B1;SNRPD3;CDC5L;POLR2H;SRSF3;DBR1;TFIP11;WDR83;HNRNPA1;RBM15B;POLR2I;POLR2L;TXNL4A;RBMX2;CSTF3;U2AF2;GPKOW;GEMIN5
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.572889337225734,-1.5622039112281987,0.05357142857142857,0.1033575250285433,1.0,8/17,17.77%,CLU;HAP1;PRNP;RTN1;GGA3;ROCK1;RTN2;RTN4
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4689567208048865,-1.5616386495982544,0.015873015873015872,0.10355150826295553,1.0,22/44,25.62%,GRIK3;NLGN2;TSHZ3;ATP1A2;NLGN3;GRM6;NRXN1;SHANK3;NLGN1;LRRK2;OPHN1;MEF2C;CACNG7;RELN;CDH2;CCL2;GRM2;SYT1;DGKI;GRIK1;CLN3;GRM3
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.5567266200607357,1.5606733292108061,0.05128205128205128,0.07860529395915834,1.0,9/21,9.97%,TIMM8A;ROMO1;TIMM10;PMAIP1;TIMM13;TOMM22;COX18;TIMM8B;HSPA4
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5793072393446398,1.5602601055873802,0.07142857142857142,0.0784860602529626,1.0,5/16,5.36%,CLDN1;CLDN2;CLDN16;CLDN12;CLDN14
prerank,microtubule nucleation (GO:0007020),-0.5434896590373597,-1.5596547464678467,0.03773584905660377,0.10452101953203453,1.0,11/20,18.39%,TUBG2;TUBGCP6;CLASP1;CLASP2;TPPP;CCDC57;NDEL1;RANBP9;SLAIN2;TUBGCP5;CSNK1D
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5096258525218393,1.559317163590219,0.0,0.07851883691575766,1.0,9/20,21.64%,POLR2F;POLR2D;POLR2C;POLR2K;POLR2J;POLR2G;POLR2H;POLR2I;POLR2L
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5096258525218393,1.559317163590219,0.0,0.07851883691575766,1.0,9/20,21.64%,POLR2F;POLR2D;POLR2C;POLR2K;POLR2J;POLR2G;POLR2H;POLR2I;POLR2L
prerank,negative regulation of protein polymerization (GO:0032272),-0.49040935306325656,-1.5591567485291076,0.0,0.10470810738434758,1.0,11/26,16.34%,CLIP3;TUBB4A;STMN2;SNCA;DYRK1A;SLIT2;MAP2;KANK3;SSH1;KANK1;MYADM
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5571450756974766,1.558943023399792,0.0,0.07843939791036275,1.0,9/17,19.61%,ETV4;SULT2B1;CYP27B1;ZBED2;BMP4;MED1;SFRP4;KDF1;SFN
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5064515340151574,1.5580299045378505,0.04878048780487805,0.07877995283549534,1.0,17/26,27.42%,FBXO5;CENPE;NEK6;DLGAP5;UBE2C;DUSP1;LCMT1;ANAPC11;PLK1;NSMCE2;ESPL1;CDC6;CUL3;HECW2;RIOK2;CDC23;CCNB1
prerank,regulation of immune response (GO:0050776),0.33996168929734455,1.5566781786481736,0.0,0.07946018459549761,1.0,70/168,30.62%,ULBP3;COL1A1;IFITM1;IL4I1;COL1A2;CD1A;FOXP3;CD276;LRP8;LAIR2;SYK;TKFC;TREM1;TGFB2;CXADR;ULBP1;XIAP;CD81;ICAM1;SELL;CD1B;COL3A1;NCR3LG1;FCGR3B;TREML2;C3;FCGR1A;MICB;CD8B;FCGR3A;LYN;CD300LD;PLSCR1;ZMPSTE24;ADCY7;ERAP1;TNFSF4;CD3D;CXCL13;CD300LF;RAET1E;HLA-F;CRTAM;OSCAR;TYROBP;ICAM2;ELMOD2;CD3G;CD300A;SH2D1A;TREML4;HCST;ITGB2;FCGR2A;COL17A1;CASP8;PDCD1;FCRLB;SLAMF6;CD3E;SLA2;BCL6;NCR3;AHR;SIGLEC7;IRF7;IFNL1;SAMHD1;RSAD2;CD300LB
prerank,striated muscle tissue development (GO:0014706),-0.4814913348613276,-1.5556622004035172,0.037037037037037035,0.10692085964591105,1.0,12/34,15.11%,POPDC2;BVES;CFLAR;MYOZ2;PGM5;SGCG;MEF2C;MYL6;MYOZ1;SGCD;CSRP3;TBX2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.497212945329363,-1.5554022132064316,0.038461538461538464,0.10669204933849924,1.0,10/23,20.41%,HDAC4;ACTN3;CLK2;GCK;SOGA1;C1QTNF3;NUPR1;GSK3A;INS;CRY1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.48808997996722264,1.554817579168671,0.0,0.08070384336073434,1.0,14/27,24.24%,ALG8;ALG11;ALG2;GCNT1;TPI1;TKT;GK;ST8SIA6;B3GNT5;G6PD;ALG6;B4GALT5;GAL3ST2;RRM2
prerank,type I interferon signaling pathway (GO:0060337),0.41726459890941453,1.55323013735593,0.019230769230769232,0.08128513646373747,1.0,27/65,30.69%,IFITM3;IFITM1;IFITM2;IFI6;OAS2;MYD88;IRAK1;STAT1;IRF8;BST2;IFIT3;OASL;MX1;ISG15;XAF1;IRF6;EGR1;OAS3;HLA-F;TYK2;STAT2;IFI35;IRF3;IRF7;SAMHD1;RSAD2;IRF9
prerank,cellular response to type I interferon (GO:0071357),0.41726459890941453,1.55323013735593,0.019230769230769232,0.08128513646373747,1.0,27/65,30.69%,IFITM3;IFITM1;IFITM2;IFI6;OAS2;MYD88;IRAK1;STAT1;IRF8;BST2;IFIT3;OASL;MX1;ISG15;XAF1;IRF6;EGR1;OAS3;HLA-F;TYK2;STAT2;IFI35;IRF3;IRF7;SAMHD1;RSAD2;IRF9
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.4960843713467212,-1.5520232340593751,0.0,0.10935897876343802,1.0,12/28,17.18%,SYNGR1;CAMK2A;SLC8A2;DLG4;GRIK2;SYP;SHISA7;RAB3A;CAMK2B;DBN1;NCDN;RAB3GAP1
prerank,nuclear transport (GO:0051169),0.6062762658334147,1.5516073273620539,0.022727272727272728,0.08217263754723038,1.0,13/16,28.62%,HMGA1;NXT2;ANP32A;NUTF2;RSRC1;NXT1;NUP205;NPM1;BANF1;RBM15B;RGS14;NUP98;XPO1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4144321283554912,1.5515858300021825,0.021739130434782608,0.0818959619999333,1.0,16/50,15.51%,GNL3L;CCT6A;CCT2;CCT3;XRCC5;CCT8;CCT7;NAT10;NEK2;AURKB;FBXO4;NAF1;HNRNPC;MAPK15;CCT4;TCP1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.450642205185481,-1.5479371765216692,0.019230769230769232,0.11264285983664142,1.0,18/50,10.05%,GSTM2;ANK2;HRC;AKAP6;JPH2;TRPC1;CASQ1;DMD;CAPN3;JPH4;GPER1;CALM1;PDE4D;SNCA;CASQ2;PRKACA;NOS1;JPH3
prerank,skeletal system morphogenesis (GO:0048705),-0.45359803784348046,-1.5470306286916262,0.0,0.11275072696630195,1.0,20/39,22.95%,FGFR1;DSCAML1;PDGFRA;HOXD3;FGFR2;HOXA4;HOXB4;MEGF8;HOXB3;SKI;CYP26B1;HOXD4;HOXD9;ANKRD11;SOX11;FUZ;OSR2;HOXC4;LRP6;SPEF2
prerank,cellular response to alkaloid (GO:0071312),-0.5831208791287109,-1.5466030460080609,0.0,0.11261964754131856,1.0,9/18,17.89%,RYR3;GSTM2;TRPV1;RYR1;CASQ2;SLC8A1;RYR2;CRHBP;CASP3
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3681884040119395,-1.5445167951832466,0.0,0.11426709853799752,1.0,70/161,24.76%,PKD1;MPZ;IGSF11;PALLD;PLXNB3;TRO;TENM1;KIRREL3;CDH19;ROBO3;CNTN2;DSCAML1;CDHR3;PTPRS;MYOT;PTPRM;NEXN;SLITRK2;CADM3;CLDN5;CLDN11;LRFN5;NLGN1;AMIGO1;DCHS1;L1CAM;CDH23;UNC5D;LRRC4B;SDK1;ADGRL3;SLITRK3;OBSL1;FAT4;NTNG1;CDH10;NPTN;PCDHB4;LRRC4C;CADM1;CRB1;TENM3;MAG;PCDHB6;CDH2;CNTN4;PCDHB5;IL1RAPL1;HMCN1;ROBO4;DSCAM;AMIGO2;PCDHGC3;CNTN6;ADGRL1;TENM2;SLITRK1;PCDHB3;CDH5;PTPRT;GPC6;CDH8;PCDHB2;GRID2;PCDHB10;CDH26;CELSR2;CDH4;CDH20;FAT2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.47369981314923826,-1.544328558194282,0.0,0.11401265141922254,1.0,11/33,6.27%,GSTM2;AKAP6;JPH2;PKD2;TRPC1;CASQ1;CAPN3;HAP1;GPER1;CALM1;SNCA
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5202747695175178,-1.5434249404231228,0.05263157894736842,0.11454358304880498,1.0,13/24,20.37%,SORBS1;PPP1R3E;PPP1R3C;PPP1R3F;EPM2AIP1;GCK;INPP5K;AKT2;INSR;PPP1R3B;GSK3A;INS;PPP1R3G
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5464431488323308,-1.5430761147702006,0.015384615384615385,0.11468006050945888,1.0,8/15,18.42%,NPHP3;DAAM2;CSNK1E;WNT5B;TIAM1;SFRP1;CSNK1D;RSPO3
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.534722109308418,-1.541934356861699,0.019230769230769232,0.11516483638059512,1.0,13/24,25.34%,PDE2A;OR51E2;PDE3B;RASD2;GNAI1;PDE4D;PDE3A;PRKAR2B;GPR61;PEX5L;RAPGEF2;PRKAR1A;UBE2B
prerank,negative regulation of protein modification process (GO:0031400),-0.4248939268676933,-1.539070459339977,0.0,0.11738542384343356,1.0,25/75,12.76%,ATP2B4;DMD;MAPT;TARDBP;FXYD1;WWTR1;ATG14;BEX4;NTRK3;SNTA1;PRNP;TERF2IP;CRTAP;CADM4;SLIT2;PTEN;LRRK2;PRKAA2;TPPP;CORO1C;FBLN1;PID1;INPP5K;TINF2;DAB2IP
prerank,cellular response to interleukin-12 (GO:0071349),0.43640833494725106,1.539046071051251,0.0,0.09052052894553386,1.0,21/47,23.25%,RALA;P4HB;TALDO1;HNRNPF;CNN2;CAPZA1;PSME2;HSPA9;RPLP0;SNRPA1;PAK2;GSTO1;TCP1;CFL1;HNRNPA2B1;MSN;CDC42;IL12B;CD47;IL12RB2;TYK2
prerank,aorta morphogenesis (GO:0035909),-0.5532357618141951,-1.5376015940869097,0.057692307692307696,0.1181242732079777,1.0,9/17,15.77%,MYLK;BMPR1A;TBX1;RBPJ;EFEMP2;HEY1;TBX2;ADAMTS9;HEY2
prerank,histone H4-K16 acetylation (GO:0043984),-0.5201170664767903,-1.537499803709332,0.05172413793103448,0.1178984160251298,1.0,10/19,24.41%,KANSL3;JADE1;MSL1;ING4;KMT2A;KAT7;OGT;KANSL1;KAT8;JADE2
prerank,inorganic cation transmembrane transport (GO:0098662),-0.3498323405217976,-1.5372622190572036,0.0,0.11759807859677313,1.0,94/268,23.43%,PKD1;RYR3;CACNA1H;SCNN1D;KCNB1;ATP2B4;KCNQ4;SLC25A27;CACNA1C;UCP3;KCNN3;ASIC3;ATP1A2;SLC6A16;KCNA5;TRPV1;PKD2;SCN7A;TRPC1;KCNK3;SCN3B;SLC9A9;SCARA5;SCN9A;ABCC8;SLC8A2;SCN4A;SLC39A13;SLC24A4;KCNH2;SCN11A;SCN2B;P2RX7;SCN1B;KCNA2;SLC8A1;KCNK4;KCND1;ATP1A4;TRPC6;KCNE2;SCN4B;TRPC4;SLC24A3;ATP1A3;ABCC9;CACNA1G;KCNA1;KCNAB3;SLC30A8;KCNJ8;SLC8A3;LRRC55;SCN3A;SCNN1B;RHAG;SLC41A1;KCND3;KCNE1;MCOLN3;TRPV3;TMEM175;KCNQ5;MCOLN1;SLC30A4;KCNA4;SCNN1G;KCNC1;KCNJ1;SLC6A1;SLC6A17;CACNA1A;ATP6V1B1;ATP4A;KCNK2;OTOP2;SLC9A5;KCNS2;SCN5A;KCNN1;HCN3;KCNS3;KCNK7;KCNF1;SLC6A15;KCNH5;LRRC52;TRPC3;ANO6;ASIC4;TRPM7;KCNG1;KCNH1;KCNK6
prerank,response to interferon-gamma (GO:0034341),0.389219474613434,1.537111104813168,0.0,0.0914424605119974,1.0,24/71,16.96%,TDGF1;IFITM3;IFITM1;CCL24;IFITM2;GAPDH;WNT5A;CCL20;CYP27B1;CCL22;PDE12;CCL4;CCL3;STAT1;CXCL16;GBP5;GCH1;CCL26;KYNU;IRF8;BST2;CCL17;SYNCRIP;IL23R
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3969476170963611,-1.5365433987055308,0.0,0.11771848402293783,1.0,28/89,15.31%,DDX17;CIRBP;RBFOX3;RBM5;NOVA1;SRSF4;RBM24;ZC3H10;CELF1;RBM25;RBM4;MBNL1;SFSWAP;CELF4;FXR2;CELF6;RBFOX2;QKI;SF1;NOVA2;SON;TIA1;CELF2;JMJD6;YTHDC1;PCBP4;SRSF12;NSRP1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.38699492289877246,1.5361658004887586,0.0,0.091914393665208,1.0,26/65,21.64%,POLR2F;POLR2D;EAF1;CDK7;NELFCD;GTF2H3;NCBP1;CCNK;SSRP1;NCBP2;ADRM1;POLR2C;GTF2F2;POLR2K;MLLT3;POLR2J;LEO1;POLR2G;CDK12;CTR9;NELFE;ERCC2;POLR2H;ELP4;POLR2I;POLR2L
prerank,neuron projection extension (GO:1990138),-0.44337747586107407,-1.5352484193802094,0.05263157894736842,0.11810295389395793,1.0,8/32,7.04%,ULK1;NLGN3;NRP2;PPP3CB;MAP1B;ULK2;TMEM108;FLRT1
prerank,ceramide catabolic process (GO:0046514),0.5461946640170247,1.5351848467012692,0.025,0.09216200224457173,1.0,6/16,14.83%,NEU1;HEXB;GLA;ASAH2B;GM2A;ACER2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5450726386183372,-1.5347247866779312,0.03389830508474576,0.11814487100968099,1.0,10/21,9.51%,FLNA;ANK2;KCNA5;CACNA2D1;KCNH2;NPPA;SCN1B;SNTA1;KCNE2;SCN4B
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5474216607069776,1.534626756964673,0.03636363636363636,0.0921507719078744,1.0,12/20,21.73%,RCC2;CCND1;CDK1;FBXO5;CDC25C;CDK4;RAB11A;RAD51B;CDC25A;CDC7;STOX1;DTL
prerank,DNA damage checkpoint signaling (GO:0000077),0.4804075149027397,1.534366090282517,0.0,0.09206637276105462,1.0,12/30,19.63%,CHEK1;E2F1;INTS7;PRPF19;RHNO1;CHEK2;HUS1;CLSPN;TIPRL;FBXO6;CDC5L;BRIP1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.43631375146643026,-1.5326254044117313,0.0392156862745098,0.11931310273641095,1.0,16/44,20.17%,LMOD1;TENM1;GSN;WHAMM;CDC42EP3;EVL;NCK1;FER;NCKAP1L;FCHSD1;LMOD2;CDC42EP4;BAIAP2;CCL11;FCHSD2;CCL21
prerank,axon development (GO:0061564),-0.4184012232269365,-1.5311480860467424,0.0,0.12035959191871165,1.0,34/77,18.58%,APBB1;S100B;BRSK1;PLP1;MAPT;DSCAML1;ZDHHC17;MAP1A;SLITRK2;MAP1B;ANK3;SPTBN4;ADGRB1;FGFR2;MTR;AMIGO1;L1CAM;NEFH;PARD3;GAP43;SLITRK3;MAPK8IP3;NTNG1;TAOK2;SLITRK5;RAB3A;ISL2;KLF7;ATL1;CNTN4;BAIAP2;CAMSAP2;RTN4;DCC
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.48923371984232905,1.531138604222706,0.04,0.09406308607245088,1.0,7/22,12.48%,CHEK1;ZWINT;NABP2;AURKB;CHMP4C;ZW10;BUB1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.4865420463396181,-1.5309024013770816,0.0,0.12001932506772348,1.0,16/29,21.92%,DSCAML1;OSR1;PDGFRA;HOXD3;FGFR2;HOXA4;HOXB4;TBX1;MEGF8;HOXB3;HOXD4;HOXD9;SOX11;FUZ;OSR2;HOXC4
prerank,regulation of activated T cell proliferation (GO:0046006),0.44111232134318173,1.530721402428443,0.038461538461538464,0.09415487712064846,1.0,15/33,24.93%,IL23A;FOXP3;TNFSF9;RPS3;IL27RA;IGFBP2;IDO1;CLC;IL23R;LILRB4;HMGB1;IL12B;CRTAM;SCRIB;IL12RB1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5022950362631782,-1.5305786093499183,0.037037037037037035,0.11983020995874984,1.0,9/25,11.10%,ATP1B2;ANK2;DMD;WNK3;PIRT;ACTN2;ANK3;TRPC6;STAC
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4418834717204323,1.5304851407274556,0.021739130434782608,0.09406475605300413,1.0,16/36,21.12%,CCT6A;CCT2;CCT3;XRCC5;CCT8;CCT7;NEK2;AURKB;FBXO4;NAF1;MAPK15;CCT4;TCP1;HNRNPA2B1;HNRNPA1;MAPKAPK5
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5352579373395414,1.5303925567837715,0.0,0.09397522209329232,1.0,9/22,12.26%,RPIA;TALDO1;PGD;RPE;HKDC1;TKT;PGLS;G6PC3;RPEL1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.4172632047526649,-1.5300954881880025,0.0,0.12001211540081244,1.0,21/59,20.59%,PDE2A;ADCY5;GABBR1;FLNA;ADCY2;LPAR1;ADCY4;AKAP12;GNAI1;CORT;ADCY9;CHRM2;P2RY12;GNAL;OPRL1;ADCY6;HTR4;CHRM5;GNAI2;HTR1E;CHRM3
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.46159913111338574,-1.5287828524810392,0.037037037037037035,0.1210389862321348,1.0,13/39,9.83%,FHL1;ANK2;FXYD6;FXYD7;WNK3;FXYD1;SCN3B;FXYD2;SCN2B;SCN1B;TRPC6;SCN4B;FGF12
prerank,lamellipodium assembly (GO:0030032),-0.4966608043270269,-1.5287629276535577,0.0,0.12055483028720627,1.0,11/25,16.23%,VCL;WHAMM;ARHGEF6;KIT;SRGAP2;S1PR1;ABLIM3;P2RY12;RAC1;ARHGEF7;CCDC88A
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.3625442803845725,-1.5284782755412631,0.0,0.1203665954778996,1.0,41/123,20.39%,GPM6B;GDNF;ATP1B2;TPM1;LGI1;PLP1;STMN4;ULK1;PKD2;MAPT;PTPRM;MYOC;LIMA1;ATCAY;MICALL1;STMN2;TMEM108;NLGN1;L1CAM;FRY;GPM6A;MAP2;NRTN;LAMB1;OPHN1;PPP1R9A;NPY;RAC1;MARK4;CNTN4;ROCK1;NCDN;BLOC1S1;RAB13;VAPA;BTG2;FRYL;CCL21;RAPGEF2;FAM161B;SNAPIN
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.45081030265893407,1.526226841777654,0.02,0.09640815703889437,1.0,16/40,18.78%,ENTPD7;RNASEH1;SND1;NUDT1;NUDT15;NUDT5;PNPT1;NCBP1;EXOSC7;ENTPD2;DNASE1L1;PPP1R8;RNASEH2A;XRN2;ENTPD6;RNASEH2B
prerank,nuclear membrane organization (GO:0071763),-0.5009992895906223,-1.5242776089646333,0.018867924528301886,0.12396161098837338,1.0,6/19,8.09%,DCTN1;TARDBP;AKAP8L;GPER1;TOR1AIP1;TMEM43
prerank,negative regulation of macroautophagy (GO:0016242),-0.49590463809081886,-1.5242546075228547,0.0,0.12354408277611818,1.0,10/24,23.81%,NRBP2;TSC1;LRRK2;FEZ2;TSC2;NUPR1;CHMP4A;SMG1;MTOR;PINK1
prerank,cell projection organization (GO:0030030),-0.4951641158750083,-1.5242018375421174,0.0425531914893617,0.12316591890665202,1.0,13/30,14.97%,ATP1B2;GSN;NEFH;RHOQ;RHOJ;PARVA;NCKAP1L;NPHP1;KIF17;QRICH2;P2RY12;RAC1;PACSIN2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.5349958527381443,-1.5237994928643825,0.08163265306122448,0.12297039723702295,1.0,9/21,12.76%,EPN2;ARNT;ITGB3;PRKCB;CADM4;TMEM204;EMILIN1;GRB10;DAB2IP
prerank,positive regulation of immune effector process (GO:0002699),0.46659494133884094,1.5232680711801538,0.0,0.09839442036399754,1.0,15/31,28.33%,IL23A;PHB;IL1B;CD46;CD81;XBP1;RPS19;IL23R;MYB;TNFSF4;IL12B;IL12RB1;PTPRJ;IFNG;IL10
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5066385381563461,1.523267621438109,0.02127659574468085,0.09807701900798464,1.0,13/22,21.92%,MAD2L1;FBXO5;ZWINT;BUB3;TRIP13;ZW10;BUB1;PLK1;CENPF;KNTC1;CDC20;BUB1B;TTK
prerank,adherens junction organization (GO:0034332),-0.4199302569397437,-1.5232634177733573,0.05172413793103448,0.12295537742895159,1.0,21/43,24.66%,JAM3;PIP5K1C;VCL;CDH19;CADM2;FERMT2;CDHR3;CADM3;DCHS1;CTNND1;CDH10;CADM1;TJP1;CDH2;SMAD7;CDH5;ACTB;CDH8;RAMP2;CDH4;CDH20
prerank,potassium ion transmembrane transport (GO:0071805),-0.3774995078075167,-1.523132866751434,0.0,0.12261957419605925,1.0,55/136,24.96%,KCNB1;ATP1B2;KCNQ4;KCNN3;ATP1A2;KCNA5;PKD2;SLC12A4;KCNK3;SLC9A9;ABCC8;FXYD2;KCNIP2;SLC24A4;KCNH2;KCNA2;KCNK4;KCND1;ATP1A4;KCNT2;KCNE2;SLC24A3;ATP1A3;ABCC9;KCNA1;KCNAB3;KCNJ8;LRRC55;KCND3;KCNE1;TMEM175;KCNQ5;KCNA4;KCNJ9;KCNC1;KCNJ1;ATP4A;KCNK2;SLC9A5;KCNS2;KCNE4;KCNN1;HCN3;KCNS3;KCNK7;KCNF1;KCNH5;LRRC52;KCNG1;KCNH1;KCNK6;KCNJ5;KCNN2;HCN2;LRRC38
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.4554464983030687,-1.5219393757557338,0.01818181818181818,0.12320982623141223,1.0,24/41,27.18%,TPM1;RAPGEF3;LPAR1;FERMT2;MYOC;PXN;SORBS3;ARHGEF10;EVL;PPM1F;ARHGEF15;RAC1;SFRP1;RHOA;CCDC88A;LIMCH1;TESK1;RHOC;TGFB3;FHOD1;SYNPO2L;RGCC;ITGB1BP1;PPM1E
prerank,neuron migration (GO:0001764),-0.44807338361830473,-1.5215090297855138,0.018518518518518517,0.12322943621899235,1.0,27/49,25.11%,FGFR1;MAP1B;DNER;PAFAH1B1;PHOX2B;CEP85L;GPM6A;MDGA1;ADGRL3;NAV1;ASTN1;MEF2C;ASTN2;MARK1;RAC1;FGF13;RELN;DISC1;SEMA3A;SPOCK1;RAPGEF2;TUBB2A;DCX;CDKL5;CCK;TUBB2B;POMGNT2
prerank,cellular response to metal ion (GO:0071248),-0.3710885590519632,-1.5209956015622486,0.0,0.12314316282231527,1.0,52/126,23.72%,RYR3;CACNA1H;ADD1;RASGRP2;ITPKB;PKD2;DLG2;CAPN3;ANK3;MEF2A;CARF;DLG4;SYT10;RYR1;SNCA;NLGN1;PRNP;SYT11;CLIC4;CYP11B1;LRRK2;PRKAA2;KCNA1;SYT2;SYT9;SYT6;SYT5;MEF2C;AQP1;MAPK1;MAPK3;SLC41A1;MT1X;MCOLN1;BRAF;MAPK8;CAMK2D;ZNF658;CRHBP;CPNE8;EGFR;CPNE4;SCN5A;BNIP3;MT1M;B2M;ACER1;SYT1;CPNE6;PLCG2;KCNH1;SYT3
prerank,glycogen metabolic process (GO:0005977),-0.5266416518505758,-1.5200719317378992,0.03508771929824561,0.12375973340905366,1.0,9/26,14.54%,PYGM;GYG1;PPP1R3C;CALM1;NR1D1;GYS2;PRKAG2;AGL;UGP2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.46566295881773545,-1.5193109984713586,0.0,0.12398687081160721,1.0,15/39,15.37%,IP6K3;ITPKB;SOCS2;TTC7B;PI4KB;PIK3R1;PI4KA;PIP4K2B;FAM126A;PIK3C3;TMEM150A;IP6K1;PIK3R3;PI4K2A;PIP4K2A
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.48202335781355665,-1.51846484770182,0.03773584905660377,0.12417743877899344,1.0,14/27,22.99%,GSTM2;ATP1A2;PKD2;CALM1;PLN;CASQ2;TLR9;GNB5;TRDN;CLIC2;CRHR1;SLN;DRD4;CALM2
prerank,cellular response to hypoxia (GO:0071456),0.3563583112062779,1.5180396500534175,0.0,0.10207887075876225,1.0,37/127,14.34%,PSMD14;MYC;SUV39H2;CA9;PSMB2;TBL2;PSMB9;PSMA5;P4HB;PSMB3;VHL;PSME3;SUV39H1;PSMA3;HYOU1;PSMA7;PMAIP1;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;BMP7;PSME1;PSMF1;AQP3;PSMD11;UBA52;GATA6;PSMD1
prerank,tRNA methylation (GO:0030488),0.46809269944003357,1.5178718484979046,0.046511627906976744,0.10207178061412589,1.0,15/32,22.52%,METTL2A;METTL1;TRMT10C;FTSJ1;HSD17B10;METTL6;THUMPD3;TRMT112;TRMT61B;NSUN2;DALRD3;METTL2B;TRMT5;TRMT10A;TRMT12
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.4302348155767551,-1.5177867418408701,0.07407407407407407,0.12422772234293121,1.0,20/46,19.82%,NPHP3;PKD2;SRF;BBS4;BBS5;CCDC39;NDRG4;CCDC40;HAND1;MEGF8;FOXN4;RYR2;SOX17;MEF2C;TBX2;BBS7;AHI1;SMO;SOX18;DLL1
prerank,calcium ion import into cytosol (GO:1902656),-0.5753298210028176,-1.5159356870642846,0.02040816326530612,0.12566079420357956,1.0,7/15,14.21%,ATP2B4;TRPV1;CACNA2D1;SLC8A2;SLC8A1;SLC8A3;TRPV3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3937966249109543,-1.5153050974705582,0.0,0.12567067397354603,1.0,38/80,24.46%,ZER1;CLU;CSNK1E;ATXN3;RNF185;RNF19A;RNF180;CSNK1A1;RNF217;DET1;BAG2;KCNE2;LRRK2;SIRT2;ZYG11B;KLHL40;DAB2IP;TRIB2;ECSCR;BBS7;ARIH2;RNF144B;NUPR1;HECTD1;CSNK1D;TMEM259;DNAJB2;FBXW7;ARIH1;RNF14;GSK3A;PRICKLE1;SMAD7;PIAS1;OSBPL7;PSMC5;RNF144A;GABARAP
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.34893276793430505,-1.515161986205886,0.0,0.1254059183401748,1.0,59/191,17.86%,PER1;PDE2A;FLCN;BCL2L2;EPM2A;TSC1;TRIM39;ATP2B4;MAPKBP1;SFRP5;ARNTL;PPP2R5B;HDAC7;MAGI2;ITPR1;PDE3B;DUSP3;GPER1;WTIP;PDE4D;ZMYND11;RORA;P2RX7;NR1D1;BCL2;TNFAIP8L1;SLIT2;PPEF2;PTEN;PHLDA3;CARD8;OTUD7A;MSTN;PRKAA2;OTUD3;PDE3A;DGKG;PRDM15;OTUD7B;C1QTNF3;WWC2;UBR2;INPP5K;DAB2IP;PPM1A;SPRY3;PPM1B;UBR1;ESR1;WWC3;TLE1;PHLPP2;MYADM;NLRX1;TSC2;MAPK14;DEPDC5;DLG5;MARK3
prerank,regulation of peptidase activity (GO:0052547),0.5186947037691468,1.5139349407401224,0.043478260869565216,0.10550352680208755,1.0,6/19,9.91%,PRSS22;PSMA3;CSTB;CTSH;ATP13A2;HDAC1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.3855325368813648,-1.5127252547361287,0.016129032258064516,0.12695532055528744,1.0,40/94,26.53%,ATP2B4;RAF1;CAPRIN2;HRC;TENM1;RAPGEF3;DMD;SPTBN4;TRIM6;PDE4D;NTRK3;SNCA;HDAC6;CNKSR3;NGF;CAMK1;TERF2IP;NCK1;PRKD1;NOS1;PTEN;PPM1F;MTCP1;INPP5K;BRAF;NTF3;EGFR;RAMP3;RASSF2;SMAD7;RPTOR;SH2D3C;GPD1L;BCAR3;LATS1;PINK1;HCLS1;FNIP1;DOCK7;AKAP9
prerank,regulation of blood coagulation (GO:0030193),0.5010831679646671,1.5115818174956797,0.03773584905660377,0.10711114862393935,1.0,13/23,26.66%,FAP;F12;EPHB2;THBD;FOXA2;PROC;HPSE;F2R;SERPINE1;CAV1;THBS1;KNG1;SERPINE2
prerank,RNA export from nucleus (GO:0006405),0.36290904335156937,1.5110597690755607,0.0,0.10726428234571557,1.0,43/104,20.91%,NUP37;RAN;CPSF3;ALYREF;THOC3;NUP155;U2AF1;XPO5;MAGOH;RAE1;SLBP;NUP62CL;NUP93;NUP35;MAGOHB;EIF4A3;NCBP1;SEH1L;DDX39A;SRSF9;SEC13;NUP210;NUP43;NXT1;GLE1;NUP50;NUP88;NUP107;EIF4E;NCBP2;CPSF2;NUP205;THOC6;NUP62;NUP160;NDC1;RBM8A;CPSF4;HNRNPA2B1;SRSF3;NXF3;HNRNPA1;RBM15B
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4020213681377285,1.5106112244830674,0.022727272727272728,0.10748667664564668,1.0,19/54,15.61%,SHMT2;MTHFD1;MTHFD1L;GPT2;DHFR;ASS1;GOT2;ALDH18A1;SLC19A1;SDHAF3;ALDH5A1;MTHFD2;MDH2;L2HGDH;GCLM;NIT2;ACOT4;ACOT8;ACLY
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5493962494927428,-1.5103989138067053,0.05357142857142857,0.12866352808188444,1.0,8/19,17.77%,CLU;HAP1;PRNP;RTN1;GGA3;ROCK1;RTN2;RTN4
prerank,digestive tract development (GO:0048565),-0.44491721010074525,-1.5096079383742544,0.037037037037037035,0.12896758980309894,1.0,21/38,23.93%,PKD1;FOXF1;CLMP;GLI3;FGFR2;CCDC39;CCDC40;RARB;KIT;MEGF8;GLI2;RARRES2;NPY;BBS7;EDNRB;PCSK5;SMO;NIPBL;CHD8;PYY;PKDCC
prerank,postsynaptic membrane organization (GO:0001941),-0.5778164484046084,-1.5081763606313643,0.06779661016949153,0.13004712041496796,1.0,11/19,17.26%,NLGN2;NLGN3;NRXN1;NLGN4X;SHANK3;DLG4;NLGN1;NRXN2;SHISA7;MUSK;NLGN4Y
prerank,negative regulation of cell migration (GO:0030336),-0.3677502861490155,-1.5079758765987994,0.014925373134328358,0.12973745244733764,1.0,45/135,15.67%,FLCN;ADARB1;ATP1B2;DUSP22;TPM1;PLXNB3;VCL;BMPR1A;FGF2;CHRD;TMEFF2;MAGI2;RECK;MITF;PHLDB2;CITED2;DUSP3;PODN;CLDN5;DLC1;CLASP1;NDRG4;DPYSL3;NGFR;RHOB;CLIC4;EVL;SRGAP2;SLIT2;PTEN;CLASP2;CORO1C;MCC;DAB2IP;EPHA4;NAV3;ADORA3;SCAI;SRGAP2C;RAC1;SFRP1;IGFBP5;KANK1;PIP5KL1;TP53INP1
prerank,plasma membrane organization (GO:0007009),-0.4049786529793389,-1.5078141912201517,0.01818181818181818,0.12949718487979184,1.0,29/60,24.90%,ANK2;EHD2;PLSCR4;ANK3;WHAMM;MICALL1;SNX33;P2RX7;PACSIN1;STX2;A4GALT;SYT11;EPB41L3;AHNAK2;ANXA6;DYSF;SYTL4;RAB3A;PACSIN2;PACSIN3;CHMP4A;DEGS1;PLSCR5;ABCD1;CAV3;ANO6;ABCD2;CLN3;SMPD1
prerank,epithelial structure maintenance (GO:0010669),0.5668810584350846,1.5072091032097243,0.0,0.10973790660953497,1.0,9/16,24.22%,TFF2;TFF1;CXADR;VSIG1;STRAP;TFF3;NOD2;RBP4;MUC13
prerank,protein polymerization (GO:0051258),-0.4248760692650747,-1.507066399386121,0.0392156862745098,0.1300947556379128,1.0,16/52,14.18%,FAM107A;GSN;CASQ1;MAPT;GAS7;TRIM6;CHMP3;ARHGAP6;CASQ2;WASF1;MAP7D3;WASF3;CORO7;TPPP;RAC1;FGF13
prerank,embryonic limb morphogenesis (GO:0030326),-0.46230630034455195,-1.5068112435318184,0.0,0.12982161441691467,1.0,14/35,15.11%,AFF3;CACNA1C;MYH3;FBXW4;OSR1;INTU;GLI3;MBNL1;ZNF358;MEGF8;ECE1;SKI;CYP26B1;TBX2
prerank,skeletal muscle organ development (GO:0060538),-0.4626222863952443,-1.505705591001121,0.038461538461538464,0.1304468805213782,1.0,10/30,13.67%,POPDC2;BVES;CFLAR;MYOZ2;TCF21;DISP1;MEF2C;MYL6;MYOZ1;CSRP3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.49150973128448705,-1.5050496956854305,0.0,0.13057141438083272,1.0,20/30,32.41%,CSNK2A2;ABLIM3;NPEPPS;HSPA1L;LEPROT;ARIH2;VPS11;RNF31;FBXW7;GSK3A;RHOU;BAP1;PINK1;UBL4B;MICALL2;SH3GLB1;SAE1;HPS4;TOMM7;ATG13
prerank,regulation of neuron differentiation (GO:0045664),-0.39208185971628406,-1.5050161438352576,0.0,0.1301346952163114,1.0,34/74,25.05%,FGFR1;ADRA2B;HOXD3;NLGN1;CASZ1;NGF;ALK;LRRK2;HEY1;MEF2C;TIAM1;MMD2;RHOA;ZFHX3;CNTN4;ROCK1;TCF4;GPRC5B;NTF3;ZC4H2;SIN3A;SOX11;PCP4;BEND6;CDK5RAP3;CDK5RAP2;DLL1;SOX2;ID2;NREP;ZFHX2;VWC2;MMD;NBL1
prerank,alpha-amino acid catabolic process (GO:1901606),0.4803720838083405,1.5045031929675898,0.0,0.11152135536008685,1.0,9/27,13.76%,IL4I1;HSD17B10;GOT2;KMO;IDO1;ACMSD;ALDH4A1;KYNU;TDO2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4377653898871601,-1.504400866798787,0.01694915254237288,0.1301937672273729,1.0,14/31,17.49%,CLIP3;TTBK2;TUBB4A;STMN2;SNCA;CLASP1;DYRK1A;MAP2;CLASP2;NAV3;FGF13;APC;ATXN7;CAMSAP2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.5047192387757007,-1.5037353449224908,0.05172413793103448,0.13057968467563769,1.0,12/23,18.20%,TSC1;FERMT2;MYOC;DUSP3;PIK3R1;COL16A1;PPM1F;RAC1;SFRP1;ROCK1;IQSEC1;MAPRE2
prerank,lymphocyte chemotaxis (GO:0048247),0.4391416477169501,1.5024800912144403,0.045454545454545456,0.1124240062289545,1.0,15/39,17.07%,SLC12A2;CCL24;CXCL11;CCL20;CCL22;CCL4;CCL3;CXCL16;CYP7B1;CCL26;CXCL10;HSD3B7;ADAM8;CCL17;PIK3CG
prerank,fatty acid transmembrane transport (GO:1902001),-0.5612012964728313,-1.5020685611634375,0.0,0.13207160465413814,1.0,10/18,24.13%,ACACB;PRKAB2;PRKAG2;PRKAA2;SLC27A1;CPT1B;CD36;ABCD4;ABCD1;ABCD2
prerank,cellular response to ATP (GO:0071318),-0.5338181521243507,-1.501684054373128,0.037037037037037035,0.13205819049938822,1.0,7/15,18.82%,RYR3;TRPV1;P2RY1;P2RX7;P2RY12;SSH1;P2RY11
prerank,regulation of interleukin-17 production (GO:0032660),0.4442733818323345,1.5013574769389997,0.025,0.11307828385648011,1.0,18/32,28.37%,OSM;IL23A;PHB;FOXP3;SLC7A5;IL21;MYD88;IL23R;TGFB1;NOD2;TNFSF4;IL12B;IL36RN;PRKCQ;CCL1;IFNG;SLAMF6;IL18
prerank,negative regulation of viral life cycle (GO:1903901),0.473950417941799,1.500694266741875,0.0392156862745098,0.11320996605936787,1.0,7/19,15.18%,IFITM3;LY6E;IFITM1;IFITM2;TRIM26;BST2;TRIM11
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.4596811693911387,-1.5004313387418202,0.03508771929824561,0.13288674624234503,1.0,19/36,27.02%,CDH19;CDHR3;NLGN1;DCHS1;CDH23;CDH10;PCDHB4;PCDHB6;PCDHB5;PCDHGC3;PCDHB3;CDH5;CDH8;PCDHB2;PCDHB10;CDH20;SELP;PCDHB14;CDH13
prerank,protein autoprocessing (GO:0016540),0.5278144744726782,1.5003761996714875,0.046511627906976744,0.11320298806136506,1.0,9/16,26.24%,KLK6;F12;PCSK9;MYRF;SPRTN;FXN;MYRFL;CASP4;HTRA2
prerank,polyol metabolic process (GO:0019751),-0.43383571194061105,-1.4985951304478904,0.0,0.1342579856524162,1.0,14/47,14.11%,INPP5B;IP6K3;PLCD4;ITPKB;INPP5A;INPP4A;INPPL1;SYNJ1;CALM1;NUDT10;NUDT11;PTEN;PLCE1;IP6K1
prerank,sodium ion transmembrane transport (GO:0035725),-0.40152823868488985,-1.4974533925471998,0.0,0.1350408558049069,1.0,32/87,20.47%,SCNN1D;ATP1B2;ASIC3;ATP1A2;SLC6A16;PKD2;SCN7A;SCN3B;SLC9A9;SCN9A;FXYD2;SLC8A2;SCN4A;SLC24A4;SCN11A;SCN2B;SCN1B;SLC8A1;ATP1A4;SCN4B;SLC24A3;ATP1A3;SLC8A3;SCN3A;SCNN1B;SCNN1G;SLC6A1;SLC6A17;ATP4A;SLC9A5;SCN5A;HCN3
prerank,protein monoubiquitination (GO:0006513),0.42741373422337686,1.4971856422883356,0.025,0.1150855169824321,1.0,14/36,21.73%,UBE2T;RAD18;RNF40;FANCL;UHRF1;UBE3D;DTX3L;LEO1;KBTBD8;RAG1;CTR9;KLHL12;CUL3;DTL
prerank,regulation of cellular localization (GO:0060341),-0.4154439967225133,-1.4970833170784095,0.016129032258064516,0.13492112677441057,1.0,18/47,15.81%,ADCY5;BRSK1;KIAA1614;GSN;NUMA1;CSNK1E;DVL3;NR1D1;PARD6G;FES;MAP2;LRRK2;EPHA5;PPM1F;FER;EFNA5;STXBP4;CAMK2D
prerank,nucleic acid-templated transcription (GO:0097659),0.4054935172267491,1.4968538181854631,0.0,0.11486730619014368,1.0,23/42,26.59%,POLR2F;POLR2D;E2F1;PTMA;DRG1;TAF1B;POLR2C;POLR2K;POLR2J;POLR2G;POLR2H;PAX8;POLR2I;MED20;NFKBIB;POLR2L;PWP1;POLR3A;RNPS1;TERT;NKX2-8;POLR2B;PPP5C
prerank,negative regulation of axonogenesis (GO:0050771),-0.4559275427842083,-1.4967672545121873,0.020833333333333332,0.1348022320925588,1.0,16/28,20.40%,ULK1;PTPRS;ULK2;RUFY3;NGFR;GDI1;PTEN;MAP2;FGF13;MAG;RHOA;SEMA3G;MCF2;RTN4;DCC;TRIM46
prerank,organelle assembly (GO:0070925),-0.31812336299150584,-1.4958944589359473,0.0,0.13519324565954788,1.0,126/404,18.87%,STARD9;TTLL3;NPHP3;PKD1;CIRBP;POGZ;LMOD1;PGM5;FLNA;IFT80;WDR19;GABARAPL1;RFX2;TMOD2;ULK1;EIF4ENIF1;GSN;ATG2B;MYH6;DZIP1;MAPT;CNGB1;KLHL41;ZFYVE1;TUBGCP6;ATG9A;CAPN3;RABL2B;TTBK2;CENPT;CEP126;WDR45;INTU;EHD2;ULK2;IFT81;ATG14;CHMP3;BBS4;CYS1;BBS5;GOLGA8A;DYNC2H1;WDR11;MAP1LC3C;HDAC6;DZIP1L;CD34;TMOD1;INPP5E;STK36;CFAP44;CCDC66;EXOC7;BBS1;CC2D2A;TP53INP2;FBF1;PARVA;CFAP54;TEKT2;ATG16L2;BSCL2;NEK1;ABLIM3;GOLGA8B;ATXN2;SYNPO;CSDE1;RAB23;PTPDC1;CEP164;GOLGA8N;CEP162;CCDC57;EXOC3;LMOD2;MAPRE3;PIK3C3;MYOZ1;BBS2;PACS2;PLA2G4C;FLII;CENPC;TSG101;VPS37A;DISC1;TEKT3;RILPL1;HAUS4;CLUAP1;CFAP70;PCM1;TUBGCP5;ATXN2L;GBF1;TP53INP1;CEP63;EMC6;RAB11FIP3;BBS7;CEP290;DHX29;CDS2;ARMC9;BBS9;TXNDC15;PCNT;STX12;IFT122;NEK7;VPS4A;HAUS3;ABCA3;AHI1;GABARAPL2;TMEM138;CDC14A;ATG12;MAPRE2;CHMP4A;CSNK1D;FITM1;GOLGA8R;ARL3
prerank,epithelial cell differentiation (GO:0030855),0.35702987846508705,1.4956264904695618,0.0,0.11553814263911984,1.0,41/99,22.71%,ANXA4;CDK1;VDAC1;MCIDAS;HDAC2;CCNO;ACTL8;RAB10;TAGLN2;UPK3A;DNPH1;PTER;PROX1;CASP6;EHF;HDAC1;SETSIP;SIX1;UPK2;ZNF703;GRHL2;KDR;BMP4;GATA6;E2F8;OVOL3;PPARG;SIX3;EDF1;IRF6;DLX3;OVOL1;PIH1D1;PAX2;ALDOC;VIL1;OVOL2;E2F7;DMBT1;PCK2;CTSB
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.4377989464878837,-1.4955916806480472,0.017241379310344827,0.1350742321904247,1.0,26/48,27.18%,TPM1;RAPGEF3;LPAR1;SYNPO2;FERMT2;MYOC;PXN;SORBS3;ARHGEF10;EVL;PPM1F;SYNPO;ARHGEF15;RAC1;SFRP1;RHOA;CCDC88A;LIMCH1;TESK1;RHOC;TGFB3;FHOD1;SYNPO2L;RGCC;ITGB1BP1;PPM1E
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5665111909242816,1.495526817254686,0.0,0.1152858443954745,1.0,9/15,24.22%,TFF2;TFF1;SOX9;VSIG1;STRAP;TFF3;NOD2;RBP4;MUC13
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.4326406705733057,-1.4939671123611564,0.0,0.13653595099417554,1.0,17/48,13.95%,FLCN;LMO3;SMAD4;DUSP3;GPER1;DUSP26;CNKSR3;PTEN;EMILIN1;SPRY1;FBLN1;SYNJ2BP;TIMP3;DAB2IP;RANBP9;SPRY3;SEMA6A
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.4043347041298807,1.493588776280945,0.0,0.11696930757535008,1.0,22/47,24.06%,PNPO;PSAT1;SQLE;DHCR7;SC5D;HSD17B10;AKR1C4;OSBPL3;BAAT;CYP39A1;CYP7B1;MSMO1;HSD3B7;TM7SF2;ACOT8;INSIG1;SLC27A5;HSD17B4;EBP;HMGCR;OSBPL2;OSBP
prerank,regulation of microtubule depolymerization (GO:0031114),-0.46538494882475523,-1.4934278404907848,0.017543859649122806,0.1365705896034824,1.0,15/24,26.63%,TTBK2;MAP1A;MAP1B;STMN2;CLASP1;CLASP2;NAV3;FGF13;APC;ATXN7;CAMSAP2;APC2;SPEF1;TAOK1;CAMSAP1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4973163246124332,-1.4913423178022096,0.031746031746031744,0.13833099015866637,1.0,9/20,17.45%,ATP1A2;OR51E2;GPER1;AR;ATP1A3;NR3C1;MGARP;TFPI;TRERF1
prerank,rRNA catabolic process (GO:0016075),0.5380023606161329,1.4894562264204994,0.05128205128205128,0.12036784585346594,1.0,8/16,15.81%,EXOSC5;EXOSC4;EXOSC8;EXOSC7;EXOSC3;DIS3;EXOSC2;DEDD2
prerank,regulation of protein polymerization (GO:0032271),-0.45980002984849566,-1.4888301360868037,0.08163265306122448,0.14048594540757187,1.0,18/33,26.63%,GBA2;MAPT;PLEKHG2;MAP2;FCHSD1;TPPP;MAPRE3;ARL2;DBN1;CAMSAP2;FCHSD2;ESAM;TPPP3;PAK3;ARHGAP28;LATS1;HCLS1;CAMSAP1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.55229702866487,-1.4886434813483114,0.019230769230769232,0.14019511198735368,1.0,8/17,22.99%,CALM1;PARD3;CADM4;PPEF2;SIRT2;INPP5K;SMAD7;CALM2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.47860308657394407,1.4880576944881354,0.047619047619047616,0.12131735360995878,1.0,10/23,14.68%,PSMD14;PSME3;NUDT15;PSME2;CTSC;EFNA1;UCHL5;GPX1;PSME1;GBA
prerank,innate immune response (GO:0045087),0.30622322507797545,1.4879835893844842,0.0,0.12101697559944524,1.0,80/270,22.47%,CLPB;SIGLEC15;SHMT2;IFITM3;RNF39;IFITM1;SKP2;F12;SRMS;RIPK2;IFITM2;PPP1R14B;PHB;IFI6;CAPZA1;SERINC5;CYP27B1;LCN2;SYK;DEFA6;SRPK1;TKFC;TREM1;PML;ATAD3A;CLEC5A;COLEC10;SLPI;CYBA;RPL39;TRIM27;CLEC6A;MYD88;RELA;IRAK1;TRIM14;WFDC10A;NOS2;TRIM26;APOBEC3F;CXCL16;NLRC5;VNN1;GCH1;KYNU;PI3;TIFA;CXCL10;C3;BST2;TRIM11;MX1;ISG15;PPARG;RNF187;FRK;ADAM15;TRIM59;IL23R;PIK3CG;OTULIN;LYN;PGLYRP4;NOD2;FYN;LCK;ANG;CORO1A;PGLYRP3;NCF2;TRIM28;YES1;DMBT1;RNASE7;HMGB1;SERINC3;TRIM31;CYBB;TRIM22;MSRB1
prerank,negative regulation of organelle assembly (GO:1902116),-0.43801690050712105,-1.4860792674328718,0.057692307692307696,0.14254657697924503,1.0,16/34,23.81%,MDM1;KAT2B;SMAD4;EVI5L;LRRK2;FEZ2;TCHP;KAT2A;NUPR1;CHMP4A;CDK5RAP2;ODF2L;TESK1;CEP97;CAV3;PINK1
prerank,negative regulation of synaptic transmission (GO:0050805),-0.5116414950001841,-1.485966920308984,0.03571428571428571,0.14209595843081482,1.0,7/24,9.79%,PRRT1;GRIK3;NLGN4X;TMEM25;SYT11;PTEN;LRRK2
prerank,response to lipopolysaccharide (GO:0032496),0.333750573937324,1.485862411717163,0.0,0.12229402083461936,1.0,67/148,28.45%,IL1A;CXCL5;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;SCARB1;IL1B;WNT5A;CYP27B1;DEFA6;PF4;TNFAIP3;CARD17;HMGB2;PLAA;MAPKAPK3;SLPI;CD80;XBP1;MYD88;RELA;IRAK1;NOS2;MAPKAPK2;CXCL9;HNRNPA0;GCH1;CXCL10;CXCL6;TNIP3;TRIB1;NOCT;F2R;IL23R;PALM3;PF4V1;IL36B;TNFRSF1B;CHMP5;NOD2;CTR9;ADAM9;SERPINE1;TNFSF4;CD86;CXCL13;GIT1;HMGB1;NFKBIB;ZC3H12A;PRDX3;SRR;S100A14;RPS6KA3;IL36RN;TICAM1;CARD16;GSTP1;IL36G;TNFRSF11A;IL37;IRAK3;DEFA1;IL10;TRAF6
prerank,sphingosine metabolic process (GO:0006670),0.5521147739688916,1.4838752531836645,0.0625,0.12322914696987536,1.0,6/16,14.83%,SPTLC1;SGPP2;SPTLC2;ASAH2B;GBA;ACER2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.4504038487942751,-1.4837029335486043,0.017543859649122806,0.14433262801409014,1.0,12/31,13.00%,FAM107A;DUSP22;MYOC;PHLDB2;ARHGAP6;DLC1;APOD;PTEN;CLASP2;SEMA3E;CORO1C;AJAP1
prerank,axonal transport (GO:0098930),-0.42254710623646174,-1.4834498767999422,0.0,0.14427878970872293,1.0,17/36,24.68%,AP3S2;DCTN1;MAPT;HAP1;PAFAH1B1;TMEM108;KIF1A;DST;KIF1B;AP3B2;MGARP;NEFL;BLOC1S1;SNAPIN;SOD1;KIF3A;FBXW11
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3834683595858112,-1.4832751919866112,0.01694915254237288,0.1439801346256283,1.0,37/77,24.90%,PALM;TENM1;TAPT1;BBS4;PIK3R1;CDC42EP3;P2RX7;NLGN1;CROCC;GPM6A;RHOQ;DPYSL3;MSTN;PLCE1;NDEL1;ABI2;P2RY12;DEF8;ARPC2;CDC42EP4;RAC1;MARK4;APC;CCDC88A;DOCK11;WASF2;FUZ;CCL21;TENM2;BCAS3;CDC42EP2;CEP120;BRK1;OCLN;ARHGAP35;TGFB3;AKIRIN1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.5574567422971587,-1.4830319801614285,0.08928571428571429,0.14386674030929905,1.0,6/17,10.32%,PRRT2;SYNGR1;STX1B;STX2;SYP;SNAP25
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.47458922208272736,1.4826974928697216,0.06976744186046512,0.12338825458351879,1.0,10/25,17.43%,ACSL6;BAAT;THEM5;ACOT7;DBI;ACOT13;ACOT4;ACOT8;ACLY;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.47458922208272736,1.4826974928697216,0.06976744186046512,0.12338825458351879,1.0,10/25,17.43%,ACSL6;BAAT;THEM5;ACOT7;DBI;ACOT13;ACOT4;ACOT8;ACLY;OXSM
prerank,dendrite morphogenesis (GO:0048813),-0.4454117091349811,-1.482065314784804,0.03389830508474576,0.1443934124652444,1.0,12/34,14.08%,MAP6;CTNND2;PTN;MEF2A;SHANK3;DLG4;DIP2A;PTEN;MAP2;SDC2;TAOK2;KLF7
prerank,microtubule depolymerization (GO:0007019),0.5224072031172871,1.4820455205497594,0.041666666666666664,0.12338428772139697,1.0,9/18,16.25%,KIF24;KIF2A;KIF18A;STMN1;KIF14;KATNB1;KIF2C;CKAP5;KIF18B
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.44941334963562685,-1.4814242798613573,0.038461538461538464,0.14461317001605417,1.0,15/34,15.87%,FLCN;SYNGAP1;LZTR1;MYOC;DLC1;MFN2;KCTD10;SPRY1;ARHGAP24;RASIP1;DAB2IP;SPRY3;SCAI;KANK1;MAPKAP1
prerank,rRNA methylation (GO:0031167),0.49664744908155317,1.4804452329149431,0.07692307692307693,0.12447016014809174,1.0,8/19,15.62%,EMG1;FBL;TFB2M;NSUN3;TFB1M;TRMT112;MRM1;NSUN5
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.4586731945355443,-1.4801014346171486,0.0,0.14531535750482058,1.0,22/36,30.95%,CSNK2A2;LRRK2;ABLIM3;NPEPPS;HSPA1L;LEPROT;ARIH2;VPS11;RNF31;FBXW7;PARL;GSK3A;RHOU;BAP1;PINK1;UBL4B;MICALL2;SIAH3;SH3GLB1;SAE1;HPS4;TOMM7
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4547110820264624,-1.47939683626102,0.07017543859649122,0.14541006437564086,1.0,16/31,23.27%,MYH7;TPM1;MYL2;TGFBR3;MYH6;TCAP;FGFR2;S1PR1;HAND1;ACTC1;MYL3;ANKRD1;MYBPC3;SMAD7;TTN;MYLK2
prerank,myeloid leukocyte differentiation (GO:0002573),0.38734061320807545,1.4788741966301937,0.0,0.125286174457827,1.0,33/70,27.66%,E2F1;DHRS2;CSF2;TNFSF11;GLO1;LEF1;SNX10;PML;CDK4;CEBPA;EPHA2;DCSTAMP;RUNX1;BATF;EFNA2;MMP9;BMP4;PPARG;DEK;TGFBR2;CDC42;SRP54;IFI16;BATF2;CDK2;OSCAR;TYROBP;SPI1;TNFRSF11A;CEBPE;IFNG;FARP2;CASP8
prerank,regulation of ion transport (GO:0043269),-0.41325110159699213,-1.478606282922005,0.01694915254237288,0.14571445974733224,1.0,20/74,12.33%,PER1;VAMP2;GDNF;KCNA5;PXK;ANK3;SPTBN4;SYT10;SNCA;P2RX7;ITGB3;KCNA2;SYT11;CHRNA3;NOS1;SYT2;SYT9;SYT6;SYT5;KCNJ8
prerank,heart looping (GO:0001947),-0.42451082590784084,-1.477808028189252,0.05555555555555555,0.14601686560679034,1.0,18/42,19.82%,NPHP3;PKD2;SRF;BBS4;BBS5;CCDC39;NDRG4;CCDC40;HAND1;FOXN4;SOX17;MEF2C;TBX2;BBS7;AHI1;SMO;SOX18;DLL1
prerank,amino acid import across plasma membrane (GO:0089718),0.5009976052600612,1.4771826074779266,0.02040816326530612,0.12658979985464575,1.0,8/24,8.86%,SLC6A20;SLC1A5;SLC1A4;SLC6A14;SLC7A1;SLC7A5;SLC6A6;TSPO2
prerank,blood circulation (GO:0008015),-0.4155492325599666,-1.4767271079869986,0.03389830508474576,0.14658593781177362,1.0,21/48,21.24%,MYL2;NPR1;SGCG;HOXB2;AGTR1;PLN;SCPEP1;ADORA2A;SGCD;TRDN;MEOX2;ACTC1;CYB5R3;ADCY6;ROCK1;ELN;NPPB;COL4A3;AVPR1A;SOD1;HTR7
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5271096022510794,1.476693293023223,0.07317073170731707,0.12664190063947925,1.0,9/18,16.16%,HSD17B12;TECR;ACSL6;HACD2;ACSL3;ELOVL1;ACSL5;ELOVL7;ACSF3
prerank,regulation of cellular response to stress (GO:0080135),0.34811922683506386,1.4761678364896282,0.0,0.12669369494910787,1.0,42/114,17.82%,NUP37;RPA3;CEBPB;NUP155;NEK6;RAE1;NUP93;YWHAE;NUP35;AJUBA;CHCHD2;PNPT1;SEH1L;SEC13;NUP210;RSL1D1;NUP43;MANF;HSBP1;NUP50;PTGES3;NUP88;DNAJC2;NUP107;NEK4;FKBP4;MAPKAPK2;GSK3B;ARMT1;DNAJC7;NUP205;MLST8;NPM1;IER3;RPA2;NUP62;HSPH1;NUP160;HSP90AB1;DYRK3;NDC1;BAG4
prerank,positive regulation of kinase activity (GO:0033674),-0.3653195425395649,-1.4758633528508913,0.0196078431372549,0.14718106632271122,1.0,44/110,20.25%,FGFR1;EPHA7;RAP1A;MAPT;DDR2;PDGFRA;ROR2;FGFR2;NTRK3;TAB2;KIT;DSTYK;PRKAG2;ALK;EPHA5;FLT4;NTRK1;ROR1;MERTK;MAPRE3;EPHA4;RELN;CDKN1A;MMD2;MUSK;EPHA3;EPHA6;INSRR;PIFO;RAD50;TIE1;DUSP19;AZU1;INSR;EGFR;ERBB4;ALS2;EEF1A2;RASSF2;LMO4;RET;CAMKK1;CCL21;RAPGEF2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4974264884811285,1.4753930873009364,0.0,0.12726583322502588,1.0,8/20,12.34%,CCT2;HSPD1;PSMG1;PSMG3;PFDN6;PTGES3;HSPA4;LONP1
prerank,RNA methylation (GO:0001510),0.3929882912204041,1.4747058592746614,0.03225806451612903,0.12757506297137133,1.0,24/56,23.73%,METTL2A;FBL;HENMT1;METTL1;TRMT10C;TFB2M;TGS1;FTSJ1;NSUN3;METTL6;TFB1M;THUMPD3;TRMT6;RBM15;TRMT112;TRMT61B;NSUN2;NSUN5;METTL2B;TRMT5;RBM15B;TRMT10A;TRMT12;METTL5
prerank,positive regulation of interleukin-2 production (GO:0032743),0.47369717889127333,1.4732813895594834,0.02127659574468085,0.12840010152713738,1.0,9/26,14.21%,IL1A;IL1B;PNP;RPS3;STOML2;CARD11;CD80;RUNX1;TRAF2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3493775919690319,1.47309036244225,0.0,0.12809135881961803,1.0,20/87,8.13%,ENC1;CALR;CAPRIN1;PUS7;CST4;CDK5;GZMB;DHFR;MRPL13;GAPDH;IGF2BP1;NCL;CSTB;EIF4A3;NANOS3;IGF2BP3;RPS3;CNOT10;GRB7;IGF2BP2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4355797087104255,1.472927572700231,0.0,0.12775224272179375,1.0,20/45,23.25%,RALA;P4HB;TALDO1;HNRNPF;CNN2;CAPZA1;PSME2;HSPA9;RPLP0;SNRPA1;PAK2;GSTO1;TCP1;CFL1;HNRNPA2B1;MSN;CDC42;IL12B;IL12RB2;TYK2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5098740502840864,1.4721683447115217,0.09523809523809523,0.1281847727334538,1.0,7/16,20.03%,PIGM;DPM2;PIGW;PIGF;PIGA;PIGN;PIGX
prerank,embryonic skeletal system development (GO:0048706),-0.4519288099635499,-1.4713662667598733,0.01639344262295082,0.1515682208317003,1.0,17/34,21.92%,WNT9A;DSCAML1;OSR1;PDGFRA;HOXD3;HOXA4;HOXB4;MEGF8;HOXB3;XYLT1;HOXD4;HOXD9;PCSK5;SOX11;FUZ;OSR2;HOXC4
prerank,neuromuscular synaptic transmission (GO:0007274),-0.5058298614380781,-1.4695556963171132,0.11538461538461539,0.15291198841586276,1.0,11/19,23.70%,DTNA;SLC5A7;CHRNA3;FCHSD1;KIF1B;CHRNB4;ERC1;FCHSD2;CHAT;ERC2;TBC1D24
prerank,snRNA transcription (GO:0009301),0.3625225406888226,1.4693060957284882,0.022727272727272728,0.13062941271457265,1.0,27/68,26.04%,POLR2F;POLR2D;INTS7;CDK7;NABP2;NCBP1;CCNK;NCBP2;POLR2C;TAF9;GTF2F2;POLR2K;GTF2E1;POLR2J;POLR2G;INTS5;RPRD1B;POLR2H;POLR2I;POLR2L;GTF2A1;GTF2E2;GTF2B;GTF2A2;INTS2;POLR2B;TAF5
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.525111741986387,-1.4685771224570492,0.019230769230769232,0.15353996431313768,1.0,8/17,12.42%,DLG2;LRRC7;MTCL1;PARD3B;PARD3;CLIC4;SYNJ2BP;CRB1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5339357430403859,-1.468287732091544,0.09090909090909091,0.15334155053790022,1.0,8/15,22.59%,RBM24;CPEB1;CPEB2;CPEB3;YBX3;UNK;ZNF385A;CPEB4
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.44743188769425474,-1.468201399345517,0.0,0.15302729932168782,1.0,14/35,17.85%,FLNA;PLXNB3;SEMA6C;NRP2;SEMA4C;SEMA3E;SEMA6D;SEMA6A;RAC1;SEMA3B;SEMA3G;SEMA3A;PLXNA4;PLXNB1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.39962465074868936,1.4681779798450807,0.025,0.13121061886225316,1.0,18/53,18.79%,CCND1;CDKN3;CDK7;GTPBP4;BLM;CCNO;CCNE1;CCNI2;CDC25C;CCNK;CCNF;CCNJ;PKMYT1;CDC25A;BCCIP;HSP90AB1;CDC6;STOX1
prerank,phospholipid dephosphorylation (GO:0046839),-0.50511925306151,-1.4681658518402019,0.03333333333333333,0.15256913431315988,1.0,7/26,12.67%,INPP5B;MTMR9;SYNJ1;MTMR10;INPP5F;PTEN;INPP5K
prerank,negative regulation of cell motility (GO:2000146),-0.36762489068907217,-1.468119369692016,0.028985507246376812,0.152113878288813,1.0,35/107,15.67%,FLCN;ADARB1;DUSP22;TPM1;PLXNB3;VCL;CHRD;TMEFF2;MAGI2;RECK;MITF;CITED2;DUSP3;PODN;CLDN5;DLC1;DPYSL3;NGFR;RHOB;CLIC4;SRGAP2;SLIT2;PTEN;FBLN1;EPHA4;NAV3;ADORA3;SCAI;SRGAP2C;SPOCK3;SFRP1;IGFBP5;KANK1;PIP5KL1;TP53INP1
prerank,actin filament polymerization (GO:0030041),-0.4634861410298412,-1.467608132903607,0.044444444444444446,0.15238646301809372,1.0,8/27,14.01%,FAM107A;GSN;GAS7;ARHGAP6;WASF1;WASF3;CORO7;RAC1
prerank,neurotransmitter transport (GO:0006836),-0.3900386046548602,-1.4659017483983647,0.0,0.1542183004581387,1.0,28/71,22.74%,VAMP2;BRSK1;ATP1A2;SLC6A16;SLC17A7;SLC5A7;NRXN1;SYNJ1;SNPH;SYN2;PPFIA4;NRXN2;SNAP25;SLC18A3;SLC1A2;RAB3A;APBA1;SLC38A2;GLUL;SLC29A1;SYN1;SNAPIN;RIMS1;CHAT;SLC6A15;SLC17A8;SYT1;PPFIA2
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.3771698597994398,-1.4644025563605778,0.0,0.1554911129890193,1.0,40/100,20.44%,VAMP2;SLC2A4;ADCY5;SORBS1;ADCY2;ADCY4;KAT2B;PDE3B;GPER1;PIK3R1;CPEB1;RAB12;CPEB2;RHOQ;ADCY9;PRKACA;CYP11B1;ZFP36L1;GCK;FER;MYO5A;PRKAR2B;CYP11A1;HDAC5;INPP5K;LPIN1;HDAC9;MGARP;PLA2G1B;ADCY6;CRHBP;RAB13;AKT2;INSR;CRHR1;RPS6KB1;GSK3A;NR4A3;LHCGR;RAB8B
prerank,calcium ion import (GO:0070509),-0.48502736729189155,-1.4643879580743229,0.01818181818181818,0.15500368003294088,1.0,11/26,19.87%,CACNA1H;CACNA1C;CACNB2;SLC25A23;MICU3;SLC8A1;TRPC4;CACNA1G;CACNA1A;CACNA1B;CACNA1I
prerank,rRNA transcription (GO:0009303),0.5205971633147344,1.4635982859206076,0.04878048780487805,0.1353812807710869,1.0,12/15,33.25%,NIFK;GTF3A;TAF1B;GTF3C4;GTF3C3;ANG;GTF3C2;SIRT7;GTF3C6;TCOF1;GTF3C5;GTF3C1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.4519406694946704,-1.463193678753547,0.07272727272727272,0.15583654473789918,1.0,21/38,27.73%,IFT80;WDR19;IFT81;DYNC2H1;KIF17;CLUAP1;PCM1;TTC21B;IFT122;DYNLRB2;KIF3C;WDR35;IFT46;KIF3A;TRAF3IP1;KIFAP3;IFT43;TRIP11;IFT172;IFT27;IFT140
prerank,regulation of neurotransmitter transport (GO:0051588),-0.5553079649987707,-1.4620072276755225,0.0196078431372549,0.1566642202546646,1.0,10/16,29.03%,CPLX3;CAMK2A;MEF2C;CHRNB4;KCNMB4;SYN1;RIMS1;CPLX2;FLOT1;MCTP1
prerank,RNA catabolic process (GO:0006401),0.41617028156468644,1.4611483784157746,0.0,0.1370869232107017,1.0,18/46,18.78%,FEN1;RNASEH1;SND1;LSM5;PNPT1;NCBP1;CNOT10;EXOSC7;ZPR1;DNA2;LSM2;YTHDF2;LSM6;PPP1R8;RNASEH2A;XRN2;NUDT16L1;RNASEH2B
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5106378655990567,1.4600873947600368,0.0425531914893617,0.13780283134246216,1.0,5/15,5.08%,RNASEH1;RPP40;POP1;LACTB2;POP7
prerank,regulation of cellular response to heat (GO:1900034),0.3743673986115068,1.4600096207310083,0.0,0.13756896399589616,1.0,30/76,17.82%,NUP37;RPA3;NUP155;RAE1;NUP93;YWHAE;NUP35;SEH1L;SEC13;NUP210;NUP43;HSBP1;NUP50;PTGES3;NUP88;DNAJC2;NUP107;FKBP4;MAPKAPK2;GSK3B;DNAJC7;NUP205;MLST8;RPA2;NUP62;HSPH1;NUP160;HSP90AB1;NDC1;BAG4
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5363587288030803,-1.4591860892163733,0.044444444444444446,0.1596780234749925,1.0,10/16,25.12%,CRMP1;DPYSL3;DPYD;NT5M;DPYSL5;NT5E;DPYSL4;DPYSL2;UPB1;TET2
prerank,mesonephric tubule development (GO:0072164),-0.5137391399911939,-1.4585109111506454,0.07936507936507936,0.15972269289529958,1.0,6/17,9.34%,PKD1;PKD2;OSR1;FGFR2;TCF21;SLIT2
prerank,negative regulation of endocytosis (GO:0045806),-0.4885789271243619,-1.4584623898213476,0.037037037037037035,0.15934285108567092,1.0,9/23,17.55%,SNX33;SYT11;PRKD1;LGALS3;NR1H2;RAC1;EPHA3;LRSAM1;PACSIN3
prerank,protein localization to membrane (GO:0072657),-0.3412359559222166,-1.4582561231009714,0.0,0.15907812813818037,1.0,66/191,20.62%,DPP6;KCNB1;KCNIP3;NLGN2;FLNA;CACNB2;ANK2;WDR19;CYP46A1;RAP1A;DLG2;FERMT2;CAPN3;KCNIP4;RABEP1;WNK3;PTN;MAGI2;EHD2;SCN3B;RAB34;ACTN2;NRXN1;ANK3;SYNE3;TTC7B;SLMAP;LRRC7;SPTBN4;TMEM88;ZDHHC15;SHANK3;DLG4;P2RY1;RAB12;PACSIN1;NLGN1;EPB41L3;CLASP2;NRXN2;RAMP1;MYO5A;FAM126A;RDX;SYNJ2BP;INPP5K;RAB3A;TMEM150A;PACS2;FGF13;BRAF;ROCK1;MYADM;RAB13;RAB3C;PLEKHF1;RAMP3;ARL3;EFR3B;SAV1;RAPGEF6;RAB40A;RAPGEF2;RAB8B;TM9SF1;MADCAM1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.48515524161536555,-1.457984586079025,0.07142857142857142,0.15898368238626773,1.0,13/26,24.68%,SKP1;TAOK2;KAT7;MAPK1;MAPK3;MAPK11;MAP2K7;MAPK8;BTRC;UBB;MAP3K7;MAP3K8;FBXW11
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.38535165069445637,1.4572819720411547,0.02702702702702703,0.13975686215953445,1.0,24/49,26.47%,P4HB;BCAP31;PMAIP1;BBC3;STYXL1;BCL2L1;RTKN2;NOC2L;PPIF;PTPMT1;MMP9;PLAUR;UBQLN1;SLC9A3R1;LCK;BAX;BID;URI1;CAV1;MCL1;TP53;NDUFS3;BECN1;BCL2L10
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.47477752925126887,-1.4569627817971567,0.01639344262295082,0.15989863850189143,1.0,17/33,23.96%,WDR91;FGF2;PDGFRA;ATG14;PIK3R1;KIT;PRKD1;TNFAIP8L3;DAB2IP;P2RY12;PIK3R3;PDGFB;PIK3IP1;CCL21;PIK3R2;WDR81;FLT1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3671006362049441,1.4567921288558063,0.023255813953488372,0.13992628766548051,1.0,27/67,26.04%,POLR2F;POLR2D;INTS7;CDK7;NABP2;NCBP1;CCNK;NCBP2;POLR2C;TAF9;GTF2F2;POLR2K;GTF2E1;POLR2J;POLR2G;INTS5;RPRD1B;POLR2H;POLR2I;POLR2L;GTF2A1;GTF2E2;GTF2B;GTF2A2;INTS2;POLR2B;TAF5
prerank,protein phosphorylation (GO:0006468),-0.3026446590535056,-1.4563559475034604,0.0,0.16016545405336563,1.0,181/479,24.12%,PRRT1;PKD1;NRBP2;MKNK1;TNNI3K;DMPK;IP6K3;NIM1K;SIK3;MAP3K3;FGFR1;CSNK2A2;BRSK1;ULK1;TGFBR3;BMPR1A;PNCK;DDR2;TTBK2;MAP3K6;WNK3;PPP3CB;HIPK4;STRADA;CSNK1E;PXK;SNRK;CAMK2A;ULK2;PDGFRA;EEF2K;FGFR2;ILK;CLK3;RPS6KA5;CLK2;CDK9;MAPK10;DCLK1;CDC42BPA;PRKCB;CDK20;PRPF4B;PRKCA;STK36;PRKG1;TLR9;RPS6KA2;CDK3;CSNK1A1;FES;KIT;AURKC;CAMK1;PRKACA;DAPK1;GRK5;PRKD1;HIPK3;CDC42BPB;GDF7;DYRK1A;PRKAG2;ALK;LRRK2;PRKAA2;MAML1;MAST2;FLT4;NEK1;FER;MAP4K5;TLR3;GRK4;CDK17;FAM20B;TSSK3;MAST4;STK32B;NTRK1;PRKG2;TAOK2;MERTK;FAM20C;LATS2;MAST1;MEX3B;DAB2IP;ABI2;MAPK1;EPHA4;MAPK3;DAPK3;RICTOR;MARK1;MARK4;RELN;STK33;NEK10;BMX;PPP4R1;ERC1;MORC3;CDK15;CAMK2B;BRD2;PEAK1;MUSK;EPHA3;TRIB2;PDGFB;GDF6;BRAF;ROCK1;MAPK8;CAMK2D;SGK3;INSRR;MAP4K2;AATK;NEK7;MAPK14;ERG;AKT2;NRK;ACVR2A;INSR;MARK3;EGFR;CDK14;STK32A;ERBB4;CSNK1D;SMAD2;CCL11;USP15;CSNK2B;TESK2;MAP3K10;PDK2;RET;SLK;BMPR1B;MAP3K12;RPS6KB1;EFEMP1;GSK3A;STK19;CAMKK2;MYLK3;CRY1;CCL2;MAP2K6;MKNK2;GTF2H4;MAP3K7;SMAD7;MAPK12;TBCK;RNASEL;PAK3;PKN1;CDKL2;SMG1;TNKS;MTOR;NUAK1;LATS1;HIPK1;MYLK2;PRKCD;WNK1;CDK11B;RIPK1;PIM1;PINK1;CDKL5;PKDCC;FLT1;NRBP1;PRKCH
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.4904397475354939,-1.456069022855446,0.057692307692307696,0.16001285948094457,1.0,6/20,12.26%,SOCS2;PXN;PIK3R1;GH1;GHR;PRL
prerank,chromosome organization (GO:0051276),0.34404372924068066,1.4554802188945477,0.0,0.14125127496463002,1.0,33/100,17.04%,RFWD3;CENPH;CENPW;MYC;NUF2;NUP155;SUV39H1;RAE1;HDAC2;NDC80;HMGN4;AXIN2;HDAC10;PADI3;HMGN1;MSH3;SMARCA4;PADI1;POLE3;HMGB2;HMGA2;HDAC1;COPS5;RAD23B;DDB1;MSH6;CDT1;UBA52;CUL4A;CENPV;TOP2A;LRWD1;SOX1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.5565234307825019,-1.4554611807514382,0.0425531914893617,0.1605831613990883,1.0,9/17,22.91%,HAND2;AKAP6;PDE9A;MEF2A;PRKCA;ROCK1;CAMK2D;NR4A3;TRPC3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.32037960621192624,1.4538638285874035,0.0,0.14238180213731946,1.0,39/179,14.60%,PSMD14;THY1;PSMB2;PSMB9;PSMA5;PSMB3;RIPK2;PSME3;KHDRBS1;PSMA3;UBE2N;SKAP1;PSMA7;CD276;PSMD13;SYK;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;STOML2;CARD11;BTN1A1;PSMB5;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;INPP5D;VTCN1;PSMD11;PSMD1;PAK1
prerank,modulation by host of symbiont process (GO:0051851),0.43214452534760794,1.4533133775225844,0.06976744186046512,0.14232487651725054,1.0,9/32,9.91%,TFAP4;SMARCB1;LEF1;RRP1B;SMARCA4;HMGA2;CCL4;CCL3;HDAC1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.39908258221723364,1.4530600708332153,0.0,0.14226826891740543,1.0,12/44,12.90%,POLR2F;CHEK1;ATAD2;CDCA4;HMGA1;POLR1C;POLR1B;DDX21;TAF1A;POLR1A;TAF1B;POLR2K
prerank,negative regulation of programmed cell death (GO:0043069),0.2925894402001482,1.451464898833259,0.0,0.14378833199661956,1.0,125/372,21.55%,MYC;MAD2L1;DCPS;DPEP1;ANXA4;TDGF1;CDK1;VDAC1;HSPD1;DHRS2;CBX4;VHL;RIPK2;TRIAP1;ARL6IP1;MET;GLO1;HDAC2;KIF14;IFI6;MYDGF;PTMA;FIGNL1;WNT5A;PRDX5;SHH;PRKDC;CARD14;LEF1;PSMD10;CDSN;CD44;CTSH;ARF4;CIAPIN1;SOX9;TMBIM6;ATAD3A;BCL2L1;BFAR;ERCC5;HSPA9;CLEC5A;HNRNPK;CASP2;BCL2A1;PPIF;HMGA2;XIAP;XBP1;DNAJC3;AATF;PRAME;PA2G4;HDAC1;MYD88;NAA15;RELA;ADAM10;IRAK1;CEACAM5;PAK2;IGF1R;PRELID1;SEMA4D;GSK3B;PROC;WDR73;ARHGDIA;TM7SF3;COPS5;PRDX2;TAF9;PRLR;POU4F1;NAA35;WNT11;THOC6;PLK1;DNAJA1;DHCR24;CIB1;PRKCI;VTCN1;NPM1;KDR;MMP9;BMP4;MIEN1;HTATIP2;UBA52;GATA6;PDCD10;YME1L1;NUP62;IFIT3;MED1;PLAUR;NUAK2;HSPA5;RAB7A;PPT1;ANXA5;CFL1;BAG4;API5;FHL2;BIRC5;BNIP1;FXN;TPT1;NFKBIA;PROK2;COMP;BID;TMEM14A;BIRC7;PAX2;UFM1;DDRGK1;RPS6KA1;UBE2Z;MCL1;OPN3;PRDX3
prerank,negative regulation of telomere maintenance (GO:0032205),-0.5409007488618984,-1.4513180579815472,0.07547169811320754,0.16497044383995862,1.0,9/16,29.45%,TERF2IP;RTEL1;RAD50;SMG6;TNKS;ERCC1;SLX4;TNKS2;ERCC4
prerank,negative regulation of viral process (GO:0048525),0.36516977558084024,1.4511766442815677,0.05263157894736842,0.14360468145077265,1.0,24/67,21.78%,IFITM3;IFITM1;IFITM2;SRPK1;PML;PROX1;SLPI;OAS2;TRIM27;TRIM14;TRIM26;STAT1;APOBEC3F;BST2;TRIM11;OASL;MX1;ISG15;BANF1;PLSCR1;OAS3;TRIM28;IFI16;TRIM31
prerank,maintenance of protein location in nucleus (GO:0051457),-0.5148824318212096,-1.450923883486105,0.05555555555555555,0.1649151587268939,1.0,9/20,16.03%,SUPT7L;SYNE1;SUN1;BBS4;SUN2;SKP1;ARL2;MORC3;TAF3
prerank,negative regulation of neuron projection development (GO:0010977),-0.40831795248278946,-1.4507593729044344,0.0425531914893617,0.16464006183327332,1.0,23/55,18.58%,LPAR1;STX1B;CRMP1;PTPRS;STMN2;DENND5A;NLGN1;RUFY3;DPYSL3;NGFR;GDI1;PTEN;EPHA4;MAG;RHOA;KANK1;ADCY6;MCF2;SEMA3A;RTN4;SPOCK1;MYLIP;DCC
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3506566247195613,1.4506903905913422,0.0,0.14369868754405016,1.0,29/92,14.34%,PSMD14;PSMB2;FBXO5;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;RBL1;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;CDK4;PSMD12;CDKN2A;PSMB5;AURKA;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1
prerank,positive regulation of cell division (GO:0051781),0.4005470477728561,1.4502714796502263,0.046511627906976744,0.14379217426664653,1.0,21/44,23.30%,KIF20B;RACGAP1;SSTR5;KIF23;KIF14;SHH;AURKB;CXCR5;ECT2;OR2A4;SPAST;DRD2;CENPV;CDC6;PKP4;CDC42;RXFP3;CUL3;GIPC1;CDC14C;CSPP1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.3418326692725813,-1.4490481700967743,0.014925373134328358,0.16584813401916793,1.0,75/168,27.79%,LCAT;PITPNM2;PIP5K1C;AGPAT1;CSNK2A2;INPP4A;INPPL1;FGF2;PLA2G5;PLA2G4B;MTMR9;ABHD8;SYNJ1;PI4KB;PIK3R1;PI4KA;PCYT1B;DGKE;INPP5E;INPP5F;CHKB;PLD6;PIP4K2B;AGPAT4;PTEN;ABHD4;LIPI;SLC27A1;DDHD2;DGKG;PIK3C3;INPP5K;PITPNM3;DDHD1;PLA2G4C;PIK3R3;LPIN1;PI4K2A;BMX;ETNK2;PLA2G1B;PIP4K2A;PCYT1A;CDS2;CDIPT;PISD;CSNK2B;PLD2;DGKB;PIKFYVE;PLEKHA3;RUFY1;PLEKHA4;CHAT;PIK3R2;GPD1L;CPNE6;CHKA;PLCG2;SBF1;MTMR12;DGKD;LPIN3;PIP5K1A;PIK3R6;CLN3;MTMR7;PLA2G4A;PIK3C2A;DGKA;PIK3R5;TPTE2;SLC44A2;FIG4;OCRL
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3456148982823868,1.447178024997849,0.0,0.146636295928298,1.0,38/97,19.93%,NUP37;CPSF3;ALYREF;THOC3;NUP155;U2AF1;MAGOH;RAE1;SLBP;NUP93;NUP35;MAGOHB;EIF4A3;NCBP1;SEH1L;DDX39A;SRSF9;SEC13;NUP210;NUP43;NXT1;GLE1;NUP50;NUP88;NUP107;EIF4E;NCBP2;CPSF2;NUP205;THOC6;NUP62;NUP160;NDC1;RBM8A;CPSF4;HNRNPA2B1;SRSF3;NXF3
prerank,mRNA export from nucleus (GO:0006406),0.3391209428221342,1.4467247843543218,0.0,0.14672119863487942,1.0,31/103,13.26%,NUP37;POLR2D;CPSF3;ALYREF;THOC3;NUP155;U2AF1;MAGOH;RAE1;SLBP;NUP93;NUP35;MAGOHB;EIF4A3;NCBP1;SEH1L;DDX39A;SRSF9;SEC13;NUP210;NUP43;NXT1;GLE1;NUP50;NUP88;NUP107;EIF4E;NCBP2;CPSF2;NUP205;THOC6
prerank,hemopoiesis (GO:0030097),-0.3587370354845519,-1.4466909222152402,0.01639344262295082,0.1682525562586745,1.0,30/94,15.96%,YJEFN3;FLCN;MEIS1;TGFBR3;TPO;KIRREL3;SNRK;L3MBTL1;ZNF160;FGFR2;TAL1;CD34;ATF4;KIT;KMT2A;KITLG;FSTL3;ZBTB16;FLT3LG;FLT4;RRAS;MFAP5;NOTCH4;WNT2B;TOX;FST;SFRP1;PDGFB;ARIH2;NOTCH2
prerank,negative regulation of cell projection organization (GO:0031345),-0.41322500733806417,-1.4466866161953056,0.07142857142857142,0.16775180460314273,1.0,20/46,20.25%,LPAR1;STX1B;CRMP1;PTPRS;STMN2;DENND5A;PRNP;DPYSL3;PTEN;EPHA4;GORASP1;SPRY3;MAG;KANK1;ADCY6;SEMA3A;SPOCK1;MYLIP;DCC;RAPGEF2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.44887698575701274,1.446587899451416,0.021739130434782608,0.14653202859887077,1.0,10/28,13.27%,MYC;E2F1;WNT2;EREG;WNT5A;CDK4;S100A6;DHX9;FN1;AGT
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.514751706454598,-1.4463999201878028,0.07017543859649122,0.1677162778029743,1.0,13/21,26.57%,AHNAK;CACNB2;DMD;NPPA;CACNB1;GNB5;STAC2;STAC;CRHR1;DRD4;CACNB3;CACNB4;NOS1AP
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.43296662465992897,1.4461076071209398,0.02,0.14664707001306562,1.0,12/39,12.46%,CHEK1;FANCB;PARPBP;RAD51AP1;TIMELESS;ACTR2;RMI2;PPP4C;FIGNL1;WRAP53;FUS;KDM1A
prerank,positive regulation of protein polymerization (GO:0032273),-0.4106587678381557,-1.445998295989355,0.017543859649122806,0.16757251759163636,1.0,31/65,24.37%,LMOD1;TENM1;DCTN1;MAPT;NUMA1;CLIP1;CDC42EP3;CLASP1;FES;EVL;NCK1;FER;NCKAP1L;FCHSD1;TPPP;LMOD2;NAV3;ARL2;CDC42EP4;RAC1;SLAIN2;BAIAP2;CCL11;FCHSD2;CDK5RAP2;CCL21;TPPP3;CAV3;CDC42EP2;PINK1;OCLN
prerank,mRNA processing (GO:0006397),0.30578840906992116,1.4459835036676905,0.0,0.14633819220706473,1.0,111/292,22.59%,POLR2F;POLR2D;CSTF2;CPSF3;ALYREF;SNRPF;SNRPD1;PRPF19;THOC3;LSM7;CDK7;LSM5;PABPC1;HNRNPF;PPIH;LSM4;SNRPG;SF3B3;U2AF1;CSTF1;MAGOH;PRPF4;PPIL1;SNRPB;RNF113A;GTF2H3;SNRPC;EFTUD2;MAGOHB;LSM8;TBRG4;EIF4A3;PHF5A;SNRPD2;NCBP1;SNRPE;DDX39A;SRSF9;SF3B6;PTBP1;NONO;RALY;RSRC1;SNRNP40;SNRPB2;BUD31;RBM15;HNRNPK;DHX9;NUDT21;SF3B5;PRPF40A;PRPF6;LSM2;CLP1;SNRPA1;GEMIN6;NCBP2;PSPC1;HNRNPC;FUS;CRNKL1;CPSF2;POLR2C;ELAVL1;GTF2F2;DHX8;POLR2K;HNRNPA0;THOC6;RBM22;POLR2J;UBL5;LSM6;CTNNBL1;POLR2G;USP39;PUF60;DDX41;LSM3;ELAVL2;SYNCRIP;TRA2B;SF3A3;HNRNPR;PPIL3;RBM8A;CPSF4;RPRD1B;HNRNPA2B1;SNRPD3;CDC5L;ERCC2;POLR2H;SRSF3;DBR1;TFIP11;WDR83;HNRNPA1;RBM15B;POLR2I;POLR2L;TXNL4A;RBMX2;GEMIN2;CSTF3;RNGTT;U2AF2;GPKOW;GEMIN5;CMTR2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3565801572542936,-1.445861073307139,0.0,0.16718632711666284,1.0,47/138,19.46%,NPR2;EFS;LIFR;FGFR1;PILRB;NPR1;EPHA7;DDR2;ANGPTL1;SHC4;PTN;GFRA2;PDGFRA;ROR2;FGFR2;NTRK3;NPPA;NGF;SHC2;FES;KIT;ALK;EPHA5;FLT4;FER;NTRK1;ROR1;MERTK;EPHA4;RAPGEF1;MUSK;EPHA3;EPHA6;INSRR;NTF3;TIE1;TRIO;AHI1;TNK2;NPPC;NPPB;ACVR2A;INSR;EGFR;ERBB4;RET;SH2D6
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.4611611124528167,-1.445709552836741,0.07017543859649122,0.16696411693819926,1.0,15/24,29.90%,SEMA6C;SEMA4C;SEMA3E;MEGF8;SEMA6D;SEMA6A;SEMA3B;SEMA3G;DSCAM;SEMA3A;SEMA3C;SEMA4B;SEMA3D;SEMA6B;SEMA5B
prerank,positive regulation of cytokine production (GO:0001819),0.308039690306282,1.4441202720598483,0.0,0.14814170328837162,1.0,140/321,30.97%,POLR2F;POLR3K;CEBPB;OSM;IL1A;POLR1C;HSPD1;EREG;RIPK2;CSF2;G3BP1;IL23A;PHB;GAPDH;XRCC5;ZP3;CD276;POLR3C;IL1B;WNT5A;SLC7A5;SYK;PNP;PRKDC;RPS3;CD46;STOML2;CARD11;TMED10;DHX9;MDK;IL21;POLR3B;CYBA;CD80;XBP1;TRIM27;CLEC6A;NOX1;MYD88;RELA;FFAR2;IRAK1;RUNX1;IL17A;NOS2;CEBPG;ZFPM1;BATF;AGPAT2;SORL1;GBP5;LAMTOR5;DRD2;POLR2K;IL17F;BRCA1;AGT;PRKCZ;TRAF2;C3;MAPK13;NFKB2;ISG15;RAB1A;DDX41;HPSE;F2R;IL23R;PIK3CG;POLR3G;TGFB1;CRCP;EGR1;NOD2;SERPINE1;POLR2H;MMP8;TNFSF4;CHI3L1;SULF2;CD86;IFI16;HMGB1;POLR2L;IL12B;HYAL2;LTB;ITK;CRTAM;CD2;IL12RB2;POLR3A;CD58;SCRIB;NFAM1;TYROBP;TRIM15;XRCC6;TICAM1;ZBP1;CTNNB1;IL12RB1;CREBBP;PTPN11;PRKCQ;CCL1;HIF1A;ANXA1;TIGIT;IFNG;CLEC7A;CD244;PARK7;SLAMF6;IL10;IL18;GLMN;TLR7;TRAF6;HILPDA;PIK3CD;PIBF1;IRF3;NOD1;RASGRP1;EIF2AK2;BTN3A2;NLRP3;ADAM17;IRF7;IFNL1;CD6;CCDC88B;AIRE;TLR8;SCIMP;IL26;LACC1;XCL1
prerank,regulation of actin filament polymerization (GO:0030833),-0.38708612029036854,-1.4439459459886284,0.0,0.1687048948693015,1.0,28/67,23.51%,LMOD1;TENM1;GBA2;PLEKHG2;CDC42EP3;EVL;NCK1;SLIT2;KANK3;FER;NCKAP1L;FCHSD1;LMOD2;CDC42EP4;SSH1;KANK1;DBN1;MYADM;BAIAP2;CCL11;FCHSD2;ESAM;CCL21;PAK3;ARHGAP28;CDC42EP2;LATS1;PRKCD
prerank,cell-cell junction assembly (GO:0007043),-0.3914650658638201,-1.4434557392760055,0.03278688524590164,0.16888145121792228,1.0,21/64,14.72%,FLCN;JAM3;PIP5K1C;TLN1;GJC1;VCL;CDH19;CTNND2;CDHR3;CNTNAP1;CLDN5;CLDN11;DCHS1;PRKCA;CTNND1;EPB41L3;FBF1;CDH10;TJP1;CDH2;RHOA
prerank,regulation of myotube differentiation (GO:0010830),-0.4420683718485716,-1.4434130543259207,0.0784313725490196,0.16841580117543242,1.0,9/24,17.48%,DMPK;HDAC4;RBM24;SMYD1;MAML1;HDAC5;HDAC9;MAPK14;PIEZO1
prerank,protein deacetylation (GO:0006476),-0.40061095357032067,-1.441410995785019,0.047619047619047616,0.17016381593389912,1.0,19/44,21.02%,SIN3B;HDAC4;FLNA;RCOR3;HDAC7;HDAC6;MORF4L1;SIRT2;SIRT4;HDAC5;MTA3;PRDM5;HDAC9;SIN3A;TRERF1;BAZ2A;BRMS1L;SIRT1;SIRT3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4132150865838093,1.4410717535405706,0.0,0.15083757786546378,1.0,15/32,24.24%,E2F1;TFDP1;FBXO5;CDK5;DHFR;CCNE1;ZPR1;POLA1;CDT1;CDC6;CDC45;ORC1;E2F7;CDK16;RRM2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.41538304101281814,-1.4410614767594454,0.017543859649122806,0.17014868243725095,1.0,19/42,21.17%,MYH7;FOXF1;TPM1;MYL2;TGFBR3;BMPR1A;MYH6;FGFR2;RBPJ;HAND1;HEY1;MEF2C;HEY2;MYL3;NPY2R;SOX11;GSK3A;MYBPC3;SMAD7
prerank,smoothened signaling pathway (GO:0007224),-0.4322649857584311,-1.4409392937814132,0.018518518518518517,0.16976285950123465,1.0,8/32,11.56%,EVC2;PTCHD1;TTBK2;PTCH2;GLI3;STK36;CC2D2A;GLI2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.5062295359338043,1.440830184621305,0.023255813953488372,0.15072980887313134,1.0,9/22,11.13%,DUSP4;DUSP18;PPM1G;DUSP16;PPP1CA;DUSP9;DUSP6;PDP1;DUSP1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3789375227772658,-1.4401833739056609,0.04,0.17027712357318606,1.0,35/69,27.72%,PLCD4;PITPNM2;FGFR1;PIRT;NYAP1;PDGFRA;PI4KB;PIK3R1;PLCL1;PI4KA;INPP5F;NGF;PTEN;ZFP36L1;SIRT2;NTRK1;PIK3C3;PLCE1;OGT;RHOA;HTR2B;MYO16;PLCD1;PLCB1;RPS6KB1;PIK3R2;PLCB2;KCNH1;HTR2A;EXOC1;PIK3C2A;PLCL2;PIK3R5;TPTE2;LTK
prerank,synaptic vesicle cycle (GO:0099504),-0.46830789419571567,-1.4396174027961004,0.0196078431372549,0.1703407905155677,1.0,14/30,21.91%,VAMP2;PIP5K1C;BRSK1;SLC17A7;CPLX3;SYT10;SNCA;NLGN1;SNAP25;RAB3A;PLD2;SNAPIN;RIMS1;SLC17A8
prerank,regulation of TORC1 signaling (GO:1903432),-0.46524248467692475,-1.439579387605741,0.04,0.16987896442997552,1.0,10/28,19.45%,FLCN;SIK3;SZT2;RRAGC;KLHL22;RRAGB;RNF152;DEPDC5;KPTN;RRAGD
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3435136556066729,1.4394811966804402,0.0,0.1518788063253677,1.0,39/107,21.42%,IL1A;CXCL5;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;IL1B;WNT5A;DEFA6;PF4;TNFAIP3;CARD17;HMGB2;PLAA;CD80;XBP1;MYD88;RELA;IRAK1;CXCL9;CXCL10;CXCL6;TNIP3;PF4V1;IL36B;TNFRSF1B;CHMP5;NOD2;CTR9;ADAM9;SERPINE1;TNFSF4;CD86;CXCL13;GIT1;HMGB1;NFKBIB;ZC3H12A
prerank,pyroptosis (GO:0070269),0.4785694462121055,1.4389241586228079,0.06818181818181818,0.15224607816811242,1.0,12/18,30.39%,GZMB;GSDMA;DHX9;GZMA;GSDMC;GSDMB;NAIP;CASP4;ZBP1;APIP;CASP8;AIM2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4281642353706187,-1.4377013382255919,0.03389830508474576,0.17169755831635727,1.0,17/36,25.32%,EPHA7;PPP2R5B;PPP2R5D;CALM1;TAOK2;NEK10;PDGFB;RAD50;RASSF2;INS;TESK1;PDGFD;ERRFI1;CALM2;PDGFA;GPNMB;MOB1B
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3375070365432056,-1.437678730696599,0.0,0.1712606050826577,1.0,65/153,25.72%,PDE2A;TMEM100;DUSP22;RAP1A;BMPR1A;MAPT;MAPK7;MAGI2;SMAD4;DUSP3;PHOX2B;STMN2;NTRK3;KIDINS220;TBX1;CILP;SOX5;DSTYK;PRKD1;NOS1;ZFP36L1;SIRT2;FLT4;NR3C1;PDE3A;NTRK1;HSPB1;MEF2C;INPP5K;DAB2IP;RAPGEF1;SEMA6A;MAP2K5;SFRP1;PDGFB;SMAD9;PDE8A;ZFP36;CLEC3B;MAPK14;GAS1;ACVR2A;EGFR;VSTM2A;ANKRD1;BMPR1B;RPS6KB1;SETX;RAPGEF2;CCL2;SOX6;SMAD7;PTPN12;DLX1;PLCG1;RAMP2;HGF;NR4A1;ADAMTS7;FLT1;SNAI2;ZFP36L2;AMHR2;SMAD3;RUNX2
prerank,regulation of kinase activity (GO:0043549),-0.3593212472994465,-1.4373914417886382,0.01639344262295082,0.17111249349540797,1.0,41/93,23.96%,TSPYL2;FGFR1;EPHA7;MAPT;DDR2;PDGFRA;ROR2;FGFR2;NTRK3;CDKN1C;KIT;DSTYK;ALK;EPHA5;FLT4;LDB2;NTRK1;ROR1;MERTK;PLCE1;EPHA4;MUSK;EPHA3;EPHA6;INSRR;PIFO;RAD50;TIE1;RBL2;INSR;EGFR;ERBB4;ANKRD54;LMO4;RET;CAMKK2;SOD1;DRD4;TTN;EPHB6;FLT1
prerank,positive regulation of cilium assembly (GO:0045724),-0.5180823572605864,-1.4352887206301943,0.034482758620689655,0.1728083019503444,1.0,10/16,27.24%,TAPT1;HAP1;BBS4;CROCC;MARK4;CCDC88A;FUZ;CEP120;ARHGAP35;CCP110
prerank,negative regulation of protein ubiquitination (GO:0031397),0.38573320174010267,1.4350930587803261,0.04081632653061224,0.155735005476515,1.0,9/49,6.99%,GNL3L;SOX4;PRR7;FBXO5;PRMT3;GTPBP4;LIMK1;RPS3;TNFAIP3
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5283066701884077,-1.4348716427308559,0.06382978723404255,0.17299316734805958,1.0,7/17,15.59%,ADCY5;ADCY2;ADCY4;ADCY9;PRKACA;PRKAR2B;ADCY6
prerank,limb morphogenesis (GO:0035108),-0.4708477179253501,-1.4336423812179335,0.05660377358490566,0.17392555776514884,1.0,12/22,25.26%,MYH3;FBXW4;GLI3;MBNL1;MEGF8;SKI;CYP26B1;PCSK5;BMPR1B;LRP6;NIPBL;HOXA11
prerank,negative regulation of execution phase of apoptosis (GO:1900118),0.5222779471913199,1.4333780018749387,0.07547169811320754,0.15674272643345435,1.0,7/15,24.20%,BCL2L1;PAK2;RNF34;MTRNR2L3;MTRNR2L1;MTRNR2L9;DFFA
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.4574889859645915,-1.433277820084844,0.058823529411764705,0.17392606531702814,1.0,9/25,20.37%,MYOCD;AKAP6;RBM24;SMYD1;MAML1;MEF2C;MAPK14;PIEZO1;MYLK3
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.3722386396238879,-1.4325314183939215,0.014492753623188406,0.17443993062177673,1.0,50/107,27.79%,INPP5B;IP6K3;PITPNM2;PIP5K1C;INPP4A;INPPL1;FGF2;PLA2G5;MTMR9;SYNJ1;PI4KB;PIK3R1;PI4KA;MTMR10;INPP5E;INPP5F;PIP4K2B;PTEN;SLC27A1;PIK3C3;INPP5K;PITPNM3;PLA2G4C;PIK3R3;PI4K2A;BMX;PLA2G1B;PIP4K2A;CDIPT;PLCD1;PLCB1;PIKFYVE;PLEKHA3;RUFY1;PLEKHA4;PIK3R2;PLCB2;PLCG1;PLCG2;SBF1;MTMR12;PIP5K1A;PIK3R6;MTMR7;PLA2G4A;PIK3C2A;PIK3R5;TPTE2;FIG4;OCRL
prerank,tight junction assembly (GO:0120192),0.40419465912543967,1.4324532884615946,0.02564102564102564,0.1573604009695215,1.0,19/50,19.89%,CLDN1;CLDN2;CLDN16;CLDN12;CLDN14;PARD6B;ACTG1;ECT2;LSR;PAK2;POF1B;PECAM1;MARVELD2;PRKCI;GRHL2;CRB3;CLDN4;STRN;F11R
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4782956655408471,-1.432411967776089,0.018867924528301886,0.17405505357136847,1.0,13/33,15.42%,PTPRM;ADGRB1;NR2F2;EVL;SLIT2;PTEN;DCN;CORO1C;MCC;SYNJ2BP;DAB2IP;KRIT1;ADAMTS9
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.3712395099275107,-1.4322469537876916,0.015625,0.17382547087740657,1.0,36/80,27.41%,GPR17;PTH1R;LPAR1;GALR2;AGTR1;ACTN2;P2RY1;ADRA1A;PTGER3;CHRM2;ADRA1D;VIP;PLCE1;TACR1;P2RY12;GPR20;OPRL1;HTR2B;ESR1;P2RY11;C5AR2;LHCGR;LPAR6;CCKAR;GNA11;ADRA1B;LPAR4;HTR2A;GNA14;NMBR;F2RL3;GPR4;P2RY4;CCKBR;F2RL1;NMUR1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.312851973004237,1.4319986071023367,0.0,0.15753211825791355,1.0,57/182,18.06%,SPTBN2;MIA2;COPZ1;KDELR3;TMED2;TMED3;TMED9;KDELR2;COPB2;KDELR1;AREG;ERGIC3;BCAP31;FOLR1;LMAN2;STX17;HYOU1;CTAGE9;CAPZA1;SEC13;ARF4;COG6;CTSC;GOLT1A;F5;COG5;YKT6;COPA;CD55;YIF1A;TMED10;COPG1;F7;ZW10;TRAPPC6A;COPG2;YIF1B;SPAST;RAB2A;CTAGE8;PROC;CTAGE4;CTAGE6;COPB1;ARCN1;DCTN5;RAB1A;CTAGE15;TFG;VTI1A;DYNLL1;NSF;PREB;CTSZ;TMED4;CNIH1;CNIH4
prerank,regulation of axon extension (GO:0030516),-0.4024416538781587,-1.4318029964462478,0.047619047619047616,0.17382625080895317,1.0,14/38,17.77%,NTN1;MAPT;PTPRS;MACF1;RUFY3;L1CAM;OLFM1;MAP2;MAG;SEMA3G;DBN1;SIN3A;SEMA3A;RTN4
prerank,regulation of axonogenesis (GO:0050770),-0.41292189508623484,-1.4317306700323973,0.018518518518518517,0.17347165574637854,1.0,22/51,18.66%,MAP6;PLXNB3;BRSK1;RUFY3;AMIGO1;NGF;NGFR;GDI1;SLIT2;PTEN;CHODL;LRRC4C;EPHA4;TIAM1;MAG;CDH2;RHOA;MCF2;PLXNA4;RTN4;PLXNB1;SIPA1L1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4010963412168971,1.4316771380094653,0.020833333333333332,0.15755575872952038,1.0,28/56,30.20%,HSPD1;IL23A;ZP3;CD276;IL1B;SLC7A5;IL21;TRIM27;CEBPG;ZFPM1;ISG15;IL23R;TNFSF4;IL12B;CRTAM;CD2;IL12RB2;SCRIB;IL12RB1;CLEC7A;CD244;SLAMF6;IL18;TLR7;RASGRP1;BTN3A2;IFNL1;TLR8
prerank,respiratory chain complex IV assembly (GO:0008535),0.45696839188381877,1.4314845356617198,0.06976744186046512,0.15731507637949912,1.0,11/22,27.12%,COX20;COA6;COX18;COA1;SCO2;COA3;COX19;COX17;FASTKD3;PET117;SMIM20
prerank,regulation of double-strand break repair (GO:2000779),0.41859289656244475,1.4314373499536082,0.05405405405405406,0.15698783057166596,1.0,18/38,25.53%,CHEK1;OTUB2;RAD51AP1;TIMELESS;ACTR2;PPP4C;FIGNL1;PML;WRAP53;KDM1A;FOXM1;RPA2;DEK;SPIRE2;SIRT6;MGMT;OTUB1;PPP4R2
prerank,negative regulation of cellular component organization (GO:0051129),-0.3870738487351427,-1.4312505750785376,0.030303030303030304,0.1737265437489389,1.0,21/68,19.01%,CRYAB;RAF1;ULK1;RAPGEF3;TMEFF2;CLU;SNX33;HSPA2;HDAC6;SYT11;AR;PRKD1;RTEL1;RDX;LGALS3;SACS;EPHA3;LRSAM1;DNAJB6;PACSIN3;DNAJB2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.493659355619201,-1.4306368743445819,0.03773584905660377,0.17347688588776156,1.0,5/23,7.91%,FLCN;TGFB1I1;SMAD4;CITED2;CDKN1C
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.493659355619201,-1.4306368743445819,0.03773584905660377,0.17347688588776156,1.0,5/23,7.91%,FLCN;TGFB1I1;SMAD4;CITED2;CDKN1C
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4622187678592055,-1.4298550969796848,0.03773584905660377,0.17380498091986343,1.0,12/31,16.02%,MAP3K3;FGF2;STARD13;HDAC7;RHOJ;HDAC5;HDAC9;MEOX2;MAP2K5;RHOA;GATA2;TBXA2R
prerank,cilium assembly (GO:0060271),-0.31234500322474223,-1.4297800502259626,0.0,0.17343025131782994,1.0,132/292,28.66%,TTLL3;NPHP3;PKD1;FLNA;IFT80;WDR19;RFX2;CCDC13;GSN;DZIP1;DCTN1;CNGB1;RABL2B;TTBK2;CEP126;INTU;TUBB4A;EHD2;CSNK1E;IFT81;ACTR1A;SPATA6;BBS4;PAFAH1B1;CYS1;BBS5;DYNC2H1;WDR11;HDAC6;DZIP1L;CCDC39;INPP5E;STK36;CFAP44;CCDC66;CLASP1;CCDC40;EXOC7;BBS1;CC2D2A;PRKACA;FBF1;PARVA;CFAP54;TEKT2;TMEM80;NEK1;ABLIM3;TUBA1A;RAB23;PTPDC1;PRKAR2B;CEP164;CEP162;NPHP1;CCDC57;EXOC3;KIF17;BBS2;NINL;MARK4;DCTN2;DISC1;TEKT3;RILPL1;HAUS4;CLUAP1;CFAP70;PCM1;GBF1;CEP63;RAB11FIP3;BBS7;CEP290;TTC21B;ARMC9;BBS9;TXNDC15;PCNT;IFT122;HAUS3;AHI1;TMEM138;CDC14A;DYNLRB2;CSNK1D;ARL3;CDK5RAP2;RPGR;FUZ;CEP192;RAB8B;KIF3C;WDR35;CNGA4;DCX;CEP97;CEP89;RFX3;RSPH4A;UBXN10;RHO;IFT46;KIF3A;ARL6;BBIP1;TRAF3IP1;TTC8;C2CD3;CDC14B;WDPCP;EXOC1;KIFAP3;IFT43;ALMS1;ABCC4;AKAP9;CNTRL;TRIP11;SPAG16;CCP110;IFT172;ASAP1;DYNC1H1;IFT27;IFT140;OCRL;PTPN23;CEP19;CCDC28B;UNC119B;ATAT1
prerank,cellular response to organic cyclic compound (GO:0071407),-0.3395734699350942,-1.42829991107188,0.015625,0.17488027371636622,1.0,53/147,22.13%,PDE2A;RYR3;ADCY5;ADCY2;ATP1A2;AKAP6;TRPV1;RAPGEF3;PKD2;RAP1A;GPER1;GNAI1;P2RY1;RORA;P2RX7;FES;AR;GNG2;ZFP36L1;LRRK2;ATP1A3;NR3C1;PDE3A;EPG5;MEF2C;AQP1;INPP5K;P2RY12;RAPGEF1;KCNE1;SSH1;SFRP1;MGARP;CYP1A1;IGFBP5;PDGFB;ESR1;TFPI;ADCY6;CRHBP;CASP3;EGFR;GABRG2;RAMP3;P2RY11;GPBAR1;NR4A3;RAPGEF2;HCN3;CCL2;KAT5;SSTR2;ACTB
prerank,protein-DNA complex disassembly (GO:0032986),0.49701711008468963,1.4257507516253325,0.07547169811320754,0.16282367650445825,1.0,8/18,12.57%,MYC;HMGA1;SET;SMARCB1;GRWD1;SMARCA4;SMARCD2;SMARCC1
prerank,mitotic cell cycle phase transition (GO:0044772),0.31817126171655435,1.425539885379237,0.0,0.16251281441463286,1.0,74/206,21.67%,MYC;CCND1;CEP72;CDKN3;E2F1;TACC3;DBF4;CDK1;CDK7;SKP2;RCC1;UBE2S;INHBA;KHDRBS1;CEP250;CHEK2;EIF4EBP1;PHLDA1;CCNO;E2F3;CCNE1;YWHAE;MASTL;NEK2;AJUBA;CCNI2;CDC25C;CDK4;TUBB4B;HAUS2;CDKN2A;ANAPC1;YWHAG;USP37;UBE2C;TUBA4A;CCNF;HAUS8;EIF4E;CEP76;AURKA;CCNJ;SPAST;GSPT1;PPME1;TRIM71;PKMYT1;CKAP5;LCMT1;HAUS1;HAUS6;PLK1;TUBG1;FOXM1;USH1C;CEP78;PLK4;CDC25A;CUL4A;DYNLL1;HAUS7;USP26;ACVR1B;CDC7;MAPRE1;SSNA1;CEP41;HSP90AA1;SPDYA;CRLF3;CDK6;CUL3;TUBB;CDK2
prerank,regulation of signal transduction (GO:0009966),-0.32516492352596565,-1.4254575168320385,0.016666666666666666,0.17816507319873906,1.0,63/192,20.85%,TSPYL2;NCAM1;TCF7L1;YJEFN3;GDNF;LIFR;IGFBP6;RGS11;GNG7;SOCS2;ZDHHC17;CLU;INTU;RGS2;PXN;WWTR1;USP20;IFT81;SLC8A2;GIT2;FGFR2;ILK;WDR11;RORA;TMEM108;FRRS1L;RIC8B;ZDHHC7;PRNP;KCTD8;GRK5;NCK1;PRKD1;TMEM204;LRRK2;TULP3;GRK4;RGS5;SYNJ2BP;SLC8A3;PLCE1;IGFBP4;OGT;RGS8;IGFBP5;LRIT3;ESR1;GDF5;CD63;TSC2;GAS1;RSPO3;CD36;PLCB1;ANKRD54;RGS6;MDFIC;DLL1;SIRT1;RGS12;FUZ;RFNG;ZFAND2B
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.4474595034885475,-1.4252270371077551,0.06779661016949153,0.17793057399342824,1.0,14/33,21.28%,ATP2B4;FGF2;STARD13;MECP2;ANGPT4;MEF2C;HDAC5;MEOX2;MAP2K5;RHOA;TBXA2R;CSNK2B;AGTR2;MMRN2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.4324399585522388,-1.4249794244228464,0.0392156862745098,0.17777164089174533,1.0,16/37,22.91%,CACNB2;ANK2;MYLK;GRM6;WNK3;CAMK2A;P2RX7;P2RX2;TRPC6;LGALS3;PLA2G1B;PDGFB;FFAR1;CCL2;WFS1;TRPC3
prerank,response to ionizing radiation (GO:0010212),0.3802019762908056,1.4243296755637458,0.047619047619047616,0.16324930496017012,1.0,15/67,6.96%,RFWD3;MYC;INTS7;BRCC3;RAD51AP1;RHNO1;BLM;TICRR;FIGNL1;NABP2;XRCC4;INIP;TOPBP1;ECT2;RAD9B
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5063213662332331,-1.423753452419788,0.08333333333333333,0.17912022949216902,1.0,9/20,13.80%,MYOCD;CNN1;SRF;ADRB2;CHRM2;CHRNA3;PLCE1;DAPK3;SETD3
prerank,negative regulation of DNA binding (GO:0043392),0.4264113567213511,1.4236079671467141,0.02040816326530612,0.16398194960207532,1.0,14/30,20.69%,E2F1;TFAP4;MSX2;MDFI;LEF1;HMGA2;KDM1A;SUMO1;GZMA;CPNE1;ZNF675;SUMO3;NFKBIA;IFI16
prerank,regulation of protein phosphorylation (GO:0001932),-0.32298764022057674,-1.4235297171714136,0.028169014084507043,0.17895895287087488,1.0,85/252,21.15%,TSPYL2;FLCN;CLIP3;HRC;EPHA7;FGF2;TARDBP;PPP2R5B;AKAP8L;PPP2R5D;WWTR1;WDFY2;SPTBN4;GPER1;ATG14;DVL3;ILK;P2RY1;FAXDC2;NTRK3;FGF22;ITGB3;RSPO1;FXR2;ATF4;PRNP;TBX1;TERF2IP;CADM4;SLIT2;PTEN;LRRK2;VEGFB;FLT4;FER;NPTN;CORO1C;PELI2;NTRK1;RARRES2;FBLN1;PID1;AKTIP;HSPB1;THPO;PLCE1;INPP5K;DAB2IP;MAPK3;FGF17;DVL2;LEPR;RAC1;PIK3R3;EFNA5;MUSK;FGF7;AKAP8;PIP5KL1;CCDC88A;MYADM;FGF5;FGF10;PDE8A;FAS;AKT2;FGF1;ACVR2A;INSR;FGF16;EGFR;ERBB4;CSNK1D;CDK5RAP3;ANGPT1;ANKRD54;LIMCH1;FKBP8;SIRT1;CAMKK2;PHIP;VEGFC;TESK1;FGF9;SOD1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.47262509717857437,-1.423328367306714,0.07407407407407407,0.17872484003861797,1.0,17/28,27.93%,CACNA1H;KCNB1;SYT10;SYT11;CACNA1G;SYT2;SYT9;SYT6;SYT5;RAB3GAP1;CACNA1I;SYT1;SYT3;STXBP1;DOC2B;SYT15;STX1A
prerank,neutral amino acid transport (GO:0015804),0.46172289572437264,1.422879383847249,0.04081632653061224,0.16447960536417378,1.0,7/28,6.61%,SLC6A20;SLC1A5;SLC1A4;SLC6A14;SLC38A5;SLC7A5;SLC6A6
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.4711190415009719,-1.4224143212795028,0.0,0.17949653249530378,1.0,8/26,14.80%,ADCY5;PPP3CB;NR1D1;PLA2G6;EPHA5;KLF7;EFNA5;STXBP4
prerank,axon extension (GO:0048675),-0.4673416037527045,-1.4219649597344635,0.057692307692307696,0.17948215839860746,1.0,8/23,10.63%,ULK1;NLGN3;NRP2;PPP3CB;MAP1B;ULK2;SLIT2;SLIT3
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3294765333864289,1.421962468850293,0.0,0.16494585432992304,1.0,30/110,14.60%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;SYK;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;FOS;PSMF1;PSMD11;PSMD1;PAK1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4339397157343251,1.4218362743877657,0.05405405405405406,0.16466226798541864,1.0,17/33,31.80%,CALR;PDIA3;CANX;BCAP31;SEC13;TAP1;IDE;ERAP1;HLA-F;MFSD6;TAP2;SEC24A;TAPBPL;TAPBP;SEC24D;ERAP2;SEC24C
prerank,response to glucagon (GO:0033762),-0.4862648572359741,-1.4216495590013207,0.0784313725490196,0.17944348978475555,1.0,7/19,15.59%,ADCY5;ADCY2;ADCY4;ADCY9;PRKACA;PRKAR2B;ADCY6
prerank,protein localization to cell junction (GO:1902414),-0.5146877961984865,-1.4212923215627618,0.019230769230769232,0.17928349465633645,1.0,10/21,20.57%,JAM3;NLGN2;FERMT2;DLG4;NLGN1;ARHGEF18;TJP1;BSN;CGNL1;HEG1
prerank,digestive tract morphogenesis (GO:0048546),-0.5107531840721441,-1.4212469481271608,0.05555555555555555,0.1788819257814036,1.0,10/15,22.85%,RBPMS2;FOXF1;PDGFRA;FGFR2;TCF21;SOX17;BBS7;SOX11;NIPBL;ID2
prerank,regulation of fat cell differentiation (GO:0045598),-0.3688662400136906,-1.4206476509844665,0.016129032258064516,0.1791352837590704,1.0,37/79,25.44%,LMO3;ARNTL;FERMT2;RUNX1T1;WWTR1;WDFY2;GPER1;PPARD;RORA;NR1D1;ZADH2;GNB3;ZFPM2;ZBTB16;ZFP36L1;SIRT2;RARRES2;ASXL1;SFRP1;GATA2;PTPRQ;TRIB2;GPS2;TRIO;ZFP36;FTO;MEDAG;SIRT1;ZNF385A;ANKRD26;ID2;TMEM64;LPL;WNT10B;ZFP36L2;BBS12;SMAD3
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.5054443111361984,-1.4205907181916295,0.046153846153846156,0.17878444731028215,1.0,9/18,23.65%,FLCN;TFE3;SOX13;FNDC5;FTO;VSTM2A;INS;SIRT1;PIM1
prerank,activation of protein kinase A activity (GO:0034199),-0.5082975376492403,-1.420402318000522,0.1,0.1785076059607833,1.0,7/17,15.59%,ADCY5;ADCY2;ADCY4;ADCY9;PRKACA;PRKAR2B;ADCY6
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5123264559079874,1.4201433005906332,0.08571428571428572,0.16607183195572964,1.0,7/17,21.48%,SULT2B1;SULT1C2;SULT1C3;BPNT1;SULT1A3;TPST2;ABHD14B
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.37217827568888767,-1.4183902279013414,0.018867924528301886,0.18024722157669543,1.0,33/86,20.37%,LMOD1;CFL2;TENM1;DCTN1;SYNPO2;MAPT;CLU;NUMA1;CLIP1;STMN2;CDC42EP3;CLASP1;FES;EVL;NCK1;PSEN1;EFEMP2;FER;NCKAP1L;SYNPO;FCHSD1;LMOD2;NAV3;ARL2;CDC42EP4;RAC1;SLAIN2;BAIAP2;CCL11;FCHSD2;CDK5RAP2;CCL21;MYLK3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.32171279880344306,-1.418224285766449,0.0,0.179991932172566,1.0,69/220,21.05%,FLCN;HAND2;LMO3;EPHA7;TGFBR3;RAP1A;FGF2;PLA2G5;GLIPR2;MTURN;FERMT2;GCNT2;ZDHHC17;CCL14;SMAD4;PDGFRA;DUSP3;ROR2;GPER1;FGFR2;P2RY1;DUSP26;NTRK3;CNKSR3;PRKCA;ADRA1A;NDRG4;NECAB2;DSTYK;TNFAIP8L3;PTEN;FLT4;EMILIN1;SPRY1;RRAS;NTRK1;ROR1;FBLN1;SYNJ2BP;THPO;TIMP3;DAB2IP;MAPK3;RANBP9;SPRY3;MAP2K7;SEMA6A;ACKR3;NEK10;FAM83D;HTR2B;PDGFB;BRAF;NOTCH2;FGF10;PDE8A;EGFR;CCL23;ERBB4;CCL11;RAMP3;CD36;FBXW7;ANGPT1;MAP3K12;CCL21;RAPGEF2;CCL2;PDGFD
prerank,T cell migration (GO:0072678),0.5263114972937003,1.418021085672581,0.038461538461538464,0.16830349314020693,1.0,12/18,28.67%,SLC12A2;CXCL11;CCL20;CCL3;CXCL16;CCL26;CXCL10;PIK3CG;MSN;ZAP70;DEFA1;PIK3CD
prerank,telomere organization (GO:0032200),0.4065795237570213,1.4179276540368768,0.022727272727272728,0.1680134623746826,1.0,13/41,15.65%,RPA3;POLD2;DCLRE1B;BLM;XRCC5;PRKDC;RECQL4;DNA2;APEX1;PTGES3;HUS1;RPA2;POLD1
prerank,regulation of cytoskeleton organization (GO:0051493),-0.35416718409036807,-1.417439372194088,0.014492753623188406,0.18047773304127337,1.0,52/110,26.74%,FAM107A;GPM6B;MAP6;RND2;CORO2B;MAPT;PHLDB1;NEXN;SYDE1;PHLDB2;SORBS3;P2RX7;DLC1;CLASP1;RHOQ;RHOB;SPATA4;CLIC4;BICD2;EPHA5;PRKAA2;TPPP;TAOK2;MAPK1;MAPK3;TJP1;RICTOR;RAC1;EFNA5;RHOA;EPHA3;ROCK1;CCDC88A;MAP6D1;IQCJ-SCHIP1;BAIAP2;PLXNB1;TESK1;RHOBTB1;PAK3;MTOR;PRKCD;RHOC;ARHGAP35;PDGFA;TRAF3IP1;CLN3;ARHGAP17;SPEF1;TAOK1;KATNBL1;CAPN2
prerank,cellular defense response (GO:0006968),0.38269033525031326,1.4168151403019802,0.0,0.16869228913202855,1.0,17/47,25.79%,CLEC5A;LGALS3BP;DCDC2;RELA;ADORA2B;CXCL9;CXCR2;CCR3;PRF1;GNLY;IL1RL2;MNDA;NCF2;ITK;TYROBP;FOSL1;BECN1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3924933994381533,1.4165938042297939,0.0,0.16880005769264914,1.0,15/42,19.09%,EREG;POLR3C;AKIRIN2;NMI;DHX9;POLR3B;CYBA;GBP5;GRN;FPR2;OASL;ADAM8;POLR3G;PLSCR1;SLC15A4
prerank,phosphorylation (GO:0016310),-0.3001132309041383,-1.416021917855428,0.0,0.18174645198143893,1.0,143/384,25.01%,PRRT1;NRBP2;MKNK1;TNNI3K;DMPK;IP6K3;NIM1K;SIK3;FGFR1;BRSK1;EPHA7;ULK1;BMPR1A;MAP3K6;WNK3;PPP3CB;STRADA;CSNK1E;PXK;SNRK;CAMK2A;ILK;PI4KA;CLK3;RPS6KA5;CLK2;CDK9;MAPK10;DCLK1;CDC42BPA;PRKCB;CDK20;PRPF4B;PRKCA;DGKE;STK36;PRKG1;GK5;CDK3;CSNK1A1;AURKC;CAMK1;PRKACA;DAPK1;GRK5;PRKD1;HIPK3;CDC42BPB;DYRK1A;PRKAG2;ALK;LRRK2;PRKAA2;MAML1;MAST2;NEK1;FER;MAP4K5;DGKG;GRK4;CDK17;FAM20B;TSSK3;NTRK1;PRKG2;TAOK2;MERTK;FAM20C;LATS2;MAST1;MEX3B;MAPK1;MAPK3;DAPK3;MARK1;MARK4;NEK10;BMX;PPP4R1;MORC3;CDK15;CAMK2B;BRD2;PEAK1;TRIB2;HTR2B;PDGFB;BRAF;ROCK1;MAPK8;CAMK2D;SGK3;MAP4K2;AATK;NEK7;TNK2;ERG;NRK;ACVR2A;INSR;MARK3;SHPK;CDK14;CSNK1D;CCL11;TESK2;DGKB;PDK2;RET;BMPR1B;MAP3K12;GSK3A;STK19;CAMKK2;MYLK3;CCL2;MKNK2;TBCK;RNASEL;CERKL;PAK3;PKN1;CDKL2;MTOR;NUAK1;LATS1;HIPK1;LIMD1;PRKCD;WNK1;CDK11B;PIM1;PINK1;CDKL5;NRBP1;PRKCH;DGKI;SIK2;CDK11A;DGKD;TLK1;MAP4K3;PDK4
prerank,replication fork processing (GO:0031297),0.4049909467808087,1.4156489955019804,0.041666666666666664,0.16913373161918996,1.0,9/35,7.91%,RFWD3;ALYREF;EME1;TRAIP;BLM;MMS22L;ZRANB3;TONSL;DNA2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.35316635715301675,-1.4153807276033636,0.014492753623188406,0.182130231948276,1.0,55/120,26.63%,ZNF135;GDNF;ZMYM6;BRSK1;FGF2;MAPT;FERMT2;ADGRB3;PHLDB1;PHLDB2;WTIP;ZDHHC15;SHANK3;FGFR2;RUFY3;CLASP1;TBX1;CHRNA3;EGLN1;CLASP2;KIF1A;LRRK2;FLT4;SDC2;LRRC4C;PID1;MEF2C;ABI2;EPHA4;EFNA5;SFRP1;CDH2;ZMYM3;CAPZB;SIPA1L1;ZRANB1;DLL1;PHIP;RC3H1;STRIP1;ADGRA2;KRT1;SARM1;PAK3;FMNL2;PPFIA2;HMOX1;ARHGAP35;GPNMB;ARC;CHN1;TANC2;BMPER;CEACAM1;CAMSAP1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.44485816567233705,-1.4150027903095515,0.037037037037037035,0.18241731551586432,1.0,15/26,25.26%,NKX3-2;WNT9A;CHADL;SOX5;ZBTB16;TRPS1;GDF5;GDF6;BMPR1B;EFEMP1;SOX6;ADAMTS7;PKDCC;SNAI2;HOXA11
prerank,regulation of receptor internalization (GO:0002090),-0.4544576702430815,-1.4145078048085007,0.05,0.1824667469350654,1.0,12/35,19.11%,MAGI2;DLG4;GH1;RSPO1;RIN3;ATXN2;ANKRD13A;NTF3;CD63;AHI1;INSR;ANGPT1
prerank,autophagy of nucleus (GO:0044804),-0.5112406651516845,-1.4120629623846639,0.06,0.18501291542731402,1.0,5/16,4.89%,ULK1;ATG2B;ATG9A;WDR45;ULK2
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4815041226155672,-1.4119848511440203,0.03508771929824561,0.18463250781487375,1.0,10/24,22.85%,MYOCD;MYH6;TCAP;SLC8A1;MEF2C;KDM6B;CBY1;AKAP13;ALPK3;TTN
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4452736793146665,-1.4118337674379637,0.08163265306122448,0.18439466218475656,1.0,19/36,25.62%,GRIK3;KCNB1;GRM6;GRIA4;GRIK2;GRIA3;GRIA2;HOMER2;HOMER3;GNAQ;GRIN2A;PLCB1;GRM2;CPEB4;GRID2;GRIN2C;GRIK1;CLN3;GRM3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.36374915966237703,-1.4118195164985645,0.03333333333333333,0.18392426763836686,1.0,43/104,27.41%,RBPMS2;TGFB1I1;BMPR1A;DAND5;CHRD;MAGI2;WFIKKN2;SMAD4;SKOR1;CILP;FSTL3;EMILIN1;SPRY1;SKI;PPM1A;FST;SMAD9;IL17RD;ACVR2A;SMAD2;UBB;TRIM33;BMPR1B;SIRT1;PRDM16;VASN;SMAD7;PIN1;DLX1;IGSF1;CD109;VWC2;PEG10;NBL1;SMAD3;SNX25;ZNF451;BMPER;CRIM1;HSPA1A;NOG;SMURF1;LDLRAD4
prerank,regulation of stem cell population maintenance (GO:2000036),0.4731206984673,1.4117776832070168,0.08163265306122448,0.17299506657862576,1.0,7/19,16.36%,MYC;WDR43;LOXL2;HMGA2;ELAVL1;CNOT1;ZNF706
prerank,negative regulation of cell junction assembly (GO:1901889),-0.46315320727897163,-1.4112708809500714,0.06779661016949153,0.18420240327441414,1.0,9/25,11.29%,FAM107A;DUSP22;PHLDB2;ARHGAP6;DLC1;APOD;PTEN;CLASP2;CORO1C
prerank,central nervous system neuron differentiation (GO:0021953),-0.43425020603598374,-1.41106685697924,0.04,0.18413026334972366,1.0,17/34,23.04%,CEND1;GBA2;MAPT;CHD5;PHOX2B;MDGA1;MAP2;FOXN4;OPHN1;TOX;NPY;ZC4H2;SIN3A;SPOCK1;MDGA2;LRP6;GRID2
prerank,cellular response to calcium ion (GO:0071277),-0.3819593649967214,-1.4104799531229615,0.031746031746031744,0.18452246269776096,1.0,32/68,23.72%,RYR3;ADD1;RASGRP2;ITPKB;PKD2;CAPN3;MEF2A;CARF;SYT10;RYR1;NLGN1;SYT11;CLIC4;PRKAA2;SYT2;SYT9;SYT6;SYT5;MEF2C;MCOLN1;BRAF;CAMK2D;CRHBP;CPNE8;CPNE4;SCN5A;ACER1;SYT1;CPNE6;PLCG2;KCNH1;SYT3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.39113183916402255,1.410114813883274,0.023809523809523808,0.17435843829922765,1.0,18/36,28.45%,TESC;TNFSF11;IL23A;LEF1;PF4;DCSTAMP;RUNX1;IL17A;CTNNBIP1;POU4F1;IL23R;IL12B;LIF;OCSTAMP;IFNG;CASP8;HAX1;TRAF6
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4361859211916878,1.4097248784470073,0.06521739130434782,0.17419794364708394,1.0,9/22,18.89%,MMP7;HM13;APH1A;RELA;ADAM10;NCSTN;TGFB1;MBTPS2;ADAM9
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.4937117909498527,-1.4093864905738989,0.0625,0.1852597830078248,1.0,11/20,23.27%,TNRC6A;AGO4;WTIP;CELF1;TNRC6C;MOV10L1;AGO3;TNRC6B;AGO1;HELZ;LIMD1
prerank,androgen metabolic process (GO:0008209),0.48033429621134066,1.4091493059328,0.0625,0.1743464902703872,1.0,10/18,23.04%,SRD5A1;SRD5A3;HSD17B10;AKR1C4;SPP1;SHH;MED1;HSD17B4;UGT2B7;HSD3B1
prerank,cardiac muscle tissue development (GO:0048738),-0.3961553950945375,-1.4089679276174782,0.03225806451612903,0.18525477028709494,1.0,27/51,26.52%,MYOCD;BMPR1A;TCAP;SGCG;SMAD4;NPPA;MAML1;CACNA1G;HEY1;SGCD;CSRP3;ACTC1;TBX2;ADAMTS9;HEY2;NOTCH2;NPPB;ANKRD1;KDM6B;CBY1;SCN5A;AKAP13;TTN;MYLK2;SGCZ;BMP5;NDUFV2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.4304419114581718,1.4087566306608488,0.04081632653061224,0.17424273503253476,1.0,7/28,10.14%,MYC;DACH1;PDGFRB;TOM1L1;NABP2;PARP4;FGFR4
prerank,regulation of interferon-gamma production (GO:0032649),0.35510849303905445,1.4081553207228916,0.02127659574468085,0.17436254248573174,1.0,38/84,31.69%,HSPD1;INHBA;IL23A;FOXP3;ZP3;CD276;IL1B;SLC7A5;C1QBP;IL21;TRIM27;CEBPG;ZFPM1;ISG15;IL23R;LILRB4;TNFSF4;HMGB1;ZC3H12A;IL12B;CD47;CRTAM;CD2;IL12RB2;IL36RN;SCRIB;IL12RB1;CLEC7A;CD244;SLAMF6;IL18;TLR7;RASGRP1;BTN3A2;IFNL1;TLR8;XCL1;CD274
prerank,regulation of cellular senescence (GO:2000772),0.41484564312661976,1.407158868526244,0.0392156862745098,0.17501014487985173,1.0,9/30,10.35%,HMGA1;FBXO5;RBL1;NEK6;PNPT1;RSL1D1;CDKN2A;HMGA2;NEK4
prerank,response to interferon-beta (GO:0035456),0.476019799493642,1.4067923766458825,0.075,0.17501647172046195,1.0,12/25,20.69%,IFITM3;IFITM1;IFITM2;PNPT1;IKBKE;STAT1;BST2;XAF1;UBE2K;PLSCR1;MNDA;IFI16
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.4775150199323561,-1.405964495263092,0.0847457627118644,0.18861126278106743,1.0,14/26,23.51%,PLXNB3;EVL;EVI5L;SLIT2;ARHGAP24;TCHP;SRGAP2C;KANK1;CAPZB;CCL21;ODF2L;TESK1;CEP97;PRKCD
prerank,regulation of mitotic nuclear division (GO:0007088),0.3820321145270891,1.405284365783303,0.045454545454545456,0.17624031668927573,1.0,22/56,17.58%,NME6;CHEK1;IL1A;KIF20B;FBXO5;RCC1;EREG;PDGFRB;TOM1L1;IL1B;NEK2;CDC25C;PDXP;AURKA;DUSP1;PKMYT1;BMP7;LCMT1;BMP4;NUP62;DMRT1;LRP5
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.5014461123647643,-1.4048385139270452,0.07692307692307693,0.18963135142535992,1.0,5/16,10.38%,DDR2;CLASP1;CLASP2;EFEMP2;EMILIN1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.3106286253962021,-1.4044977369079643,0.0,0.18959253866238202,1.0,135/356,25.02%,RBPMS;FLCN;CLIP3;ATP2B4;RAF1;CSPG4;CAPRIN2;TENM1;RAPGEF3;RAP1A;IL6R;BMPR1A;FGF2;DDR2;WNK3;SMAD4;WDFY2;GPER1;CALM1;TRIM6;ATG14;DVL3;ILK;P2RY1;FAXDC2;RPS6KA5;GH1;NTRK3;SNCA;CDK9;FGF22;ITGB3;HDAC6;RSPO1;TAB2;FXR2;PRNP;NGF;BMP3;TBX1;CAMK1;TERF2IP;GHR;PRKD1;GDF7;NOS1;PRKAG2;MSTN;LRRK2;VEGFB;FLT4;NPTN;ANGPT4;MTCP1;PELI2;NTRK1;TAOK2;RARRES2;AKTIP;MAPRE3;THBS4;THPO;MAPK1;MAPK3;FGF17;DVL2;LEPR;RAC1;PIK3R3;RELN;EFNA5;NEK10;CDKN1A;MMD2;ENPP2;MUSK;PDGFB;GDF5;S1PR2;FGF7;GDF6;BRAF;NTF3;RAD50;FGF5;DUSP19;AZU1;FGF10;PDE8A;FAS;TNK2;AKT2;FGF1;ACVR2A;INSR;FGF16;EGFR;ERBB4;CSNK1D;ALS2;CSNK2B;RAMP3;RASSF2;ANGPT1;LIMCH1;CAMKK1;INS;SIRT1;CCL21;CAMKK2;RAPGEF2;VEGFC;TESK1;FGF9;PDGFD;TNFRSF14;RPTOR;SH2D3C;BCAR3;PIN1;INHA;CALM2;LATS1;HGF;PLCG2;RIPK1;ADCYAP1;PINK1;NKX3-1;GDF11;TWSG1;PDGFA;MMD;TGFB3;GPNMB
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.4789712210449721,1.403786716845182,0.044444444444444446,0.17663449976919518,1.0,12/21,21.92%,MAD2L1;ZWINT;BUB3;TRIP13;ZW10;BUB1;PLK1;CENPF;KNTC1;CDC20;BUB1B;TTK
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.4789712210449721,1.403786716845182,0.044444444444444446,0.17663449976919518,1.0,12/21,21.92%,MAD2L1;ZWINT;BUB3;TRIP13;ZW10;BUB1;PLK1;CENPF;KNTC1;CDC20;BUB1B;TTK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.4789712210449721,1.403786716845182,0.044444444444444446,0.17663449976919518,1.0,12/21,21.92%,MAD2L1;ZWINT;BUB3;TRIP13;ZW10;BUB1;PLK1;CENPF;KNTC1;CDC20;BUB1B;TTK
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.4900393029588723,-1.402851452287066,0.08695652173913043,0.19065079568602095,1.0,9/23,15.81%,HAND2;RGS2;PDE9A;SMAD4;MEF2A;PRKCA;MLIP;ROCK1;CAMK2D
prerank,insulin receptor signaling pathway (GO:0008286),-0.3683496688602458,-1.4027450772056873,0.029411764705882353,0.19026771894694036,1.0,29/72,22.45%,ATP6V1G2;SORBS1;GAB1;PIK3R1;ZNF106;RHOQ;CAV2;FER;SOGA1;GRB10;FOXO4;RARRES2;GRB14;PIK3R3;APC;BAIAP2;SOS1;AKT2;INSR;ATP6V0A1;ATP6V1B1;PDK2;ATP6V1E1;TCIRG1;GSK3A;INS;PHIP;PIK3R2;BCAR3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4873723278550463,1.4019251045150636,0.043478260869565216,0.1778696605334318,1.0,10/20,20.81%,PTDSS1;MGST2;GSS;CHAC2;CHAC1;GGCT;GCLM;CNDP2;PLSCR1;FPGS
prerank,"transcription, DNA-templated (GO:0006351)",0.3023793314679467,1.4012513518102254,0.0,0.17819682033991818,1.0,90/215,27.56%,NFE2L3;POLR2F;POLR2D;POLR3K;E2F1;TFDP1;POLR1C;EAF1;CDK7;CBFB;EREG;ETV7;ABT1;TFB2M;TRIM24;NELFCD;GTF2H3;TFAM;PTMA;DDX21;NCBP1;CCNK;GTF3A;NFYA;SSRP1;DRG1;TAF1A;TTF2;XBP1;TRIP13;NCBP2;TAF1B;BRF2;POLR2C;TAF9;GTF2F2;POLR2K;MLLT3;GTF2E1;POLR2J;HSF2BP;LEO1;POLR2G;SLC25A33;GTF3C4;NOCT;SMN1;TEFM;TAF4;POLR3G;CRCP;DEK;BTF3;CTR9;NELFE;GTF3C3;ERCC2;POLR2H;PAX8;GTF3C2;POLR2I;MED20;NFKBIB;TAF15;POLR2L;PWP1;RNGTT;GTF2A1;TAF4B;POLR3A;TP53;RNPS1;NELFA;GTF2E2;IVNS1ABP;GTF2B;GTF2A2;NKX2-8;TCFL5;POLR2B;TAF5;LHX1;TAF2;FOXE3;NELFB;PPP5C;PRMT5;TBPL1;WDR61;GTF2F1
prerank,regulation of cell differentiation (GO:0045595),-0.32778505358424415,-1.4010482383116118,0.0,0.1926378631443128,1.0,44/150,16.85%,DDX17;GDNF;FGFR1;RAF1;KLHL41;PHLDB1;PHLDB2;SRF;LTBP4;FGFR2;CDK9;NLGN1;CASZ1;PRKCB;MEGF10;NR1D1;ATF4;GNB3;KIAA1109;CLASP1;NGF;TBX1;FES;AR;CAMK1;PRKACA;ALK;ZFP36L1;CLASP2;CEBPD;TRPS1;HEY1;NOTCH4;LGALS3;TIAM1;SUPT6H;ZFHX3;PTPRQ;EPHA3;ROCK1;HEY2;APC;NTF3;GPS2
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.46099084602260587,-1.4005093363253345,0.03389830508474576,0.19284149367939407,1.0,13/20,26.63%,TTBK2;STMN2;CLASP1;CLASP2;NAV3;FGF13;APC;ATXN7;CAMSAP2;APC2;SPEF1;TAOK1;CAMSAP1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.47572925691775536,-1.40025270557215,0.09615384615384616,0.19279523380915894,1.0,12/24,22.85%,MYH7;TPM1;MYL2;TGFBR3;MYH6;FGFR2;HAND1;ADAMTS9;MYL3;MYBPC3;SMAD7;ID2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5377936026266013,-1.4002262494369624,0.020833333333333332,0.19234293886540216,1.0,8/17,11.05%,ATP1B2;CACNA1C;ATP1A2;GJC1;SLC8A1;PRKACA;ATP1A3;RYR2
prerank,positive regulation of translational initiation (GO:0045948),0.4593159696132324,1.4000049007901845,0.11904761904761904,0.17947660019025136,1.0,8/22,19.64%,POLR2D;CDC123;KHDRBS1;YTHDF1;YTHDF2;POLR2G;RPS6KB2;UHMK1
prerank,response to interferon-alpha (GO:0035455),0.5160071547378315,1.3996813801250998,0.13043478260869565,0.1795534462592328,1.0,6/17,14.67%,IFITM3;IFITM1;IFITM2;LAMP3;PDE12;BST2
prerank,DNA packaging (GO:0006323),0.46560924795050473,1.3983038351373767,0.11904761904761904,0.18082365108360027,1.0,6/15,15.83%,CHAF1B;CHAF1A;NOC2L;AIFM1;HAT1;BANF1
prerank,natural killer cell mediated immunity (GO:0002228),0.4695235267485775,1.3980074498151853,0.1276595744680851,0.18073445185147735,1.0,6/20,11.10%,ULBP3;GZMB;ULBP2;TUBB4B;ULBP1;CEBPG
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4465593668479574,-1.3977069581385981,0.05172413793103448,0.19542767584543042,1.0,7/26,9.35%,VAMP2;FHL1;ATP1B2;ANK2;ACTN2;CASQ2;KCNE2
prerank,nucleotide catabolic process (GO:0009166),0.5162930180839913,1.3972085037327429,0.09523809523809523,0.1811586545531718,1.0,8/16,20.45%,NUDT15;ITPA;PNP;DNPH1;GPX1;VCP;NT5C2;DERA
prerank,actin cytoskeleton reorganization (GO:0031532),-0.390401314394783,-1.3970096861663368,0.05357142857142857,0.1960042841699845,1.0,22/63,18.66%,EFS;FLNA;GSN;GAB1;SYDE1;PDLIM4;WHAMM;CDC42BPA;KIT;CDC42BPB;PARVA;S1PR1;FER;RICTOR;RHOA;S1PR2;FGF7;INSRR;FGF10;THSD7A;NRK;SIPA1L1
prerank,regulation of cell killing (GO:0031341),0.4958120332076917,1.3969316090744377,0.07017543859649122,0.18106907521181265,1.0,7/16,9.89%,IL11;WNT5A;TGFB2;CD55;CYBA;ICAM1;NOX1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.3749548005317301,-1.396767238547834,0.05172413793103448,0.19572669760672087,1.0,25/64,23.20%,MTMR9;PLIN5;WDR6;TAB2;ZKSCAN3;BCL2;KLHL22;TIMP4;RIC1;SIRT2;TIMP2;RASIP1;TIMP3;DAB2IP;LEPR;HTR2B;ROCK1;NUPR1;EIF4G3;CDK5RAP3;GSK3A;INS;GOLGA2;MTOR;HGF
prerank,cellular protein localization (GO:0034613),-0.30383621045860854,-1.3965785364762617,0.0,0.1957410147007676,1.0,95/303,20.06%,PRRT1;SEC31B;JAM3;SNX1;DNAJC27;TBC1D1;SGSM2;RIC3;FBLN5;FLNA;ANK2;TBC1D17;VCL;ARL4D;STX1B;DMD;RABGAP1;CNTN2;FERMT2;ATG9A;CAPN3;RABL2B;WDR45;TBC1D10A;USP6;RRAGC;TBC1D26;RABL2A;CNTNAP1;VPS45;BBS4;RAB6B;ZDHHC15;STX16;SNX15;REEP1;WDR11;PACSIN1;TRIM23;HDAC6;CROCC;SNX27;ITSN1;STX2;COPZ2;RAB28;NGFR;MFN2;EVI5L;EPB41L3;RAB5B;TBC1D2B;GPIHBP1;BICD2;RIC1;LRRK2;NAPB;SGSM1;GGA3;RAB23;WLS;VPS33B;NPHP1;CEP68;HERC2;TBC1D13;CNTLN;BBS2;PACS2;VIPAS39;RRAGB;CSRP3;KIF13A;TICAM2;FGF7;TBC1D25;HEY2;RTP5;SGSM3;STX12;FGF10;CD63;AHI1;GGA2;EGFR;TRAPPC8;RAB24;ANGPT1;ADPRH;SNX31;HHEX;RRAGD;ESAM;TBC1D12;RPGR
prerank,histone H4-K5 acetylation (GO:0043981),-0.5101377811899198,-1.396452681863163,0.06896551724137931,0.1949909888522084,1.0,8/15,24.41%,KANSL3;JADE1;ING4;KAT7;OGT;KANSL1;KAT8;JADE2
prerank,histone H4-K8 acetylation (GO:0043982),-0.5101377811899198,-1.396452681863163,0.06896551724137931,0.1949909888522084,1.0,8/15,24.41%,KANSL3;JADE1;ING4;KAT7;OGT;KANSL1;KAT8;JADE2
prerank,negative regulation of cell cycle process (GO:0010948),0.38462274255189455,1.3958413844540325,0.0,0.18213523503922666,1.0,30/61,27.60%,NME6;CHEK1;E2F1;TFDP1;CBX3;FBXO5;TOM1L1;NEK2;AURKB;CHMP4C;RNF2;UXT;RBBP8;BMP7;BRCA1;BMP4;E2F8;DMRT1;ESPL1;CDC7;E2F7;SUZ12;EZH2;RBBP7;RRM2;AURKAIP1;CHMP2A;EED;FBXO43;CBX5
prerank,Golgi to endosome transport (GO:0006895),-0.5259632081712153,-1.395646436263515,0.09090909090909091,0.19562823665691306,1.0,6/15,17.93%,MON2;CORO7;KLHL20;VPS13A;GBF1;EPS15
prerank,response to ATP (GO:0033198),-0.4889211886770871,-1.395416194266308,0.07407407407407407,0.19544344701854066,1.0,11/19,27.82%,RYR3;TRPV1;P2RY1;P2RX7;ABCC9;P2RY12;SSH1;P2RY11;TRPC3;P2RY4;HSP90B1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.4522043194011459,1.3952042880814588,0.10869565217391304,0.18252617760477838,1.0,10/19,27.12%,COX20;COX18;COA1;SCO2;COA3;COX19;COX17;FASTKD3;PET117;SMIM20
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.498234554281359,-1.3947053915940235,0.0847457627118644,0.19583364589105567,1.0,10/21,21.04%,BMPR1A;FGF2;MEF2D;FOXJ2;ADAMTS1;MFN2;IGFBP5;PDGFB;NR4A3;FGF9
prerank,Fc receptor signaling pathway (GO:0038093),0.32318960602309593,1.3938231929163458,0.0,0.18387780715201146,1.0,30/111,14.60%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;SYK;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;FOS;PSMF1;PSMD11;PSMD1;PAK1
prerank,regulation of mRNA processing (GO:0050684),-0.40726646846609965,-1.393520626371773,0.0,0.19703699045606934,1.0,20/35,25.99%,PABPN1;SAFB2;QKI;SF1;SLTM;ZFP36L1;SON;TIA1;SRPK3;JMJD6;YTHDC1;SUPT6H;AHCYL1;LARP7;KHDRBS2;CDK11B;RBM39;CDK11A;METTL16;PTCD2
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5100678252956959,-1.3932579586149474,0.047619047619047616,0.19671830320439368,1.0,6/15,13.14%,CACNA1H;KCNB1;SYT10;NLGN1;CACNA1G;RAB3A
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4782492088418573,-1.393089594482792,0.03125,0.19642306298895554,1.0,12/26,13.03%,TMEFF2;MYOC;PHLDB2;SHANK3;PIK3R1;ARHGAP6;DLC1;CLASP1;CLASP2;ARHGEF18;INPP5K;TJP1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.46312169743350784,-1.3929257019839898,0.10714285714285714,0.19623858151731302,1.0,13/20,29.90%,SEMA6C;SEMA4C;SEMA3E;SEMA6D;SEMA6A;SEMA3B;SEMA3G;SEMA3A;SEMA3C;SEMA4B;SEMA3D;SEMA6B;SEMA5B
prerank,positive regulation of developmental process (GO:0051094),-0.332840965754927,-1.392749785554275,0.015873015873015872,0.19598952505284098,1.0,58/165,20.76%,GDNF;NR2C2;FGFR1;RAPGEF3;FZD4;BMPR1A;TAPT1;PHLDB1;PTN;NUMA1;SYDE1;NRXN1;PHLDB2;SRF;DVL3;ZDHHC15;SHANK3;DLG4;PACSIN1;NLGN1;CLASP1;KRT2;SOX5;AR;CAMK1;RBM19;PLD6;PSEN1;ALK;ZBTB16;CLASP2;DCN;CORO1C;CPEB3;BMP1;PRL;GRIP1;DAB2IP;DDHD1;DVL2;RELN;FST;CAMK2B;ENPP2;ARHGEF7;PDGFB;VLDLR;RTN4;TP53BP1;INSR;DLG5;PLCB1;ADGRL1;BMPR1B;INS;SIRT1;BNIP3;SOX6
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.33023198547711086,-1.3927308274580503,0.017241379310344827,0.19554575774070573,1.0,57/143,27.06%,ADCY5;ATP2B4;CACNA1C;HRC;ATP1A2;LPAR1;TRPC1;SCGN;AGTR1;PDGFRA;GPER1;SLC8A2;PLN;DLG4;P2RY1;RYR1;TMEM178A;SLC8A1;CDH23;ADRA1A;PTGER3;PRKACA;CCR10;ADRA1D;TRPC6;TRPC4;CAV2;NPTN;RYR2;ATP2B3;PLCE1;TACR1;S1PR3;ACKR3;ESR1;TBXA2R;CACNA1A;ACKR2;FFAR1;CD36;C5AR2;PTGFR;CALB2;TRPC3;CAV3;ADRA1B;ADCYAP1;CHRNA10;C1QTNF1;CLN3;SMAD3;BDKRB1;P2RY4;TAC1;AVPR1B;CCKBR;F2RL1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.49182818683164237,-1.3926556162300934,0.1320754716981132,0.19516923686116763,1.0,6/22,8.07%,RBPMS;SH2B1;BMPR1A;SMAD4;WWTR1;CILP
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5319626731093319,-1.3924218272058215,0.1111111111111111,0.19494613784514345,1.0,8/16,24.66%,FGFR2;MN1;NPR3;SFRP1;RHOA;PLXNB1;SOX8;TNN
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4671883844824927,1.3918167697077481,0.06976744186046512,0.1859964789779529,1.0,11/22,22.81%,TMED9;DERL1;SEC61B;SURF4;SEC13;VCP;PREB;FAF2;OS9;AUP1;LMAN1
prerank,regulation of water loss via skin (GO:0033561),0.5120818871709631,1.3917921739262797,0.11764705882352941,0.18510654367183832,1.0,12/17,26.91%,CLDN1;STMN1;MET;LSR;CLDN4;KDF1;FA2H;SFN;ALOXE3;ABCA12;ALOX12;ALOX12B
prerank,establishment of skin barrier (GO:0061436),0.5120818871709631,1.3917921739262797,0.11764705882352941,0.18510654367183832,1.0,12/17,26.91%,CLDN1;STMN1;MET;LSR;CLDN4;KDF1;FA2H;SFN;ALOXE3;ABCA12;ALOX12;ALOX12B
prerank,positive regulation of nervous system development (GO:0051962),-0.4160647814720854,-1.3904510427612646,0.017241379310344827,0.19686367886633296,1.0,17/44,17.85%,NLGN2;NUMBL;NLGN3;SLITRK2;NRXN1;GPER1;CUX2;NLGN1;LRRC4B;BHLHB9;NUMB;ZNF335;IL1RAPL1;SPEN;SERPINF1;SOX11;DLG5
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.39006655354326464,1.3902132116867205,0.02,0.18670393972610355,1.0,18/37,28.40%,CEBPB;IL4I1;FOXP3;CD80;PLA2G2F;VTCN1;LST1;LYN;LILRB4;PLA2G2D;MNDA;CD86;TYROBP;CD300A;SDC4;CTLA4;IL10;GLMN
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.43874332822653983,-1.3896584582651292,0.0847457627118644,0.19739228288222296,1.0,16/38,15.81%,CACNA1C;CACNB2;ANK2;KCNA5;SCN3B;CACNA2D1;CTNNA3;KCNH2;SCN2B;SCN1B;KCNE2;SCN4B;CACNA1G;KCND3;KCNE1;CAMK2D
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.507576685089665,-1.38872023272838,0.125,0.19837012636170506,1.0,9/17,19.49%,VAMP2;AKAP6;ANK3;NPPA;KCNE2;RNF207;KCNE1;KCNS2;KCNE4
prerank,regulation of programmed cell death (GO:0043067),0.30666774252924905,1.3886787799263132,0.0,0.1877653336529558,1.0,57/185,21.10%,CALR;DCPS;PERP;TP73;SKP2;CDK5;TRIAP1;PHB;TRIM24;LRP8;PMAIP1;ANP32A;STK26;TNFSF9;RTKN;RPS3;RSL1D1;GLS2;BRMS1;SOX9;NAE1;APEX1;CASP2;CASP6;DNAJA3;JAK3;TOX3;TNFRSF10B;PRELID1;OLFM4;STAT1;TM7SF3;PRDX2;POU4F1;NME1;ACTN4;LCMT1;AGT;CXCL10;TRAF2;HTATIP2;ACER2;VCP;NUP62;STEAP3;LGALS1;BIRC5;TPT1;IGFBP3;BAX;BID;PAX8;PAX2;TNFRSF10A;HSP90AA1;BCL2L14;ANP32B
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.4110904059579825,1.3882441197491042,0.08823529411764706,0.18774104754243556,1.0,19/41,30.97%,AZGP1;IL23A;CD1A;IL21;NOS2;CD1B;IL23R;RAET1E;HLA-F;IL12B;CRTAM;TYROBP;SPI1;IL12RB1;CD1E;SLAMF6;NCR3;RASGRP1;XCL1
prerank,positive regulation of cell differentiation (GO:0045597),-0.31146966491641964,-1.3879297443142096,0.01694915254237288,0.19874250540795935,1.0,102/246,26.89%,TGFB1I1;GDNF;TMEM100;FGFR1;LMO3;ADRA2B;ARNTL;CDON;RAP1A;IL6R;BMPR1A;PLA2G5;BOC;ZHX3;GLIPR2;DDR2;FERMT2;GCNT2;PTN;RBM24;AGTR1;SMAD4;WWTR1;WDFY2;MEF2A;SRF;HOXD3;SMYD1;PPARD;RBM4;CD34;HOXB4;NGF;FES;SOX5;AR;CAMK1;OLFM1;BNIP2;PRKD1;KITLG;ZBTB16;ZFP36L1;RRAS;RARRES2;MEF2C;HIF1AN;TIAM1;MAPK11;MMD2;SFRP1;CDH2;RHOA;RANBP3L;TCF15;GDF5;GDF6;SPAG9;TCF4;GPRC5B;ZC4H2;SIN3A;ZFP36;MAPK14;HOXA5;SOX11;ACVR2A;MEDAG;PCP4;GPC1;SMAD2;BEND6;CD36;PLCB1;BMPR1B;INS;RAPGEF2;SOX6;ZNF385A;MAPK12;DLX1;MTOR;ID2;HGF;PKDCC;VWC2;PRKCH;TMEM64;LPL;MMD;TGFB3;AKIRIN1;NBL1;HOXA11;SMAD3;MYF6;RUNX2;RGCC;CEACAM1;ASCL1;XKR8;BTG1
prerank,negative regulation of cell growth (GO:0030308),-0.32714092511849413,-1.3874268207727107,0.04918032786885246,0.19904891431864297,1.0,42/121,20.40%,TSPYL2;FLCN;FHL1;APBB1;MYL2;CAPRIN2;DACT3;NPR1;ULK1;RERG;JADE1;PTPRS;PRDM11;SMAD4;ULK2;WFDC1;SLIT2;MAP2;SLIT3;CGRRF1;SOX17;TCHP;FGF13;CDKN1A;MAG;SFRP1;SEMA3G;SIPA1;CDKN2C;OSTN;NPPB;APBB2;RTN4;SMARCA2;DCC;DCUN1D3;DNAJB2;AGTR2;TP53TG5;GSK3A;SIRT1;TRIM46
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4153996027528016,-1.387111276454207,0.03571428571428571,0.1988626122488344,1.0,25/51,28.99%,RBPMS2;BMPR1A;DAND5;CHRD;SMAD4;GREM2;SKOR1;CHRDL1;FSTL3;SKI;FSTL1;SMAD9;ACVR2A;TRIM33;BMPR1B;SMAD7;DLX1;VWC2;NBL1;BMPER;CRIM1;NOG;SMURF1;BMPR2;LEMD2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5345670925826893,-1.3856218737693056,0.10526315789473684,0.20010497578200534,1.0,14/17,28.71%,ANK2;CACNA2D1;KCNH2;SCN1B;SNTA1;KCNE2;SCN4B;KCNE1;KCNE4;SCN5A;CAV3;AKAP9;NOS1AP;KCNE5
prerank,regulation of nervous system process (GO:0031644),-0.511625629459587,-1.3855409198691029,0.1956521739130435,0.1997682610350945,1.0,10/19,26.53%,NPTX1;SLC8A2;DLGAP2;TMEM108;NPTXR;SLC8A3;BEGAIN;DLGAP4;DLGAP3;AKAP9
prerank,anion transport (GO:0006820),0.3854091479436563,1.3850706008153217,0.05128205128205128,0.19116146412486162,1.0,9/37,13.18%,LRRC8E;VDAC1;SLC22A11;ABCC11;SLC19A1;LRRC8D;SLCO1B3;TSPO;LRRC8B
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.540824711529872,-1.3849679541678437,0.1702127659574468,0.20009067016655135,1.0,7/15,20.15%,HAND2;PDE9A;MEF2A;PRKCA;ROCK1;CAMK2D;NR4A3
prerank,negative regulation of viral genome replication (GO:0045071),0.38050212452291243,1.3843715650270907,0.05263157894736842,0.19165391215891367,1.0,18/51,21.69%,IFITM3;IFITM1;IFITM2;SRPK1;PROX1;SLPI;OAS2;HMGA2;APOBEC3F;BST2;OASL;MX1;ISG15;BANF1;PLSCR1;OAS3;IFI16;APOBEC3B
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3410791066133136,1.384329139224343,0.0,0.19125423927679475,1.0,37/99,21.46%,TRIB3;CEBPB;E2F1;TP73;ERO1A;CHEK2;IFI6;PMAIP1;C1QBP;PRKDC;PML;BBC3;IKBKE;EPHA2;BCL2L1;ZNF622;CASP2;BCL2A1;CHAC1;AIFM1;STK24;TNFRSF10B;POU4F1;BRCA1;MSH6;TRAF2;GSKIP;CUL4A;HINT1;TNFRSF1B;BAX;SFN;BAK1;DNAJC10;IFI16;CUL3;MCL1
prerank,positive regulation of phosphorylation (GO:0042327),-0.3164185146883581,-1.3841312459381367,0.0,0.2005808924039859,1.0,84/243,21.04%,FLCN;CLIP3;FGFR1;EPHA7;FGF2;DDR2;WDFY2;PDGFRA;ROR2;GPER1;ARNT;ATG14;DVL3;FGFR2;ILK;P2RY1;FAXDC2;NTRK3;P2RX7;FGF22;ITGB3;RSPO1;FXR2;TBX1;KIT;AR;DSTYK;PSEN1;FZD7;ALK;LRRK2;EPHA5;PRKAA2;VEGFB;FLT4;NCKAP1L;NPTN;PELI2;NTRK1;ROR1;RARRES2;MERTK;AKTIP;THPO;EPHA4;MAPK3;FGF17;DVL2;LEPR;RAC1;PIK3R3;EFNA5;BCL10;MUSK;EPHA3;FGF7;EPHA6;INSRR;PIFO;RAD50;TIE1;FGF5;FGF10;PDE8A;FAS;AKT2;DSCAM;FGF1;ACVR2A;INSR;FGF16;EGFR;ERBB4;CSNK1D;ANGPT1;LMO4;RET;LIMCH1;INS;SIRT1;CAMKK2;VEGFC;TESK1;FGF9
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.5273609232825266,-1.38391367491891,0.12962962962962962,0.20043543481701487,1.0,8/16,22.65%,MAGI2;FSTL3;SKI;FST;ACVR2A;CSNK2B;SMAD7;IGSF1
prerank,energy reserve metabolic process (GO:0006112),-0.4626683922947969,-1.3837293156363706,0.06896551724137931,0.2001853185678701,1.0,8/19,14.54%,PYGM;ADRB3;PPP1R3C;PRKAG2;PID1;GFPT2;LEPR;UGP2
prerank,cellular metal ion homeostasis (GO:0006875),-0.3457135932145246,-1.3829004053162792,0.0,0.2008611051738402,1.0,26/101,13.99%,TPCN2;DMPK;PTH1R;ATP1B2;ATP2B4;ANK2;ATP1A2;KCNMA1;CCL14;STIM1;SLC8A2;SLC24A4;SLC8A1;ELANE;ATP1A4;SLC24A3;ATP1A3;NPTN;CTRC;RYR2;ATP2B3;SLC8A3;SLC41A1;CSRP3;TRDN;RGN
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4512426481694557,-1.381693247523289,0.10909090909090909,0.20222577847554693,1.0,11/23,25.97%,GSN;GPER1;PLA2G1B;ECSCR;PIAS4;PLA2R1;CCL2;PLCG1;ANO6;PDCD4;RGCC
prerank,positive regulation of immunoglobulin production (GO:0002639),0.40413445409168536,1.3813886059499345,0.04,0.19427672006518532,1.0,15/29,30.97%,EPHB2;PHB;IL21;XBP1;PAXIP1;TNFSF4;CD86;RBP4;HMCES;TNFRSF4;GPI;IL10;PHB2;MAD2L2;XCL1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4769129580731615,-1.3808013717066003,0.11290322580645161,0.20268460868983063,1.0,10/18,17.85%,TTC23;RAB34;KIF7;STK36;EVC;SFRP1;ARMC9;TXNDC15;SMO;DLG5
prerank,regulation of synapse assembly (GO:0051963),-0.3978859518458556,-1.3805951898426414,0.05660377358490566,0.20241077445544636,1.0,22/47,23.91%,NLGN2;NLGN3;SLITRK2;NRXN1;CUX2;SNCA;LRFN5;NLGN1;SETD5;MDGA1;LRRC4B;SLITRK3;BHLHB9;MEF2C;MUSK;IL1RAPL1;DLG5;SLITRK1;SLIT1;GPC6;GRID2;CLSTN2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5059940870641244,1.3803508014831696,0.09615384615384616,0.19486257800590048,1.0,5/16,7.74%,SRPRB;RAB10;SPCS1;SEC61A1;SEC61G
prerank,response to cAMP (GO:0051591),-0.40307704123961074,-1.378389990792625,0.06666666666666667,0.20503301365736093,1.0,14/37,20.47%,PDE2A;AKAP6;RAPGEF3;PKD2;RAP1A;ZFP36L1;AQP1;INPP5K;RAPGEF1;KCNE1;IGFBP5;CRHBP;RAPGEF2;HCN3
prerank,glutamate metabolic process (GO:0006536),0.4571244912049892,1.3777717914638212,0.11363636363636363,0.1976025849043417,1.0,6/19,12.40%,GAD1;GOT2;ALDH18A1;GLS2;ALDH5A1;GCLM
prerank,positive regulation of collagen metabolic process (GO:0010714),0.5078746252333708,1.3777469643134401,0.1282051282051282,0.1966813607322935,1.0,8/15,17.50%,HDAC2;AMELX;RUNX1;SUCO;BMP4;F2R;TGFB1;CREB3L1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5078746252333708,1.3777469643134401,0.1282051282051282,0.1966813607322935,1.0,8/15,17.50%,HDAC2;AMELX;RUNX1;SUCO;BMP4;F2R;TGFB1;CREB3L1
prerank,long-chain fatty acid transport (GO:0015909),-0.4540157208441788,-1.377671063380559,0.061224489795918366,0.2054200203211766,1.0,14/31,24.13%,ACACB;PRKAB2;PRKAG2;PRKAA2;SLC27A1;CPT1B;SPX;SLC27A6;CD36;RPS6KB1;ABCD4;ABCD1;FABP4;ABCD2
prerank,zinc ion transport (GO:0006829),0.45842576805357327,1.3773572195647938,0.043478260869565216,0.19676587479216065,1.0,10/21,18.49%,SLC39A11;SLC30A2;TRPM2;SLC30A6;SLC39A8;SLC30A5;SLC39A2;SLC30A9;SLC39A7;SLC30A1
prerank,negative regulation of signal transduction (GO:0009968),-0.3123923728954501,-1.3767299928662668,0.0,0.20632357257949455,1.0,83/251,19.90%,TNS2;KANK2;NTN1;CSNK2A2;DACT3;SFRP5;PALM;EPN2;FGF2;PTCH2;RGS2;GLI3;NXN;NLGN4X;TMEM25;TRABD2B;PLIN5;KIF7;SNCA;PRKCB;METTL3;TLR9;NDRG4;CILP;BCL2;NCK1;PIP4K2B;APOD;NFATC1;FSTL3;CADM4;PTEN;CARD8;LRRK2;DCN;TULP3;MEGF8;EMILIN1;SPRY1;GRB10;HEY1;PID1;HIF1AN;INPP5K;DAB2IP;EGFL7;CYP26B1;GRB14;SPRY3;ASXL1;SEMA6A;SFRP1;TMBIM1;GATA2;IGFBP5;PIP4K2A;GLIS2;KANK1;LEPROT;BTRC;TLE1;CRHBP;GPS2;IFT122;TSC2;KCTD21;HIC1;EGFR;GPC1;SUFU;BEND6;DCC;LRRC14;DKK3;TAX1BP3;FBXW7;AGTR2;HHEX;RPS6KB1;DLL1;CBY1;ZNF653;GSK3A
prerank,positive regulation of bone mineralization (GO:0030501),-0.4264963773633869,-1.3764508228166012,0.10714285714285714,0.206333587523581,1.0,14/35,24.85%,GPM6B;BMPR1A;OSR1;PTN;P2RX7;SLC8A1;KL;MEF2C;ACVR2A;BMPR1B;OSR2;ANO6;PKDCC;TGFB3
prerank,proteasomal protein catabolic process (GO:0010498),0.28864740956023865,1.3757605719442878,0.0,0.1981630165329161,1.0,51/202,16.21%,PSMD14;ENC1;PSMB2;PSMB9;PSMA5;PRPF19;SKP2;PSMB3;FBXO45;PSME3;PSMA3;KIF14;DERL1;PSMA7;PMAIP1;PSMD13;GID8;PSME2;PSMC2;PSMC4;PSMD10;TRIM72;ERCC8;PML;PSMD12;BFAR;PSMB5;KCTD5;PLAA;UBE3D;TRIM2;PRAME;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;TRIM71;RAD23B;DDB1;SPSB2;PSME1;PSMF1;PSMD11;PSMD1;NHLRC1;VCP;CUL4A;RNF34;RNF187;UBE2A
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3889508629496306,1.3756229105218514,0.06382978723404255,0.19790979297742778,1.0,19/37,30.97%,EPHB2;PHB;WNT5A;SLC7A5;IL21;XBP1;FFAR2;NOD2;TNFSF4;CD86;RBP4;TNFRSF4;CD244;GPI;IL10;PHB2;SCIMP;LACC1;XCL1
prerank,positive regulation of GTPase activity (GO:0043547),-0.3195097550745149,-1.3754803778315117,0.015151515151515152,0.20721037365945977,1.0,80/199,24.82%,ARHGEF26;FLCN;TSC1;TBC1D1;RASGRP2;SGSM2;TBC1D17;RAPGEF3;RAP1A;ASAP3;RABGAP1;FERMT2;CCL14;TBC1D10A;USP6;TBC1D20;TBC1D26;SYDE1;DVL3;NTRK3;ARHGEF10;EVI5L;GARNL3;RGS10;SRGAP2;TBC1D2B;GNB5;CAV2;RIC1;SIPA1L2;SGSM1;RAB11FIP2;ARHGEF15;SYDE2;CORO1C;NTRK1;ARHGAP24;NDEL1;TBC1D13;TIAM1;RGS8;RAPGEF1;ADRB1;SFRP1;ARHGEF7;ARHGAP29;SNX18;TBC1D25;NTF3;RALGAPA1;SIPA1;SGSM3;RAB3GAP1;DOCK11;PLXNB1;CCL23;MAPRE2;ALS2;CCL11;SIPA1L1;TAX1BP3;ADPRH;RGS6;RAPGEF6;TBC1D12;CCL21;RAPGEF2;CCL2;BCAS3;TBCK;PRTN3;BCAR3;PIN1;RSU1;ADCYAP1;CDKL5;ARHGAP11B;RGS1;PIP5K1A;APC2
prerank,vitamin transport (GO:0051180),0.41591045192272424,1.375268954687372,0.04878048780487805,0.19796525789296476,1.0,8/26,14.07%,TCN1;SLC5A6;FOLR1;SLC52A2;SLC19A1;TTPA;SLC52A3;CD320
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.34623658780532385,1.3751995713631922,0.02564102564102564,0.19763695436176262,1.0,28/67,22.80%,DKC1;RAN;CCT6A;CDK1;CCT2;CCT3;GTSE1;CCT8;CCT7;ECT2;ZPR1;JUP;DTX3L;NMD3;ORMDL3;LAMTOR5;PLK1;RBM22;CCT4;TCP1;TGFB1;CARD10;TRIM28;ZC3H12A;MCRS1;IPO5;HYAL2;LIF
prerank,focal adhesion assembly (GO:0048041),-0.4885171368669279,-1.3749106763245722,0.08771929824561403,0.207650784982319,1.0,12/21,18.97%,SORBS1;FERMT2;ACTN2;ACTN3;WHAMM;ACTN1;DLC1;TAOK2;PEAK1;ARHGEF7;THSD1;TESK2
prerank,visual system development (GO:0150063),-0.4038113550806359,-1.3743918882165098,0.09090909090909091,0.20782212422218158,1.0,10/41,11.67%,MEIS1;MAB21L2;MAB21L1;SALL2;MEIS2;PBX3;CPAMD8;CHRDL1;PBX2;MEIS3
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.453958407393795,-1.3734753229396461,0.05357142857142857,0.20850519609653612,1.0,11/23,18.59%,MAP6;DYNC1I1;KIF5A;KIF5C;KIF1A;TUBA1A;KIF1C;KIF1B;CCDC88A;MAP6D1;HOOK3
prerank,response to insulin (GO:0032868),-0.35919303405468755,-1.3734047408030725,0.04838709677419355,0.2082238706137205,1.0,31/79,20.44%,VAMP2;SLC2A4;TSC1;SORBS1;KAT2B;PDE3B;PIK3R1;CPEB1;RAB12;EPM2AIP1;CPEB2;RHOQ;ZFP36L1;GCK;FER;SLC27A1;MYO5A;HDAC5;INPP5K;CELA2A;OGT;LPIN1;HDAC9;PLA2G1B;RAB13;AKT2;INSR;RPS6KB1;GSK3A;SIRT1;RAB8B
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.486590852413123,-1.3728990861490442,0.08771929824561403,0.20835197137554567,1.0,8/18,15.73%,TSC1;FERMT2;MYOC;COL16A1;PPM1F;RAC1;SFRP1;ROCK1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3190090724048335,1.3724529471104656,0.0,0.2007793499032407,1.0,37/111,20.78%,GNL3L;RPA3;CAPG;USP50;CSF2;FERMT1;MMP1;GTF2H3;SKAP1;AJUBA;SYK;PSMC2;PSMC4;RPS3;ERCC5;MYD88;BIK;GSK3B;MMP3;GBP5;DDB1;CDT1;VCP;RPA2;ISG15;CUL4A;SUMO1;TGFB1;PLEK;PIH1D1;BAX;BID;ERCC2;FSCN1;HSP90AA1;BAK1;CXCL13
prerank,regulation of cellular respiration (GO:0043457),0.4802917294220022,1.372304562340979,0.06521739130434782,0.20052244873502678,1.0,8/16,17.60%,SHMT2;PNPT1;TRAP1;NOS2;PRELID1;VCP;NOA1;IDE
prerank,calcium ion homeostasis (GO:0055074),-0.3483904020489555,-1.3722896318844917,0.02,0.20858131931891724,1.0,24/94,15.20%,TPCN2;DMPK;PTH1R;ATP2B4;ANK2;JPH2;CCL14;STIM1;SLC8A2;SLC24A4;SNCA;SLC8A1;ELANE;TMTC2;SLC24A3;NPTN;CTRC;RYR2;ATP2B3;SLC8A3;CSRP3;TRDN;RGN;HTR2B
prerank,positive regulation of cell junction assembly (GO:1901890),-0.38808062073755045,-1.37100329737036,0.05084745762711865,0.20956142182977822,1.0,19/56,15.73%,TSC1;NLGN2;NLGN3;FERMT2;MYOC;SLITRK2;NRXN1;CUX2;CLDN5;COL16A1;NLGN1;LRRC4B;PPM1F;BHLHB9;NPHP1;RAC1;SFRP1;IL1RAPL1;ROCK1
prerank,glucose transmembrane transport (GO:1904659),-0.5085479577261678,-1.3709642387092127,0.09259259259259259,0.2092194295687907,1.0,4/18,5.73%,SLC2A4;SLC45A1;SLC2A11;PPARD
prerank,neuron projection organization (GO:0106027),-0.5020840921096615,-1.3694914499686723,0.125,0.21092202038850147,1.0,9/16,24.13%,DCTN1;MAP1A;PRNP;PSEN1;ATP1A3;INSR;INS;ABCD1;ABCD2
prerank,positive regulation of DNA recombination (GO:0045911),0.45618596699515523,1.368960468899421,0.06666666666666667,0.20430405170526963,1.0,12/24,29.94%,FANCB;RAD51AP1;TIMELESS;ACTR2;WRAP53;FUS;PAXIP1;ERCC2;HMCES;OOEP;PARP1;MAD2L2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3749692792199128,1.368691226255488,0.044444444444444446,0.20444562081481452,1.0,27/53,24.82%,DPEP1;BCL2L12;TRIAP1;ARL6IP1;LAMP3;IFI6;YWHAE;CD44;CSNK2A1;XIAP;GPX1;PAK2;CAAP1;LAMTOR5;DHCR24;MMP9;RNF34;PLAUR;PIH1D1;SFN;PAX2;RPS6KA1;SH3RF1;RPS6KA3;NAIP;THBS1;CARD16
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.349856138698572,-1.3685308079028873,0.06557377049180328,0.21162810013510489,1.0,32/73,24.46%,ZER1;CLU;CSNK1E;RNF19A;RNF180;CSNK1A1;RNF217;DET1;BAG2;PTEN;LRRK2;SIRT2;ZYG11B;KLHL40;TRIB2;BBS7;ARIH2;RNF144B;HECTD1;CSNK1D;CDK5RAP3;DNAJB2;FBXW7;ARIH1;RNF14;GSK3A;PRICKLE1;SMAD7;CAV3;PIAS1;RNF144A;GABARAP
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.46642722560795663,-1.3680358209865198,0.09090909090909091,0.21180744842624735,1.0,15/24,26.77%,VAMP2;PPP3CB;SYT10;SYT11;RIMS3;SYT2;SYT9;SYT6;SYT5;RIMS1;SYT1;SYT3;ARHGAP17;DOC2B;SYT15
prerank,triglyceride catabolic process (GO:0019433),0.4560759672775887,1.3676810817940834,0.07692307692307693,0.2054964925309876,1.0,5/19,11.15%,FABP6;PNPLA4;LIPG;PNPLA1;PNPLA3
prerank,regulation of biomineral tissue development (GO:0070167),0.4298960209583642,1.3675678443816197,0.04,0.20523120604923983,1.0,6/24,7.25%,NOTUM;CEBPB;FBXO5;CYP27B1;ANKH;SOX9
prerank,cellular response to chemical stress (GO:0062197),0.33020021095704816,1.3667702887513886,0.0,0.2055961649183303,1.0,38/100,22.32%,LRRC8E;ERO1A;DHRS2;SLC4A11;VRK2;CHCHD2;PRDX5;PNPT1;ERMP1;VKORC1L1;LRRC8D;ATP13A2;CYBA;PRDX1;NOX1;GPX1;GPX2;BRF2;LONP1;PRDX2;GSR;CYCS;SLC25A24;G6PD;TRPV4;ZFAND1;STOX1;PYCR1;FANCC;EIF2S1;CAV1;TMEM161A;NCF2;KEAP1;ZC3H12A;PRDX3;ALDH3B1;CYBB
prerank,protein localization to plasma membrane (GO:0072659),-0.34065254178136994,-1.366607257777314,0.017857142857142856,0.21373430689598066,1.0,55/130,24.79%,DPP6;KCNB1;KCNIP3;FLNA;CACNB2;ANK2;RAP1A;KCNIP4;WNK3;EHD2;SCN3B;RAB34;ACTN2;ANK3;TTC7B;SLMAP;SPTBN4;TMEM88;P2RY1;RAB12;PACSIN1;EPB41L3;CLASP2;RAMP1;MYO5A;FAM126A;RDX;INPP5K;GORASP1;RAB3A;TMEM150A;PACS2;FGF13;ROCK1;CCDC88A;MYADM;RAB13;ASB3;RAB3C;PLEKHF1;RAMP3;EFR3B;RAPGEF6;RAB40A;RAPGEF2;RAB8B;PACS1;LRP6;CAV3;RAMP2;STXBP1;FAM126B;CACNB3;TNFRSF1A;PIP5K1A
prerank,spliceosomal complex assembly (GO:0000245),-0.3994469262700954,-1.366305913287868,0.05357142857142857,0.2135673878429447,1.0,14/45,11.64%,LUC7L2;SRSF5;RBM5;LUC7L3;DDX39B;SF3B1;CELF1;LUC7L;CELF4;CELF6;SF1;CELF2;SRPK3;YTHDC1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.41358558199757584,1.365963875495894,0.07692307692307693,0.20600968191502778,1.0,11/31,14.19%,GLYATL1;DDAH1;GOT2;ALDH18A1;GLS2;ALDH5A1;SLC39A8;CAD;GCLM;ALDH4A1;NIT2
prerank,platelet aggregation (GO:0070527),-0.4234050349656415,-1.3654395763078702,0.06349206349206349,0.21454163162136872,1.0,11/32,13.05%,CSRP1;MYL9;FLNA;TLN1;VCL;PDGFRA;ILK;ITGB3;ACTN1;HSPB1;P2RY12
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.4059417795118732,-1.3643577918856165,0.09375,0.2154517382592947,1.0,20/43,24.29%,FGFR1;LPAR1;FGF2;PDGFRA;NTRK3;ARHGAP6;ADRA1A;KIT;P2RY12;HTR2B;ESR1;GNAQ;NTF3;EGFR;AVPR1A;PLCB2;PLCG1;FLT1;RASGRP4;HTR2A
prerank,cellular response to arsenic-containing substance (GO:0071243),0.49672181252983805,1.3639741221680808,0.16666666666666666,0.2078991694876872,1.0,8/15,21.42%,GSTO2;PPIF;GSTO1;VCP;MAPK13;ZFAND1;HNRNPA1;ZC3H12A
prerank,protein localization to cell periphery (GO:1990778),-0.33344610926512525,-1.363655180002769,0.0,0.2158797929565043,1.0,55/136,24.79%,DPP6;KCNB1;KCNIP3;FLNA;CACNB2;ANK2;WDR19;RAP1A;KCNIP4;RABEP1;WNK3;EHD2;SCN3B;RAB34;ACTN2;ANK3;TTC7B;SLMAP;SPTBN4;TMEM88;P2RY1;RAB12;PACSIN1;EPB41L3;CLASP2;RAMP1;MYO5A;FAM126A;RDX;INPP5K;RAB3A;TMEM150A;PACS2;FGF13;ROCK1;MYADM;RAB13;RAB3C;PLEKHF1;RAMP3;ARL3;EFR3B;RAPGEF6;RAB40A;RAPGEF2;RAB8B;PACS1;LRP6;CAV3;RAMP2;STXBP1;FAM126B;CACNB3;TNFRSF1A;PIP5K1A
prerank,regulation of phospholipase C activity (GO:1900274),-0.5213941565252453,-1.3634007268347776,0.03076923076923077,0.215689790830817,1.0,9/15,23.96%,FGFR1;FGF2;PDGFRA;NTRK3;KIT;ESR1;NTF3;PLCG1;FLT1
prerank,regulation of MAPK cascade (GO:0043408),-0.3290384742513566,-1.3631897030313356,0.014492753623188406,0.2153816049051036,1.0,48/161,18.07%,FGFR1;ADRA2B;EPHA7;TGFBR3;LPAR1;FGF2;ADRB3;ZDHHC17;PRDM11;MYOC;DUSP3;ROR2;GPER1;FGFR2;NTRK3;P2RX7;ADRB2;ADRA1A;TLR9;TBX1;KIT;KSR1;ADRA1D;PPEF2;CAV2;FLT4;RRAS;PRDM15;PELI2;NTRK1;ROR1;TAOK2;THPO;DAB2IP;MAPK1;MAPK3;RIT2;SPRY3;NEK10;FAM83D;PDGFB;ROCK1;DUSP19;FGF10;FAS;NRK;INSR;EGFR
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4435431778965956,-1.3627132438625804,0.05172413793103448,0.2154705811926289,1.0,12/27,27.70%,RORA;GNB3;ACADVL;ACADL;FMO5;PDK2;SIRT1;MLYCD;PDK4;ABCB11;NR1H4;NCOR2
prerank,regulation of cellular component movement (GO:0051270),-0.36611929557904993,-1.3625762486863986,0.03389830508474576,0.2151839449827205,1.0,16/49,18.27%,ZSWIM8;RAF1;NRG2;TGFBR3;BTC;HDAC6;ZSWIM6;ACTN1;INPP5F;FES;CADM4;DAPK3;RHOA;ROCK1;EGFR;ERBB4
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.34577192513171334,-1.3616145094543497,0.031746031746031744,0.21594298202990192,1.0,49/102,27.55%,PIP5K1C;FGFR1;FGF2;GAB1;PPP2R5B;MYOC;PDGFRA;ROR2;GPER1;PIK3R1;GH1;NTRK3;KIT;PIP4K2B;PTEN;DCN;NTRK1;ROR1;FBXL2;DAB2IP;MAPK1;MAPK3;EPOR;PDGFB;PIP4K2A;NTF3;CBL;TSC2;WNT16;INSR;PLXNB1;EGFR;PIK3IP1;INS;SIRT1;PDGFD;HGF;FLT1;NKX3-1;PDGFA;PIP5K1A;EPO;HCLS1;SELP;CEACAM1;F2RL1;PIK3R5;NLRC3;FSHR
prerank,activation of GTPase activity (GO:0090630),-0.34350600308573276,-1.3607662827330416,0.03773584905660377,0.21673808967621092,1.0,36/98,21.38%,ARHGEF26;TSC1;TBC1D1;SGSM2;TBC1D17;RABGAP1;TBC1D10A;USP6;TBC1D26;SYDE1;NTRK3;ARHGEF10;EVI5L;GARNL3;TBC1D2B;SIPA1L2;SGSM1;ARHGEF15;SYDE2;CORO1C;ARHGAP24;TBC1D13;TIAM1;ARHGAP29;TBC1D25;NTF3;RALGAPA1;SIPA1;SGSM3;SIPA1L1;TAX1BP3;ADPRH;TBC1D12;CCL21;BCAS3;TBCK
prerank,cation transport (GO:0006812),-0.33115545071916325,-1.3603586800166116,0.0,0.2169411313383448,1.0,74/168,28.87%,SCNN1D;KCNMB1;KCNQ4;ATP1A2;KCNA5;SCN7A;CNGB1;KCNMA1;KCNK3;SCN3B;SCN9A;ABCC8;SLC8A2;SCN4A;KCNIP2;SCN11A;KCNA2;SLC8A1;KCNK4;PIEZO2;ATP1A4;TRPC6;SCN4B;ABCC9;KCNA1;ATP10D;KCNAB3;KCNMB2;KCNJ8;SLC8A3;AQP1;KCNMB4;SCN3A;SCNN1B;RHAG;SLC41A1;KCND3;SLC47A1;FGF13;MCOLN1;KCNA4;SCNN1G;KCNC1;KCNJ1;SLC6A17;PIEZO1;KCNS2;SLC36A4;SCN5A;KCNN1;KCNS3;KCNK7;KCNF1;ANO6;TRPM7;KCNG1;KCNH1;KCNK6;KCNMB3;KCNJ5;KCNN2;CLN3;SLC9B2;KCNC4;SCN1A;NEDD4L;SLC39A1;SGK1;SLC6A9;KCNB2;SLC4A4;SLC6A3;SLC17A4;CALHM1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4714142749664458,-1.3594867589575792,0.09090909090909091,0.2175544873940636,1.0,8/24,8.14%,FGFR1;FGF2;PLA2G5;AGTR1;PDGFRA;FGFR2;NTRK3;KIT
prerank,brain development (GO:0007420),-0.3195593311023868,-1.3581082426278164,0.017857142857142856,0.2188881468478912,1.0,57/144,24.19%,POU6F1;MEIS1;EML1;ROGDI;EPHA7;MEIS2;NNAT;PBX3;DSCAML1;HAP1;SYNJ1;BBS4;SHANK3;PAFAH1B1;CIC;AMIGO1;NDRG4;MDGA1;SMARCA1;ADGRL3;APOD;PBX2;PTEN;ADGRL2;NFIB;MEIS3;MAST1;ARNT2;BBS2;RELN;HSPG2;ZNF335;UGP2;CDH2;ZFHX3;CNTN4;CA10;AATK;SLC6A17;RAB3GAP1;GRIN2A;AMIGO2;KLHL17;CDK5RAP3;AGTR2;CDK5RAP2;RAPGEF2;SOX6;BPTF;SETD1A;PCDH18;NIPBL;SPEF2;CHD8;ZFHX2;GRIN2C;RAB18
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4236213569555804,1.3568699714538381,0.05714285714285714,0.21707771585621746,1.0,9/24,28.03%,AZGP1;IL23A;CD1A;CD1B;IL23R;HLA-F;IL12B;IL12RB1;CD1E
prerank,negative regulation of histone modification (GO:0031057),0.5013479089569707,1.356435746166857,0.15217391304347827,0.2171384821386651,1.0,6/15,13.06%,SET;FOXP3;SDR16C5;NOC2L;PRMT6;BRCA1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4573297950150298,1.3564053767003448,0.10526315789473684,0.21670138377095624,1.0,9/22,17.25%,IFNGR2;SOCS1;STAT1;NLRC5;SOCS3;PPARG;SUMO1;PTPN2;HSP90AB1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4918284636260344,-1.355661419484245,0.06,0.22187335746304693,1.0,9/16,17.90%,ANK2;TAPT1;BCAP29;LRRK2;RYR2;SEC16B;GBF1;GABARAPL2;VAPA
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3124922633861466,-1.3549433688552721,0.0,0.22229723650371902,1.0,77/255,20.64%,HAND2;FGFR1;ADRA2B;TENM1;LPAR1;RAP1A;FGF2;PLA2G5;GLIPR2;MTURN;ADRB3;FERMT2;GCNT2;CCL14;PDGFRA;ROR2;GPER1;FGFR2;P2RY1;GH1;NTRK3;ADRB2;PRKCA;ADRA1A;TLR9;NDRG4;ELANE;TBX1;SEMA4C;NECAB2;KIT;DSTYK;KSR1;ADRA1D;TNFAIP8L3;CAV2;LRRK2;FLT4;DIRAS2;PELI2;NTRK1;ROR1;TAOK2;THPO;DAB2IP;MAPK3;RIT2;MAP2K7;MID1;ACKR3;NEK10;HTR2B;PDGFB;BRAF;ROCK1;NOTCH2;DUSP19;FGF10;PDE8A;DIRAS1;FGF1;INSR;EGFR;CCL23;ERBB4;CCL11;RAMP3;CD36;FBXW7;ANGPT1;RET;MAP3K12;INS;SOX2;CCL21;RAPGEF2;CCL2
prerank,regulation of wound healing (GO:0061041),0.36751225680967065,1.354789417684081,0.04,0.2191458191501914,1.0,15/43,20.24%,CLDN1;CASK;EPHB2;PLAU;EPPK1;ACTG1;TNFAIP3;DUOX2;FOXA2;TNFRSF12A;F2R;CLDN4;SERPINE1;CAV1;VIL1
prerank,membrane assembly (GO:0071709),-0.4150966720578241,-1.3545420652668176,0.04838709677419355,0.22250576361395827,1.0,12/36,17.26%,NLGN2;NLGN3;NRXN1;NLGN4X;ANK3;NLGN1;STX2;PTEN;NRXN2;IL1RAPL1;VPS4A;NLGN4Y
prerank,telomere maintenance (GO:0000723),0.3669478939171514,1.35453961577845,0.022727272727272728,0.21897864537064454,1.0,15/51,15.65%,RPA3;POLD2;DCLRE1B;BLM;XRCC5;PRKDC;RECQL4;DNA2;APEX1;PTGES3;HUS1;NSMCE2;TPRKB;RPA2;POLD1
prerank,cellular response to insulin stimulus (GO:0032869),-0.3413719864479628,-1.35428574095063,0.015873015873015872,0.2224809315403766,1.0,47/124,20.55%,VAMP2;SLC2A4;ATP6V1G2;SORBS1;GAB1;KAT2B;PDE3B;PIK3R1;ZNF106;CPEB1;RAB12;ZDHHC7;CPEB2;RHOQ;CAV2;ZFP36L1;GCK;FER;SLC27A1;MYO5A;SOGA1;GRB10;FOXO4;RARRES2;HDAC5;INPP5K;GRB14;PIK3R3;LPIN1;HDAC9;PLA2G1B;APC;BAIAP2;SOS1;RAB13;AKT2;INSR;ATP6V0A1;ATP6V1B1;PDK2;ATP6V1E1;TCIRG1;RPS6KB1;GSK3A;INS;RAB8B;PHIP
prerank,negative regulation of phosphorylation (GO:0042326),-0.3561721455751803,-1.354156858707197,0.03333333333333333,0.22218555273922624,1.0,32/81,22.71%,HDAC4;MAPT;TARDBP;ACTN3;WWTR1;ATG14;NTRK3;PRKRIP1;PRNP;CDKN1C;TERF2IP;CADM4;SLIT2;PTEN;LRRK2;CORO1C;FBLN1;PID1;INPP5K;DAB2IP;CDKN1A;PIP5KL1;ROCK1;MYADM;CDKN2C;NUPR1;CDK5RAP3;FKBP8;SIRT1;TESK1;LRP6;INHA
prerank,positive regulation of heart contraction (GO:0045823),-0.4784356964466674,-1.35260477100928,0.03773584905660377,0.22383986427204786,1.0,7/20,11.05%,HRC;ATP1A2;RGS2;SCN3B;NPPA;ADRA1A;RYR2
prerank,mRNA transport (GO:0051028),0.32171627721873347,1.3524993861084016,0.0,0.22135769379553977,1.0,30/102,13.26%,NUP37;CPSF3;ALYREF;THOC3;NUP155;U2AF1;MAGOH;RAE1;SLBP;NUP93;NUP35;MAGOHB;EIF4A3;NCBP1;SEH1L;DDX39A;SRSF9;SEC13;NUP210;NUP43;NXT1;GLE1;NUP50;NUP88;NUP107;EIF4E;NCBP2;CPSF2;NUP205;THOC6
prerank,sodium ion transport (GO:0006814),-0.3437125409151881,-1.3524952037360913,0.03773584905660377,0.22358137370232287,1.0,41/88,28.68%,SCNN1D;ASIC3;ATP1A2;SLC6A16;PKD2;SCN7A;SCN3B;SCN9A;SLC8A2;SCN4A;SLC24A4;SCN11A;SCN2B;SCN1B;SLC8A1;ATP1A4;SCN4B;SLC24A3;SLC8A3;SCN3A;SCNN1B;FGF13;SCNN1G;SLC6A1;SLC6A17;SCN5A;HCN3;SLC6A15;ANO6;ASIC4;HCN2;SLC9B2;SCN1A;NEDD4L;SGK1;SLC6A9;SLC6A8;SLC4A4;SLC6A3;SLC17A4;SLC6A7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.3630141901187256,1.3523004231247402,0.03571428571428571,0.22106305545502072,1.0,18/52,17.88%,PSMD14;BRCC3;PRPF19;DCLRE1C;UBE2N;POLB;DCLRE1B;XRCC5;XRCC4;PRKDC;ERCC8;HMGB2;POLA1;BRCA1;NSMCE2;SUMO1;LIG3;PAXIP1
prerank,regulation of DNA recombination (GO:0000018),0.43346311204237603,1.3520004989065348,0.13636363636363635,0.22086813883725562,1.0,13/31,17.23%,CHEK1;ALYREF;RAD51AP1;BLM;PPP4C;FIGNL1;ZRANB3;MSH3;KDM1A;MSH6;KPNA2;RPA2;IL7R
prerank,positive regulation of protein modification process (GO:0031401),-0.32070162583159373,-1.351708631073908,0.03076923076923077,0.22424607881403782,1.0,75/205,24.16%,FLCN;CLIP3;ARNTL;RAPGEF3;FGF2;TRABD2B;WDFY2;GPER1;CALM1;ATG14;DVL3;ILK;P2RY1;FAXDC2;NTRK3;FGF22;ITGB3;RSPO1;FXR2;DLC1;TBX1;CAMK1;TERF2IP;DYRK1A;LRRK2;VEGFB;FLT4;RAMP1;NPTN;PELI2;NTRK1;RARRES2;AKTIP;THPO;MAPK3;FGF17;DVL2;LEPR;RAC1;PIK3R3;EFNA5;MUSK;FGF7;FGF5;FGF10;PDE8A;FAS;RAB3GAP1;AKT2;FGF1;ACVR2A;INSR;FGF16;EGFR;ERBB4;CSNK1D;ANGPT1;LIMCH1;SIRT1;CAMKK2;VEGFC;TESK1;FGF9;KAT5;CDH5;GOLGA2;PIN1;CALM2;NNMT;HGF;PRKCD;RIPK1;PINK1;NKX3-1;CAMTA1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3846909034470774,-1.3512263871363848,0.05660377358490566,0.22456293419810908,1.0,26/49,26.50%,PLCD4;PITPNM2;FGFR1;PIRT;PDGFRA;PI4KB;PIK3R1;PLCL1;PI4KA;INPP5F;NGF;TNFAIP8L3;NTRK1;PIK3C3;PLCE1;OGT;RHOA;PLCD1;PLCB1;RPS6KB1;PIK3R2;PLCB2;KCNH1;EXOC1;PIK3C2A;PLCL2
prerank,regulation of DNA replication (GO:0006275),0.38695487231733317,1.3511630768776344,0.075,0.22155786119242057,1.0,19/50,20.25%,S100A11;DSCC1;FBXO5;EREG;GTPBP4;MCIDAS;BLM;ESCO2;DNA2;DHX9;USP37;ORC5;ATAD5;CDT1;GMNN;CDC6;NPM2;PDS5A;ORC3
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4717101552214623,1.3500630255500414,0.0784313725490196,0.22253848027194018,1.0,5/15,15.45%,C2CD4A;OSM;IL1B;FFAR2;ADAM8
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3913807438020634,1.3490294080123275,0.0851063829787234,0.22356366184481097,1.0,17/35,26.88%,IL1A;EREG;PDGFRB;IL1B;DLGAP5;AURKA;ANAPC11;NSMCE2;NUP62;DMRT1;ESPL1;LRP5;TGFA;CUL3;EGF;EPGN;CDC23
prerank,regulation of T cell cytokine production (GO:0002724),0.46248748894593333,1.3477127052104947,0.12,0.22490137441277508,1.0,8/19,21.75%,FOXP3;CD55;TRAF2;CLC;TNFRSF1B;LILRB4;TNFSF4;HLA-F
prerank,negative regulation of apoptotic process (GO:0043066),0.26553108280934046,1.3473666804313724,0.0,0.22484618168657258,1.0,150/466,21.91%,FOXQ1;MYC;MAD2L1;DPEP1;ANXA4;TDGF1;CDK1;VDAC1;HSPD1;DHRS2;CBX4;VHL;RIPK2;TRIAP1;ARL6IP1;SET;LAMP3;GLO1;HDAC2;KIF14;IFI6;MYDGF;PTRH2;PTMA;FIGNL1;YWHAE;WNT5A;PRDX5;CEACAM6;SHH;PRKDC;CARD14;LEF1;PSMD10;CD44;CTSH;ARF4;CIAPIN1;SOX9;TMBIM6;ATAD3A;BCL2L1;BFAR;ERCC5;HSPA9;CLEC5A;HNRNPK;MDK;CSNK2A1;CASP2;BCL2A1;MAZ;PPIF;HMGA2;XIAP;XBP1;DNAJC3;AATF;TRIM27;PRAME;PA2G4;HDAC1;MYD88;NAA15;RELA;ADAM10;IRAK1;GPX1;TOX3;CEACAM5;PAK2;IGF1R;SIX1;PRELID1;SEMA4D;FGF20;GSK3B;PROC;WDR73;ARHGDIA;COPS5;PLA2G3;PRDX2;ITGA5;TAF9;PRLR;POU4F1;NAA35;LAMTOR5;WNT11;THOC6;PLK1;DNAJA1;DHCR24;CIB1;PRKCI;VTCN1;NPM1;KDR;MMP9;BMP4;MIEN1;HTATIP2;UBA52;GATA6;GRN;PDCD10;YME1L1;NUP62;IFIT3;ADAM8;MED1;PLAUR;F2R;PRKCG;NUAK2;HSPA5;PPT1;ANXA5;CFL1;BAG4;API5;MTRNR2L3;FHL2;BIRC5;BNIP1;MTRNR2L1;FXN;TPT1;NFKBIA;PROK2;COMP;BID;SFN;TMEM14A;BIRC7;PAX2;CAV1;UFM1;DDRGK1;RPS6KA1;ZC3H12A;MSH2;UBE2Z;MCL1;OPN3;PRDX3;FOXB1;NOTCH1;LGMN
prerank,regulation of vasoconstriction (GO:0019229),-0.43225469770845726,-1.346921617293162,0.09302325581395349,0.2305602109234568,1.0,15/27,28.18%,AGTR1;ADRA1A;ADRA1D;ECE1;KCNMB2;KCNMB4;AVPR2;TBXA2R;CHRM3;AVPR1A;ZDHHC21;ADRA1B;ADM;AVPR1B;BMPR2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.4336451776867888,-1.346495160837799,0.08064516129032258,0.23051896088572005,1.0,14/32,15.70%,CAPRIN2;CUX2;ZDHHC15;SHANK3;NLGN1;PTEN;KIF1A;LRRK2;BHLHB9;ABI2;EPHA4;RELN;CAMK2B;DBN1
prerank,positive regulation of inflammatory response (GO:0050729),0.3426450862888446,1.3463185192645302,0.047619047619047616,0.2260052682578859,1.0,40/86,28.44%,C2CD4A;OSM;IL23A;ZP3;IL1B;WNT5A;MGST2;CEBPA;NMI;DHX9;MDK;IL21;CCL3;CD81;PLA2G7;VAMP8;PLA2G3;AGT;GRN;RPS19;MAPK13;ADAM8;FEM1A;NFKBIA;SNX4;SERPINE1;MMP8;TNFSF4;C2CD4B;IL12B;HYAL2;CD47;ZBP1;CCL1;VAMP7;ETS1;IFNG;IFI35;IL18;TLR7
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.47932773474356777,1.3458741661098386,0.08888888888888889,0.22609327274135319,1.0,11/15,34.62%,IL23A;IL1B;CD80;IL17F;IL23R;IL12B;IL18;RASGRP1;IL17D;CARD9;CD84
prerank,response to ethanol (GO:0045471),0.48185592288778284,1.3455382508466907,0.06382978723404255,0.22591496924063825,1.0,6/15,18.98%,GRIN2B;GOT2;CHRNB2;TH;GLRA2;ADCY7
prerank,negative regulation of viral entry into host cell (GO:0046597),0.48173462561768443,1.344923355464275,0.11320754716981132,0.22617164421441435,1.0,6/16,15.18%,IFITM3;LY6E;IFITM1;IFITM2;TRIM26;TRIM11
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4924307066038722,-1.3441294663469519,0.10526315789473684,0.23299260219324489,1.0,9/16,25.75%,PRKAG2;SIRT4;ACADVL;ACADL;NR4A3;MLYCD;ABCD1;PDK4;ABCB11
prerank,positive regulation of organelle organization (GO:0010638),-0.4030364046044387,-1.3433252406269869,0.10869565217391304,0.23359286388724765,1.0,12/31,17.56%,PLA2G5;FYCO1;SYNJ1;SORBS3;P2RX7;CALCOCO2;ADRB2;UVRAG;ATL3;MGARP;RAB3GAP1;AKT2
prerank,embryonic heart tube development (GO:0035050),-0.48367228782493116,-1.3433046109908084,0.12,0.23310923476946863,1.0,9/18,19.53%,CITED2;NDRG4;HAND1;MEGF8;RYR2;SOX17;TBX2;IFT122;SOX18
prerank,chordate embryonic development (GO:0043009),-0.3708535405329022,-1.3427936793839672,0.034482758620689655,0.23332811859396238,1.0,18/57,16.75%,PKD1;FLCN;FOXF1;FGFR1;EGFL8;PKD2;MYH6;FGFR2;FOXD3;MBNL1;ZNF568;TBX1;ZNF358;ARNT2;XYLT1;HINFP;LMX1B;PCSK5
prerank,protein O-linked glycosylation (GO:0006493),0.3246780609230661,1.3427330272996576,0.02702702702702703,0.22837688179283777,1.0,32/93,20.61%,POMK;GALNT6;C1GALT1C1;B3GNT4;DPM2;TMTC4;CHST4;C1GALT1;POFUT1;PLOD3;DPM1;MUC5AC;B3GNT2;GCNT1;GALNT5;B3GALNT2;ST6GAL1;GALNT3;PGM3;SLC35C1;GALNT1;SDF2L1;ST8SIA6;GALNT7;B3GNT3;B3GNT5;MUC20;MUC17;B3GNT8;B4GALT5;TET3;MUC16
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.49238740694805055,-1.3426750192423245,0.12962962962962962,0.23299817998480213,1.0,6/17,14.96%,MAP3K3;FGF2;HDAC7;RHOJ;HDAC9;GATA2
prerank,defense response to virus (GO:0051607),0.31269116176207135,1.341325760539441,0.0,0.22963587181087924,1.0,32/127,15.99%,CLPB;EXOSC5;IFITM3;IFITM1;SKP2;ABCE1;IFITM2;G3BP1;EXOSC4;PHB;IFI6;PMAIP1;SERINC5;ATAD3A;BCL2L1;NT5C3A;PDE12;IFI44L;IL21;OAS2;MYD88;RELA;STAT1;APOBEC3F;NLRC5;CXCL10;BST2;IFIT3;OASL;MX1;ISG15;PRF1
prerank,negative regulation of cell differentiation (GO:0045596),-0.310063669337043,-1.3412098215669928,0.015151515151515152,0.23487562371011744,1.0,74/182,26.75%,NPHP3;MEIS1;NKX3-2;WNT9A;MYOCD;ARNTL;MEIS2;EID2B;TWIST2;CHRD;FERMT2;OSR1;HDAC7;RUNX1T1;WWTR1;GPER1;CHADL;RORA;ITGB3;ABCA1;ZADH2;TBX1;ZFPM2;PTEN;ZBTB16;MSTN;SIRT2;SPRY1;HEY1;NOTCH4;SKI;NR1H2;DAB2IP;ASXL1;SFRP1;RANBP3L;GATA2;TRIB2;CNTN4;GDF5;ABCA5;RORB;GPS2;TRIO;IL17RD;ANKRD2;EGFR;SUFU;DLL1;EFEMP1;SOX2;SIRT1;VASN;SMAD7;ANKRD26;ID2;SOX8;LIMD1;ADAMTS7;ESRRB;SDHAF2;PDCD4;SNAI2;TMEM64;TNN;WNT10B;ZFP36L2;BBS12;SMAD3;CRIM1;METTL14;BMP5;ASCL1;NOG
prerank,motor neuron axon guidance (GO:0008045),-0.48499858662134476,-1.3383345632468586,0.14814814814814814,0.238608160433987,1.0,9/16,21.85%,NTN1;SLIT2;TMEFF1;RNF165;EPHA4;RAC1;NTN5;SEMA3A;SLIT1
prerank,cellular component disassembly (GO:0022411),0.3605524657814752,1.3377721198542778,0.08823529411764706,0.2335975929151016,1.0,21/60,17.72%,MMP7;MMP13;CAPG;CTSV;KIF9;KLK7;MMP11;MMP1;TIMP1;CD44;MMP10;ADAM10;MMP2;MMP3;CAPN1;MMP9;MMP12;ADAM8;ADAM15;DYRK3;MMP15
prerank,ion homeostasis (GO:0050801),-0.4183494333010151,-1.337312393366415,0.12,0.23945242148169854,1.0,17/30,29.37%,FHL1;WNK3;UNC80;SLC4A7;SLC30A8;RHAG;SLC30A4;CAMK2D;SLC4A3;KLHL3;WNK1;SLC4A5;SLC4A1;NEDD4L;SLC4A4;SLC12A5;SLC4A10
prerank,positive regulation of signaling (GO:0023056),-0.3988140458195162,-1.3371685710217542,0.08196721311475409,0.2392250930390257,1.0,19/37,28.14%,BVES;LGI1;ILK;DLG4;SNCA;INPP5F;GRIK2;RIMS3;ECE1;WLS;CARTPT;SOX11;RAMP3;RIMS1;SYT1;CLSTN2;CLSTN3;PTPN23;RAB29
prerank,regulation of cellular catabolic process (GO:0031329),-0.35569691471260545,-1.3369519448286296,0.04838709677419355,0.23909219743330148,1.0,28/61,25.75%,TPCN2;WDR91;MAPT;RRAGC;ITPR1;HDAC6;DAPK1;PIP4K2B;LRRK2;SOGA1;HSPB1;FBXL2;DAPK3;RRAGB;PIP4K2A;ROCK1;DEPDC5;NUPR1;RRAGD;ABCD1;BOK;RPTOR;PIK3R2;OSBPL7;KAT8;RRAGA;RAB39B;ABCB11
prerank,modified amino acid transport (GO:0072337),0.49699055690222094,1.3362650755984211,0.09302325581395349,0.23515079257701124,1.0,5/17,6.82%,SLC6A20;SLC1A4;SLC5A6;FOLR1;SLC19A1
prerank,regulation of JUN kinase activity (GO:0043506),-0.3797341198900956,-1.3356558447933295,0.14285714285714285,0.24058351594006436,1.0,13/33,21.15%,SASH1;DVL3;NPPA;TLR9;MAP3K4;HIPK3;PPEF2;DAB2IP;DVL2;DUSP19;MAPK8IP1;MAP3K10;MAP3K7
prerank,cytosolic transport (GO:0016482),-0.33352240531456323,-1.335098172131967,0.05084745762711865,0.24096989877812014,1.0,41/108,28.14%,SNX1;WDR91;TBC1D17;RAB9B;DCTN1;TBC1D10A;RBSN;ANKFY1;MON2;RAB6B;STX16;DENND5A;DENND2A;CORO7;RIC1;KLHL20;VTI1B;AKTIP;PIK3C3;VPS13A;ERC1;GBF1;SPAG9;EPS15;HEATR5A;HOOK3;HEATR5B;PIKFYVE;PREPL;CCDC91;CLTCL1;WDR81;GGA1;CLN3;VPS13C;MAGEL2;VPS26B;VPS54;VPS52;PTPN23;RAB29
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.34336409125603246,1.3347318057262414,0.06666666666666667,0.2368882159835191,1.0,18/58,18.79%,RCC2;CCND1;TFDP1;CDK1;FBXO5;CDCA5;CDC25C;DLGAP5;CDK4;RAB11A;UBE2C;RAD51B;ANAPC11;NSMCE2;CDC25A;ESPL1;CDC7;STOX1
prerank,cortical cytoskeleton organization (GO:0030865),-0.3916767917915014,-1.3343502767431428,0.10526315789473684,0.24152199888619424,1.0,19/41,25.87%,RND2;NLGN1;RHOQ;RHOB;EPB41L3;NCKAP1L;PPP2R3C;RAC1;RHOA;FHOD3;ROCK1;RAB13;RHOBTB1;STRIP1;FMNL3;FMNL2;RHOC;FHOD1;NCKAP1
prerank,osteoclast differentiation (GO:0030316),0.4416069112511489,1.333902511055415,0.16071428571428573,0.2375704628451689,1.0,11/22,27.60%,TNFSF11;GLO1;SNX10;EPHA2;DCSTAMP;EFNA2;OSCAR;OCSTAMP;TYROBP;TNFRSF11A;FARP2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.4274448831376683,-1.3336109526124489,0.09259259259259259,0.24205331420305365,1.0,8/27,14.98%,ATP2B4;MYOZ2;AKAP6;ACTN3;PRNP;MYOZ1;HOMER2;HOMER3
prerank,histone H4 acetylation (GO:0043967),-0.36430770552266206,-1.3334395639456447,0.05084745762711865,0.24184199902215567,1.0,15/48,13.68%,PER1;KANSL3;APBB1;JADE1;CHD5;DMAP1;MSL1;ING4;BRD8;KMT2A;MORF4L1;EPC1;ACTL6B;KAT7;OGT
prerank,receptor-mediated endocytosis (GO:0006898),-0.31410690290165355,-1.3330361861038438,0.031746031746031744,0.24198255657633028,1.0,48/133,23.07%,TPCN2;SNX1;PIP5K1C;PDLIM7;LMBR1L;NLGN3;ADRB3;MASP1;STAB1;CUBN;MICALL1;PI4KB;SNCA;TMEM108;ADRB2;INPP5F;STAB2;DNAJC13;SNAP91;WASF1;LRP1B;CAV2;RAMP1;GRK4;SFTPD;AP4E1;COLEC12;AP2A2;ACKR3;HSPG2;VLDLR;SCARF1;INSR;EPS15;FCHSD2;RAMP3;CD36;COLEC11;DNM1;HBB;DLL1;AP2M1;PIKFYVE;LRP6;CLTCL1;RAB31;SGIP1;RAMP2
prerank,endothelial cell development (GO:0001885),-0.4157039928486114,-1.332671968171266,0.08695652173913043,0.24193817251773345,1.0,12/25,21.12%,PDE2A;RAPGEF3;RAP1A;PDE4D;GSTM3;RDX;RAPGEF1;MYADM;ROBO4;SOX18;RAPGEF2;COL22A1
prerank,regulation of myelination (GO:0031641),-0.4365593622379327,-1.3325786446529724,0.06382978723404255,0.24158115692333507,1.0,9/25,11.78%,LGI4;JAM2;PTN;PTPRZ1;PARD3;SIRT2;RNF10;TPPP;DICER1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.40737229825312016,1.3297855127494165,0.18181818181818182,0.24271682289628985,1.0,9/29,15.66%,RPA3;CDK7;GTF2H3;ERCC5;RAD23B;DDB1;UBA52;RPA2;CUL4A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4669492885611898,1.3294107025524617,0.10638297872340426,0.2427435284384253,1.0,9/20,29.56%,PHB;CD46;CD55;CD70;MSH2;IL12B;SLA2;IL18;BTN3A2
prerank,nucleotide metabolic process (GO:0009117),0.4108273034524787,1.3284642884349052,0.05555555555555555,0.2435508835674133,1.0,15/23,31.93%,NUDT5;DCK;PNP;DCTD;CMPK1;CTPS2;CMPK2;RNASEH2B;ME1;ENPP3;FHIT;GUK1;PARK7;NMNAT1;AK7
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4863291127139441,-1.3268437630966008,0.13114754098360656,0.24985651157708064,1.0,10/18,23.11%,FLCN;APOD;RAB23;OTUD7B;LATS2;SIN3A;SUFU;CABP1;MDFIC;LATS1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.4169700643990758,1.326555487691069,0.0851063829787234,0.24570052524692484,1.0,17/29,24.43%,HSD17B12;SCD;TECR;ACSL6;HACD2;ACSL3;ELOVL1;ACSL5;ELOVL7;ACLY;ACSF3;PPT1;FASN;ELOVL6;SLC25A1;GCDH;HSD17B8
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.45954136415550584,1.3265297449731503,0.14893617021276595,0.2452731042172732,1.0,10/15,31.57%,FOXP3;TGFB2;JAK3;TGFB1;LILRB4;HLA-F;IRAK3;IL10;XCL1;TNF
prerank,DNA modification (GO:0006304),0.42554783047499445,1.3255330492122697,0.1111111111111111,0.24670471484569093,1.0,7/24,12.75%,EXOSC5;UNG;EXOSC4;NTHL1;NEIL3;EXOSC3;MPG
prerank,eye development (GO:0001654),-0.36357622346306395,-1.3248234653001865,0.08955223880597014,0.2526923076923077,1.0,22/57,24.19%,MEIS1;MAB21L2;CACNA1C;MAB21L1;SALL2;MEIS2;PBX3;CPAMD8;CHRDL1;PBX2;MEIS3;SKI;CEP290;ABCB5;RAB3GAP1;BMPR1B;EFEMP1;SOX2;NIPBL;SH3PXD2B;HIPK1;RAB18
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3796440663274222,-1.3245634826459656,0.09615384615384616,0.25240741653868404,1.0,9/36,12.70%,DYNC1I1;MYO15A;HAP1;PAFAH1B1;TRAK2;KIF1A;MYO5A;MYO1C;NDEL1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.44572030906703625,-1.3241886985526612,0.09615384615384616,0.2525435014311103,1.0,7/19,16.03%,SUPT7L;TAPT1;BBS4;SKP1;ARL2;MORC3;TAF3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.4700294191152957,-1.3241072501520743,0.08620689655172414,0.2522418212157064,1.0,7/18,14.21%,CRTC3;RPS6KA5;PRKD1;EPHA5;CRTC1;CRTC2;RELN
prerank,DNA conformation change (GO:0071103),0.44697363569613563,1.3239977628530872,0.125,0.24836486633974428,1.0,9/18,21.40%,TOP1MT;HMGB3;TOP1;HMGB2;TOP3B;HAT1;TOP2A;TOP3A;HMGB1
prerank,regulation of cytokinesis (GO:0032465),0.32072234363856944,1.3238187349149086,0.024390243902439025,0.24812180894418143,1.0,34/83,23.30%,KIF20B;RACGAP1;SSTR5;KIF23;KIF20A;KIF14;AURKB;CXCR5;ECT2;RAB11A;CHMP4C;BCL2L1;PDXP;PRPF40A;OR2A4;RAB11FIP4;AURKA;SPAST;DRD2;PLK1;E2F8;PLK4;CENPV;CDC6;PKP4;CDC42;RXFP3;E2F7;GIT1;CUL3;GIPC1;CDC14C;MYO19;CSPP1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3378598723060053,1.3235120678711578,0.08333333333333333,0.24759213477119207,1.0,29/55,35.11%,COA1;NDUFS6;FOXRED1;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;NDUFAF2;NUBPL;NDUFAF3;NDUFA1;NDUFB9;TMEM126A;NDUFB6;NDUFB5;NDUFB4;NDUFS3;NDUFAF6;NDUFAF4;NDUFS1;NDUFB7;NDUFA2;NDUFC1;NDUFS5;NDUFB2;TMEM126B;NDUFA6;NDUFS8
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3378598723060053,1.3235120678711578,0.08333333333333333,0.24759213477119207,1.0,29/55,35.11%,COA1;NDUFS6;FOXRED1;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;NDUFAF2;NUBPL;NDUFAF3;NDUFA1;NDUFB9;TMEM126A;NDUFB6;NDUFB5;NDUFB4;NDUFS3;NDUFAF6;NDUFAF4;NDUFS1;NDUFB7;NDUFA2;NDUFC1;NDUFS5;NDUFB2;TMEM126B;NDUFA6;NDUFS8
prerank,mismatch repair (GO:0006298),0.4244297002740236,1.3235040378123244,0.06,0.24709633638607478,1.0,11/29,17.13%,RPA3;TP73;EXO1;POLD2;LIG1;MSH3;PMS2;MSH6;RPA2;POLD1;RNASEH2A
prerank,acylglycerol catabolic process (GO:0046464),0.40122068022476925,1.323170354879479,0.0784313725490196,0.24729903329149647,1.0,12/29,24.63%,FABP6;ABHD12;PNPLA4;LIPG;PNPLA1;PNPLA3;LYPLA2;ABHD2;ABHD12B;LIPE;FAAH;DAGLA
prerank,negative regulation of axon extension (GO:0030517),-0.38928825476351264,-1.323116169450449,0.12727272727272726,0.2532867707068098,1.0,18/31,28.34%,SEMA6C;PTPRS;SEMA4C;MAP2;SEMA3E;SEMA6D;SEMA6A;SEMA3B;MAG;SEMA3G;SEMA3A;RTN4;TRIM46;SEMA3C;SEMA4B;SEMA3D;MT3;SEMA6B
prerank,central nervous system development (GO:0007417),-0.28958188583839306,-1.323045301250564,0.037037037037037035,0.25293037688986814,1.0,87/260,22.01%,PKD1;POU6F1;MEIS1;MAL;S100B;ATN1;EML1;ROGDI;NPTX1;SZT2;EPHA7;MEIS2;NNAT;PBX3;PKD2;GSN;VIT;GBA2;DSCAML1;HAP1;SYNJ1;DNER;TAGLN3;PTPRZ1;CIC;DCLK1;AMIGO1;HAPLN2;NDRG4;MDGA1;SNTG2;SMARCA1;ADGRL3;APOD;PBX2;PTEN;ZBTB16;ADGRL2;HPCAL4;NFIB;ADAM23;ADORA2A;TPPP;MEIS3;MAST1;SLC8A3;SH3GL3;ARNT2;RELN;HSPG2;ZNF335;UGP2;CDH2;ZFHX3;CNTN4;CA10;MOG;GLIS2;AATK;SPINK5;SLC6A17;RAB3GAP1;AHI1;GRIN2A;SMO;AMIGO2;SOX11;SPOCK1;CNTN6;KLHL17;CHST8;HAPLN4;CDK5RAP3;POU3F3;AGTR2;CDK5RAP2;DLL1;SOX6;BPTF;SETD1A;LOXL3;DCX;NCAN;ADGRA2;PCDH18;LIG4;NHEJ1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.36644630095238034,-1.3227326190738604,0.07272727272727272,0.25288325591992294,1.0,23/65,18.32%,NRP2;PXN;PIK3R1;ITGB3;SHC2;NCK1;PRKD1;VEGFB;FLT4;DOCK1;NCKAP1L;HSPB1;DAB2IP;MAPK11;ELMO2;RAC1;CLEC14A;RHOA;ROCK1;ELMO1;BAIAP2;MAPK14;WASF2
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.45599244470818123,-1.3224029407866675,0.06349206349206349,0.2527098032644405,1.0,11/24,13.03%,TMEFF2;MYOC;PHLDB2;PIK3R1;ARHGAP6;DLC1;CLASP1;CLASP2;ARHGEF18;INPP5K;TJP1
prerank,heart morphogenesis (GO:0003007),-0.37805611897758645,-1.3222190992742069,0.03508771929824561,0.2525731102124988,1.0,23/52,23.27%,TBX19;TGFBR3;BMPR1A;TCAP;DLC1;TBX1;OLFM1;MDM4;MEGF8;RYR2;HEY1;SOX17;ACTC1;TBX2;HTR2B;HEY2;FLRT2;INSR;ANKRD1;MYBPC3;NIPBL;TTN;MYLK2
prerank,dendritic cell chemotaxis (GO:0002407),0.4858883982611838,1.322139798042552,0.10204081632653061,0.2484738375437647,1.0,6/16,22.30%,TRPM2;CXCR4;CXCR2;PIK3CG;HMGB1;CXCR1
prerank,regulation of epithelial cell migration (GO:0010632),-0.3763692604929391,-1.3220296578106108,0.1016949152542373,0.2524009484234571,1.0,19/51,17.77%,SASH1;GLIPR2;PTN;MACF1;HDAC6;CLASP1;RHOJ;EVL;CLASP2;PPM1F;DOCK1;CORO1C;MCC;DAB2IP;CAPN7;ENPP2;FGF10;GLUL;RTN4
prerank,calcium ion transmembrane transport (GO:0070588),-0.3457797083693019,-1.3214382784300724,0.08695652173913043,0.25284036088827977,1.0,23/85,14.77%,PKD1;RYR3;ATP2B4;CACNA1C;TRPV1;PKD2;TRPC1;CACNA2D1;SLC8A2;SLC25A23;SLC24A4;MICU3;P2RX7;SLC8A1;TRPC6;TRPC4;SLC24A3;CACNA1G;ATP2B3;SLC8A3;MCOLN3;TRPV3;MCOLN1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.33524746375108516,-1.3214113522329016,0.03571428571428571,0.2524352279574212,1.0,42/104,24.98%,RASGRP2;NTN1;ARHGAP33;FGF2;RERG;RRAGC;SHC2;RGL2;ERAS;RALGDS;KSR1;PRKD1;DIRAS3;RGL1;ARHGEF18;RRAS;PLCE1;KRIT1;TIAM1;MAPK11;RIT2;RAC1;CDKN1A;RRAD;ARHGAP31;CCDC88A;RUNDC3A;SOS1;MAPK14;TNK2;PLD2;ARL3;RAPGEF6;RAPGEF2;SETDB1;SHC3;RASSF1;USP28;RIT1;RAB18;USP8;ARHGAP1
prerank,regulation of acute inflammatory response (GO:0002673),0.47590564163487237,1.321100281457773,0.1276595744680851,0.24968998138277454,1.0,7/18,21.37%,C2CD4A;OSM;F12;FFAR2;ADAM8;PLA2G2D;C2CD4B
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3226997722732006,-1.320903915298947,0.0,0.25285495958023696,1.0,47/113,25.47%,PDE2A;DUSP22;TGFBR3;BMPR1A;FERMT2;GCNT2;MAPK7;PXN;WFIKKN2;SMAD4;CLDN5;PARD3;CILP;SOX5;ZFP36L1;ZMIZ1;NR3C1;ARHGEF18;PDE3A;MEF2C;SKI;SFRP1;RHOA;USP9Y;GDF5;SMAD9;CBL;CLEC3B;ZFYVE9;SMAD2;USP15;LRRC32;UBB;HPGD;ANKRD1;SIRT1;SOX6;MAP3K7;SMAD7;CDH5;DLX1;TWSG1;TGFB3;ZFP36L2;AMHR2;SMAD3;FNTA
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.44143710605165276,1.3206902822755715,0.1,0.2498168141490617,1.0,6/20,10.28%,SLC39A10;RPS3;KCNN4;CARD11;CD81;RELA
prerank,autophagosome maturation (GO:0097352),-0.4332526568851273,-1.320411534292496,0.08196721311475409,0.2530408417106232,1.0,20/33,25.93%,GABARAPL1;CALM1;LIX1L;ATG14;CHMP3;MAP1LC3C;UVRAG;EPG5;LIX1;VTI1B;VPS33B;VIPAS39;TSG101;GABARAPL2;MAP1LC3A;TECPR1;ATP2A2;GABARAP;CLN3;VPS33A
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.4088911709836851,-1.3203287538119637,0.11475409836065574,0.25272682230348004,1.0,12/37,17.14%,FLCN;SFRP5;PPP2R5B;MAGI2;GPER1;PTEN;PHLDA3;MSTN;OTUD3;INPP5K;PHLPP2;TSC2
prerank,regulation of endothelial cell migration (GO:0010594),-0.33712384626123665,-1.3188675451581082,0.03225806451612903,0.2545847900989983,1.0,26/85,17.62%,SASH1;FGF2;PTPRM;NRP2;PTN;ADGRB1;ZNF580;ITGB3;PRKCA;RHOJ;RHOB;NR2F2;PRKD1;SLIT2;ATOH8;FLT4;DCN;RRAS;ANGPT4;SYNJ2BP;DAB2IP;KRIT1;RAC1;ADAMTS9;GLUL;FGF1
prerank,drug catabolic process (GO:0042737),0.47428845417266136,1.3187819454138296,0.12244897959183673,0.2521531731004341,1.0,4/17,7.15%,CYP2S1;CYP2W1;NUDT15;CYP2F1
prerank,sulfur amino acid metabolic process (GO:0000096),0.4644314367714762,1.3184100508655383,0.1590909090909091,0.2522284334704672,1.0,8/20,15.13%,AHCY;DPEP1;MTHFD1;MAT1A;SMS;ADO;CTH;MPST
prerank,sulfation (GO:0051923),0.4784727672470558,1.318141354109505,0.2,0.2520053415953489,1.0,4/16,7.07%,SULT2B1;CHST4;SULT1C2;SULT1C3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3407821834830838,1.318032820801702,0.05263157894736842,0.2516687747890945,1.0,35/70,35.11%,COA6;UQCC3;COX6B1;NDUFS6;COX7A2L;UQCRQ;UQCRH;CYCS;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;COX4I1;CYC1;COX5B;COX7B;UQCRC1;NDUFA1;NDUFB9;NDUFB6;NDUFB5;COX5A;NDUFB4;NDUFS3;NDUFA4;NDUFS1;NDUFB7;UQCRHL;NDUFA2;NDUFC1;NDUFS5;NDUFB2;NDUFA6;NDUFS8
prerank,regulation of cellular component organization (GO:0051128),-0.30656963546025634,-1.3179313843509368,0.04477611940298507,0.25576072605719213,1.0,51/136,24.56%,FAM107A;RASGRP2;STON1;RAP1A;EGLN2;SOCS2;PTCH2;AGTR1;SLITRK2;LTBP4;ANGPTL7;WFDC1;PACSIN1;KIAA1109;SETD5;RAB5B;NRG3;ARHGEF11;TAOK2;OPHN1;PLCE1;DAB2IP;TJP1;GFAP;RAB4B;RIT2;RAPGEF1;MARK4;PACSIN2;PAPPA2;ROCK1;CAMK2D;SGK3;PIFO;TSC2;CAMSAP2;PACSIN3;SPOCK1;CD36;RAPGEF2;RUFY1;RUFY2;SETD1A;RPTOR;MTOR;LATS1;BAP1;CDK11B;PINK1;ZFYVE16;CDK11A
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.45278176456210617,-1.3177659571828264,0.12244897959183673,0.25549644095141566,1.0,9/20,19.22%,SYNGAP1;LZTR1;MFN2;SLIT2;SPRY1;DAB2IP;SPRY3;MAPKAP1;CGNL1
prerank,exogenous drug catabolic process (GO:0042738),0.484970948444024,1.3174131117170849,0.10416666666666667,0.25210987774827404,1.0,4/16,7.15%,CYP2S1;CYP2W1;NUDT15;CYP2F1
prerank,zinc ion transmembrane transport (GO:0071577),0.44417240549548326,1.3171184482326133,0.11363636363636363,0.2521162538034432,1.0,10/22,18.49%,SLC39A11;SLC30A2;SLC39A10;TRPM2;SLC30A6;SLC39A8;SLC30A5;SLC39A2;SLC39A7;SLC30A1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3995352399098081,1.3169534817782063,0.09523809523809523,0.251849743766495,1.0,9/29,11.16%,RUVBL1;MYC;TCF7;AXIN2;LEF1;RBBP5;SMARCA4;HDAC1;BCL9L
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.42598118026030457,-1.3168855881733532,0.08333333333333333,0.2566130062866356,1.0,7/25,14.01%,DLG4;ITGB3;PSEN1;RIN3;ATXN2;ANKRD13A;RAC1
prerank,regulation of presynapse assembly (GO:1905606),-0.44488552571624357,-1.3160102533969995,0.10638297872340426,0.25728250961731586,1.0,9/18,21.89%,SLITRK2;SNCA;LRFN5;MDGA1;LRRC4B;SLITRK3;IL1RAPL1;SLITRK1;GPC6
prerank,regulation of presynapse organization (GO:0099174),-0.44488552571624357,-1.3160102533969995,0.10638297872340426,0.25728250961731586,1.0,9/18,21.89%,SLITRK2;SNCA;LRFN5;MDGA1;LRRC4B;SLITRK3;IL1RAPL1;SLITRK1;GPC6
prerank,regulation of cell motility (GO:2000145),-0.31689956494373905,-1.3146206908283424,0.03508771929824561,0.25898721848654943,1.0,43/128,19.42%,NTN1;FLNA;RAF1;PLXNB3;NRG2;FGF2;AMOTL1;TTBK2;BTC;NEXN;MACF1;BEX4;FGF22;INPP5F;FES;RHOB;CADM4;HACE1;LDB2;FBLN1;DAPK3;FGF17;RAC1;SPOCK3;RHOA;ENPP2;FGF7;ROCK1;SGK3;FGF5;AMOTL2;ROBO4;FGF10;AKT2;FGF1;PLXNA4;SST;PLXNB1;FGF16;EGFR;ERBB4;LMO4;SLK
prerank,lung development (GO:0030324),-0.4057426204281903,-1.3145978697624587,0.109375,0.2585437381061762,1.0,17/34,22.88%,NPHP3;PKD1;FOXF1;FGF2;FGFR2;CCDC39;TCF21;CCDC40;GLI2;FGF7;FGF10;ABCA3;FGF1;SOX11;FGF9;LOXL3;ERRFI1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4713913361075145,1.3142061736256918,0.14,0.2551469411244396,1.0,6/15,11.37%,TRIAP1;PSMD10;BCL2L1;PPIF;GPX1;PRELID1
prerank,negative regulation of peptidase activity (GO:0010466),0.35847630710745915,1.3138414150701954,0.10638297872340426,0.2552376621362196,1.0,24/52,27.96%,SERPINB5;GAPDH;CSTB;TIMP1;SERPINB1;CRB2;SERPINE3;SERPINA10;SERPIND1;SERPINA7;SERPINA4;SERPING1;SERPINB7;AGT;SERPINE1;CST7;SERPINB8;CSTA;SERPINA1;KNG1;SERPINE2;SERPINH1;SERPINB9;PARK7
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3998231963458869,1.3134274639859236,0.07317073170731707,0.2554184112096237,1.0,10/30,18.71%,ETV4;CBFB;CTSV;CYP27B1;ZBED2;RUNX1;AQP3;GRHL2;MED1;HOXA7
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.49332556382696335,-1.3131828241688295,0.16071428571428573,0.26025703749245876,1.0,8/19,20.91%,NXF1;PABPN1;DDX25;DDX19A;POLDIP3;HHEX;NXF5;MCM3AP
prerank,proteolysis (GO:0006508),0.27452897738884696,1.3131668172712105,0.0,0.2553277839436177,1.0,83/273,19.72%,MMP7;FAP;PRSS33;NLN;PRSS22;CAPN12;HM13;TMPRSS3;ACAN;GZMB;F12;CTSV;MIPEP;VHL;BACE2;PLAU;MMP1;MMEL1;LRP8;CPZ;KLK12;OLR1;CPD;PSMC4;ERMP1;SPCS1;CTSH;MME;CTSC;APEH;PSMB5;APH1A;PCSK1;REN;DPP3;CASP2;CASP6;CPN1;F7;CTSE;ADAM10;ADAMTS12;MMP2;PROC;XPNPEP1;MMP3;CAPN1;LONP1;CLPP;PRSS48;LAP3;MMP24;THOP1;MMP9;YME1L1;MMP12;CNDP2;TMPRSS7;PRSS3;NCSTN;SPRTN;LCN1;FBXO6;CTSZ;GZMA;PCSK7;IDE;ST14;PRSS54;MMP15;CPNE1;DESI1;PRSS21;PSMD6;RSPRY1;PCSK6;ZMPSTE24;SDE2;CTSA;TMPRSS4;ERAP1;TYSND1;MMP8
prerank,iron-sulfur cluster assembly (GO:0016226),0.4630983999882229,1.311774034038817,0.11627906976744186,0.2570606495076766,1.0,8/21,19.65%,CIAO1;GLRX3;CIAPIN1;HSPA9;ISCA2;FXN;LYRM4;NUBPL
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3978585861673369,-1.3113565122583866,0.09259259259259259,0.2628556636345935,1.0,21/42,28.83%,FGFR1;ADRA2B;HOXD3;NGF;MEF2C;MMD2;RHOA;TCF4;GPRC5B;ZC4H2;SIN3A;SOX11;PCP4;BEND6;DLX1;VWC2;MMD;NBL1;ASCL1;BRINP2;KCTD11
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.49388235228635613,-1.3112210049729307,0.13636363636363635,0.26258189156361483,1.0,4/15,8.32%,RAPGEF3;EHD2;ADGRB1;CAMK1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.26592750946474275,1.309323142219416,0.0,0.2603588503425637,1.0,97/312,21.72%,PSMD14;MAD2L1;DCAF12;PSMB2;CDK1;FBXO5;PTTG1;STT3B;PSMB9;PSMA5;SKP2;FBXL18;PSMB3;UBE2S;FBXO45;PSME3;PSMA3;KIF14;BUB3;DERL1;PSMA7;SEC61B;PSMD13;GID8;PSME2;PSMC2;PSMC4;PSMD10;TRIM72;ERCC8;PML;AURKB;PSMD12;ANAPC1;FBXO4;BFAR;PSMB5;KCTD5;PLAA;ERLIN1;UBE2C;UBE3D;CCNF;TRIM2;PRAME;AURKA;PSMD8;CDC26;FOXRED2;PSMB4;PSMD3;PSMB1;PSMA4;TRIM71;RAD23B;DDB1;SPSB2;PSME1;PSMF1;ANAPC11;PLK1;FBXL13;PSMD11;UBE2J1;UBA52;PSMD1;NHLRC1;VCP;CUL4A;RNF34;RNF187;FBXL14;UBE2A;ERLIN2;HSPA5;MAN1B1;FBXO6;UBQLN1;FAF2;FEM1A;OS9;UBE2K;PSMD6;CDC20;BUB1B;UBE2D1;PSMD5;AUP1;RBCK1;DNAJC10;KBTBD7;HECW1;CUL3;UBXN8;HECW2;CDK2;PSMC1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2898894748585954,1.309010046023409,0.03125,0.26025879164759824,1.0,43/160,14.58%,NOTUM;PSMD14;PSMB2;DKK4;PSMB9;PSMA5;PSMB3;UBAC2;PSME3;PSMA3;RUVBL2;PSMA7;KREMEN2;PSMD13;WNT5A;AXIN2;PSME2;PSMC2;PSMC4;PSMD10;PTPRO;PSMD12;SOX9;LRP4;PSMB5;MDK;STK4;ZNRF3;HDAC1;PSMD8;IGFBP2;PSMB4;GSK3B;PSMD3;PSMB1;PSMA4;MLLT3;WNT11;PSME1;PSMF1;PSMD11;PSMD1;IGFBP1
prerank,positive regulation of axon extension (GO:0045773),-0.427109859230905,-1.3086796611319926,0.09433962264150944,0.2661243763731627,1.0,8/22,17.57%,NTN1;MAPT;MACF1;RUFY3;L1CAM;MEGF8;DBN1;DSCAM
prerank,positive regulation of programmed cell death (GO:0043068),-0.2884099824331763,-1.308407077126819,0.014925373134328358,0.26619320119835377,1.0,90/274,23.16%,ARHGEF26;FLCN;CLIP3;APBB1;RBM5;ADAMTSL4;ARHGEF17;MLLT11;KCNMA1;CLU;ARHGEF9;PNMA1;GPER1;MOAP1;JMY;PLEKHG2;SNCA;HDAC6;ARHGEF6;ITSN1;ATF4;OBSCN;NGF;ING4;RPS6KA2;NGFR;RHOB;OLFM1;DAPK1;PSEN1;SLIT2;PHLDA3;LRRK2;QRICH1;ARHGEF18;ARHGEF11;CALHM2;NTRK1;APH1B;FGD1;LATS2;PNMA3;TNFSF10;DAB2IP;ERCC3;TIAM1;DAPK3;KLF11;GADD45B;MARK4;PRMT2;SFRP1;CSRNP3;SOS2;BCL10;ARHGEF7;PSEN2;PIDD1;PIP5KL1;MAPK8;RNF122;APC;MCF2;FAS;TRIO;SOS1;HOXA5;CASP3;ING3;CASP9;UBB;DCUN1D3;RASSF2;MAP3K10;APAF1;FGD2;ANKRD1;CRADD;SIRT1;ING5;BNIP3;AKAP13;SOD1;BOK;ARHGEF3;BCL2L11;BAD;GADD45G;LATS1;ANO6
prerank,protein targeting (GO:0006605),0.30488613789126623,1.3077812083052707,0.024390243902439025,0.26179226195972544,1.0,33/120,16.02%,AP1S3;TOMM34;SRPRB;ZDHHC9;TIMM23;ATG3;BCAP31;TOMM40;TIMM10;TIMM13;SPCS1;TOMM22;SEC61A1;TOMM20;LAMP2;SEC61G;ZDHHC12;TIMM17B;RAB3IP;TIMM8B;ZDHHC3;RABGEF1;ZDHHC24;YIF1B;TSPO;KATNB1;SORL1;ZDHHC6;PRKCI;PEX16;NACA2;FUT10;AP1M2
prerank,endoderm formation (GO:0001706),0.3740442223466731,1.3068312930690398,0.0851063829787234,0.2626720908479866,1.0,15/35,19.72%,DUSP4;COL11A1;INHBA;TBX20;HMGA2;FN1;DUSP1;MMP2;ITGA5;LAMB3;LAMA3;MMP9;DUSP2;MMP15;MMP8
prerank,epidermal cell differentiation (GO:0009913),0.36948186763742324,1.3065091363581105,0.043478260869565216,0.2625011446437215,1.0,22/44,26.41%,EREG;HDAC2;WNT5A;CDSN;EPHA2;HDAC1;EVPL;GATA6;DSP;OVOL3;MED1;SCEL;PITX2;ST14;OVOL1;ADAM9;ERCC2;OVOL2;OPN3;CSTA;CTNNB1;ANXA1
prerank,positive regulation of catalytic activity (GO:0043085),0.39239222540000146,1.306424776004916,0.08888888888888889,0.26213074983580165,1.0,15/38,21.43%,SSBP1;YWHAB;XRCC5;XRCC4;MSH3;APH1A;ABL2;FGFR4;MSH6;CIB1;NCSTN;NOD2;FXN;CAV1;MSH2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.28727039512037766,-1.30631350128321,0.0136986301369863,0.2690212243696251,1.0,136/399,21.05%,NFATC4;ATP6V1G2;SORBS1;EFS;FGFR1;PILRB;EPHA7;FGF2;GAB1;DDR2;SOCS2;ANGPTL1;SHC4;NRP2;HAP1;PXN;ANKS1A;GFRA2;PDGFRA;ROR2;PIK3R1;FGFR2;ZNF106;TIAL1;GH1;NTRK3;FGF22;ITGB3;FRS3;ADRB2;ITSN1;FLRT1;NGF;RHOQ;RBFOX2;GIGYF1;SHC2;FES;KIT;NGFR;GHR;NCK1;PSEN1;PRKD1;CHRNA3;ALK;CAV2;EPHA5;VEGFB;SIRT2;FLT4;KL;DOCK1;SDC2;FER;NCKAP1L;SOGA1;TIA1;GRB10;FOXO4;NTRK1;ROR1;APH1B;RARRES2;MERTK;MAPK1;EPHA4;MAPK3;TIAM1;ARPC2;FGF17;MAPK11;GRB14;AP2A2;RAPGEF1;ELMO2;RAC1;PIK3R3;EFNA5;RHOA;MUSK;EPHA3;ARHGEF7;PSEN2;PDGFB;FGF7;HNRNPH1;ROCK1;EPHA6;APC;INSRR;NTF3;TIE1;COL4A6;FGF5;ELMO1;FGF10;COL4A2;BAIAP2;FLRT2;SOS1;CBL;TSC2;MAPK14;AHI1;TNK2;AKT2;FGF1;INSR;CASP3;FGF16;EGFR;ATP6V0A1;ERBB4;WASF2;ATP6V1B1;SIPA1L1;PLCB1;PLAT;ANGPT1;PDK2;RET;SH2D6;ATP6V1E1;TCIRG1;DNM1;GSK3A;SETX;INS;AP2M1;NR4A3;RAPGEF2;PHIP;VEGFC;FGF9;PDGFD
prerank,negative regulation of chemotaxis (GO:0050922),-0.3987159923665427,-1.3061567399007041,0.1694915254237288,0.2688071564085226,1.0,11/31,17.58%,SEMA6C;DUSP3;ELANE;SEMA4C;SLIT2;SEMA3E;SEMA6D;SEMA6A;SEMA3B;SEMA3G;SEMA3A
prerank,signal release from synapse (GO:0099643),-0.3927137556797476,-1.305676271568812,0.08333333333333333,0.26850223859229483,1.0,22/43,28.52%,VAMP2;PIP5K1C;BRSK1;CPLX3;NRXN1;SYT10;SNCA;SNPH;SYN2;NRXN2;SNAP25;RAB3A;SYN1;SNAPIN;RIMS1;SYT1;STXBP1;CPLX2;LIN7A;STX1A;OTOF;DVL1
prerank,neurotransmitter secretion (GO:0007269),-0.3927137556797476,-1.305676271568812,0.08333333333333333,0.26850223859229483,1.0,22/43,28.52%,VAMP2;PIP5K1C;BRSK1;CPLX3;NRXN1;SYT10;SNCA;SNPH;SYN2;NRXN2;SNAP25;RAB3A;SYN1;SNAPIN;RIMS1;SYT1;STXBP1;CPLX2;LIN7A;STX1A;OTOF;DVL1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.3317288402506327,-1.305406495824802,0.045454545454545456,0.2685314977038902,1.0,52/121,27.79%,IP6K3;PITPNM2;PIP5K1C;ITPKB;INPP4A;INPPL1;FGF2;SOCS2;MTMR9;SYNJ1;TTC7B;PI4KB;PIK3R1;PI4KA;INPP5E;INPP5F;PIP4K2B;PTEN;SLC27A1;FAM126A;PIK3C3;INPP5K;PITPNM3;TMEM150A;IP6K1;PIK3R3;PI4K2A;BMX;PIP4K2A;CDIPT;EFR3B;PIKFYVE;PLEKHA3;RUFY1;PLEKHA4;PIK3R2;SMG1;PLCG2;SBF1;FAM126B;PIGQ;MTMR12;PIP5K1A;PIK3R6;PIGG;MTMR7;PIK3C2A;TTC7A;PIK3R5;TPTE2;FIG4;OCRL
prerank,Ras protein signal transduction (GO:0007265),-0.30852402285237024,-1.3040415988188963,0.05,0.2701423370275231,1.0,56/137,24.98%,RASGRP2;NTN1;RAPGEF3;RAP1A;FGF2;RERG;AGTR1;CDC42EP3;ARHGAP6;SHC2;MYO9B;RGL2;NGFR;RHOB;ERAS;WASF1;RALGDS;KSR1;PRKD1;GDI1;HACE1;RRAS;ARHGEF11;PLCE1;ABI2;TIAM1;GNA12;MAPK11;RIT2;RAPGEF1;CDC42EP4;RAC1;CDKN1A;RHOA;ARHGAP29;ROCK1;SGSM3;ELMO1;SOS1;MAPK14;TAX1BP3;RAPGEF6;ARHGAP5;RAPGEF2;CTNNAL1;SETDB1;SHC3;RASSF1;ARHGEF3;USP28;ARHGDIG;CDC42EP2;RIT1;BRK1;USP8;ARHGAP1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.33279449913832004,1.3034630816204265,0.023255813953488372,0.26533679589132203,1.0,26/96,16.53%,SPTBN2;AP1S3;AP1S1;KIF2A;KIF18A;KIF15;RACGAP1;CTSV;CENPE;CANX;KIF23;CAPZA1;SEC13;KIF22;KIF3B;CLTA;CTSE;AP2S1;KIF4B;KIF2C;CLTC;AP2B1;DCTN5;AP1M2;DYNLL1;RAB7A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.33279449913832004,1.3034630816204265,0.023255813953488372,0.26533679589132203,1.0,26/96,16.53%,SPTBN2;AP1S3;AP1S1;KIF2A;KIF18A;KIF15;RACGAP1;CTSV;CENPE;CANX;KIF23;CAPZA1;SEC13;KIF22;KIF3B;CLTA;CTSE;AP2S1;KIF4B;KIF2C;CLTC;AP2B1;DCTN5;AP1M2;DYNLL1;RAB7A
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.510286877078852,-1.3032107217710027,0.15789473684210525,0.2710607397511496,1.0,12/17,22.92%,ANK2;SCN3B;KCNH2;SNTA1;KCNE2;RYR2;KCNJ8;KCNE1;KCNE4;SCN5A;GPD1L;CAV3
prerank,RNA splicing (GO:0008380),0.3159250772441363,1.3031425450464513,0.075,0.2651840078241962,1.0,32/97,17.03%,DDX47;SNRPF;SNRPD1;LSM4;SNRPG;SF3B3;U2AF1;MAGOH;PRPF4;SNRPB;RNF113A;KHSRP;MAGOHB;SNRPD2;NCBP1;SRPK1;PTBP1;NONO;RSRC1;SNRNP40;PRPF6;SNRPA1;NCBP2;HNRNPC;FUS;DHX8;LSM6;USP39;CDK12;SYNCRIP;TRA2B;SF3A3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.44023048589993413,-1.3028253512932721,0.1320754716981132,0.27125633267198873,1.0,9/18,25.35%,FAM107A;KLF9;ZFP36L1;NR3C1;AQP1;ZFP36;SSTR2;BCL2L11;ZFP36L2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.44074179469808156,1.3025039448345246,0.13333333333333333,0.26545097198861906,1.0,8/20,15.82%,CBFB;IRAK2;WNT5A;DHX9;IRAK1;RUNX1;TAF9;ELF1
prerank,regulated exocytosis (GO:0045055),-0.31503140796517415,-1.3022582518315002,0.03225806451612903,0.27158796422586806,1.0,79/157,28.28%,VAMP2;PIP5K1C;FLNA;SYNGR1;TLN1;VCL;CPLX3;CLU;PPP3CB;ACTN2;ITIH4;CALM1;SYT10;F8;SNCA;ITGB3;ACTN1;CFD;PCDH7;SYT11;CYB5R1;RIMS3;VEGFB;SNAP25;RAB11FIP2;SYT2;SYT9;HABP4;MMRN1;VTI1B;RARRES2;SYT6;SYT5;ALDOA;SYTL4;TIMP3;RAB3A;CDC37L1;NHLRC2;PDGFB;TMX3;CRHBP;CD63;STEAP2;CLEC3B;SCG3;CD36;F13A1;ITGA2B;SNAPIN;RIMS1;VEGFC;A1BG;SOD1;TPH1;RAB11FIP5;ENDOD1;SYT1;RAB31;SYNGR3;TTN;HGF;SYT3;CD109;STXBP1;PDGFA;TGFB3;ARHGAP17;CPLX2;SELP;ABCC4;SYT15;ISLR;LHFPL2;BRPF3;BLK;STX1A;OTOF;RAB11B
prerank,eye photoreceptor cell development (GO:0042462),0.471176226623603,1.3019794685974284,0.16279069767441862,0.265782926206379,1.0,7/15,14.64%,THY1;CRB2;RP1;TH;NRL;RPGRIP1L;USH1C
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.41433859313492133,-1.3019264629689695,0.12698412698412698,0.2716794615597801,1.0,11/26,32.45%,TLR9;TLR3;GPS2;LRRC14;CD36;NFKBIL1;OTUD4;FLOT1;CACTIN;BIRC2;TLR2
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.403209771481715,-1.3017777870696403,0.09523809523809523,0.27136183868157043,1.0,9/31,13.99%,HSPB8;DNAJC18;ATXN3;HSPA2;HDAC6;OPTN;DAB2IP;BAG3;HSPA1L
prerank,positive regulation of defense response (GO:0031349),0.3215264093648909,1.301516356218702,0.038461538461538464,0.2660696199913151,1.0,31/95,19.78%,OSM;EREG;IL23A;ZP3;POLR3C;IL1B;WNT5A;MGST2;AKIRIN2;CEBPA;NMI;DHX9;MDK;IL21;POLR3B;CYBA;CCL3;PLA2G7;GBP5;AGT;GRN;MAPK13;FPR2;ADAM8;FEM1A;POLR3G;PLSCR1;NFKBIA;SLC15A4;SERPINE1;TNFSF4
prerank,negative regulation of translation (GO:0017148),0.3100650048659785,1.3013884109932492,0.0625,0.26582887363938207,1.0,27/84,16.77%,ENC1;CALR;CAPRIN1;PUS7;GZMB;DHFR;MRPL13;GAPDH;EIF4EBP1;IGF2BP1;NCL;EIF4A3;YTHDF1;NANOS3;IGF2BP3;RPS3;CNOT10;GRB7;IGF2BP2;EIF4E2;MEX3D;TRIM71;MALSU1;YTHDF2;CNOT1;EIF3E;SYNCRIP
prerank,steroid biosynthetic process (GO:0006694),0.3335180981083518,1.3012258810279465,0.0,0.26554530457061154,1.0,26/62,24.06%,CYP51A1;SRD5A1;SQLE;DHCR7;SC5D;HSD17B10;AKR1C4;OSBPL3;BAAT;FDXR;CYP39A1;PRLR;CYP7B1;MSMO1;HSD3B7;TM7SF2;ACOT8;INSIG1;SLC27A5;FDFT1;HSD17B4;EBP;HMGCR;OSBPL2;HSD3B1;OSBP
prerank,detection of chemical stimulus involved in sensory perception of smell (GO:0050911),0.4006821649762142,1.3010228717355423,0.13636363636363635,0.26543759687723373,1.0,20/20,59.97%,OR2A4;OR2A7;OR6K3;OR4E2;GPR148;OR12D2;OR10Z1;OR10K1;OR10J1;OR6N2;OR12D3;OR10J3;OR10K2;OR6K2;OR10T2;OR6K6;OR10R2;OR13G1;OR1K1;OR2A25
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.32237356068798173,1.3006769822668185,0.044444444444444446,0.2655483144610449,1.0,26/101,16.53%,SPTBN2;AP1S3;AP1S1;KIF2A;KIF18A;KIF15;RACGAP1;CTSV;CENPE;CANX;KIF23;CAPZA1;SEC13;KIF22;KIF3B;CLTA;CTSE;AP2S1;KIF4B;KIF2C;CLTC;AP2B1;DCTN5;AP1M2;DYNLL1;RAB7A
prerank,positive regulation of leukocyte activation (GO:0002696),0.508361554739366,1.300476388816742,0.047619047619047616,0.2653539934053442,1.0,8/16,27.40%,HSPD1;WNT5A;CEBPA;SPACA3;HAVCR1;CD2;THBS1;CLEC7A
prerank,detection of chemical stimulus involved in sensory perception (GO:0050907),0.4118027592312878,1.2998184962139518,0.11904761904761904,0.26598559844510494,1.0,18/22,51.75%,OR2A4;PKD2L1;OR2A7;OR6K3;OR4E2;GPR148;OR5AN1;OR12D2;OR10Z1;OR10K1;OR10J1;OR6N2;OR12D3;OR10J3;OR10K2;OR6K2;OR10T2;OR6K6
prerank,respiratory tube development (GO:0030323),-0.4196295148682093,-1.2990088365931227,0.15517241379310345,0.2752276164715553,1.0,15/29,21.13%,NPHP3;FOXF1;FGF2;FGFR2;CCDC39;TCF21;CCDC40;GLI2;FGF7;PCSK5;ABCA3;FGF1;HECA;FGF9;LOXL3
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3511707740207145,-1.298817737643592,0.05263157894736842,0.2750233852551085,1.0,33/77,27.39%,RBPMS2;ATP2B4;EPN2;BMPR1A;DAND5;FGF2;CHRD;SMAD4;SKOR1;FSTL3;CADM4;SLIT2;EMILIN1;SPRY1;SKI;DAB2IP;SPRY3;SMAD9;ACVR2A;GPC1;AGTR2;HHEX;TRIM33;BMPR1B;SMAD7;MMRN2;DLX1;VWC2;NBL1;BMPER;CRIM1;NOG;SMURF1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.4462683149603853,1.2986992539649846,0.15217391304347827,0.2670481856944856,1.0,9/16,31.57%,MDK;RELA;IRAK1;FUT7;FUT4;ITGB2;ETS1;TRAF6;TNF
prerank,lipid biosynthetic process (GO:0008610),0.3141267064855285,1.298065816414709,0.05,0.26763076536873137,1.0,24/74,18.48%,CYP51A1;SRD5A1;AGPAT5;SCD;PDSS1;ACSL6;XBP1;LIPG;PDSS2;FDXR;IDI2;MCAT;PRLR;AGPS;ACSL5;ACLY;FITM2;NDUFAB1;ACSF3;PCYT2;OXSM;FDFT1;MVK;AGPAT3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.4837073103865702,1.297895188668914,0.10416666666666667,0.26734755250959513,1.0,6/15,15.57%,CANX;IL27RA;OAS2;STAT1;OASL;MX1
prerank,central nervous system neuron development (GO:0021954),-0.5077153438249173,-1.2976061770753557,0.125,0.2764629001881841,1.0,6/15,13.79%,GBA2;MAPT;PTEN;MAP2;LHX6;NPY
prerank,respiratory system development (GO:0060541),-0.4071311793673674,-1.2975866387882284,0.06666666666666667,0.2760035414423235,1.0,16/34,21.13%,NPHP3;FOXF1;FGF2;FGFR2;PHOX2B;CCDC39;TCF21;DISP1;CCDC40;GLI2;SMCHD1;FGF7;ABCA3;FGF1;FGF9;LOXL3
prerank,positive regulation of ossification (GO:0045778),-0.3812322478945434,-1.2975273147042476,0.11475409836065574,0.275562750291556,1.0,16/39,24.85%,GPM6B;BMPR1A;OSR1;PTN;P2RX7;SLC8A1;ZBTB16;KL;MEF2C;SOX11;ACVR2A;BMPR1B;OSR2;ANO6;PKDCC;TGFB3
prerank,skin development (GO:0043588),0.3349332991781404,1.2971376504336176,0.10256410256410256,0.26818584312496585,1.0,32/70,26.91%,CLDN1;COL1A1;EREG;COL1A2;STMN1;MET;WNT5A;CDSN;EPHA2;LSR;COL3A1;EVPL;DHCR24;GATA6;DSP;MED1;SCEL;ST14;CLDN4;ADAM9;KDF1;FA2H;SFN;OPN3;ALOXE3;ITGA6;ABCB6;CSTA;ABCA12;ALOX12;ANXA1;ALOX12B
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.39174960781900137,1.2966798464248168,0.11764705882352941,0.2682037147986697,1.0,9/28,28.03%,AZGP1;IL23A;CD1A;CD1B;IL23R;HLA-F;IL12B;IL12RB1;CD1E
prerank,ceramide metabolic process (GO:0006672),0.34790782250423213,1.2954983645118066,0.1111111111111111,0.26938051245002526,1.0,26/51,27.16%,SPTLC1;CERS6;SMPD2;SPTLC2;PNPLA1;ASAH2B;CERS2;ORMDL3;DEGS2;FUT7;SGPL1;GBA;CLN6;ACER2;FA2H;SPTSSB;ORMDL2;PLA2G15;ALOXE3;ASAH2;FUT6;ABCA12;PPP2CA;FUT3;ALOX12B;PPP2R1A
prerank,cognition (GO:0050890),-0.3583384642455565,-1.2954336662711463,0.0967741935483871,0.27861042112165213,1.0,9/43,8.99%,FAM107A;GTF2A1L;SOBP;PTCHD1;SLC8A2;CUX2;BBS4;SETD5;GPR155
prerank,positive regulation of hormone secretion (GO:0046887),0.44088274999509103,1.2949946285483092,0.09090909090909091,0.26980301613852103,1.0,7/17,19.13%,TFR2;SPP1;HCAR2;VAMP8;PLA2G3;NMB;SNX4
prerank,regulation of GTPase activity (GO:0043087),-0.3018992216534621,-1.294754101778865,0.07042253521126761,0.2795788181923713,1.0,72/181,24.54%,FLCN;BVES;RASGRP2;SGSM2;PLXNB3;RAPGEF3;RAP1A;ASAP3;RABGAP1;FERMT2;CCL14;TBC1D20;GPSM1;DVL3;PRKG1;CPEB2;EVI5L;RGS10;SRGAP2;GNB5;CAV2;RIC1;LRRK2;EPHA5;RAB11FIP2;NTRK1;FGD1;RDX;RASIP1;NDEL1;DAB2IP;EPHA4;RGS8;RAPGEF1;ARL2;EFNA5;ADRB1;SFRP1;EPHA3;ARHGEF7;SNX18;SGSM3;RAB3GAP1;DOCK11;PLXNA4;PLXNB1;CCL23;MAPRE2;ALS2;CCL11;SIPA1L1;RGS6;KLRK1;FGD2;RAPGEF6;CCL21;RAPGEF2;CCL2;BCAS3;SOD1;PRTN3;BCAR3;PIN1;RSU1;FICD;WNK1;FGD5;ADCYAP1;CDKL5;ARHGAP11B;ARHGAP15;RGS1
prerank,sphingolipid catabolic process (GO:0030149),0.4667664782446923,1.2946300834286115,0.16279069767441862,0.2698390487313686,1.0,8/16,22.53%,GLA;SMPD2;ASAH2B;SGPL1;ACER2;PPT1;PDXDC1;ASAH2
prerank,extracellular matrix disassembly (GO:0022617),0.34777682499643675,1.2942449386990782,0.08333333333333333,0.2696828913034125,1.0,20/60,17.72%,MMP7;MMP13;CAPG;CTSV;KIF9;KLK7;MMP11;MMP1;TIMP1;CD44;MMP10;ADAM10;MMP2;MMP3;CAPN1;MMP9;MMP12;ADAM8;ADAM15;MMP15
prerank,bicellular tight junction assembly (GO:0070830),0.3621502311688115,1.2940768284656965,0.06818181818181818,0.2693143524246952,1.0,19/47,24.40%,CLDN1;CLDN2;CLDN16;CLDN14;PARD6B;ECT2;PAK2;POF1B;PECAM1;MARVELD2;PRKCI;GRHL2;CRB3;CLDN4;STRN;F11R;CLDN9;FRMPD2;CLDN10
prerank,histone deacetylation (GO:0016575),-0.36785108992241256,-1.2929722188902568,0.1,0.28259118701476604,1.0,23/46,28.62%,PER1;SIN3B;HDAC4;RCOR3;HDAC6;MORF4L1;SIRT2;HDAC5;MTA3;PRDM5;HDAC9;SIN3A;TRERF1;BAZ2A;BRMS1L;SIRT1;TBL1X;MIER2;ELK4;ZNF541;MTA1;MSL3;MIER1
prerank,microtubule bundle formation (GO:0001578),-0.3769922990689968,-1.292668391903571,0.11594202898550725,0.28257713475206475,1.0,18/41,23.41%,TTLL3;NUMA1;CLIP1;MTCL1;CCDC66;CLASP1;CCDC40;NCKAP5L;GAS2L1;NAV1;TPPP;MARK4;CDK5RAP2;GAS2L2;DCX;TPPP3;RSPH4A;AAAS
prerank,hexose metabolic process (GO:0019318),0.3715165463100146,1.2921586415196864,0.05405405405405406,0.2716469013269717,1.0,18/41,23.35%,SORD;PMM2;SLC35A2;FUCA2;GALK2;FUOM;AKR1A1;GALK1;KHK;KCNJ11;DCXR;SLC37A4;ALDOC;GALM;BRAT1;ADPGK;ALDOB;FBP1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3782622444843489,-1.2920519835247548,0.08620689655172414,0.28333233155897103,1.0,17/45,23.77%,MAP3K3;FGFR1;FGF2;HDAC7;PRKCA;RHOJ;PRKD1;ANGPT4;HSPB1;HDAC9;GATA2;PDGFB;MAPK14;ANGPT1;SIRT1;PLCG1;HMOX1
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.39268453645485146,-1.2920424322535917,0.16981132075471697,0.2828329347558471,1.0,9/22,16.90%,HDAC7;CD34;PRNP;SFTPD;NAV3;HOMER2;HOMER3;VSIG4;ZFP36
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3274259031093422,1.2916940122063107,0.11904761904761904,0.2717003493873344,1.0,23/72,18.90%,FAP;HM13;PRPF19;GZMB;CTSV;PMAIP1;CTSH;TNFAIP3;CTSC;CHMP4C;ADAMTS12;LONP1;DDB1;CLPP;UBA52;YME1L1;VCP;ISG15;CTSZ;GZMA;IDE;RSPRY1;NGLY1
prerank,renal water homeostasis (GO:0003091),-0.40672335955712,-1.29114941721126,0.09433962264150944,0.28386815534335114,1.0,10/30,15.59%,ADCY5;ADCY2;ADCY4;ADCY9;PRKACA;RAB11FIP2;PRKAR2B;AQP1;AVPR2;ADCY6
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.33961791982350514,1.291015743292588,0.06382978723404255,0.27234652577946455,1.0,19/48,25.51%,NME6;CHEK1;MAD2L1;TOM1L1;ZWINT;NABP2;ZW10;PTPN3;BUB1;BMP7;BMP4;TGFB1;SLC9A3R1;BUB1B;RFPL1;SCRIB;AURKAIP1;CTNNB1;CDKN1B
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3535469373582658,1.290541798286664,0.125,0.27252525252525256,1.0,14/50,13.27%,SERPINB5;GAPDH;TIMP1;SERPINB1;CRB2;SERPINE3;SERPINA10;SERPIND1;SERPINA7;SERPINA4;SERPING1;SORL1;SERPINB7;AGT
prerank,substantia nigra development (GO:0021762),-0.3749284605502618,-1.2902079789188572,0.0967741935483871,0.2847832037935008,1.0,18/40,26.33%,SYPL2;NDRG2;PLP1;CALM1;MAOB;INA;SIRT2;RHOA;MAPKAP1;CCDC14;POTEE;FGF9;ACTB;SYNGR3;CALM2;CNP;GNB4;CKB
prerank,detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.4083965941989455,1.288576768392188,0.13513513513513514,0.2750238197733894,1.0,5/35,5.25%,CST1;AZGP1;CST4;CST2;LPO
prerank,autophagy of mitochondrion (GO:0000422),-0.3719489404135074,-1.2883493085550421,0.08333333333333333,0.28752099397178293,1.0,8/39,6.17%,GABARAPL1;ULK1;ATG2B;ATG9A;WDR45;ULK2;ATG14;MAP1LC3C
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3920317073237576,1.2874596111543823,0.12727272727272726,0.27620745713755745,1.0,19/33,31.79%,THY1;HSPD1;TNFSF11;IL23A;PRKDC;SH3KBP1;NOD2;LCK;TNFSF4;IL12B;CD47;TYROBP;XRCC6;TICAM1;PRKCQ;CLEC7A;CCDC88B;SIRPG;SIRPB1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.37211456712589264,-1.287022052587068,0.07272727272727272,0.2892546525424867,1.0,14/42,15.20%,RYR3;ATP2B4;TRPV1;PKD2;FGF2;ITPR1;CACNA2D1;SLC8A2;RYR1;SLC8A1;RYR2;SLC8A3;TRPV3;HTR2B
prerank,negative regulation of ATPase activity (GO:0032780),-0.5165817077547085,-1.2870138162761537,0.16071428571428573,0.28873253223103823,1.0,8/16,21.90%,TSC1;PXK;PLN;TLR9;VCPKMT;PAM16;SIRT1;SLN
prerank,phospholipid biosynthetic process (GO:0008654),0.36933405142611075,1.2862573572183276,0.10810810810810811,0.2775547368612589,1.0,14/36,20.94%,CPNE7;SRD5A3;AGPAT5;DOLK;CPNE3;IDI2;DPAGT1;FDPS;FITM2;PCYT2;CPNE1;AGPAT3;NUS1;IDI1
prerank,positive regulation of autophagy (GO:0010508),-0.33751414375328254,-1.2856625577836878,0.07936507936507936,0.29070542223283735,1.0,28/86,21.58%,FLCN;EPM2A;ULK1;GPSM1;TRIM6;DAPK1;PRKD1;LRRK2;PRKAA2;DCN;OPTN;WAC;TPCN1;RNF152;TFEB;TP53INP1;ROCK1;TRIM34;TSC2;PLEKHF1;GSK3A;SIRT1;CAMKK2;BNIP3;TRIM8;MAP3K7;KAT5;TRIM38
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4291383227921348,-1.2855670996931494,0.13846153846153847,0.2902814573005183,1.0,8/26,6.27%,CACNB2;ANK2;AKAP6;TRPC1;CASQ1;CAPN3;GPER1;SNCA
prerank,negative regulation of interleukin-10 production (GO:0032693),0.45670772854443853,1.285512521401098,0.1111111111111111,0.27795300280876284,1.0,8/16,24.31%,IL23A;FOXP3;JAK3;IL23R;LILRB4;MMP8;IL12B;TYROBP
prerank,non-motile cilium assembly (GO:1905515),-0.4204447408139978,-1.2854225203223422,0.16666666666666666,0.2900235297044715,1.0,14/29,25.09%,CCDC13;DCTN1;BBS4;BBS1;TMEM80;DISC1;PCM1;CEP290;IFT122;CSNK1D;FUZ;CEP89;TTC8;C2CD3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.29526943531981015,-1.2845051361852025,0.04285714285714286,0.29129377435407927,1.0,52/190,19.29%,FLCN;TNRC6A;ATP2B4;HAND2;PGR;RBMS3;BMPR1A;FGF2;MAPT;TARDBP;MECP2;AGO4;TCEAL1;CITED2;GPER1;TRIM6;DLG4;CLDN5;CELF1;CD34;TNRC6C;CILP;DIP2A;OLFM1;PSEN1;ATOH8;RIN3;PRKAA2;SLC24A3;EMILIN1;ATXN2;OPTN;DICER1;ANKRD13A;MEF2C;AGO3;SFRP1;SFMBT2;HINFP;GATA2;PDGFB;ESR1;HEY2;NOTCH2;MYADM;RBL2;SMO;SOX11;TNRC6B;AGO1;FBXW7;PARP15
prerank,mitochondrion organization (GO:0007005),0.2981051316013892,1.2844229019961244,0.0,0.27908254072902833,1.0,43/163,15.66%,TOMM34;MTFR2;SSBP1;MTX1;HSPD1;MTFR1;TIMM23;TFB2M;PHB;BCAP31;TOMM40;TFAM;TIMM10;HSD17B10;MGME1;CHCHD2;PNPT1;TIMM13;TFB1M;TOMM22;TOMM20;TIMM50;STOML2;ATAD3A;CXADR;BCL2L1;TIMM17B;TIMM8B;AIFM1;DNAJA3;BIK;TSPO;CHCHD3;COX7A2L;LONP1;CYCS;GBA;COX7A2;YME1L1;SLIRP;MYH14;MX1;SLC25A33
prerank,intracellular pH reduction (GO:0051452),0.35356911633538524,1.2840541626002178,0.07894736842105263,0.2790584894690601,1.0,12/35,19.14%,ATP6V1C2;RAB20;ATP6V1G1;CLCN3;ATP6V0B;ATP6V1A;GPR89A;TMEM9;ATP6V1F;RAB7A;GPR89B;ATP6V0A4
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.4361908613042146,1.28355691190701,0.1568627450980392,0.2792222480740396,1.0,10/17,19.64%,DNMT1;DNMT3B;KDM1A;BRCA1;WDR5;MYB;PAXIP1;PIH1D1;CTR9;AUTS2
prerank,potassium ion homeostasis (GO:0055075),-0.427984388611337,-1.2830918580464123,0.140625,0.29334632109600933,1.0,7/24,9.99%,ATP1B2;ATP1A2;KCNMA1;SLC12A4;KCNH2;ATP1A4;ATP1A3
prerank,negative regulation of binding (GO:0051100),0.3117772340364377,1.2829879203568453,0.046511627906976744,0.27971848953814477,1.0,27/78,20.69%,GNL3L;E2F1;TFAP4;GTPBP4;MDFI;PPP1CA;LEF1;AURKB;TMBIM6;SLPI;HMGA2;AURKA;CTNNBIP1;ZFPM1;GSK3B;SORL1;KDM1A;SUMO1;CTSZ;GZMA;CPNE1;SUMO3;NFKBIA;BAX;CAV1;TFIP11;IFI16
prerank,positive regulation of wound healing (GO:0090303),0.38089751272764705,1.2828857808569571,0.14583333333333334,0.2793401293245747,1.0,16/36,28.28%,CLDN1;F12;FERMT1;ACTG1;DUOX2;XBP1;HPSE;F2R;CLDN4;SERPINE1;THBS1;ARFGEF1;REG3A;ANXA1;CLEC7A;INSL3
prerank,regulation of interleukin-12 production (GO:0032655),0.32648550563362316,1.282846835699037,0.10869565217391304,0.27883873899886563,1.0,23/51,30.44%,HSPD1;RIPK2;IL23A;C1QBP;SYK;MDK;IL17A;JAK3;IL23R;TNFSF4;HMGB1;IL12B;LTB;CD47;THBS1;TIGIT;IFNG;CLEC7A;IRAK3;IL10;PIBF1;TLR8;SCIMP
prerank,T cell activation (GO:0042110),0.32811484577831357,1.2826176064722166,0.07142857142857142,0.27860834633465775,1.0,38/90,29.66%,SOX4;HSPD1;DDOST;FOXP3;CD276;LFNG;CD44;CXADR;MDK;GPR89A;TREML2;CHD7;MICB;PIK3CG;GPR89B;PTPN2;CD8B;MSN;LCK;TNFSF4;JAG2;ITK;CRTAM;CD2;ZAP70;SCRIB;CD3G;TNFRSF4;CLEC7A;CASP8;RHOH;CD3E;SLA2;PPP3CA;IFNE;PIK3CD;RASGRP1;LCP1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4296523049193303,1.2823056636787846,0.20408163265306123,0.27844080227480583,1.0,6/21,6.25%,THY1;IL1RN;SKAP1;IL1B;CEACAM6;CD44
prerank,regulation of viral entry into host cell (GO:0046596),0.3587062837769602,1.2806773855775304,0.10526315789473684,0.2803157661890694,1.0,13/37,22.32%,IFITM3;LY6E;IFITM1;P4HB;IFITM2;TRIM27;TRIM14;TRIM26;TRIM11;LGALS1;TMPRSS4;TRIM31;TRIM22
prerank,positive regulation of DNA repair (GO:0045739),0.34521867915481436,1.279612332163007,0.0425531914893617,0.28152499412916526,1.0,24/43,30.16%,BRCC3;TIMELESS;UBE2N;HDAC10;ERCC8;RPS3;DHX9;CEBPG;WRAP53;BRCA1;FOXM1;EYA1;PRKCG;TMEM161A;TRIM28;SPIRE2;HMGB1;MGMT;RNF8;TIGAR;NPAS2;OOEP;PARP1;PCNA
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.46872467473477025,-1.2791984867966542,0.16981132075471697,0.2998914637907784,1.0,5/18,13.02%,JAM3;MSTN;RARRES2;MAPK1;MAPK3
prerank,epithelial tube morphogenesis (GO:0060562),-0.37412925368666294,-1.2789429109231762,0.13725490196078433,0.29981425552382396,1.0,12/34,18.66%,PKD1;PKD2;RHOB;SLIT2;MEGF8;RYR2;GLI2;SOX17;MEF2C;RASIP1;FGF10;CSNK2B
prerank,positive regulation of lyase activity (GO:0051349),-0.4680290741977884,-1.278324277667532,0.15384615384615385,0.30065040965650036,1.0,4/15,9.17%,CACNA1C;ISCU;STIM1;NOS1
prerank,cellular response to organic substance (GO:0071310),-0.30720560351333137,-1.2772886834475194,0.047619047619047616,0.3018742216420868,1.0,36/120,20.64%,CACNA1H;AKAP6;BMPR1A;SOCS2;MAPK7;NCOA1;CDK9;HDAC6;DPYSL3;GHR;CYP11B1;NOS1;PTPN14;SLIT2;LRRK2;RAMP1;SLIT3;PID1;PTPN5;CERS1;INPP5K;MAP2K5;SFRP1;RHOA;CYP1A1;IGFBP5;PDGFB;IL1RAPL1;MAPK8;CLEC3B;ACVR2A;IL18R1;RAMP3;BMPR1B;RPS6KB1;CCL2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4502833274070056,1.2772724643562403,0.17391304347826086,0.28453803019944895,1.0,5/15,15.71%,ARMC10;PSMD10;CD44;KDM1A;RNF34
prerank,chromatin disassembly (GO:0031498),0.4692858707371131,1.2770289144375115,0.13725490196078433,0.28383611345737386,1.0,7/16,12.57%,HMGA1;SET;SMARCB1;GRWD1;SMARCA4;SMARCD2;SMARCC1
prerank,nucleosome disassembly (GO:0006337),0.4692858707371131,1.2770289144375115,0.13725490196078433,0.28383611345737386,1.0,7/16,12.57%,HMGA1;SET;SMARCB1;GRWD1;SMARCA4;SMARCD2;SMARCC1
prerank,autophagosome assembly (GO:0000045),-0.3668671911917269,-1.27698487627391,0.11290322580645161,0.30184265047953174,1.0,20/56,18.50%,GABARAPL1;ULK1;ATG2B;ATG9A;WDR45;ULK2;ATG14;MAP1LC3C;MFN2;TP53INP2;ATG16L2;RAB23;PIK3C3;PACS2;TP53INP1;EMC6;STX12;GABARAPL2;ATG12;TRAPPC8
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.4504738895465527,-1.2769802923628535,0.14545454545454545,0.30130841569992195,1.0,6/18,12.44%,RIC3;SLC5A7;COLQ;RAPSN;CHRNA3;CHRNB4
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.48357301329370683,-1.2769315527059548,0.2037037037037037,0.30077606867571716,1.0,10/17,24.77%,ADD1;VCL;PPP1R12A;CLDN5;S1PR3;S1PR2;ROCK1;CDH5;ZDHHC21;TNFRSF1A
prerank,aerobic electron transport chain (GO:0019646),0.3286908794381761,1.2763881490765272,0.07894736842105263,0.2844986357052871,1.0,34/69,35.11%,UQCC3;COX6B1;NDUFS6;COX7A2L;UQCRQ;UQCRH;CYCS;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;COX4I1;CYC1;COX5B;COX7B;UQCRC1;NDUFA1;NDUFB9;NDUFB6;NDUFB5;COX5A;NDUFB4;NDUFS3;NDUFA4;NDUFS1;NDUFB7;UQCRHL;NDUFA2;NDUFC1;NDUFS5;NDUFB2;NDUFA6;NDUFS8
prerank,regulation of T cell differentiation (GO:0045580),0.3765441880461722,1.2762029456833237,0.12,0.2843020221858361,1.0,18/39,28.02%,CBFB;TCF7;FOXP3;MDK;XBP1;RUNX1;PRELID1;ZNF683;FANCA;IL36B;PRDM1;CRTAM;CD2;ZAP70;IL2RA;IFNG;CTLA4;RHOH
prerank,positive regulation of apoptotic process (GO:0043065),-0.2785641975545394,-1.2752738398078236,0.015625,0.30325161091044467,1.0,87/296,20.66%,ARHGEF26;FLCN;CLIP3;TRIM39;APBB1;RBM5;ADAMTSL4;ARHGEF17;EPHA7;MLLT11;KCNMA1;CLU;ARHGEF9;PRDM11;PNMA1;GPER1;MOAP1;JMY;PLEKHG2;SNCA;ARHGEF6;ITSN1;DLC1;ATF4;OBSCN;PRNP;NGF;ING4;RPS6KA2;NGFR;PTGIS;RHOB;OLFM1;DAPK1;PSEN1;SLIT2;PHLDA3;SIRT2;QRICH1;ARHGEF18;ARHGEF11;CALHM2;APH1B;FGD1;LATS2;BACE1;PNMA3;TNFSF10;DAB2IP;ERCC3;TIAM1;DAPK3;KLF11;GADD45B;PRMT2;SFRP1;CSRNP3;SOS2;BCL10;ARHGEF7;PSEN2;PIDD1;PIP5KL1;MAPK8;RNF122;APC;MCF2;FAS;TRIO;SOS1;HOXA5;NUPR1;CASP3;ING3;CASP9;UBB;DCUN1D3;RASSF2;MAP3K10;APAF1;FGD2;ANKRD1;CRADD;SIRT1;ING5;BNIP3;AKAP13
prerank,protein export from nucleus (GO:0006611),0.4014380032851551,1.2744807248800858,0.09433962264150944,0.2865697135114103,1.0,6/26,5.52%,CALR;RAN;CSE1L;XPO5;NUTF2;DUSP16
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4118326022149078,-1.274323612476126,0.15789473684210525,0.3044600703235278,1.0,11/25,14.51%,DCTN1;MAPT;NUMA1;CLIP1;STMN2;CLASP1;FES;NAV3;ARL2;RAC1;SLAIN2
prerank,negative regulation of secretion by cell (GO:1903531),0.34830990989595423,1.274048965941905,0.10869565217391304,0.2866139018419148,1.0,14/38,22.80%,OSM;CYP51A1;IL11;RHBDF2;PNKD;ERP29;VAMP8;DRD2;TNFRSF1B;SLC30A1;NOTCH1;IL12B;HMGCR;LIF
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.36397136191728485,-1.2736534918237077,0.06666666666666667,0.30495568205443535,1.0,7/48,6.56%,PRRT2;JAM3;CRYAB;RAF1;ULK1;CLU;HDAC6
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3665763270373787,-1.2717510703545623,0.11666666666666667,0.30774846460396826,1.0,16/52,18.77%,CLIP3;SORBS1;ATP2B4;WNK3;NUMA1;GPER1;GNAI1;PIK3R1;CNPY4;STAC2;STAC;LGALS3;EPHA3;EFCAB7;EGFR;RAMP3
prerank,regulation of angiogenesis (GO:0045765),-0.2968610986747194,-1.2706209319907944,0.06153846153846154,0.3092155177841506,1.0,69/189,23.96%,YJEFN3;ATP2B4;NPR1;RAPGEF3;SASH1;FGF2;FOXJ2;GAB1;MECP2;PTPRM;STAB1;STIM1;PDE3B;ADGRB1;CLDN5;CD34;PRKCB;PRKCA;ADAMTS1;HSPB6;RHOJ;PTGIS;RHOB;PRKD1;EGLN1;VEGFB;SEMA3E;DCN;EMILIN1;RRAS;ANGPT4;FOXO4;HSPB1;THBS4;SYNJ2BP;PRL;AQP1;DAB2IP;KRIT1;SEMA6A;HSPG2;SFRP1;GATA2;ECSCR;ROCK1;SPINK5;TIE1;GLUL;COL4A2;NPPB;SERPINF1;HOXA5;FGF1;COL4A3;FGF16;AGO1;HHEX;ANGPTL4;SIRT1;VEGFC;ADGRA2;KRT1;CDH5;PLCG1;RAMP2;HIPK1;ATF2;HMOX1;FLT1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.44075488148579434,1.2701496579509441,0.17073170731707318,0.29262193900969813,1.0,8/19,21.95%,RGPD4;NUP35;KPNA7;KPNB1;KPNA2;RGPD1;RGPD3;IPO5
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3041437682194158,-1.2699242987686916,0.05084745762711865,0.30992449757513024,1.0,47/157,21.05%,HAND2;RAP1A;FGF2;PLA2G5;GLIPR2;MTURN;FERMT2;GCNT2;CCL14;PDGFRA;ROR2;GPER1;FGFR2;P2RY1;NTRK3;PRKCA;ADRA1A;NDRG4;NECAB2;DSTYK;TNFAIP8L3;FLT4;NTRK1;ROR1;THPO;MAPK3;MAP2K7;ACKR3;HTR2B;PDGFB;BRAF;NOTCH2;FGF10;PDE8A;EGFR;CCL23;ERBB4;CCL11;RAMP3;CD36;FBXW7;ANGPT1;MAP3K12;CCL21;RAPGEF2;CCL2;PDGFD
prerank,negative regulation of double-strand break repair (GO:2000780),0.40823703961897234,1.2689722002558832,0.1111111111111111,0.29405208436153063,1.0,5/25,9.33%,FANCB;PARPBP;OTUB2;RMI2;HMGA2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4370649328858193,1.2682867995755527,0.15,0.29434515617121837,1.0,8/18,17.50%,HDAC2;AMELX;RUNX1;SUCO;BMP4;F2R;TGFB1;CREB3L1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.393129919976492,-1.268131160802449,0.15517241379310345,0.3127739472626217,1.0,11/29,21.48%,FAM107A;CYP46A1;SCGN;PTN;SHANK3;SHISA7;EPHA4;RELN;INS;NSG1;CALB2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3494893556602738,1.2673971371474946,0.07317073170731707,0.29562574217149284,1.0,20/50,21.46%,E2F1;TP73;CHEK2;PRKDC;PML;IKBKE;EPHA2;BCL2L1;CASP2;BCL2A1;AEN;BRCA1;MSH6;TNFRSF1B;BAX;SFN;BAK1;IFI16;MSH2;MCL1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.43022335285029734,1.2669357144949107,0.16326530612244897,0.29613641752808323,1.0,12/19,31.57%,IL1B;CCL3;IRAK1;TGFB1;LYN;MTDH;TICAM1;IL18;HCK;CD6;CCL5;TNF
prerank,regulation of dopamine secretion (GO:0014059),-0.43500990608142576,-1.2664475689818036,0.13559322033898305,0.3152143619928438,1.0,9/22,12.21%,GDNF;SYT10;SNCA;KCNA2;SYT11;SYT2;SYT9;SYT6;SYT5
prerank,positive regulation of monooxygenase activity (GO:0032770),0.384189550568955,1.2660071660044794,0.19230769230769232,0.29718799666399154,1.0,5/27,5.37%,CDH3;DHFR;SCARB1;IL1B;CYP27B1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.38407234173039945,-1.265826633129178,0.16129032258064516,0.31579765449671227,1.0,10/39,7.02%,CSRP1;MYL9;FLNA;TLN1;VCL;PDGFRA;ILK;ITGB3;ACTN1;MEGF10
prerank,protein modification process (GO:0036211),0.30846359319762795,1.2657894286788776,0.09090909090909091,0.29703183355308865,1.0,26/76,25.53%,RPN1;RPN2;ERO1A;SERP1;UBE2S;LOXL2;ATG3;PRKDC;PARP4;ABL2;SEPHS1;B4GALT7;LCMT1;UBL5;UBA52;MANBA;MMP15;UBE2L6;YES1;MCRS1;UBE2D2;WWP2;UBL4A;CSNK1G3;ICMT;PPP4R2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.40447223377185654,-1.2655672236290711,0.17777777777777778,0.31563120662337374,1.0,12/27,25.73%,GBA2;PLEKHG2;FCHSD1;DBN1;FCHSD2;ESAM;PAK3;ARHGAP28;LATS1;BRK1;ARHGAP35;HCLS1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.30891369485491704,-1.2651229743370365,0.04081632653061224,0.31598941725089397,1.0,26/108,16.26%,TPCN2;DMPK;PTH1R;ATP2B4;ANK2;CCL14;STIM1;SLC8A2;SLC39A13;SLC24A4;SLC8A1;ELANE;SLC24A3;NPTN;CTRC;RYR2;ATP2B3;SLC30A8;SLC8A3;SLC41A1;CSRP3;TRDN;RGN;MT1X;HTR2B;SLC39A12
prerank,dendritic cell migration (GO:0036336),0.43813693798962056,1.2647226588028189,0.17307692307692307,0.2981781472576872,1.0,6/18,22.30%,TRPM2;CXCR4;CXCR2;PIK3CG;HMGB1;CXCR1
prerank,negative regulation of JNK cascade (GO:0046329),-0.3837704320112938,-1.2645735806773064,0.16071428571428573,0.31642565731087874,1.0,10/30,24.01%,PER1;DUSP3;ZMYND11;NPPA;HIPK3;DUSP19;GPS2;MAPK8IP1;PINK1;PDCD4
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.30078380166286656,-1.2644420197620192,0.06451612903225806,0.3161323760138003,1.0,37/132,23.76%,GLP2R;ADCY5;PTH1R;ADCYAP1R1;ADCY2;ADRB3;ADCY4;POMC;VIPR2;ADRB2;ADCY9;PRKACA;GNG2;RAMP1;ADORA2A;PRKAR2B;VIP;MC1R;GPR20;AVPR2;ADRB1;ADCY6;TSHB;MAPK14;HTR4;CRHR1;GPR27;RAMP3;P2RY11;GPBAR1;LHCGR;HTR7;CRHR2;PLCG1;RAMP2;PLCG2;ADCYAP1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.33887648105579105,-1.2641944742917692,0.07017543859649122,0.31617188744450836,1.0,24/77,18.95%,ATP1B2;ATP2B4;ATP1A2;TRPV1;SLC12A4;SLC9A9;FXYD2;CACNA2D1;SLC8A2;KCNH2;SLC8A1;ATP1A4;KCNE2;ATP1A3;ABCC9;KCNJ8;SLC8A3;TRPV3;KCNJ9;SLC39A12;KCNJ1;SLC6A1;ATP4A;SLC9A5
prerank,cellular response to amyloid-beta (GO:1904646),-0.39028090675180016,-1.2632235953699709,0.14,0.3173783850865546,1.0,12/35,18.84%,CACNA2D1;ADRB2;CACNB1;PRNP;NGFR;PSEN1;ATP1A3;NTRK1;EPHA4;GRIN2A;CACNA1A;CD36
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.45057749556741256,-1.2627162774902845,0.19298245614035087,0.31798243343692995,1.0,8/16,25.35%,FAM107A;GPER1;ZFP36L1;NR3C1;ZFP36;SSTR2;BCL2L11;ZFP36L2
prerank,negative regulation of phosphatase activity (GO:0010923),0.39211102045628154,1.2624696175611456,0.1111111111111111,0.30107974423935335,1.0,20/27,36.74%,MASTL;SH2D4A;TGFB2;STYXL1;PPP1R1B;SEMA4D;GSK3B;PPP1R35;TIPRL;URI1;PPP1R11;FKBP1B;SH3RF2;CHP1;PPP1R36;FKBP1A;GPATCH2;PPP1R26;ZCCHC9;BOD1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.3765484930271765,1.2619566008782044,0.15384615384615385,0.3015560604522009,1.0,8/26,19.89%,SYK;OLR1;ICAM1;SEMA4D;PECAM1;EZR;MSN;F11R
prerank,diterpenoid metabolic process (GO:0016101),-0.35216218597512045,-1.2616701835044546,0.10344827586206896,0.31944888945233785,1.0,18/57,18.10%,RDH5;BCO2;LRAT;ADH1B;GPIHBP1;AKR1C1;SDC3;SDC2;PNLIP;RARRES2;CLPS;ALDH1A1;HSPG2;CYP4V2;OPN1SW;AKR1B1;RLBP1;GPC1
prerank,response to axon injury (GO:0048678),-0.4577071008984578,-1.2615629871005152,0.18,0.3190431060453906,1.0,10/18,23.04%,MTR;GAP43;DPYSL3;APOD;MAPK8IP3;P2RY12;MORN4;SOD1;SARM1;NREP
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.41014002774234204,-1.261540795522076,0.12962962962962962,0.31854472545374335,1.0,10/30,18.07%,PTH1R;ILK;SNCA;AR;PSEN1;FZD7;NCKAP1L;BCL10;DSCAM;EGFR
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.43349067431771476,1.261532771237332,0.1875,0.3017318430771141,1.0,13/20,24.43%,DGAT2;SCD;THEM5;ACSL3;FAR2;ACLY;FITM2;PPT1;FASN;HSD17B4;SLC25A1;GCDH;HSD17B8
prerank,positive regulation of endocytosis (GO:0045807),-0.37052310396348215,-1.2609772565578754,0.1320754716981132,0.3188924626777174,1.0,20/45,27.21%,CLIP3;CLU;ANKFY1;CALY;SNCA;NLGN1;NCKAP1L;CBL;DLL1;CCL21;B2M;RAB31;SGIP1;ANO6;CLN3;SMPD1;HIP1;F2RL1;FLOT1;NEDD4L
prerank,organelle transport along microtubule (GO:0072384),-0.3819941751992127,-1.2607794707137991,0.14754098360655737,0.3186926402645797,1.0,10/28,18.72%,DYNC1I1;MAPT;HAP1;PAFAH1B1;TRAK2;BICD2;ARHGAP21;NDEL1;RHOT2;UBB
prerank,regulation of glycolytic process (GO:0006110),0.3279197691222252,1.2607115467401468,0.1,0.3030007174826971,1.0,29/67,27.24%,NUP37;PFKFB3;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;EIF6;NUP50;NUP88;NUP107;GAPDHS;PFKFB4;NUP205;NUP62;NUP160;NDC1;MLXIPL;GIT1;FBP1;PGAM1;ZBTB20;NUP98;HIF1A;TIGAR;IFNG
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.40796336742987827,-1.2606746275991154,0.16071428571428573,0.3183532400708827,1.0,11/27,14.51%,DCTN1;MAPT;MECP2;NUMA1;CLIP1;CLASP1;FES;NAV3;ARL2;RAC1;SLAIN2
prerank,regulation of interleukin-10 production (GO:0032653),0.3503148564444548,1.2605663745953584,0.13043478260869565,0.3026373293398519,1.0,28/46,36.09%,HSPD1;IL23A;FOXP3;SYK;CD46;JAK3;PRKCZ;ISG15;IL23R;LILRB4;NOD2;MMP8;TNFSF4;HMGB1;IL12B;CD47;TYROBP;TIGIT;CLEC7A;PIBF1;XCL1;CD274;LILRA5;CD28;TLR4;PDCD1LG2;IL13;LILRB1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.35412237169154526,1.260327188200917,0.10869565217391304,0.3026517207909716,1.0,21/39,35.11%,NDUFS6;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;NDUFA1;NDUFB9;NDUFB6;NDUFB5;NDUFB4;NDUFS3;NDUFA4;NDUFS1;NDUFB7;NDUFA2;NDUFC1;NDUFS5;NDUFB2;NDUFA6;NDUFS8
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.392250762565203,1.2601201117018184,0.16666666666666666,0.30231002975694576,1.0,11/24,29.64%,SERPINB1;TNFAIP3;CARD17;LILRB4;GIT1;ZC3H12A;CARD16;GSTP1;FFAR4;PYDC1;NLRP3
prerank,protein lipidation (GO:0006497),0.33758183891049437,1.2595955117475974,0.06666666666666667,0.30254213984232414,1.0,21/57,22.63%,PIGM;PIGU;ZDHHC9;DPM2;ZDHHC5;DPM1;PIGW;ZDHHC12;ZDHHC3;ZDHHC13;PGAP2;PIGF;ZDHHC6;PIGO;PIGA;ZDHHC16;WDR45B;ATG5;PIGN;DPM3;PGAP3
prerank,mammary gland development (GO:0030879),0.3972731199164682,1.2595855541502743,0.10638297872340426,0.3020244740612015,1.0,7/23,12.69%,TDGF1;WNT2;WNT7B;OXTR;APLN;PRLR;WNT3
prerank,protein deubiquitination (GO:0016579),0.2599018220066727,1.259558967131811,0.027777777777777776,0.30154799257387793,1.0,80/257,23.95%,RUVBL1;PSMD14;MYC;OTUB2;SHMT2;PSMB2;BRCC3;CDK1;USP50;PSMB9;PSMA5;ACTL6A;SKP2;PSMB3;SMAD1;PSME3;PSMA3;POLB;KDM1B;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;USP18;TNFAIP3;TOMM20;PSMD12;ACTR8;PSMB5;USP37;USP10;UCHL5;RNF128;SPATA2;PSMD8;PSMB4;PSMD3;STAMBP;PSMB1;PSMA4;COPS5;RAD23B;ADRM1;BRCA1;PSME1;PSMF1;PSMD11;TRAF2;TNIP3;UBA52;PSMD1;VCP;USP1;CDC25A;CLSPN;USP38;OTULIN;USP26;PSMD6;NFKBIA;STAM;CDC20;CFTR;UBE2D1;PSMD5;VCPIP1;KEAP1;ZC3H12A;MCRS1;PSMC1;STAMBPL1;ACTR5;ENY2;USP5;RCE1;DESI2;TP53;BARD1
prerank,positive regulation of developmental growth (GO:0048639),-0.3512844339473665,-1.2593201768436098,0.11864406779661017,0.3200530513385421,1.0,27/50,30.77%,NTN1;MAPT;MACF1;ACTN3;GH1;ITSN2;RUFY3;L1CAM;NGF;GHR;SYT2;DBN1;INSR;PLCB1;DLL1;RIMS1;SYT1;CPNE6;SYT3;CDKL5;ISLR2;NEDD4L;SMURF1;CPNE5;LEP;GOLGA4;ZFYVE27
prerank,positive regulation of intracellular transport (GO:0032388),-0.39780279504568894,-1.259090439494352,0.15384615384615385,0.3200697165382743,1.0,11/36,16.57%,VAMP2;TENM1;TBC1D20;EHD2;NUMA1;ACTN2;RUFY3;OAZ2;PCM1;CEP290;PCNT
prerank,amide biosynthetic process (GO:0043604),0.35404764396419536,1.2589695785277866,0.18,0.30205517164670836,1.0,14/49,14.68%,SLC25A15;SPTLC1;RHCE;CERS6;ASS1;NANP;SMPD2;PCSK1;SPTLC2;PNPLA1;NMRAL1;CERS2;DEGS2;GBA
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4197099319896498,1.2588127307607078,0.125,0.3017567626170198,1.0,8/23,19.28%,MMP7;HM13;BACE2;APH1A;ADAM10;NCSTN;ADAM9;ERAP1
prerank,neuromuscular junction development (GO:0007528),-0.4260949932087549,-1.2585890637018782,0.15625,0.3205049617870522,1.0,10/24,16.32%,PDZRN3;CACNB2;DCTN1;ANK3;CACNB1;UNC13C;LRRK2;PPFIBP1;MUSK;ZC4H2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.4949745432908562,-1.257984414361162,0.14285714285714285,0.3208768211623955,1.0,9/15,26.98%,CSPG4;UST;DCN;DSEL;CSGALNACT2;CHST12;NCAN;CHST14;CSPG5
prerank,carboxylic acid metabolic process (GO:0019752),0.35904478029277825,1.257872635792708,0.08333333333333333,0.30288803099154166,1.0,13/33,24.45%,LIPT2;CYP2S1;TBXAS1;GSTO2;ST6GAL1;CYP4F8;GSTO1;ACOT4;CYP4F3;SLC2A1;CYP2J2;CYP4F2;PON3
prerank,regulation of glucose import (GO:0046324),-0.3997138007603889,-1.257506387635828,0.14285714285714285,0.32113925705501045,1.0,15/34,24.37%,SORBS1;PIK3R1;RHOQ;PRKAG2;GRB10;PID1;PLA2G1B;PEA15;RTN2;AKT2;INSR;GSK3A;INS;CLTCL1;OCLN
prerank,protein maturation (GO:0051604),0.30729443650933974,1.257425247382994,0.0975609756097561,0.3028040996282039,1.0,29/94,19.47%,CIAO1;TESC;LIPT2;HSPD1;F12;DUOXA2;MMEL1;CPZ;GLRX3;CPD;MME;APH1A;PCSK1;CASP2;CPN1;F7;NAA15;NAA50;ADAM10;SORL1;NAA35;TSPAN17;NDUFAB1;NCSTN;PCSK7;PCSK6;SDE2;TMPRSS4;TYSND1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3771330588558234,1.2567923807318673,0.11764705882352941,0.30353952270366574,1.0,17/30,31.62%,ABCE1;WNT5A;USP18;TTLL12;NLRC5;YTHDF2;ISG15;PTPN2;HSP90AB1;UBE2K;OAS3;ZBP1;PTPN11;STAT2;YTHDF3;SAMHD1;CNOT7
prerank,RNA metabolic process (GO:0016070),0.29407029787344013,1.2559149176256652,0.08888888888888889,0.30454490617357066,1.0,52/128,22.06%,POLR2F;DKC1;POLR2D;RNASEH1;SND1;HNRNPF;TP53RK;PRPF4;PABPC3;MRPL44;LAGE3;LSM8;TBRG4;FASTKD2;PNPT1;NCBP1;NUFIP1;PTBP1;EXOSC7;SNRNP40;HNRNPK;DHX9;WDR74;DDX54;CLP1;DUSP11;NCBP2;HNRNPC;POLR2C;GTF2F2;DHX8;POLR2K;HNRNPA0;POLR2J;APOBEC1;RBM3;POLR2G;DEDD2;PPP1R8;SYNCRIP;RNASEH2A;XRN2;HNRNPR;RNASEH2B;HNRNPA2B1;POLR2H;TFIP11;HNRNPA1;POLR2I;ZC3H12A;POLR2L;RNGTT
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.33795034082525194,-1.2557789147651386,0.12903225806451613,0.324100489733649,1.0,24/68,21.15%,FGFR1;TENM1;SASH1;FGF2;DVL3;GH1;TLR9;ELANE;KIT;MAP3K4;LRRK2;DIRAS2;DAB2IP;DVL2;NEK10;HTR2B;PDGFB;DUSP19;DIRAS1;FGF1;EGFR;MAP3K10;PDGFD;MAP3K7
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.40381560747971385,-1.2548470426519744,0.1320754716981132,0.32521907136021705,1.0,15/33,25.97%,PTPRM;NGFR;NR2F2;ATOH8;CAV2;SYNJ2BP;PRL;MEF2C;KRIT1;COL4A3;CCL2;IL12A;SCG2;FLT1;RGCC
prerank,receptor clustering (GO:0043113),-0.44253046492385084,-1.254525074110315,0.2037037037037037,0.3252730259034252,1.0,11/28,15.09%,FLNA;DLG2;PTN;MAGI2;NRXN1;LRRC7;DLG4;NLGN1;NRXN2;SYNJ2BP;MUSK
prerank,lytic vacuole organization (GO:0080171),-0.3833846998538302,-1.252878894159189,0.14754098360655737,0.32769058016870184,1.0,13/31,26.12%,TPCN2;ABCA1;ZKSCAN3;LRRK2;AKTIP;CLVS2;TFEB;HOOK3;SNAPIN;MTOR;TPP1;CLN3;HPS1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.4306297486050339,-1.2525659553231534,0.1935483870967742,0.3278321626416233,1.0,8/25,15.73%,TSC1;ASAP3;SYNPO2;SHANK3;SYNPO;RDX;RAC1;ROCK1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.35778245148668275,1.2507846942932228,0.07142857142857142,0.31234835620677937,1.0,19/54,16.42%,RFWD3;CHEK1;CCND1;BRCC3;CDK1;EME1;TIPIN;CHEK2;BLM;TICRR;PRKDC;TOPBP1;RAD9B;HMGA2;BRCA1;HUS1;PLK1;RPA2;CLSPN
prerank,diol metabolic process (GO:0034311),0.4583398889604861,1.2501208798073282,0.125,0.31273345111441053,1.0,8/16,22.53%,SGPP2;PTS;GCHFR;DEGS2;GCH1;SPR;HSP90AA1;ASAH2
prerank,detection of mechanical stimulus (GO:0050982),-0.43148430852916925,-1.250071999316522,0.1896551724137931,0.3317671700273033,1.0,10/19,22.92%,PKD1;PKD1L2;PKD2;TCAP;PIEZO2;CSRP3;CDH2;PIEZO1;TTN;CAV3
prerank,regulation of developmental growth (GO:0048638),-0.37982495859601784,-1.2499124989996426,0.12280701754385964,0.33156549173194083,1.0,13/30,23.11%,OLFM1;GHR;MBD5;LATS2;PRL;MUSK;SIN3A;INSR;PLCB1;DLL1;SOD1;NIPBL;LATS1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.3586315690460229,-1.2496378637868382,0.09836065573770492,0.3315322023045878,1.0,16/46,19.00%,AGPAT1;PLA2G5;PLA2G4B;ABHD8;DGKE;PLD6;AGPAT4;ABHD4;LIPI;SLC27A1;DDHD2;DGKG;DDHD1;PLA2G1B;PLD2;DGKB
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3186470671906044,1.2485871611157726,0.06382978723404255,0.31503436454235434,1.0,33/77,32.08%,USP50;RIPK2;WNT5A;SERPINB1;TNFAIP3;CARD17;CCL3;MYD88;IL17A;GBP5;F2R;EGR1;LILRB4;NOD2;MNDA;IFI16;GIT1;ZC3H12A;TYROBP;CARD16;GSTP1;FFAR4;IFNG;CLEC7A;CASP8;NLRP2;PYDC1;PANX1;NLRP3;TLR8;AIM2;TNF;LILRA5
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4198242289790795,1.248343892202641,0.17142857142857143,0.3148914865666276,1.0,8/21,17.06%,YWHAB;YWHAE;MASTL;STYXL1;PPP1R1B;GSK3B;PPP1R8;TIPRL
prerank,nuclear export (GO:0051168),0.32652664884480265,1.248216976048636,0.1,0.31445963672985344,1.0,18/82,6.08%,CALR;RAN;ALYREF;CSE1L;THOC3;NUP155;U2AF1;XPO5;MAGOH;RAE1;NUP62CL;MAGOHB;EIF4A3;NUTF2;RITA1;NCBP1;DDX39A;SRSF9
prerank,regulation of catecholamine secretion (GO:0050433),-0.4099417882250079,-1.2481754854423925,0.18333333333333332,0.33372139731056477,1.0,9/26,12.21%,KCNB1;SYT10;SNCA;KCNA2;SYT11;SYT2;SYT9;SYT6;SYT5
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3054613365946378,1.2481120917700659,0.06976744186046512,0.3141448728828276,1.0,41/100,24.61%,SOX4;PERP;INHBA;HDAC2;EIF3C;NAT10;EIF4A3;VPS35;PRKDC;YTHDF1;RPS4X;EIF6;UHRF1;FGFR4;ASPH;EIF3D;ELAVL1;EZR;AGT;PLK1;NPM1;CLN6;LARP4B;RBM3;NSUN5;ASPSCR1;EIF3E;TGFB1;NFKBIA;VGLL4;MSN;PASK;WNT7A;HSP90AA1;BAK1;EEF2;METTL5;AURKAIP1;THBS1;LARP4;HNRNPD
prerank,post-translational protein modification (GO:0043687),0.2595397882612661,1.2469166084353498,0.02702702702702703,0.31558122392156684,1.0,91/324,17.64%,NOTUM;PSMD14;DCAF13;DSCC1;STT3A;PDIA6;PSMB2;EVA1A;STT3B;PSMB9;PSMA5;P4HB;SKP2;FBXL18;ASB9;PSMB3;VHL;PSME3;PSMA3;PSMA7;ESCO2;TMEM132A;MSLN;PSMD13;FUCA2;TIMP1;AMELX;DCAF7;SPP1;PSME2;PSMC2;PSMC4;PSMD10;RAB8A;ERCC8;RBBP5;PSMD12;RAB11A;F5;FBXO4;SERPINA10;NAE1;PSMB5;CKAP4;LMO7;FBXW9;SERPIND1;VGF;CCNF;DNAJC3;FN1;LRR1;ADAM10;AFP;PCSK9;PSMD8;RAB2A;FBXO41;PSMB4;PSMD3;PSMB1;PROC;PSMA4;COPS5;DDB1;SUMF2;SHISA5;SPSB2;PRKCSH;PSME1;PSMF1;FBXL13;PSMD11;BMP4;KLHL11;PSMD1;C3;IGFBP1;SOCS3;KBTBD8;CUL4A;RAB1A;WDR5;COMMD1;FBXL14;SUMF1;FBXO6;WSB2;FEM1A;TULP4;LGALS1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.43501387588603596,-1.2466016356323393,0.11320754716981132,0.33599451027649463,1.0,6/22,9.97%,PDE3B;GPER1;ASXL3;APOD;ALK;BSCL2
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4140817050144428,-1.245733397824234,0.15,0.3371829315575749,1.0,11/24,20.98%,PALM;TENM1;PIK3R1;NLGN1;GPM6A;RHOQ;DPYSL3;DOCK11;CCL21;TENM2;BCAS3
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.42320644458669626,-1.2456544645535677,0.18518518518518517,0.3367467744693,1.0,11/22,25.02%,CALM1;TAOK2;NEK10;PDGFB;RAD50;RASSF2;INS;PDGFD;CALM2;PDGFA;GPNMB
prerank,regulation of protein targeting to membrane (GO:0090313),-0.39385168797389924,-1.2455950445567001,0.17307692307692307,0.3363120568433626,1.0,9/29,17.56%,KCNB1;ANK3;MTCL1;PRNP;GDI1;MYO1C;INPP5K;KCNE1;AKT2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.37346284202071206,1.245305676501886,0.12244897959183673,0.3182028659850082,1.0,15/29,26.24%,INHBA;PMAIP1;PPP2R1B;PML;PAK2;AGT;TRAF2;TNFRSF12A;DEDD2;BID;CAV1;HYAL2;THBS1;G0S2;HTRA2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2786130940194166,1.2449799157387744,0.029411764705882353,0.3182282309005908,1.0,48/184,14.62%,NOTUM;PSMD14;PSMB2;DKK4;PSMB9;PSMA5;SHISA2;PSMB3;UBAC2;PSME3;PSMA3;MDFI;RUVBL2;PSMA7;KREMEN2;PSMD13;WNT5A;AXIN2;PSME2;PSMC2;PSMC4;PSMD10;PTPRO;PSMD12;SOX9;LRP4;RNF43;PSMB5;MDK;STK4;ZNRF3;HDAC1;PSMD8;IGFBP2;CTNNBIP1;PSMB4;GSK3B;PSMD3;PSMB1;PSMA4;MLLT3;WNT11;PSME1;PSMF1;PSMD11;PSMD1;IGFBP1;SOX30
prerank,mitotic cytokinesis (GO:0000281),0.3458703244768876,1.2447565173174246,0.14285714285714285,0.31792827182302635,1.0,16/48,13.68%,INCENP;CEP55;RACGAP1;CENPA;KIF23;KIF20A;STMN1;RTKN;ECT2;SPAST;MYH10;KIF4B;STAMBP;CKAP2;ANLN;PLK1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.30278486716594905,-1.2446463033256343,0.04411764705882353,0.3376299485847148,1.0,57/140,24.54%,FLCN;RASGRP2;SGSM2;RAPGEF3;RAP1A;ASAP3;FERMT2;CCL14;TBC1D20;MTMR9;MTCL1;PLIN5;CALM1;DVL3;EVI5L;RGS10;SRGAP2;GNB5;CAV2;RIC1;RAB11FIP2;NTRK1;NDEL1;RGS8;RAPGEF1;ADRB1;SFRP1;RHOA;ARHGEF7;SNX18;MAPK8;SGSM3;RAB3GAP1;DOCK11;PLXNB1;CCL23;MAPRE2;ALS2;CCL11;RGS6;RAPGEF6;CCL21;RAPGEF2;CCL2;BCAS3;MAPK12;PRTN3;BCAR3;PIN1;RSU1;CALM2;ADCYAP1;PINK1;CDKL5;RHOC;ARHGAP11B;RGS1
prerank,calcium ion transport into cytosol (GO:0060402),-0.42708093544831643,-1.2445423199543808,0.15217391304347827,0.33724042293421846,1.0,9/21,11.05%,ATP2B4;CACNA1C;JPH2;JPH4;CACNA2D1;SLC8A1;ADRA1A;JPH3;RYR2
prerank,regulation of JNK cascade (GO:0046328),-0.3223132077874322,-1.244174261324748,0.06557377049180328,0.3375292814385279,1.0,33/102,23.81%,PER1;DUSP22;TGFBR3;MTURN;DUSP3;TRAF1;ZMYND11;PJA2;TLR9;ANKRD6;FZD7;MAPK8IP3;FLT4;TAOK2;DAB2IP;GADD45B;MAP4K2;SH3RF3;DUSP19;GPS2;SEMA3A;WNT16;EGFR;MAPK8IP1;PLCB1;RASSF2;EDA2R;MAP3K10;CCL21;TIRAP;GADD45G;RIPK1;PINK1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.40768803423548877,-1.2438726729216063,0.15517241379310345,0.33759186122698936,1.0,15/34,22.59%,CLU;HAP1;PRNP;RTN1;GGA3;EPHA4;GSAP;ROCK1;RTN2;RTN4;CASP3;GSK3A;IFNGR1;LRRTM3;PIN1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.39472993158591685,-1.243785814709534,0.14285714285714285,0.33723430552346045,1.0,10/27,17.18%,CSPG4;CHST3;B3GAT1;CHST15;DCN;CHST7;XYLT1;CHST9;CSGALNACT2;CHST12
prerank,positive regulation of protein catabolic process (GO:0045732),0.3012117854371172,1.243186281735725,0.125,0.3204559428118158,1.0,28/83,21.73%,ASB9;CSNK2A3;IL1B;WNT5A;VPS35;TNFAIP3;C4BPA;CSNK2A1;C4BPB;GSK3B;SORL1;OAZ3;DDB1;EZR;VCP;ADAM8;NSF;RAB7A;IDE;TNFRSF1B;ADAM9;AXIN1;VGLL4;MSN;HSP90AA1;HECW1;HECW2;DTL
prerank,regulation of autophagosome assembly (GO:2000785),-0.3668465091155858,-1.2416834915949277,0.12903225806451613,0.34111528222455884,1.0,11/33,20.21%,PIP4K2B;LRRK2;FEZ2;PIP4K2A;LRSAM1;RAB3GAP1;NUPR1;CHMP4A;ADPRH;TBC1D12;PIKFYVE
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3690386575626085,-1.2416736238196628,0.16,0.34058871075810404,1.0,12/29,25.54%,NGF;NTRK1;RAPGEF1;RELN;MMD2;EPOR;NOTCH2;FGF10;STK19;LRRD1;RASGRP4;EPO
prerank,response to hydrogen peroxide (GO:0042542),0.3275966307953672,1.240416590854146,0.12195121951219512,0.32539628631253603,1.0,19/47,21.55%,GLRX2;TRPM2;STK26;RPS3;ECT2;TNFAIP3;PPIF;STK24;RELA;APTX;GPX1;PDCD10;MAPK13;FXN;ADAM9;FYN;NET1;PAX2;PRDX3
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.4303617766743847,-1.2401547380265163,0.21428571428571427,0.3428099156522541,1.0,9/22,21.72%,CACNA1C;CAP2;PALM;STIM1;LTB4R2;EDNRB;CRHR1;GNAI2;GRM2
prerank,regulation of insulin secretion (GO:0050796),-0.32107861137665133,-1.2398646357076442,0.12962962962962962,0.3428634002648522,1.0,24/97,14.80%,ADCY5;KCNB1;NLGN2;CACNA1C;ARNTL;NNAT;KCNA5;RAPGEF3;RAP1A;PPP3CB;ITPR1;ABCC8;GPER1;PRKCA;NR1D1;EPHA5;GCK;SNAP25;SIRT4;SLC30A8;CELA2A;EFNA5;SFRP1;STXBP4
prerank,fluid transport (GO:0042044),0.42853112591221565,1.2397819178746656,0.20454545454545456,0.3261323968759395,1.0,5/17,13.89%,SLC4A11;UPK3A;AQP5;AQP9;AQP3
prerank,protein K63-linked deubiquitination (GO:0070536),0.37888846942023846,1.2392847193475582,0.13513513513513514,0.3267139823337115,1.0,8/29,11.75%,PSMD14;OTUB2;SHMT2;BRCC3;USP50;TNFAIP3;SPATA2;STAMBP
prerank,organic acid transport (GO:0015849),0.3051293952342192,1.239256516715571,0.04878048780487805,0.3261744649366799,1.0,34/95,24.51%,SLC6A20;SLC1A5;SLC1A4;SLC5A6;FOLR1;SLC6A14;SLC7A1;SLC7A11;AKR1C4;SLC38A5;ABCC11;GOT2;SLC6A6;SLC19A1;LRRC8D;SLCO1B3;SLC25A17;SLC7A4;SLC3A2;SLC16A10;SLCO1C1;SLC27A5;SLC13A3;SLC43A2;SLC25A48;SLC7A7;ABCC2;SLC7A8;SLC6A18;SLC27A4;SLCO1A2;SLC7A6;SLC26A8;SLC46A1
prerank,regulation of complement activation (GO:0030449),0.3678446785208172,1.2390977921595498,0.14285714285714285,0.3259018883344906,1.0,13/37,19.19%,PHB;IL1B;C1QBP;CD46;CD55;C4BPA;CD81;CPN1;SERPING1;C4BPB;C3;C2;C8G
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3341778978046858,-1.2389973355695283,0.11538461538461539,0.3440026438965734,1.0,19/69,14.01%,FLCN;GPR17;KANK2;RAF1;LPAR1;STARD13;MYOC;DLC1;ABCA1;STARD8;MYO9B;KCTD10;ARHGEF18;OPHN1;RASIP1;GPR20;RIT2;SCAI;RAC1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4009778728412209,1.2388114600230542,0.15789473684210525,0.32595159851151506,1.0,7/15,20.09%,TACSTD2;SOX9;SIX1;AGT;BMP4;PAX8;PAX2
prerank,regulation of protein ubiquitination (GO:0031396),0.29152933356449384,1.2386938885614833,0.08888888888888889,0.3255671004624006,1.0,32/101,21.14%,GNL3L;SOX4;PRR7;PRMT3;RIPK2;GTPBP4;UBE2N;DERL1;NDFIP2;PSMD10;RPS3;TNFAIP3;FBXO4;XIAP;BRCA1;DNAJA1;HSPBP1;ISG15;TBC1D7;COMMD1;PRKCG;SPRTN;UBQLN1;HSP90AB1;FANCI;PAXIP1;AXIN1;UBE2D1;BIRC7;CAV1;HSP90AA1;CUL3
prerank,axoneme assembly (GO:0035082),0.3566554129143186,1.2384523457686487,0.14893617021276595,0.3253346218303663,1.0,9/28,11.79%,RP1;CCDC103;DNAAF2;SPAG1;TTC26;RSPH9;CFAP74;DNAAF3;SPAG17
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4504900023119619,1.2374584432455968,0.20930232558139536,0.32617494717505763,1.0,5/15,12.51%,TRIAP1;ARMC10;CD44;KDM1A;TAF9
prerank,granulocyte differentiation (GO:0030851),0.4179038956579645,1.2372841574649502,0.18181818181818182,0.3260173286628751,1.0,11/20,26.89%,E2F1;LEF1;PML;CDK4;CEBPA;JAGN1;DEK;SRP54;CDK2;SPI1;CEBPE
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4423192455155539,1.2364667939654292,0.17391304347826086,0.3267974305738964,1.0,7/19,19.65%,CIAO1;CIAPIN1;HSPA9;ISCA2;FXN;LYRM4;NUBPL
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3876160851724247,1.235878444272349,0.18181818181818182,0.32720065844574914,1.0,17/27,31.14%,RIPK2;UBE2N;IRAK2;TNFAIP3;RELA;IRAK1;AAMP;UBA52;OTULIN;NOD2;CASP8;TRAF6;NOD1;ITCH;UBC;LACC1;IKBKG
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3172376432320221,1.2357173284634282,0.10869565217391304,0.3268366220690769,1.0,22/72,21.42%,RFC3;FEN1;RPA3;RFC5;RFC2;POLD2;GTF2H3;DNA2;ERCC5;PDE12;DDB1;UBA52;RPA2;POLD1;CUL4A;DNASE1L1;REXO4;XRN2;RFC4;ERCC2;DDX1;ZC3H12A
prerank,mRNA 3'-end processing (GO:0031124),0.3084780231377423,1.2353156973121842,0.14583333333333334,0.32701463765843913,1.0,24/77,15.40%,POLR2D;CSTF2;CPSF3;ALYREF;THOC3;PABPC1;U2AF1;CSTF1;MAGOH;SLBP;MAGOHB;EIF4A3;CPSF4L;NCBP1;DDX39A;SRSF9;NUDT21;CLP1;GRSF1;NCBP2;CPSF2;THOC6;ZNF473;LEO1
prerank,negative regulation of protein secretion (GO:0050709),0.34242377718155376,1.2352288265618712,0.10638297872340426,0.3266335170342341,1.0,10/37,16.18%,BMP8A;CYP51A1;IRS1;IL1B;RAB11FIP1;RHBDF2;ERP29;DRD2;KCNJ11;F2R
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.35002778491936865,-1.2348016480353847,0.13333333333333333,0.3518660057818201,1.0,16/52,20.12%,ATP2B4;FGFR1;FGF2;MECP2;PRKCA;PRKD1;ANGPT4;HSPB1;MEF2C;GATA2;PDGFB;MAPK14;CSNK2B;ANGPT1;AGTR2;SIRT1
prerank,negative regulation of innate immune response (GO:0045824),0.33776372411632744,1.2346476516630316,0.1111111111111111,0.32731311940877683,1.0,14/37,20.69%,LYAR;USP18;TNFAIP3;NMI;TTLL12;SERPING1;NLRC5;YTHDF2;GRN;RPS19;ISG15;PTPN2;OAS3;IFI16
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.4289327027047081,1.2342124884620262,0.21568627450980393,0.3275636679014388,1.0,8/16,20.34%,CARD14;TNFSF15;IRAK1;TNFRSF10B;TRAF2;CARD10;CHI3L1;TNFRSF10A
prerank,regulation of chromosome segregation (GO:0051983),0.39889413432650317,1.234157105161259,0.14893617021276595,0.32712796533469424,1.0,8/17,20.76%,RMI2;RAD18;AURKB;CSNK2A1;KIF2C;BUB1;CDC6;MKI67
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.38928244382767363,-1.2339618588496335,0.14754098360655737,0.35276458049373716,1.0,7/27,13.20%,MEIS2;DUSP3;TAL1;PRKCA;USP2;CCDC57;ASNS
prerank,regulation of fibroblast migration (GO:0010762),-0.4484194930234529,-1.2338413540867623,0.22413793103448276,0.35228350834409206,1.0,6/20,15.13%,FGF2;DDR2;CORO1C;GNA12;RAC1;ARHGEF7
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.44189697384835824,-1.2337320195715304,0.16666666666666666,0.3519074467602641,1.0,9/20,26.38%,CLK2;GCK;SOGA1;C1QTNF3;GSK3A;INS;CRY1;MST1;DKKL1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.30871823531145626,-1.2330073414851206,0.1111111111111111,0.35300819803884853,1.0,36/100,22.84%,PDE2A;RYR3;AKAP6;TRPV1;RAPGEF3;PKD2;RAP1A;DEFB124;RRAGC;P2RY1;CPEB1;P2RX7;SLIT2;ZFP36L1;PDE3A;CPEB3;MEF2C;AQP1;INPP5K;P2RY12;RRAGB;RAPGEF1;KCNE1;SSH1;SFRP1;IGFBP5;CRHBP;GABRG2;P2RY11;RRAGD;RAPGEF2;HCN3;RPTOR;ACTB;CPEB4;MTOR
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2958760484571499,-1.2329212432519718,0.11940298507462686,0.3525879836793632,1.0,59/140,27.41%,DMD;TARDBP;WWTR1;CALM1;ATG14;PDE4D;NTRK3;SNCA;CNKSR3;PARD3;PRKRIP1;DBNDD2;PRNP;TERF2IP;NCK1;CADM4;SLIT2;PPEF2;PTEN;PRKAG2;LRRK2;PPM1F;SIRT2;EMILIN1;CORO1C;FBLN1;PID1;HSPB1;INPP5K;DAB2IP;TAB1;SFRP1;TRIB2;PIP5KL1;GNAQ;NTF3;MYADM;DUSP19;TSC2;CDK5RAP3;RASSF2;FKBP8;TESK1;SMAD7;LRP6;GPD1L;ERRFI1;CAV3;CALM2;PRKCD;OCLN;TRAF3IP1;SNX25;CEACAM1;NOG;DEPTOR;ITGB1BP1;PPM1E;LDLRAD4
prerank,regulation of DNA repair (GO:0006282),0.33971662617326975,1.2329202803807906,0.17647058823529413,0.3288759884403207,1.0,17/41,20.62%,BRCC3;POLH;UBE2N;AXIN2;ERCC8;PML;RPS3;WRNIP1;DHX9;CEBPG;WRAP53;BRCA1;USP1;EYA1;DEK;TMEM161A;TRIM28
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3866391326985643,1.2326955108922242,0.1282051282051282,0.32875342442730127,1.0,11/27,20.67%,TRIB3;CEBPB;ERO1A;BBC3;CHAC1;AIFM1;TNFRSF10B;TRAF2;BAX;BAK1;DNAJC10
prerank,skeletal muscle contraction (GO:0003009),-0.452093927553728,-1.2325691107496273,0.203125,0.35293396793015414,1.0,6/19,11.10%,MYH7;MYH3;TCAP;TNNT3;STAC2;STAC
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.33149631566361254,1.2325124289610891,0.13333333333333333,0.3284285111987559,1.0,17/58,13.68%,INCENP;CEP55;RACGAP1;CENPA;KIF23;KIF20A;STMN1;RTKN;AURKB;ECT2;SPAST;MYH10;KIF4B;STAMBP;CKAP2;ANLN;PLK1
prerank,neuromuscular process (GO:0050905),-0.43438745020621916,-1.2321716434019705,0.1724137931034483,0.35310262236006607,1.0,5/19,10.70%,PRRT2;DCTN1;NRXN1;PAFAH1B1;KCNA1
prerank,vasculature development (GO:0001944),-0.43826719330413905,-1.2320801535539765,0.2459016393442623,0.35265495079333203,1.0,9/17,22.88%,FOXF1;PDGFRA;TCF21;FLT4;NOTCH4;FBXW7;SOX18;CDH5;ERRFI1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3041794071309858,1.2311430160079984,0.11904761904761904,0.3303496992057447,1.0,21/81,12.19%,ENC1;CALR;CAPRIN1;PUS7;GZMB;DHFR;MRPL13;GAPDH;IGF2BP1;NCL;EIF4A3;NANOS3;IGF2BP3;RPS3;CNOT10;GRB7;IGF2BP2;EIF4E2;ORMDL3;SORL1;TRIM71
prerank,regulation of adaptive immune response (GO:0002819),0.4467281431180865,1.2310601361552806,0.175,0.3299497335457385,1.0,10/18,37.19%,IL4I1;SKAP1;TRIM27;ADCY7;TNFSF4;AHR;IRF7;EIF2AK4;SAMSN1;SASH3
prerank,regulation of ion transmembrane transport (GO:0034765),-0.37036375594605325,-1.231031882322932,0.07547169811320754,0.3542141370753972,1.0,19/35,29.85%,AKAP6;WNK3;KCNH2;P2RX7;CASQ2;KCNE2;KCNJ8;KCNJ9;KCNJ1;AHCYL1;CHRM3;ANO6;WNK1;KCNJ5;AKAP9;NEDD4L;KCNE5;CALHM1;KCNJ12
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.43088424779997503,1.230520778477419,0.18181818181818182,0.3304681400920667,1.0,6/17,24.06%,RAN;ERLIN1;KPNB1;ERLIN2;MBTPS2;ABCG1
prerank,regulation of defense response to virus by host (GO:0050691),0.35083322288995666,1.2303656085699517,0.1590909090909091,0.3303622707547628,1.0,14/33,25.72%,IL23A;TNFAIP3;DHX9;TARBP2;DTX3L;STAT1;APOBEC3F;MICB;IL23R;HSP90AA1;ZC3H12A;IL12B;IL12RB1;TRAF3IP2
prerank,muscle tissue morphogenesis (GO:0060415),-0.45636080367245524,-1.2303599673264343,0.2037037037037037,0.35497915006984676,1.0,10/17,23.27%,MYLK;TGFBR3;TCAP;TBX1;EFEMP2;ACTC1;HEY2;ANKRD1;TTN;MYLK2
prerank,sensory perception of bitter taste (GO:0050913),0.39987498902193214,1.2303477857622225,0.15151515151515152,0.32981801660195426,1.0,5/36,5.25%,CST1;AZGP1;CST4;CST2;LPO
prerank,positive regulation of double-strand break repair (GO:2000781),0.40632449989574293,1.2301428319817194,0.19047619047619047,0.32969531429934523,1.0,9/32,14.52%,FANCB;RAD51AP1;TIMELESS;ACTR2;PRKDC;DTX3L;WRAP53;FUS;FOXM1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4139877839090167,-1.2296787096747643,0.1724137931034483,0.3557563182564222,1.0,13/26,19.90%,TNS2;PRKCB;NCK1;PIP4K2B;GRB10;PID1;INPP5K;GRB14;PIP4K2A;KANK1;TSC2;RPS6KB1;GSK3A
prerank,spermatid development (GO:0007286),-0.3448447768602527,-1.2295726665980733,0.14516129032258066,0.3554383897265175,1.0,8/39,8.89%,RFX2;JAM2;DPY19L2;BBS4;TTC21A;DDX25;PLD6;PRM2
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4262536240201902,-1.2294405400004682,0.22807017543859648,0.3550341991921626,1.0,10/19,23.23%,LY6H;CHRM2;CHRNA3;RGS10;RGS8;GNAQ;PLCB1;CHRM5;CHRM3;GNA11
prerank,regulation of secretion by cell (GO:1903530),-0.3444620631797532,-1.228937729617725,0.16666666666666666,0.35509599907567413,1.0,22/52,24.29%,VAMP2;CPLX3;HAP1;CAMK2A;RAB12;DISP1;LGI3;STXBP5L;RIC1;MEF2C;CHRNB4;KCNMB4;RAB3A;RAB13;RAB3C;SYN1;INS;RAB8B;RIMS1;SYT1;CCKAR;RHBDF1
prerank,regulation of ossification (GO:0030278),0.3596238070036181,1.2289177120645551,0.15384615384615385,0.3313404067363407,1.0,9/34,8.48%,NOTUM;KREMEN2;WNT5A;CYP27B1;ANKH;SOX9;TGFB2;LRP4;MDK
prerank,establishment of endothelial barrier (GO:0061028),-0.39879554562445346,-1.2286902497342371,0.17857142857142858,0.35511410582675085,1.0,12/28,20.25%,PDE2A;RAPGEF3;RAP1A;PDE4D;RDX;TJP1;RAPGEF1;MYADM;ROBO4;SOX18;RAPGEF6;RAPGEF2
prerank,cellular response to copper ion (GO:0071280),-0.4407555483050661,-1.2281846766581983,0.23076923076923078,0.3555085387061678,1.0,7/18,27.84%,SNCA;PRNP;AQP1;MT1X;MT1M;MT1A;MT3
prerank,regulation of BMP signaling pathway (GO:0030510),-0.3296895905394357,-1.2275314550735246,0.13333333333333333,0.3560029014605824,1.0,33/73,28.18%,RBPMS2;BMPR1A;DAND5;CHRD;NUMA1;SMAD4;SKOR1;FSTL3;RBPJ;RNF165;SKI;FSTL1;FST;GDF5;SMAD9;ZNF423;SOX11;ACVR2A;SMAD2;TRIM33;BMPR1B;SMAD7;CDH5;DLX1;VWC2;TWSG1;NBL1;BMPER;CRIM1;NOG;SMURF1;FBXL15;BMPR2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4128685367712813,-1.2270464773228205,0.21428571428571427,0.356308108227785,1.0,13/27,19.90%,TNS2;PRKCB;NCK1;PIP4K2B;GRB10;PID1;INPP5K;GRB14;PIP4K2A;KANK1;TSC2;RPS6KB1;GSK3A
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.2968880175097613,-1.2265776354365052,0.08928571428571429,0.35671321121035393,1.0,59/154,24.12%,PKD1;MKNK1;DMPK;CSNK2A2;BRSK1;ULK1;PNCK;TTBK2;HIPK4;CSNK1E;CAMK2A;ULK2;RPS6KA5;PRKCB;PRKCA;RPS6KA2;CSNK1A1;CAMK1;PRKACA;PRKD1;HIPK3;DYRK1A;LRRK2;MAST2;MAST4;STK32B;LATS2;MAST1;MAPK1;RICTOR;MARK1;MORC3;PDGFB;ROCK1;MAPK8;CAMK2D;SGK3;MAPK14;AKT2;MARK3;STK32A;CSNK1D;MAP3K10;MAP3K12;RPS6KB1;PIKFYVE;MKNK2;MAPK12;PKN1;SMG1;TNKS;MTOR;LATS1;HIPK1;PRKCD;WNK1;RIPK1;PINK1;PRKCH
prerank,regulation of protein kinase B signaling (GO:0051896),-0.2825660649277915,-1.226507347693302,0.028985507246376812,0.3562826902819156,1.0,59/200,20.17%,FLCN;FGFR1;SFRP5;NRG2;FGF2;GAB1;FERMT2;TSPYL5;GCNT2;PPP2R5B;MYOC;BTC;MAGI2;PDGFRA;GPER1;RASD2;PIK3R1;FGFR2;NTRK3;FGF22;KIT;KITLG;TNFAIP8L3;PTEN;PHLDA3;MSTN;FLT3LG;KL;OTUD3;RRAS;MC1R;NTRK1;THPO;INPP5K;P2RY12;FGF17;RICTOR;RAC1;PDGFB;ESR1;AKR1C2;FGF7;PHLPP2;FGF5;FGF10;TSC2;AKT2;FGF1;RTN4;INSR;FGF16;EGFR;ERBB4;RAMP3;ANGPT1;RET;INS;SIRT1;CCL21
prerank,positive regulation of cell population proliferation (GO:0008284),0.24667202869773902,1.2263245323981453,0.0,0.33556317972268207,1.0,140/455,21.92%,CIAO1;SOX4;MYC;MCTS1;CALR;E2F1;TDGF1;OSM;KIF20B;FBXO5;IRS1;LAMC2;TIPIN;ESM1;RASSF10;CXCL5;IL11;WNT2;EREG;SAPCD2;CDC123;WDR77;SSR1;CSF2;PDGFRB;CSNK2A3;AREG;ROMO1;PHB;HDAC2;KIF14;FGF19;EPHA1;SAAL1;GDF9;IL1B;WNT5A;TBRG4;TIMP1;TBX20;CEACAM6;GID8;SHH;LEF1;REG1A;CDK4;CTSH;PROX1;SOX9;S100A6;NACC1;TGFB2;RTKN2;RPS4X;DHX9;MDK;CSNK2A1;MAZ;BAMBI;IL21;FAM98A;HMGA2;CD81;XBP1;PRAME;NOX1;HDAC1;FN1;FGFR4;RELA;ADAM10;CDCA7L;IGF1R;FGF20;PRMT1;STAT1;STAMBP;CAPN1;KDM1A;PRLR;RPS9;NME1;STX3;AGT;MAPK15;ZNF703;FGF3;CIB1;PRKCI;NPM1;KDR;BMP4;FAM98B;CXCR2;GRN;FOXM1;PAK1;PDCD10;BST2;ACER2;RAB25;SLC35F6;SLC25A33;RNF187;HPSE;F2R;UBE2A;IL7R;TGFB1;LRP5;SLC25A5;LYN;INSL4;REG1B;NOD2;EGR4;BIRC5;FXN;CDC7;STOX1;PROK2;RPRD1B;TGFBR2;TNFSF4;MLXIPL;HES1;TGFA;PAX2;CD86;TSPAN31;SPDYA;RPL23;CDK6;CUL3;DDRGK1;PRDX3;CDK2;NOTCH1;LGMN;TTK
prerank,phosphatidic acid metabolic process (GO:0046473),-0.3591766403167271,-1.2257328157913383,0.11864406779661017,0.35705999681420586,1.0,17/48,19.00%,AGPAT1;PLA2G5;PLA2G4B;ABHD8;DGKE;PLD6;AGPAT4;PLA2G6;ABHD4;LIPI;SLC27A1;DDHD2;DGKG;DDHD1;PLA2G1B;PLD2;DGKB
prerank,hippo signaling (GO:0035329),-0.41371798865468784,-1.2256420636519254,0.18181818181818182,0.3565872596045802,1.0,13/26,19.20%,TEAD3;AMOTL1;WWTR1;DCHS1;TEAD1;FAT4;LATS2;TJP1;DVL2;TEAD2;AMOTL2;CASP3;SAV1
prerank,positive regulation of transferase activity (GO:0051347),0.2808062315340423,1.2254244600185653,0.02857142857142857,0.33697535282884233,1.0,37/144,14.28%,DKC1;RFC3;MYC;TRIB3;DSCC1;RFC5;DCUN1D5;CCT2;RFC2;UBE2N;EPHB2;PDGFRB;EPHB3;MET;XRCC5;EPHA1;NEK2;SERINC5;RPS2;EPHB4;AURKB;EPHA2;NAF1;ZNF622;DBI;DDR1;PTGES3;FGFR4;DTX3L;WRAP53;IGF1R;SORL1;MAPK15;PLK1;GRHL2;KDR;CCT4
prerank,regulation of cell morphogenesis (GO:0022604),-0.4024082691272424,-1.2254185817493939,0.14285714285714285,0.3564453125,1.0,18/32,28.84%,ZNF135;ZMYM6;FERMT2;MACF1;WTIP;MYO9A;NTNG1;EFNA5;ZMYM3;CAPZB;ZRANB1;PHIP;STRIP1;FMNL2;ARC;CAMSAP1;ZMYM4;SH3D19
prerank,nucleosome organization (GO:0034728),0.33097742327283614,1.225302082912257,0.14893617021276595,0.33660605168157703,1.0,17/56,15.49%,CHAF1B;HMGA1;CHAF1A;SET;SMARCB1;GRWD1;SMARCA4;POLE3;SOX9;SPTY2D1;HMGB2;ZNHIT1;SMARCD2;SMARCC1;NPM1;LIN54;VPS72
prerank,regulation of gluconeogenesis (GO:0006111),-0.39974770641482027,-1.2248994610178778,0.16,0.3569328151716147,1.0,12/25,25.06%,CLK2;GCK;ZNF692;SOGA1;C1QTNF3;OGT;PDK2;INS;SIRT1;CRY1;NNMT;MST1
prerank,mitotic spindle assembly (GO:0090307),0.34579311175595784,1.2248120889012548,0.17307692307692307,0.3369439193761292,1.0,17/40,22.30%,KIF2A;MZT1;RACGAP1;KIF23;CHEK2;AURKB;RAB11A;KIF3B;TPX2;KIF4B;KPNB1;SMC1A;BCCIP;WRAP73;KIF4A;MISP;KIFC1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.36606786894058396,1.2238837455337843,0.1346153846153846,0.33823851090347284,1.0,14/39,16.95%,RFWD3;MYC;FBXO5;POLH;UBE2N;SMYD2;WRNIP1;HMGA2;NEK4;ARMT1;IER3;USP1;RPA2;NSMCE1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3637618818434713,1.2236203908653058,0.1590909090909091,0.3381395988967293,1.0,7/27,12.43%,RNASEH1;CPSF3;POP1;LACTB2;POP7;PDE12;NHP2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.385712522978221,-1.2217260005608568,0.16393442622950818,0.36261429624360003,1.0,7/25,9.09%,BMPR1A;NRP2;SMAD4;FGFR2;TBX1;ZFPM2;PARVA
prerank,membrane protein proteolysis (GO:0033619),0.36274346271045377,1.2214960400869974,0.10256410256410256,0.34149959662618823,1.0,13/39,19.28%,MMP7;HM13;BACE2;CTSH;APH1A;RELA;ADAM10;CLPP;NCSTN;TGFB1;MBTPS2;ADAM9;ERAP1
prerank,nucleosome assembly (GO:0006334),0.37910862332414064,1.2205911869526647,0.16666666666666666,0.34251074564480294,1.0,9/30,15.92%,CHAF1B;CHAF1A;GRWD1;SOX9;SPTY2D1;HMGB2;HAT1;NPM1;HIRA
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.41922038861464206,-1.2205262756249557,0.18,0.364629812240961,1.0,11/27,24.16%,CACNA1C;ANK2;PDE4D;CTNNA3;PLN;RYR2;FGF13;CAMK2D;SCN5A;CAV3;ATP2A2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.289727392968353,-1.2204313827350435,0.125,0.36427705212825545,1.0,37/133,23.76%,GLP2R;ADCY5;PTH1R;ADCYAP1R1;ADCY2;ADRB3;ADCY4;POMC;VIPR2;ADRB2;ADCY9;PRKACA;GNG2;RAMP1;ADORA2A;PRKAR2B;VIP;MC1R;GPR20;AVPR2;ADRB1;ADCY6;TSHB;MAPK14;HTR4;CRHR1;GPR27;RAMP3;P2RY11;GPBAR1;LHCGR;HTR7;CRHR2;PLCG1;RAMP2;PLCG2;ADCYAP1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.4464702582439993,1.2200446091292547,0.2,0.3427645045161885,1.0,12/18,29.88%,GSK3B;ZNF205;SLC35F6;SLC25A5;BAX;BID;TMEM102;TMEM14A;BAK1;FZD9;HIP1R;CHCHD10
prerank,autophagosome organization (GO:1905037),-0.358829252487033,-1.219999098927846,0.15,0.36435159452646854,1.0,18/53,18.16%,GABARAPL1;ULK1;ATG2B;ATG9A;WDR45;ULK2;ATG14;MAP1LC3C;TP53INP2;ATG16L2;RAB23;PIK3C3;PACS2;TP53INP1;EMC6;STX12;GABARAPL2;ATG12
prerank,ephrin receptor signaling pathway (GO:0048013),0.30030912375047836,1.219453356270731,0.175,0.3434118194357206,1.0,31/82,21.04%,GRIN2B;ACTR3;ACTR2;EFNA3;EPHB2;EPHB3;EPHA1;EPHB4;ARPC5;EFNA4;ACTG1;EPHA2;EFNB1;APH1A;EFNA1;ARHGEF28;AP2S1;MMP2;EFNA2;ARPC3;MMP9;PAK1;AP2B1;NCSTN;LYN;VAV3;FYN;CDC42;YES1;VAV2;GIT1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.30616763044683887,1.2188329667885496,0.12195121951219512,0.3439496626451549,1.0,14/74,10.97%,EPHB2;IL23A;SLC7A1;ZP3;CD276;IL1B;PNP;CD46;CHRNB2;IL21;CD80;CD81;JAK3;CD70
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4492000610605039,1.2187798462112824,0.19444444444444445,0.3434494037926035,1.0,7/15,28.62%,GET4;EMC8;EMC10;EMC1;EMC7;UBL4A;EMC3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4312213838187844,1.2180665945037934,0.20408163265306123,0.34411033520897677,1.0,5/19,10.16%,GNPNAT1;PMM2;GFPT1;GNPDA1;PGM3
prerank,regulation of cell cycle process (GO:0010564),0.30195654485386475,1.2179264413974018,0.0967741935483871,0.34389640175974034,1.0,30/104,13.92%,CHEK1;SND1;KIF20B;DBF4;FBXO5;TIPIN;KNSTRN;RACGAP1;RCC1;KIF20A;CEP250;RMI2;NEK2;CDC25C;AURKB;SPAG5;ECT2;RAB11A;SOX9;BCL2L1;PDXP;CSNK2A1;PRPF40A;HMGA2;RAB11FIP4;AURKA;PKMYT1;BUB1;PLK1;YTHDF2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.27989859010188467,1.217588461207504,0.09302325581395349,0.34389654447675616,1.0,35/123,15.19%,PSMD14;CELSR1;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;CELSR3;PSMA7;PSMD13;WNT5A;PSME2;PSMC2;PSMC4;LEF1;PSMD10;PSMD12;PSMB5;PSMD8;AP2S1;ARHGEF19;PSMB4;PSMD3;PSMB1;PSMA4;FZD10;CLTC;WNT11;PSME1;PSMF1;PSMD11;PSMD1;AP2B1;PLCB3
prerank,protein processing (GO:0016485),0.30134000899833824,1.2175130872019118,0.19047619047619047,0.34352385088671733,1.0,40/96,25.26%,KLK6;HM13;F12;TMEM208;MMEL1;CPZ;CPD;SPCS1;CTSH;MME;STOML2;APH1A;PCSK1;CASP2;CPN1;F7;ADAM10;PCSK9;YME1L1;PRSS3;MYRF;NCSTN;SPRTN;PCSK7;SPCS2;FXN;PCSK6;ZMPSTE24;SDE2;TMPRSS4;TYSND1;SEC11C;SRGN;CPXM1;LGMN;MYRFL;RCE1;CASP4;SEC11A;METAP2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3651101448376991,1.2160600440264278,0.16,0.34554532114917585,1.0,8/27,14.97%,DTYMK;DCTD;CMPK1;CTPS2;AK2;GSR;NME1;GLRX
prerank,regulation of cartilage development (GO:0061035),-0.42036642545615627,-1.2159378762756174,0.1320754716981132,0.3721283415111269,1.0,8/18,20.76%,TAPT1;SOX5;ZBTB16;TRPS1;BMP1;KAT2A;BMPR1B;SOX6
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.398980160521573,-1.2153769929180702,0.16666666666666666,0.37262957279926545,1.0,8/25,15.20%,RYR3;PKD2;FGF2;ITPR1;RYR1;RYR2;ANXA6;HTR2B
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2567947123623963,-1.2151819468603273,0.0,0.3723656331902633,1.0,137/418,24.87%,TCF7L1;PHF1;APBB3;APBB1;ZSCAN26;NR2C2;SSBP2;HCFC2;ZNF516;DMTF1;ZNF280D;ARNTL;ATF7;SOX15;ZNF219;ZBTB4;CHD3;HP1BP3;ZNF536;PHF12;ZNF273;PRDM2;SAP30L;ZNF676;MITF;WWTR1;BNC2;PPARGC1B;WTIP;YY1AP1;RPS6KA5;ZNF519;RORA;PRDM8;SKOR1;ZNF284;CASZ1;ZNF626;KAT6B;NAB2;ATF4;FOXN3;NFYB;ZNF732;TERF2IP;RHOXF1;SOX13;AKAP17A;GON4L;FZD7;ZNF331;TULP3;ZMIZ1;NR3C1;FOXN4;ZNF117;ZNF37A;FOXO4;GLI4;CXXC1;SOX17;MEF2C;NFIL3;WWC2;ZNF274;ZFAT;KAT7;VSX1;ARNT2;DAPK3;SOX7;DVL2;IRF2;UBE2V1;ERC1;HINFP;ZFHX3;TFEB;ESR1;TEAD2;DENND4A;WWC3;LMX1B;ZNF423;ZFPL1;RORB;MZF1;ATXN1L;ZFP37;SPIN1;APBB2;ZNF98;SOX11;INSR;SAP30;HIC1;BAZ2A;SUFU;SMARCA2;PFDN5;MED23;ZNF431;RNF14;SOX18;EFEMP1;ZNF653;ZNF2;INS;SOX2;SOX6;MLLT6;NR1D2;SERTAD3;NFIA;HOXB1;SCRT1;IGSF1;ZNF682;RFX3;ZNF350;CREM;NFYC;LIMD1;ATF2;JMJD1C;ESRRB;CDK11B;CELSR2;ZNF395;SUPT3H;NFX1;NKX3-1;SNAI2;CDK11A;HOXD13;BNC1;ZNF502
prerank,negative regulation of interferon-gamma production (GO:0032689),0.3690803428144343,1.2148956835920608,0.2391304347826087,0.3468701425467786,1.0,18/28,37.43%,INHBA;FOXP3;C1QBP;LILRB4;TNFSF4;HMGB1;ZC3H12A;IL36RN;XCL1;CD274;AXL;HAVCR2;TLR4;PDCD1LG2;LILRB1;LGALS7;LAPTM5;LGALS9B
prerank,sensory perception (GO:0007600),-0.35706672167241643,-1.2146271118447,0.13793103448275862,0.37297790937654635,1.0,15/48,21.51%,ASIC3;SCN9A;BBS4;P2RX7;KCNA2;CDH23;KCNK4;PENK;ADORA2A;GNAL;OPRL1;MRGPRX2;PCDH15;CCL2;TMEM150C
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4326112217002362,1.2143070965843048,0.1794871794871795,0.3472719424372986,1.0,9/16,19.91%,SHMT2;UQCC2;PDE12;PPIF;COX7A2L;COX7A2;VCP;SLC25A33;MLXIPL
prerank,cell projection assembly (GO:0030031),-0.42580011250664085,-1.2140275727126852,0.17777777777777778,0.3735601062925827,1.0,8/22,14.01%,GSN;NEFH;RHOQ;RHOJ;PARVA;NCKAP1L;QRICH2;RAC1
prerank,cell-substrate junction assembly (GO:0007044),-0.382407812395002,-1.2134005281638394,0.13559322033898305,0.3743094267814221,1.0,13/32,15.96%,SORBS1;FERMT2;ACTN2;ACTN3;WHAMM;ACTN1;DLC1;LAMC1;TAOK2;DST;PEAK1;ARHGEF7;THSD1
prerank,import into cell (GO:0098657),0.34818800286828616,1.213351975470499,0.1276595744680851,0.3485016004176763,1.0,11/41,11.22%,LRRC8E;SLC6A20;SLC5A6;SLC6A14;SLC7A1;SLC7A5;SLC6A6;SLC19A1;LRRC8D;TSPO2;SLC11A2
prerank,generation of neurons (GO:0048699),-0.2817133665176027,-1.2133291174933787,0.0625,0.37393209455171844,1.0,53/195,18.15%,RNF112;NRBP2;WNT9A;EML1;FGFR1;BRSK1;ARNTL;FZD4;MAPT;NLGN4X;MAP1B;DNER;CTF1;PAFAH1B1;PHOX2B;SNPH;CEP85L;WNT6;NGRN;GPM6A;MDGA1;WNT5B;SMARCA1;ADGRL3;FZD7;ATOH8;NAV1;MYEF2;ASTN1;HEY1;OPHN1;MEF2C;MYT1L;WNT2B;ASTN2;MARK1;LHX6;RAC1;FUT9;FGF13;RELN;DISC1;IL1RAPL1;HEY2;LMX1B;FZD8;IRX6;SEMA3A;WNT16;SOX11;SPOCK1;CASP3;LHX4
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3752312900692147,1.213114141887629,0.15,0.3482302341965751,1.0,5/39,5.25%,CST1;AZGP1;CST4;CST2;LPO
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.3339087768837975,-1.2130246580255024,0.17307692307692307,0.37397690514556237,1.0,26/71,21.61%,PKD1;FAM107A;KANK2;FHL1;PKD2;JADE1;ZNF655;LSM11;ADAMTS1;PTEN;RDX;UBE2E2;CDKN1A;PRMT2;APC;CDKN2C;FGF10;RBL2;EGFR;MYO16;KMT2E;DCUN1D3;PLCB1;INO80;CCL2;RPTOR
prerank,peptidyl-lysine methylation (GO:0018022),0.4329911727069845,1.2128695688632234,0.2558139534883721,0.3480124838988542,1.0,8/19,11.61%,SUV39H2;SUV39H1;SMYD3;SMYD2;EEF2KMT;TRMT112;METTL21A;SETD6
prerank,polyol biosynthetic process (GO:0046173),-0.448905307804208,-1.2118536533256667,0.09615384615384616,0.37567492950514486,1.0,3/16,2.91%,IP6K3;ITPKB;FGF2
prerank,protein secretion (GO:0009306),0.3287711094265956,1.2115558057169389,0.10256410256410256,0.3500603330547049,1.0,19/61,16.86%,MIA2;PDIA4;PDX1;CANX;RAB15;CTAGE9;RAB10;RAB8A;MTTP;FAM3B;RAB3D;COPG1;COPG2;CTAGE8;CTAGE4;CTAGE6;CTAGE15;STEAP3;PREB
prerank,cellular component assembly (GO:0022607),-0.2771654163084976,-1.210221981749211,0.10294117647058823,0.3787108144282322,1.0,64/252,17.77%,LIMS2;TTLL3;VAMP2;FAM107A;SH3BGR;ADD1;GPM6B;NLGN2;FLNA;WDR19;FLNC;GSN;CALD1;NLGN3;FERMT2;CAPN3;TCAP;NLGN4X;LIMA1;MITF;ANK3;TRAF1;ILK;DLG4;MYO9A;SYCE1;NLGN1;NEFH;PARD3;TEAD1;RHOQ;CCDC40;RHOJ;LAMC1;DPYSL3;KMT2A;DET1;WASF1;PARVA;WASF3;MDM4;NCKAP1L;TSPAN4;MAGI1;OPHN1;TINF2;QRICH2;RANBP9;CDAN1;RAC1;ADD2;RHOA;TEAD2;APC;REC8;CEP290;BSN;FAS;BAIAP2;ABCA3;NLGN4Y;WIPF1;FSCN3;RTN4
prerank,dendritic spine morphogenesis (GO:0060997),-0.4463222482749966,-1.2099405999684545,0.21052631578947367,0.3787341667319816,1.0,5/16,9.43%,CTNND2;SHANK3;DLG4;DIP2A;PTEN
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.2623493082729821,-1.2091692031738188,0.04054054054054054,0.3797616656624489,1.0,122/367,24.37%,CALCOCO1;PDE2A;TNRC6A;MYOM1;BVES;HAND2;ANK2;RBMS3;ACTA1;GSN;FGF2;OSR1;CLU;ACTA2;MAPK7;MAGI2;AGO4;MITF;CITED2;ANK3;GPER1;HOXD3;CUX2;CLDN5;GH1;ZNF580;NTRK3;CELF1;SNCA;P2RX7;FGF22;CD34;INPP5F;TNRC6C;ATF4;WNT6;TLR9;NGF;AR;OLFM1;RHOXF1;PSEN1;MPHOSPH8;RBPJ;PPM1F;SLC24A3;CNTF;EMILIN1;RNF207;TLR3;ECE1;HEY1;PID1;RDX;MEF2C;AGO3;MAPK1;MAPK3;FGF17;MAPK11;PIK3R3;AVPR2;MAP2K5;HINFP;ACTC1;GATA2;SEC16B;MUSK;PDGFB;FGF7;BRAF;ROCK1;MAPK8;HEY2;SLC38A2;TLE1;NTF3;FGF5;AZU1;FGF10;CD63;MAPK14;AHI1;HOXA5;SMO;FGF1;WNT16;SOX11;INSR;FGF16;RAMP3;CD36;TNRC6B;POU3F3;AGO1;MED23;VSTM2A;ANGPT1;GSK3A;INS;RIMS1;SETDB1;FGF9;IFNGR1;ADAM19;KLF2;CDH5;OSR2;UBR5;WFS1;MTOR;TTN;ID2;RAMP2;MYLK2;PLCG2;SETDB2;ATF2;ZNF804A;NKX3-1;C1QTNF1;OCLN
prerank,mesenchyme development (GO:0060485),-0.45591803788770113,-1.20910728637973,0.24,0.3792820041743713,1.0,4/15,6.34%,FOXF1;PKD2;FGFR2;CRELD1
prerank,endodermal cell differentiation (GO:0035987),0.3605633080911977,1.2090701519551752,0.14,0.35439810364166235,1.0,13/31,19.72%,COL11A1;INHBA;HMGA2;FN1;MMP2;ITGA5;LAMB3;LAMA3;MMP9;LEO1;MMP15;CTR9;MMP8
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3625402772368622,-1.2088080586534184,0.21311475409836064,0.37930438341794265,1.0,11/31,20.41%,PER1;KANK2;CRY2;ARNTL;TCF21;STRN3;PIAS2;SFRP1;VPS11;SIRT1;CRY1
prerank,chromatin assembly (GO:0031497),0.3511935360064854,1.2082061550288539,0.15789473684210525,0.35553681576811696,1.0,11/36,14.44%,CHAF1B;CHAF1A;GRWD1;POLE3;SOX9;SPTY2D1;HMGB2;NOC2L;HMGA2;NPM1;LIN54
prerank,fat cell differentiation (GO:0045444),-0.33828768383518687,-1.2081696046394552,0.17543859649122806,0.38003478244992606,1.0,22/58,23.78%,CLIP3;ZNF516;BBS4;WNT5B;FAM120B;BSCL2;C1QTNF3;PID1;STEAP4;BBS2;GDF6;BBS7;BBS9;AKT2;CBY1;SIRT1;NR4A3;PRDM16;SENP2;SOX8;NR4A1;OSBPL11
prerank,ion transport (GO:0006811),-0.3079238975174817,-1.207756174542372,0.09523809523809523,0.38020844885888355,1.0,49/111,31.43%,KCNN3;SLC17A7;CNGB1;SLC12A4;P2RX1;SLC26A11;SLC9A9;SLC8A2;SLC24A4;SLC8A1;PIEZO2;ATP1A4;CHRNA3;TRPC6;SLC24A3;GLRB;ATP10D;SLC1A2;SLC8A3;CHRNB4;MCOLN1;PIEZO1;SLC26A7;SLC9A5;KCNN1;SLC26A4;SLC17A8;SLC15A2;ANO6;WNK1;KCNN2;SLC4A1;SLC15A3;VDAC2;SLC39A1;CTNS;SLC17A4;SLC26A2;CALHM1;SLC12A5;LRRC8A;SLC36A1;SLC1A6;PDZD3;HCN4;TRPM3;SLC20A2;GRIN1;SLC1A3
prerank,extracellular structure organization (GO:0043062),-0.27559731101671586,-1.2066095190589359,0.08955223880597014,0.3822087510747556,1.0,65/206,21.57%,ITGA7;JAM3;ITGA10;ADAMTSL4;FBLN5;ADAMTS10;FGF2;COL6A1;COL28A1;VIT;ADAMTSL3;DDR2;LAMA2;LAMA5;JAM2;ADAMTS8;LAMB2;NID1;RECK;COL24A1;COLQ;COL6A2;COL16A1;ITGB3;ADAMTS1;PAPLN;LAMC1;LAMA4;ADAMTSL1;SH3PXD2A;DCN;LAMB1;MFAP5;COL4A5;COL5A3;MIA;COL23A1;TNC;APLP1;MMP27;ADAMTS13;HSPG2;PDGFB;ADAMTS9;COL13A1;COL27A1;SPINK5;COL4A6;ADAMTS5;COL4A2;ELN;MMP17;COL4A3;TEX14;MMP16;PXDN;ITGA2B;MMP28;ITGA8;MADCAM1;ITGA9;COL22A1;NCAN;ADAMTS3;ADAM19
prerank,positive regulation of binding (GO:0051099),0.2864231115618823,1.20651577245334,0.075,0.35808737558974807,1.0,34/86,24.78%,TRIB3;RAN;RIPK2;STMN1;MET;DERL1;NCBP1;HMGB2;DHX9;BAMBI;STK4;DTX3L;CEBPG;NMD3;GSK3B;NME1;CDT1;MMP9;BMP4;PPARG;PLAUR;EDF1;GMNN;IDE;MMP8;HES1;CAV1;RPL11;EPB41;HMGB1;MEN1;WNT3A;EGF;TERT
prerank,cilium-dependent cell motility (GO:0060285),-0.41806962871053843,-1.2056754273493624,0.18518518518518517,0.38355342059576314,1.0,8/22,15.79%,EFHC1;CCDC39;CFAP44;CFAP54;TEKT2;EFHC2;TEKT3;DNAH1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2853637317281043,-1.2047733042793909,0.07272727272727272,0.38471463429536584,1.0,45/129,25.72%,TGFB1I1;RGMA;TMEM100;DUSP22;TGFBR3;BMPR1A;FERMT2;GCNT2;PXN;WFIKKN2;SMAD4;CLDN5;PARD3;GDF7;ZMIZ1;MEGF8;ARHGEF18;SKI;MAPK3;RHOA;USP9Y;GDF5;GDF6;SMAD9;CBL;ZFYVE9;ACVR2A;SMAD2;USP15;LRRC32;UBB;HPGD;BMPR1B;SIRT1;MAP3K7;SMAD7;CDH5;PDCD4;ZFYVE16;TWSG1;TGFB3;AMHR2;SMAD3;FNTA;RUNX2
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.3184350736254865,-1.2045979072148716,0.14285714285714285,0.38457706578154566,1.0,30/89,20.63%,VAMP2;STON1;USP6;HAP1;CHMP3;RAB12;PACSIN1;INPP5F;FES;DNAJC13;LGI3;STXBP5L;RAB5B;LRRK2;OPHN1;SLC30A8;MAPK1;MAPK3;RAB3A;RAB4B;RIT2;PACSIN2;TSC2;RAB13;GAS1;PACSIN3;RAB3C;RUFY1;RAB8B;RUFY2
prerank,mitochondrion disassembly (GO:0061726),-0.35296310259794916,-1.2045714778988217,0.13114754098360656,0.38405465869565086,1.0,7/35,6.17%,GABARAPL1;ULK1;ATG2B;ATG9A;WDR45;ULK2;MAP1LC3C
prerank,regulation of neuroblast proliferation (GO:1902692),-0.43758152222353536,-1.2037907529705205,0.1509433962264151,0.38503129937341035,1.0,5/15,14.56%,SMARCD3;PTN;LRRK2;ZNF335;DISC1
prerank,long-term synaptic potentiation (GO:0060291),-0.4152336355487069,-1.203391851696085,0.23636363636363636,0.3853602796415604,1.0,7/21,12.34%,VAMP2;NFATC4;MPP2;TSHZ3;SLC8A2;NPTN;SLC8A3
prerank,ventricular septum development (GO:0003281),-0.3620272097447974,-1.203155286973677,0.16071428571428573,0.3852773577275679,1.0,14/37,17.96%,PDE2A;TGFBR3;BMPR1A;DAND5;SMAD4;CITED2;ZFPM2;SLIT2;MDM4;SLIT3;HEY1;HEY2;SOX11;HECTD1
prerank,glycolytic process (GO:0006096),0.37528265854779697,1.203141863133268,0.14634146341463414,0.364450812283613,1.0,13/28,25.25%,PGAM4;GAPDH;LDHA;HKDC1;TPI1;ENO4;GAPDHS;PKLR;PKM;ALDOC;ALDOB;PFKL;PGAM1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3074724829734619,1.203134669357398,0.15384615384615385,0.36387867600059315,1.0,34/82,21.67%,CEP72;CDK1;CEP250;GTSE1;KIF14;YWHAE;NEK2;TUBB4B;HAUS2;YWHAG;TUBA4A;ATAD5;HAUS8;CEP76;AURKA;TPX2;CKAP5;HAUS1;HAUS6;PLK1;NPM1;TUBG1;CEP78;CENPF;PLK4;DYNLL1;HAUS7;DYRK3;MAPRE1;SSNA1;CEP41;HSP90AA1;TUBB;CDK2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3048050989605018,-1.2029696638074898,0.14285714285714285,0.38505791488430513,1.0,35/95,24.46%,TRIM39;FOXF2;ZER1;CLU;MAP1A;CSNK1E;RNF19A;RNF180;CSNK1A1;RNF217;DET1;BAG2;LRRK2;SIRT2;ZYG11B;WAC;KLHL40;GNA12;OGT;TRIB2;BBS7;ARIH2;RNF144B;HECTD1;CSNK1D;DNAJB2;ARIH1;RNF14;GSK3A;PRICKLE1;SMAD7;CAMLG;PIAS1;RNF144A;GABARAP
prerank,natural killer cell activation involved in immune response (GO:0002323),-0.4102315090518185,-1.202270197086569,0.20754716981132076,0.3858906737657326,1.0,1/20,0.20%,VAMP2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.43633360369355895,1.2021995866545818,0.2222222222222222,0.36504756601787225,1.0,9/16,28.72%,VHL;ADIPOR1;SOCS1;SOCS3;PTPN2;CAV1;PPP2CA;PPP2R1A;PIBF1
prerank,external encapsulating structure organization (GO:0045229),-0.27114887792675896,-1.2014519284956295,0.08695652173913043,0.38721185526831736,1.0,67/207,22.66%,ITGA7;JAM3;ITGA10;ADAMTSL4;FBLN5;ADAMTS10;FGF2;COL6A1;COL28A1;VIT;ADAMTSL3;DDR2;LAMA2;LAMA5;JAM2;ADAMTS8;LAMB2;NID1;RECK;COL24A1;COLQ;COL6A2;COL16A1;ITGB3;ADAMTS1;PAPLN;LAMC1;LAMA4;ADAMTSL1;SH3PXD2A;DCN;LAMB1;MFAP5;COL4A5;COL5A3;MIA;COL23A1;TNC;APLP1;MMP27;ADAMTS13;HSPG2;PDGFB;ADAMTS9;COL13A1;COL27A1;SPINK5;COL4A6;ADAMTS5;COL4A2;ELN;MMP17;COL4A3;MMP16;PXDN;ITGA2B;MMP28;ITGA8;MADCAM1;ITGA9;COL22A1;NCAN;ADAMTS3;ADAM19;TGM1;ECM2;MMP19
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.2860613013381052,-1.2011749302559642,0.1320754716981132,0.3872764496472107,1.0,54/145,27.06%,GPR17;ADCY5;CACNA1C;JPH2;LPAR1;JPH4;AGTR1;CACNA2D1;PDGFRA;GPER1;DLG4;P2RY1;P2RX7;SLC8A1;ADRA1A;PTGER3;P2RX2;CCR10;ADRA1D;JPH3;NPTN;RYR2;PLCE1;TACR1;GPR20;S1PR3;ACKR3;OPRL1;PLA2G1B;ESR1;TBXA2R;CACNA1A;ACKR2;FFAR1;CD36;C5AR2;PTGFR;LPAR6;TRPC3;CAV3;ADRA1B;LPAR4;ADCYAP1;CHRNA10;C1QTNF1;CACNB3;F2RL3;GPR4;BDKRB1;P2RY4;TAC1;AVPR1B;CCKBR;F2RL1
prerank,microvillus assembly (GO:0030033),0.4365455131950893,1.2011371248228278,0.25,0.3664038137436617,1.0,6/15,19.29%,FXYD5;RAP2B;STK26;EZR;RAP2A;SLC9A3R1
prerank,protein localization to centrosome (GO:0071539),-0.4307436317174205,-1.200835504011163,0.15873015873015872,0.38750400048154776,1.0,9/18,20.20%,BBS4;KIAA0753;DCTN2;PCM1;GOLGB1;CCDC14;CSNK1D;HOOK3;CEP192
prerank,positive regulation of cell adhesion (GO:0045785),-0.3054479888637485,-1.2005548672898392,0.1694915254237288,0.38754081959042797,1.0,27/78,22.82%,FLCN;TPM1;VIT;CHRD;CITED2;TFE3;DUSP26;MEGF10;PRKCA;FSTL3;PPM1F;NCKAP1L;MAGI1;EPHA4;P2RY12;ARL2;RAC1;ZFHX3;PDGFB;AZU1;RET;CCL21;SMAD7;FBLN2;ECM2;IL12A;RSU1
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.32272620580362454,-1.2003020431383038,0.19607843137254902,0.387441975230881,1.0,26/78,20.98%,LMOD1;CCL27;CFL2;TENM1;SYNPO2;NUMA1;SORBS3;NTRK3;CDC42EP3;P2RX7;FES;EVL;NCK1;FER;NCKAP1L;SYNPO;FCHSD1;LMOD2;CDC42EP4;NTF3;BAIAP2;CCL11;FCHSD2;CCL21;MYLK3;BCAS3
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3878419875414416,1.2000961055422463,0.20512820512820512,0.36792920296203074,1.0,9/24,19.61%,SULT2B1;CBFB;CTSV;RUNX1;AQP3;BMP4;SFRP4;KDF1;SFN
prerank,endomembrane system organization (GO:0010256),-0.2830052178549385,-1.1991163691102606,0.09375,0.38941434378896533,1.0,59/190,19.73%,RNF112;SEC31B;DMPK;SYNGR1;TJAP1;TBC1D20;SYNE1;ANK3;SUN1;ATP8B2;SNX33;GOLGA8A;DYNC2H1;SUN2;LMAN1L;PLEKHM2;CLASP1;A4GALT;CSNK1A1;DNAJC13;SYP;PRKD1;OBSL1;CAV2;CLASP2;LRRK2;HACE1;ARHGAP21;GOLGA8B;OPTN;VPS33B;GOLGA8N;DYSF;AKTIP;RAB30;ATL3;GORASP1;ATL2;PI4K2A;ATL1;SEC16B;GBF1;ARHGEF7;TICAM2;COG1;DYM;VPS11;GOLGB1;VPS4A;VAPA;CSNK1D;TRAPPC8;ALS2;HOOK3;PLEKHF1;GOLGA8R;CTDNEP1;ATP8B3;DNM1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.4123424352536755,-1.199030994582105,0.24074074074074073,0.38904271835514476,1.0,9/20,18.27%,TGFBR3;BMPR1A;FGF2;FGFR2;ZFPM2;RBPJ;MEF2C;TBX2;ERBB4
prerank,response to cytokine (GO:0034097),0.2587315555556774,1.1988884140319338,0.04878048780487805,0.3698652950559835,1.0,44/145,19.82%,SHMT2;IFITM3;IFITM1;DDOST;IFITM2;LAMP3;IRAK2;IL1B;KHSRP;TIMP1;CYP27B1;LEF1;PML;MME;IKBKE;CXCR4;BCL2L1;MAPKAPK3;MYD88;RELA;ADAM10;IRAK1;JAK3;FOXA2;MAPKAPK2;STAT1;FOXH1;CXCL16;TAF9;POU4F1;COL3A1;GCH1;KYNU;BST2;MX1;ISG15;XAF1;IL23R;PTPN2;IL1RL2;PLSCR1;ADAM9;TMEM102;CHI3L1
prerank,apoptotic mitochondrial changes (GO:0008637),0.36175852060872926,1.198824965986774,0.18181818181818182,0.3694793044963522,1.0,13/33,20.50%,HSPD1;ATG3;IFI6;VPS35;BBC3;TIMM50;BCL2L1;GGCT;BIK;BAX;BID;SFN;BAK1
prerank,organelle disassembly (GO:1903008),0.36507088239585095,1.1986953222962857,0.2,0.3690600003612602,1.0,14/32,21.39%,MCTS1;CDK1;VRK1;KIF9;DENR;MTIF2;TEX264;GFM2;VCP;UFC1;DYRK3;ZFAND1;UFM1;DDRGK1
prerank,negative regulation of catalytic activity (GO:0043086),-0.4136743563135895,-1.198066677410307,0.14285714285714285,0.3907235129813257,1.0,13/24,28.77%,PPP1R12A;CAMK2A;PLN;HDAC6;NOS1;SERPINA5;TMBIM1;SIRT1;SLN;CLN3;MT3;NES;OXA1L
prerank,peptidyl-serine modification (GO:0018209),-0.2829437305192262,-1.1973805423162138,0.10909090909090909,0.391536918292121,1.0,60/164,24.12%,PKD1;MKNK1;DMPK;CSNK2A2;BRSK1;ULK1;PNCK;TTBK2;GALNT16;HIPK4;CSNK1E;CAMK2A;ULK2;RPS6KA5;PRKCB;PRKCA;RPS6KA2;CSNK1A1;CAMK1;PRKACA;PRKD1;HIPK3;DYRK1A;LRRK2;MAST2;MAST4;STK32B;LATS2;MAST1;MAPK1;RICTOR;MARK1;MGAT5B;MORC3;PDGFB;ROCK1;MAPK8;CAMK2D;SGK3;MAPK14;AKT2;MARK3;STK32A;CSNK1D;MAP3K10;MAP3K12;RPS6KB1;PARP2;MKNK2;MAPK12;PKN1;SMG1;TNKS;MTOR;LATS1;HIPK1;PRKCD;WNK1;PINK1;PRKCH
prerank,cholesterol metabolic process (GO:0008203),0.32210554358930815,1.1968086323150617,0.12244897959183673,0.3722258981871643,1.0,27/66,22.36%,SULT2B1;CYP51A1;SQLE;NSDHL;DHCR7;NR0B2;CEL;IDI2;FDPS;ACAT2;FDX1;MSMO1;DHCR24;TM7SF2;GBA;CLN6;ACLY;HMGCS1;G6PD;INSIG1;FDFT1;MVK;CETP;EBP;IDI1;TSKU;HMGCR
prerank,regulation of TOR signaling (GO:0032006),-0.3242734626011754,-1.1961412829770781,0.18333333333333332,0.3934647767318774,1.0,22/67,21.61%,FLCN;EPM2A;TSC1;FBXO9;ARNTL;RRAGC;TNFAIP8L1;PRKAA2;UBR2;GNA12;RRAGB;RICTOR;WDR59;FAM83D;UBR1;TSC2;DEPDC5;RRAGD;GSK3A;SIRT1;TBCK;RPTOR
prerank,negative regulation of growth (GO:0045926),-0.28142255339763933,-1.196029259564653,0.171875,0.393170009052684,1.0,37/121,21.49%,TSPYL2;FLCN;FHL1;APBB1;MYL2;CAPRIN2;DACT3;NPR1;RERG;JADE1;PRDM11;SMAD4;WFDC1;ING4;SLIT2;SLIT3;CGRRF1;SOX17;TCHP;CDKN1A;SFRP1;MT1X;NOTCH2;SIPA1;CDKN2C;NPPB;APBB2;RTN4;SMARCA2;DCUN1D3;DNAJB2;AGTR2;TP53TG5;SIRT1;ING5;SERTAD3;MT1M
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3447571358416779,1.1958416008350092,0.1590909090909091,0.3738336576379149,1.0,16/36,23.73%,EIF5A;RNF183;BCAP31;PMAIP1;RPS3;BBC3;STYXL1;BCL2L1;MSX1;SLC9A3R1;LCK;BAX;BID;CAV1;RPS7;TP53
prerank,amide transport (GO:0042886),0.39046625075860414,1.1957801522496236,0.20454545454545456,0.37342673719374236,1.0,12/27,24.86%,SLC5A6;FOLR1;SLC38A5;UPK3A;SLC19A1;ABCA13;GLTPD2;TAP1;SLC14A2;TAP2;SLC46A1;ABCA12
prerank,regulation of intracellular transport (GO:0032386),-0.37155264565940194,-1.1955702261241927,0.12903225806451613,0.39374817866077055,1.0,15/35,23.41%,CRYAB;HAP1;NUMA1;RBM4;NEFH;INPP5F;MAP2;LRRK2;NDEL1;TTC21B;GAS1;GRIPAP1;MYBPC3;MYLK2;AAAS
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2966836336768799,-1.1953588968772184,0.10294117647058823,0.3935744307377535,1.0,29/91,26.61%,ATP2B4;RAF1;CAPRIN2;TENM1;RAPGEF3;TRIM6;NTRK3;SNCA;HDAC6;NGF;CAMK1;TERF2IP;PRKD1;NOS1;MTCP1;BRAF;NTF3;EGFR;RAMP3;RPTOR;SH2D3C;BCAR3;LATS1;PINK1;HCLS1;FNIP1;DOCK7;AKAP9;IFNA5
prerank,positive regulation of nervous system process (GO:0031646),-0.4285189533766469,-1.1949892038828918,0.23636363636363636,0.3938560201019464,1.0,6/16,14.94%,NLGN2;PARD3;RNF10;TPPP;DICER1;CARTPT
prerank,lipid homeostasis (GO:0055088),0.31121205807332103,1.1948544884999868,0.11627906976744186,0.37463321167614094,1.0,19/57,20.68%,DGAT2;ACOXL;TLCD1;CEBPA;PNPLA4;ATP13A2;XBP1;ABHD5;LIPG;PNPLA1;PNPLA3;ORMDL3;POLD1;PPARG;FITM2;ORMDL2;CETP;MLXIPL;HNF4A
prerank,positive regulation of catabolic process (GO:0009896),0.30015799615480754,1.192545571541203,0.13157894736842105,0.37850729517396187,1.0,23/62,23.95%,ASB9;CSNK2A3;IL1B;WNT5A;TNFAIP3;C4BPA;CSNK2A1;C4BPB;GSK3B;SORL1;OAZ3;DDB1;VCP;NSF;SCT;RAB7A;IDE;AXIN1;HECW1;HECW2;DTL;WWP2;BARD1
prerank,regulation of catabolic process (GO:0009894),0.40813071739810863,1.1917055651500348,0.23404255319148937,0.3795483455383678,1.0,3/17,3.52%,FAP;ODC1;CHEK2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.36839533788297285,-1.1911987380657127,0.2786885245901639,0.40101608241494746,1.0,13/33,23.96%,GAB1;PRKD1;VEGFB;FLT4;HSPB1;DAB2IP;SEMA6A;MAPK14;GAS1;VEGFC;RAMP2;NR4A1;FLT1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.38403652130323795,-1.1909518041967384,0.2909090909090909,0.40095255970271654,1.0,9/23,19.50%,APOD;GDI1;LRRK2;RAB23;INPP5K;KCNE1;SUFU;CABP1;MDFIC
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.34847654505091186,-1.1907116613191702,0.16666666666666666,0.4008093075218242,1.0,18/41,20.12%,TNS2;SORBS1;GKAP1;PRKCB;NCK1;PIP4K2B;GRB10;PID1;INPP5K;GRB14;OGT;PIP4K2A;KANK1;TSC2;RPS6KB1;GSK3A;INS;SIRT1
prerank,defense response to symbiont (GO:0140546),0.28280230991954713,1.1905709209933866,0.058823529411764705,0.3814226833607941,1.0,28/118,15.99%,EXOSC5;IFITM3;IFITM1;SKP2;ABCE1;IFITM2;G3BP1;EXOSC4;IFI6;PMAIP1;SERINC5;BCL2L1;NT5C3A;PDE12;IFI44L;IL21;OAS2;MYD88;RELA;STAT1;APOBEC3F;NLRC5;BST2;IFIT3;OASL;MX1;ISG15;PRF1
prerank,regulation of cell migration (GO:0030334),-0.27011502596154496,-1.1904690357114718,0.07936507936507936,0.40079946807068645,1.0,125/386,21.88%,FLCN;FAM107A;ADARB1;DUSP22;FLNA;TPM1;PLXNB3;SEMA6C;MYLK;SASH1;VCL;FGF2;AMOTL1;TWIST2;CHRD;TMEFF2;FERMT2;TTBK2;GCNT2;MYOC;NEXN;MAGI2;MACF1;RECK;MITF;CAMK2A;CITED2;PDGFRA;DUSP3;ROR2;GPER1;PODN;CLDN5;BEX4;NTRK3;SUN2;FGF22;RUFY3;PRKCA;DLC1;SEMA4C;KIT;DPYSL3;NGFR;RHOB;WNT5B;CLIC4;SRGAP2;SLIT2;PTEN;HACE1;NTNG1;PPM1F;SEMA3E;FER;LAMB1;LDB2;MYO1C;NUMB;CORO1C;RDX;EPHA4;TIAM1;TJP1;NAV3;GNA12;ADORA3;FGF17;SEMA6D;SCAI;SEMA6A;SRGAP2C;RAC1;PIK3R3;SEMA3B;CAMK2B;SFRP1;RHOA;ENPP2;IGFBP5;PDGFB;SEMA3G;FGF7;SPAG9;KANK1;PIP5KL1;TP53INP1;ROCK1;SGK3;APC;NTF3;MYADM;FGF5;AMOTL2;ROBO4;FGF10;IGSF10;SMO;AKT2;SEMA3A;FGF1;PLXNA4;INSR;SST;DLG5;PLXNB1;FGF16;EGFR;ERBB4;CCL11;LMO4;RET;LIMCH1;SLK;ARPIN;INS;FUZ;SRGAP1;FGF9;PDGFD;SMAD7;PTP4A1;SEMA3C;CDH5;PTPRT
prerank,protein K11-linked ubiquitination (GO:0070979),0.3661727310848492,1.190123317917345,0.225,0.38162085133294543,1.0,7/27,16.21%,UBE2T;UBE2S;ANAPC1;UBE2C;CDC26;ANAPC11;UBE2A
prerank,cellular response to ketone (GO:1901655),-0.3743512092413518,-1.1884738529389536,0.18518518518518517,0.40457457553609216,1.0,12/38,17.45%,ADCY5;KLF9;ADCY2;GNAI1;AR;GNG2;NR3C1;AQP1;SFRP1;AKR1C2;ADCY6;TRERF1
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.2944698766068263,-1.1881375450157967,0.11475409836065574,0.4048245394768011,1.0,38/107,19.84%,TCF7L1;DAAM2;DACT3;SFRP5;CTNND2;MACF1;NXN;TRABD2B;AMER2;FGFR2;RSPO1;PSEN1;NFATC1;FZD7;LRRK2;RSPO2;GRB10;WLS;SKI;TIAM1;SOX7;DISC1;SFRP1;ESR1;KANK1;GNAQ;BTRC;TLE1;TSC2;SPIN1;HIC1;CDK14;RSPO3;ZRANB1;TAX1BP3;HHEX;MDFIC;CBY1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2565867692733624,-1.1879653310411598,0.1044776119402985,0.4046103098330909,1.0,148/451,23.30%,PER1;ZNF540;CIPC;MBD1;CRYAB;HDAC4;CRY2;BEND5;SCMH1;CIART;TSHZ3;ARNTL;BTAF1;NACC2;EID2B;ZNF219;USP47;TWIST2;ZBTB4;RCOR3;ZHX3;CAPN3;PHF12;MECP2;TCEAL7;PRDM11;PBXIP1;RUNX1T1;GLI3;UIMC1;FOXP2;SMAD4;CITED2;CREBZF;L3MBTL1;IKZF4;ZMYND11;PPARD;RPS6KA5;DMAP1;HDAC6;CIC;NR1D1;KAT6B;ZNF568;ING4;FOXN3;CDKN1C;RBFOX2;ZNF174;ZKSCAN3;NR2F2;EPC1;SOX13;ZFPM2;MPHOSPH8;EID1;RING1;RBPJ;ATOH8;ZBTB16;HAND1;ZNF425;PPM1F;SIRT2;NR3C1;HEY1;ARID4A;NFIL3;NR1H2;HDAC5;INPP5K;DAB2IP;KAT7;MTA3;SOX7;PRDM5;HDAC9;PRMT2;SFRP1;SFMBT2;HINFP;PHC2;TBX2;PDGFB;ARID5A;ZGPAT;GLIS2;HEY2;BTRC;THRA;TLE1;SMARCC2;ZNF423;SPEN;ZNF658;RORB;SIN3A;TNP1;TRERF1;SMAD2;SMARCA2;ZNF224;PFDN5;DPF2;HEXIM1;ZNF24;DKK3;POU3F3;PLCB1;KLF10;HHEX;MAP3K10;SMARCE1;PIAS4;ZBTB14;MDFIC;SOX18;TRIM33;HMX1;CBY1;ZNF653;SIRT1;PRICKLE1;ID3;CRY1;DPF3;PRDM16;EHMT1;TLE2;EIF4A2;LOXL3;NR1D2;KAT5;PHC1;PCGF6;ARID5B;CBFA2T2;SUMO4;ZNF639;RFX3;NIPBL;ID2;SOX8;ZNF350;BAP1;LIMD1;CHD8
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2978375618741406,1.1875506247673062,0.175,0.386311393848963,1.0,22/73,17.35%,CBFB;ABCE1;IRAK2;VRK2;SYK;USP18;TNFAIP3;IFNGR2;SOCS1;SPATA2;IRAK1;RUNX1;AGPAT2;STAT1;TRAF2;SOCS3;ELF1;SUMO1;PALM3;PTPN2;HSP90AB1;OTULIN
prerank,carboxylic acid transport (GO:0046942),0.32063076261779705,1.1871943175940867,0.175,0.386382518663497,1.0,10/55,7.34%,SLC6A20;SLC1A5;SLC1A4;SLC6A14;SLC7A1;SLC38A5;SLC7A5;SLC16A13;SLC6A6;SLC16A3
prerank,regulation of dendrite extension (GO:1903859),-0.4340284498027141,-1.1871674473015463,0.24074074074074073,0.40587766599515945,1.0,10/16,29.29%,ITSN2;SYT2;OSTN;RIMS1;SYT1;CPNE6;SYT3;NEDD4L;SMURF1;CPNE5
prerank,ureteric bud development (GO:0001657),-0.4145061743125432,-1.187061889246954,0.2,0.40555690528461613,1.0,5/19,9.34%,PKD2;OSR1;FGFR2;TCF21;SLIT2
prerank,neuron differentiation (GO:0030182),-0.28464580708047726,-1.1853177404362056,0.09090909090909091,0.40866513457239834,1.0,48/170,18.15%,RNF112;NRBP2;WNT9A;HAND2;BRSK1;TENM1;PBX3;FZD4;NLGN4X;CTF1;SRF;PHOX2B;SNPH;PHOX2A;WNT6;NGRN;WNT5B;SMARCA1;PBX2;FZD7;ATOH8;ALK;EPHA5;MYEF2;FOXN4;ATP8A2;GLI2;OPHN1;MEF2C;MYT1L;WNT2B;ERCC3;ISL2;VSX1;TENM3;LHX6;FUT9;IL1RAPL1;LMX1B;RORB;SPINK5;FZD8;IRX6;WNT16;SOX11;SPOCK1;CASP3;LHX4
prerank,negative regulation of ossification (GO:0030279),0.3967051561236714,1.185066790266809,0.2,0.3902200616369998,1.0,5/22,9.42%,KREMEN2;SOX9;LRP4;MDK;CCL3
prerank,glycoprotein biosynthetic process (GO:0009101),0.29425777846238815,1.18461526855376,0.13043478260869565,0.3905052338538178,1.0,22/81,15.74%,ALG1;PMM2;ALG5;B3GNT4;SERP1;DDOST;FUT1;ALG3;B3GNT2;GCNT1;ALG1L2;B3GALNT2;CANT1;DAD1;B3GALT6;B4GALT7;ST8SIA6;FUT7;FUT2;B3GNT3;B3GNT5;FUT10
prerank,positive regulation of interferon-beta production (GO:0032728),0.33232099310337204,1.1842424058026026,0.17647058823529413,0.39068804604799084,1.0,15/34,30.20%,RIPK2;POLR3C;DHX9;POLR3B;OAS2;ISG15;POLR3G;OAS3;HSP90AA1;POLR3A;PTPN11;TLR7;IRF3;IRF7;TLR8
prerank,BMP signaling pathway (GO:0030509),-0.32917062290859156,-1.1839848910570403,0.18,0.41088231491805816,1.0,29/62,28.52%,RGMA;TMEM100;TGFBR3;BMPR1A;CHRD;SMAD4;GDF7;MEGF8;MAPK3;USP9Y;GDF5;GDF6;SMAD9;ACVR2A;SMAD2;USP15;BMPR1B;SMAD7;PDCD4;ZFYVE16;TGFB3;AMHR2;SMAD3;RUNX2;BMP5;NOG;SMURF1;BMPR2;HIVEP1
prerank,stress-activated MAPK cascade (GO:0051403),-0.3311383054277013,-1.1832078401235762,0.19607843137254902,0.41179157627026336,1.0,27/61,24.89%,MAPK10;ARHGEF6;TAB2;SKP1;ZFP36L1;TAOK2;MAPK1;MAPK3;MAPK11;MAP2K7;TAB1;UBE2V1;MAP2K4;MAPK8;BTRC;MAP4K2;GPS2;ZFP36;MAPK14;UBB;MAP3K10;MAP3K12;MAP3K7;SH2D3C;MAP3K8;FBXW11;MAP4K3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.39200687346118795,-1.1829032313645493,0.23728813559322035,0.4120024374579538,1.0,13/24,25.44%,TGFBR3;SMAD4;LTBP4;LATS2;SOX11;SMAD2;DKK3;TRIM33;SMAD7;DLX1;NREP;LATS1;SMAD3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.2540081182713011,1.182830827054539,0.03225806451612903,0.39309969636223113,1.0,62/248,15.06%,CDH3;SOX4;NOTUM;RUVBL1;PSMD14;COL1A1;PSMB2;DKK4;PSMB9;PSMA5;LGR5;PSMB3;UBAC2;PSME3;PSMA3;RUVBL2;FOLR1;PTK7;PSMA7;KREMEN2;PSMD13;WNT5A;AXIN2;LGR6;PPP1CA;GID8;PSME2;PSMC2;PSMC4;PSMD10;PTPRO;PSMD12;SOX9;LRP4;JUP;PSMB5;MDK;BAMBI;STK4;ZNRF3;XIAP;HDAC1;PSMD8;IGFBP2;NRARP;PSMB4;GSK3B;PSMD3;PSMB1;PSMA4;MLLT3;WNT11;ZNF703;PSME1;SEMA5A;PSMF1;PSMD11;PSMD1;IGFBP1;GSKIP;VCP;TMEM9
prerank,negative regulation of hydrolase activity (GO:0051346),-0.32278180118408434,-1.1823922089835326,0.24615384615384617,0.41254043089703507,1.0,15/53,13.79%,PLXNB3;MAPK7;CAMK2A;GPSM1;PLIN5;PTX3;CPEB2;NOS1;SERPINA5;MAP2;EGLN1;LRRK2;RDX;DAB2IP;ARL2
prerank,regulation of cellular protein localization (GO:1903827),-0.33140210470937154,-1.1815587454852983,0.16666666666666666,0.41365287780105015,1.0,18/46,22.59%,MAPT;MAP1A;CSNK1E;DVL3;CCDC66;MAP2;PRKAA2;PPM1F;SETD2;NDEL1;GBF1;GPC1;TRIM67;TRIM46;RAB11FIP5;GPC6;SUMO4;PIN1
prerank,negative regulation of MAPK cascade (GO:0043409),-0.30456206166853467,-1.1809725056344431,0.16393442622950818,0.4140431896705106,1.0,23/90,13.95%,FLCN;LMO3;RGS2;SMAD4;DUSP3;GPER1;DUSP26;P2RX7;UCHL1;CNKSR3;PPEF2;PTEN;EMILIN1;SPRY1;PRDM15;FBLN1;SYNJ2BP;INPP5K;TIMP3;DAB2IP;RANBP9;SPRY3;SEMA6A
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.38073789893123,-1.1803469482354942,0.20754716981132076,0.4148109381338945,1.0,9/22,21.15%,SASH1;DVL3;TLR9;MAP3K4;DAB2IP;DVL2;DUSP19;MAP3K10;MAP3K7
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2959082086121651,1.180198184834868,0.06976744186046512,0.39766256817854295,1.0,23/81,15.69%,CCND1;CDKN3;TFAP4;CDK7;GTPBP4;BLM;CCNO;CCNE1;CCNI2;CDC25C;PSMD10;CCNK;PROX1;PSRC1;CDKN2A;CEBPA;CCNF;CCNJ;PKMYT1;CDK5RAP1;PLK1;CDC25A;BCCIP
prerank,positive regulation of JNK cascade (GO:0046330),-0.32587620039860365,-1.1800447390232347,0.1864406779661017,0.4147292383344328,1.0,25/72,23.64%,DUSP22;MTURN;TRAF1;PJA2;TLR9;ANKRD6;FZD7;FLT4;TAOK2;DAB2IP;GADD45B;MAP4K2;SH3RF3;DUSP19;SEMA3A;WNT16;MAPK8IP1;PLCB1;RASSF2;EDA2R;MAP3K10;CCL21;TIRAP;GADD45G;RIPK1
prerank,telomere maintenance via telomerase (GO:0007004),0.37326704925538046,1.179640087945911,0.1794871794871795,0.3980694205852747,1.0,10/28,21.67%,DKC1;GAR1;SHQ1;NOP10;PTGES3;WRAP53;NHP2;HSP90AB1;HSP90AA1;CDK2
prerank,regulation of exocytosis (GO:0017157),-0.3371585518861265,-1.1791490872046828,0.1774193548387097,0.4160405164760174,1.0,15/43,18.33%,VAMP2;HAP1;CHMP3;RAB12;SNCA;RAB2B;CLASP1;LGI3;STXBP5L;CLASP2;SYTL4;RAB3A;IL1RAPL1;RAB13;RAB3C
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4069875723416483,-1.178878736550868,0.28125,0.4161262764604246,1.0,8/20,15.70%,CAPRIN2;CUX2;OBSL1;BHLHB9;RELN;CAMK2B;IL1RAPL1;DBN1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4229196120403329,-1.1785377860079638,0.2765957446808511,0.41630264959856894,1.0,4/18,9.34%,IL6R;PTN;ZNF580;SLIT2
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.415684967953558,-1.1782958171508797,0.2037037037037037,0.4162063410311995,1.0,9/17,20.15%,CLIP3;GH1;PRKCB;PRKAG2;INPP5K;PLA2G1B;BRAF;RTN2;NR4A3
prerank,retinoid metabolic process (GO:0001523),-0.30396711949498145,-1.1770719892643753,0.1864406779661017,0.4181293778502479,1.0,22/80,18.10%,RDH5;BCO2;LRAT;ADH1B;CYP27C1;SCPEP1;GPIHBP1;AKR1C1;SDC3;SDC2;PNLIP;RARRES2;CLPS;CYP26B1;ALDH1A1;HSPG2;CYP1A1;CYP4V2;OPN1SW;AKR1B1;RLBP1;GPC1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3157987408123517,1.1766966593052541,0.2222222222222222,0.40348518997097615,1.0,23/44,30.00%,WDR43;IL1B;PNPT1;ZPR1;GRSF1;RELA;TRMT112;UTP15;HEATR1;NMD3;RBM22;BMP4;MYCN;TGFB1;RIOK1;U2AF2;TP53;RIOK2;WDR75;LIN28A;LIN28B;SUPV3L1;SIRT7
prerank,cellular response to UV (GO:0034644),0.3171509611077699,1.17642012871473,0.2,0.4033951752466292,1.0,32/74,25.03%,CHEK1;MYC;RHNO1;TRIAP1;RUVBL2;MMP1;TIMP1;AURKB;MME;HYAL3;NOC2L;MMP2;MMP3;DDB1;KDM1A;PTPRK;NPM1;MMP9;MAPK13;CDC25A;POLD1;SDE2;EIF2S1;TMEM161A;BAK1;OPN3;HYAL2;ACTR5;PPID;TP53;CARD16;CREBBP
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.33058136691675266,-1.1763563835899002,0.1568627450980392,0.4191681224754689,1.0,9/45,8.40%,RBPMS2;IL6R;BMPR1A;FGF2;MEF2D;FOXJ2;ADAMTS1;ELANE;MFN2
prerank,positive regulation of synapse assembly (GO:0051965),-0.38695232349239267,-1.1763396058230184,0.23214285714285715,0.4186164637958298,1.0,8/28,10.13%,NLGN2;NLGN3;SLITRK2;NRXN1;CUX2;NLGN1;LRRC4B;BHLHB9
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.27831141418300404,-1.176237139002089,0.13846153846153847,0.41818235040051477,1.0,42/190,18.83%,TRIM39;POGZ;HNRNPDL;GDNF;NOVA1;AFF3;PEG3;PRDM6;NKAPL;STX1B;TARDBP;AFF1;PRDM2;PRDM11;MTMR9;SLC8A2;TRIM6;PHOX2B;PCBP3;RSPO1;SLC8A1;GNB3;ZNF445;PSEN1;NOVA2;ZFP36L1;MEGF8;YBX3;CGGBP1;PCBP4;PRDM5;ZNF335;HINFP;TFEB;TRIM34;ZNF407;PCBP2;AFF4;TOB2;ZNF827;ZNF462;ZNF513
prerank,wound healing (GO:0042060),-0.30472048205105984,-1.17533968765757,0.21052631578947367,0.41943543500680386,1.0,17/65,13.19%,CFLAR;RAF1;TPM1;FGF2;MACF1;PDGFRA;SRF;ITGB3;SYT11;AHNAK2;FZD7;ANXA6;DST;DYSF;SYTL4;RAB3A;MYOZ1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3930389422192017,1.1747585907869833,0.24390243902439024,0.40598731889190176,1.0,7/18,22.62%,UNG;NTHL1;NEIL3;ERCC5;MPG;SMUG1;TDG
prerank,protein dephosphorylation (GO:0006470),-0.2840346811015738,-1.1746931041673965,0.21311475409836064,0.42022233211184024,1.0,49/138,25.20%,TNS2;PTPN21;DUSP22;PPP1R12A;PPP2R2B;PPP2R3A;PPP2R5B;PTPRS;PTPRM;PPP3CB;PPP2R5D;DUSP3;PTPRZ1;PPM1M;DUSP26;CTDSP2;NCK1;PTPN14;PPEF2;PTEN;PPM1L;PPM1F;PPP3CC;PPP2R2D;PTPN5;PPM1A;PPTC7;TAB1;PPM1B;PPP4R1;SSH1;PPP2CB;BTRC;RPRD1A;PPP1CB;CTDNEP1;EYA2;EYA4;PTPRT;PTPN12;PTPRB;LHPP;CTDSP1;SDHAF2;SBF1;ILKAP;FBXW11;MTMR7;CDC14B
prerank,miRNA metabolic process (GO:0010586),0.41964988989005325,1.1746777377601179,0.2222222222222222,0.4055088620618416,1.0,6/17,12.19%,RAN;SND1;XPO5;KHSRP;TARBP2;TRIM71
prerank,cellular response to inorganic substance (GO:0071241),0.398329035298504,1.174632754702306,0.30952380952380953,0.4050485576696283,1.0,3/17,3.74%,DPEP1;TIMELESS;BLM
prerank,positive regulation of cell communication (GO:0010647),-0.3813413930563712,-1.174556469592339,0.22641509433962265,0.41994180178598856,1.0,12/27,23.91%,LGI1;ANK3;ILK;DLG4;GRIK2;RIMS3;WLS;CARTPT;SOX11;RIMS1;SYT1;CLSTN2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3148405980449803,1.1741306814820793,0.16981132075471697,0.405474004822539,1.0,19/46,22.02%,RAN;KHDRBS1;GTSE1;YWHAE;IL1B;ECT2;ZPR1;JUP;DHX9;NCBP2;GSK3B;RBM22;TGFB1;XPO4;TRIM28;ANP32B;ZC3H12A;IPO5;HYAL2
prerank,metal ion transport (GO:0030001),-0.29507140994371506,-1.1739784204545711,0.16666666666666666,0.4205335485964126,1.0,22/85,15.23%,RYR3;CACNA1C;PKD2;TRPC1;ITPR1;CAMK2A;CACNA2D1;SLC8A2;RYR1;NIPAL4;SLC8A1;CDH23;PSEN1;TRPC4;RAMP1;RYR2;SLC30A8;SLC8A3;SLC41A1;CACNG7;PSEN2;TUSC3
prerank,cellular amino acid catabolic process (GO:0009063),0.2911656992880027,1.1738496664807574,0.2564102564102564,0.4055649519818901,1.0,30/84,24.65%,SHMT2;IL4I1;HSD17B10;DDAH1;GAD1;GOT2;GLS2;MCCC2;MAT1A;ALDH5A1;KMO;NOS2;SDSL;IDO1;ACMSD;ALDH4A1;KYNU;ALDH7A1;TDO2;HNMT;QDPR;HAAO;SDS;GSTZ1;ECHS1;CRYM;GLDC;GCDH;SHMT1;GLUD2
prerank,regulation of chemotaxis (GO:0050920),-0.35788673871435395,-1.1738242808611348,0.17543859649122806,0.4202917617120397,1.0,12/31,22.82%,ZSWIM8;PDGFRA;DUSP3;ZSWIM6;ELANE;PPM1F;RARRES2;P2RY12;PDGFB;CCL21;ADGRA2;MYCBP2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.25078097488210915,-1.1736997240367013,0.0547945205479452,0.420025088635869,1.0,151/498,22.07%,CALCOCO1;CAND2;HDAC4;APBB1;SMARCD3;TGFB1I1;FOXF1;HAND2;FOXF2;ZNF516;MYOCD;ARNTL;MLLT11;FZD4;FGF2;TRIM45;CAPN3;ACTA2;PRDM11;PPP3CB;ELF2;GLI3;MITF;SMAD4;CITED2;TFE3;DVL3;ILK;PPARD;TAL1;NCOA1;NPAS3;KCNH2;RORA;CASZ1;NR1D1;KAT6B;TEAD1;ATF4;TBX1;CDKN1C;AR;KMT2A;ZKSCAN3;SMARCA1;NR2F2;EPC1;TP53INP2;PSEN1;GDF7;NFATC1;FZD7;NOS1;DYRK1A;ATOH8;EDRF1;ZBTB16;MSTN;RXRB;QRICH1;ZMIZ1;NFIB;RNF10;ARHGEF11;JMJD6;ZNF496;GLI2;WAC;HEY1;KDM3A;CXXC1;WBP2;SOX17;MAPRE3;NOTCH4;MEF2C;NFIL3;NR1H2;MED17;INPP5K;PPM1A;RXRA;ARNT2;EBF3;SETD3;MAP2K7;KMT2B;UBE2V1;PRMT2;SFRP1;BCL10;HINFP;ZFHX3;TFEB;PDGFB;ESR1;FGF7;GDF6;RLF;TEAD2;GLIS2;TP53INP1;TCF4;HEY2;BTRC;KAT2A;SMARCC2;CEP290;ZNF423;RORB;IRX6;SPIN1;TRERF1;SOX11;TP53BP1;ZFP90;NAT14;EGFR;ERBB4;SMAD2;SMARCA2;KMT2E;AFAP1L2;POU3F3;ZBTB48;PLCB1;HHEX;RET;MDFIC;RNF14;SOX18;CDK5RAP2;MAP3K12;RAI1;SOX2;CAMKK2;ING5;PHIP;PRDM16;FLI1;USP21;FZD1;NR1D2;PSMD9;KAT5;SERTAD3;KLF2;TRIM56;OSR2;LRP6;TRIM44
prerank,RNA interference (GO:0016246),0.40310738047811545,1.1735940414686044,0.20833333333333334,0.4056057180175089,1.0,6/17,10.41%,TSN;HENMT1;MRPL44;DHX9;CLP1;TARBP2
prerank,inflammatory response (GO:0006954),0.25757262908400314,1.1732927174650634,0.11764705882352941,0.405679584469399,1.0,94/217,31.75%,CEBPB;IL1A;CXCL5;CCL24;CXCL8;CXCL3;RIPK2;IL1RN;CXCL1;CXCL11;CXCL2;IL1B;CCL20;PRDX5;OLR1;CD44;CCL22;ADCY1;PF4;HYAL3;CXCR4;PARP4;CYBA;CCL4;CCL3;NOX1;RELA;CCRL2;NOS2;MAPKAPK2;CXCL9;VNN1;HNRNPA0;CCL26;FOS;FUT7;CXCL10;CXCL6;CXCR2;FPR3;ABCF1;FPR2;ADAM8;CCR3;F2R;CCL17;PIK3CG;TGFB1;PF4V1;IL36B;PLA2G2D;PROK2;TNFSF4;CHI3L1;F11R;LY75;CXCL13;HMGB1;ELF3;CYBB;ADGRE5;IL36RN;NFAM1;NAIP;THBS1;IL2RA;TRAF3IP2;CCL1;IL36G;ANXA1;TNFRSF4;ITGB2;IL37;IFNG;XCR1;IL18;CCL7;PIK3CD;MMP25;NCR3;PTGIR;NOD1;NLRP3;TAC4;ITCH;XCL1;IL22;IKBKG;IL17D;XCL2;CCL5;TNF;IKBKB;FPR1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.3447884547556144,1.1732689404793692,0.23076923076923078,0.40513953310289913,1.0,15/34,25.46%,THY1;RPS3;KCNN4;CARD11;CD81;RELA;EZR;PTPN2;LILRB4;LCK;GBP1;DGKZ;CD300A;PTPRJ;SH2D1A
prerank,positive regulation of response to stimulus (GO:0048584),0.3308637354177039,1.1728654141592794,0.25,0.4055451078434694,1.0,11/44,16.95%,MYC;HMGA1;WNT5A;CDKN2A;TGFB2;DHX9;HMGA2;CD80;TAF9;HOMER1;NSMCE1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.3663674865096272,-1.172730129722085,0.22413793103448276,0.42167353581420797,1.0,18/32,26.77%,SYT10;SYT11;RIMS3;LRRK2;SYT2;SYT9;SYT6;SYT5;RAB3A;RIMS4;SYN1;SNAPIN;PREPL;RIMS1;SYT1;SYT3;RAB27A;SYT15
prerank,response to light stimulus (GO:0009416),-0.33073043657222956,-1.172598043094485,0.1509433962264151,0.4214184274928273,1.0,16/58,16.86%,CIRBP;CRY2;BRSK1;MAPK10;REV1;OPN4;ELANE;GPR88;CPT1B;ERCC3;UBE4B;MAP2K7;MAPK8;OPN1SW;PRIMPOL;FECH
prerank,'de novo' posttranslational protein folding (GO:0051084),0.33964524887388725,1.1721674853954818,0.21951219512195122,0.4064621197043028,1.0,11/30,20.33%,CCT2;ERO1A;UGGT1;HSPA14;HSPA9;PTGES3;DNAJC7;SDF2L1;HSPA5;HSPA13;SDF2
prerank,carbohydrate catabolic process (GO:0016052),0.32702457989157846,1.1721178015322526,0.16279069767441862,0.4059068024357112,1.0,17/40,26.20%,PGAM4;NEU1;GAPDH;LDHA;HKDC1;TPI1;ENO4;GAPDHS;PKLR;MANBA;PKM;ALDOC;DERA;ALDOB;PFKL;PGAM1;NAGA
prerank,mitotic recombination (GO:0006312),0.4049572558396673,1.1719829484741506,0.21568627450980393,0.4055674771440147,1.0,4/15,14.18%,RAD54B;MSH3;NSMCE2;TPRKB
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3681429442341799,1.1718261934170644,0.26,0.4053773289980386,1.0,10/28,19.39%,TRIB3;DCUN1D5;FBXO5;UBE2N;LIMK1;RPS2;DTX3L;PLK1;FEM1A;AXIN1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2940074401418842,-1.1701617969954041,0.1509433962264151,0.42635667023721857,1.0,19/70,15.87%,PHF1;HDAC4;SF3B1;MECP2;KAT2B;CREBZF;PHF2;TAF1C;HDAC6;EPC1;DIRAS3;MPHOSPH8;MYO1C;WBP2;HDAC5;CGGBP1;ZNF335;DNMT3A;KAT2A
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.3687709992427593,1.1700534598721795,0.24324324324324326,0.40857417217171105,1.0,10/29,21.67%,DKC1;GAR1;SHQ1;NOP10;PTGES3;WRAP53;NHP2;HSP90AB1;HSP90AA1;CDK2
prerank,neuron maturation (GO:0042551),-0.42230430230836824,-1.1695434584391353,0.21428571428571427,0.42697272371978956,1.0,7/18,24.36%,LGI4;ADGRB3;ANKS1A;ACTL6B;SCARF1;SRRM4;MTCH1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4427543020980369,1.1693917357882626,0.2978723404255319,0.40866200046743645,1.0,8/17,20.79%,IRS1;SMARCA4;SOCS1;JAK3;IL7R;CISH;STAT5A;STAT5B
prerank,cellular response to interleukin-7 (GO:0098761),0.4427543020980369,1.1693917357882626,0.2978723404255319,0.40866200046743645,1.0,8/17,20.79%,IRS1;SMARCA4;SOCS1;JAK3;IL7R;CISH;STAT5A;STAT5B
prerank,regulation of dephosphorylation (GO:0035303),-0.4452535709657546,-1.1693809406314846,0.27419354838709675,0.4266986440000912,1.0,7/15,33.31%,MTMR9;INPP5K;CDK5RAP3;SMG6;SMG5;PPP1R16B;MTMR4
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3301233262639429,1.169278581719616,0.14634146341463414,0.40832111386073505,1.0,10/32,18.81%,CYP51A1;MOCS3;SRD5A1;MOCOS;FDXR;PRLR;GCH1;GPHN;FDFT1;PYCR1
prerank,regulation of histone acetylation (GO:0035065),-0.35672507499393796,-1.1687575692529633,0.23214285714285715,0.42766739948169585,1.0,12/33,14.57%,FLCN;MYOCD;RAPGEF3;RPS6KA5;SNCA;SETD5;KMT2A;CAMK1;NOS1;HDAC5;MAPK3;TADA2B
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3565180740114386,1.1683315208388796,0.17777777777777778,0.40964812841806697,1.0,10/31,16.41%,COPZ1;COPB2;COG6;COG5;COPA;COPG1;COPG2;COPB1;VTI1A;NSF
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3032307738074071,-1.1679970895393925,0.14814814814814814,0.4289625543303976,1.0,36/98,27.41%,FLCN;TGFB1I1;TGFBR3;DAND5;WFIKKN2;SMAD4;CITED2;LTBP4;CDKN1C;EMILIN1;SPRY1;LATS2;SKI;PPM1A;ZEB2;IL17RD;SOX11;SMAD2;UBB;DKK3;TRIM33;SIRT1;PRDM16;VASN;SMAD7;PIN1;NREP;LATS1;CD109;PEG10;SMAD3;SNX25;ZNF451;HSPA1A;SMURF1;LDLRAD4
prerank,base conversion or substitution editing (GO:0016553),-0.4189119206326564,-1.1679846810620251,0.25862068965517243,0.42840879971743395,1.0,5/17,18.98%,ADARB1;ADARB2;METTL3;NUDT16;APOBEC2
prerank,histone lysine demethylation (GO:0070076),-0.38231019080645146,-1.1675908354438458,0.20689655172413793,0.42865174919233784,1.0,15/24,35.39%,PHF2;KDM2A;KDM3A;KDM4B;KDM5D;KDM6B;JMJD1C;KDM4E;UTY;KDM4A;PHF8;KDM4C;KDM3B;KDM5B;KDM6A
prerank,extracellular matrix organization (GO:0030198),-0.2585262359671557,-1.166483917557567,0.125,0.4305830360968613,1.0,87/284,21.57%,ITGA7;JAM3;GPM6B;ITGA10;ADAMTSL4;DPT;FBLN5;COL21A1;ADAMTS10;GSN;FGF2;LOXL4;COL6A1;COL28A1;VIT;ADAMTSL3;DDR2;LAMA2;LAMA5;JAM2;ADAMTS8;LAMB2;NID1;RECK;COL24A1;COLQ;COL6A2;COL16A1;ITGB3;ADAMTS1;PAPLN;ELANE;LAMC1;CRTAP;LAMA4;ADAMTSL1;SH3PXD2A;DCN;LAMB1;P3H2;CTRB2;TIMP2;DST;CTRB1;MFAP5;BMP1;TLL1;SCUBE1;COL4A5;COL5A3;MIA;COL23A1;OPTC;TNC;APLP1;MMP27;ADAMTS13;HSPG2;PDGFB;ADAMTS9;COL13A1;COL27A1;SPINK5;COL4A6;ADAMTS5;COL4A2;ELN;MMP17;FLRT2;COL4A3;MMP16;COL25A1;SCUBE3;HTRA1;COLGALT2;PXDN;ITGA2B;MMP28;ITGA8;MADCAM1;ITGA9;COL22A1;LOXL3;COL20A1;NCAN;ADAMTS3;ADAM19
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3784488172140192,1.1661489327242514,0.24,0.41343527244082906,1.0,8/26,13.32%,DACH1;BLM;XRCC5;ZRANB3;RPS3;MSH3;SUB1;MSH6
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3733802997044451,1.1653308805505356,0.21428571428571427,0.4144901738280894,1.0,11/24,23.71%,NUDT19;CYP2W1;ACBD5;CEL;ACOT8;CYP4F3;CYP4F11;PLA2G15;FAAH;CYP26A1;CYP4F2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3994295941657383,-1.1638793538666024,0.25925925925925924,0.4355173597240277,1.0,12/25,21.82%,BMPR1A;NUMA1;SMAD4;RBPJ;RNF165;GDF5;ZNF423;SOX11;ACVR2A;SMAD2;BMPR1B;CDH5
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.4379335235015285,-1.1638778887266203,0.22641509433962265,0.43491994222097696,1.0,6/17,16.07%,CHMP3;DNAJC13;RDX;MAPK1;MAPK3;VPS11
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.31652029565972034,-1.1637381760901415,0.18867924528301888,0.4345877686282386,1.0,26/81,20.41%,FNTB;RGS11;CNGB1;GNG7;RGS2;CAMK2A;USP20;GPER1;CALM1;GIT2;RIC8B;ZDHHC7;SYP;KCTD8;GRK5;TULP3;GRK4;RGS5;PLCE1;ROCK1;NMT2;RAMP3;PLCB1;RGS6;RGS12;CRY1
prerank,membrane repolarization (GO:0086009),-0.4713544926626137,-1.1634820562699204,0.2459016393442623,0.4345322859429576,1.0,7/15,13.83%,ATP1B2;ATP1A2;KCNIP2;KCNH2;KCNE2;KCND3;KCNE1
prerank,gene silencing by miRNA (GO:0035195),-0.381666682112483,-1.1633301303170303,0.21818181818181817,0.43432673375718994,1.0,13/31,18.94%,TNRC6A;ZC3H7A;AGO4;WTIP;RBM4;TNRC6C;DICER1;NOTCH4;AGO3;PRKRA;ZFP36;TNRC6B;AGO1
prerank,regulation of humoral immune response (GO:0002920),0.3415964242749972,1.1633063349233663,0.2558139534883721,0.41864959789224504,1.0,14/41,20.78%,ZP3;C1QBP;CD46;CD55;C4BPA;CD81;CPN1;SERPING1;C4BPB;GATA6;C3;C2;C8G;CXCL13
prerank,histone ubiquitination (GO:0016574),0.3901791129856401,1.1629204497463352,0.27906976744186046,0.4187839762748791,1.0,8/21,18.61%,UBE2N;RNF40;UHRF1;DTX3L;LEO1;UBE2A;RAG1;CTR9
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3033295536505043,1.1625882493542308,0.17391304347826086,0.4188692937335717,1.0,27/61,30.39%,MYC;PERP;GRIN2B;USP50;RIPK2;BCAP31;PMAIP1;SYK;ASPH;CYCS;F2R;FYN;BAK1;IFI16;HMGB1;LGMN;PDCD5;TTBK1;HTRA2;CLEC7A;CASP8;CYFIP2;NLRP2;FOXL2;NOD1;NLRP3;AIM2
prerank,cellular response to cytokine stimulus (GO:0071345),0.22962410251866772,1.1625268666276696,0.03225806451612903,0.4184359945540667,1.0,172/463,28.69%,MYC;SLC12A2;CCND1;TDGF1;OSM;IL1A;IL20RA;IL11;CCL24;CXCL8;TCF7;EREG;CSF2;IFITM2;IL1RN;CXCL1;COL1A2;TNFSF11;MMP1;IL23A;IRAK2;PHB;CXCL2;GAPDH;LRP8;IL1B;KHSRP;WNT5A;CCL20;PNPT1;TIMP1;LCN2;SYK;LEF1;RPS3;CCL22;PF4;MME;CEBPA;SOX9;HYAL3;CXCR4;BCL2L1;IL27RA;DHX9;PDE12;DUOX2;STK39;USP10;DCSTAMP;CD80;CCL4;CCL3;XBP1;IFNGR2;SOCS1;ICAM1;FN1;ABL2;JUNB;RELA;IRAK1;IL17A;JAK3;NOS2;DUSP1;BATF;ADAMTS12;MMP2;GSK3B;STAT1;FOXH1;IL19;MMP3;GBP5;PRLR;POU4F1;IL17F;STX3;BRCA1;CCL26;IL13RA2;FOS;INPP5D;CIB1;SDC1;CXCL10;MMP9;IRF8;UBA52;GBA;SOCS3;MAPK13;IL22RA2;CCL17;SYNCRIP;IL23R;PTPN2;UBE2K;TGFB1;IL1RL2;BAG4;IL36B;TNFRSF1B;ZNF675;EGR1;BIRC5;STAT5A;FYN;LCK;CHI3L1;MNDA;CD86;FSCN1;HSP90AA1;PTAFR;IFI16;GBP1;STAT5B;ZC3H12A;MCL1;IL12B;HYAL2;ASAH2;CD47;LIF;GBP3;FASLG;PTPN7;IL12RB2;TYK2;CD58;TP53;IL36RN;OCSTAMP;SHMT1;NPNT;IL2RA;SELPLG;IL12RB1;PTPN11;CSF2RA;PTPRJ;CDKN1B;IL2RB;GBP4;ZEB1;CCL1;HIF1A;IL36G;RPL13A;ITGAX;HTRA2;ANXA1;HNRNPU;IL20RB;ITGB2;HAS2;IL5;IL37;STAT2;IRAK3;SLA2;HAX1;IL10;IL18;TRAF6;IFNE;CCL7;BCL6;PIK3CD;OPRM1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.36064227954624506,1.1615508154972523,0.2571428571428571,0.42023615994898317,1.0,12/24,35.81%,FPR3;FPR2;MICB;LYN;SPG21;SLA2;NCR3;FPR1;FCER1G;LAX1;BCAR1;SH2B2
prerank,regulation of T cell activation (GO:0050863),0.3461373846349256,1.1612598429812309,0.2619047619047619,0.420173624595911,1.0,18/45,26.56%,THY1;HSPD1;IL4I1;TNFSF11;TNFSF9;JAK3;PRELID1;VTCN1;TNFRSF1B;LCK;SIT1;TNFSF8;TNFSF18;CD47;CRTAM;CD2;PRKCQ;TIGIT
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.37290544240668655,1.16121281668969,0.3,0.4197241906222286,1.0,15/24,31.14%,RIPK2;UBE2N;IRAK2;TNFAIP3;IRAK1;AAMP;UBA52;RNF34;NOD2;CASP8;TRAF6;NOD1;ITCH;UBC;IKBKG
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.31095424713697134,1.161055512993458,0.19148936170212766,0.4193726908987188,1.0,22/51,24.82%,DPEP1;TRIAP1;ARL6IP1;LAMP3;IFI6;YWHAE;CD44;CSNK2A1;XIAP;GPX1;LAMTOR5;DHCR24;SFN;CST7;PAX2;IFI16;RPS6KA1;SH3RF1;RPS6KA3;NAIP;THBS1;CARD16
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.35277336813825094,-1.1608366556270173,0.16363636363636364,0.4393973104501389,1.0,10/31,14.72%,DLG2;LRRC7;MTCL1;PARD3B;MYO9A;PARD3;OPHN1;SYNJ2BP;CRB1;RHOA
prerank,regulation of G0 to G1 transition (GO:0070316),0.3193695539853287,1.160354548757187,0.26666666666666666,0.42013184052201186,1.0,9/40,13.06%,CHEK1;E2F1;TFDP1;CBX3;RHNO1;RNF2;UXT;RBBP8;BRCA1
prerank,cellular response to peptide (GO:1901653),-0.32908715486482226,-1.1593458632944884,0.20754716981132076,0.4421444727255016,1.0,18/57,18.84%,CACNA2D1;GPER1;LDOC1;ADRB2;CACNB1;PRNP;NGFR;PSEN1;CYP11B1;ZFP36L1;ATP1A3;NTRK1;CYP11A1;EPHA4;VIM;GRIN2A;CACNA1A;CD36
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.257624422164228,-1.1588031522627615,0.0967741935483871,0.4428519851403104,1.0,69/218,23.89%,PER1;TRIM39;CFLAR;S100B;MAP3K3;FLNA;MAPKBP1;LPAR1;TRIM52;MAP3K14;CAPN3;ZDHHC17;LURAP1;TRIM6;TRAF1;ZMYND11;RORA;PRKCB;TAB2;NR1D1;TLR9;TERF2IP;PRKD1;CARD8;OTUD7A;LITAF;OPTN;OTUD7B;WLS;PELI2;ROR1;HSPB1;TNFSF10;DAB2IP;S100A13;PPM1A;PPM1B;UBE2V1;RHOA;BCL10;HTR2B;TICAM2;ESR1;PIDD1;GPRC5B;TRIM34;TLE1;NLRX1;APOL3;VAPA;MIB2;RNF31;EDA2R;SIRT1;CCL21;TRIM62;AKAP13;TRIM8;MAP3K7;TRIM38;TIRAP;SUMO4;PLCG2;ALPK1;MUL1;RIPK1;HMOX1;PINK1;RHOC
prerank,presynapse assembly (GO:0099054),-0.4420805010170864,-1.1584284342107507,0.20754716981132076,0.4429848570517914,1.0,10/18,21.46%,NLGN2;NLGN3;NLGN4X;NLGN1;PTEN;IL1RAPL1;BSN;NLGN4Y;FZD1;LRRTM3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3750565460103105,1.1583971098204398,0.24528301886792453,0.42381140870324746,1.0,7/20,13.06%,SOX4;RUVBL2;FOXP3;IL1B;RPS6KA4;DIP2B;BRCA1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.37681836165393634,-1.1582102373547607,0.25862068965517243,0.4428686984657135,1.0,13/32,28.54%,PTPRS;NR1D1;TLR9;TLR3;DAB2IP;TICAM2;GPS2;LRRC14;SARM1;NFKBIL1;OTUD4;F2RL1;CACTIN
prerank,regulation of defense response (GO:0031347),0.28565403621128904,1.1575118207886461,0.25,0.4250590387313476,1.0,36/81,31.21%,LRP8;WNT5A;PIK3AP1;TKFC;USP18;XIAP;SPATA2;MYD88;RELA;ADAMTS12;SETD6;GRN;TMSB4X;IL1RL2;NOD2;ZMPSTE24;ERAP1;TNFSF4;SEMA7A;CASP4;ELMOD2;ZBP1;ACE2;ANXA1;IL37;CASP8;PARK7;BCL6;HCK;NLRP6;SAMHD1;DAGLB;LACC1;XCL1;AREL1;CASP5
prerank,histone deubiquitination (GO:0016578),-0.44700775330961035,-1.1572476576887236,0.2909090909090909,0.44421801920369075,1.0,10/17,27.81%,UIMC1;USP49;USP51;KAT2A;ATXN7;USP15;USP21;SUPT3H;USP3;USP16
prerank,sphingolipid metabolic process (GO:0006665),0.2822389017856293,1.1568053570949874,0.1951219512195122,0.42599884039524744,1.0,39/112,22.55%,SPTLC1;HACD3;CERS6;NEU1;HEXB;GLA;GLB1;ALDH3B2;SGPP2;TECR;SMPD2;SPTLC2;CERS2;HACD2;ORMDL3;SUMF2;UGT8;DEGS2;GM2A;SPNS2;FUT7;ELOVL1;SGPL1;GBA;ACER2;ELOVL7;SUMF1;PPT1;CTSA;FA2H;SPTSSB;ORMDL2;PDXDC1;PLA2G15;ALOXE3;ALDH3B1;ELOVL6;ASAH2;FUT6
prerank,filopodium assembly (GO:0046847),-0.43610451162202035,-1.1565065230887428,0.2,0.445228892335631,1.0,8/16,27.40%,SRGAP2;FGD1;S1PR2;FGD2;FGD5;SPEF1;DNM3;FGD6
prerank,transition metal ion transport (GO:0000041),0.3226037508066393,1.1562687489506114,0.2222222222222222,0.42656818871628926,1.0,12/33,18.49%,TFR2;SLC31A1;ATP2C1;HEPHL1;SLC39A8;SLC11A2;ATP7B;SLC30A5;SLC39A2;SLC30A9;ATOX1;SLC30A1
prerank,protein insertion into ER membrane (GO:0045048),0.3371652426955762,1.1560137376567854,0.2619047619047619,0.4264812964552847,1.0,7/35,7.74%,SERP1;GET4;SEC61B;EMC8;EMC10;TRAM1;SEC61G
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3543187859191656,1.1560042598706548,0.29545454545454547,0.4259004219059819,1.0,12/28,29.64%,SERPINB1;TNFAIP3;CARD17;LILRB4;GIT1;ZC3H12A;CARD16;GSTP1;FFAR4;IL10;PYDC1;NLRP3
prerank,histone H2A acetylation (GO:0043968),0.42997857781342824,1.1555852586877087,0.3111111111111111,0.4263241800231411,1.0,4/16,3.14%,RUVBL1;ACTL6A;YEATS4;RUVBL2
prerank,regulation of anoikis (GO:2000209),0.40087187054825346,1.1545719134878292,0.21568627450980393,0.4277641501865203,1.0,8/19,21.82%,PTRH2;CEACAM6;BRMS1;CEACAM5;ITGA5;CAV1;MCL1;NOTCH1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.40748065749320256,1.1535965031404738,0.29545454545454547,0.42932699660202417,1.0,8/16,27.35%,COX6B1;COX7A2L;CYCS;COX4I1;COX5B;COX7B;COX5A;NDUFA4
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.3790997721944557,1.1528319704952443,0.16666666666666666,0.43056834045433395,1.0,6/22,11.10%,ULBP3;GZMB;ULBP2;TUBB4B;ULBP1;CEBPG
prerank,antibacterial humoral response (GO:0019731),0.33845941893063375,1.1527740145591563,0.26666666666666666,0.4300649250406926,1.0,15/33,30.92%,DEFA6;SLPI;RPL39;WFDC10A;PI3;SEMG1;ANG;DMBT1;RNASE7;WFDC3;DEFA1;SEMG2;WFDC9;WFDC13;WFDC12
prerank,negative regulation of immune response (GO:0050777),-0.2646016739876883,-1.1527629158474293,0.16417910447761194,0.4529486681901825,1.0,50/172,24.64%,GLP2R;ADCY5;PTH1R;MAPKBP1;ADCYAP1R1;ADCY2;ADRB3;ADCY4;POMC;VIPR2;ADRB2;ADCY9;PRKACA;GNG2;SIRT2;RAMP1;FER;ADORA2A;PRKAR2B;VIP;MC1R;LGALS3;GPR20;AVPR2;ADRB1;PPM1B;TRAFD1;ADCY6;SPINK5;TSHB;PCBP2;MAPK14;HTR4;CRHR1;GPR27;RAMP3;P2RY11;GPBAR1;LHCGR;RC3H1;HTR7;DHX58;CRHR2;PLCG1;RAMP2;PLCG2;MUL1;ADCYAP1;PRKAR1A;TRAF3IP1
prerank,phagosome acidification (GO:0090383),0.3166349170322391,1.1506606610784695,0.20454545454545456,0.4342417277632623,1.0,8/28,19.14%,ATP6V1C2;RAB20;ATP6V1G1;ATP6V0B;ATP6V1A;ATP6V1F;RAB7A;ATP6V0A4
prerank,regulation of lamellipodium assembly (GO:0010591),-0.34315662304261496,-1.1505255833479264,0.2962962962962963,0.4574694486072272,1.0,15/32,25.87%,PLXNB3;PIK3R1;SLIT2;MSTN;FER;PLCE1;ABI2;ARPC2;RAC1;CAPZB;WASF2;BRK1;OCLN;AKIRIN1;NCKAP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.38294632038240867,-1.150005936833348,0.3220338983050847,0.45812493334538756,1.0,5/18,11.73%,TGFBR3;BMPR1A;RBPJ;S1PR1;HEY1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.29246821356979524,-1.1498889713706197,0.19642857142857142,0.4578043394639721,1.0,33/88,25.47%,DUSP22;TGFBR3;BMPR1A;FERMT2;GCNT2;PXN;WFIKKN2;SMAD4;CLDN5;PARD3;ZMIZ1;ARHGEF18;SKI;RHOA;USP9Y;GDF5;SMAD9;CBL;ZFYVE9;SMAD2;USP15;LRRC32;UBB;HPGD;SIRT1;MAP3K7;SMAD7;CDH5;TWSG1;TGFB3;AMHR2;SMAD3;FNTA
prerank,neuropeptide signaling pathway (GO:0007218),-0.31682147720612286,-1.1496641657782534,0.21428571428571427,0.4576939881372733,1.0,28/62,31.44%,SORCS1;GALR2;SORCS3;NPPA;GALR1;QRFP;PENK;NTSR1;GLRB;NXPH3;SORCS2;NPY;LTB4R2;OPRL1;NPPB;RAPGEF2;SSTR2;PTGDR2;ADCYAP1;PYY;CYSLTR2;NMUR1;CPE;SSTR4;LTB4R;GPR149;MCHR2;OPRK1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4486177572861052,-1.1492672778936925,0.25862068965517243,0.45798983246413455,1.0,5/15,7.46%,NLGN2;HAP1;NPAS4;NLGN1;ADRA1A
prerank,cellular response to BMP stimulus (GO:0071773),-0.3170723872360366,-1.149199293362766,0.1509433962264151,0.4575601574871835,1.0,32/68,28.52%,RGMA;TMEM100;TGFBR3;BMPR1A;SMAD4;PHOX2B;GDF7;MEGF8;MAPK3;SFRP1;USP9Y;GDF5;GDF6;SMAD9;ACVR2A;SMAD2;USP15;VSTM2A;BMPR1B;SMAD7;DLX1;ADAMTS7;PDCD4;ZFYVE16;TGFB3;AMHR2;SMAD3;RUNX2;BMP5;SMURF1;BMPR2;HIVEP1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.41199831878168197,-1.1489589421571649,0.3018867924528302,0.4573892409700394,1.0,6/18,14.50%,MAPKBP1;TLR9;ELANE;SSC5D;OTUD7B;MAP2K5
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.41368298487795135,1.148801337774097,0.25,0.4373175366660709,1.0,3/15,12.34%,USP50;MYD88;GBP5
prerank,organic anion transport (GO:0015711),0.28070151480984723,1.1482081982277812,0.14893617021276595,0.438036099726163,1.0,25/92,19.34%,LRRC8E;CA9;SLC22A11;SLC35A2;SLC4A11;SLC35B2;SLC52A2;ABCC11;SLC19A1;LRRC8D;SLCO1B3;SLC39A8;SLC52A3;AQP9;SLC25A19;SLCO4A1;SLC25A17;CYB5R2;SLC25A24;SLC35C2;SLCO1C1;CA6;CYB5R4;SLC9A3R1;CFTR
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.36495063837253977,-1.1481569340403772,0.2909090909090909,0.4585908543153974,1.0,14/37,23.81%,PLIN5;DLG4;ITGB3;PTX3;RIN3;SIRT2;ATXN2;OPTN;ANKRD13A;EDNRB;INS;ANKRD13D;BTN2A2;PINK1
prerank,cardiac myofibril assembly (GO:0055003),-0.4365974877441584,-1.148096378135238,0.2857142857142857,0.458100926427712,1.0,8/15,15.02%,MYL2;TCAP;PDGFRA;MEF2A;OBSL1;CSRP3;ACTC1;FHOD3
prerank,cellular protein catabolic process (GO:0044257),0.30816278024691696,1.1476844415829321,0.18181818181818182,0.438406356633538,1.0,20/57,18.51%,FAP;GZMB;CTSV;CHEK2;CTSH;CTSC;CLTA;PCSK9;AP2S1;ADAMTS12;LONP1;CLTC;CLPP;YME1L1;AP2B1;RAB7A;CTSZ;GZMA;IDE;RSPRY1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.42668444304891,1.1469016592509274,0.2777777777777778,0.4393413819101964,1.0,6/16,18.86%,VPS25;VTA1;CHMP4C;CHMP5;LEPROTL1;STAM
prerank,mitochondrial membrane organization (GO:0007006),0.3639692837291691,1.146760164581529,0.25,0.4389710841721678,1.0,13/28,20.87%,MTX1;PMAIP1;APOO;TIMM50;BCL2L1;HSPA9;PPIF;CHCHD6;CHCHD3;SLC25A5;MTX2;BAK1;SAMM50
prerank,regulation of filopodium assembly (GO:0051489),-0.3466222636434865,-1.1460690427895455,0.3103448275862069,0.462279574211689,1.0,15/38,20.98%,PALM;TENM1;PIK3R1;NLGN1;FXR2;GAP43;GPM6A;RHOQ;DPYSL3;SRGAP2C;DOCK11;CAPZB;CCL21;TENM2;BCAS3
prerank,positive regulation of T cell cytokine production (GO:0002726),0.37937103433086455,1.1454972013681608,0.2,0.4412818722568626,1.0,11/21,30.97%,IL1B;CD55;CD81;PRKCZ;TRAF2;TNFSF4;IL18;TRAF6;NLRP3;RSAD2;XCL1
prerank,Wnt signaling pathway (GO:0016055),-0.2982592022509684,-1.1452261521996412,0.23809523809523808,0.4634820774550048,1.0,26/91,18.90%,TCF7L1;WNT9A;DIXDC1;SFRP5;FZD4;FERMT2;CSNK1E;NXN;DVL3;WNT6;CSNK1A1;WNT5B;FZD7;SKP1;PTEN;LRRK2;WLS;WNT2B;DVL2;SFRP1;BTRC;APC;FZD8;WNT16;UBB;ZRANB1
prerank,RNA stabilization (GO:0043489),0.34256080897977415,1.144793176570846,0.25,0.44177066744407084,1.0,9/26,15.93%,DKC1;E2F1;PABPC1;AXIN2;NAF1;FUS;ELAVL1;NSUN2;NOCT
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.2971772478081064,-1.1447860050431529,0.2,0.46390151134766017,1.0,25/73,21.17%,ZER1;CLU;CSNK1E;RNF19A;RNF180;CSNK1A1;RNF217;DET1;BAG2;LRRK2;SIRT2;ZYG11B;KLHL40;TRIB2;BBS7;ARIH2;RNF144B;HECTD1;CSNK1D;DNAJB2;ARIH1;RNF14;GSK3A;PRICKLE1;SMAD7
prerank,regulation of protein localization to cell surface (GO:2000008),-0.3599016756820625,-1.1443711548265014,0.2542372881355932,0.4641981381563523,1.0,12/32,22.92%,GPM6B;RIC3;MAP1A;ACTN2;SNX33;GBF1;LEPROT;TAX1BP3;GOPC;RAB11FIP5;GPD1L;CAV3
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3256201473697912,-1.1443577686181465,0.16071428571428573,0.46359464392357713,1.0,20/49,22.87%,PDE2A;MAP3K14;KCNK4;PIEZO2;TLR3;HABP4;AQP1;MAPK3;MAP2K4;BCL10;MAPK8;FAS;PIEZO1;TNFSF14;ANKRD1;CRADD;BNIP3;TMEM150C;CASP8AP2;BAD
prerank,neural crest cell differentiation (GO:0014033),-0.39556109275708207,-1.1440276040961586,0.2909090909090909,0.4638302060707954,1.0,9/19,24.28%,TAPT1;MEF2C;CDH2;HTR2B;SOX11;LRP6;SOX8;FAM172A;SNAI2
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3862002900989261,-1.1440209528035192,0.2982456140350877,0.4632287950662624,1.0,7/30,10.64%,SORBS1;PRKAB2;GPER1;ASXL3;PRKAG2;PRKAA2;SIRT4
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.39512643546285237,-1.143934129398319,0.2830188679245283,0.4627137080095715,1.0,10/20,25.87%,RHOQ;NCKAP1L;FHOD3;ROCK1;RAB13;STRIP1;FMNL3;FMNL2;FHOD1;NCKAP1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.3733933505323107,-1.1437920755256599,0.24,0.4623692264767962,1.0,7/21,22.15%,ABCA8;NR1H2;RXRA;GPS2;ABCA3;SIRT1;CES1
prerank,mammary gland epithelium development (GO:0061180),0.439824596091108,1.1434347465108872,0.2916666666666667,0.44413351758628633,1.0,6/15,17.15%,WNT2;WNT7B;EPHA2;WNT3;ZNF703;IRF6
prerank,regulation of cell junction assembly (GO:1901888),-0.377282828801325,-1.1432905257827897,0.2786885245901639,0.46294320864362876,1.0,13/27,24.37%,RAP1A;CLDN5;SETD5;PRKACA;MYO1C;MEF2C;TJP1;RAPGEF1;ROCK1;RAPGEF2;PRKCH;SNAI2;OCLN
prerank,selective autophagy (GO:0061912),-0.31481436714671424,-1.1422997890891888,0.14583333333333334,0.4645526011881481,1.0,15/54,18.72%,ULK1;ATG2B;DYNC1I1;ULK2;ATG14;MAP1LC3C;HDAC6;CALCOCO2;WDFY3;UBE2V1;VIM;DYNC1LI2;PCNT;KLHL3;UBB
prerank,natural killer cell activation (GO:0030101),0.33794674390163115,1.1407866840760412,0.25,0.44876828733465024,1.0,15/41,29.24%,ULBP3;ULBP2;ULBP1;PRDX1;IL21R;ELF4;IL12B;CD2;RABL3;CASP8;CD244;IFNE;PIK3CD;NCR3;RASGRP1
prerank,cellular response to lipid (GO:0071396),0.24057949868887546,1.140733462231807,0.09375,0.44820033358878836,1.0,64/210,21.42%,TESC;IL1A;IRS1;CXCL5;CXCL8;WNT2;CXCL3;CXCL1;CXCL11;RUVBL2;WNT7B;CXCL2;PTK7;IL1B;WNT5A;SPP1;DEFA6;ADCY1;PF4;TNFAIP3;CARD17;SOX9;HMGB2;PLAA;CD80;XBP1;ABL2;MYD88;RELA;FFAR2;IRAK1;FZD10;POU4F1;CXCL9;WNT3;WNT11;ZNF703;CXCL10;CXCL6;TNIP3;MED1;ADAM15;INSIG1;PF4V1;LYN;IL36B;TNFRSF1B;CHMP5;NOD2;CTR9;ADAM9;SERPINE1;CFTR;MSN;WNT8B;TNFSF4;URI1;PAX2;CD86;CXCL13;GIT1;HMGB1;NFKBIB;ZC3H12A
prerank,negative regulation of anoikis (GO:2000811),0.4103938262356634,1.1404892218262743,0.2830188679245283,0.4481008581873852,1.0,7/15,21.82%,PTRH2;CEACAM6;CEACAM5;ITGA5;CAV1;MCL1;NOTCH1
prerank,hexose transmembrane transport (GO:0008645),-0.416274665633953,-1.1404528780494148,0.2549019607843137,0.4681325496124459,1.0,4/21,5.73%,SLC2A4;SLC45A1;SLC2A11;PPARD
prerank,regulation of mononuclear cell migration (GO:0071675),-0.37460865703049495,-1.140102572793853,0.22448979591836735,0.46844417155728596,1.0,6/22,13.02%,SLIT2;MSTN;RARRES2;LGALS3;MAPK1;MAPK3
prerank,regulation of cilium assembly (GO:1902017),-0.31746479657490445,-1.1394825891649214,0.25862068965517243,0.46927139858967293,1.0,23/61,24.51%,TBC1D1;TBC1D17;RABGAP1;TAPT1;TBC1D10A;TBC1D20;BBS4;CROCC;EVI5L;TBC1D2B;TBC1D13;TCHP;MARK4;CCDC88A;SGSM3;FUZ;ODF2L;TESK1;CEP97;CEP120;TBC1D24;CDKL5;ARHGAP35
prerank,transition metal ion homeostasis (GO:0055076),0.3559558083613956,1.139220338315876,0.21739130434782608,0.4498976687374848,1.0,8/25,16.25%,TFR2;HMOX2;ATP13A2;SLC40A1;XIAP;HEPHL1;COMMD1;FTL
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.35589183230894605,1.1391901836923355,0.22916666666666666,0.44931499915213274,1.0,8/28,7.80%,IL1A;INHBA;CSF2;IFI6;IL1B;PPP2R1B;PF4;BCL2L1
prerank,ERBB2 signaling pathway (GO:0038128),-0.3605691272964036,-1.1381640639837143,0.2826086956521739,0.47172765668162303,1.0,6/31,7.04%,NRG2;GAB1;MYOC;BTC;PIK3R1;PRKCA
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.36673579469166767,-1.1376534825431468,0.29508196721311475,0.4724406231663182,1.0,16/32,23.80%,MPP2;NLGN3;NPAS4;CHRNA3;LRRK2;MEF2C;NPFF;RAB3GAP1;GRIN2A;GABRG1;GABRG2;GSK3A;DRD4;GRID2;GABRA1;GRIN2C
prerank,cellular lipid catabolic process (GO:0044242),0.39787550051438336,1.1376477258734468,0.3125,0.452096943448644,1.0,8/24,9.85%,NUDT19;PLBD1;ACBD5;MGST2;ABHD12;AOAH;CEL;LIPG
prerank,glycerophospholipid metabolic process (GO:0006650),0.2876777922687824,1.1376200835770898,0.23684210526315788,0.45146640377856223,1.0,27/73,21.54%,CPNE7;PIGM;DPM2;PDGFRB;SERINC5;ABHD12;GDPD1;PIGW;PDXP;CPNE3;PLA2G7;PNPLA3;ACP6;PLA2G3;PLA2G4E;PIGF;PLA2G4D;PLCB3;PIGA;CPNE1;PLEK;PLA2G2D;CETP;PIGN;PIGX;PGP;PLA2G15
prerank,autonomic nervous system development (GO:0048483),-0.4109954173243099,-1.1374131480730332,0.2833333333333333,0.47236218488408493,1.0,8/20,17.75%,GDNF;PHOX2B;PHOX2A;RHOXF1;NTRK1;EDNRB;SEMA3A;SOX11
prerank,RNA polyadenylation (GO:0043631),0.36288883523391896,1.1372367911789167,0.26666666666666666,0.4511056984746918,1.0,7/24,15.40%,CPSF3;PABPC1;PNPT1;CLP1;GRSF1;CPSF2;LEO1
prerank,mRNA polyadenylation (GO:0006378),0.36288883523391896,1.1372367911789167,0.26666666666666666,0.4511056984746918,1.0,7/24,15.40%,CPSF3;PABPC1;PNPT1;CLP1;GRSF1;CPSF2;LEO1
prerank,signal transduction by p53 class mediator (GO:0072331),0.3489252527915885,1.1370041302038199,0.2,0.4509569203617792,1.0,15/33,26.59%,TRIAP1;PMAIP1;USP10;BATF;POU4F1;MYO6;ACER2;HINT1;PAXIP1;IFI16;E2F7;TP53;MAGEA2;FHIT;MYBBP1A
prerank,potassium ion import across plasma membrane (GO:1990573),-0.34935872552099095,-1.136415641288604,0.19298245614035087,0.4738251372845481,1.0,13/42,18.48%,ATP1B2;ATP1A2;SLC12A4;FXYD2;KCNH2;ATP1A4;KCNE2;ATP1A3;ABCC9;KCNJ8;KCNJ9;KCNJ1;ATP4A
prerank,epidermis development (GO:0008544),0.2874553478657363,1.1362556482075967,0.25,0.4521321086736475,1.0,23/69,22.70%,GRHL3;LAMC2;KLK7;GJB5;HDAC2;RBP2;CDSN;ATP2C1;EDAR;HDAC1;LAMB3;EVPL;LAMA3;GRHL2;GATA6;DSP;OVOL3;SCEL;OVOL1;KRT15;OVOL2;KRT83;KRT32
prerank,regulation of cell growth (GO:0001558),-0.2569049023849122,-1.1354973551851268,0.16176470588235295,0.4752126901737297,1.0,56/203,20.50%,TSPYL2;FLCN;FAM107A;FHL1;APBB1;RASGRP2;MYL2;CAPRIN2;LGI1;DACT3;NPR1;AKAP6;USP47;RERG;EGLN2;SOCS2;JADE1;PTCH2;PRDM11;AGTR1;SMAD4;LTBP4;WFDC1;KIAA1109;BCL2;KLHL22;SLIT2;SLIT3;NRG3;ARHGEF11;TAOK2;CGRRF1;SOX17;PLCE1;TCHP;N6AMT1;CDKN1A;SFRP1;PAPPA2;CAMK2D;SGK3;SIPA1;CDKN2C;NPPB;APBB2;RTN4;SPOCK1;EGFR;SMARCA2;DCUN1D3;DNAJB2;AGTR2;TP53TG5;INS;SIRT1;INO80
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.23782326789690506,-1.1341097799967612,0.08108108108108109,0.4779193222718774,1.0,150/454,25.85%,TCF7L1;PHF1;APBB3;TSC1;APBB1;ZSCAN26;NR2C2;SSBP2;HCFC2;ZNF516;DMTF1;ZNF280D;ARNTL;ATF7;SOX15;ZNF219;ZBTB4;CHD3;HP1BP3;ZNF536;PHF12;ZNF273;PRDM2;SAP30L;ZNF676;MITF;WWTR1;BNC2;PPARGC1B;WTIP;YY1AP1;RPS6KA5;ZNF519;RORA;PRDM8;SKOR1;DDX25;ZNF284;CASZ1;ZNF626;KAT6B;RBBP6;NAB2;ATF4;FOXN3;NFYB;ZNF732;TERF2IP;RHOXF1;SOX13;AKAP17A;GON4L;FZD7;ZNF331;TULP3;ATXN2;NR3C1;FOXN4;ZNF117;ZNF37A;FOXO4;GLI4;CXXC1;SOX17;MEF2C;NFIL3;WWC2;ZNF274;ZFAT;KAT7;VSX1;ARNT2;DAPK3;SOX7;DVL2;IRF2;RBM4B;UBE2V1;ERC1;HINFP;ZFHX3;TFEB;ESR1;TEAD2;DENND4A;WWC3;LMX1B;ZNF423;CCDC88A;ZFPL1;RORB;MZF1;EIF2B4;ATXN1L;ZFP37;SPIN1;APBB2;ZNF98;SOX11;INSR;SAP30;HIC1;BAZ2A;SUFU;SMARCA2;PFDN5;MED23;ZNF431;RNF14;SOX18;EFEMP1;ZNF2;INS;SOX2;SOX6;MLLT6;NR1D2;SERTAD3;NFIA;HOXB1;SCRT1;IGSF1;ZNF682;RFX3;ZNF350;CREM;NFYC;LIMD1;ATF2;JMJD1C;ESRRB;CDK11B;CELSR2;ZNF395;SUPT3H;NFX1;NKX3-1;SNAI2;CDK11A;HOXD13;PDGFA;BNC1;ZNF502;FOXO3;ZNF33A;ZNF143;GATA1;HCLS1;SPIN3;ZNF221
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.32378282456121643,1.134032258977965,0.2391304347826087,0.4563163349594003,1.0,15/37,27.60%,CHEK1;E2F1;TFDP1;CBX3;RNF2;UXT;RBBP8;BRCA1;CDC7;SUZ12;EZH2;RBBP7;RRM2;EED;CBX5
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.39365034156364503,1.1338105694477305,0.3333333333333333,0.4562684003227612,1.0,6/16,16.44%,TRIB3;SOX9;ERLIN1;BRCA1;APOC1;ERLIN2
prerank,aminoglycan biosynthetic process (GO:0006023),0.31158242741585024,1.1331974417463666,0.275,0.45703289667782987,1.0,13/49,14.46%,B3GNT4;HS6ST2;HS3ST1;AGRN;B3GNT2;HS2ST1;GALNT5;B3GALT6;B4GALT7;EXT2;SDC1;B3GNT3;PXYLP1
prerank,regulation of nuclear division (GO:0051783),0.3839921536547459,1.132345142891662,0.36538461538461536,0.4585911569928193,1.0,7/20,12.39%,KIF20B;FBXO5;RCC1;NEK2;CDC25C;PDXP;PKMYT1
prerank,ruffle organization (GO:0031529),-0.40582899229929037,-1.1322963723689645,0.2830188679245283,0.4814995709251584,1.0,8/16,27.50%,TPM1;LIMA1;INPP5K;RAC1;AIF1L;CCL21;PIP5K1A;CORO1B
prerank,regulation of receptor recycling (GO:0001919),-0.4197839437877783,-1.1317946027674968,0.29411764705882354,0.4821467739082616,1.0,5/17,10.95%,BVES;SNCA;INPP5F;OPTN;ECE1
prerank,regulation of cell cycle (GO:0051726),0.2334449962003672,1.1317807413989178,0.18518518518518517,0.4592586429073898,1.0,64/287,14.99%,FAP;CHEK1;MYC;DDIAS;CALR;CCND1;WDR12;CDKN3;SND1;CKS2;CKS1B;KIF20B;TP73;TFAP4;FBXO5;CDK7;SKP2;LIN9;CDK5;CXCL8;INHBA;CDC123;MCIDAS;CSNK2A3;NEK6;PES1;BOP1;FIGNL1;MASTL;TBRG4;PNPT1;RNF40;DLGAP5;NANOS3;PML;CDK4;PROX1;CDKN2A;SOX9;TGFB2;MYBL2;CSNK2A1;TTLL12;HMGA2;XIAP;JUNB;ADAM10;PRR11;DUSP1;CDC26;POU4F1;PTPRK;BMP7;BRCA1;ZNF703;ZBED6;PLK1;DHCR24;BMP4;GATA6;LIN54;FOXM1;CENPF;SMIM22
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3703775309285884,-1.1315959194402543,0.2653061224489796,0.48219881013208843,1.0,10/23,20.46%,PDE2A;PDE9A;PDE4D;NUDT10;NUDT11;ENTPD4;NUDT16;NT5E;ACAT1;MLYCD
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.2988920508118378,-1.1313419150595039,0.24561403508771928,0.482155876154623,1.0,34/76,27.55%,FGFR1;FGF2;GAB1;MYOC;PDGFRA;ROR2;GPER1;PIK3R1;GH1;NTRK3;KIT;DCN;NTRK1;ROR1;EPOR;PDGFB;NTF3;CBL;WNT16;INSR;PLXNB1;INS;SIRT1;PDGFD;HGF;FLT1;NKX3-1;PDGFA;EPO;HCLS1;SELP;F2RL1;PIK3R5;FSHR
prerank,positive regulation of cell motility (GO:2000147),0.2516811810007229,1.1313254857394688,0.16279069767441862,0.4595427139683353,1.0,49/209,15.42%,CLDN1;MMP7;CEMIP;TDGF1;COL1A1;LAMC2;MGAT5;CCL24;EPHB2;PDGFRB;PLAU;GTSE1;CFAP20;DUOXA2;EPHA1;IL1B;LGR6;CEACAM6;LEF1;CTSH;ACTG1;FAM83H;GRB7;MDK;DUOX2;MAZ;CCL3;XBP1;F7;CPNE3;ADAM10;IGF1R;SEMA4D;PECAM1;CXCL16;ACTN4;WNT11;CCL26;ZNF703;SEMA5A;CIB1;KDR;MMP9;MIEN1;GRN;PAK1;PDCD10;SMIM22;RHOD
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3366745636140201,1.1312031411873706,0.3111111111111111,0.4593077705862722,1.0,17/39,22.14%,CHEK1;BRCC3;CDK1;BLM;TICRR;NABP2;TOPBP1;NAE1;HMGA2;BRCA1;HUS1;PLK1;CLSPN;CDC6;ORC1;DTL;CDC14C
prerank,cell-cell junction organization (GO:0045216),-0.3002459909823185,-1.1303961737100854,0.2222222222222222,0.48365214002168283,1.0,16/77,9.90%,LIMS2;FLCN;NLGN2;TLN1;GJC1;CDH19;CADM2;CTNND2;CDHR3;NLGN4X;CADM3;CLDN5;DCHS1;CTNND1;SDK1;CDH10
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.29411418362808733,-1.1303753302197173,0.234375,0.4830753681591717,1.0,28/97,20.17%,DUSP22;HAND2;SASH1;MTURN;TRAF1;PJA2;TLR9;SEMA4C;ANKRD6;MAP3K4;FZD7;FLT4;TAOK2;DAB2IP;GADD45B;MID1;GDF6;MAP4K2;SH3RF3;DUSP19;SEMA3A;WNT16;MAPK8IP1;PLCB1;RASSF2;EDA2R;MAP3K10;CCL21
prerank,sensory organ development (GO:0007423),-0.31154819998752736,-1.1293235102501564,0.27419354838709675,0.48502712681923865,1.0,16/56,20.11%,MEIS1;MAB21L2;MAB21L1;SALL2;MEIS2;PBX3;CPAMD8;CHRDL1;PBX2;ECE1;MEIS3;SMCHD1;ABCB5;AHI1;BMPR1B;SOX2
prerank,regulation of immunoglobulin production (GO:0002637),0.35117484726793224,1.1292754239121554,0.17647058823529413,0.46319843565523916,1.0,11/28,29.18%,EPHB2;PHB;IL21;XBP1;TNFSF4;CD86;RBP4;TNFRSF4;GPI;IL10;PHB2
prerank,protein ADP-ribosylation (GO:0006471),-0.36180913988972635,-1.1292705769893578,0.26785714285714285,0.48452083047383315,1.0,11/28,22.60%,PARP6;SIRT2;SIRT4;PARP16;PARP15;SIRT1;ART4;PARP2;SIRT3;PARP3;TNKS
prerank,regulation of ruffle assembly (GO:1900027),-0.3974511554287721,-1.129245602484334,0.2692307692307692,0.48396872261957813,1.0,8/23,15.57%,NLGN1;EVL;RDX;ARHGAP24;NDEL1;P2RY12;DEF8;KANK1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2726276549125758,1.127456732479393,0.14634146341463414,0.46650082548748384,1.0,27/78,27.40%,IL1A;EPHB2;IL23A;WNT5A;SYK;PF4;DHX9;CYBA;OAS2;CCL3;IL17A;IL17F;ADAM8;NOD2;ARFGEF2;OAS3;MMP8;CD86;HMGB1;IL12B;CD2;TYROBP;THBS1;PTPN11;PTPRJ;IFNG;CLEC7A
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.25718923008432437,1.1261304221467305,0.1951219512195122,0.46888340261948325,1.0,37/147,15.29%,SLC25A15;SPTLC1;HACD3;RHCE;CERS6;MOCS3;INHBA;PAH;ALDH3B2;MOCOS;SGPP2;ASS1;NANP;MGST2;STARD7;GCNT1;PCSK1;GSTO2;CSNK2A1;AKR1A1;SLC44A1;SPTLC2;NMRAL1;LPCAT2;CERS2;HACD2;GSTO1;DEGS2;GCH1;SPNS2;ELOVL1;SLC44A3;SGPL1;ACER2;TYW1;ELOVL7;GPHN
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.27160283351249687,1.1255879643552686,0.16216216216216217,0.4694858802330635,1.0,35/75,28.12%,PSME3;TRIAP1;PSMD10;TMBIM6;BCL2L1;RTKN2;NOC2L;CSNK2A1;MAZ;PPIF;RELA;GPX1;PRELID1;CAAP1;MMP9;BMP4;SLC35F6;PLAUR;SLC25A5;PIH1D1;FXN;URI1;TMEM14A;MCL1;ASAH2;ITGA6;SH3RF1;THBS1;NDUFS3;GSTP1;BCL2L10;TGFBR1;GHITM;PARK7;FZD9
prerank,regulation of calcium ion import (GO:0090279),-0.3974787743073409,-1.1253668757778619,0.27586206896551724,0.49238154549492974,1.0,11/24,22.92%,PKD2;GRM6;WNK3;PLN;PRNP;LGALS3;PSEN2;PDGFB;CCL2;SLN;CAV3
prerank,mRNA metabolic process (GO:0016071),0.2837794540511562,1.1253205368109944,0.23809523809523808,0.46952660035301985,1.0,32/91,19.46%,CPSF3;SNRPF;LSM5;EREG;SNRPG;U2AF1;SLBP;PABPC3;SNRPB;TBRG4;PNPT1;NCBP1;SNRPE;SRSF9;PTBP1;NONO;CNOT10;NUDT21;LSM2;NCBP2;HNRNPA0;SSB;YTHDF2;LSM6;ZNF473;USP39;LSM3;SF3A3;HNRNPR;NUDT16L1;HNRNPA2B1;SNRPD3
prerank,establishment of mitotic spindle orientation (GO:0000132),0.37720290307295984,1.125162126438251,0.2222222222222222,0.4691892699729815,1.0,8/24,13.68%,MAD2L1;SAPCD2;CENPA;SPDL1;NDC80;GPSM2;ZW10;PLK1
prerank,peptide metabolic process (GO:0006518),0.2790302637356118,1.1248562358916299,0.2222222222222222,0.4692906708960688,1.0,17/79,10.72%,DPEP1;NLN;RHCE;HM13;MMACHC;MIPEP;BACE2;GLRX2;CPZ;CPD;SPCS1;DNPEP;MME;APEH;PCSK1;CPN1;GPX1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.44961177744188136,-1.1246889345199522,0.3114754098360656,0.4933715193556527,1.0,7/15,13.83%,KCNA5;KCNIP2;KCNH2;KCNE2;KCNJ8;KCND3;KCNE1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3557143994300059,1.1244697416881506,0.32608695652173914,0.46948225528189425,1.0,8/27,14.32%,RIPK2;UBE2N;IRAK2;TNFAIP3;IRAK1;TIFA;AAMP;UBA52
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2833947297766589,1.1244294404512387,0.22727272727272727,0.46893557356566556,1.0,25/75,21.14%,TRIB3;DCUN1D5;RIPK2;UBE2N;DERL1;RPS2;NDFIP2;PSMD10;FBXO4;XIAP;KDM1A;BRCA1;PLK1;HSPBP1;TBC1D7;COMMD1;SPRTN;UBQLN1;FANCI;PAXIP1;AXIN1;UBE2D1;BIRC7;CAV1;CUL3
prerank,transferrin transport (GO:0033572),0.30071972678906655,1.124319107726224,0.20588235294117646,0.4685407298089696,1.0,10/35,19.14%,ATP6V1C2;TFR2;ATP6V1G1;ATP6V0B;ATP6V1A;CLTC;ATP6AP1;ATP6V1F;STEAP3;ATP6V0A4
prerank,regulation of interleukin-2 production (GO:0032663),0.3154375471503762,1.1238277695516679,0.3181818181818182,0.4691980254872269,1.0,14/48,14.21%,IL1A;FOXP3;IL1B;PNP;RPS3;TNFAIP3;STOML2;CARD11;CD80;TRIM27;RUNX1;IL17F;EZR;TRAF2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3633016215203385,-1.1220433361411868,0.2857142857142857,0.49968574800332966,1.0,10/26,23.81%,MAPK7;ATF4;LRRK2;HSPB1;PDE8A;INS;SIRT1;NME5;NOL3;PINK1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.419937749614773,-1.1218634114912789,0.3620689655172414,0.4993983040791786,1.0,9/17,30.24%,BMPR1A;RBPJ;HEY1;HEY2;NOTCH2;SNAI2;NOG;ACVR1;HEYL
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4009472952441651,1.1218082711631139,0.2972972972972973,0.47309246617064205,1.0,11/16,31.62%,USP18;TTLL12;NLRC5;YTHDF2;ISG15;PTPN2;OAS3;STAT2;YTHDF3;SAMHD1;CNOT7
prerank,negative regulation of protein catabolic process (GO:0042177),-0.33333150297444836,-1.1214743147540183,0.19642857142857142,0.4998254802995057,1.0,17/42,20.08%,FLNA;SNRNP70;ADGRB1;SNCA;FMN2;TIMP4;RIC1;SIRT2;MDM4;TIMP2;TIMP3;DAB2IP;ROCK1;AZIN2;EGFR;CDK5RAP3;INS
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3385747437749353,1.121391285519204,0.30952380952380953,0.47348727397587326,1.0,16/32,25.62%,TESC;PLAU;SYK;TGFB2;EPHA2;EFNA1;CIB1;ACER2;PIK3CG;LYN;ADAM9;SERPINE1;LIF;EPHA8;PTPN11;RAC3
prerank,regulation of intracellular signal transduction (GO:1902531),-0.244898086874074,-1.121372187442022,0.15873015873015872,0.4993749577306319,1.0,147/424,25.30%,ARHGEF26;PDE2A;INPP5B;FLCN;ARHGAP10;PRKAB2;PIP5K1C;FBXO9;ARHGEF17;CSNK2A2;AKAP6;TRIP10;ARHGAP33;MAPT;STARD13;CHD3;CAPN3;PPP2R5B;ARHGEF9;PRDM11;MYOC;RRAGC;SYDE1;AKAP12;RASD2;L3MBTL1;TRIM6;TRAF1;GNAI1;JMY;PLEKHG2;NTRK3;MYO9A;FAM13B;NLGN1;ARHGAP6;ARHGAP20;ARHGEF6;ITSN1;DLC1;PJA2;STARD8;OBSCN;RHOQ;RHOJ;MYO9B;RHOB;PIP4K2B;SRGAP2;PTEN;CARD8;PRKAG2;LRRK2;PRKAA2;ARHGAP21;MDM4;ARHGAP19;USP2;ARHGEF18;OPTN;RRAS;ARHGEF11;SYDE2;PRKAR2B;NTRK1;TAOK2;OPHN1;ARHGAP23;FGD1;ARHGAP24;HSPB1;WWC2;FBXL2;DAB2IP;MAPK1;MAPK3;TIAM1;GNA12;MAPK11;RRAGB;RICTOR;RIT2;RGN;RAC1;SOS2;RHOA;FAM83D;ARHGEF7;ARHGAP29;PIDD1;PIP4K2A;TP53INP1;MAPKAP1;WWC3;ARHGAP31;TAF3;MCF2;RAD50;TRIO;SOS1;RHOT2;MAPK14;FGF1;NRK;EGFR;PEX5L;CSNK2B;RASSF2;ANKRD54;FGD2;ARHGAP5;ING5;SRGAP1;AKAP13;MAP2K6;EHMT1;ZNF385A;KAT5;TBCK;GRM2;PIK3R2;PAK3;MBD3;SUMO4;ARHGEF3;PIN1;TMBIM4;SLC15A2;MTOR;ARHGDIG;NUAK1;ARHGAP28;RHOU;HIPK1;PLCG2;RHOC;RASGRF2;ARHGAP11B;ARHGAP35;ARHGAP15;PRKAR1A;TBP;PIP5K1A;ARHGAP1;TAF11;ARHGAP17;ARAP3
prerank,protein modification by small protein removal (GO:0070646),0.23239552520582615,1.120907511400062,0.13157894736842105,0.4737314717186882,1.0,55/268,15.41%,RUVBL1;PSMD14;MYC;OTUB2;PSMB2;BRCC3;CDK1;USP50;PSMB9;PSMA5;ACTL6A;SKP2;PSMB3;SMAD1;PSME3;PSMA3;POLB;KDM1B;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;USP18;TNFAIP3;TOMM20;PSMD12;ACTR8;PSMB5;USP37;USP10;UCHL5;RNF128;PSMD8;PSMB4;TOR1A;PSMD3;STAMBP;PSMB1;PSMA4;COPS5;RAD23B;ADRM1;BRCA1;PSME1;PSMF1;PSMD11;TRAF2;TNIP3;UBA52;PSMD1;VCP;USP1;CDC25A
prerank,retina homeostasis (GO:0001895),0.31829043577658905,1.120642384511607,0.28888888888888886,0.4738555364385589,1.0,8/32,9.49%,CDH3;AZGP1;CST4;POC1B;CRB2;ACTG1;ZG16B;PRDX1
prerank,macrophage differentiation (GO:0030225),0.3961454425567934,1.1199988641045038,0.3333333333333333,0.47476973024348773,1.0,8/15,33.26%,CSF2;MMP9;BMP4;CDC42;IFNG;CASP8;PARP1;VEGFA
prerank,negative regulation of calcium ion transport (GO:0051926),-0.39942149268752647,-1.1197245029491492,0.2909090909090909,0.5026843634986689,1.0,9/18,25.54%,ATP1A2;PLN;NOS1;INPP5K;PACSIN3;SLN;CAV3;CD33;EPO
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.3537133793597596,-1.1194377233321422,0.2857142857142857,0.5027210019997477,1.0,9/24,14.45%,SETD1B;SETD5;SETD4;VCPKMT;KMT2A;SETD2;OGT;SETD3;ZNF335
prerank,anion transmembrane transport (GO:0098656),0.2901575897051127,1.119426384168807,0.17073170731707318,0.47511548380643115,1.0,20/66,18.02%,LRRC8E;SLC6A20;SLC35A2;SLC5A6;SLC7A1;SLC38A5;SLC7A5;MFSD12;SLC19A1;LRRC8D;SLC25A22;SFXN2;SLC39A8;SLC25A19;SFXN1;LRRC8B;SLC3A2;SLC35C2;SLC25A5;SLC13A3
prerank,negative regulation of developmental process (GO:0051093),-0.2971385858508202,-1.1192783572786704,0.21311475409836064,0.5023616661388249,1.0,28/73,24.08%,SFRP5;RAPGEF3;MAPT;PTPRS;TBX1;NFIB;ARHGEF15;HEY1;NOTCH4;VAT1;SPRY3;SRGAP2C;KLF7;SFRP1;TBX2;KANK1;ROCK1;HEY2;DCC;DLL1;ARPIN;FUZ;BNIP3;RC3H1;PARP3;MUL1;PINK1;NKX3-1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.4444311866902355,1.1188417652696014,0.40384615384615385,0.47595116573424334,1.0,4/15,4.64%,ENTPD7;NUDT1;NUDT15;NUDT5
prerank,regulation of mitochondrion organization (GO:0010821),-0.34559966545151416,-1.118445054578882,0.2982456140350877,0.503654530500182,1.0,18/43,26.85%,PDE2A;FLCN;CSNK2A2;MAPT;HDAC6;LRRK2;PID1;MGARP;RHOT2;PISD;FBXW7;PARL;GSK3A;MUL1;PINK1;MFF;DNM1L;GOLPH3
prerank,glycolipid biosynthetic process (GO:0009247),0.33581379257105637,1.1183302164206317,0.2619047619047619,0.4763983934509686,1.0,15/37,22.63%,PIGM;PIGU;DPM2;DPM1;PIGW;ST8SIA6;PGAP2;PIGF;B3GNT5;PIGO;PIGA;PIGN;DPM3;B4GALT6;PGAP3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3870988245812718,-1.1180500754593128,0.29508196721311475,0.50387562489961,1.0,13/22,23.80%,MPP2;NLGN3;NPAS4;CHRNA3;LRRK2;MEF2C;NPFF;RAB3GAP1;GRIN2A;GSK3A;DRD4;GRID2;GRIN2C
prerank,regulation of phagocytosis (GO:0050764),0.3094598517556066,1.117861372832543,0.1951219512195122,0.4769037639014472,1.0,11/53,11.60%,CALR;LYAR;LMAN2;SYT7;SCARB1;IL1B;SYK;IL15RA;SPACA3;CYBA;OLFM4
prerank,protein mannosylation (GO:0035268),-0.4220946251060539,-1.1176860537088975,0.24193548387096775,0.5039337686638311,1.0,7/18,9.59%,TMTC1;POMT2;DPY19L2;FKRP;POMT1;TMTC2;B4GAT1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3552427663323201,-1.1174336418978719,0.25,0.503864333868493,1.0,16/31,25.44%,TGFBR3;SMAD4;LTBP4;FSTL3;LATS2;FSTL1;FST;SOX11;SMAD2;DKK3;TRIM33;SMAD7;NREP;LATS1;TWSG1;SMAD3
prerank,organelle organization (GO:0006996),-0.23921283429940932,-1.1169136868850758,0.1917808219178082,0.5046628288305833,1.0,137/400,24.24%,RNF112;SEC31B;ZNF135;MICAL3;ARHGAP10;ZMYM6;PALLD;TPM1;GABPB1;PKD2;TJAP1;CENPT;TBC1D20;NUMA1;RAB34;SYNE1;SYNE3;CNTNAP1;DES;PLIN5;KIF5C;ATP8B2;WTIP;CHMP3;GOLGA8A;DYNC2H1;VPS13D;PACSIN1;LMAN1L;PEX19;PLEKHM2;GEM;CLASP1;CSNK1A1;PRKD1;PRM2;CDC42BPB;OBSL1;WASF3;CAV2;CLASP2;LRRK2;HACE1;MTX3;BSCL2;KLHL20;ARHGAP21;MAST2;GOLGA8B;PYROXD2;SIRT4;OPTN;MAST4;GOLGA8N;DST;FGD1;RAB30;MAST1;KRT25;PLCE1;ATL3;ABI2;GORASP1;RANBP9;SLC25A36;MARK1;ATL2;SEMA6A;MARK4;PI4K2A;ATL1;MCOLN1;PACSIN2;SEC16B;GBF1;ARHGEF7;TICAM2;COG1;ZMYM3;DYM;RANBP10;VPS11;SIPA1;GOLGB1;VPS4A;RHOT2;RAB3GAP1;ABCA3;ATXN7;PACSIN3;CAPZB;VAPA;EPS15;CHMP4A;CSNK1D;FITM1;TRAPPC8;CCL11;PLEKHF1;DPYSL2;PLD2;GOLGA8R;ZRANB1;ATP8B3;FGD2;CECR2;PIKFYVE;ABCD4;FAM161B;PHIP;CCL2;BCAS3;SIRT3;STRIP1;NRF1;TRAPPC11;ABCD1;LIG4;STX7;DNAJC28;PITPNB;BRWD1;FMNL3;FMNL2;GOLGA2;RAB31;WDR81;RHOU;LIMD1;FGD5;PINK1;ZNF501;KIF3A;CHMP7;ABCD2;RAB18;ZFYVE16
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3230738423000576,-1.1168065234423556,0.26666666666666666,0.504199763850543,1.0,14/51,18.77%,CLIP3;SORBS1;ATP2B4;WNK3;CNST;GPER1;PIK3R1;CNPY4;STAC2;STAC;LGALS3;EPHA3;EGFR;RAMP3
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3969601933752681,1.1165371252301834,0.3111111111111111,0.4790077861632551,1.0,9/18,20.50%,IFI6;BBC3;TIMM50;BCL2L1;GGCT;BAX;BID;SFN;BAK1
prerank,response to molecule of bacterial origin (GO:0002237),0.30045385781155465,1.116052093750758,0.2765957446808511,0.4796710755766131,1.0,23/65,23.75%,CXCL8;CXCL2;IL1B;CYP27B1;TNFAIP3;HMGB2;MAPKAPK3;SLPI;IRAK1;NOS2;MAPKAPK2;HNRNPA0;GCH1;TRIB1;NOCT;F2R;IL23R;PALM3;PRDX3;SRR;S100A14;GPR31;RPS6KA3
prerank,cellular response to nitrogen compound (GO:1901699),0.3552962079103614,1.1156664173451731,0.2857142857142857,0.4798302358938124,1.0,3/17,8.48%,TIMELESS;BLM;PDE12
prerank,acyl-CoA metabolic process (GO:0006637),0.34880003333764986,1.115388112692251,0.25,0.47995946146264085,1.0,10/31,17.43%,ACSL6;BAAT;THEM5;ACOT7;DBI;ACOT13;ACOT4;ACOT8;HMGCS1;OXSM
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.39050468134503913,-1.114315756610228,0.3333333333333333,0.5097391411687272,1.0,6/23,10.70%,JPH2;ANK3;SNCA;SLC8A1;TMTC2;KCNA1
prerank,positive regulation of protein metabolic process (GO:0051247),0.2619585812569633,1.1138646340355973,0.18421052631578946,0.4831239863586048,1.0,37/113,21.85%,ASB9;INHBA;CSNK2A3;IL23A;TFR2;IL1B;WNT5A;TNFAIP3;C4BPA;CSNK2A1;UHRF1;CD80;C4BPB;GSK3B;PRMT1;SORL1;OAZ3;DDB1;IL17F;AGT;GBA;VCP;RAB1A;NSF;RAB7A;IL23R;TGFB1;IDE;MTPN;NFKBIA;AXIN1;CD86;WNT7A;HECW1;HECW2;DTL;IL12B
prerank,negative regulation of inflammatory response (GO:0050728),-0.2521626749768185,-1.1134298614697835,0.2328767123287671,0.5116337674838094,1.0,51/202,23.76%,GLP2R;ADCY5;PTH1R;ADCYAP1R1;ADCY2;ADRB3;ADCY4;MAPK7;POMC;VIPR2;GPER1;PPARD;RORA;LRFN5;ADRB2;NR1D1;ELANE;ADCY9;PTGIS;PRKACA;GNG2;RAMP1;ADORA2A;C1QTNF3;PRKAR2B;VIP;MC1R;GPR20;AVPR2;ADRB1;ADCY6;TSHB;GPS2;MAPK14;HTR4;CRHR1;GPR27;RAMP3;P2RY11;FNDC4;GPBAR1;INS;LHCGR;HTR7;CRHR2;CDH5;PLCG1;RAMP2;PLCG2;PRKCD;ADCYAP1
prerank,peptidyl-lysine modification (GO:0018205),0.28060222590287387,1.1132208553928984,0.22727272727272727,0.48380773101372904,1.0,31/99,18.42%,NUP37;LIPT2;NUP155;LOXL2;RAE1;RNF113A;NUP93;NUP35;PLOD3;HDAC10;SEH1L;NUP210;NUP43;P3H4;NUP50;NUP88;RANGAP1;NUP107;RNF212B;METTL21A;UBA2;NUP205;NSMCE2;CTH;NUP62;NUP160;NDUFAB1;EYA1;SUMO1;NDC1;SUMO3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.27396504391263793,1.1125581616150297,0.2708333333333333,0.4846807266312411,1.0,20/73,22.02%,IL1A;HSPD1;EREG;IL1B;WNT5A;SYK;DHX9;CYBA;XBP1;MYD88;IL17A;NOS2;IL17F;MAPK13;F2R;NOD2;MMP8;TNFSF4;HMGB1;HYAL2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3534274529081882,-1.1123081967666455,0.29545454545454547,0.5137884075428357,1.0,11/21,25.56%,TENM1;ZNF345;NAB2;AR;ZNF76;MAF1;RPTOR;MTOR;CHD8;ELL;ZNF143
prerank,lysosome organization (GO:0007040),-0.3290682934499676,-1.1121391352592098,0.3114754098360656,0.5135461661689258,1.0,14/35,26.12%,TPCN2;ABCA1;ZKSCAN3;LRRK2;AKTIP;CLVS2;TFEB;HOOK3;SNAPIN;MTOR;TPP1;CLN3;VPS33A;HPS1
prerank,positive regulation of cell migration (GO:0030335),0.23750184471207542,1.1116267587941422,0.13953488372093023,0.48653481543456206,1.0,58/256,14.99%,CLDN1;MMP7;CEMIP;S100A11;TDGF1;COL1A1;KIF20B;FBXO5;LAMC2;MGAT5;CCL24;EPHB2;PDGFRB;PLAU;FERMT1;GTSE1;EPHA1;ZP3;IL1B;C1QBP;LGR6;CEACAM6;LEF1;CTSH;ACTG1;RAB11A;SOX9;FAM83H;TGFB2;GRB7;PLAA;MDK;MAZ;CCL3;XBP1;F7;CPNE3;APELA;FN1;ADAM10;IGF1R;SEMA4D;PECAM1;CXCL16;ACTN4;WNT11;CCL26;ZNF703;SEMA5A;CIB1;KDR;MMP9;MIEN1;GRN;PAK1;PDCD10;RAB25;SMIM22
prerank,pyruvate metabolic process (GO:0006090),0.292968306051748,1.111583017329774,0.35,0.4859947088560379,1.0,19/54,22.88%,VDAC1;PGAM4;GLO1;GAPDH;LDHA;HKDC1;SLC16A3;TPI1;ENO4;GAPDHS;PKLR;PKM;ALDOC;SDS;PCK2;ALDOB;ME1;SRR;PFKL
prerank,response to organophosphorus (GO:0046683),0.400847025380119,1.1114183561787734,0.22448979591836735,0.4857927226334143,1.0,5/16,15.06%,RFC3;DUOX2;VGF;STAT1;KCNJ11
prerank,cellular response to ionizing radiation (GO:0071479),0.3099250878333064,1.1096164162201678,0.275,0.48912922099503964,1.0,8/47,6.96%,INTS7;RAD51AP1;RHNO1;BLM;XRCC5;FIGNL1;ECT2;RAD9B
prerank,collagen fibril organization (GO:0030199),-0.28498621201966745,-1.1092646432437474,0.24193548387096775,0.5198154303211332,1.0,30/88,21.47%,DPT;COL21A1;LOXL4;COL6A1;COL28A1;DDR2;COL24A1;COL6A2;COL16A1;CRTAP;P3H2;DST;BMP1;TLL1;COL4A5;COL5A3;COL23A1;OPTC;COL13A1;COL27A1;COL4A6;COL4A2;COL4A3;COL25A1;COLGALT2;PXDN;COL22A1;LOXL3;COL20A1;ADAMTS3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2943372065703968,1.108886075925808,0.23255813953488372,0.4903690816964433,1.0,23/57,24.43%,HSD17B10;AKR1C4;OSBPL3;BAAT;XBP1;LIPG;MCAT;CYP39A1;ACMSD;CYP7B1;HSD3B7;ACOT8;ACLY;NDUFAB1;ACSF3;OXSM;SLC27A5;HSD17B4;SDS;SRR;OSBPL2;OSBP;HSD17B8
prerank,response to peptide hormone (GO:0043434),-0.3248882090359011,-1.10884171572123,0.3392857142857143,0.5200249998680315,1.0,16/51,20.41%,TSC1;TGFBR3;GPER1;GNAI1;EPM2AIP1;CYP11B1;ZFP36L1;SLC27A1;CYP11A1;CELA2A;OGT;IGFBP5;ROCK1;EIF2B4;SIRT1;CRY1
prerank,steroid metabolic process (GO:0008202),0.2578392956384696,1.1087902315096247,0.18181818181818182,0.4900017501782281,1.0,28/90,24.04%,SULT2B1;CYP51A1;DHRS2;SRD5A1;HSD17B10;AKR1C4;CYP27B1;SHH;BAAT;UGT1A3;FDXR;CYP39A1;TSPO;PRLR;FDX1;CYP7B1;MSMO1;DHCR24;CYP2B6;FDFT1;LIPA;HSD17B4;CYP24A1;UGT2B7;LGMN;HSD3B1;CYP26A1;UGT1A7
prerank,stem cell differentiation (GO:0048863),-0.35790039557104125,-1.1087839448497674,0.3018867924528302,0.5194895122012453,1.0,12/38,16.24%,LMBR1L;OSR1;FGFR2;HOXB4;GPM6A;KIT;SETD2;FOXO4;MEF2C;SFRP1;HTR2B;MEOX1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.43095908408464945,-1.1087176459983907,0.3333333333333333,0.5189668016405482,1.0,11/17,23.01%,SETD1B;SETD4;KMT2A;SETD2;SETD3;ASH1L;KMT2B;SETD7;EHMT1;SETD1A;SETMAR
prerank,cellular response to radiation (GO:0071478),0.3180251887435661,1.108617850331133,0.32653061224489793,0.48976644150603466,1.0,7/42,6.96%,INTS7;RAD51AP1;RHNO1;BLM;FIGNL1;ECT2;RAD9B
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3128571326867583,-1.1085013441572895,0.2698412698412698,0.5190395358761161,1.0,25/60,23.53%,CSNK2A2;ULK1;WNK3;HIPK4;CAMK2A;CDC42BPA;PRKCA;PRKD1;HIPK3;CDC42BPB;DYRK1A;LRRK2;MAPK1;ROCK1;MAPK8;CAMK2D;CSNK2B;MAP3K10;MAP3K12;GSK3A;TNKS;HIPK1;MYLK2;PRKCD;WNK1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.36013651398061763,-1.1077051174237187,0.32653061224489793,0.5204928883127315,1.0,10/30,17.18%,CSPG4;CHST3;CHST15;IDS;DCN;DSEL;CHST7;CHST9;CSGALNACT2;CHST12
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.3148479613123951,-1.1073882799443335,0.26865671641791045,0.5205521461281661,1.0,11/44,13.90%,PER1;TSC1;ZC3H7A;GCNT2;ATG14;ZC3H10;DDX25;NANOS1;ATXN2;YTHDC1;RBM4B
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.33851838897576875,-1.106693794483654,0.3,0.5216015962695495,1.0,10/31,16.34%,LIMS2;FLNA;FERMT2;MYOC;ILK;TRIOBP;DOCK1;RAC1;ARHGEF7;MYADM
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4143985195879244,-1.1065465656907916,0.3333333333333333,0.5212386751403039,1.0,8/15,27.50%,WASF1;WASF3;ABI2;WASF2;FCHSD2;BRK1;NCKAP1;CORO1B
prerank,regulation of osteoblast differentiation (GO:0045667),-0.28494784773974,-1.1062565058050133,0.23214285714285715,0.5214784685518085,1.0,29/78,26.75%,IL6R;BMPR1A;TWIST2;CHRD;ZHX3;DDR2;FERMT2;HDAC7;WWTR1;FGFR2;ATF4;PRKACA;PRKD1;MEF2C;SKI;RANBP3L;RORB;SOX11;ACVR2A;SUFU;BMPR1B;HGF;LIMD1;SNAI2;TMEM64;TNN;RUNX2;CRIM1;NOG
prerank,aortic valve morphogenesis (GO:0003180),-0.3451499899850663,-1.1059521149401184,0.3684210526315789,0.5215475541830142,1.0,10/31,16.93%,NPPA;NFATC1;SLIT2;EMILIN1;SLIT3;HEY1;ROCK1;HEY2;TIE1;ELN
prerank,maintenance of blood-brain barrier (GO:0035633),-0.3704576045737912,-1.1059088468754708,0.3559322033898305,0.5209821609225993,1.0,8/29,7.93%,JAM3;VCL;DMD;LAMA2;JAM2;WNK3;CLDN5;LAMC1
prerank,regulation of protein catabolic process (GO:0042176),0.2713176708446051,1.10542562883722,0.23076923076923078,0.4967596180727102,1.0,32/100,22.36%,MAD2L1;CYP51A1;ASB9;SF3B3;ODC1;CSNK2A3;CHEK2;PHB;AZIN1;WNT5A;TNFAIP3;C4BPA;CSNK2A1;ATP13A2;C4BPB;GSK3B;SORL1;OAZ3;DDB1;VCP;TMEM9;PRKCG;NSF;RAB7A;IDE;SNX12;CTSA;AXIN1;HECW1;HECW2;DTL;HMGCR
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.30463559952314223,-1.1054232592864235,0.288135593220339,0.5212553217339989,1.0,24/64,20.98%,MEIS1;TNRC6A;MYL9;MEIS2;KAT2B;AGO4;L3MBTL1;PRKCB;TNRC6C;FES;KMT2A;ZBTB16;MEF2C;LGALS3;AGO3;KMT2B;SIN3A;HOXA5;KMT2E;TNRC6B;AGO1;ITGA2B;NR4A3;SETD1A
prerank,regulation of fibroblast proliferation (GO:0048145),0.31606591256660455,1.1053488088616297,0.24390243902439024,0.49632726854127174,1.0,11/46,13.27%,MYC;E2F1;WNT2;EREG;WNT5A;CDK4;S100A6;DHX9;FN1;B4GALT7;AGT
prerank,peptidyl-tyrosine modification (GO:0018212),-0.30855268730593716,-1.1052022966420603,0.2542372881355932,0.5211097460134042,1.0,20/56,19.85%,FGFR1;DDR2;PDGFRA;FGFR2;FES;KIT;DYRK1A;FLT4;FER;NTRK1;ABI2;EPHA4;RELN;EPHA3;PDGFB;TPST1;INSR;EGFR;ERBB4;EFEMP1
prerank,copper ion homeostasis (GO:0055070),0.3809615327434517,1.1050419433248895,0.3125,0.49630218860595043,1.0,8/17,25.24%,SLC31A1;XIAP;ATP7B;COMMD1;ATOX1;COX19;ABCB6;CCDC22
prerank,phospholipid translocation (GO:0045332),-0.34860201950918895,-1.1049608508278532,0.24528301886792453,0.5212128006593209,1.0,13/29,26.48%,PLSCR4;ATP8B2;P2RX7;ABCA1;ATP10D;ATP8A2;ATP9B;ATP10A;ATP8B3;PLSCR5;ANO6;ATP8B4;ATP11C
prerank,positive regulation of interleukin-12 production (GO:0032735),0.31851448646263864,1.1049228220851939,0.2558139534883721,0.49591502320472136,1.0,11/34,22.48%,HSPD1;RIPK2;IL23A;SYK;MDK;IL17A;IL23R;TNFSF4;HMGB1;IL12B;LTB
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3521607680419047,-1.1047021932811056,0.32075471698113206,0.5212367033792853,1.0,7/27,15.20%,RYR3;PKD2;FGF2;ITPR1;RYR1;RYR2;HTR2B
prerank,glutathione metabolic process (GO:0006749),0.33574007526801875,1.1046437908742797,0.26,0.4959484147498281,1.0,13/40,17.19%,DPEP1;MMACHC;GLRX2;MGST2;GSS;CHAC2;CHAC1;GGCT;GPX1;GCLM;GSR;CNDP2;G6PD
prerank,glucose homeostasis (GO:0042593),-0.2732694729721573,-1.1045818862284253,0.19672131147540983,0.5209565987960244,1.0,27/79,22.92%,SLC2A4;KCNB1;CRY2;HECTD4;PIK3R1;NR1D1;NGFR;CYP11B1;PRKAA2;GCK;MBD5;SLC30A8;INPP5K;LEPR;CRTC2;KLF7;CARTPT;INSR;PDK2;INS;SIRT1;CRY1;PIK3R2;OAS1;WFS1;BAD;CAV3
prerank,positive regulation of response to external stimulus (GO:0032103),0.2557557093420958,1.1045650200901538,0.16666666666666666,0.49543268340983126,1.0,37/131,19.78%,OSM;EREG;PDGFRB;IL23A;ZP3;POLR3C;IL1B;WNT5A;MGST2;AKIRIN2;CEBPA;NMI;DHX9;MDK;IL21;POLR3B;CYBA;CCL3;THBD;PLA2G7;GBP5;STX3;CCL26;AGT;GRN;MAPK13;FPR2;OASL;ADAM8;FEM1A;POLR3G;TGFB1;PLSCR1;NFKBIA;SLC15A4;SERPINE1;TNFSF4
prerank,positive regulation of chemotaxis (GO:0050921),-0.32587080070824476,-1.1044633680185767,0.3220338983050847,0.5206996686697627,1.0,13/44,17.57%,IL6R;FGF2;PTN;ZNF580;NTRK3;PRKD1;PPM1F;MEGF8;RARRES2;HSPB1;P2RY12;PDGFB;DSCAM
prerank,regulation of steroid metabolic process (GO:0019218),-0.3925490426595583,-1.1044522698637183,0.32,0.5200952456198386,1.0,8/23,28.26%,RORA;GNB3;ACADVL;ACADL;FMO5;ABCB11;NR1H4;STAR
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.28031954726510644,-1.1042186074301104,0.2923076923076923,0.5200643190998276,1.0,29/104,18.07%,PKD1;ATP2B4;FGFR1;TENM1;PKD2;FGF2;FERMT2;SLC8A2;CALM1;GH1;SNCA;ADRB2;ELANE;KIT;CAMK1;LRRK2;SLC27A1;DIRAS2;MTCP1;MAPRE3;DAB2IP;PARP16;NEK10;RHOA;HTR2B;PDGFB;DIRAS1;FGF1;EGFR
prerank,mRNA catabolic process (GO:0006402),0.2990860972712315,1.103514497172946,0.3111111111111111,0.49718372886919543,1.0,11/39,18.34%,MRTO4;LSM5;EXOSC4;PNPT1;CNOT10;PDE12;LSM2;YTHDF2;LSM6;XRN2;NUDT16L1
prerank,regulation of autophagy (GO:0010506),-0.25447293932449455,-1.1035108219982372,0.22857142857142856,0.521064080384559,1.0,72/222,24.04%,TPCN2;FLCN;ATP6V1G2;PRKAB2;CSNK2A2;ULK1;MAPT;RRAGC;ITPR1;MTMR9;TRIM6;WDR6;HDAC6;UCHL1;TAB2;EXOC7;PRKACA;ZKSCAN3;DAPK1;BCL2;KLHL22;PRKD1;PIP4K2B;PRKAG2;LRRK2;PRKAA2;SIRT2;DCN;SOGA1;OPTN;HSPB1;RASIP1;FBXL2;GFAP;DAPK3;RRAGB;TPCN1;RNF152;LEPR;TFEB;HTR2B;PIP4K2A;TP53INP1;ROCK1;MAPK8;TRIM34;DEPDC5;NUPR1;CASP3;ATP6V0A1;ATP6V1B1;EIF4G3;PLEKHF1;EEF1A2;FBXW7;RRAGD;ATP6V1E1;GSK3A;BNIP3;TRIM8;KAT5;BOK;TRIM38;RPTOR;PIK3R2;GOLGA2;MTOR;BAD;HGF;OSBPL7;PINK1;KAT8
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3426642506219273,1.1032730681327596,0.32608695652173914,0.4972153426476791,1.0,18/31,34.60%,HSPD1;IL23A;SYK;CD46;PRKCZ;ISG15;NOD2;TNFSF4;HMGB1;IL12B;TIGIT;CLEC7A;PIBF1;XCL1;CD274;LILRA5;CD28;TLR4
prerank,activation of protein kinase B activity (GO:0032148),-0.37234282425027343,-1.1031948627862078,0.29411764705882354,0.5211886872360862,1.0,14/31,27.84%,ADRA2B;NTRK3;RICTOR;PDGFB;MAPKAP1;NTF3;CCDC88A;FGF1;INSR;INS;MTOR;PINK1;ITGB1BP1;MT3
prerank,regulation of translational initiation (GO:0006446),0.28277166006273713,1.1022036814609457,0.17142857142857143,0.4991610230238097,1.0,17/67,16.46%,POLR2D;CEBPB;CDC123;KHDRBS1;EIF4EBP1;NCBP1;YTHDF1;MTIF2;GLE1;DNAJC3;NCBP2;EIF3B;EIF3H;NPM1;YTHDF2;POLR2G;EIF3E
prerank,cellular response to starvation (GO:0009267),-0.2708332658520679,-1.1016433015149842,0.23076923076923078,0.5243972856729973,1.0,51/147,25.27%,FLCN;ATP6V1G2;NIM1K;SZT2;BRSK1;GABARAPL1;ZFYVE1;WDR45;RRAGC;ATG14;MAP1LC3C;ATF4;PRKD1;PRKAG2;GAS2L1;LRRK2;PRKAA2;RRP8;PIK3C3;MAPK1;MAPK3;ASNS;RRAGB;RNF152;WDR59;CDKN1A;SFRP1;CARTPT;TFEB;MAPK8;FAS;DEPDC5;GABARAPL2;ATP6V1B1;KPTN;KLF10;RRAGD;ATP6V1E1;TCIRG1;SIRT1;RPTOR;MAP1LC3A;CPEB4;MTOR;NUAK1;ATF2;SIK2;GABARAP;RRAGA;PDK4;FOXO3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3070075258004313,1.1014830185254905,0.2826086956521739,0.4999661600562851,1.0,14/42,16.05%,ACTL6A;HDAC2;SMARCB1;SMARCA4;ACTR8;SPTY2D1;HDAC1;ZNHIT1;MTA2;SMARCD2;HNRNPC;SMARCC1;VPS72;CHD4
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.31381668244198013,-1.1012125122979126,0.26153846153846155,0.5247072723709983,1.0,15/42,20.68%,TNRC6A;EIF4ENIF1;RBM24;CELF1;NANOS1;METTL3;TNRC6C;ZFP36L1;CPEB3;ROCK1;ZFP36;FTO;BTG2;TNRC6B;RC3H1
prerank,triglyceride biosynthetic process (GO:0019432),0.38969096346259124,1.1011363080095586,0.36585365853658536,0.5001663099128029,1.0,9/16,33.37%,DGAT2;GK;PNPLA3;LPGAT1;PCK2;AGMO;MOGAT1;DGAT1;MOGAT3
prerank,L-amino acid transport (GO:0015807),0.3473707870127027,1.1008571959927127,0.30952380952380953,0.5001652342257852,1.0,8/28,15.14%,SLC6A20;SLC1A4;SLC7A1;SLC38A5;SLC7A5;SLC25A22;SFXN1;SLC3A2
prerank,vasculogenesis (GO:0001570),0.3120180533902303,1.1007816310177978,0.2653061224489796,0.4996057666079732,1.0,16/33,28.40%,PDGFRB;WNT7B;TBX20;SHH;APELA;ENG;KDR;TGFB1;TGFBR2;CAV1;TNNI3;NOTCH1;SPRED1;HAS2;APLNR;GLMN
prerank,positive regulation of nuclear division (GO:0051785),0.35078185411678814,1.1003211415680714,0.3333333333333333,0.5002631867043449,1.0,10/26,20.04%,IL1A;EREG;PDGFRB;IL1B;AURKA;NUP62;DMRT1;LRP5;NPM2;TGFA
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.33099320501733254,-1.1002446141438664,0.22033898305084745,0.5261424320344963,1.0,13/35,19.16%,MTURN;ARNT;TAL1;FAXDC2;FES;NCKAP1L;BRD1;THPO;MAPK11;MAPK14;HOXA5;ACVR2A;ANKRD54
prerank,cellular response to reactive oxygen species (GO:0034614),-0.29955783201817293,-1.1001646029288614,0.3392857142857143,0.5256590132993567,1.0,20/62,20.24%,TPM1;PKD2;MAPT;MAPK7;PXN;PDGFRA;ZNF580;HDAC6;RHOB;FER;AQP1;MAPK1;MAPK3;MAPK8;ANKZF1;EGFR;PDK2;SETX;SIRT1;CAMKK2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.41271592074564906,-1.0998080698006922,0.3148148148148148,0.5257661669302331,1.0,6/15,25.01%,RORA;GNB3;PDK2;SIRT1;MLYCD;PDK4
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3572140656076451,-1.0993613363619097,0.2857142857142857,0.526261814773564,1.0,12/30,24.37%,CLIP3;SORBS1;PIK3R1;GH1;RHOQ;BRAF;AKT2;INSR;INS;NR4A3;CLTCL1;OCLN
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2699947529493911,1.0985439179970542,0.23076923076923078,0.5038179492576886,1.0,27/87,20.50%,GNL3L;MMP1;AJUBA;LIMK1;SYK;RPS3;ATP13A2;BIK;GSK3B;MMP3;BMP7;SDC1;CDT1;CRB3;VCP;HAS3;RAB7A;SUMO1;TGFB1;PLEK;PIH1D1;STX18;STAM;BAX;BID;VIL1;BAK1
prerank,iron ion transport (GO:0006826),0.282486861688661,1.098489365029022,0.26666666666666666,0.5032416813606367,1.0,12/47,16.30%,ATP6V1C2;TFR2;ATP6V1G1;SLC40A1;ATP6V0B;HEPHL1;ATP6V1A;SLC11A2;CLTC;ATP6AP1;ATP6V1F;STEAP3
prerank,regulation of dendrite development (GO:0050773),-0.3344387419855843,-1.098153653322797,0.3220338983050847,0.5283870524970008,1.0,13/39,18.58%,ADGRB3;PTN;ZDHHC15;PACSIN1;CHRNA3;ALK;SDC2;DAB2IP;MARK1;VLDLR;DBN1;CAMSAP2;DCC
prerank,"phagocytosis, engulfment (GO:0006911)",-0.3385121528736045,-1.0979449881379022,0.23636363636363636,0.5282799911988272,1.0,10/36,21.18%,GSN;XKR4;ADGRB1;MEGF10;DOCK1;RAC1;GULP1;ELMO1;CD36;RHOBTB1
prerank,B cell activation involved in immune response (GO:0002312),0.4031915334973696,1.0977580680531072,0.3137254901960784,0.5043334753750262,1.0,5/15,25.68%,EXOSC3;BATF;MSH6;MSH2;RNF8
prerank,cellular transition metal ion homeostasis (GO:0046916),0.2669835210026601,1.0977180506435478,0.23529411764705882,0.5037722501891883,1.0,26/90,19.55%,MYC;TFR2;SLC31A1;SLC39A10;LCN2;GLRX3;ATP6V1G1;FRRS1;HMOX2;ATP13A2;SLC40A1;HEPHL1;SLC39A8;ATP6V1A;SLC11A2;ATP7B;SLC30A5;ATP6AP1;SLC30A9;FTL;SLC39A7;ATOX1;SLC30A1;FXN;COX19;LCK
prerank,negative regulation of neurogenesis (GO:0050768),-0.32293797784445966,-1.0973083246665358,0.2549019607843137,0.5292134877111889,1.0,15/35,22.12%,PTN;RUFY3;NGFR;GDI1;PTEN;GORASP1;MAG;RHOA;PCM1;MCF2;RTN4;CCL11;HOOK3;RAPGEF2;B2M
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3258013799756308,1.0970120821494524,0.28205128205128205,0.5043775031930199,1.0,8/34,12.43%,DKC1;GAR1;DCLRE1B;SHQ1;NOP10;PTGES3;WRAP53;NHP2
prerank,negative regulation of gene expression (GO:0010629),-0.23878930012131985,-1.0969135632834117,0.19117647058823528,0.5294262440246623,1.0,76/307,19.29%,ZNF540;FLCN;PHF1;TSC1;TNRC6A;PTBP2;ATP2B4;ASB1;HAND2;SAMD4A;PGR;RBMS3;EIF4ENIF1;BMPR1A;FGF2;MAPT;TARDBP;MECP2;KAT2B;AGO4;TCEAL1;CITED2;CREBZF;GPER1;TRIM6;ZC3H10;RPS6KA5;CLDN5;CELF1;RBM4;CD34;NANOS1;METTL3;FXR2;TNRC6C;SYT11;CILP;DIP2A;OLFM1;EPC1;DAPK1;PSEN1;MPHOSPH8;ATOH8;PRKAA2;SLC24A3;EMILIN1;NPTN;CPEB3;DICER1;MEF2C;AGO3;DAPK3;DXO;HDAC9;SFRP1;SFMBT2;NUDT16;HINFP;GATA2;IGFBP5;PDGFB;ESR1;DNMT3A;HEY2;NOTCH2;MYADM;ZFP36;RBL2;SMO;SOX11;BTG2;TNRC6B;AGO1;FBXW7;PARP15
prerank,muscle cell development (GO:0055001),-0.3584104231333731,-1.0966546976782885,0.3958333333333333,0.5294618421466545,1.0,13/33,23.07%,ANK2;MYH6;DMD;TCAP;MEGF10;SLC8A1;EFEMP2;DYSF;HEY2;ALPK3;TTN;CAV3;RAMP2
prerank,regulation of embryonic development (GO:0045995),-0.3385777075740157,-1.0963927434979504,0.2909090909090909,0.5294863275335229,1.0,8/34,12.08%,NPHP3;NR2C2;PHLDB1;PHLDB2;CLASP1;RBM19;CLASP2;SOX17
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4087794694067205,-1.0963281885608467,0.3125,0.5289490499521066,1.0,7/17,15.07%,ZDHHC17;FSTL3;SLIT2;TMEM204;FSTL1;FST;LRIT3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.41085923111402367,1.096049913757072,0.3148148148148148,0.5059886732735521,1.0,10/15,29.94%,MAD2L1;FBXO5;LIMK1;DTX3L;RPL11;RPL23;RPS7;PARK7;BAG5;MAD2L2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.26170938558238904,1.0956081670988569,0.25,0.5064053197703527,1.0,36/125,18.64%,SOX4;MYC;IRS1;EREG;PDGFRB;EIF3C;IL1B;NAT10;EIF4A3;PRKDC;YTHDF1;TGFB2;DNA2;RPS4X;EIF6;DHX9;ATAD5;XBP1;NOX1;FGFR4;NMD3;PRMT1;EIF3D;NLRC5;ELAVL1;NPM1;CDT1;KDR;LARP4B;RBM3;NSUN5;HSPH1;EIF3E;NPM2;NOD2;MTPN
prerank,chromatin remodeling (GO:0006338),0.250172108811755,1.094870755415052,0.18181818181818182,0.5071464327513653,1.0,21/103,11.36%,RUVBL1;MYC;SUV39H2;NPM3;CBX3;ACTL6A;RUVBL2;HDAC2;SMARCB1;FOXP3;NUDT5;TOP1;SMARCA4;POLE3;SOX9;ACTR8;HMGA2;HDAC1;MTA2;SMARCD2;HNRNPC
prerank,ganglioside biosynthetic process (GO:0001574),-0.4230127444384063,-1.0944863079831104,0.375,0.5324942790934409,1.0,8/15,29.02%,ST6GALNAC3;ST8SIA3;ST3GAL5;B4GALNT1;ST6GALNAC6;ST6GALNAC5;B3GALT4;ST8SIA2
prerank,positive regulation of cell development (GO:0010720),-0.33173732828557134,-1.094063649678166,0.30612244897959184,0.5329874983323243,1.0,14/36,25.51%,NUMBL;GPER1;BHLHB9;PDE3A;NUMB;ZNF335;SPEN;SERPINF1;SOX11;LIG4;RFX3;BAD;HOXA11;MYF6
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.4004137310255128,-1.0940404552444936,0.3275862068965517,0.5324260095995997,1.0,5/16,8.11%,PTN;RBM24;LTBP3;HOXB4;SOX5
prerank,platelet degranulation (GO:0002576),-0.2709074564880599,-1.0938680925951676,0.2923076923076923,0.5323262306952358,1.0,48/105,27.52%,FLNA;TLN1;VCL;CLU;ACTN2;ITIH4;CALM1;F8;ITGB3;ACTN1;CFD;PCDH7;CYB5R1;VEGFB;HABP4;MMRN1;VTI1B;RARRES2;ALDOA;SYTL4;TIMP3;CDC37L1;NHLRC2;PDGFB;TMX3;CD63;CLEC3B;SCG3;CD36;F13A1;ITGA2B;VEGFC;A1BG;SOD1;TPH1;ENDOD1;TTN;HGF;CD109;STXBP1;PDGFA;TGFB3;SELP;ABCC4;ISLR;LHFPL2;BRPF3;BLK
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2968227727536356,-1.0934271538910434,0.3448275862068966,0.5326755587325789,1.0,25/79,22.24%,CLIP3;SORBS1;ATP2B4;WNK3;GPER1;PIK3R1;ZDHHC7;RHOQ;CNPY4;AR;STAC2;STAC;NUMB;VTI1B;PID1;LGALS3;TMBIM1;EPHA3;VPS4A;EGFR;RAMP3;INS;AP2M1;ACTB;STX7
prerank,T cell mediated immunity (GO:0002456),0.385870924763704,1.093021197188867,0.3220338983050847,0.5109106375273723,1.0,4/16,10.97%,CTSH;CD46;CD55;CD70
prerank,myeloid cell differentiation (GO:0030099),0.3002282134148531,1.0929413227145406,0.2702702702702703,0.5104865029772406,1.0,18/49,22.02%,IL11;INHBA;CSF2;CEBPA;HSPA9;RUNX1;JAK3;RPS14;ZFPM1;RPS19;PRKX;PTPN2;DYRK3;SLC25A5;LYN;IFI16;PRDX3;KLF1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.35085015337448766,1.092570579437475,0.35555555555555557,0.510965814162301,1.0,7/17,18.39%,PLBD1;LCLAT1;PLA2G2F;PLA2G4E;PLA2G4D;LPGAT1;PLA2G2D
prerank,calcium-mediated signaling (GO:0019722),-0.2852701108593594,-1.092201470601175,0.35185185185185186,0.5353313271348255,1.0,34/101,23.35%,TPCN2;DMPK;CACNA1C;ANK2;PPP3CB;PLA2G4B;AGTR1;RCAN2;P2RX7;SLC8A1;PRNP;PRKACA;CCR10;LRRK2;PPP3CC;RYR2;PPP1R9A;PLCE1;P2RY12;ACKR3;HTR2B;EDNRB;AZU1;ACKR2;EGFR;P2RY11;ADGRL1;CAMKK2;CHRM3;PTGFR;PTGDR2;RCAN1;PLCG1;PLCG2
prerank,membrane fusion (GO:0061025),-0.3280199477437698,-1.0921849541738406,0.3114754098360656,0.5347041902570054,1.0,13/34,28.82%,VAMP2;RABEP1;HACE1;VTI1B;VPS33B;DYSF;VAPA;DNM1;RIMS1;DNM1L;DNM3;OTOF;MYOF
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4076617559891862,1.0917217104737245,0.3541666666666667,0.5123592131737521,1.0,4/15,12.58%,NAA20;NAA15;NAA50;NAA35
prerank,regulation of cholesterol efflux (GO:0010874),-0.3344809767951702,-1.091636744496332,0.30434782608695654,0.5353985249954571,1.0,9/30,22.15%,YJEFN3;ABCA8;NR1H2;RXRA;ABCA5;GPS2;ABCA3;SIRT1;CES1
prerank,cellular glucose homeostasis (GO:0001678),-0.31702727065027897,-1.0909324029133862,0.2962962962962963,0.5363853989371292,1.0,9/42,9.93%,KCNB1;GPER1;PIK3R1;NR1D1;NGFR;PRKACA;PRKAA2;GCK;ZNF236
prerank,actin filament bundle organization (GO:0061572),-0.3624172321641907,-1.0902084905773102,0.3333333333333333,0.5371413857441157,1.0,9/31,19.40%,FAM107A;ADD1;CALD1;LIMA1;DPYSL3;ADD2;BAIAP2;FSCN3;AIF1L
prerank,negative regulation of cell population proliferation (GO:0008285),-0.23493730009849317,-1.0901618070464367,0.21052631578947367,0.5365911680779321,1.0,100/361,20.37%,TNS2;FLCN;KANK2;SPEG;TSC1;GNRH1;ADARB1;RBM5;TGFB1I1;WNT9A;RAF1;SFRP5;MYOCD;TENM1;NACC2;TGFBR3;IGFBP6;PKD2;RERG;ADAMTS8;MAGI2;KAT2B;CHD5;ROR2;ADGRB1;GPER1;LDOC1;PODN;CELF1;WDR6;ZBTB49;DLC1;ADAMTS1;ADRA1A;NDRG4;NGF;ING4;RPS6KA2;CDKN1C;AR;MFN2;MN1;APOD;PTPN14;PTEN;MSTN;SIRT2;MDM4;OGN;P3H2;ZBTB17;ATP8A2;VIP;FOXO4;NTRK1;MCC;FBLN1;CGRRF1;SKI;TINF2;DAB2IP;TES;ADORA3;SLC16A2;SOX7;KLF11;AVPR2;CDKN1A;MORC3;SFRP1;PRKRA;GATA2;IGFBP5;GDF5;TP53INP1;APC;CDKN2C;INCA1;MNT;TSC2;NUPR1;SOX11;SST;DLG5;PLXNB1;COL4A3;CCL23;BTG2;ERBB4;MYO16;SMARCA2;CSNK2B;DNAJB2;KLF10;BMPR1B;DLL1;SOX2;FUZ;RAPGEF2;ING5
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3717329669859027,1.0900567056446298,0.30612244897959184,0.5148123714362942,1.0,7/21,19.58%,RPA3;GTF2H3;ERCC5;DDB1;RPA2;CUL4A;ERCC2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3717329669859027,1.0900567056446298,0.30612244897959184,0.5148123714362942,1.0,7/21,19.58%,RPA3;GTF2H3;ERCC5;DDB1;RPA2;CUL4A;ERCC2
prerank,regulation of neuroinflammatory response (GO:0150077),0.3657679221674161,1.0898815993913111,0.28888888888888886,0.5145262672142843,1.0,8/19,31.57%,IL1B;MMP3;MMP9;TNFRSF1B;MMP8;DAGLA;IL18;TNF
prerank,Golgi organization (GO:0007030),-0.2618758617656997,-1.089673977549806,0.3188405797101449,0.5372148331047271,1.0,38/129,19.55%,TJAP1;TBC1D20;SYNE1;ATP8B2;STX16;VAMP4;GOLGA8A;DYNC2H1;LMAN1L;PLEKHM2;CLASP1;CSNK1A1;PRKD1;OBSL1;CLASP2;LRRK2;HACE1;ARHGAP21;GOLGA8B;OPTN;VTI1B;GOLGA8N;RAB30;ATL3;GORASP1;ATL2;PI4K2A;SEC16B;GBF1;ARHGEF7;TICAM2;COG1;DYM;GOLGB1;CSNK1D;TRAPPC8;GOLGA8R;ATP8B3
prerank,regulation of establishment of protein localization (GO:0070201),-0.38497085403135184,-1.0893844272275426,0.3103448275862069,0.5373056482195636,1.0,4/15,23.15%,CORO2B;CEP290;GAPVD1;CEP120
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.349328525833193,1.0892706059556023,0.36363636363636365,0.5150114622186728,1.0,6/27,9.20%,SLC6A20;SLC1A4;SLC7A1;SLC38A5;SLC7A5;SLC25A22
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3913953591663773,-1.089173493911127,0.3333333333333333,0.5371471231180414,1.0,8/21,17.18%,CSPG4;CHST3;CHST15;DCN;CHST7;CHST9;CSGALNACT2;CHST12
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.4491345914646787,-1.0888747339080538,0.35294117647058826,0.5372594412470985,1.0,4/15,19.51%,PYGM;CALM1;AGL;PHKA2
prerank,organophosphate biosynthetic process (GO:0090407),0.3055735725198589,1.0887827881101357,0.30303030303030304,0.5154394622542217,1.0,14/38,18.48%,PNPO;MOCS3;MOCOS;AGPAT5;TPI1;TKT;GK;IPPK;GPHN;IPMK;FITM2;PCYT2;G6PD;AGPAT3
prerank,positive regulation of macrophage migration (GO:1905523),-0.3765210563340594,-1.0879718357943158,0.32727272727272727,0.5388411102574209,1.0,5/18,13.05%,MSTN;RARRES2;MAPK1;MAPK3;P2RY12
prerank,sprouting angiogenesis (GO:0002040),-0.31037538469623716,-1.0865180335798978,0.3,0.5415955197932613,1.0,19/50,23.41%,YJEFN3;CCBE1;FGF2;RECK;SRF;PARVA;SLIT2;VEGFB;SEMA3E;FLT4;JMJD6;PIK3R3;RSPO3;ANGPT1;DLL1;VEGFC;ADGRA2;RAMP2;NR4A1
prerank,nitrogen compound transport (GO:0071705),0.25066499342426213,1.0859846611400936,0.3170731707317073,0.5215403134968851,1.0,42/136,22.96%,SLC12A2;CMTM6;SLC6A20;SLC1A5;SLC1A4;TCN1;SLC6A14;SLC7A1;SLC7A11;SLC38A5;SLC7A5;SLC52A2;SLC6A6;LRRC8D;SLC44A1;SLC52A3;AQP9;SLC6A4;CD320;SLC7A4;CENPF;SLC3A2;SLC16A10;SCAMP3;RAB7A;PPT1;NDC1;RHBG;ARRDC5;SLC43A2;SLC15A4;SNX4;CHMP2B;SLC25A48;CHMP1A;SLC7A7;ABCC2;SLC7A8;SLC18A1;SLC18A2;SLC6A18;TMEM30B
prerank,cholesterol transport (GO:0030301),-0.31172141458927244,-1.0858159708276613,0.3050847457627119,0.5427048013421074,1.0,12/43,18.84%,LCAT;ABCA8;CLU;LIMA1;ABCG4;ABCA1;OSBPL5;AKR1C1;ABCA5;STX12;VPS4A;CD36
prerank,protein localization to lysosome (GO:0061462),0.31140063599421747,1.085430960163425,0.3111111111111111,0.5223219224386947,1.0,8/28,16.53%,SH3BP4;ATP13A2;CD81;RNF128;SORL1;LAMTOR5;GLMP;RAB7A
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.394478020693277,1.0853845310837114,0.29411764705882354,0.52181908001826,1.0,10/15,27.53%,DNMT1;DNMT3B;BRCA1;WDR5;MYB;PAXIP1;CTR9;AUTS2;CTNNB1;WDR61
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.29766673173981184,-1.08522159494722,0.3230769230769231,0.5435638140826017,1.0,21/62,20.17%,TSC1;GPM6B;VCL;MYOC;MACF1;DUSP3;CLASP1;SEMA3E;CORO1C;AJAP1;DAPK3;EFNA5;SFRP1;PEAK1;RHOA;EPHA3;ROCK1;CD36;LIMCH1;SLK;CCL21
prerank,RNA processing (GO:0006396),-0.254354285021453,-1.0852117040693896,0.21666666666666667,0.5429258283853217,1.0,33/170,10.92%,SRSF5;DDX17;RBPMS;SRSF11;RNPC3;ADARB1;RBM5;LUC7L3;RBM6;NOVA1;DDX39B;ADARB2;SF3B1;SRSF4;TARDBP;PABPN1;SRRM1;AKAP8L;RRAGC;CELF1;PRPF3;RBM4;MBNL1;PRPF4B;ELAVL4;METTL3;PRKACA;HNRNPH3;RBMS1;SNRPN;SON;ALKBH5;CELF2
prerank,regulation of cell adhesion (GO:0030155),0.2576035863309248,1.0852074390198823,0.23684210526315788,0.5216516416210709,1.0,32/129,15.45%,C2CD4A;TESC;P4HB;CXCL8;TGFBI;EPHB2;EPHB3;PLAU;ADGRG1;KIF14;FUT1;C1QBP;IBSP;CXCR4;EPHA2;MDK;EFNA1;ABL2;CD164;ADAM10;CXCR3;DUSP1;ARHGDIB;SEMA4D;ARHGDIA;STX3;SEMA5A;FUT7;YTHDF2;FUT2;RHOD;ADAM8
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.29850009737764144,-1.0849531732216209,0.3225806451612903,0.5429016700152364,1.0,27/67,24.08%,TSC1;HP1BP3;EGLN2;CPEB1;RORA;FMN2;CPEB2;PTGIS;ZFP36L1;EGLN1;SIRT2;MDM4;ANGPT4;NPEPPS;SLC8A3;AQP1;SFRP1;MGARP;SIRT1;BNIP3;EPAS1;CPEB4;MTOR;BAD;HMOX1;PINK1;NKX3-1
prerank,regulation of peptide hormone secretion (GO:0090276),-0.3005703276118432,-1.084835094915434,0.32075471698113206,0.5425771260370842,1.0,12/66,10.32%,KCNB1;CACNA1C;ARNTL;KCNA5;RAPGEF3;RAP1A;PPP3CB;ITPR1;ABCC8;PRKCA;GCK;SNAP25
prerank,bile acid biosynthetic process (GO:0006699),0.35910593429794624,1.0841738008122648,0.3142857142857143,0.5229724732982062,1.0,12/25,24.06%,HSD17B10;AKR1C4;OSBPL3;BAAT;CYP39A1;CYP7B1;HSD3B7;ACOT8;SLC27A5;HSD17B4;OSBPL2;OSBP
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3473617856366985,-1.0841471398190106,0.3389830508474576,0.5436251848406582,1.0,12/29,24.14%,CLU;BAG2;KCNE2;PTEN;DAB2IP;ECSCR;NUPR1;CDK5RAP3;FBXW7;CAV3;OSBPL7;PSMC5
prerank,negative regulation of wound healing (GO:0061045),-0.34949095359660515,-1.0840391936744,0.32075471698113206,0.5432149138531365,1.0,9/26,15.42%,FGF2;PHLDB2;CD34;CLASP1;PTEN;CLASP2;AJAP1;MYOZ1;TFPI
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.3903010172548208,-1.083725670588712,0.40384615384615385,0.5433936887318804,1.0,9/16,32.03%,GPER1;ECSCR;CCL2;PLCG1;ANO6;PDCD4;RGCC;CD40;CD160
prerank,positive regulation of dendrite extension (GO:1903861),-0.40856153342272,-1.0837025867100372,0.35185185185185186,0.5428244430805186,1.0,13/15,37.37%,ITSN2;SYT2;RIMS1;SYT1;CPNE6;SYT3;NEDD4L;SMURF1;CPNE5;UNC13A;RNF157;SYT17;CPNE9
prerank,positive regulation of insulin secretion (GO:0032024),-0.3295367412072848,-1.0834060299484516,0.3,0.5427899038593057,1.0,7/36,12.15%,NLGN2;NNAT;PPP3CB;GPER1;PLA2G6;GCK;SLC30A8
prerank,glycolipid metabolic process (GO:0006664),0.3065402911283687,1.083307274320906,0.3181818181818182,0.5244427639145385,1.0,14/52,16.74%,NEU1;HEXB;GLA;GLB1;PIGW;SMPD2;SUMF2;UGT8;ST8SIA6;GM2A;FUT2;GBA;B3GNT5;SUMF1
prerank,fatty acid metabolic process (GO:0006631),0.2518255683154879,1.0822551404910643,0.2826086956521739,0.5263532310071398,1.0,53/114,32.43%,NUDT19;ADIPOR1;ACBD5;AOAH;ACSL6;BAAT;ACOT7;XBP1;CEL;LIPG;GPX1;MCAT;PNPLA3;ACSL3;MSMO1;ACSL5;SGPL1;ACOT4;ACOT8;ACLY;PPARG;NDUFAB1;ACSF3;FASN;OXSM;SLC27A5;FA2H;CYP4F11;PLA2G15;ALOXE3;CYP2J2;FAAH;HACL1;SLC27A4;CYP4F2;HSD17B8;PON3;GPX4;CPT2;ALOX12;ALOX12B;PEX2;ALOX5AP;ACOT6;LIPH;ACSM4;ACSBG1;ACSM3;ACSL4;ACOX1;CBR4;ADIPOR2;MECR
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.251997348120244,1.081181984639031,0.16666666666666666,0.5282727809597725,1.0,27/109,18.25%,TRIB3;INCENP;CCND1;THY1;CDKN3;SYAP1;CDK7;GTPBP4;BLM;CCNO;CCNE1;CCNI2;CDC25C;CCNK;CCNF;HMGA2;CCNJ;PKMYT1;CIB1;TRIB1;PDCD10;CDC25A;BCCIP;CDK12;CDC6;LRP5;PIH1D1
prerank,RNA 3'-end processing (GO:0031123),0.28674724025626014,1.0807676139557012,0.3333333333333333,0.528790129027118,1.0,18/64,13.26%,CSTF2;CPSF3;ALYREF;THOC3;U2AF1;CSTF1;MAGOH;MAGOHB;PNPT1;EIF4A3;NCBP1;DDX39A;SRSF9;NUDT21;CLP1;NCBP2;CPSF2;THOC6
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.37507272934505304,1.080587232762312,0.4117647058823529,0.5284356191672405,1.0,7/22,20.50%,ACTR2;PRKDC;HMGA2;DTX3L;WRAP53;NUDT16L1;TFIP11
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.30049446049825024,1.0798755738880994,0.275,0.5295173341170959,1.0,19/44,31.57%,OCIAD2;PIGU;VHL;ADIPOR1;SOCS1;JAK3;SOCS3;F2R;HES1;CAV1;CRLF3;NOTCH1;EGF;IL10;IL10RA;IFNL1;IL26;CCL5;TNF
prerank,hyaluronan catabolic process (GO:0030214),0.37764879865807316,1.079229235708222,0.358974358974359,0.5307893407950057,1.0,4/17,7.31%,CEMIP;HEXB;CD44;HYAL3
prerank,cellular response to osmotic stress (GO:0071470),-0.3661367833987593,-1.0790458194214108,0.35714285714285715,0.5529098667893525,1.0,7/22,12.43%,MYLK;PKD2;CAPN3;WNK3;ZFP36L1;YBX3;AQP1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.3399206368086611,1.0789560038728134,0.2830188679245283,0.5301613811567434,1.0,6/23,7.80%,IL1A;CSF2;IFI6;IL1B;PF4;BCL2L1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.3399206368086611,1.0789560038728134,0.2830188679245283,0.5301613811567434,1.0,6/23,7.80%,IL1A;CSF2;IFI6;IL1B;PF4;BCL2L1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.4088933685881313,-1.0789426094931907,0.3793103448275862,0.5524805518835322,1.0,8/16,20.20%,BBS4;KIAA0753;DCTN2;PCM1;CCDC14;CSNK1D;HOOK3;CEP192
prerank,microtubule polymerization or depolymerization (GO:0031109),0.34622812936389114,1.0783879041140922,0.3695652173913043,0.5307961476115038,1.0,10/26,17.56%,KIF24;KIF2A;KIF18A;STMN1;KIF14;KATNB1;KIF2C;CKAP5;KIF18B;TRPV4
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.3299646546146653,-1.0771204706007875,0.3018867924528302,0.5563150615415371,1.0,14/33,23.35%,PKD1;TRIM39;ATP2B4;MN1;PTEN;CDKN1A;STXBP4;FAM83D;PAGR1;FBXW7;INO80;SUSD2;ID2;PLCG2
prerank,cellular response to pH (GO:0071467),-0.404990871441719,-1.0767936335096007,0.34545454545454546,0.5564349410048275,1.0,5/18,21.44%,TRPV1;KCNK4;MCOLN1;INSRR;RAB11FIP5
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.32495886760875703,-1.0766083816269392,0.3448275862068966,0.5561621251385449,1.0,15/39,24.85%,GPM6B;BMPR1A;OSR1;PTN;P2RX7;SLC8A1;WNT6;KL;MEF2C;ACVR2A;BMPR1B;OSR2;ANO6;PKDCC;TGFB3
prerank,dendritic spine organization (GO:0097061),-0.3506952485893893,-1.0761081645281103,0.423728813559322,0.5567903982855159,1.0,6/27,9.43%,CTNND2;SHANK3;DLG4;PRNP;DIP2A;PTEN
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3421764782197524,-1.0758150716262802,0.34782608695652173,0.5569728019344062,1.0,7/28,13.99%,MAPT;ITPR1;SLC8A2;P2RX2;LRRK2;RIT2;RGN
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3240582006693691,-1.0752706233586589,0.3230769230769231,0.557704382628493,1.0,8/37,15.43%,PER1;HAND2;SASH1;PJA2;MAP3K4;DAB2IP;GADD45B;GDF6
prerank,regulation of bone mineralization (GO:0030500),-0.29192279345396,-1.0752606162982945,0.2545454545454545,0.5570935370954321,1.0,10/55,12.29%,GPM6B;BMPR1A;DDR2;OSR1;PTN;P2RX7;SLC8A1;S1PR1;KL;MEF2C
prerank,histone H3 acetylation (GO:0043966),-0.3184958276673757,-1.0752122172598793,0.3114754098360656,0.5566106357865289,1.0,13/40,24.41%,PER1;SUPT7L;JADE1;KAT2B;KAT6B;ING4;BRD1;KAT7;KAT2A;ING5;MAP3K7;SUPT3H;JADE2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.40664052361277725,-1.0748919843817466,0.3333333333333333,0.5566660145022888,1.0,7/17,15.57%,FLCN;MYOC;DLC1;KCTD10;RASIP1;SCAI;KANK1
prerank,positive regulation of exosomal secretion (GO:1903543),0.3960945961564511,1.0742217280966426,0.40476190476190477,0.5405231028532406,1.0,8/15,29.71%,ATP13A2;SDC1;RAB7A;STAM;CHMP2A;SDC4;IFNG;SNF8
prerank,histone monoubiquitination (GO:0010390),0.3462879876747441,1.0741429080486162,0.3181818181818182,0.5400749766535747,1.0,10/24,21.29%,RNF40;UHRF1;RNF2;DTX3L;DDB1;LEO1;RAG1;CTR9;TRIM37;PCGF1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3221490251446426,-1.073971979294489,0.3090909090909091,0.5585308179543521,1.0,14/45,16.34%,LIMS2;FLNA;CAPRIN2;FERMT2;MYOC;CUX2;ILK;TRIOBP;OBSL1;DOCK1;RAC1;ARHGEF7;IL1RAPL1;MYADM
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3192089353924826,1.0735248315307089,0.32608695652173914,0.541078274115864,1.0,13/38,20.46%,IL1A;DHFR;LYPLA1;GLA;SCARB1;IL1B;DDAH1;GCH1;SPR;NOSIP;CAV1;HSP90AA1;NUS1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.323870730336252,-1.0734812758242591,0.3333333333333333,0.5590987883053781,1.0,15/44,20.92%,NPR2;ADCY5;ADCY2;NPR1;ADCY4;NPPA;ADCY9;AK5;PANK4;ADCY6;NPPC;NPPB;ACAT1;AMPD1;ADSL
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.27472597683774724,1.073236662027701,0.3409090909090909,0.5409722029751796,1.0,20/64,21.21%,CCND1;CEBPB;CDK1;CBFB;LEF1;CDK4;CDKN2A;SOX9;CCNC;RELA;HNF1A;MED14;SUB1;MED1;MED30;PAXIP1;BAX;TRIM28;MED31;MED20
prerank,membrane lipid biosynthetic process (GO:0046467),0.299291197396644,1.0723297832526875,0.36585365853658536,0.5426680068794567,1.0,16/54,15.27%,SPTLC1;HACD3;CERS6;ALDH3B2;SGPP2;SPTLC2;CERS2;HACD2;DEGS2;ST8SIA6;SPNS2;ELOVL1;SGPL1;ACER2;B3GNT5;ELOVL7
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.32096050233818585,-1.0723284698767332,0.3898305084745763,0.5612609328020757,1.0,11/30,24.74%,LCAT;CSNK2A2;PCYT1B;CHKB;SLC27A1;LPIN1;PCYT1A;CSNK2B;CHAT;CHKA;LPIN3
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2785329956749487,-1.072310595857568,0.2542372881355932,0.5606292423602471,1.0,30/84,22.92%,ADARB1;WWTR1;DUSP3;DUSP26;SNCA;SLC8A1;PRKRIP1;DBNDD2;CDKN1C;PRKAG2;PPM1F;CORO1C;HSPB1;SLC8A3;INPP5K;DAB2IP;TAB1;CDKN1A;PTPRQ;TRIB2;GNAQ;SH3BP5L;DUSP19;TSC2;CDK5RAP3;TESK1;PTPRT;LRP6;PTPRB;CAV3
prerank,cellular response to glucose starvation (GO:0042149),-0.33269222467028975,-1.0721992236909696,0.32075471698113206,0.5602922273548906,1.0,10/42,13.20%,NIM1K;SZT2;BRSK1;ATG14;ATF4;PRKAG2;PRKAA2;RRP8;PIK3C3;ASNS
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.29000841315301595,-1.07211091684452,0.2833333333333333,0.5598827575818437,1.0,28/87,20.88%,PLXNB3;FGF2;PTPRM;NRP2;ARNT;ZNF580;ITGB3;PRKCA;NR2F2;PRKD1;ATOH8;CAV2;VEGFB;FLT4;VIP;THBS4;SYNJ2BP;PRL;EGFL7;KRIT1;HTR2B;PDGFB;TIE1;FGF16;CCL11;ANGPT1;SIRT1;VEGFC
prerank,limb development (GO:0060173),-0.348169457608091,-1.0718734104624783,0.32653061224489793,0.5598921685446033,1.0,10/26,19.64%,INTU;KAT2B;GLI3;RSPO2;MEGF8;KAT2A;FGF10;PCSK5;IFT122;BMPR1B
prerank,cardiac conduction system development (GO:0003161),-0.3835428184782267,-1.0715695460213908,0.3617021276595745,0.5599850522536338,1.0,10/23,20.07%,BMPR1A;SMAD4;NPPA;MAML1;CACNA1G;HEY1;HEY2;NOTCH2;NPPB;SCN5A
prerank,cardiac atrium morphogenesis (GO:0003209),0.3772832251911312,1.0711593865769935,0.37777777777777777,0.544782230746104,1.0,5/17,11.11%,TBX20;PROX1;TGFB2;ENG;ZFPM1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.333116758838576,-1.070740007349353,0.31746031746031744,0.5613599872593448,1.0,13/37,20.98%,CCL27;RAPGEF3;PDGFRA;NTRK3;FES;SEMA3E;TJP1;DAPK3;NOTCH2;NTF3;BAIAP2;ESAM;BCAS3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3900773277513247,1.0705105247890747,0.3,0.5455706018034909,1.0,11/17,31.56%,WNT5A;STK39;CCL4;CCL3;ADAM10;CXCL13;CCL7;ADAM17;XCL1;XCL2;CCL5
prerank,negative regulation of chemokine production (GO:0032682),-0.37651420248879147,-1.0702277510200573,0.3620689655172414,0.561752970430353,1.0,8/17,30.50%,ELANE;APOD;C1QTNF3;MAP2K5;OAS1;MUL1;F2RL1;KLF4
prerank,negative regulation of catabolic process (GO:0009895),-0.30960071799805744,-1.0697467882066911,0.34545454545454546,0.5624779009410467,1.0,11/47,10.13%,HDAC4;FLNA;PDE3B;ACTN3;ADGRB1;FMN2;ZDHHC7;ALK;BSCL2;SIRT2;MDM4
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.39799013650747966,-1.0696520211925136,0.34,0.5620999069106118,1.0,8/17,23.23%,CHRM2;RGS10;RGS8;GNAQ;PLCB1;CHRM5;CHRM3;GNA11
prerank,MAPK cascade (GO:0000165),-0.2361576896323578,-1.069379812432798,0.2753623188405797,0.5621586313706696,1.0,90/297,21.77%,NCAM1;FNTB;GFRA1;GDNF;SYNGAP1;MAP3K3;FGFR1;RAF1;NRG2;FGF2;DLG2;PABPN1;BTC;GFRA3;ACTN2;CAMK2A;GFRA2;LRRC7;PDGFRA;SPTBN4;MEF2A;CALM1;SHANK3;PIK3R1;FGFR2;DLG4;FGF22;FRS3;SHC2;KIT;RGL2;RALGDS;KSR1;KITLG;SKP1;RGL1;ZFP36L1;LRRK2;FLT3LG;NRTN;KL;PRKG2;TAOK2;MEF2C;DAB2IP;MAPK1;MAPK3;RANBP9;FGF17;MAPK11;RIT2;ARL2;MAP2K7;FGF13;CAMK2B;HTR2B;PDGFB;FGF7;BRAF;MAPK8;PEA15;BTRC;NEFL;FGF5;FGF10;ZFP36;SOS1;PPP1CB;RASA3;IL17RD;FGF1;NRK;MARK3;FGF16;EGFR;ERBB4;UBB;ANGPT1;RET;SETX;CAMKK2;RAPGEF2;CCL2;FGF9;MAP3K7;PSMD9;MAPK12;GOLGA7;PIK3R2;SHC3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.21198809496469478,1.0692562175187037,0.15,0.5480024485611045,1.0,98/346,21.73%,PSMD14;MAD2L1;PSMB2;PTTG1;PSMB9;PSMA5;SKP2;RNF114;PSMB3;UBE2S;FBXO45;PSME3;PSMA3;TOM1L1;KIF14;BUB3;PSMA7;PSMD13;RNF6;RNF40;NDFIP2;GID8;PSME2;PSMC2;PSMC4;PSMD10;TRIM72;ERCC8;PML;AURKB;TNFAIP3;PSMD12;ANAPC1;RNF43;BFAR;PSMB5;KCTD5;PLAA;UBE2C;UHRF1;ZNRF3;UBE3D;TRIM2;XBP1;PRAME;RNF128;AURKA;DTX3L;PSMD8;CDC26;KLHL8;PSMB4;PSMD3;PSMB1;PSMA4;TRIM71;RAD23B;ADRM1;DDB1;SPSB2;RNF149;PSME1;PSMF1;ANAPC11;PLK1;PSMD11;PSMD1;NHLRC1;VCP;UBA1;CUL4A;RNF34;RNF187;FBXL14;UBE2A;UBQLN1;FEM1A;OS9;UBE2K;VPS37B;PSMD6;UBE3C;UBE2L6;CDC20;BUB1B;UBE2D1;PSMD5;RBCK1;KBTBD7;HECW1;CUL3;MVB12A;HECW2;KEAP1;CBLC;RNF19B;PSMC1;DTL
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.3872384448973419,-1.068579673613487,0.3225806451612903,0.5635958923405907,1.0,3/16,5.30%,MYOCD;CLU;SRF
prerank,regulation of macroautophagy (GO:0016241),-0.26296919307312344,-1.0683267841587945,0.273972602739726,0.5634664177114502,1.0,36/109,25.42%,NRBP2;EPM2A;TSC1;ATP6V1G2;PRKAB2;ULK1;RRAGC;GPSM1;HDAC6;UCHL1;EXOC7;PRKACA;PRKAG2;LRRK2;PRKAA2;DCN;WAC;RRAGB;TBC1D25;MAPK8;TSC2;CASP3;ATP6V0A1;ATP6V1B1;RRAGD;ATP6V1E1;SIRT1;BNIP3;MAP3K7;RPTOR;SMG1;MTOR;PINK1;RRAGA;CLN3;EXOC1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.33606808293184043,-1.0678645697114677,0.4166666666666667,0.5637819643858608,1.0,14/38,20.83%,TENM1;CADM3;NLGN1;AMIGO1;DCHS1;FAT4;CADM1;CRB1;TENM3;IL1RAPL1;HMCN1;AMIGO2;ADGRL1;TENM2
prerank,inner ear morphogenesis (GO:0042472),0.33737139576880787,1.0677154328850536,0.32558139534883723,0.5513926477868604,1.0,14/24,28.04%,EPHB2;SOX9;SIX1;MYO6;CHD7;USH1C;MYO3B;PAX8;PAX2;DCANP1;HPN;TIFAB;HOXA1;TFAP2A
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3397261683710387,1.0677010776968165,0.30612244897959184,0.5507592691406792,1.0,12/23,30.18%,PSMC2;PSMC4;HNF1A;MED14;SUB1;MED1;MED30;PAXIP1;TP53;MED13;MED4;HNF1B
prerank,negative regulation of macrophage activation (GO:0043031),-0.37964666683975795,-1.0674519344284377,0.3170731707317073,0.5642620935776937,1.0,3/15,7.83%,LRFN5;NR1D1;SYT11
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.27629901066895096,-1.0670093780890963,0.35185185185185186,0.5646998644306085,1.0,23/86,19.64%,RBPMS;FLCN;TGFB1I1;SH2B1;BMPR1A;NUMA1;SMAD4;CITED2;BMP3;CDKN1C;GDF7;RBPJ;MSTN;RNF165;GDF5;GDF6;ZNF423;ZEB2;SOX11;ACVR2A;SMAD2;CSNK2B;BMPR1B
prerank,histone H3 deacetylation (GO:0070932),-0.4084517571245869,-1.0668871334388628,0.3076923076923077,0.5643120397006008,1.0,4/15,14.29%,PER1;HDAC4;SIRT2;HDAC9
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.2892639910758197,-1.0661707395225113,0.2857142857142857,0.5655724548722613,1.0,21/63,28.99%,CNR1;ADRB3;CHRM2;MC1R;NPY;HTR2B;HTR4;AGTR2;CHRM5;LHCGR;HTR1E;CHRM3;CCL2;HTR7;SSTR2;DRD4;HTR2A;HTR5A;HRH2;NPY1R;SSTR4
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.30996300179751646,-1.0653881406023682,0.37735849056603776,0.5668403253259651,1.0,20/49,20.98%,TNRC6A;MYL9;MTURN;KAT2B;AGO4;L3MBTL1;FAXDC2;TNRC6C;KMT2A;THPO;MEF2C;AGO3;KMT2B;SIN3A;KMT2E;TNRC6B;AGO1;ITGA2B;NR4A3;SETD1A
prerank,determination of left/right symmetry (GO:0007368),-0.3214314136952749,-1.0651686774207592,0.3888888888888889,0.5667801402662482,1.0,8/38,10.29%,NPHP3;PKD2;DAND5;CITED2;CCDC39;CCDC40;TBX1;MEGF8
prerank,protein depolymerization (GO:0051261),-0.32690419142122884,-1.0650951507496351,0.36363636363636365,0.566299370008009,1.0,7/28,8.73%,MICAL3;CFL2;STMN4;GSN;DSTN;STMN2;NCKAP5L
prerank,erythrocyte differentiation (GO:0030218),0.2899276421192494,1.0648433089710716,0.38636363636363635,0.557579168328354,1.0,16/43,22.02%,LYAR;INHBA;HSPA9;TSPO2;JAK3;RPS14;CEBPG;ZFPM1;RPS19;MED1;PTPN2;DYRK3;SLC25A5;LYN;ALAS1;KLF1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.34037608279475334,1.0647048677562172,0.3148148148148148,0.5573322202721582,1.0,8/27,12.44%,PRDX4;PRDX5;DUOX2;CYBA;PRDX1;NOX1;GPX1;PRDX2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3582055877497473,-1.0646988962090111,0.359375,0.5668036738642342,1.0,6/20,15.77%,TGFBR3;OLFM1;RBPJ;SPRY1;HEY1;HEY2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.36319393365099584,-1.064505719284574,0.43333333333333335,0.5666003920376195,1.0,8/28,15.24%,FGF2;PDGFRA;ATG14;KIT;PRKD1;TNFAIP8L3;P2RY12;PDGFB
prerank,peptidyl-proline modification (GO:0018208),0.32850671605933757,1.06337372601792,0.42105263157894735,0.559951180341425,1.0,14/30,26.69%,NTMT1;PPIH;PPIL1;PPIB;PPIF;FKBP4;OGFOD1;PPIAL4A;PPIL3;PPIAL4C;PPID;PPIL6;FKBP1B;PPIAL4G
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.33529944666795874,-1.0620974635758778,0.423728813559322,0.5719099738993055,1.0,8/33,8.44%,AKAP6;TRPC1;CASQ1;CAPN3;GPER1;SNCA;P2RX7;P2RX2
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.39152642600539866,-1.061968879260799,0.34545454545454546,0.571609511341167,1.0,5/17,17.68%,FLCN;HDAC4;ACTN3;PID1;NUPR1
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.2718766392654063,-1.0615330259919573,0.3380281690140845,0.571993407948126,1.0,36/91,25.51%,TGFBR3;FGF2;OSR1;FGFR2;NR1D1;TBX1;CDKN1C;LAMC1;PRKD1;ZFP36L1;LAMB1;MCC;TINF2;DAB2IP;SFRP1;GDF5;FGF7;TIE1;FGF10;ZFP36;FGF1;NUPR1;FGF16;EGFR;ANGPT1;SCN5A;SOX2;NR4A3;FGF9;OSR2;B2M;BAD;NR4A1;NKX3-1;NME2;MTSS1
prerank,cellular iron ion homeostasis (GO:0006879),0.2886039062068832,1.0604902394904274,0.40540540540540543,0.5662490374472352,1.0,12/53,11.22%,MYC;TFR2;LCN2;GLRX3;ATP6V1G1;FRRS1;HMOX2;ATP13A2;SLC40A1;HEPHL1;ATP6V1A;SLC11A2
prerank,neutrophil activation (GO:0042119),0.38348123407419554,1.0602049545725194,0.3392857142857143,0.5663025583967082,1.0,4/16,14.45%,CXCL8;SYK;CXCL6;CXCR2
prerank,cation transmembrane transport (GO:0098655),0.29368151415776167,1.0596697509905815,0.3333333333333333,0.5669215378061953,1.0,13/44,15.14%,SLC6A20;SLC7A1;SLC38A5;SLC7A5;TRPM2;MFSD12;ATP1B1;ATP13A2;SFXN2;SLC25A19;SFXN1;KCNJ11;SLC3A2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.25944044756189244,1.05916037454767,0.2619047619047619,0.5674448661922751,1.0,23/82,19.14%,CEMIP;COL1A1;COL11A1;LHFPL5;KCNQ1;TIMM10;TIMM13;CHRNB2;TIMM8B;DCDC2;CACNA1D;SLC52A3;MARVELD2;EML2;ALDH7A1;USH1C;MYH14;TPRN;GRAP;EYA1;BIRC5;MYO3B;ATP6V0A4
prerank,protein transport (GO:0015031),-0.22739670854045857,-1.058852479160294,0.3472222222222222,0.5778500793432528,1.0,90/354,20.64%,SEC31B;VAMP2;SNX1;ATP6V1G2;DNAJC27;TBC1D1;SGSM2;TBC1D17;ARL4D;STX1B;RABGAP1;ARRDC4;RABL2B;ZDHHC17;CLU;TBC1D10A;USP6;TBC1D26;MACF1;RAB34;RABL2A;ANK3;VPS45;SNX33;CHMP3;RAB6B;STX16;VAMP4;SNX15;WDR11;RAB12;TRIM23;HDAC6;PRKCB;SNX27;NEURL1B;STX2;ABCA1;COPZ2;RAB28;NGFR;BBS1;EVI5L;RAB5B;LRP1B;TBC1D2B;GPIHBP1;RIC1;NAPB;SGSM1;RAMP1;ARRDC2;GGA3;OPTN;RD3;RAB23;WLS;VPS33B;HERC2;TBC1D13;RAB3A;BBS2;VIPAS39;KIF13A;MCOLN1;TICAM2;VLDLR;LRSAM1;TBC1D25;CEP290;SGSM3;STX12;RAB13;GGA2;ATP6V0A1;ATP6V1B1;RAB3C;VAMP5;RAMP3;CD36;RAB24;ADPRH;SNX31;ATP6V1E1;TCIRG1;TBC1D12;RPGR;RUFY1;RAB8B;PREPL
prerank,plasma membrane invagination (GO:0099024),-0.33793857784171055,-1.0587734160710338,0.3333333333333333,0.5773200218696303,1.0,8/29,18.84%,GSN;SNX33;DOCK1;GULP1;RHOA;SNX18;ELMO1;CD36
prerank,regulation of telomere maintenance (GO:0032204),0.3234389665199896,1.0585972511573503,0.3333333333333333,0.5685311463412827,1.0,4/25,6.37%,MYC;GNL3;XRCC5;PML
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2768965573442361,1.0579319067761892,0.35714285714285715,0.5696282169918286,1.0,9/54,8.31%,E2F1;TFDP1;TP73;GZMB;YWHAB;YWHAE;PMAIP1;BBC3;YWHAG
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.2891737159213068,-1.0570634437755393,0.35185185185185186,0.5810931996516334,1.0,22/69,18.27%,FGFR1;DDR2;PDGFRA;FGFR2;FES;KIT;GHR;DYRK1A;FLT4;FER;NTRK1;ABI2;EPHA4;MAPK3;RELN;BMX;EPHA3;PDGFB;AATK;INSR;EGFR;ERBB4
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2583491179513567,1.0561072382078573,0.3333333333333333,0.5736441286617134,1.0,24/74,27.40%,IL1A;EPHB2;IL23A;WNT5A;SYK;PF4;DHX9;CYBA;OAS2;CCL3;IL17A;NOD2;ARFGEF2;OAS3;MMP8;HMGB1;IL12B;CD2;TYROBP;THBS1;PTPN11;PTPRJ;IFNG;CLEC7A
prerank,cellular response to amino acid starvation (GO:0034198),-0.2786494616364695,-1.055754427470781,0.3230769230769231,0.5836795583579638,1.0,21/70,19.65%,FLCN;ATP6V1G2;SZT2;RRAGC;ATF4;PRKD1;MAPK1;MAPK3;RRAGB;RNF152;WDR59;CDKN1A;TFEB;MAPK8;FAS;DEPDC5;ATP6V1B1;KPTN;RRAGD;ATP6V1E1;TCIRG1
prerank,retinol metabolic process (GO:0042572),-0.3926662933660857,-1.0551448717655172,0.3333333333333333,0.584514762667656,1.0,4/17,14.81%,LRAT;ADH1B;CYP27C1;CYP1A1
prerank,RNA destabilization (GO:0050779),-0.36570429650540826,-1.054532328809755,0.3508771929824561,0.5853785289810123,1.0,6/17,16.99%,RBM24;CELF1;METTL3;DXO;ROCK1;FTO
prerank,RNA transport (GO:0050658),0.2755845942320637,1.0544581104804027,0.33962264150943394,0.5769275526390374,1.0,15/75,6.08%,ALYREF;THOC3;NUP155;U2AF1;XPO5;MAGOH;RAE1;SLBP;NUP62CL;MAGOHB;PNPT1;EIF4A3;NCBP1;DDX39A;SRSF9
prerank,negative regulation of dephosphorylation (GO:0035305),0.3656234239804595,1.0534173103538218,0.38636363636363635,0.5787859462725048,1.0,11/19,36.45%,YWHAB;SH2D4A;PPP1R8;PPP1R35;URI1;SH3RF2;CHP1;PPP1R36;GPATCH2;PPP1R26;ZCCHC9
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.2561142900960028,1.0530303879946403,0.29545454545454547,0.5794247483913403,1.0,23/91,13.77%,POLR2F;POLR2D;TDGF1;CXCL8;HNRNPF;FGF19;NCBP1;ANOS1;CD44;PTBP1;FGFRL1;FIBP;GALNT3;SHCBP1;FGFR4;NCBP2;FGF20;TRIM71;POLR2C;GTF2F2;POLR2K;FGF3;POLR2J
prerank,cartilage development (GO:0051216),-0.297486469163447,-1.0518759487738938,0.423728813559322,0.5911309544284891,1.0,20/49,26.73%,PKD1;FGF2;OSR1;HOXD3;SOX5;WNT5B;ZBTB16;NFIB;MEF2C;WNT2B;SNX19;GDF5;SOX6;OSR2;CREB3L2;COL11A2;WNT10B;HOXA11;RUNX2;TRIP11
prerank,hyaluronan metabolic process (GO:0030212),0.3378333525499614,1.0517887711262688,0.34210526315789475,0.5816891173543249,1.0,5/22,7.31%,CEMIP;HEXB;IL1B;CD44;HYAL3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.32205605745212895,1.0517472733495712,0.3611111111111111,0.5810973782465311,1.0,9/25,26.45%,PMAIP1;SMYD2;PSMD10;CD44;KDM1A;MSX1;SPRED2;SPRED1;ATR
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3462019408158123,1.0513956274202112,0.38461538461538464,0.581385183039039,1.0,15/25,29.19%,SF3B3;PRPF4;KHSRP;SNRNP40;PRPF6;TRA2B;SF3A3;DBR1;WDR83;TXNL4A;GEMIN2;LSM1;DDX23;MPHOSPH10;BCAS2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.37633665661022186,-1.0511468698803512,0.3728813559322034,0.5923192807140986,1.0,6/20,9.99%,ATP1B2;ATP1A2;KCNMA1;SLC8A1;ATP1A4;ATP1A3
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.28600694714404595,-1.0506436273717505,0.3728813559322034,0.5928280808059783,1.0,18/66,18.66%,LCAT;CSNK2A2;PLA2G5;PLA2G4B;PCYT1B;CHKB;TMEM86B;PLA2G6;ABHD4;SLC27A1;NR1H2;PLA2G4C;LPIN1;ENPP2;PLA2G1B;PCYT1A;ABCA3;CSNK2B
prerank,carbohydrate derivative transport (GO:1901264),0.36376863667972437,1.0501700878581113,0.3333333333333333,0.5839314264571243,1.0,8/17,26.05%,SCARB1;SLC25A19;SLC29A2;SLC10A7;SLC15A4;ABCG1;PLA2G10;MFSD2A
prerank,cellular senescence (GO:0090398),0.32818003324529854,1.0498030249500256,0.4117647058823529,0.5844540683710066,1.0,5/25,9.33%,CALR;HMGA1;PML;CDKN2A;HMGA2
prerank,negative regulation of neuron differentiation (GO:0045665),0.33842918191134824,1.0497747803450481,0.35555555555555557,0.5838353392934085,1.0,7/22,19.99%,CALR;SOX9;GSK3B;BMP7;SIX3;MED1;HES1
prerank,protein targeting to membrane (GO:0006612),0.25300600066204065,1.0496670320049895,0.35714285714285715,0.5833769838661663,1.0,22/82,18.93%,ZDHHC9;SSR1;ARL6IP1;ATG3;PEX13;ACBD5;SEC61A1;TRAM1;ZDHHC12;RAB3IP;ZDHHC3;RABGEF1;ZDHHC24;YIF1B;ZDHHC6;SLC25A17;PRKCI;PEX16;NACA2;SIL1;VPS37B;SSR2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3733463205138231,1.0495414557842278,0.34782608695652173,0.5829726235892643,1.0,4/17,13.79%,IL4I1;ASS1;JAK3;VTCN1
prerank,negative regulation of DNA replication (GO:0008156),0.41098416558248396,1.0495213659720823,0.4,0.5823710777701007,1.0,6/15,19.68%,S100A11;GTPBP4;MCIDAS;GMNN;CDC6;PDS5A
prerank,regulation of immune effector process (GO:0002697),0.31377459618689646,1.049519401057038,0.358974358974359,0.581678603242431,1.0,12/40,19.19%,C1QBP;CD46;CD55;C4BPA;CD81;CPN1;SERPING1;C4BPB;C3;ZNF683;C2;C8G
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3731853444256624,-1.049243039987598,0.4074074074074074,0.5954651607234969,1.0,7/16,27.10%,PPM1F;NOTCH4;TJP1;DENND6A;ADAM19;RGCC;FLOT1
prerank,sympathetic nervous system development (GO:0048485),-0.39507727573109974,-1.0490063982945084,0.4423076923076923,0.5954754192028964,1.0,6/16,17.75%,GDNF;NRP2;PHOX2B;NTRK1;SEMA3A;SOX11
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.2854446085485706,-1.048845488490927,0.36,0.5952137714665331,1.0,26/59,27.06%,GPR17;LPAR1;NGF;NTRK1;GPR20;RAPGEF1;RAC1;MMD2;EPOR;NOTCH2;FGF10;MAPRE2;ALS2;STK19;LRRD1;AKAP13;ABRA;LPAR6;ARHGEF3;LPAR4;RASGRP4;EPO;SYNPO2L;F2RL3;GPR4;F2RL1
prerank,activation of phospholipase C activity (GO:0007202),-0.32817907667988544,-1.0486762531646503,0.3559322033898305,0.5950633439810542,1.0,14/32,27.41%,LPAR1;ARHGAP6;ADRA1A;P2RY12;HTR2B;GNAQ;EGFR;AVPR1A;PLCB2;PLCG1;RASGRP4;HTR2A;AVPR1B;NMUR1
prerank,histone modification (GO:0016570),0.24670053774234138,1.048546843719717,0.38235294117647056,0.5835707614259534,1.0,22/109,12.36%,RUVBL1;INCENP;NTMT1;UBE2N;RUVBL2;PHB;HDAC2;MRGBP;HLCS;HDAC10;AURKB;PADI3;PADI1;BRMS1;UHRF1;HDAC1;NAA50;MTA2;PRMT1;PRMT6;CARM1;RPS6KA4
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.34452490174803463,-1.0482126377722978,0.3770491803278688,0.595576393440168,1.0,10/29,20.17%,FGF2;PDGFRA;ATG14;KIT;PRKD1;TNFAIP8L3;P2RY12;PDGFB;EEF1A2;CCL21
prerank,regulation of intracellular protein transport (GO:0033157),-0.3560534430808316,-1.0480894861580607,0.375,0.5952552747827843,1.0,9/31,16.57%,VAMP2;TENM1;RUFY3;PTPN14;OAZ2;NDEL1;PCM1;CEP290;PCNT
prerank,chromatin organization (GO:0006325),0.2366041883653148,1.047416613207487,0.3125,0.5860375970788991,1.0,26/138,10.83%,RUVBL1;MYC;SUV39H2;NPM3;CBX3;ACTL6A;LOXL2;SUV39H1;RUVBL2;HDAC2;HMGN4;SMARCB1;FOXP3;NUDT5;HDAC10;TOP1;PADI3;HMGN1;SMARCA4;PADI1;SOX9;HMGB2;HMGA2;HDAC1;MTA2;SMARCD2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3283927663047125,1.0472490342640794,0.38,0.5858165418483895,1.0,8/21,18.10%,CXCL8;STMN1;YWHAB;MET;RPGRIP1L;MRAP;MRAP2;PLEK
prerank,cellular response to interferon-gamma (GO:0071346),0.2393115420269844,1.0459792143409918,0.275,0.5881566956109677,1.0,47/112,31.56%,TDGF1;CCL24;GAPDH;WNT5A;CCL20;CD44;PML;CCL22;PDE12;OAS2;CCL4;CCL3;IFNGR2;ICAM1;TRIM26;STAT1;GBP5;CCL26;IRF8;OASL;FCGR1A;CCL17;SYNCRIP;IRF6;OAS3;PTAFR;GBP1;HLA-F;TRIM31;TRIM22;CD47;GBP3;CD58;IL12RB1;GBP4;CCL1;RPL13A;IFNG;CCL7;IRF3;HCK;IRF7;IRF9;XCL1;XCL2;GBP7;CCL5
prerank,apical junction assembly (GO:0043297),0.2905046769023863,1.0459455396350625,0.38461538461538464,0.5876057531288894,1.0,16/54,19.89%,CLDN1;CLDN2;CLDN16;CLDN14;PARD6B;ECT2;PAK2;POF1B;PECAM1;MARVELD2;PRKCI;GRHL2;CRB3;CLDN4;STRN;F11R
prerank,ventricular septum morphogenesis (GO:0060412),-0.3177858397617539,-1.0456485974979373,0.38181818181818183,0.6003086321412074,1.0,10/28,17.75%,TGFBR3;BMPR1A;SMAD4;CITED2;ZFPM2;SLIT2;SLIT3;HEY1;HEY2;SOX11
prerank,cellular protein-containing complex assembly (GO:0034622),0.23159198555304383,1.0451123038973422,0.39473684210526316,0.5887330030127564,1.0,42/158,15.51%,CENPW;CCT2;HSPD1;PSMG1;SMAD1;POMP;CENPE;CENPA;SHQ1;NUP93;PSMD13;PSMG3;FCHO1;DLGAP5;PFDN6;CCDC103;DHX9;DNAAF2;CYBA;SPAG1;AIFM1;PTGES3;CLTA;HSPA4;NUP107;VBP1;AP2S1;DNAAF3;COX7A2L;VAMP8;ADRM1;LONP1;PRLR;ANLN;CLTC;NUP205;PSMD11;TRAF2;USH1C;COX7A2;CENPF;TCP1
prerank,glutathione derivative metabolic process (GO:1901685),-0.3564528292418079,-1.0450513641892387,0.38,0.6003884436905746,1.0,7/21,19.33%,GSTM2;GSTM5;GSTA4;GSTM3;HPGDS;GSTT2B;GSTM4
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3564528292418079,-1.0450513641892387,0.38,0.6003884436905746,1.0,7/21,19.33%,GSTM2;GSTM5;GSTA4;GSTM3;HPGDS;GSTT2B;GSTM4
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3318514970458018,-1.0440522299471555,0.40384615384615385,0.6025117379580937,1.0,5/30,9.09%,ITGA7;JAM3;CTNNA3;ITGB3;PARVA
prerank,heterochromatin assembly (GO:0031507),0.37470644767880534,1.0440418818222248,0.38636363636363635,0.5903286638432756,1.0,7/20,9.91%,HMGA1;SUV39H1;BEND3;CDKN2A;POLE3;HMGA2;HDAC1
prerank,iron ion homeostasis (GO:0055072),0.2749062073387204,1.0435547208202638,0.39473684210526316,0.5908619076745594,1.0,12/56,11.22%,MYC;TFR2;LCN2;GLRX3;ATP6V1G1;FRRS1;HMOX2;ATP13A2;SLC40A1;HEPHL1;ATP6V1A;SLC11A2
prerank,mRNA destabilization (GO:0061157),0.2882714135922375,1.0435159932033233,0.32608695652173914,0.5902581573543444,1.0,10/34,15.71%,POLR2D;DCPS;KHSRP;PLEKHN1;YTHDF1;PDE12;MEX3D;TRIM71;YTHDF2;CNOT1
prerank,superoxide metabolic process (GO:0006801),0.3185749194626421,1.0434032444218304,0.3,0.5897862173177284,1.0,10/29,25.57%,DUOX2;CYBA;PRDX1;NOX1;NOS2;PRDX2;CYB5R4;NCF2;CYBB;ALOX12
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.35970195434705876,-1.0431524858861552,0.4117647058823529,0.6041911978020102,1.0,11/25,26.57%,CACNA1C;ANK2;CALM1;CTNNA3;RYR2;FGF13;CAMK2D;CAV3;ATP2A2;AKAP9;NOS1AP
prerank,receptor signaling pathway via STAT (GO:0097696),-0.37574025389592824,-1.0430103902412287,0.40816326530612246,0.6038628015685464,1.0,12/25,27.40%,PKD1;PKD2;SOCS2;GHR;THPO;IFNAR1;CLCF1;CCL2;PIAS1;STAT4;IL31RA;STAT6
prerank,regulation of protein-containing complex assembly (GO:0043254),0.2330544271374593,1.0423726978817582,0.2926829268292683,0.5915815319316948,1.0,31/107,20.50%,GNL3L;KIF9;MMP1;AJUBA;SYK;HJURP;RPS3;SVIP;BIK;NCLN;GSK3B;SORL1;MMP3;LCMT1;MAPK15;CDT1;PRKCZ;TRAF2;GBA;VCP;HSPA5;SUMO1;PREB;TGFB1;PIH1D1;BAX;BID;HSP90AA1;CDC42;TFIP11;BAK1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.334585213910182,1.0419252440598685,0.4,0.5920327550433595,1.0,10/28,16.42%,CHEK1;BRCC3;CDK1;BLM;TICRR;TOPBP1;HMGA2;BRCA1;PLK1;CLSPN
prerank,regulation of inflammatory response (GO:0050727),0.22305193411569532,1.0406802197269167,0.2727272727272727,0.5946398144494476,1.0,82/197,31.57%,OSM;IL23A;ZP3;IL1B;WNT5A;VPS35;PIK3AP1;MGST2;USP18;TNFAIP3;AOAH;CEBPA;NMI;DHX9;MDK;IL21;XIAP;CCL3;SPATA2;MYD88;RELA;FFAR2;PLA2G7;ADAMTS12;SETD6;PROC;MMP3;AGT;MMP9;GRN;GBA;TMSB4X;MAPK13;FPR2;PPARG;PTPN2;FEM1A;OTULIN;IL1RL2;MVK;TNFRSF1B;NOD2;NFKBIA;SERPINE1;MMP8;TNFSF4;SEMA7A;IL12B;HYAL2;CD47;ENPP3;GPR31;CASP4;DAGLA;ZBP1;SMPDL3B;ACE2;CCL1;FFAR4;ANXA1;ETS1;IL37;IFNG;IFI35;PARK7;IL10;IL18;TLR7;BCL6;TEK;LPCAT3;HCK;SNX6;NLRP3;NLRP6;DAGLB;LACC1;XCL1;AREL1;CASP5;CCL5;TNF
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3150766603024568,-1.0405701261365372,0.3770491803278688,0.6094515443121982,1.0,12/39,16.69%,WNK3;CALM1;TRIM6;PARD3;CADM4;PPEF2;PRKAG2;SIRT2;INPP5K;MAPK1;S1PR2;AZU1
prerank,protein destabilization (GO:0031648),-0.31798294804765426,-1.0401929241801882,0.3469387755102041,0.6097549174502509,1.0,12/33,24.68%,GSN;CAPN3;SNCA;NR1D1;PRNP;GGA3;SOX17;BTRC;SIRT1;SENP2;MUL1;FBXW11
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2548438556102003,1.0395056613606553,0.4375,0.5970980159905241,1.0,34/75,30.63%,ANXA4;IRAK2;FOXP3;PSMD10;DAP;TNFAIP3;CDKN2A;BRMS1;IRAK1;SETD6;NLRC5;BMP7;TMSB4X;COMMD1;NWD1;OTULIN;ZNF675;NFKBIA;RBCK1;TRIM37;G3BP2;NFKBIB;ZC3H12A;SPI1;CCDC22;FOXJ1;IRAK3;IL10;NLRP2;PYDC1;NLRP3;ITCH;AIM2;CHP1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.3792257678502464,-1.0393987321879559,0.43859649122807015,0.6108328515557097,1.0,5/15,9.99%,ATP1B2;ATP1A2;SLC8A1;ATP1A4;ATP1A3
prerank,response to amino acid starvation (GO:1990928),-0.273384286456989,-1.0388040398737892,0.3384615384615385,0.6117992426261805,1.0,21/71,19.65%,FLCN;ATP6V1G2;SZT2;RRAGC;ATF4;PRKD1;MAPK1;MAPK3;RRAGB;RNF152;WDR59;CDKN1A;TFEB;MAPK8;FAS;DEPDC5;ATP6V1B1;KPTN;RRAGD;ATP6V1E1;TCIRG1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.36692795327965017,-1.0386353135272195,0.3333333333333333,0.6116230647072685,1.0,7/20,18.10%,FGF2;DSTYK;NPTN;SPRY1;SPRY3;LRIT3;GPC1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3329856519329579,-1.0382424716629046,0.4107142857142857,0.6118930589557221,1.0,15/30,27.50%,PIK3R1;MSTN;CORO1C;PLCE1;ABI2;ARPC2;RAC1;ENPP2;ARHGEF7;WASF2;BRK1;OCLN;AKIRIN1;NCKAP1;CORO1B
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2898076470644672,-1.0379829637999811,0.3,0.611895284167586,1.0,30/76,24.90%,MYOCD;RGS2;UCHL1;SLC8A1;PKIG;CDKN1C;NR2F2;PTEN;SPRY1;PRKAR2B;LATS2;SLC8A3;RASIP1;INPP5K;DAB2IP;SPRY3;APC;INCA1;HEXIM1;CDK5RAP3;HHEX;SIRT1;HEG1;TESK1;LRP6;CAV3;LATS1;PRKCD;PRKAR1A;SMPD1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3750937683656123,1.03764818514881,0.40816326530612246,0.6021689946590628,1.0,5/19,9.45%,RNF183;PMAIP1;TMBIM6;BCL2L1;XBP1
prerank,regulation of protein sumoylation (GO:0033233),-0.3623770557697519,-1.0376276883315048,0.36363636363636365,0.6121940575443833,1.0,6/18,10.26%,HDAC4;PIAS3;CAPN3;RASD2;RWDD3;ZMIZ1
prerank,phospholipid metabolic process (GO:0006644),0.2722943449022993,1.0368755380757226,0.34375,0.6036286375436277,1.0,21/63,18.48%,CYP2W1;AGPAT5;PLBD1;ABHD12;SMPD2;PLAA;PDXP;LIPG;IDI2;PNPLA3;AGPAT2;ACP6;PLA2G2F;PLA2G3;PLA2G4E;PLA2G4D;FITM2;PCYT2;FDFT1;PLA2G2D;AGPAT3
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3295520882996679,1.0364260366653022,0.3684210526315789,0.6042701143382221,1.0,12/25,26.69%,PPIH;PPIL1;PPIB;PPIF;FKBP4;PPIAL4A;PPIL3;PPIAL4C;PPID;PPIL6;FKBP1B;PPIAL4G
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.2876136870408743,1.0361288073202837,0.3684210526315789,0.6043029656474955,1.0,17/51,20.62%,MYC;BRCC3;UBE2N;PMAIP1;ERCC8;RPS3;DHX9;HMGA2;CEBPG;WRAP53;BRCA1;MSX1;EYA1;NSMCE1;SPRED2;TMEM161A;TRIM28
prerank,regulation of response to biotic stimulus (GO:0002831),0.32782865274763967,1.0357806881292813,0.4222222222222222,0.6045163780827746,1.0,7/29,19.28%,LRP8;TKFC;CD55;XIAP;GATA6;ZMPSTE24;ERAP1
prerank,Rho protein signal transduction (GO:0007266),-0.28541603262062226,-1.035279060300871,0.38596491228070173,0.6169751858668476,1.0,21/54,23.09%,NTN1;AGTR1;CDC42EP3;ARHGAP6;RHOJ;MYO9B;NGFR;RHOB;ARHGEF11;GNA12;CDC42EP4;RHOA;ARHGAP29;ROCK1;TAX1BP3;ARHGAP5;CTNNAL1;ARHGEF3;ARHGDIG;CDC42EP2;RHOU
prerank,peroxisomal membrane transport (GO:0015919),0.32431835804939224,1.0351724550854853,0.4444444444444444,0.6054510056853745,1.0,6/27,14.02%,PEX7;PEX13;ACBD5;PEX10;SLC25A17;PEX16
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2837957637899203,1.0351293546190659,0.39473684210526316,0.6048129900469358,1.0,7/53,6.99%,GNL3L;SOX4;PRR7;PRMT3;GTPBP4;RPS3;TNFAIP3
prerank,T cell proliferation (GO:0042098),-0.36435425079907735,-1.0348728134065768,0.40384615384615385,0.6171692097120068,1.0,5/15,21.39%,LMBR1L;PPP3CB;CADM1;TNFSF14;CTPS1
prerank,triglyceride metabolic process (GO:0006641),0.30057084304513093,1.0339041958061204,0.3333333333333333,0.6074680568294241,1.0,12/44,20.10%,FABP6;DGAT2;PNPLA4;LIPG;PNPLA1;GK;PNPLA3;LPGAT1;APOC1;SLC27A5;CETP;CAV1
prerank,regulation of phosphorylation (GO:0042325),0.23608828759414635,1.0333762012512657,0.32432432432432434,0.6080235774776357,1.0,30/121,17.92%,NUP37;EREG;NUP155;INHBA;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;PML;CDKN2A;NUP43;MCM7;EIF6;NUP50;PTGES3;SOCS1;NUP88;FN1;NUP107;NLRC5;NUP205;BMP7;BMP4;NUP62;NUP160;DYNLL1;NDC1;LYN
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2496276174515274,1.0328306624396446,0.34285714285714286,0.6085521574883478,1.0,32/93,20.45%,CEP72;KIF24;CDK1;CEP250;YWHAE;NEK2;TUBB4B;HAUS2;RAB11A;YWHAG;TUBA4A;RAB3IP;HAUS8;B9D1;CEP76;TMEM216;RPGRIP1L;CKAP5;HAUS1;HAUS6;PLK1;TUBG1;CEP78;PLK4;TCTN3;DYNLL1;HAUS7;SCLT1;MAPRE1;SSNA1;CEP41;HSP90AA1
prerank,endocardial cushion development (GO:0003197),-0.3439409954420666,-1.032763425754436,0.375,0.6217277889717459,1.0,6/20,15.11%,FOXF1;BMPR1A;CRELD1;MDM4;HEY1;TBX2
prerank,regulation of protein localization to membrane (GO:1905475),-0.3343325458631717,-1.032016313540008,0.4528301886792453,0.6231170917854991,1.0,12/29,24.89%,GSN;ZDHHC7;NECAB2;AR;VTI1B;VPS4A;GPC1;INS;GPC6;ACTB;STX7;CLN3
prerank,gliogenesis (GO:0042063),-0.3584135014986177,-1.0319558018281396,0.4262295081967213,0.6226451525592035,1.0,6/17,16.69%,PHOX2B;METTL3;NFIB;RELN;CDH2;AZU1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.3384558257624592,-1.031436050915816,0.39622641509433965,0.6234117376582935,1.0,5/24,11.16%,KCNB1;ANK3;MTCL1;PRNP;MYO1C
prerank,clathrin-dependent endocytosis (GO:0072583),-0.348549327174717,-1.0313247869734785,0.36,0.6231072807719618,1.0,13/26,26.30%,PIP5K1C;ITSN2;ITSN1;INPP5F;SNAP91;SIGLEC1;AP2A2;FCHSD2;DLL1;AP2M1;SGIP1;DNAJC6;FCHO2
prerank,membrane organization (GO:0061024),-0.22998828975598876,-1.0310267060755318,0.3188405797101449,0.623205296469772,1.0,67/237,22.92%,VAMP2;FNBP1;DMPK;PIP5K1C;SYNGR1;ANK2;TRIP10;EPN2;FZD4;CNTN2;RABEP1;BTC;SYNJ1;ANK3;SUN1;CHMP3;VAMP4;REEP1;TOR1AIP1;AMPH;SUN2;ADRB2;ITSN1;A4GALT;TMEM43;MFN2;CHRM2;SYP;HACE1;SYT2;SLC18A3;SYT9;CORO1C;VTI1B;VPS33B;DYSF;ARPC2;DVL2;AP2A2;TRDN;AVPR2;PACSIN2;EPS15L1;RTP5;CCDC88A;MYADM;VPS4A;CBL;AZIN2;VAPA;EPS15;EGFR;CHMP4A;UBB;CTDNEP1;DNM1;AP2M1;PLEKHA3;RIMS1;GLTP;GAPVD1;ACTB;CLTCL1;SYT1;RTP1;SGIP1;CAV3
prerank,oligodendrocyte development (GO:0014003),-0.40184702500051095,-1.0309971622085015,0.4489795918367347,0.6225884290945046,1.0,5/15,16.59%,PLP1;CNTNAP1;PRDM8;TPPP;EIF2B4
prerank,cholesterol homeostasis (GO:0042632),0.26343611290619107,1.0309685066432699,0.3617021276595745,0.6128338093530562,1.0,23/62,22.83%,TMEM97;DGAT2;SCARB1;MTTP;RALY;XBP1;LIPG;FGFR4;PCSK9;CYP39A1;CYP7B1;INSIG1;LRP5;MALL;ABCG5;APOM;CETP;CAV1;HNF4A;LDLR;TSKU;PLA2G12B;ABCG8
prerank,water transport (GO:0006833),0.3607395313878444,1.0308082690531444,0.32558139534883723,0.6125493159943077,1.0,6/17,20.66%,UPK3A;AQP5;AQP9;AQP3;CFTR;SLC5A1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.2557670352713691,-1.0305850736606101,0.4,0.6228041445361876,1.0,34/139,16.39%,TEAD3;NR2C2;RXRG;PGR;HDAC7;KAT2B;THRB;WWTR1;PPARD;RORA;CDK9;NPPA;NR1D1;TEAD1;RARB;AR;RBPJ;MAML1;RXRB;NR3C1;NOTCH4;NR1H2;HDAC5;MED17;NR2C1;ERCC3;RXRA;HDAC9;ESR1;TEAD2;THRA;NOTCH2;TAF3;RORB
prerank,Notch signaling pathway (GO:0007219),0.27750978009238497,1.0305428215100478,0.48,0.6126106397134558,1.0,14/60,11.68%,MYC;NOTCH3;NLE1;POFUT1;WWC1;DLGAP5;DTX2;GMDS;APH1A;MDK;ADAM10;DTX3L;NRARP;STAT1
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.2253122983837154,-1.0303538707471425,0.4264705882352941,0.6227458631154903,1.0,83/309,20.64%,PDE2A;RYR3;ATP2B4;WNT9A;TPM1;AKAP6;TRPV1;RAPGEF3;PKD2;RAP1A;FZD4;DEFB124;MAPT;PABPN1;OR51E2;RRAGC;PXN;PDGFRA;GPER1;LDOC1;P2RY1;MTR;CPEB1;RORA;P2RX7;NR1D1;WNT6;TBX1;FES;KCNK4;WNT5B;DAPK1;PRKD1;FZD7;GNG2;SLIT2;ZFP36L1;FER;PDE3A;CPEB3;PID1;MEF2C;CERS1;AQP1;INPP5K;DAB2IP;MAPK1;MAPK3;P2RY12;RRAGB;RAPGEF1;KCNE1;SSH1;SFRP1;RHOA;BCL10;IGFBP5;EPHA3;PDGFB;TICAM2;ESR1;VIM;ADCY6;MAPK8;RORB;CRHBP;ZFP36;MAPK14;SHPK;EGFR;RAMP3;P2RY11;PDK2;RET;RRAGD;ANKRD1;GPBAR1;SETX;NR4A3;CAMKK2;RAPGEF2;HCN3;CCL2
prerank,positive regulation of cartilage development (GO:0061036),-0.3803736529103452,-1.0296571149916107,0.41509433962264153,0.6239075522947177,1.0,10/18,25.26%,TAPT1;SOX5;ZBTB16;BMP1;GDF5;GDF6;BMPR1B;SOX6;PKDCC;HOXA11
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3151645794994679,-1.0294044208246855,0.4098360655737705,0.6239652017195625,1.0,13/35,23.02%,TSC1;CRY2;PPP1R12A;MAGI2;CALM1;PPP6R2;BOD1L1;CSNK2B;AGTR2;BOD1L2;MTOR;CALM2;NUAK1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.35076935368809803,-1.0290960085977308,0.4666666666666667,0.6240616807381651,1.0,9/21,21.56%,BCL2L2;MOAP1;BCL2;FAS;CASP3;CASP9;DCC;GSK3A;BOK
prerank,protein targeting to peroxisome (GO:0006625),0.3244664875046405,1.0290143694318339,0.5294117647058824,0.6161833112425916,1.0,6/29,14.02%,PEX7;PEX13;ACBD5;PEX10;SLC25A17;PEX16
prerank,positive regulation of DNA metabolic process (GO:0051054),0.2704262726057738,1.0284340296209544,0.4186046511627907,0.6169928250266339,1.0,13/58,13.06%,MYC;BRCC3;UBE2N;PDGFRB;GNL3;ERCC8;PML;RPS3;DHX9;FGFR4;CEBPG;WRAP53;BRCA1
prerank,negative regulation of T cell proliferation (GO:0042130),0.3066091423366582,1.0283244724159433,0.43902439024390244,0.6166411645409167,1.0,14/33,28.40%,CEBPB;IL4I1;FOXP3;CD80;PLA2G2F;VTCN1;LILRB4;PLA2G2D;CD86;CRTAM;SCRIB;SDC4;IL10;GLMN
prerank,establishment of mitotic spindle localization (GO:0040001),0.32541977486197304,1.0280622674030038,0.3404255319148936,0.6166847893512418,1.0,9/29,13.68%,MAD2L1;SAPCD2;CENPA;SPDL1;NDC80;GPSM2;ZW10;KPNB1;PLK1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3554364604961634,1.0276973793182786,0.46153846153846156,0.6167283142192754,1.0,3/21,1.73%,GRIN2B;USP50;PSMB9
prerank,positive regulation of gene expression (GO:0010628),-0.21991593107552543,-1.0276257600508656,0.35714285714285715,0.6275042812508929,1.0,118/460,20.08%,CALCOCO1;PDE2A;CIRBP;RBM20;TNRC6A;MYOM1;HAND2;AGPAT1;SAMD4A;ANK2;RBMS3;ACTA1;SF3B1;GSN;FGF2;OSR1;CLU;ACTA2;KAT2B;RBM24;AGO4;MITF;CITED2;LURAP1;ANK3;GPER1;HOXD3;CUX2;PHF2;PIK3R1;TAF1C;CLDN5;ZNF580;NTRK3;CELF1;P2RX7;FGF22;CD34;ELAVL4;METTL3;FXR2;TNRC6C;ATF4;WNT6;TLR9;NGF;LARP6;AR;OLFM1;RHOXF1;PSEN1;RBPJ;DYRK1A;PPM1F;SLC24A3;CNTF;EMILIN1;RNF207;TLR3;HABP4;MYO1C;C1QTNF3;CPEB3;HEY1;PID1;WBP2;RDX;CADM1;MEF2C;AGO3;MAPK1;S100A13;MAPK3;FGF17;MAPK11;PIK3R3;AVPR2;HINFP;ACTC1;GATA2;SEC16B;MUSK;HTR2B;PDGFB;FGF7;VIM;BRAF;ROCK1;MAPK8;HEY2;KAT2A;SLC38A2;TLE1;FGF5;AZU1;FGF10;MAPK14;HOXA5;SMO;FGF1;WNT16;SOX11;FGF16;EGFR;POLDIP3;RAMP3;CD36;TNRC6B;POU3F3;AGO1;MED23;VSTM2A;ANGPT1;PLA2R1;RPS6KB1;GSK3A;SETX;INS
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.33964297098341667,-1.0270990750200177,0.4262295081967213,0.6281021062588003,1.0,12/31,21.82%,EPN2;FGF2;RHOJ;SYNJ2BP;TJP1;SEMA6A;ADAMTS9;GLUL;FGF1;FGF16;DLL1;KLF2
prerank,sodium ion homeostasis (GO:0055078),-0.33365298105499136,-1.0270185417218876,0.4426229508196721,0.627640592607596,1.0,8/24,18.48%,ATP1B2;ATP1A2;SLC8A1;ATP1A4;ATP1A3;SCNN1B;SCNN1G;ATP4A
prerank,mucosal immune response (GO:0002385),0.3354197263351509,1.0267305659688803,0.48,0.6188538836888929,1.0,4/20,10.98%,DEFA6;RPL39;FFAR2;NOS2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.26292368042984415,1.026717734803409,0.45,0.618159303599043,1.0,20/74,13.77%,POLR2F;POLR2D;HNRNPF;FGF19;NCBP1;ANOS1;PTBP1;FGFRL1;FIBP;GALNT3;SHCBP1;FGFR4;NCBP2;FGF20;TRIM71;POLR2C;GTF2F2;POLR2K;FGF3;POLR2J
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.2579941448005962,-1.0265153324631067,0.45454545454545453,0.6284891252254177,1.0,28/92,19.11%,SASH1;FGF2;GLIPR2;NRP2;ZNF580;ITGB3;HDAC6;PRKCA;CLASP1;RHOB;PRKD1;ATOH8;CLASP2;PPM1F;FLT4;DOCK1;RRAS;ANGPT4;CAPN7;RAC1;ENPP2;FGF7;FGF10;FGF1;IQSEC1;RTN4;MAPRE2;ANGPT1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.2907527215022737,-1.0259085871707383,0.41935483870967744,0.6292971176616208,1.0,12/43,16.73%,PKD1;GDNF;PKD2;FGF2;TCF21;SLIT2;SEMA3E;GLI2;NOTCH4;RASIP1;TIE1;FGF10
prerank,microglial cell activation (GO:0001774),-0.3414695677845217,-1.0256008105758088,0.3888888888888889,0.6294260604146709,1.0,3/22,6.27%,MAPT;CLU;SNCA
prerank,phospholipid catabolic process (GO:0009395),0.31475523322230925,1.0254827559429944,0.44680851063829785,0.621241079754756,1.0,6/22,13.66%,PLBD1;ABHD12;GDPD1;LIPG;PLA2G4E;PLA2G4D
prerank,nuclear envelope organization (GO:0006998),-0.35137480410713207,-1.02486232123849,0.3617021276595745,0.6308016612811784,1.0,5/21,8.09%,DMPK;SUN1;TOR1AIP1;SUN2;TMEM43
prerank,response to peptide (GO:1901652),0.30722285305371944,1.0248491614194737,0.40476190476190477,0.6222281536426219,1.0,18/37,27.34%,MMP13;IRS1;REG1A;MMP2;STAT1;MMP3;MMP9;MMP12;REG1B;NOD2;STAT5A;FYN;STAT5B;CHRNA7;CALCR;REG3A;ANXA1;STAT2
prerank,cellular response to misfolded protein (GO:0071218),-0.3508266825542302,-1.0231591987572939,0.40298507462686567,0.6346076598637354,1.0,4/19,6.82%,DNAJC18;POMT2;ATXN3;RNF185
prerank,alpha-amino acid metabolic process (GO:1901605),0.30823257233875406,1.0229752581799523,0.41025641025641024,0.626321966595983,1.0,8/40,6.74%,DPEP1;MTHFD1;GPT2;DDAH1;ASS1;GOT2;ALDH18A1;GLS2
prerank,hepaticobiliary system development (GO:0061008),0.35020465099831805,1.0225135511076857,0.4772727272727273,0.6268844294463798,1.0,8/20,13.13%,MET;PROX1;CEBPA;LSR;XBP1;PCSK9;CEBPG;PRKCSH
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3662778059990406,-1.02213278451614,0.421875,0.6366983435693069,1.0,8/20,21.61%,GPER1;SFRP1;ESR1;CRHBP;EGFR;RAMP3;KAT5;SSTR2
prerank,regulation of MAP kinase activity (GO:0043405),-0.2722588764740217,-1.0220687848997583,0.375,0.6362022809152806,1.0,27/96,18.89%,FGFR1;TENM1;FGF2;RGS2;GH1;UCHL1;ELANE;KIT;KSR1;PPEF2;LRRK2;SPRY1;DIRAS2;INPP5K;DAB2IP;SPRY3;TSG101;NEK10;TRIB2;HTR2B;PDGFB;DUSP19;DIRAS1;FGF1;FGF16;EGFR;CDK5RAP3
prerank,ncRNA metabolic process (GO:0034660),0.3071181938932863,1.0215360705083236,0.35,0.6286813388549397,1.0,6/34,4.73%,RAN;NIFK;HENMT1;XPO5;PIWIL1;KHSRP
prerank,histone acetylation (GO:0016573),-0.27855360482459124,-1.0214681783154582,0.3728813559322034,0.6370740829973283,1.0,25/69,24.41%,PER1;APBB1;SUPT7L;JADE1;KAT2B;CHD5;DMAP1;KAT6B;ING4;BRD8;MORF4L1;EPC1;BRD1;ACTL6B;KAT7;KAT2A;ING3;EP400;ING5;MAP3K7;KAT5;ATF2;SUPT3H;KAT8;JADE2
prerank,negative regulation of lyase activity (GO:0051350),-0.39829776718049564,-1.021000848140066,0.39655172413793105,0.6376171315116353,1.0,7/16,25.62%,PALM;RD3;LTB4R2;EDNRB;GNAI2;GRM2;GRM3
prerank,response to purine-containing compound (GO:0014074),-0.3710403675466791,-1.0206172893560597,0.38461538461538464,0.6379093029297472,1.0,5/17,11.05%,P2RY1;RYR1;P2RX7;ABCC9;RYR2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.37941864798365005,1.0205463135498227,0.43478260869565216,0.6305623348885558,1.0,10/15,28.04%,MTHFD1;MTHFD1L;IRX5;EIF4A3;SIX1;TGFBR2;LHX1;TGFBR1;HOXA1;TFAP2A
prerank,regulation of interleukin-6 production (GO:0032675),0.2428084877530803,1.0204454535264662,0.375,0.6301493518803896,1.0,35/104,28.44%,IL1A;HSPD1;EREG;IL1B;WNT5A;SYK;TNFAIP3;DHX9;CYBA;XBP1;MYD88;IL17A;NOS2;MAPKAPK2;IL17F;GBA;MAPK13;F2R;LILRB4;NOD2;MMP8;TNFSF4;HMGB1;ZC3H12A;HYAL2;CD47;TYROBP;PTPN11;FOXJ1;IL37;IFNG;CLEC7A;IRAK3;IL10;TLR7
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.27085020287789746,-1.0203863750310609,0.4444444444444444,0.6379801711691724,1.0,12/80,6.52%,SNX1;SGSM2;TBC1D17;RAB9B;DCTN1;TBC1D10A;RBSN;ANKFY1;RAB6B;STX16;DENND5A;DENND2A
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.36995124309172955,1.0203119009582255,0.40816326530612246,0.6298504036532522,1.0,8/19,18.71%,PDP1;ABL2;RFK;PDP2;AGT;POR;NOD2;FXN
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.28877150762469295,1.0201029614950754,0.36363636363636365,0.6297027603551841,1.0,14/38,19.58%,TRIAP1;PMAIP1;PSMD10;BBC3;BCL2L1;PPIF;BIK;GPX1;PRELID1;MMP9;PLAUR;FXN;BAX;BID
prerank,vascular transport (GO:0010232),-0.2652632399362131,-1.02000299355717,0.3584905660377358,0.6382809368384874,1.0,22/83,18.27%,SLC2A4;ATP1B2;ATP2B4;SLC16A12;ATP1A2;ABCC5;SLC8A2;ATP1A4;SLC24A3;ABCC9;SLC27A1;SLC7A2;SLC1A2;KCNJ8;SLC16A2;LEPR;SLC38A2;SLC6A1;SLC6A17;SLC4A3;INSR;SLC29A1
prerank,negative regulation of nervous system development (GO:0051961),0.3277922344643264,1.0199473419254887,0.45454545454545453,0.6294426069339114,1.0,8/18,24.76%,IL1B;SORL1;ROBO2;PAX6;WNT7A;NOTCH1;WNT3A;DYNLT1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3125268529679765,1.0186667327491716,0.425531914893617,0.6321136676134066,1.0,9/28,20.95%,MYC;INHBA;CCL3;ZFPM1;PTPN2;ZNF675;LILRB4;HOXA7;CDK6
prerank,regulation of cell development (GO:0060284),0.2900274200761494,1.0181348100655119,0.41025641025641024,0.632939746368792,1.0,9/40,14.99%,ASCL2;SIGLEC15;IL1B;HES6;HMGB2;WNT3;YTHDF2;GRN;RPS19
prerank,sensory perception of sound (GO:0007605),0.24986516958209662,1.0174548639582173,0.3953488372093023,0.6340763605625169,1.0,23/85,19.14%,CEMIP;COL1A1;COL11A1;LHFPL5;KCNQ1;TIMM10;TIMM13;CHRNB2;TIMM8B;DCDC2;CACNA1D;SLC52A3;MARVELD2;EML2;ALDH7A1;USH1C;MYH14;TPRN;GRAP;EYA1;BIRC5;MYO3B;ATP6V0A4
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3617329637996183,-1.016757714525065,0.4576271186440678,0.6465572331692796,1.0,7/17,24.37%,PPP1R12A;MAGI2;CALM1;AGTR2;MTOR;CALM2;CD33
prerank,regulation of protein kinase activity (GO:0045859),-0.2565180411234349,-1.0160297330035581,0.40350877192982454,0.6477666795530791,1.0,36/104,22.92%,TSPYL2;RAP1A;DDR2;WWTR1;SNCA;TAB2;PRKRIP1;DBNDD2;PRKAG2;PPM1F;UVRAG;MAPRE3;HSPB1;PLCE1;INPP5K;TAB1;RELN;CDKN1A;MMD2;TRIB2;GNAQ;DUSP19;AZU1;TSC2;ALS2;RASSF2;ANKRD54;CAMKK1;SIRT1;CCL21;CAMKK2;RAPGEF2;SOD1;LRP6;TTN;CAV3
prerank,Rac protein signal transduction (GO:0016601),-0.33198055460053927,-1.015577179080021,0.4528301886792453,0.6482569597313932,1.0,9/18,27.02%,WASF1;HACE1;ABI2;TIAM1;RAC1;ELMO1;BRK1;NCKAP1;CDH13
prerank,multivesicular body assembly (GO:0036258),0.31201838999504716,1.0154308702566113,0.45,0.6391796246819459,1.0,10/30,21.16%,VPS25;VTA1;RAB11A;CHMP4C;CHMP5;VPS37B;STAM;CHMP2B;CHMP1A;MVB12A
prerank,establishment of vesicle localization (GO:0051650),-0.3513285504369553,-1.014650952893965,0.41304347826086957,0.6498916543231573,1.0,4/18,7.83%,KIF5A;SYNJ1;KIF5C;SYT11
prerank,DNA double-strand break processing (GO:0000729),0.3666823112044301,1.0144471283572276,0.5098039215686274,0.6408178516859847,1.0,5/18,13.06%,UBE2N;BLM;DNA2;RBBP8;BRCA1
prerank,regulation of hippo signaling (GO:0035330),-0.35932519767781973,-1.0138137959927078,0.47368421052631576,0.6512654919653178,1.0,8/20,17.86%,WTIP;WWC2;WWC3;IQCJ-SCHIP1;MAPK14;SOX11;DLG5;MARK3
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.300613031717761,1.013720485275549,0.40540540540540543,0.6420289733854261,1.0,15/31,29.22%,THY1;SOCS1;SEMA4D;PRKCZ;SOCS3;PTPN2;LILRB4;CAV1;HYAL2;PPP2CA;CD300A;PTK6;PPP2R1A;PIBF1;MVP
prerank,response to glucocorticoid (GO:0051384),-0.3222566462731595,-1.013573265168921,0.39285714285714285,0.6511886044046116,1.0,11/27,25.35%,FAM107A;SLIT2;ZFP36L1;SLIT3;NR3C1;ZFP36;PDCD7;SSTR2;BCL2L11;HSD3B2;ZFP36L2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.27757696523215186,1.0129673713166525,0.35714285714285715,0.6432622591731426,1.0,11/39,22.02%,THY1;LRP8;RAP2B;DOK7;EFNA1;AGT;DLG3;FCGR1A;LILRB4;CAV1;HYAL2
prerank,anterior/posterior pattern specification (GO:0009952),-0.27098039385203926,-1.012720356306923,0.36538461538461536,0.6525011486457034,1.0,17/62,21.92%,HOXD3;HOXA4;HOXB4;TBX1;WLS;HEY1;HOXB3;SKI;HOXD4;HOXD9;HEY2;PCSK5;HOXA5;SMAD2;HHEX;HOXC5;HOXC4
prerank,regulation of protein export from nucleus (GO:0046825),0.3423990394558221,1.0123452405651072,0.41304347826086957,0.6441075807629276,1.0,11/23,23.95%,GTSE1;YWHAE;IL1B;RANGAP1;GSK3B;RBM22;XPO4;UHMK1;ANP32B;TP53;BARD1
prerank,protein heterooligomerization (GO:0051291),-0.3592910260001674,-1.012118616225883,0.41509433962264153,0.6534022250297724,1.0,4/16,8.48%,PKD1;CPSF7;PKD2;MAT2A
prerank,protein catabolic process (GO:0030163),-0.2696089413060485,-1.0115938407235912,0.4576271186440678,0.6541589962817929,1.0,14/60,15.51%,DENND3;FBXO17;CAPN3;UBE2G2;RAB12;NR1D1;ELANE;FBXO44;FBXO27;UBE2G1;DAB2IP;CELA2A;ADAMTS9;LRSAM1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3393855997477143,1.0110343735741512,0.5405405405405406,0.6468003954313336,1.0,8/20,26.12%,HS6ST2;GLCE;HS2ST1;EXT2;HPSE;SULF2;NDST3;EXT1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.32254725584310445,1.0107484825289053,0.4722222222222222,0.6468215997986893,1.0,6/25,12.51%,DDIAS;TRIAP1;CD44;BCL2L1;KDM1A;TAF9
prerank,positive regulation of reproductive process (GO:2000243),-0.30837576034046765,-1.0104109861726063,0.4482758620689655,0.6565742526478705,1.0,8/35,12.81%,CACNA1H;TACR2;SYDE1;SIRT2;PDE3A;VIP;TACR1;CFAP69
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.332967872537674,1.0101612494662935,0.36,0.6478334983589972,1.0,7/20,15.88%,RASSF10;PROX1;MDK;SHCBP1;TRIM71;KDM1A;SIX3
prerank,midbody abscission (GO:0061952),0.3488228556545803,1.009908746020926,0.425531914893617,0.6478658741794274,1.0,6/17,20.42%,CEP55;KIF20A;CHMP4C;CHMP5;CHMP2B;CHMP1A
prerank,RNA biosynthetic process (GO:0032774),0.29628134669637995,1.009513784644555,0.41509433962264153,0.6481947383852087,1.0,14/32,29.32%,PRIM2;PRIM1;TTF2;POLA1;BRF2;SMN1;TAF4;TERT;GTF2B;TAF5;PRMT5;TBPL1;NCOA6;TAF7
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2626507307510404,-1.0094791992788976,0.41379310344827586,0.6582358937527273,1.0,27/72,23.81%,FAM107A;HDAC4;DCUN1D4;PIAS3;TSPYL5;RASD2;RWDD3;LRRK2;KLHL40;BCL10;WDR48;UBB;DCUN1D3;CDK5RAP3;FBXW7;ANGPT1;PIAS4;GSK3A;PRICKLE1;CRY1;SMAD7;SENP2;WFS1;MYCBP2;PIAS1;MUL1;PINK1
prerank,negative regulation of response to wounding (GO:1903035),0.33263286377280266,1.0090864665292232,0.4358974358974359,0.648646300391091,1.0,6/20,11.14%,CASK;KLK8;RTN4R;EPPK1;MDK;CERS2
prerank,keratinocyte differentiation (GO:0030216),0.3104682271937168,1.009004801282214,0.36363636363636365,0.6481228499252386,1.0,14/32,27.19%,EREG;WNT5A;CDSN;EPHA2;EVPL;DSP;MED1;SCEL;ST14;ADAM9;OPN3;CSTA;ANXA1;EXPH5
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3521155984716672,-1.008793504392606,0.47540983606557374,0.6592503857108948,1.0,8/27,18.39%,ZDHHC15;VPS13D;OBSL1;BICD2;OPTN;VPS13A;GBF1;CSNK1D
prerank,eye morphogenesis (GO:0048592),-0.356675197958376,-1.0083266517253087,0.41818181818181815,0.6597710383611167,1.0,10/19,34.37%,MFAP5;SKI;TENM3;IFT122;EFEMP1;NIPBL;ALDH1A3;RARG;COL5A1;FBN1
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.23854898305944067,-1.0082685183037494,0.4225352112676056,0.6592986936887505,1.0,61/203,21.68%,FLCN;ATP2B4;NOVA1;ASB1;MYOCD;ARNTL;RGS2;ACTN3;SRF;TFE3;PLCL1;RPS6KA5;NR1D1;ATF4;SYT11;EVL;LAMA4;RBPJ;PTEN;NOVA2;NFIB;NPTN;SPX;SPRY1;CORO1C;NPR3;HEY1;MCC;MEF2C;NR1H2;WWC2;DAB2IP;BBS2;ALDH1A1;KLF7;IP6K1;TRPV3;HDAC9;SFRP1;ROCK1;HEY2;RAB11FIP3;WWC3;ZNF423;ADAMTS5;CRHBP;IL17RD;EGFR;IL18R1;ABHD6;GSK3A;INS;HS3ST5;TLE3;LNPEP;VASN;MAP2K6;SMAD7;RAB11FIP5;IFNGR1;PARP3
prerank,positive regulation of cell cycle (GO:0045787),-0.2708421809582652,-1.0077997979628865,0.40298507462686567,0.6597993498543522,1.0,18/65,18.07%,PKD1;MEIS2;PKD2;CITED2;DUSP3;FGFR2;TAL1;CCPG1;PRKCA;USP2;CCDC57;MAPRE3;USP19;ASNS;NUDT16;PDGFB;NUPR1;EGFR
prerank,regulation of mitotic spindle organization (GO:0060236),0.2933198960171566,1.0077714216475642,0.48936170212765956,0.6504331364927807,1.0,13/35,20.42%,TACC3;RAE1;PSRC1;CHMP4C;GPSM2;DRG1;TPX2;CLTC;PLK1;NUP62;CHMP5;CHMP2B;CHMP1A
prerank,protein autophosphorylation (GO:0046777),-0.23739749126252818,-1.0075712467720221,0.38235294117647056,0.6597333285395368,1.0,54/156,23.96%,MKNK1;MAP3K3;FGFR1;ULK1;DDR2;WNK3;CAMK2A;ULK2;PDGFRA;EEF2K;FGFR2;CLK2;FES;KIT;DAPK1;GRK5;PRKD1;DYRK1A;ALK;LRRK2;FLT4;FER;NTRK1;TAOK2;MEX3B;EPHA4;MAPK3;DAPK3;STK33;BMX;CAMK2B;PEAK1;MUSK;CAMK2D;INSRR;AATK;INSR;MARK3;EGFR;ERBB4;MAP3K10;SLK;MAP3K12;PIKFYVE;CAMKK2;MKNK2;SMG1;MTOR;MYLK2;RIPK1;PIM1;PINK1;CDKL5;FLT1
prerank,aortic valve development (GO:0003176),-0.3066232849490105,-1.0074767315908981,0.46296296296296297,0.6593754921750489,1.0,10/35,16.93%,NPPA;NFATC1;SLIT2;EMILIN1;SLIT3;HEY1;ROCK1;HEY2;TIE1;ELN
prerank,response to glucose (GO:0009749),-0.30169877885238977,-1.0070707786834878,0.5,0.6596205088063914,1.0,9/44,12.15%,VAMP2;KCNB1;GPER1;PRKACA;GYS2;PRKAA2;GCK;ZNF236;SLC30A8
prerank,organophosphate ester transport (GO:0015748),0.3309792999704848,1.0067351479228823,0.42105263157894735,0.6524922626672628,1.0,6/23,11.37%,TRIAP1;SCARB1;MTTP;PRELID2;SLC25A19;PRELID1
prerank,regulation of Golgi organization (GO:1903358),-0.3496574396580238,-1.0065433218804907,0.45161290322580644,0.6603067498879911,1.0,10/16,31.46%,RBSN;MYO5A;MAPK1;MAPK3;CAMSAP2;PDE4DIP;MAP2K2;AKAP9;RAB33B;EHD3
prerank,transport across blood-brain barrier (GO:0150104),-0.2630353792278635,-1.0064597102123078,0.4230769230769231,0.6598649265439436,1.0,23/85,18.84%,SLC2A4;ATP1B2;ATP2B4;SLC16A12;ATP1A2;ABCC5;SLC8A2;ATP1A4;SLC24A3;ABCC9;SLC27A1;SLC7A2;SLC1A2;KCNJ8;SLC16A2;LEPR;SLC38A2;SLC6A1;SLC6A17;SLC4A3;INSR;SLC29A1;CD36
prerank,establishment of spindle orientation (GO:0051294),0.3165563765681021,1.0064527080886778,0.4583333333333333,0.6524701110906702,1.0,7/30,9.90%,MAD2L1;SAPCD2;CENPA;SPDL1;NDC80;GPSM2;ZW10
prerank,negative regulation of biosynthetic process (GO:0009890),-0.37178167285117825,-1.0063117244779514,0.5166666666666667,0.6593864908151595,1.0,8/17,29.65%,GPER1;ASXL3;EMILIN1;INS;ABCD1;ABCD2;CEACAM1;SLC30A10
prerank,positive regulation of interferon-alpha production (GO:0032727),0.33394947155697136,1.0063006388979887,0.4523809523809524,0.6521165923307328,1.0,4/20,11.68%,HSPD1;RIPK2;DHX9;STAT1
prerank,response to dsRNA (GO:0043331),0.3173445520969949,1.0058300292995463,0.425,0.65251178257279,1.0,6/24,28.45%,PMAIP1;PDE12;SLC3A2;TICAM1;IRAK3;IFNE
prerank,cardiac ventricle development (GO:0003231),-0.35960494756847317,-1.005627400292067,0.4666666666666667,0.6605768255302126,1.0,7/19,20.07%,PDE2A;DAND5;MDM4;HEY1;HEY2;HECTD1;SCN5A
prerank,protein-containing complex disassembly (GO:0032984),-0.2977519485183627,-1.004841549451391,0.5,0.6620080897481373,1.0,24/54,25.93%,GABARAPL1;LIX1L;CHMP3;DVL3;MAP1LC3C;CSNK1A1;UVRAG;EPG5;LIX1;VTI1B;VPS33B;VIPAS39;DVL2;TSG101;APC;VPS4A;GABARAPL2;FZD1;MAP1LC3A;LRP6;TECPR1;GABARAP;CLN3;VPS33A
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.27083577797395453,-1.004822982352711,0.43478260869565216,0.6613980247652385,1.0,27/67,26.48%,KLF9;TGFBR3;PTPRM;FGFR2;CDKN1C;NR2F2;ATOH8;CAV2;NFIB;MCC;SYNJ2BP;PRL;TINF2;DAB2IP;KRIT1;SFRP1;GDF5;NUPR1;FBXW7;SOX2;B2M;SCG2;NKX3-1;SNAI2;MTSS1;RGCC;CEACAM1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2583543855401806,1.0046666429536881,0.41025641025641024,0.6548044749179421,1.0,30/75,26.91%,FAAH2;ACSL6;ASAH2B;GPX1;AIG1;PNPLA3;ACSL3;ELOVL1;ACSL5;ACOT4;ACOT8;CYP4F3;HSD17B4;CYP4F11;ALOXE3;LTA4H;ELOVL6;ASAH2;CYP2J2;FAAH;HACL1;SLC27A4;CYP4F2;DAGLA;GPX4;CPT2;ALOX12;GSTP1;PLA2G10;ALOX12B
prerank,macroautophagy (GO:0016236),-0.24506707889875126,-1.0045659596629883,0.4411764705882353,0.6614430710922674,1.0,32/115,18.66%,PRKAB2;VPS39;CSNK2A2;GABARAPL1;ULK1;ZFYVE1;LIX1L;ATG14;CHMP3;MAP1LC3C;MFN2;PIP4K2B;PRKAG2;PRKAA2;UVRAG;EPG5;LIX1;VTI1B;VPS33B;PIK3C3;TMEM74;VIPAS39;TSG101;VPS37A;PIP4K2A;VPS4A;KLHL3;GABARAPL2;ATG12;CHMP4A;ATG4B;CSNK2B
prerank,regulation of cell-cell adhesion (GO:0022407),-0.2984900018970888,-1.0044036554038154,0.423728813559322,0.661226744997012,1.0,9/41,14.26%,EPHA7;CITED2;MEGF10;MDGA1;FSTL3;MAGI1;TENM3;FUT9;EFNA5
prerank,cellular macromolecule catabolic process (GO:0044265),0.27859888143207945,1.0041930626394775,0.4666666666666667,0.6552202983982233,1.0,16/49,18.90%,RNASEH1;SND1;STT3B;CHEK2;PNPT1;NCBP1;EXOSC7;MANBA;DNASE1L1;PPP1R8;FBXO6;RNASEH2A;XRN2;IDE;RNASEH2B;NGLY1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.38044635846759856,-1.0041510758842633,0.3968253968253968,0.6612532299952782,1.0,8/16,25.98%,PDGFRA;FER;PDGFB;PLAT;NR4A3;PDGFD;PDGFA;PIK3C2A
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.30436951301545,-1.004056930557745,0.4482758620689655,0.6608792242458977,1.0,13/37,17.79%,CORO2B;FZD4;GCNT2;MYOC;FZD7;SEMA3E;CORO1C;FBLN1;AJAP1;EFNA5;RHOA;KANK1;SPOCK1
prerank,response to UV (GO:0009411),0.2373098279155764,1.003939175001775,0.4473684210526316,0.6553419115606118,1.0,32/95,21.85%,MYC;FEN1;CCND1;POLH;RHNO1;TRIAP1;RUVBL2;ZRANB3;ERCC8;AURKB;ERCC5;NOC2L;RELA;GPX1;KDM1A;PTPRK;MSH6;NPM1;USP1;MAPK13;CDC25A;POLD1;UBE2A;SPRTN;SDE2;ERCC2;EIF2S1;TMEM161A;BAK1;MSH2;DTL;IL12B
prerank,response to estradiol (GO:0032355),-0.3111019397853071,-1.003846944967028,0.4444444444444444,0.6606641294451926,1.0,11/35,21.61%,SOCS2;GPER1;GH1;STRN3;SFRP1;ESR1;CRHBP;EGFR;RAMP3;KAT5;SSTR2
prerank,cellular response to sterol (GO:0036315),-0.3780379655143339,-1.003448131891688,0.45,0.6610721419413872,1.0,5/16,23.79%,RORA;SMO;LRP6;CES1;OSBPL7
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3392560182998145,1.0026697368642319,0.4909090909090909,0.6580511742813803,1.0,5/18,12.90%,WDR43;LYAR;UTP15;HEATR1;POLR2K
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3313058041904065,1.0026596317889123,0.4222222222222222,0.6573280411228294,1.0,5/18,17.31%,UGGT1;EDEM2;UBA52;MAN1B1;OS9
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.256896525695156,1.0024535546033642,0.45454545454545453,0.6572520544352336,1.0,18/56,20.10%,BCAP31;PMAIP1;PML;RPS3;BBC3;STYXL1;BCL2L1;PAK2;AGT;TRAF2;TNFRSF12A;DEDD2;TRAF7;SLC9A3R1;LCK;BAX;BID;CAV1
prerank,icosanoid metabolic process (GO:0006690),0.263140372033108,1.0022813513649669,0.40384615384615385,0.6569815623663344,1.0,20/51,26.91%,DPEP1;CYP2S1;FAAH2;TBXAS1;CYP4F8;GPX1;MAPKAPK2;CYP4F3;CYP4F11;ALOXE3;LTA4H;CYP2J2;FAAH;CYP4F2;PON3;DAGLA;GPX4;ALOX12;PLA2G10;ALOX12B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.25976314750239404,1.002209591134331,0.48717948717948717,0.6549851768786996,1.0,25/63,26.98%,TMED2;AREG;FOLR1;SEC13;CTSC;F5;TMED10;TRAPPC6A;RAB1A;TFG;NSF;TRAPPC9;PREB;CTSZ;CNIH1;KLHL12;TRAPPC2L;TGFA;CUL3;LMAN1;CNIH3;SERPINA1;SEC24A;TRAPPC4;BET1
prerank,vesicle coating (GO:0006901),0.25976314750239404,1.002209591134331,0.48717948717948717,0.6549851768786996,1.0,25/63,26.98%,TMED2;AREG;FOLR1;SEC13;CTSC;F5;TMED10;TRAPPC6A;RAB1A;TFG;NSF;TRAPPC9;PREB;CTSZ;CNIH1;KLHL12;TRAPPC2L;TGFA;CUL3;LMAN1;CNIH3;SERPINA1;SEC24A;TRAPPC4;BET1
prerank,COPII vesicle coating (GO:0048208),0.25976314750239404,1.002209591134331,0.48717948717948717,0.6549851768786996,1.0,25/63,26.98%,TMED2;AREG;FOLR1;SEC13;CTSC;F5;TMED10;TRAPPC6A;RAB1A;TFG;NSF;TRAPPC9;PREB;CTSZ;CNIH1;KLHL12;TRAPPC2L;TGFA;CUL3;LMAN1;CNIH3;SERPINA1;SEC24A;TRAPPC4;BET1
prerank,cellular response to drug (GO:0035690),0.3169084809288656,1.0021861961393548,0.5128205128205128,0.6543670385202752,1.0,7/26,14.83%,MYC;DPEP1;KCNQ1;IL1B;RBM22;RAP2A;ACER2
prerank,response to organonitrogen compound (GO:0010243),0.27952641637316017,1.001665325236176,0.3939393939393939,0.6549482136609471,1.0,11/36,18.73%,DHFR;DERL1;HLCS;TRPM2;DRD2;KYNU;VCP;GPRC6A;ERLEC1;GLRA2;CCDC47
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.28720769831594695,-1.0012872182429151,0.453125,0.666492785402846,1.0,14/44,16.34%,LIMS2;FLNA;FERMT2;MYOC;ILK;TRIOBP;DOCK1;CORO1C;FBLN1;RAC1;EFNA5;ARHGEF7;KANK1;MYADM
prerank,carbohydrate homeostasis (GO:0033500),-0.27084578784024904,-1.0010128131063283,0.3148148148148148,0.6665972794237823,1.0,22/62,22.92%,SLC2A4;KCNB1;CRY2;HECTD4;NGFR;CYP11B1;PRKAA2;GCK;MBD5;SLC30A8;INPP5K;LEPR;CRTC2;KLF7;INSR;PDK2;INS;CRY1;OAS1;WFS1;BAD;CAV3
prerank,actin filament bundle assembly (GO:0051017),-0.3258369419137062,-1.00094256185881,0.4666666666666667,0.6661271069533496,1.0,9/33,19.40%,FAM107A;ADD1;CALD1;LIMA1;DPYSL3;ADD2;BAIAP2;FSCN3;AIF1L
prerank,neurogenesis (GO:0022008),-0.2906453498782427,-1.0005363441092243,0.4262295081967213,0.6666575374147174,1.0,8/42,9.03%,ROGDI;LPAR1;MAPT;HAP1;TRAK2;DCHS1;METTL3;FAT4
prerank,sterol homeostasis (GO:0055092),0.2564078884181969,0.9989336811685726,0.43478260869565216,0.6611246250731252,1.0,23/63,22.83%,TMEM97;DGAT2;SCARB1;MTTP;RALY;XBP1;LIPG;FGFR4;PCSK9;CYP39A1;CYP7B1;INSIG1;LRP5;MALL;ABCG5;APOM;CETP;CAV1;HNF4A;LDLR;TSKU;PLA2G12B;ABCG8
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.3042016289291138,0.9989272458303851,0.4,0.6604173037238293,1.0,6/29,7.80%,DDIAS;FBXO5;PSMD10;CD44;RPS3;BCL2L1
prerank,peptide hormone secretion (GO:0030072),-0.31390505562012916,-0.9988292631275324,0.47058823529411764,0.6700626232598711,1.0,7/25,18.01%,CAMK2G;LTBP4;VIP;SLC30A8;SNX19;PTPRN;CRHR1
prerank,regulation of protein secretion (GO:0050708),-0.2424094919865386,-0.9978029905576228,0.4339622641509434,0.6719736249101064,1.0,41/117,26.88%,APBB3;APBB1;KCNB1;MYOM1;CACNA1C;ARNTL;KCNA5;RAPGEF3;RAP1A;PPP3CB;ITPR1;ABCC8;FRMD4A;PRKCA;DISP1;STXBP5L;GCK;SNAP25;SYTL4;CELA2A;SERGEF;PLA2G1B;CACNA1A;FFAR1;ANKRD1;INS;KCNS3;DRD4;RFX3;IL12A;TTN;RHBDF1;CD33;TGFB3;RAPGEF4;DPP4;EXOC1;DNM1L;G6PC2;GOLPH3;GIPR
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.2776342870530033,0.9977658170305077,0.37209302325581395,0.6629077383379182,1.0,11/41,13.39%,COL1A1;LOXL2;IL1B;AXIN2;CRB2;LEF1;TGFB2;MDK;BAMBI;BCL9L;ZNF703
prerank,multivesicular body organization (GO:0036257),0.2989681132594719,0.9971210616113602,0.4888888888888889,0.6639349440891102,1.0,10/31,21.16%,VPS25;VTA1;RAB11A;CHMP4C;CHMP5;VPS37B;STAM;CHMP2B;CHMP1A;MVB12A
prerank,positive regulation of natural killer cell activation (GO:0032816),0.3606591041543209,0.9966027941758964,0.4186046511627907,0.6645146252208862,1.0,7/15,28.37%,IL23A;IL23R;HLA-F;IL12B;TYROBP;TICAM1;IL18
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.26635088690872755,-0.9964690968408776,0.46153846153846156,0.6750066037680513,1.0,18/74,15.24%,FGFR1;PLXNB3;FGF2;NRP2;AGTR1;ARNT;ZNF580;ITGB3;PRKCA;PRKD1;VEGFB;FLT4;VIP;THBS4;EGFL7;GATA2;HTR2B;PDGFB
prerank,negative regulation of immune system process (GO:0002683),0.3620106441022529,0.9964532673276398,0.5238095238095238,0.6641914003477521,1.0,6/18,18.71%,FOXP3;SOX9;COL3A1;LYN;LILRB4;HOXA7
prerank,regulation of chromosome organization (GO:0033044),0.32153108709311484,0.9961339092694865,0.425531914893617,0.6644453065277762,1.0,6/21,15.70%,MYC;RMI2;XRCC5;BUB1;CDT1;CENPV
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.26845816867880895,-0.9960027836671206,0.4745762711864407,0.6754337786106072,1.0,23/67,27.41%,TGFB1I1;DAND5;WFIKKN2;EMILIN1;SPRY1;SKI;PPM1A;IL17RD;SMAD2;UBB;SIRT1;PRDM16;VASN;SMAD7;PIN1;CD109;PEG10;SMAD3;SNX25;ZNF451;HSPA1A;SMURF1;LDLRAD4
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3365940111282499,-0.9959946476147034,0.46296296296296297,0.6747917888296675,1.0,3/19,5.78%,DAAM2;PTN;PTPRZ1
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.23944482396107478,-0.9933993427727807,0.4264705882352941,0.6812077089236641,1.0,37/134,21.58%,FLCN;ZSWIM8;ULK1;PLIN5;SNX33;TRIM6;ARNT;SNCA;P2RX7;DAPK1;PSEN1;PRKD1;LRRK2;PRKAA2;DCN;OPTN;RDX;DXO;TPCN1;RNF152;TFEB;TP53INP1;ROCK1;TRIM34;VPS11;PACSIN3;AKT2;INSR;PLEKHF1;GSK3A;INS;BNIP3;RC3H1;TRIM8;KAT5;ABCD1;TRIM38
prerank,excitatory postsynaptic potential (GO:0060079),-0.3449061421989023,-0.993043889493662,0.453125,0.6813332647067534,1.0,11/19,23.80%,MPP2;NPAS4;CHRNA3;LRRK2;MEF2C;NPFF;RAB3GAP1;GRIN2A;GSK3A;GRID2;GRIN2C
prerank,regulation of neuron migration (GO:2001222),-0.3373083712471795,-0.9930351588804298,0.49056603773584906,0.6806872934461009,1.0,13/26,24.66%,CAMK2A;SRGAP2;NTNG1;ZNF609;DAB2IP;SEMA6A;SRGAP2C;CAMK2B;IGSF10;SEMA3A;RAPGEF2;NIPBL;TNN
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.37188778386422006,-0.9927421469012784,0.4339622641509434,0.6807672555061589,1.0,8/16,24.28%,ROGDI;WNT6;TBX1;GLI2;ANKRD11;SCN5A;LRP6;EDA
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3515383784129367,0.992452633650145,0.4523809523809524,0.6737556478598824,1.0,6/21,15.35%,MYC;CDK1;CTSH;SOX9;KDR;SULT1A3
prerank,membrane lipid metabolic process (GO:0006643),0.29737891288365587,0.9924377419712629,0.4318181818181818,0.6730280499680251,1.0,8/22,26.91%,SPTLC1;MGST2;TECR;FUT2;ALOXE3;AGMO;SMPDL3B;ALOX12B
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.3145535162995827,0.9923477226379736,0.38,0.6725414243492945,1.0,11/22,26.54%,EIF5A;PMAIP1;RPL37;MSX1;SPRED2;RPS15;RPL23;RPS7;SPRED1;ATR;RPS20
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.264235145049708,-0.9916995381177124,0.4827586206896552,0.6830188039767021,1.0,23/54,28.18%,RBPMS;BMPR1A;SMAD4;BMP3;GDF7;MSTN;EMILIN1;GDF5;GDF6;ACVR2A;CSNK2B;SMAD7;PIN1;INHA;GDF11;TWSG1;TGFB3;SNX25;BMPER;BMP5;NOG;LDLRAD4;BMPR2
prerank,engulfment of apoptotic cell (GO:0043652),-0.35957858582224644,-0.9913431641858513,0.39215686274509803,0.6832152834111058,1.0,4/15,14.01%,XKR4;ADGRB1;MEGF10;RAC1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.28230633963595875,0.9913215544139115,0.40425531914893614,0.6744951214520812,1.0,23/52,32.08%,USP50;RIPK2;WNT5A;CCL3;MYD88;IL17A;GBP5;EGR1;NOD2;MNDA;IFI16;TYROBP;IFNG;CLEC7A;CASP8;NLRP2;PYDC1;PANX1;NLRP3;TLR8;AIM2;TNF;LILRA5
prerank,positive regulation of mRNA processing (GO:0050685),0.3424906784695719,0.9912230572991848,0.45454545454545453,0.6739721312096077,1.0,7/23,16.81%,NCL;NCBP1;NCBP2;DAZAP1;RBM3;LEO1;TRA2B
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.34882293897334926,-0.9911822112685527,0.4230769230769231,0.6828443685034029,1.0,9/16,35.46%,AGTR1;ECE1;AVPR2;AVPR1A;AVPR1B;EDN3;NOS3;CYP11B2;RASL10B
prerank,epithelium development (GO:0060429),0.2388123549924317,0.9911588182365082,0.5121951219512195,0.6734264026556765,1.0,37/118,20.24%,ANXA4;CDK1;VDAC1;MTHFD1;WNT2;TIMELESS;WNT7B;ACTL8;TAGLN2;UPK3A;SHH;DNPH1;PTER;PROX1;SOX9;CASP6;EHF;RIPK4;APELA;SIX1;STAT1;TRIM71;WNT3;UPK2;GRHL2;KDR;GATA6;PPARG;DLX3;TGFB1;PIH1D1;IHH;SLC9A3R1;PAX8;PAX2;ALDOC;VIL1
prerank,response to amyloid-beta (GO:1904645),-0.28758600700762343,-0.9910736974078064,0.43636363636363634,0.6824741932066823,1.0,14/44,19.17%,CACNA2D1;ADRB2;CACNB1;PRNP;NGFR;PSEN1;ATP1A3;NTRK1;EPHA4;GRIN2A;CACNA1A;RAMP3;CD36;CACNA1B
prerank,negative regulation of cation channel activity (GO:2001258),-0.30759615631729154,-0.9910392037476661,0.3620689655172414,0.6818674538639978,1.0,10/26,22.99%,GSTM2;PKD2;CALM1;CASQ2;GNB5;TRDN;CLIC2;CRHR1;DRD4;CALM2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.302340633563345,-0.9905883403446204,0.4915254237288136,0.6822831264444997,1.0,12/45,15.24%,NFATC4;FGF2;SRF;PPARD;TEAD1;NGFR;ATOH8;NFIB;NR3C1;PRL;GATA2;PDGFB
prerank,protein homotrimerization (GO:0070207),0.3406044991076376,0.990478589062544,0.4883720930232558,0.673707638095456,1.0,3/15,5.24%,SLC1A5;SIGMAR1;PNPT1
prerank,protein trimerization (GO:0070206),0.3406044991076376,0.990478589062544,0.4883720930232558,0.673707638095456,1.0,3/15,5.24%,SLC1A5;SIGMAR1;PNPT1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.27503788657170036,-0.9903509339143701,0.49122807017543857,0.6822516397897013,1.0,13/67,11.90%,ITGA10;ADAM11;FERMT2;LAMA5;PTN;ILK;COL16A1;ITGB3;ADAMTS1;PRKD1;DOCK1;DST;FBLN1
prerank,tube closure (GO:0060606),0.301417387938954,0.9894864189792839,0.5,0.675495004367403,1.0,6/31,7.44%,GRHL3;CELSR1;MTHFD1;MTHFD1L;FOLR1;TGFB2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3150624793715386,0.9890117960546951,0.48936170212765956,0.676161784548186,1.0,10/25,25.72%,IL23A;DTX3L;STAT1;APOBEC3F;IL23R;HSP90AA1;ZC3H12A;IL12B;IL12RB1;TRAF3IP2
prerank,epithelial cell morphogenesis (GO:0003382),0.35474659761421123,0.9890032088594225,0.4642857142857143,0.6754504845701348,1.0,7/16,27.17%,MET;POF1B;GRHL2;RAB25;SIPA1L3;CCDC88C;TNMD
prerank,amyloid fibril formation (GO:1990000),-0.2836673999925119,-0.988659540897256,0.5,0.6859875279550477,1.0,17/52,23.64%,GSN;MAPT;SNCA;NPPA;GGA3;APH1B;BACE1;PRL;HSPG2;MFGE8;GGA2;UBB;CD36;INS;B2M;GGA1;RIPK1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2940391592688937,0.9885343955142978,0.46808510638297873,0.6760803224904746,1.0,10/30,19.39%,TRIB3;DCUN1D5;UBE2S;UBE2N;RPS2;UBE2C;PLK1;RAB1A;CDC20;AXIN1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.30816209646818643,-0.9880123017580493,0.46808510638297873,0.6870615015605224,1.0,4/23,9.03%,PHF1;CREBZF;EPC1;MPHOSPH8
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.28635141943794706,-0.9872593836237471,0.5,0.688714578434579,1.0,14/51,14.10%,TSPYL2;ADD1;TLN1;DCTN1;EXTL1;PPP2R5B;PLA2G4B;CTDSP2;TATDN2;ZBTB17;CXXC1;ACADVL;PARP16;EXTL2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.29786282527014646,-0.9867450135581407,0.49056603773584906,0.6894026694294254,1.0,19/50,24.39%,LMO3;WDFY2;TFE3;PPARD;SOX13;ZBTB16;ZFP36L1;FNDC5;RARRES2;SFRP1;ZFP36;MEDAG;VSTM2A;INS;ZNF385A;ID2;PIM1;TMEM64;LPL
prerank,glucose metabolic process (GO:0006006),0.2763627635204317,0.9867114113648647,0.5588235294117647,0.6804746911861586,1.0,22/60,23.35%,SORD;GAPDH;GOT2;TPI1;AKR1A1;MDH2;GAPDHS;G6PC3;KCNJ11;DCXR;LRP5;SLC37A4;ALDOC;GALM;BRAT1;SLC25A13;RBP4;ADPGK;PCK2;ALDOB;SLC25A1;FBP1
prerank,regulation of centrosome cycle (GO:0046605),0.33222406609060173,0.986395126673922,0.5348837209302325,0.6806601291384217,1.0,13/22,33.77%,NAT10;CHMP4C;AURKA;NPM1;CHMP5;CHMP2B;CHMP1A;CHMP2A;RAB6C;ATF5;CHMP1B;GEN1;PKHD1
prerank,positive regulation of embryonic development (GO:0040019),-0.3626135570593907,-0.9863934856838233,0.5,0.6896271461801285,1.0,3/18,8.59%,NR2C2;OSR1;RBM19
prerank,positive regulation of metabolic process (GO:0009893),-0.24854971683753188,-0.9858862651467033,0.5283018867924528,0.6902858110784663,1.0,31/112,22.15%,ACACB;PRKAB2;AGPAT1;ZNF516;ADRB3;PPARGC1B;PHOX2B;ADRB2;MFN2;BSCL2;GRB10;KDM3A;ACADL;OGT;LEPR;LPIN1;ADRB1;THRA;APC;INSR;EBF2;CD36;KDM6B;INS;GATM;PRDM16;EPAS1;EHMT1;CNOT3;SLN;FABP4
prerank,mesoderm development (GO:0007498),-0.3395587497452439,-0.9858334709110672,0.46296296296296297,0.6897400721728199,1.0,10/18,33.37%,TBX1;BMX;TCF15;TIE1;GDF11;TBX6;JAK2;HES7;SECTM1;BTK
prerank,positive regulation of interleukin-1 production (GO:0032732),0.27349245428422897,0.9854422597337761,0.45,0.6825586590601004,1.0,25/58,32.08%,USP50;RIPK2;WNT5A;TMED10;CCL3;MYD88;IL17A;GBP5;EGR1;NOD2;MNDA;IFI16;HMGB1;TYROBP;IFNG;CLEC7A;CASP8;NLRP2;PYDC1;PANX1;NLRP3;TLR8;AIM2;TNF;LILRA5
prerank,regulation of necroptotic process (GO:0060544),-0.3384390414061084,-0.9835150209724437,0.4528301886792453,0.6950332916989026,1.0,4/23,13.68%,CFLAR;SLC25A4;YBX3;OGT
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.317845084810893,-0.9829767233831099,0.5098039215686274,0.6956575993557177,1.0,16/33,28.74%,LSM11;ADAMTS1;RDX;UBE2E2;STXBP4;FAM83D;FGF10;PAGR1;EGFR;KMT2E;PLCB1;RPTOR;PLCG2;RGCC;LSM10;PAF1
prerank,positive regulation of RNA splicing (GO:0033120),-0.31591503262530585,-0.9828712222513961,0.5,0.6952164148478729,1.0,6/31,11.07%,CIRBP;RBM20;PIK3R1;CELF4;DYRK1A;HABP4
prerank,response to retinoic acid (GO:0032526),0.24993339914295482,0.982383739862032,0.4583333333333333,0.6894700959977487,1.0,20/60,21.00%,TESC;WNT2;WNT7B;PTK7;WNT5A;CTSH;SOX9;ABL2;FZD10;WNT3;WNT11;AQP3;GATA6;ACER2;MICB;LYN;WNT8B;PAX2;TMEM161A;RBP4
prerank,negative regulation of protein metabolic process (GO:0051248),-0.2718271354795277,-0.9814506920933754,0.5454545454545454,0.6979387172436918,1.0,16/51,20.08%,CRYAB;FLNA;CLU;ADGRB1;FMN2;ITGB3;PTX3;PRNP;SIRT2;MDM4;ROCK1;EDNRB;AZIN2;EGFR;PFDN5;INS
prerank,negative regulation of cell aging (GO:0090344),0.34119744995145623,0.9807460541199626,0.4186046511627907,0.693230162029381,1.0,7/16,24.78%,FBXO5;RBL1;HMGA2;FOXM1;CDK6;AKT3;TERT
prerank,sulfur compound catabolic process (GO:0044273),0.2917950586284126,0.9807287814144768,0.46808510638297873,0.6925413669744465,1.0,11/39,16.03%,DPEP1;ACAN;HEXB;GLB1;CHAC2;CHAC1;BCAN;ADO;CTH;MPST;FITM2
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3227818435176541,-0.9803918098055432,0.5,0.6999535573968626,1.0,3/22,8.36%,TTLL3;TTLL7;TTLL11
prerank,peptidyl-threonine modification (GO:0018210),-0.2766707547702899,-0.980112560984515,0.5081967213114754,0.6998331904696486,1.0,25/67,23.53%,CSNK2A2;ULK1;GALNT16;WNK3;HIPK4;CDC42BPA;PRKCA;PRKD1;HIPK3;CDC42BPB;DYRK1A;LRRK2;MAPK1;ROCK1;MAPK8;CAMK2D;CSNK2B;MAP3K10;MAP3K12;GSK3A;TNKS;HIPK1;MYLK2;PRKCD;WNK1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.36596592895212604,-0.9798904678808398,0.4482758620689655,0.6996142376412304,1.0,6/15,23.77%,FGF2;AGTR1;NGFR;GATA2;IL12A;HMOX1
prerank,positive regulation of immune system process (GO:0002684),0.3303020290155298,0.9798899932630898,0.4583333333333333,0.6939838643986471,1.0,10/20,33.26%,ZP3;TGFB2;HCAR2;AQP3;TNFSF18;ANXA1;PIK3CD;IFNL1;RSAD2;VEGFA
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.30292322280241957,0.9790509701275879,0.5121951219512195,0.6955526058492505,1.0,9/24,21.16%,VTA1;LAPTM4B;CHMP4C;VCP;CHMP5;LEPROTL1;CHMP2B;CHMP1A;MVB12A
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.34108198324934413,0.9790339959828123,0.4375,0.6948635398327762,1.0,10/21,31.57%,WNT5A;SLC7A5;FFAR2;CLC;TNFRSF1B;NOD2;IL10;SCIMP;LACC1;TNF
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.371933031719604,-0.9789391430697842,0.4642857142857143,0.7013612412091608,1.0,4/18,9.86%,PRKAB2;PPARD;PRKAG2;PRKAA2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.33910864635511345,-0.9778933575657832,0.4576271186440678,0.7033738128712019,1.0,10/22,19.26%,MYOCD;CDKN1C;NR2F2;PTEN;LATS2;CDKN1A;APC;INCA1;HEXIM1;HHEX
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.2763162577824821,-0.9778053302356617,0.48214285714285715,0.7029281044904728,1.0,11/40,19.64%,IL6R;BMPR1A;ZHX3;DDR2;FERMT2;WWTR1;PRKD1;MEF2C;SOX11;ACVR2A;BMPR1B
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.34945300716974625,-0.9772324854037775,0.5882352941176471,0.7037092409212442,1.0,7/18,15.77%,BMPR1A;SMAD4;OLFM1;MDM4;SLIT3;HEY1;HEY2
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.36463323006326404,-0.9771437671042884,0.4528301886792453,0.703246194994587,1.0,6/18,18.89%,WDR91;RIC1;RDX;DAB2IP;VPS11;CDK5RAP3
prerank,acidic amino acid transport (GO:0015800),0.3505975819236718,0.9764930539759437,0.4,0.7010026214726616,1.0,7/18,21.86%,LRRC8E;SLC6A6;LRRC8D;SLC25A22;SLC9A3R1;SLC25A13;GIPC1
prerank,regulation of osteoclast differentiation (GO:0045670),0.27147095765347284,0.9760054723056644,0.5333333333333333,0.7017036171454892,1.0,9/35,18.23%,CEBPB;TNFSF11;IL23A;CCL3;IL17A;POU4F1;IL23R;ZNF675;LILRB4
prerank,odontogenesis (GO:0042476),0.2845021556770698,0.9750949041880589,0.4888888888888889,0.7033863508294506,1.0,13/37,17.36%,INHBA;COL1A2;HDAC2;AXIN2;AMELX;TGFB2;HDAC1;AQP5;TUFT1;AQP3;BMP4;MSX1;PITX2
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.34596036910686595,-0.9748628621117985,0.5217391304347826,0.7085804482138823,1.0,8/20,28.89%,MSTN;RARRES2;MAPK1;MAPK3;AKIRIN1;MST1;MTUS1;DDT
prerank,negative regulation of response to stimulus (GO:0048585),0.24232495341024812,0.9746679720757307,0.4523809523809524,0.7037442710884325,1.0,7/57,5.01%,THY1;CASK;FBXO5;SRMS;RBL1;FOXP3;DDAH1
prerank,prostaglandin metabolic process (GO:0006693),0.29020295483838193,0.9743099126401652,0.5098039215686274,0.7039379133353075,1.0,6/30,10.17%,CYP2S1;AKR1C4;TBXAS1;PLAA;PTGES3;CYP4F8
prerank,positive regulation of angiogenesis (GO:0045766),0.23692969569072575,0.9733095209889745,0.5428571428571428,0.7060447067357332,1.0,26/112,14.45%,IL1A;CXCL8;SMAD1;ADAM12;EPHA1;MYDGF;IL1B;FUT1;ANXA3;WNT5A;EMC10;CTSH;JUP;RLN2;MDK;HMGA2;XBP1;APELA;RUNX1;ADM2;ITGA5;BRCA1;SEMA5A;KDR;GATA6;GRN
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.29142385430745327,-0.9729072756664141,0.5087719298245614,0.7131994298155466,1.0,11/32,22.06%,HDAC6;TCF21;SAFB2;AR;KDM5D;PIAS2;PRMT2;SFRP1;RNF14;SIRT1;PKN1
prerank,protein acetylation (GO:0006473),0.30460310471380153,0.9722199968271079,0.475,0.7083918455349764,1.0,7/30,13.68%,DSCC1;NAT10;ESCO2;NAA15;NAA50;NAA35;HAT1
prerank,proton transmembrane transport (GO:1902600),-0.29936879226723906,-0.9719022085836805,0.4915254237288136,0.7151263419201112,1.0,8/33,18.94%,SLC25A27;UCP3;ATP1A2;ATP1A4;ATP1A3;ATP6V1B1;ATP4A;OTOP2
prerank,regulation of multicellular organism growth (GO:0040014),-0.35621870927009414,-0.9717689321903346,0.48,0.7149656838605525,1.0,5/18,13.39%,GH1;GHR;MBD5;PRL;BBS2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.2848501630750041,-0.971464615929698,0.5967741935483871,0.7150633388386564,1.0,12/47,18.51%,PER1;TGFBR3;SEMA4C;MAPK8IP3;TAOK2;DAB2IP;MAPK1;MAPK3;MID1;FAS;EGFR;MAPK8IP1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3296055349400317,-0.9713952541917265,0.5573770491803278,0.71459197494657,1.0,6/24,10.66%,ZER1;POMT2;ATXN3;HDAC6;RNF185;ZYG11B
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.21708575334632937,0.9711255803389998,0.5116279069767442,0.7107224149924897,1.0,49/172,22.07%,CDH3;SOX4;MYC;IRS1;CXCL8;EREG;PDGFRB;EIF3C;DUOXA2;SCARB1;IL1B;NAT10;DDAH1;EIF4A3;PRKDC;YTHDF1;ASS1;DNA2;RPS4X;EIF6;DHX9;ATAD5;FGFR4;NMD3;PRMT1;EIF3D;DDB1;ELAVL1;ZNF205;NPM1;CDT1;LPGAT1;LARP4B;RBM3;NSUN5;EIF3E;DUOXA1;PTPN2;HSP90AB1;NPM2;EGR1;PASK;MMP8;MLXIPL;HSP90AA1;EEF2;OPN3;GIPC1;LDLR
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3131503252448905,0.9710060043403181,0.5365853658536586,0.7102100498839072,1.0,12/23,29.64%,ADIPOR1;NMI;TSPAN6;RELA;BMP7;TMSB4X;CPNE1;ZC3H12A;SPI1;IFI35;ADGRG3;NLRP3
prerank,defense response to bacterium (GO:0042742),0.2189111866324033,0.9709885056875065,0.5833333333333334,0.709501231941841,1.0,43/155,24.86%,CEBPB;IL23A;ROMO1;ANXA3;LPO;LCN2;SYK;GSDMA;DEFA6;HMGB2;SLPI;OAS2;RPL39;MYD88;WFDC10A;NOS2;PRB3;PI3;SEMG1;RPS19;FPR2;ISG15;RAB1A;GNLY;IL23R;PGLYRP4;NOD2;OAS3;SERPINE1;ANG;PGLYRP3;CXCL13;DMBT1;RNASE7;GSDMC;IL12B;S100A14;GSDMB;NAIP;RPL30;PPP1R11;WFDC3;DEFB4A
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.23084880269489505,-0.9706259695697104,0.5396825396825397,0.7159684288352164,1.0,43/157,20.17%,FGFR1;NRG2;FGF2;GAB1;FERMT2;TSPYL5;GCNT2;MYOC;BTC;PDGFRA;RASD2;PIK3R1;FGFR2;FGF22;KIT;KITLG;TNFAIP8L3;FLT3LG;KL;MC1R;THPO;P2RY12;FGF17;RICTOR;RAC1;PDGFB;ESR1;AKR1C2;FGF7;FGF5;FGF10;AKT2;FGF1;RTN4;INSR;FGF16;EGFR;ERBB4;RAMP3;ANGPT1;RET;INS;CCL21
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.30034296896890594,-0.9699531830069352,0.5283018867924528,0.7172357687378956,1.0,13/32,27.72%,NYAP1;PIK3R1;PTEN;ZFP36L1;SIRT2;HTR2B;MYO16;PIK3R2;HTR2A;PIK3C2A;PIK3R5;TPTE2;LTK
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3123176659219331,-0.9696233989005942,0.5423728813559322,0.7176587508930157,1.0,11/23,25.87%,PIK3R1;MSTN;PLCE1;ABI2;ARPC2;RAC1;WASF2;BRK1;OCLN;AKIRIN1;NCKAP1
prerank,intermediate filament organization (GO:0045109),-0.3509811117122572,-0.9690436868263199,0.46153846153846156,0.7184616209335247,1.0,7/17,20.14%,DES;GFAP;VIM;NEFL;DNAJB6;KRT20;KLHL24
prerank,negative regulation of lipid storage (GO:0010888),-0.32302130689358677,-0.9688284368239745,0.5740740740740741,0.7183342092774209,1.0,4/19,12.51%,PPARD;ITGB3;ABCA1;NR1H2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.2866273881148901,0.9684905634786006,0.55,0.715734891058239,1.0,11/32,18.10%,INHBA;SHH;ARMC6;TMEM190;BATF;MLLT3;KDR;BMP4;PLD4;TGFB1;PLEK
prerank,cellular response to heat (GO:0034605),0.31084168442219196,0.9682266124847512,0.5348837209302325,0.7155551460816285,1.0,14/34,26.24%,CLPB;POLR2D;IL1A;YWHAE;HSBP1;VCP;SUMO1;HSP90AB1;TRPV4;ZFAND1;HSP90AA1;RBBP7;THBS1;HTRA2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.28122528199845154,0.9681086821171897,0.5526315789473685,0.715063041243908,1.0,6/41,6.82%,SLC5A6;SLC6A14;SLC7A11;SLC38A5;SLC7A5;SLC19A1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.30067989360750863,-0.9680912094069279,0.42857142857142855,0.7195060139761541,1.0,14/41,26.40%,CLU;MAGI2;GH1;NTF3;CD63;CBL;AHI1;INSR;ANGPT1;CCL21;B2M;SGIP1;DGKD;HIP1
prerank,response to unfolded protein (GO:0006986),0.2816695979839707,0.9680076880691246,0.5588235294117647,0.7145372505818546,1.0,18/48,20.50%,STT3B;HSPD1;DERL1;ERP44;TMBIM6;HSPA14;HSPA9;HSPA4;TM7SF3;TOR1B;DNAJA1;HSPH1;HSPA5;HSP90AB1;HSPA13;BAX;HSP90AA1;BAK1
prerank,fatty acid beta-oxidation (GO:0006635),-0.26929412738529535,-0.9676993831600073,0.5151515151515151,0.7197486185717973,1.0,17/51,26.13%,ETFDH;ACAD11;ECHDC2;PPARD;ACADVL;ACADL;ECI2;ACAT1;HADHB;ABCD4;CROT;ABCD1;BDH2;ACOX2;ABCD2;ACADM;CRAT
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.23376430627902695,0.9676891278573557,0.55,0.7145789292216409,1.0,33/128,15.41%,CEP72;CDK1;CDK7;SKP2;KHDRBS1;CEP250;CHEK2;PHLDA1;YWHAE;MASTL;NEK2;AJUBA;CDC25C;TUBB4B;HAUS2;YWHAG;TUBA4A;HAUS8;CEP76;AURKA;PPME1;PKMYT1;CKAP5;LCMT1;HAUS1;HAUS6;PLK1;TUBG1;FOXM1;USH1C;CEP78;PLK4;CDC25A
prerank,regulation of neuron apoptotic process (GO:0043523),-0.23646529761857812,-0.9674452632752751,0.5862068965517241,0.7195938775387908,1.0,32/96,25.27%,NFATC4;NRBP2;KCNB1;GDNF;EPHA7;EGLN2;PTPRZ1;ATF4;PRNP;NGF;CRLF1;BCL2;CNTF;BHLHB9;NTRK1;BACE1;MEF2C;MAG;NTF3;NUPR1;CLCF1;CCL2;SOD1;LIG4;WFS1;CPEB4;GRID2;LANCL1;PINK1;TGFB3;CLN3;FOXO3
prerank,regulation of spindle organization (GO:0090224),0.33339276198562473,0.9669326809836553,0.47368421052631576,0.7158213699530258,1.0,7/18,15.20%,TACC3;RAE1;PSRC1;GPSM2;TPX2;CLTC;NUP62
prerank,positive regulation of cell death (GO:0010942),0.2518610270635995,0.9667557454683275,0.5714285714285714,0.7156309346863092,1.0,23/61,27.24%,PRR7;GRIN2B;RIPK2;PHB;WNT5A;AXIN2;SLC6A6;GSK3B;MMP3;FOS;BMP4;HTATIP2;ACER2;EGR1;FYN;EIF2S1;ZC3H12A;TYROBP;CALCR;CDKN1B;ITGB2;DDIT4;IFNG
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3870945263674619,-0.9666015631741917,0.4772727272727273,0.7210430442473775,1.0,8/17,21.85%,FGFR1;RAI2;CELF1;CELF4;STOX2;RICTOR;UBR3;OSR2
prerank,positive regulation of B cell activation (GO:0050871),0.25898990268115507,0.9662581621155586,0.56,0.7164318422093899,1.0,12/47,19.78%,EPHB2;SYK;CHRNB2;IL21;CD81;XBP1;SH3KBP1;CD320;PAXIP1;NOD2;VAV3;TNFSF4
prerank,axonemal dynein complex assembly (GO:0070286),0.30953970808600373,0.9662388884119194,0.5294117647058824,0.715746209100616,1.0,5/22,11.73%,DNAAF5;CCDC103;DNAAF2;SPAG1;DNAAF3
prerank,regulation of transport (GO:0051049),-0.2854950443117305,-0.9662253876353204,0.5636363636363636,0.7213538938469526,1.0,9/34,13.75%,VAMP2;ICA1L;POFUT2;USP6;SNCA;FES;LRRK2;SLC30A8;LEPR
prerank,negative regulation of protein transport (GO:0051224),0.30687867145211833,0.9658892513805024,0.5,0.7159703991698388,1.0,9/25,23.92%,CYP51A1;NDFIP2;RHBDF2;ERP29;DRD2;SNX12;IL12B;HMGCR;WWP2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.30236921475700357,0.9657506839451663,0.5306122448979592,0.7156082953066384,1.0,12/30,22.95%,TNFAIP3;BCL2L1;ICAM1;GPX1;TNFRSF10B;GSK3B;BRCA1;TRAF2;RNF34;SERPINE1;TNFRSF10A;FASLG
prerank,macrophage activation (GO:0042116),-0.29392690701547863,-0.9648602282494879,0.5833333333333334,0.7243903280534482,1.0,8/35,23.35%,MAPT;CRTC3;CLU;SNCA;DYSF;AZU1;IFNGR1;PLCG2
prerank,positive regulation of DNA binding (GO:0043388),0.2780972881751177,0.9643486601236098,0.5116279069767442,0.7186550092444611,1.0,12/30,21.40%,HMGB2;CEBPG;POU4F1;NME1;MMP9;PPARG;PLAUR;EDF1;TGFB1;MMP8;HES1;HMGB1
prerank,regulation of protein localization to nucleus (GO:1900180),0.257344109841553,0.9633883777692035,0.5909090909090909,0.720824230813261,1.0,15/45,19.24%,CDK1;BYSL;GTSE1;SHH;ATP13A2;DTX3L;GSK3B;ORMDL3;LAMTOR5;PLK1;BMP4;TGFB1;LILRB4;SUMO3;CARD10
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.25581903467189904,-0.9626591068716492,0.5142857142857142,0.7291605086521588,1.0,17/72,15.13%,TGFB1I1;GLIPR2;FERMT2;GCNT2;PHLDB1;SMAD4;PHLDB2;WWTR1;CLASP1;OLFM1;PTEN;CLASP2;SPRY1;DAB2IP;TIAM1;SFRP1;EPHA3
prerank,organic substance transport (GO:0071702),-0.23034243834666598,-0.9622401728693004,0.5806451612903226,0.7295855716615148,1.0,36/125,24.33%,VAMP2;ABCA9;ABCA10;ABCA6;ARRDC4;ABCA8;CUBN;CHMP3;ABCG4;PEX19;DISP1;ABCA1;LRP1B;RAMP1;ARRDC2;SLC48A1;RD3;SLC35F3;VPS33B;SLC47A1;ABCA5;CEP290;ABCA3;SLCO2A1;RAMP3;NME4;RUFY1;ABCD1;ABCG2;RAMP2;CHKA;ABCB9;TXNIP;KIF3A;ABCD2;SLC19A2
prerank,zymogen activation (GO:0031638),0.29133669506042636,0.961706059970283,0.48936170212765956,0.7245234487043263,1.0,10/33,21.91%,PERP;F12;RIPK2;PLAU;CTSH;ASPH;PRSS3;BAK1;IFI16;LGMN
prerank,positive regulation of neuron death (GO:1901216),0.25002198089048283,0.9614324447322504,0.5,0.7244400077201717,1.0,20/46,28.04%,GRIN2B;CDK5;WNT5A;TGFB2;CCL3;PCSK9;GSK3B;FOS;GRN;EGR1;FYN;BAX;EIF2S1;TYROBP;CTNNB1;ITGB2;DDIT4;CDK5R1;IFNG;TFAP2A
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.21056901299061645,-0.9610082001883722,0.5857142857142857,0.7320003584432608,1.0,94/329,23.76%,TGFB1I1;GDNF;PRKAB2;NR2C2;AGPAT1;ZNF516;NPR1;BMPR1A;FGF2;TAPT1;GLIPR2;ADRB3;FERMT2;GCNT2;PTN;HAP1;NUMA1;SYDE1;SMAD4;LURAP1;WWTR1;PPARGC1B;PHOX2B;GH1;NLGN1;ADRB2;ABCA1;ADRA1A;SOX5;MFN2;OLFM1;GHR;RBM19;ADRA1D;ZBTB16;BSCL2;SLC27A1;GRB10;C1QTNF3;VIP;BMP1;KDM3A;CADM1;PRL;INPP5K;S100A13;ACADL;TIAM1;OGT;LEPR;LPIN1;AVPR2;ADRB1;FST;HTR2B;PDGFB;ROCK1;KAT2A;THRA;APC;TBXA2R;NPPB;SMO;SOX11;RTN4;TP53BP1;SMAD2;EBF2;CD36;PLCB1;BMPR1B;PLA2R1;KDM6B;INS;SIRT1;GATM;AVPR1A;PRDM16;EPAS1;SOX6;EHMT1;SOD1;CNOT3;HHLA2;SLN;FABP4;RFX3;MTOR;BAD;SOX8;GADD45G;ADRA1B;ESRRB;ADCYAP1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.31493676229387624,0.9610063333170722,0.5111111111111111,0.7246424313176075,1.0,10/21,23.40%,MAD2L1;FBXO5;UBE2S;UBE2C;PLK1;RAB1A;CDC20;RPL11;RPL23;RPS7
prerank,protein localization to organelle (GO:0033365),-0.23342791597080892,-0.9606205001005764,0.49122807017543857,0.7321765996535353,1.0,41/137,20.77%,VAMP2;TUB;ANK2;MICALL1;XPA;BBS4;TTC21A;TOR1AIP1;CROCC;OBSCN;PRNP;BBS1;OBSL1;BICD2;LRRK2;TULP3;GBP2;OPTN;TIA1;CEP68;CNTLN;BBS2;CSRP3;PACSIN2;GBF1;ZNF423;TTC21B;TULP1;BBS9;IFT122;GABARAPL2;VAPA;CSNK1D;SCG3;ARL3;CTDNEP1;HHEX;TRAM1L1;TULP2;PIKFYVE;WDR35
prerank,ureteric bud morphogenesis (GO:0060675),-0.33842806023647765,-0.9605564315866986,0.47692307692307695,0.7315998204876911,1.0,4/19,7.35%,GDNF;PKD2;FGF2;TCF21
prerank,positive regulation of protein kinase activity (GO:0045860),-0.22433902191235644,-0.9605136058825029,0.5606060606060606,0.7310153982604801,1.0,40/150,20.25%,RAP1A;IL6R;DDR2;CLU;STRADA;SLC8A2;CALM1;DLG4;GH1;SNCA;ITGB3;ADRB2;TAB2;NAB2;PRNP;CAMK1;PRKAG2;SLC27A1;MTCP1;TAOK2;MAPRE3;DAB2IP;EPHA4;PARP16;RELN;CDKN1A;MMD2;RHOA;PDGFB;GPRC5B;CCDC88A;DUSP19;AZU1;NRK;INSR;ALS2;RASSF2;CAMKK1;CCL21;RAPGEF2
prerank,canonical Wnt signaling pathway (GO:0060070),-0.2666300107675886,-0.960216491348369,0.5625,0.7312008098455841,1.0,19/67,17.74%,TCF7L1;WNT9A;DIXDC1;SFRP5;FZD4;CSNK1E;DVL3;WNT6;CSNK1A1;WNT5B;FZD7;PTEN;LRRK2;WNT2B;DVL2;SFRP1;APC;FZD8;WNT16
prerank,glycerolipid catabolic process (GO:0046503),0.3354689779847302,0.9599812307603682,0.5476190476190477,0.7267166544873949,1.0,6/19,13.66%,ABHD12;GDPD1;LYPLA2;ABHD2;PLA2G4E;PLA2G4D
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.27726714028475813,-0.9598709514970656,0.5689655172413793,0.7316127736493272,1.0,21/41,37.14%,POMC;CD34;SYT11;MC1R;DICER1;C5AR2;NFKBIL1;CD33;BPI;NLRC3;NR1H4;CACTIN;CX3CL1;RARA;GAS6;ARG2;SIRPA;CIDEA;LGALS9;ADIPOQ;CLEC4A
prerank,T cell activation involved in immune response (GO:0002286),0.29974286338974765,0.9597771180031928,0.5576923076923077,0.7265855998309775,1.0,9/27,36.09%,MDK;ICAM1;TNFSF18;IFNE;LCP1;CD74;FCER1G;EIF2AK4;LILRB1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.37108440933256853,0.9595934859051501,0.45098039215686275,0.7263522816875793,1.0,8/15,23.73%,GTSE1;YWHAE;IL1B;GSK3B;RBM22;XPO4;ANP32B;TP53
prerank,positive regulation of interleukin-8 production (GO:0032757),0.2451098367979633,0.9595175084036079,0.475,0.7258576831541002,1.0,24/59,31.57%,IL1B;SYK;MYD88;RELA;FFAR2;NOS2;LAMTOR5;RAB1A;F2R;NOD2;SERPINE1;CHI3L1;HMGB1;HYAL2;CD2;CD58;CLEC7A;CD244;PARK7;TLR7;NOD1;TLR8;IL17D;TNF
prerank,liver development (GO:0001889),-0.3126558829474543,-0.9593602032334602,0.5357142857142857,0.7323291124339734,1.0,7/32,7.79%,NPHP3;TGFBR3;PKD2;CITED2;PHF2;CCDC39;CCDC40
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3109689991181242,0.9592798529211748,0.5121951219512195,0.7257279114231976,1.0,5/23,8.48%,CDH3;CASK;AREG;EPPK1;MDK
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.33671946925619434,-0.957923207539155,0.44642857142857145,0.7354133558665024,1.0,9/24,24.74%,CHKB;PLA2G6;ABHD4;SLC27A1;LPIN1;ETNK2;PISD;CHKA;LPIN3
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2533304912007077,0.957356264783369,0.5609756097560976,0.7308569409113187,1.0,15/50,18.07%,PSMD14;PSME3;NUDT15;LAMP3;PSME2;PSMC2;UCHL5;GPX1;RAD23B;PSME1;PSMF1;COMMD1;PRKCG;HSP90AB1;DESI1
prerank,glycoprotein catabolic process (GO:0006516),0.34030719394258024,0.9570581690909501,0.52,0.7308130901684188,1.0,7/17,18.90%,STT3B;ADAMTS12;EDEM2;MMP12;MANBA;FBXO6;NGLY1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.31491116854525647,-0.9570550328101675,0.5416666666666666,0.7368470129148311,1.0,9/27,16.15%,DDX39B;TCEA2;ZMYND11;SETD5;CCNT2;THOC5;KAT7;THOC1;SCAF8
prerank,protein ubiquitination (GO:0016567),-0.19820186255336195,-0.9568476080797153,0.5789473684210527,0.7366695576830657,1.0,144/492,24.80%,HIF3A;RNF112;DTX3;WSB1;ZSWIM8;TRIM39;CAND2;ASB2;FBXO32;FBXO10;FBXO9;ASB1;PDZRN3;FBXL22;FBXL7;SASH1;TRIM52;LZTR1;HECTD2;UBE2QL1;KLHL42;ARRDC4;KLHL21;FBXW4;KLHL41;FBXO17;TRIM3;UBE2G2;PELI3;FBXO31;TRIM6;FBXO30;UBE2D4;UBE2E1;TRIM23;RNF185;PJA2;RBBP6;RNF146;RNF19A;RNF217;RNF38;DET1;ASB5;BCL2;KLHL22;CUL9;SKP1;FBXO24;KCTD10;RNF11;UBE3B;FBXW2;HACE1;KLHL20;LONRF1;RNF10;TRIM63;RNF115;PELI2;UNKL;FBXO44;NPEPPS;WAC;FBXO27;AKTIP;UBE2G1;FBXL5;HERC2;DZIP3;UBE2E2;UBR2;UHRF2;FBXL2;UBE4B;TRIM50;RNF152;NEDD8;UBE2V1;ANAPC16;RNF166;UBE2Q2;BCL10;UBR1;LRSAM1;CHFR;BTRC;RNF122;TRIM34;ARIH2;VPS11;SH3RF3;HLTF;CBL;RNF144B;SPSB1;KLHL3;MYLIP;RTF1;MIB2;UBB;RNF31;RNF220;UBR3;FBXW7;UBOX5;ARIH1;RNF14;TRIM33;FBXL8;SIRT1;KLHL24;TRIM62;HERC5;LNPEP;RC3H1;EPAS1;FBXL12;PSMD9;UBE2H;TRIM38;PHC1;TRIM44;UBR5;FBXO15;TRIM47;TNKS;MYCBP2;CNOT4;ZNRF1;MUL1;SPSB4;RNF167;PINK1;NFX1;FBXO25;PSMC5;TRIM41;DDB2;RNF144A;TRIM73;FBXW11;TMEM129;RRAGA
prerank,actin filament capping (GO:0051693),-0.34461433520784024,-0.9552297156574004,0.574468085106383,0.7396478324493175,1.0,6/19,17.73%,ADD1;GSN;TRIOBP;FLII;ADD2;CAPZB
prerank,barbed-end actin filament capping (GO:0051016),-0.34461433520784024,-0.9552297156574004,0.574468085106383,0.7396478324493175,1.0,6/19,17.73%,ADD1;GSN;TRIOBP;FLII;ADD2;CAPZB
prerank,regulation of cell death (GO:0010941),-0.24379618833024294,-0.9549582697123529,0.53125,0.739632948449714,1.0,32/89,24.71%,TSC1;CRYAB;FGF2;FERMT2;CLU;CELF1;SNCA;SNCB;NCK1;PRKD1;SRGAP2;LRRK2;SNCG;PARP16;RILPL1;HTR2B;APC;PDE8A;WNT16;SOX11;DCC;UBB;RAMP3;CD36;HBB;BNIP3;GPR75;SARM1;ACOX2;TMEM109;NKX3-1;PACRG
prerank,positive regulation of dephosphorylation (GO:0035306),-0.3040356736197628,-0.9546350512841949,0.5517241379310345,0.7396873817101771,1.0,9/28,24.90%,MTMR9;CALM1;DLC1;CDH5;PIN1;CALM2;PRKCD;CAMTA1;SMPD1
prerank,regulation of response to external stimulus (GO:0032101),0.22432141250794937,0.9540633312285,0.5555555555555556,0.7384426676523246,1.0,50/124,31.21%,EPHB2;CAMKMT;LRP8;WNT5A;PIK3AP1;TKFC;USP18;CXCR4;CD55;XIAP;STK24;SPATA2;MYD88;RELA;FOXA2;ADAMTS12;SETD6;METAP1;GRK1;GATA6;GRN;TMSB4X;F2R;IL1RL2;NOD2;ZMPSTE24;ERAP1;GUCY2D;TNFSF4;CAV1;SEMA7A;CASP4;ELMOD2;PPEF1;ZBP1;METAP2;ACE2;ANXA1;IL37;CASP8;PARK7;BCL6;HCK;NLRP6;SAMHD1;DAGLB;LACC1;XCL1;AREL1;CASP5
prerank,cellular response to alcohol (GO:0097306),-0.27316584832164853,-0.9537306326591407,0.5806451612903226,0.7413511630813535,1.0,13/48,23.79%,ADCY5;KLF9;ADCY2;GNAI1;GNG2;SFRP1;AKR1C2;ADCY6;SMO;PTGFR;LRP6;CES1;OSBPL7
prerank,meiosis I (GO:0007127),-0.3192623086493496,-0.9536622206546459,0.5294117647058824,0.7407900919711846,1.0,9/22,23.14%,FOXJ2;PTTG2;CCNA1;MOV10L1;FOXJ3;TDRD9;ZCWPW1;BCL2L11;DDX4
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.3243395229373413,0.9535596486606998,0.5,0.7391611135619977,1.0,4/15,12.51%,WNT5A;DHX9;AGPAT2;TAF9
prerank,transcription by RNA polymerase II (GO:0006366),0.19918687089660508,0.9535539512586769,0.6333333333333333,0.7384302588184488,1.0,103/312,26.55%,NFE2L3;POLR2F;POLR2D;CSTF2;CPSF3;INTS7;TFDP1;NOTCH3;SNRPF;EAF1;CDK7;CBFB;SNRPG;ETV7;ABT1;CSTF1;SLBP;TRIM24;NR2C2AP;SNRPB;NELFCD;E2F3;GTF2H3;NABP2;DDX21;NCBP1;HDAC10;SNRPE;NR0B2;CCNK;NFYA;SSRP1;TEAD4;TAF1A;NUDT21;TTF2;MAZ;XBP1;TRIP13;HDAC1;CLP1;NCBP2;ADRM1;CPSF2;POLR2C;TAF9;GTF2F2;POLR2K;MLLT3;GTF2E1;POLR2J;MED18;HSF2BP;ZNF473;LEO1;POLR2G;PPARG;NOCT;MED1;CDK12;TAF4;DEK;BTF3;CTR9;NELFE;CPSF4;INTS5;RPRD1B;SNRPD3;ERCC2;NR1I3;POLR2H;ELP4;HNF4A;POLR2I;MED20;TAF15;POLR2L;NOTCH1;CSTF3;RNGTT;GTF2A1;TAF4B;NRBF2;HNF4G;NELFA;ESRRA;GTF2E2;VDR;CREBBP;GTF2B;GTF2A2;NKX2-8;TCFL5;GTF2I;INTS2;POLR2B;TAF5;CSTF2T;LHX1;TAF2;FOXE3;NELFB
prerank,regulation of synapse organization (GO:0050807),-0.2989969897084247,-0.9535036797720717,0.5571428571428572,0.7405669078745244,1.0,12/25,26.95%,SLITRK2;SETD5;MDGA1;MEF2C;EPHA4;CAMK2B;IL1RAPL1;GRIPAP1;CDKL5;CLN3;SLITRK4;YWHAZ
prerank,DNA methylation or demethylation (GO:0044728),0.3338023109132076,0.9531711092482044,0.5111111111111111,0.7379550840918521,1.0,6/19,15.67%,DNMT1;BEND3;GATAD2A;DNMT3B;FOS;SPOCD1
prerank,DNA alkylation (GO:0006305),0.3338023109132076,0.9531711092482044,0.5111111111111111,0.7379550840918521,1.0,6/19,15.67%,DNMT1;BEND3;GATAD2A;DNMT3B;FOS;SPOCD1
prerank,protein modification by small protein conjugation (GO:0032446),0.19351411831742057,0.9528942576055554,0.6666666666666666,0.7379381173697731,1.0,99/381,21.45%,RFWD3;NUP37;UBE2T;ENC1;DCUN1D5;RNF39;MOCS3;ASB9;NUP155;UBE2S;VHL;FBXO45;UBE2N;TRAIP;ATG3;RAE1;TRIM24;RNF113A;DERL1;NUP93;RAD18;NUP35;RNF6;RNF40;SEH1L;PEX13;PRKDC;TRIM72;NUP210;DTX2;NUP43;FBXO4;RNF43;NAE1;LMO7;UBE2C;UHRF1;ZNRF3;CCNF;NUP50;TRIM27;NUP88;RANGAP1;PEX10;NUP107;BSPRY;DTX3L;RNF212B;TRIM14;TRIM26;KLHL8;UBA2;DDB1;TSPAN17;NUP205;BRCA1;SPSB2;ANAPC11;PLK1;NSMCE2;UBA52;VCP;TRIM11;NUP62;LEO1;UBA1;ISG15;CUL4A;RNF34;NUP160;RNF187;COMMD1;EYA1;UBE2A;TRIM54;SUMO1;UFC1;TRAF7;OS9;OTULIN;UBE2K;NDC1;RNF181;SUMO3;CTR9;SDE2;URM1;UBE2D1;BIRC7;VCPIP1;TRIM28;UFM1;HECW1;CUL3;HECW2;KEAP1;CBLC;DDRGK1;UBE2Z
prerank,determination of bilateral symmetry (GO:0009855),-0.2981436537391949,-0.9520947469688158,0.509090909090909,0.7436143525972928,1.0,4/26,7.90%,NPHP3;PKD2;CITED2;TBX1
prerank,negative regulation of T cell activation (GO:0050868),0.2709280353944931,0.9519405413218904,0.47368421052631576,0.7397912222975469,1.0,20/41,34.99%,CEBPB;IL4I1;FOXP3;CD80;JAK3;PLA2G2F;VTCN1;LILRB4;PLA2G2D;CD86;SDC4;TIGIT;IL10;GLMN;IFNL1;CD274;HAVCR2;LAX1;PDCD1LG2;TNFAIP8L2
prerank,mRNA stabilization (GO:0048255),0.26915646621684547,0.951746785476784,0.4666666666666667,0.739569858317835,1.0,13/38,16.77%,E2F1;PABPC1;IGF2BP1;AXIN2;DHX9;MYD88;MAPKAPK2;HNRNPC;FUS;ELAVL1;HNRNPA0;NOCT;SYNCRIP
prerank,phagosome maturation (GO:0090382),0.2547255010582991,0.9516575041467725,0.4864864864864865,0.739135336214136,1.0,10/37,19.90%,ATP6V1C2;MREG;RAB20;ATP6V1G1;ATP6V0B;ATP6V1A;ATP6V1F;RAB7A;ATP6V0A4;CORO1A
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.3465790493451997,-0.950543531958409,0.5625,0.7470267409101292,1.0,6/16,17.75%,PSEN1;HAND1;HEY1;HEY2;SIN3A;SOX11
prerank,regulation of multicellular organismal development (GO:2000026),0.3066442644167224,0.9504608555808588,0.5208333333333334,0.7415543875234428,1.0,6/27,9.23%,CDK1;RACGAP1;GBX2;DUSP9;DUSP6;OAS2
prerank,protein-containing complex subunit organization (GO:0043933),-0.24327310113485404,-0.9504191501501233,0.532258064516129,0.746643303189184,1.0,25/108,17.29%,VAMP2;SH3BGR;WDR19;CAPN3;TCAP;MITF;TRAF1;DLG4;PARD3;TEAD1;LAMC1;KMT2A;DET1;WASF1;WASF3;MDM4;NCKAP1L;TSPAN4;MAGI1;RANBP9;ADD2;TEAD2;APC;FAS;WIPF1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.2552557977351169,-0.9498061935069544,0.6101694915254238,0.7475168006095083,1.0,22/64,22.82%,LIMS2;FLNA;VIT;FERMT2;MYOC;ILK;TRIOBP;PPM1F;DOCK1;ARL2;RAC1;SFRP1;ARHGEF7;PDGFB;MYADM;CD36;CCL21;TESK1;FBLN2;CCL28;ECM2;RSU1
prerank,intracellular protein transport (GO:0006886),-0.20952235143528503,-0.9496916050036656,0.6197183098591549,0.7471508148482539,1.0,63/321,15.53%,SEC31B;PKD1;CLIP3;SNX1;DNAJC27;TBC1D1;SGSM2;AKAP6;TBC1D17;EIF4ENIF1;ARL4D;STX1B;RABGAP1;RABL2B;TBC1D10A;USP6;HAP1;STRADA;TBC1D26;RABL2A;VPS45;RAB6B;STX16;SNX15;TRAK2;WDR11;MAP1LC3C;TRIM23;HDAC6;NLGN1;SNX27;STX2;COPZ2;RAB28;TECPR2;NGFR;EVI5L;RAB5B;NPAP1;TBC1D2B;GPIHBP1;RIC1;NAPB;SGSM1;GGA3;IPO13;RAB23;MYO1C;WLS;VPS33B;SPRN;FAM53C;HERC2;AP4E1;TBC1D13;BAG3;VIPAS39;KIF13A;RANBP3L;HOMER3;TICAM2;TBC1D25;AP4S1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3147534480684759,-0.9494864338849185,0.5769230769230769,0.746862807860493,1.0,7/25,14.66%,RHOQ;GDI1;NUMB;PID1;INPP5K;KCNE1;TMBIM1
prerank,regulation of macrophage activation (GO:0043030),0.3015462373291135,0.9490853491101603,0.46511627906976744,0.7448549049580593,1.0,4/28,7.50%,HSPD1;WNT5A;CEBPA;SPACA3
prerank,peptidyl-arginine modification (GO:0018195),0.36052007127050223,0.9490690562076248,0.5434782608695652,0.744124943044102,1.0,3/15,11.60%,PADI3;PADI1;PRMT1
prerank,primary alcohol metabolic process (GO:0034308),-0.3201912123814338,-0.948626027249827,0.5818181818181818,0.7486173906060886,1.0,6/29,14.81%,LRAT;ADH1B;CYP27C1;CYP11B1;CYP11A1;CYP1A1
prerank,positive regulation of biosynthetic process (GO:0009891),0.2695971220063377,0.9484254068211854,0.5135135135135135,0.74498643949927,1.0,13/39,19.91%,CXCL8;HDAC2;AMELX;CYBA;RUNX1;SUCO;BMP4;F2R;TGFB1;CREB3L1;MTPN;MMP8;MLXIPL
prerank,gland development (GO:0048732),0.25376216084251013,0.9479403731142086,0.5675675675675675,0.7454546963673723,1.0,24/70,20.64%,TDGF1;STRA6;EPHB3;MET;SHH;PROX1;CEBPA;SOX9;MDK;LSR;XBP1;PCSK9;CEBPG;SIX1;EZR;WNT11;PRKCSH;SIX3;SLC9A3R1;MSN;HES1;PAX8;CAV1;SRP54
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.24069543057535803,-0.9473125023705821,0.5576923076923077,0.7514830529571253,1.0,34/97,27.40%,PRKAB2;ZNF516;ADRB3;PPARGC1B;PHOX2B;ADRB2;MFN2;BSCL2;GRB10;KDM3A;ACADL;OGT;LEPR;LPIN1;ADRB1;THRA;APC;EBF2;CD36;KDM6B;GATM;PRDM16;EPAS1;EHMT1;CNOT3;SLN;FABP4;GADD45G;ADCYAP1;ALMS1;IL4R;ACSL1;DYNC1H1;STAT6
prerank,regulation of protein processing (GO:0070613),-0.32412298870078116,-0.9467093730630703,0.4666666666666667,0.7525020975949455,1.0,6/22,17.52%,CCBE1;PRNP;BAG2;LRRK2;TNP1;GAS1
prerank,mononuclear cell differentiation (GO:1903131),0.3026749661118425,0.9464647210425196,0.5227272727272727,0.7489279578177106,1.0,7/25,20.69%,CSF2;TRPM2;BMP4;IRF8;PPARG;LYN;IFI16
prerank,sterol transport (GO:0015918),-0.33784186328922755,-0.9463419511305646,0.48214285714285715,0.7527834224002248,1.0,3/18,10.11%,LCAT;ABCA8;OSBPL5
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3407554922011862,0.9459883251134288,0.5641025641025641,0.7496592260435909,1.0,3/18,11.36%,GNL3L;NAT10;HNRNPC
prerank,positive regulation of proteolysis (GO:0045862),0.2561221978777078,0.94589898409548,0.6304347826086957,0.7491734492552916,1.0,18/54,22.00%,PERP;PRSS22;HDAC2;IL1B;CTSH;CTSC;FGFR4;ASPH;PLK1;GBA;CLN6;ADAM8;NKD2;TNFRSF1B;ADAM9;BAK1;ZC3H12A;ASTL
prerank,protein homotetramerization (GO:0051289),0.26517628431233226,0.9457803067043945,0.5135135135135135,0.7487109296594796,1.0,12/51,14.39%,HPRT1;SHMT2;SSBP1;TK1;HSD17B10;TRPM2;MAT1A;AQP5;ACOT13;GBP5;TDO2;CTH
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3248057731538928,-0.9456592118627971,0.5636363636363636,0.7539275732329516,1.0,5/19,13.20%,ASPA;SLC25A12;NAALAD2;MTHFR;ASNS
prerank,positive regulation of protein secretion (GO:0050714),-0.2520345228593875,-0.945613207466196,0.55,0.7534128193959831,1.0,13/69,12.67%,APBB3;APBB1;MYOM1;NLGN2;NNAT;OR51E2;GPER1;FRMD4A;GCK;WLS;C1QTNF3;SLC30A8;SYTL4
prerank,chemical homeostasis (GO:0048878),0.2517937843747671,0.9454679477950517,0.6170212765957447,0.7489616383121,1.0,11/58,11.15%,SLC4A11;ACOXL;TLCD1;CEBPA;PNPLA4;ATP13A2;VGF;ABHD5;PNPLA1;AQP9;PNPLA3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.23008519627474286,0.9444845543799746,0.5428571428571428,0.7506794921069726,1.0,40/130,24.04%,CYP2S1;VDAC1;MTHFD1L;SLC5A6;GLO1;PDZD11;HLCS;LDHA;GOT2;AOAH;MCCC2;PCCB;SLC16A3;BAAT;ACOT7;UGT1A3;CKMT2;AASDHPPT;ALDH4A1;ACSL3;VNN1;MSMO1;KYNU;SGPL1;ACOT4;PPARG;ACSF3;FASN;FA2H;CKMT1A;CYP4F11;BTD;PCCA;ME1;VNN3;CYP2J2;HACL1;SLC27A4;CYP26A1;UGT1A7
prerank,protein deacylation (GO:0035601),0.3106087065704581,0.9443207974100059,0.4827586206896552,0.7503501428582862,1.0,9/23,17.15%,NOTUM;LYPLA1;HDAC10;HDAC1;ABHD10;LYPLA2;ABHD17C;ABHD17B;PPT1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.3166062377873771,0.944178287522894,0.5333333333333333,0.749832815121903,1.0,9/18,28.19%,SKAP1;SYK;TGFB2;CIB1;ADAM9;CXCL13;LIF;RAC3;CD3E
prerank,epithelial cell migration (GO:0010631),-0.277010966911742,-0.9440233580944157,0.6078431372549019,0.7568237949480929,1.0,17/40,25.22%,KANK2;STARD13;PXN;NANOS1;KRT2;KIT;FSTL1;RHOA;KANK1;ROCK1;ZEB2;TESK1;ADGRA2;PKN1;SCG2;FAT2;DPP4
prerank,negative regulation of cytokine production (GO:0001818),-0.21781451242971583,-0.9436338935746078,0.5857142857142857,0.7571256253006816,1.0,65/171,30.89%,ASB1;MAPKBP1;HDAC7;RPS6KA5;CD34;TLR9;PRNP;ELANE;SYT11;APOD;SSC5D;NCKAP1L;NPTN;RNF216;OTUD7B;C1QTNF3;SFTPD;NAV3;RAC1;HDAC9;MAP2K5;HOMER2;UBA7;HOMER3;TRIB2;VSIG4;NLRX1;PCBP2;ZFP36;C5AR2;DLL1;HERC5;KAT5;DHX58;TAX1BP1;ABCD1;PIN1;INHA;IL12A;CUEDC2;BTN2A2;OTUD5;PDCD4;ABCD2;CD33;TWSG1;TRAF3IP1;BPI;GPNMB;RGCC;CEACAM1;F2RL1;NLRC3;N4BP1;NR1H4;CACTIN;PTGER4;ARRB1;MAVS;TNFRSF21;DDIT3;CX3CL1;KLF4;RARA;GAS6
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.23785970970279796,-0.943577057009815,0.6197183098591549,0.7565241719683639,1.0,43/119,23.41%,PLXNB3;FGF2;OSR1;NRP2;PTN;ARNT;FGFR2;ZNF580;ITGB3;PRKCA;TBX1;LAMC1;PRKD1;FZD7;VEGFB;FLT4;LAMB1;VIP;THBS4;EGFL7;SFRP1;STXBP4;PTPRN;HTR2B;PDGFB;FGF7;NOTCH2;FGF10;FGF1;SOX11;RTN4;EGFR;CCL11;SCN5A;SIRT1;NR4A3;VEGFC;FGF9;OSR2;TGM1;BAD;SCG2;NR4A1
prerank,transepithelial transport (GO:0070633),0.34623320794657997,0.943240966377463,0.6122448979591837,0.7516555023958045,1.0,6/16,23.70%,SLC12A2;BEST1;CXADR;RHBG;ABCC2;ABCB1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.30645348421341095,0.9417875438092804,0.4888888888888889,0.7544490773659471,1.0,10/19,30.50%,CHMP4C;DRG1;PLK1;CHMP5;CHMP2B;CHMP1A;CHMP2A;HNRNPU;CCSAP;CHMP1B
prerank,regulation of protein modification process (GO:0031399),-0.2734437945738929,-0.941605709066805,0.4909090909090909,0.7610543670603163,1.0,8/46,12.16%,FLCN;KAT2B;ATG14;CDK9;CADM4;FER;CORO1C;HSPB1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3427994909343506,-0.9414351177548093,0.5555555555555556,0.7607734022784377,1.0,7/20,14.72%,MYO9A;PARD3;CYTH3;CLASP1;FBF1;OPHN1;RHOA
prerank,bone development (GO:0060348),-0.27443055408633543,-0.9402596898568429,0.5416666666666666,0.7628708788217278,1.0,15/40,24.43%,BGLAP;MYOC;FGFR2;GH1;SKI;CYP26B1;RANBP3L;DYM;VKORC1;AKAP13;SBDS;OSR2;LRP6;SH3PXD2B;LRRC17
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.33404786160453714,0.9394054134541409,0.46153846153846156,0.760290501837035,1.0,4/20,5.35%,GPR143;BCAP31;CCL20;TRPM2
prerank,fatty acid catabolic process (GO:0009062),0.2440979447180287,0.9386594221018416,0.53125,0.7614452531072695,1.0,23/66,25.29%,NUDT19;HSD17B10;PEX13;ACBD5;PCCB;CEL;MCAT;AIG1;ABHD2;ACAT2;SLC25A17;ACOT8;MMAA;HSD17B4;PCCA;PLA2G15;ECHS1;FAAH;HACL1;DECR1;SLC27A4;EHHADH;CPT2
prerank,negative regulation of transposition (GO:0010529),0.30313852706205224,0.9384962876371382,0.4634146341463415,0.7610409113253199,1.0,7/24,21.69%,PIWIL1;APOBEC3F;SMYD5;SPOCD1;TEX19;ZNF93;APOBEC3B
prerank,negative regulation of response to external stimulus (GO:0032102),-0.23850467312513174,-0.9379579140553921,0.6666666666666666,0.7681632067647081,1.0,33/109,24.77%,MAPKBP1;FGF2;PTPRS;MAPK7;DUSP3;GPER1;PPARD;RORA;LRFN5;NR1D1;INPP5F;ELANE;PTGIS;PTEN;CARD8;SIRT2;C1QTNF3;EPHA4;AJAP1;PPM1B;TRAFD1;PCBP2;GPS2;FNDC4;DHX58;CDH5;NFKBIL1;GRID2;MUL1;PRKCD;CD109;TRAF3IP1;TNFRSF1A
prerank,cellular response to retinoic acid (GO:0071300),0.2646786409443819,0.9373590332040977,0.5869565217391305,0.763361814111874,1.0,10/42,13.12%,TESC;WNT2;WNT7B;PTK7;WNT5A;SOX9;ABL2;FZD10;WNT3;WNT11
prerank,organic hydroxy compound transport (GO:0015850),0.26557609300784923,0.9370632302758223,0.5961538461538461,0.7634301965013046,1.0,13/37,24.06%,STRA6;AKR1C4;ABCC11;SLCO1B3;AQP9;SLCO1C1;SLC27A5;ABCG5;ABCC2;RBP4;ABCG8;SLCO1A2;OSBP
prerank,negative regulation of cell adhesion (GO:0007162),-0.24651869167879603,-0.9364720399579356,0.6031746031746031,0.7713350047999935,1.0,16/68,19.11%,JAM3;PLXNB3;CORO2B;FZD4;GCNT2;PDE3B;FZD7;FBLN1;SEMA6A;RHOA;SIPA1;DSCAM;PLXNA4;SPOCK1;PLXNB1;ANGPT1
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.24380634913407545,-0.9363111612010241,0.6065573770491803,0.7709608869265703,1.0,32/88,25.29%,FAM107A;GPM6B;RND2;CORO2B;RAPGEF3;PDGFRA;DLC1;RHOQ;RHOB;EPHA5;SEMA3E;TAOK2;DAPK3;RICTOR;RAC1;EFNA5;RHOA;EPHA3;ROCK1;NOTCH2;CCDC88A;BAIAP2;ESAM;TESK1;RHOBTB1;PAK3;MTOR;PRKCD;RHOC;ARHGAP35;PDGFA;ARHGAP17
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.3551734694648653,-0.9362994674158,0.6226415094339622,0.7702913177172379,1.0,5/15,17.96%,FGFR1;FGF2;PRKD1;HSPB1;FGF16
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2205711897452166,0.9362565378487443,0.5909090909090909,0.7645332176921483,1.0,18/78,16.46%,SOX4;EIF3C;NAT10;EIF4A3;PRKDC;YTHDF1;SMPD2;RPS4X;EIF6;EFNA1;RELA;EIF3D;ELAVL1;NPM1;LARP4B;RBM3;NSUN5;EIF3E
prerank,regulation of viral release from host cell (GO:1902186),0.3064316171772808,0.9359993706876225,0.5238095238095238,0.7643473650122281,1.0,10/22,25.57%,PML;TRIM26;DDB1;TRIM11;VPS37B;CHMP2B;TRIM28;TRIM31;TRIM15;CHMP2A
prerank,pore complex assembly (GO:0046931),0.33463281034719283,0.9353405329290769,0.5,0.7652495379831143,1.0,6/18,17.62%,PDZD11;NUP93;NUP107;ADAM10;NUP205;NDC1
prerank,cellular response to virus (GO:0098586),0.27166111030367746,0.935129666245361,0.5714285714285714,0.7650962711590593,1.0,8/32,21.42%,EIF5A;IFI6;RRP1B;IL21;CXCL10;BAX;HSP90AA1;ZC3H12A
prerank,N-glycan processing (GO:0006491),-0.33953017331029434,-0.934719715448229,0.6136363636363636,0.7734692813136207,1.0,6/19,10.65%,ST8SIA1;MAN2A2;MAN1C1;ST8SIA3;GANC;ST8SIA5
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.2886074828244985,-0.9346701733126094,0.5333333333333333,0.7728577537176882,1.0,8/31,22.84%,SORBS1;PLIN5;SLC27A1;SIRT4;NR1H2;CTDNEP1;INS;MTOR
prerank,phosphatidylserine metabolic process (GO:0006658),0.2672081274507615,0.9344788981343723,0.5217391304347826,0.7664345102867847,1.0,17/32,30.62%,PTDSS1;SERINC5;ABHD12;PLA2G2F;PLA2G3;PLA2G4E;PLA2G4D;PLA2G2D;PLSCR1;ABHD12B;PLA2G15;PLA2G10;OSBPL8;PLA2G2E;LPCAT3;MBOAT1;PLA1A
prerank,protein tetramerization (GO:0051262),0.24510520244486206,0.9344550115958042,0.6578947368421053,0.7657655427944601,1.0,16/70,14.39%,HPRT1;SHMT2;GRIN2B;SSBP1;FARSB;TK1;FARSA;HSD17B10;TRPM2;MAT1A;NUDT21;AQP5;ACOT13;GBP5;TDO2;CTH
prerank,protein homooligomerization (GO:0051260),0.2230742696471087,0.9343356780950736,0.7297297297297297,0.7653167567975886,1.0,27/118,15.99%,HPRT1;SHMT2;SSBP1;SLC1A5;TK1;SIGMAR1;BLM;HSD17B10;PNPT1;TRPM2;TRIM72;BEND3;ECT2;CARD11;MAT1A;AQP5;SPAST;ACOT13;PRMT1;FUS;GBP5;ELAVL1;TIFA;TDO2;CTH;TRMT61B;PRF1
prerank,lymphocyte migration (GO:0072676),0.27670129513077574,0.933963299032481,0.575,0.765677846807803,1.0,18/35,33.26%,CCL24;CCL20;CCL22;CCL4;CCL3;CCL26;ADAM8;CCL17;MSN;CRTAM;ZAP70;CCL1;CCL7;XCL1;XCL2;CCL5;GATA3;CCL18
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.20777622246113756,0.9338443493330042,0.5517241379310345,0.7652081874426638,1.0,41/138,21.42%,ANXA4;NFKBIE;MDFI;IRAK2;HDAC2;FOXP3;NR0B2;PSMD10;DAP;HES6;TNFAIP3;PROX1;CDKN2A;BRMS1;RNF2;IRAK1;CTNNBIP1;FOXA2;CEBPG;SETD6;FOXH1;KDM1A;NLRC5;BMP7;TRIB1;TMSB4X;COMMD1;NWD1;SUMO1;OTULIN;SFRP4;PAXIP1;ZNF675;NFKBIA;ID1;TNFSF4;HES1;RBCK1;TRIM37;KEAP1;ZC3H12A
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3110181836934485,-0.9337135030385185,0.4897959183673469,0.7744411889050031,1.0,10/24,26.37%,JAM3;SLIT2;NCKAP1L;THBS4;RAC1;C5AR2;CCL21;TIRAP;DPP4;DNM1L
prerank,regulation of smooth muscle cell migration (GO:0014910),0.33062674678197995,0.933548478958682,0.5555555555555556,0.7652195278236614,1.0,7/18,19.31%,S100A11;PDGFRB;PLAU;SORL1;TRIB1;IGFBP3;SERPINE1
prerank,neural tube closure (GO:0001843),0.27480228688128255,0.9332083057225843,0.5306122448979592,0.7654270477827557,1.0,6/34,7.44%,GRHL3;CELSR1;MTHFD1;MTHFD1L;FOLR1;TGFB2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.33027643175804655,-0.9323135589611797,0.5454545454545454,0.7774463926042275,1.0,7/18,22.02%,TARDBP;ELAVL4;YBX3;ZFP36;MAPK14;ANGEL2;TIRAP
prerank,regulation of cell division (GO:0051302),-0.24573417915545204,-0.9321346057092356,0.576271186440678,0.7772455895644057,1.0,27/73,24.08%,FLCN;EFHC1;KLHL21;CALM1;BBS4;FGFR2;TAL1;INSC;AURKC;SIRT2;ZFYVE26;PRDM15;UVRAG;SETD2;PIK3C3;KIF13A;HTR2B;RAB11FIP3;FGF1;DLL1;SUSD2;AHCTF1;PIN1;CALM2;ESRRB;TXNIP;NKX3-1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.31227426613143094,-0.9318770850372946,0.49230769230769234,0.7771377157800136,1.0,6/23,15.22%,PLA2G5;PLA2G4B;PLA2G6;ABHD4;PLA2G4C;PLA2G1B
prerank,response to hexose (GO:0009746),-0.3381871151867162,-0.9317803745807852,0.54,0.7766349171105801,1.0,7/20,26.77%,VAMP2;GYS2;SLC30A8;EIF2B4;EIF2B1;LPL;SLC2A5
prerank,apoptotic process (GO:0006915),-0.2118928096353453,-0.9315444905175321,0.6875,0.7765529983032311,1.0,68/220,23.64%,MAL;DMPK;CFLAR;ATN1;RAF1;SFRP5;CASP12;NLRP1;PDE1B;PRUNE2;CAPN3;JADE1;RRAGC;ATCAY;PPARD;ARHGEF6;DLC1;ADRA1A;ING4;TBX1;NGFR;RHOB;DAPK1;BCL2;BNIP2;CDIP1;ZBTB16;ADORA2A;FEM1B;TAOK2;MAGEH1;ERCC3;DAPK3;TCHP;PLAGL1;OGT;RNF152;SEMA6A;EFNA5;THOC1;PIDD1;GDF6;NOTCH2;ELMO1;FAS;TSC2;RTN4;CASP3;TNFSF14;CASP9;DCC;DPF2;MAP3K10;APAF1;AHCYL1;BNIP3;NSG1;ZNF385A;MAP3K7;BOK;LIG4;BCL2L11;MTOR;BAD;CSRNP1;PRKCD;CDK11B;RIPK1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2337797504849803,0.9314368615872993,0.5952380952380952,0.769554346726512,1.0,18/61,21.46%,DDIAS;HYOU1;ARMC10;TMBIM6;BCL2L1;RTKN2;NOC2L;PPIF;XBP1;VNN1;DNAJA1;MMP9;PLAUR;CREB3L1;TPT1;URI1;TMEM161A;MCL1
prerank,positive regulation of cellular protein localization (GO:1903829),0.24200307960219156,0.931153938814516,0.6086956521739131,0.7697136950394279,1.0,20/66,19.43%,GNL3L;CDK1;CEP250;GNL3;NDC80;GTSE1;TM9SF4;CENPQ;DTX3L;GSK3B;ORMDL3;LAMTOR5;STX3;PLK1;CDT1;NUP62;HSP90AB1;TGFB1;CARD10;FYN
prerank,aggrephagy (GO:0035973),-0.30134227834702565,-0.9304445718223636,0.6808510638297872,0.7787033608923044,1.0,9/28,18.72%,DYNC1I1;MAP1LC3C;HDAC6;WDFY3;UBE2V1;VIM;DYNC1LI2;PCNT;UBB
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.33811592580905314,0.9295946778124555,0.5652173913043478,0.7732635707620314,1.0,4/15,11.72%,PHB;SMARCA4;HDAC1;FOXH1
prerank,cellular response to gamma radiation (GO:0071480),-0.33453245111708607,-0.9291043071025387,0.6229508196721312,0.7810342321556577,1.0,2/16,3.68%,CRYAB;TSPYL5
prerank,retinoic acid metabolic process (GO:0042573),-0.31741113725004894,-0.9286745065334362,0.5777777777777777,0.7813840754569559,1.0,5/22,12.92%,BCO2;ADH1B;CYP27C1;SCPEP1;CYP26B1
prerank,sulfur compound transport (GO:0072348),0.28871901981884496,0.9285586523443142,0.6,0.7756338958984981,1.0,6/28,11.23%,RACGAP1;SLC5A6;SLC35B2;SLC6A6;LRRC8D;SLC25A19
prerank,cholesterol efflux (GO:0033344),-0.3201356866727248,-0.9278624149720349,0.6326530612244898,0.7826370757180157,1.0,5/19,16.70%,ABCA8;ABCG4;ABCA1;ABCA5;STX12
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.21948635829351973,-0.9271979391562284,0.6507936507936508,0.7835199122812161,1.0,36/193,14.11%,INPP5B;IP6K3;PLCD4;LCAT;ITPKB;INPP5A;AGPAT1;EPHA7;INPP4A;INPPL1;PLA2G5;PPP3CB;PLA2G4B;SYNJ1;DUSP3;CALM1;PI4KA;NUDT10;PLA2G2C;GK5;FRA10AC1;PIP4K2B;TNFAIP8L3;NUDT11;PTEN;ALK;LRRK2;GCK;PLCE1;ALDOA;INPP5K;GFPT2;PPM1A;MAPK3;PLA2G4C;IP6K1
prerank,acylglycerol biosynthetic process (GO:0046463),0.3006143713877099,0.9269929658851164,0.5555555555555556,0.7793120531593312,1.0,9/21,30.19%,DGAT2;GK;PNPLA3;LPGAT1;ANG;PLA2G15;AGMO;MOGAT1;DGAT1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3209822480725125,-0.9269549160679323,0.5423728813559322,0.7834071056504777,1.0,4/19,7.35%,GDNF;PKD2;FGF2;TCF21
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.2980745822116323,0.9269413304983968,0.7878787878787878,0.77869187729288,1.0,14/23,28.67%,SOX9;MDK;LBX2;SIX1;AGT;BMP4;PAX8;PAX2;LIF;SIRT6;EGF;ITGAX;LHX1;PIK3CD
prerank,response to reactive oxygen species (GO:0000302),-0.2542846167240255,-0.9266356604716852,0.5454545454545454,0.7836116379138465,1.0,17/54,21.15%,TPM1;PKD2;MAPT;PXN;PDGFRA;APOD;FER;MAPK1;MAPK3;PTPRN;MAPK8;EGFR;PDK2;HBB;SIRT1;CAMKK2;SOD1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.2583101294832694,-0.9261846218442225,0.5901639344262295,0.7840325865450177,1.0,18/55,22.03%,CSPG4;PRELP;FGF2;LYVE1;STAB2;HPSE2;IDS;DCN;SDC3;SDC2;OGN;HSPG2;OMD;GPC1;HGSNAT;NCAN;GPC6;KERA
prerank,detection of visible light (GO:0009584),-0.3312340934244384,-0.9258632243048365,0.5416666666666666,0.7840862303492852,1.0,8/16,25.24%,CNGB1;GRM6;GNAQ;TULP1;PDE6B;GNA11;RHO;CACNA1F
prerank,monocyte chemotaxis (GO:0002548),0.27699342506572394,0.925665478887203,0.6571428571428571,0.7812231795992819,1.0,10/37,16.71%,CCL24;TNFSF11;CCL20;CCL22;PTPRO;CCL4;CCL3;CCL26;RPS19;CCL17
prerank,negative regulation of cell cycle (GO:0045786),-0.23969099542734076,-0.9247646833638504,0.6229508196721312,0.7863869532691253,1.0,28/78,24.08%,TSPYL2;MYOCD;GPER1;RPS6KA2;CDKN1C;RHOB;NR2F2;PTEN;ZBTB17;LATS2;APC;SIPA1;INCA1;NPPC;GAS1;NUPR1;BTG2;HEXIM1;HPGD;HHEX;HECA;ANGEL2;INHA;LATS1;NR4A1;RNF167;PDCD4;NKX3-1
prerank,histone lysine methylation (GO:0034968),0.28923273522032783,0.9246891619454425,0.5581395348837209,0.7828843386208569,1.0,11/34,17.88%,SUV39H2;SUV39H1;SMYD3;SMYD2;RBBP5;DPY30;TRMT112;SETD6;WDR5;WDR5B;PAXIP1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2850337953104957,0.9231668493673502,0.5227272727272727,0.7865951331295824,1.0,14/27,33.71%,WDR43;EAF1;NELFCD;LEO1;CDK12;NELFE;NELFA;RNF8;HNRNPU;NELFB;EAF2;SUPT16H;BTBD18;LDB1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3367431572125005,0.9227694336689506,0.5833333333333334,0.7868769876613766,1.0,5/16,16.40%,KLK6;PHB;MRAP;C3;MRAP2
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.34486030914608967,0.9219847222143812,0.574468085106383,0.7883984062106778,1.0,2/16,1.52%,BMP8A;IRS1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.2923837979621138,-0.9213963742699042,0.625,0.794446019926158,1.0,6/24,17.75%,HAND2;TRIM6;HEY1;HEY2;SIN3A;SOX11
prerank,COPII-coated vesicle budding (GO:0090114),0.23206560569063925,0.9208917901109289,0.6410256410256411,0.7904770723585752,1.0,26/70,26.98%,TMED2;SEC23B;AREG;FOLR1;SEC13;CTSC;F5;TMED10;TRAPPC6A;RAB1A;TFG;NSF;TRAPPC9;PREB;CTSZ;CNIH1;KLHL12;TRAPPC2L;TGFA;CUL3;LMAN1;CNIH3;SERPINA1;SEC24A;TRAPPC4;BET1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.34430583928333247,-0.9202202545935104,0.6166666666666667,0.7967082553615485,1.0,9/19,24.37%,CLDN5;PRKACA;MYO1C;NPHP1;TJP1;ROCK1;PRKCH;SNAI2;OCLN
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3160950953527776,-0.9199544058855008,0.5294117647058824,0.7967087219219271,1.0,5/17,16.70%,CPSF7;CPEB1;CDK9;CPEB3;ZC3H14
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3243594495205508,-0.9197036369025496,0.5161290322580645,0.796543332675972,1.0,6/19,20.98%,CCL27;NTRK3;FES;NTF3;BAIAP2;BCAS3
prerank,cell cycle G2/M phase transition (GO:0044839),0.22452045731341191,0.9195889428433129,0.6153846153846154,0.7931974659283145,1.0,33/129,15.41%,CEP72;CDK1;CDK7;SKP2;KHDRBS1;CEP250;CHEK2;PHLDA1;YWHAE;MASTL;NEK2;AJUBA;CDC25C;TUBB4B;HAUS2;YWHAG;TUBA4A;HAUS8;CEP76;AURKA;PPME1;PKMYT1;CKAP5;LCMT1;HAUS1;HAUS6;PLK1;TUBG1;FOXM1;USH1C;CEP78;PLK4;CDC25A
prerank,positive regulation of protein processing (GO:0010954),-0.34630530001569504,-0.9187819709218359,0.6428571428571429,0.798060148282824,1.0,5/17,17.21%,CCBE1;GSN;BAG2;TNP1;CLEC3B
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.27994658559911967,0.9185549318751998,0.5714285714285714,0.7952136922338043,1.0,4/27,7.22%,EREG;VPS25;AREG;GPRC5A
prerank,cellular response to dsRNA (GO:0071359),0.3334956357957166,0.918435456475516,0.5116279069767442,0.7948628134395216,1.0,6/16,26.68%,DHX9;PDE12;NPM1;CAV1;ZCCHC3;RALB
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3087546609021388,0.9184319541993263,0.5777777777777777,0.7940940873143382,1.0,8/20,24.20%,FAP;BCL2L1;MTRNR2L3;MTRNR2L1;ZC3H12A;TP53;MTRNR2L9;DFFA
prerank,regulation of organelle organization (GO:0033043),-0.24635500280152833,-0.9181031995921032,0.6507936507936508,0.7990610020078911,1.0,32/76,26.85%,PDE2A;MAPT;NEXN;RBSN;SYDE1;SYT11;SPATA4;CLIC4;MYO5A;RDX;MAPK1;MAPK3;TJP1;TBC1D25;VPS11;RHOT2;ZEB2;CAMSAP2;PLXNB1;PISD;PARL;PDE4DIP;MUL1;PINK1;CLN3;MFF;SPEF1;TAOK1;DNM1L;AKAP9;CAPN2;GOLPH3
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.2769938753854165,-0.9171840603423854,0.5689655172413793,0.80046529358323,1.0,9/32,20.08%,ACTN3;ARNT;P2RX7;PSEN1;PRKAA2;PID1;NUPR1;INSR;INS
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2959345703997071,-0.9168972180244713,0.6290322580645161,0.8005284729678899,1.0,13/30,26.74%,RRAGC;CPEB1;KLHL22;CPEB3;UBR2;RRAGB;UBR1;RRAGD;RPTOR;CPEB4;MTOR;RRAGA;CAPN2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.265209858020523,0.9158292288861782,0.6304347826086957,0.8001240035725236,1.0,9/26,20.33%,ERO1A;HSPA14;HSPA9;PTGES3;DNAJC7;SDF2L1;HSPA5;HSPA13;SDF2
prerank,negative regulation of platelet activation (GO:0010544),-0.3566761680713862,-0.9156214457231078,0.5102040816326531,0.8029030486602288,1.0,8/15,29.16%,PDGFRA;PRKG1;PDGFB;PRKCD;C1QTNF1;PDGFA;CEACAM1;SH2B3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.33461852566858974,-0.9150641868534019,0.6451612903225806,0.8037062367614549,1.0,2/17,1.71%,PAN2;SAMD4A
prerank,positive regulation of leukocyte migration (GO:0002687),-0.3074138612922289,-0.9149102551575456,0.5952380952380952,0.803469671541337,1.0,6/28,12.48%,JAM3;IL6R;PTN;ZNF580;NCKAP1L;LGALS3
prerank,proteoglycan metabolic process (GO:0006029),-0.2975160535990473,-0.9148143441165996,0.6470588235294118,0.8029206720336826,1.0,9/24,19.64%,CHST10;FAM20B;XYLT1;CHST9;CSGALNACT2;CHST12;GAL3ST3;CHST8;BMPR1B
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.2683712658939251,0.914668420014445,0.5333333333333333,0.8021686022500355,1.0,13/32,30.97%,WNT5A;SLC7A5;CD55;FFAR2;TRAF2;NOD2;TNFSF4;HLA-F;CLEC7A;TRAF6;SCIMP;LACC1;XCL1
prerank,artery development (GO:0060840),-0.31462640084171933,-0.9144393476341822,0.6,0.8031376530079836,1.0,4/22,10.25%,PDE2A;PKD2;TBX1;EFEMP2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.22988143541895065,0.9142395795120928,0.6052631578947368,0.8023901912271646,1.0,17/86,13.95%,MYC;DPEP1;TRIAP1;ARL6IP1;LAMP3;BCAP31;IFI6;YWHAE;PMAIP1;SYK;CD44;CSNK2A1;XIAP;GPX1;LAMTOR5;DHCR24;CYCS
prerank,regulation of cell communication (GO:0010646),-0.29061488261560514,-0.914222586286284,0.5882352941176471,0.80304194657922,1.0,10/36,15.81%,TSPYL2;ANK2;SOCS2;CASQ2;SLC8A1;GRK5;GRK4;RYR2;TRDN;CAMK2D
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.32259444615239796,0.9141383472724551,0.5357142857142857,0.801873737595622,1.0,6/16,21.52%,ENTPD7;CMPK1;ENTPD2;CMPK2;ENTPD6;ENTPD1
prerank,negative regulation of insulin secretion (GO:0046676),0.34740432101316493,0.9136985974616524,0.6041666666666666,0.8023194594824481,1.0,2/15,1.52%,BMP8A;IRS1
prerank,neuron apoptotic process (GO:0051402),-0.323959673704973,-0.9135731110539506,0.5357142857142857,0.80393173281186,1.0,7/20,21.72%,ATN1;NLRP1;NGFR;BCL2;FAS;BNIP3;LIG4
prerank,response to organic cyclic compound (GO:0014070),0.23956186552279773,0.9131508647665006,0.6410256410256411,0.802945706121602,1.0,13/57,13.89%,DHFR;IL1B;PMAIP1;HLCS;TRPM2;CYP27B1;SPP1;CHRNB2;CCL3;FGFR4;DRD2;KYNU;AQP3
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.2818537092106722,-0.9131479458526564,0.6,0.804360520992106,1.0,6/24,16.34%,GSN;SLIT2;KANK3;SSH1;KANK1;MYADM
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.2953289991213617,-0.9130951531200123,0.5964912280701754,0.8037640020105911,1.0,15/31,30.65%,PKD1;PKD2;SOCS2;GHR;FER;IFNAR1;CLCF1;CCL2;PIAS1;STAT4;IL31RA;STAT6;IL15;LEP;JAK2
prerank,protein complex oligomerization (GO:0051259),0.22411517319906932,0.912825167570877,0.6888888888888889,0.8028885560097717,1.0,21/85,16.92%,CLDN1;SHMT2;BLM;PNPT1;TRIM72;BEND3;ECT2;STOML2;CARD11;LRRC8D;NUDT21;SPAST;PRMT1;FUS;ELAVL1;TIFA;MCU;YME1L1;TRMT61B;PRF1;HOMER1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.23110806467810807,-0.9119854851682311,0.6206896551724138,0.8059609968660151,1.0,30/97,22.03%,CSPG4;PRELP;ST3GAL3;ABCC5;GCNT2;UST;CHST3;ST3GAL6;CHST15;B4GAT1;DCN;SDC3;SDC2;OGN;DSEL;NDST2;NDST1;CHST7;XYLT1;HSPG2;OMD;CHST9;CSGALNACT2;CHST12;GPC1;ANGPT1;HS3ST5;NCAN;GPC6;KERA
prerank,positive regulation of secretion by cell (GO:1903532),-0.24453253966656086,-0.9118996836450067,0.6181818181818182,0.8055032027372107,1.0,13/68,13.14%,APBB3;APBB1;KCNB1;MYOM1;STX1B;GPER1;FRMD4A;SNCA;RAB2B;CLASP1;CLASP2;SYTL4;RAB3A
prerank,histone H3-K4 methylation (GO:0051568),-0.2650289936749005,-0.9116623780103972,0.625,0.8054385958940128,1.0,13/30,28.45%,SETD1B;SETD4;KMT2A;CXXC1;OGT;KMT2B;ZNF335;PAGR1;SETD1A;SETMAR;TET2;KMT2C;KMT2D
prerank,cellular response to unfolded protein (GO:0034620),0.27625182326905784,0.9107735771686111,0.6304347826086957,0.8070804846150742,1.0,9/26,20.50%,HSPD1;TMBIM6;HSPA14;HSPA9;TM7SF3;HSPA5;HSPA13;BAX;BAK1
prerank,metal ion homeostasis (GO:0055065),-0.2738488519715107,-0.9106669755232931,0.6774193548387096,0.807040192695238,1.0,9/41,12.96%,JPH2;SLC12A4;ANK3;KCNH2;SNCA;SLC8A1;TMTC2;KCNA1;SCNN1B
prerank,bile acid metabolic process (GO:0008206),0.2779638274072145,0.9101907521012665,0.5789473684210527,0.8077429205689268,1.0,10/31,18.78%,HSD17B10;AKR1C4;OSBPL3;BAAT;CYP39A1;CYP7B1;HSD3B7;ACOT8;SLC27A5;HSD17B4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3095608157254708,0.9097314188486143,0.5625,0.8080427135684727,1.0,4/17,7.06%,CCND1;PSMD10;PROX1;PSRC1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2875349385898997,-0.9092979635063012,0.5918367346938775,0.8095936369975625,1.0,5/34,5.78%,TNS2;DUSP22;PTPRS;DUSP3;PTPRZ1
prerank,chondrocyte differentiation (GO:0002062),-0.2908593780702221,-0.9088403515305685,0.6206896551724138,0.8098842764164652,1.0,13/31,25.72%,OSR1;SOX5;WNT5B;NFIB;MEF2C;WNT2B;SNX19;BMPR1B;SOX6;OSR2;CREB3L2;WNT10B;RUNX2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2591344452534227,-0.9088263227060903,0.6557377049180327,0.8092295418535628,1.0,15/43,30.89%,POMC;CD34;SYT11;MC1R;DICER1;C5AR2;NFKBIL1;CD33;BPI;NLRC3;NR1H4;CACTIN;CX3CL1;RARA;GAS6
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.21919704066989676,0.9084407190755591,0.6774193548387096,0.8105611938155616,1.0,21/89,17.47%,TDGF1;OSM;IL11;RIPK2;IL23A;LRP8;RAP2B;CD44;EFNA1;CD80;CD81;CLEC6A;PAK2;SEMA4D;PECAM1;ITGA5;AGT;PRKCZ;IL22RA2;IL23R;TGFB1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.3114107713726414,-0.908358240200607,0.5692307692307692,0.8094060551652643,1.0,6/24,15.43%,HAND2;SASH1;PJA2;MAP3K4;GADD45B;GDF6
prerank,positive regulation of receptor internalization (GO:0002092),-0.32383386065167236,-0.9079209774018375,0.603448275862069,0.80989122816272,1.0,7/23,19.11%,MAGI2;GH1;NTF3;CD63;AHI1;INSR;ANGPT1
prerank,negative regulation of cell death (GO:0060548),0.21750993604947605,0.9074906042206758,0.7073170731707317,0.8118018599432205,1.0,27/84,21.75%,SOX4;DCPS;CDK5;RAD18;VPS35;PDE12;ATP13A2;GSK3B;TM7SF3;SORL1;POU4F1;BMP7;WNT11;ZBED6;BMP4;TRAF2;GBA;NUP62;SULT1A3;DUS2;AGR2;TNFRSF1B;FYN;ATG5;PAX2;NENF;HLA-F
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.2777237225352194,0.9069359584809311,0.5348837209302325,0.8124678538587987,1.0,5/26,7.25%,TDGF1;SYAP1;KNSTRN;ZPR1;SOX9
prerank,response to interleukin-1 (GO:0070555),0.22456076926248872,0.9069014843217258,0.6818181818181818,0.8117878909692694,1.0,33/80,28.63%,CCL24;CXCL8;IRAK2;IL1B;CCL20;CCL22;SOX9;HYAL3;USP10;CCL4;CCL3;MYD88;RELA;IRAK1;ADAMTS12;TAF9;CCL26;MAPK13;CCL17;CHI3L1;GBP1;ZC3H12A;HYAL2;CD47;GBP3;CCL1;HIF1A;ANXA1;TNFRSF11A;HAS2;IRAK3;TRAF6;CCL7
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.23957907818631097,0.9063534578068388,0.6666666666666666,0.8124314724644495,1.0,21/61,25.64%,CCND1;CEBPB;CDK1;CBFB;LEF1;CDK4;CDKN2A;SOX9;CCNC;RELA;MED14;MED1;MED30;BAX;TRIM28;MED31;MED20;TP53;CTNNB1;MED13;FOSL1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3373597567036394,0.9063159318904713,0.5660377358490566,0.8117739752104574,1.0,5/17,14.32%,RALA;VPS35;AURKA;KDR;MCU
prerank,positive regulation of telomere maintenance (GO:0032206),0.27883919843516514,0.9063007955060111,0.6216216216216216,0.8110438241591447,1.0,6/31,7.93%,GNL3;NABP2;NEK2;PML;AURKB;NAF1
prerank,lipid transport (GO:0006869),-0.2300720815171082,-0.906254174555288,0.6206896551724138,0.813503149397683,1.0,40/99,28.85%,ABCA9;ABCA10;ABCA6;ABCA8;PPARD;NCOA1;ABCG4;PEX19;ABCA1;TNFAIP8L3;OSBPL5;AKR1C1;SLC27A1;RXRA;SLC10A4;ABCA5;SLC27A3;ABCA3;SLCO2A1;CD36;NME4;PLEKHA3;SLC51A;GLTP;ABCD1;PITPNB;CHKA;ABCD2;PITPNA;CLN3;ABCB11;CEACAM1;ABCC4;CLN8;SLC10A6;ACSL1;NR1H4;SLC51B;UGCG;APOL2
prerank,connective tissue development (GO:0061448),-0.28116005666227434,-0.9062090476889423,0.7090909090909091,0.8128881114676327,1.0,14/36,26.73%,PKD1;ZNF516;HOXD3;SLC39A13;SOX5;ZBTB16;PGRMC2;SOX6;ARID5B;SOX8;SH3PXD2B;CREB3L2;COL11A2;TRIP11
prerank,activation of protein kinase activity (GO:0032147),-0.22493543841264016,-0.9061129022326161,0.6551724137931034,0.8124201291441755,1.0,34/113,23.81%,ADCY5;PILRB;ADRA2B;ADCY2;ADCY4;STRADA;NTRK3;ITGB3;ADRB2;ADCY9;PRKACA;GHR;CHRNA3;TLR3;PRKAR2B;TAOK2;RICTOR;ZFP91;PDGFB;ADCY6;MAPKAP1;NTF3;CCDC88A;FGF1;NRK;INSR;ANGPT1;INS;MAP3K7;PAK3;TIRAP;MTOR;PRKCD;PINK1
prerank,regulation of monooxygenase activity (GO:0032768),0.30583845892162687,0.9060244500599631,0.6,0.8110745041602662,1.0,7/24,13.83%,IL1A;LYPLA1;IL1B;DDAH1;SPR;POR;NOSIP
prerank,regulation of amyloid fibril formation (GO:1905906),-0.33505299673205124,-0.9052465861400634,0.6111111111111112,0.8140190124784039,1.0,3/15,8.83%,CRYAB;CLU;PSEN1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.2743385918921659,-0.9049374009357198,0.6440677966101694,0.8142227390375264,1.0,11/42,23.11%,TRIM39;FOXF2;CSNK2A2;CLU;PTEN;QRICH2;GNA12;CDK5RAP3;FBXW7;CAV3;LATS1
prerank,regulation of centrosome duplication (GO:0010824),0.27617118742483093,0.9043561627547992,0.6428571428571429,0.8144139955878404,1.0,14/30,33.77%,NAT10;CHMP4C;CCNF;CEP76;NPM1;CHMP5;CHMP2B;CHMP1A;CHMP2A;RAB6C;STIL;CHMP1B;GEN1;PKHD1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.2618105454379353,-0.9034273602105821,0.6346153846153846,0.8176288780042994,1.0,9/46,10.65%,GBA2;ST8SIA1;ST6GALNAC3;ESYT3;A4GALT;ST8SIA3;ST3GAL5;B4GALNT1;ST8SIA5
prerank,positive regulation of TOR signaling (GO:0032008),-0.2765542171170213,-0.9031072169826,0.6379310344827587,0.817707851813596,1.0,8/39,13.96%,FLCN;SIK3;RRAGC;KLHL22;NCKAP1L;RRAGB;RICTOR;WDR59
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.27757655002042847,-0.9026559500709768,0.625,0.8181177022790875,1.0,8/24,20.15%,ADRB3;COQ10A;PID1;ACADVL;GFPT2;LEPR;COX4I2;NR4A3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3351554736325424,-0.9025473168195948,0.6060606060606061,0.8177040533267893,1.0,7/17,23.96%,FGFR1;FGF2;MEF2C;COL4A3;CCL2;PLCG1;FLT1
prerank,protein autoubiquitination (GO:0051865),0.23688196006982165,0.9024707228547745,0.675,0.8184419852618865,1.0,23/61,23.92%,UBE2T;RNF183;RAD18;ERCC8;BFAR;UHRF1;UBE3D;DTX3L;TRIM71;BRCA1;TRAF2;RNF187;UBE2A;RNF181;RAG1;TRIM37;CUL3;ASB4;RNF19B;RNF141;UBE2D2;SH3RF1;WWP2
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2782373578027495,-0.9015928556363987,0.6,0.8193623862261956,1.0,6/37,6.75%,ADRA2B;NLGN3;BTC;SHANK3;HDAC6;ADRB2
prerank,amyloid-beta metabolic process (GO:0050435),0.3227504413363007,0.9012951936682743,0.6511627906976745,0.8204849878908573,1.0,6/17,17.60%,BACE2;MME;APEH;APH1A;NCSTN;IDE
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.29122419709244146,0.9011143040110067,0.6458333333333334,0.8202964538908979,1.0,3/29,4.78%,GNL3L;DACH1;NAT10
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.33821931539077404,-0.9010979066688392,0.5535714285714286,0.8196730750699511,1.0,10/16,29.31%,NPPA;SPX;NPPB;GSK3A;ADM;GPR37L1;SLC2A5;KLK2;BMPR2;KLK3
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2393522086352751,0.9010221620606964,0.675,0.8198038368454919,1.0,20/51,28.97%,IL1RN;TRAIP;RNF113A;USP18;TTLL12;NLRC5;YTHDF2;ISG15;PPARG;PALM3;PTPN2;ZNF675;OAS3;IL36RN;CARD16;GSTP1;STAT2;IRAK3;YTHDF3;PYDC1
prerank,xenobiotic transport (GO:0042908),-0.30306517055204885,-0.9008680521056224,0.6078431372549019,0.8193959185206489,1.0,6/19,22.81%,ABCC5;ABCA8;SLC47A1;ABCA3;ABCG2;SLC15A2
prerank,metanephros development (GO:0001656),-0.29480765525400304,-0.8996346435504102,0.6607142857142857,0.8215708827954602,1.0,4/26,3.85%,PKD1;GDNF;PKD2;OSR1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.2541062268140897,0.8993367701627826,0.5897435897435898,0.8232241754005515,1.0,10/42,13.48%,THY1;TNFSF11;SKAP1;IL1B;CEACAM6;CD44;MDK;FOXA2;BMP7;FUT7
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3285176031286498,-0.8990614793237757,0.6,0.8223285608495207,1.0,6/17,22.84%,SORBS1;PPARD;SIRT4;EEF1A2;INS;MTOR
prerank,protein polyubiquitination (GO:0000209),-0.19777732690180863,-0.8984491140660412,0.7941176470588235,0.8231731767293035,1.0,84/306,22.21%,WSB1;FBXO32;FBXO10;FBXO9;FBXL22;FBXL7;SASH1;HECTD2;UBE2QL1;KLHL42;FBXW4;FBXO17;TRIM3;UBE2G2;PELI3;FBXO31;TRIM6;FBXO30;TRAF1;UBE2D4;UBE2E1;RBBP6;RNF146;RNF19A;RNF217;BCL2;SKP1;UBE3B;FBXW2;HACE1;KLHL20;LONRF1;RNF216;RNF115;PELI2;UNKL;FBXO44;NPEPPS;FBXO27;AKTIP;UBE2G1;FBXL5;DZIP3;UBE2E2;UBR2;ANAPC4;UBE4B;RNF152;NHLRC4;ZFP91;UBE2V1;RNF166;UBE2Q2;LRSAM1;CHFR;BTRC;TRIM34;ARIH2;RNF144B;SPSB1;FBXO38;KLHL3;MYLIP;HECTD1;MIB2;UBB;RNF31;FBXW7;UBOX5;ARIH1;RNF14;FBXL8;TRIM62;TTC3;HERC5;LNPEP;RC3H1;FBXL12;PSMD9;UBE2H;TRIM38;TRIM56;UBR5;FBXO15
prerank,regulation of secretion (GO:0051046),0.3335234703968001,0.8981355950174987,0.5609756097560976,0.8255273760759546,1.0,4/15,13.17%,KCNQ1;OAS2;ACSL3;MYO6
prerank,cilium movement (GO:0003341),-0.2526381975835781,-0.897701876319989,0.625,0.8243209625659618,1.0,14/38,27.33%,DNHD1;CCDC39;CCDC40;CFAP54;TEKT2;TEKT3;CFAP70;DNAH1;RSPH4A;SPEF2;ADCY10;SPEF1;DNAH17;CFAP61
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.30473959591243927,-0.8972891035591651,0.5555555555555556,0.8246737477475327,1.0,4/23,4.40%,CIRBP;GDNF;EIF4ENIF1;RBM24
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.31262761031619996,0.8970948525476681,0.6326530612244898,0.827229542986872,1.0,4/17,11.68%,NOTCH3;WWC1;DLGAP5;STAT1
prerank,cellular response to hexose stimulus (GO:0071331),-0.3191253912480333,-0.8966406971484471,0.5957446808510638,0.8252900171988727,1.0,5/24,9.93%,KCNB1;GPER1;PRKACA;PRKAA2;ZNF236
prerank,mesenchymal cell differentiation (GO:0048762),-0.2589222032410631,-0.8965373486292442,0.5967741935483871,0.8247857625061908,1.0,13/51,15.77%,DDX17;FGFR1;FOXF2;TGFBR3;FGFR2;RBPJ;NOTCH4;MEF2C;RANBP3L;FAM83D;HTR2B;ROCK1;HEY2
prerank,regulation of protein binding (GO:0043393),0.20887596150990695,0.8965210478496994,0.7647058823529411,0.8277780832328046,1.0,21/108,14.13%,GNL3L;TRIB3;RAN;RIPK2;DERL1;PPP1CA;AURKB;TMBIM6;BAMBI;STK4;SLPI;AURKA;DTX3L;CTNNBIP1;ZFPM1;NMD3;GSK3B;SORL1;KDM1A;PLK1;BMP4
prerank,regulation of cellular protein metabolic process (GO:0032268),0.24860141054739807,0.8951346862389241,0.6486486486486487,0.8308541270065221,1.0,18/48,22.45%,INHBA;NOLC1;VPS35;NANOS3;UHRF1;EIF4E;AGT;METAP1;PKP3;GBA;RBM3;TGFB1;MTPN;NFKBIA;WNT7A;MAPKAPK5;GEMIN5;CYFIP1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.22879587888839975,-0.8950647268605608,0.75,0.8274860123066137,1.0,24/99,18.77%,CLIP3;SORBS1;KCNB1;ATP2B4;WNK3;ANK3;MTCL1;GPER1;PIK3R1;PRNP;CNPY4;NECAB2;BCL2;STAC2;PPP3CC;STAC;MYO1C;LGALS3;EPHA3;MAPK8;EFCAB7;AKT2;EGFR;RAMP3
prerank,positive regulation of viral life cycle (GO:1903902),0.3106991322326876,0.8950462967981269,0.5208333333333334,0.8302812878479129,1.0,8/23,19.23%,P4HB;DDB1;KPNA2;TRIM11;LGALS1;VPS37B;TMPRSS4;CHMP2B
prerank,dephosphorylation (GO:0016311),-0.21959307212467655,-0.8942566963386456,0.75,0.8286888993004066,1.0,29/138,15.79%,PTPN21;PPP1R12A;PPP2R3A;PPP2R5B;PTPRS;PTPRM;PPP3CB;PPP2R5D;DUSP3;PTPRZ1;PPM1M;DUSP26;CTDSP2;FRA10AC1;PTPN14;PPEF2;PTEN;PPM1L;PPM1F;PPP3CC;PTPN5;INPP5K;PPM1A;TAB1;PPM1B;PPP4R1;SSH1;PPP2CB;BTRC
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.21278916329054023,0.8939264576302831,0.7692307692307693,0.8322958822755241,1.0,30/77,29.64%,IL23A;ADIPOR1;PHB;IL1B;RPS3;NMI;RTKN2;TSPAN6;RELA;IRAK1;ACTN4;BMP7;EZR;TMSB4X;CPNE1;NOD2;NFKBIA;MMP8;CD86;ZC3H12A;IL12B;SPI1;IFI35;TLR7;TRAF6;ADGRG3;NOD1;PHB2;EIF2AK2;NLRP3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.34485306836942425,-0.8938145720044233,0.58,0.8290124222343066,1.0,6/15,20.68%,TARDBP;RBM24;ZFP36L1;CPEB3;ZFP36;RC3H1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.30340040477308133,-0.8936355284062284,0.5576923076923077,0.8287058908284358,1.0,9/26,18.94%,ZC3H7A;AGO4;METTL3;DICER1;AGO3;PRKRA;DGCR8;SMAD2;AGO1
prerank,regulation of exosomal secretion (GO:1903541),0.31816517938841915,0.893465468340459,0.6904761904761905,0.8325771285054673,1.0,9/18,29.71%,ATP13A2;ATP9A;SDC1;RAB7A;STAM;CHMP2A;SDC4;IFNG;SNF8
prerank,zinc ion homeostasis (GO:0055069),0.2830703840458117,0.8934089365565984,0.6666666666666666,0.8318897829305393,1.0,10/28,23.94%,SLC39A10;ATP13A2;SLC39A8;SLC30A5;SLC30A9;SLC39A7;SLC30A1;LCK;SLC39A4;MT1F
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2775878358471356,0.89339277329786,0.5625,0.8311413285090586,1.0,3/26,2.63%,CCND1;TFDP1;MTBP
prerank,sterol metabolic process (GO:0016125),0.24499256555870594,0.8931234183613599,0.6808510638297872,0.831142341197972,1.0,23/60,24.06%,SULT2B1;CYP51A1;SQLE;NSDHL;DHCR7;SC5D;NR0B2;FDXR;CYP39A1;FDX1;CYP7B1;MSMO1;TM7SF2;GBA;CLN6;INSIG1;LIPA;CETP;EBP;TSKU;HMGCR;CYP26A1;ABCG1
prerank,inorganic anion transport (GO:0015698),0.2385461597853244,0.8928495238108262,0.6666666666666666,0.8310187910372868,1.0,8/52,8.80%,CLIC1;TTYH3;RACGAP1;SLC4A11;BEST1;CLIC3;CLCN4;CLCN1
prerank,protein insertion into membrane (GO:0051205),0.27092299213219934,0.8927169507349225,0.6923076923076923,0.8306258419686531,1.0,6/31,8.78%,SERP1;GET4;SEC61B;TRAM1;SEC61G;COX18
prerank,DNA methylation (GO:0006306),0.282545743985712,0.8926797841172903,0.5957446808510638,0.829933166523829,1.0,6/23,15.67%,DNMT1;BEND3;GATAD2A;DNMT3B;FOS;SPOCD1
prerank,melanosome organization (GO:0032438),0.287560456364462,0.8923595481277395,0.6730769230769231,0.8299974086359241,1.0,8/27,18.83%,GPR143;BLOC1S4;TRAPPC6A;AP3B1;PMEL;BLOC1S3;BLOC1S2;SHROOM2
prerank,regulation of organelle assembly (GO:1902115),-0.2416820070662702,-0.8922125589761964,0.6724137931034483,0.8315923839290966,1.0,19/73,20.70%,TBC1D1;TBC1D17;GSN;RABGAP1;TBC1D10A;TBC1D20;SENP6;TBC1D2B;ATXN2;RDX;TBC1D13;TSG101;ATXN2L;VPS11;SGSM3;ADPRH;TBC1D12;PIKFYVE;SPICE1
prerank,secondary alcohol metabolic process (GO:1902652),-0.27158946775180426,-0.8917604754856322,0.6739130434782609,0.8318250453990093,1.0,10/40,15.92%,LCAT;GBA2;OSBPL1A;PPARD;ABCA1;CYP11B1;OSBPL5;CYP11A1;RXRA;ABCA5
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3415519647128912,-0.891436698038941,0.6274509803921569,0.8319301430274282,1.0,4/16,9.97%,PDE3B;PLIN5;ALK;BSCL2
prerank,regulation of proteolysis (GO:0030162),0.23952064665109507,0.8912955680113979,0.7391304347826086,0.8317471766028433,1.0,20/50,28.04%,PERP;CST4;CDK5;HDAC2;CSTB;SHH;FGFR4;ASPH;PLK1;CLN6;PLAUR;TM4SF20;CAV1;BAK1;AURKAIP1;CSTA;KNG1;SERPINE2;CASP8;CYFIP2
prerank,regulation of extracellular matrix organization (GO:1903053),0.3255941910714881,0.8910024840768582,0.5882352941176471,0.8317062925091604,1.0,5/15,13.27%,FAP;DDR1;FGFR4;RUNX1;AGT
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3196473910202299,-0.8907993986236982,0.6481481481481481,0.8327576558112529,1.0,5/20,19.07%,TMEM178A;FSTL3;TLR3;CARTPT;FBXW7
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.2957867443120309,0.8906306956607195,0.6190476190476191,0.8318409609311814,1.0,8/23,25.23%,CBFB;SLC39A10;CD81;RUNX1;ELF1;LYN;NFAM1;CD300A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3075263642849946,-0.8893687248025203,0.5576923076923077,0.8354323005106294,1.0,8/25,25.47%,FNTB;CNGB1;CALM1;GRK4;NMT2;PDE6B;RHO;FNTA
prerank,arachidonic acid metabolic process (GO:0019369),0.23828022246287586,0.8890113593744097,0.6346153846153846,0.8346050795911845,1.0,19/50,26.91%,CYP2S1;FAAH2;CYP2F1;TBXAS1;PTGES3;GPX1;PTGES2;CYP2B6;CYP4F3;CYP4F11;ALOXE3;CYP2J2;FAAH;CYP4F2;DAGLA;GPX4;ALOX12;PLA2G10;ALOX12B
prerank,hydrogen peroxide catabolic process (GO:0042744),0.3101476271034217,0.889002980987583,0.6041666666666666,0.8338301445126411,1.0,5/19,12.44%,PRDX4;PRDX5;PRDX1;GPX1;PRDX2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.2854079499678988,-0.8888162140683565,0.6181818181818182,0.8360016915335065,1.0,7/25,16.15%,DDX39B;CCNT2;THOC5;KAT7;SUPT6H;THOC1;SCAF8
prerank,chloride transport (GO:0006821),0.21604558641507376,0.888586145250035,0.7391304347826086,0.8339624679835772,1.0,11/74,8.80%,CLIC1;SLC12A2;TTYH3;GABRP;BEST1;CLIC3;SLC12A8;GABRD;CLCN3;CLCN4;CLCN1
prerank,female gamete generation (GO:0007292),-0.2799251919791568,-0.8878656491264696,0.6481481481481481,0.8376472237850138,1.0,4/28,7.05%,PTN;FMN2;NANOS1;METTL3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.23213159611871417,-0.8872882940671865,0.7931034482758621,0.8381741526847994,1.0,25/86,21.41%,VAMP2;SORCS1;RABEP1;EXOC6B;AP1S2;MON2;CORO7;KLHL20;OSBPL5;MYO5A;AP4E1;VPS13A;CLVS2;CCDC93;GBF1;AP4S1;BLOC1S1;GOLGB1;STEAP2;EPS15;AP1M1;ARL3;TXNDC5;GOPC;GOLGA7
prerank,oligodendrocyte differentiation (GO:0048709),-0.310188818828276,-0.8870439255298879,0.6981132075471698,0.8380676624393636,1.0,9/19,23.47%,PTPRZ1;PRDM8;SOX13;TPPP;SLC8A3;EIF2B4;SOX6;SOX8;EIF2B1
prerank,regulation of protein import into nucleus (GO:0042306),-0.28475071675405206,-0.8868905799764127,0.660377358490566,0.8377243690742497,1.0,17/36,26.17%,FLNA;PIK3R1;DMAP1;PSEN1;APOD;RAB23;BAG3;EFCAB7;SUFU;CABP1;MDFIC;PIK3R2;UBR5;PRKCD;SMAD3;HCLS1;TPR
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3297016867350667,-0.886642387949569,0.6166666666666667,0.8375553076582283,1.0,7/20,22.99%,MAGI2;MTMR9;CALM1;MEF2C;AGTR2;MTOR;CALM2
prerank,carbohydrate biosynthetic process (GO:0016051),0.2946775722510344,0.886589953886079,0.6458333333333334,0.8381566782532207,1.0,10/24,25.70%,FUT8;FUT1;ST8SIA6;FUT7;B4GALT1;FUT2;MPDU1;FUT6;FUT4;FUT3
prerank,estrogen metabolic process (GO:0008210),0.3102589128122739,0.8861287277902138,0.575,0.8385107864749559,1.0,9/24,29.29%,HSD17B10;UGT1A3;HSD17B4;UGT2B7;HSD3B1;UGT1A7;HSD17B8;SULT1E1;CYP3A7
prerank,endothelial cell proliferation (GO:0001935),0.31178150221162027,0.8858869742917076,0.5454545454545454,0.8384331157610814,1.0,6/18,18.94%,LOXL2;NRARP;SEMA5A;BMP4;PRKX;PROK2
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.2130604301349201,-0.8858826120528667,0.8,0.8385063436830558,1.0,36/163,16.39%,TEAD3;NR2C2;RXRG;PGR;HDAC7;KAT2B;THRB;WWTR1;PPARD;TAF1C;RORA;CDK9;NPPA;NR1D1;TEAD1;RARB;AR;RBPJ;MAML1;RXRB;NR3C1;NOTCH4;NR1H2;HDAC5;MED17;NR2C1;ERCC3;MAPK3;RXRA;HDAC9;ESR1;TEAD2;THRA;NOTCH2;TAF3;RORB
prerank,positive regulation of histone acetylation (GO:0035066),0.27506023862816453,0.8857601536356569,0.575,0.8379248632805504,1.0,8/23,18.25%,RUVBL2;SMARCB1;FOXP3;IL1B;RPS6KA4;BRCA1;PAXIP1;PIH1D1
prerank,positive regulation of vasculature development (GO:1904018),0.21840555238599677,0.8854483446898219,0.625,0.8379093523958944,1.0,22/98,14.45%,IL1A;CXCL8;ADAM12;EPHA1;MYDGF;IL1B;ANXA3;WNT5A;EMC10;CTSH;JUP;RLN2;HMGA2;XBP1;APELA;RUNX1;ADM2;BRCA1;SEMA5A;KDR;GATA6;GRN
prerank,regulation of Notch signaling pathway (GO:0008593),-0.23520930767087833,-0.8852883073256927,0.7368421052631579,0.8391405770098558,1.0,20/73,20.76%,YJEFN3;EPN2;KAT2B;METTL3;RBPJ;MAML1;ZMIZ1;HEY1;NOTCH4;SYNJ2BP;HIF1AN;EGFL7;GATA2;EGFR;BEND6;FBXW7;ENHO;DLL1;TM2D3;RFNG
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3174709396734774,-0.8846515307775945,0.6491228070175439,0.8399154239903817,1.0,9/20,19.26%,MYOCD;CDKN1C;NR2F2;PTEN;LATS2;APC;INCA1;HEXIM1;HHEX
prerank,second-messenger-mediated signaling (GO:0019932),-0.22570716459347778,-0.8845320653502682,0.6129032258064516,0.8394854957344452,1.0,25/86,23.35%,TPCN2;INPP5A;PLA2G4B;AGTR1;RCAN2;CCR10;NOS1;LRRK2;RYR2;PPP1R9A;PLCE1;P2RY12;ACKR3;HTR2B;EDNRB;ACKR2;P2RY11;CD36;AGTR2;CAMKK2;CHRM3;PTGDR2;RCAN1;PLCG1;PLCG2
prerank,regulation of transposition (GO:0010528),0.2911696751872074,0.884498746897224,0.6444444444444445,0.8394088638102845,1.0,6/21,21.69%,PIWIL1;APOBEC3F;SMYD5;SPOCD1;TEX19;APOBEC3B
prerank,embryonic digit morphogenesis (GO:0042733),-0.3103260894770476,-0.8844334740982807,0.6181818181818182,0.838993433656348,1.0,5/17,15.11%,OSR1;INTU;GLI3;ECE1;TBX2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3037084878356534,-0.8843404120583718,0.6551724137931034,0.8384786583513654,1.0,5/22,10.12%,CCBE1;ARNT;RORA;ATF4;FLT4
prerank,endoplasmic reticulum organization (GO:0007029),-0.23237145792717787,-0.884006551322129,0.7241379310344828,0.8383491916047399,1.0,16/69,17.90%,RNF112;SEC31B;VAMP2;REEP2;REEP1;LMAN1L;PRNP;CAV2;LRRK2;ATL3;TRDN;ATL2;ATL1;SEC16B;RTN4;VAPA
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3031364117035626,-0.8839902663649363,0.6938775510204082,0.8376477183640924,1.0,9/21,28.40%,SMAD4;CARF;ATF4;RBPJ;SMAD9;CREB3;RUNX2;MT3;CHD6
prerank,JNK cascade (GO:0007254),-0.2577312367460855,-0.8832462253325372,0.6226415094339622,0.8384981881165855,1.0,15/41,21.68%,MAPK10;ARHGEF6;TAB2;MAP2K7;TAB1;UBE2V1;MAP2K4;MAPK8;MAP4K2;GPS2;UBB;MAP3K10;MAP3K12;MAP3K7;SH2D3C
prerank,primary neural tube formation (GO:0014020),0.2732491749917841,0.8832309701828321,0.6444444444444445,0.8414374156309641,1.0,4/30,2.16%,GRHL3;CELSR1;MTHFD1;MTHFD1L
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.27788400872229513,-0.8830809167316902,0.64,0.8381890532894004,1.0,12/30,26.75%,TWIST2;CHRD;HDAC7;SKI;RANBP3L;RORB;SUFU;LIMD1;TMEM64;TNN;CRIM1;NOG
prerank,phospholipid transport (GO:0015914),0.22781758556649256,0.8824641714096477,0.6666666666666666,0.8425119955592179,1.0,21/51,28.91%,TRIAP1;SCARB1;MTTP;ATP11A;PRELID2;PRELID1;ATP9A;APOC1;ATP10B;PITPNM1;LDLR;OSBPL2;TMEM30B;ABCB1;ABCG1;ABCA12;PLA2G10;MFSD2A;ATP11B;OSBPL8;ATP8B1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.2761885443163176,-0.8824017346257509,0.6666666666666666,0.8389046923700704,1.0,8/32,15.64%,CAPRIN2;ADGRB3;CUX2;CHRNA3;OBSL1;SDC2;GORASP1;IL1RAPL1
prerank,male meiosis I (GO:0007141),-0.3283904158952439,-0.8820239206603837,0.6956521739130435,0.8392441348291982,1.0,6/15,23.14%,FOXJ2;CCNA1;MOV10L1;FOXJ3;TDRD9;DDX4
prerank,ethanol metabolic process (GO:0006067),-0.32490166669456205,-0.8819093900044866,0.7037037037037037,0.8387868528227415,1.0,9/16,37.05%,ADH1B;ALDH1A1;ADH5;SULT1A2;ADH7;ALDH2;ADH1C;ACSS1;SULT1A1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.29938493173810177,-0.8818450060826573,0.5535714285714286,0.8381509787917765,1.0,7/23,20.08%,ARNT;P2RX7;PSEN1;PRKAA2;PDGFB;INSR;INS
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.20308404501688287,-0.8810270196151192,0.8064516129032258,0.8392694042871216,1.0,47/166,23.89%,CFLAR;S100B;MAP3K3;FLNA;LPAR1;TRIM52;MAP3K14;ZDHHC17;LURAP1;TRIM6;PRKCB;TAB2;TLR9;TERF2IP;PRKD1;LITAF;WLS;PELI2;ROR1;TNFSF10;S100A13;PPM1A;UBE2V1;RHOA;BCL10;HTR2B;TICAM2;GPRC5B;TRIM34;APOL3;VAPA;MIB2;RNF31;EDA2R;CCL21;TRIM62;AKAP13;TRIM8;MAP3K7;TRIM38;TIRAP;ALPK1;MUL1;RIPK1;HMOX1;PINK1;RHOC
prerank,pulmonary valve morphogenesis (GO:0003184),0.32173729363975107,0.8808941219357417,0.5555555555555556,0.8455445712681807,1.0,5/17,14.13%,STRA6;TBX20;TGFB2;ROBO2;BMP4
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.29061953843338145,0.880860617637757,0.6888888888888889,0.8448592056196182,1.0,11/24,27.97%,GAPDH;TPI1;GAPDHS;PKLR;PKM;ALDOC;ADPGK;ALDOB;PFKL;PGAM1;GPI
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.18713616785767598,0.8806656357145324,0.8285714285714286,0.8445113503462766,1.0,26/132,17.92%,TDGF1;OSM;IL11;RIPK2;CSF2;IL23A;LRP8;DOK7;CD44;ARL2BP;IL21;EFNA1;CD80;CD81;CLEC6A;PAK2;SEMA4D;PECAM1;ITGA5;AGT;DLG3;SOCS3;FCGR1A;IL23R;TGFB1;LYN
prerank,prostanoid metabolic process (GO:0006692),0.29279145400955325,0.8806046143115326,0.6458333333333334,0.8438485503512548,1.0,4/18,10.17%,CYP2S1;AKR1C4;PLAA;CYP4F8
prerank,organic cation transport (GO:0015695),-0.29458457867020116,-0.8799347177174889,0.6226415094339622,0.8410399079703148,1.0,3/19,13.85%,SLC25A42;SLC5A7;SLC47A1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.32601837702815994,-0.8796693362214262,0.6507936507936508,0.8409949333891649,1.0,7/18,21.46%,CLU;EPHA4;GSAP;CASP3;GSK3A;IFNGR1;LRRTM3
prerank,modification-dependent protein catabolic process (GO:0019941),0.19504808854096747,0.8793370844208239,0.8571428571428571,0.8458517059276306,1.0,55/195,21.73%,PSMD14;MAD2L1;PTTG1;RNF114;UBE2S;FBXO45;BUB3;PSMD13;RNF6;RNF40;NDFIP2;PSMC2;AURKB;ANAPC1;RNF43;BFAR;UBE2C;UHRF1;ZNRF3;XBP1;RNF128;AURKA;DTX3L;CDC26;KLHL8;PSMD3;ADRM1;LONP1;DDB1;SPSB2;RNF149;PSMF1;ANAPC11;PLK1;PSMD11;UBA52;UBA1;ISG15;RNF34;FBXL14;UBE2A;UBQLN1;FEM1A;OS9;UBE2K;UBE3C;UBE2L6;CDC20;BUB1B;UBE2D1;CUL3;KEAP1;CBLC;RNF19B;DTL
prerank,cellular response to glucose stimulus (GO:0071333),-0.28756239705503295,-0.879221280942668,0.6730769230769231,0.841323103259304,1.0,7/29,14.84%,KCNB1;GPER1;PRKACA;PRKAA2;ZNF236;RAB11FIP2;PTPRN
prerank,stress granule assembly (GO:0034063),-0.3170981413089025,-0.8792123299961753,0.6,0.8406256489118705,1.0,5/20,15.04%,CIRBP;MAPT;ATXN2;CSDE1;ATXN2L
prerank,insulin secretion (GO:0030073),-0.3213748736156178,-0.87897715975545,0.6122448979591837,0.8405578620723549,1.0,5/16,14.84%,CAMK2G;RAB11FIP2;SLC30A8;SNX19;PTPRN
prerank,cellular zinc ion homeostasis (GO:0006882),0.28438187197772374,0.8783603936869417,0.7021276595744681,0.8475565106265431,1.0,10/27,23.94%,SLC39A10;ATP13A2;SLC39A8;SLC30A5;SLC30A9;SLC39A7;SLC30A1;LCK;SLC39A4;MT1F
prerank,response to lipid (GO:0033993),0.21241597712950264,0.8774090117648344,0.7674418604651163,0.8490348484261481,1.0,37/106,24.06%,IL1B;SCD;CYP27B1;SPP1;CTSH;SOX9;HMGB2;MAPKAPK3;SLPI;FGFR4;IRAK1;NOS2;MAPKAPK2;HNRNPA0;GCH1;AQP3;GATA6;TRIB1;ACER2;PPARG;NOCT;F2R;MICB;IL23R;PALM3;TGFB1;WNT8B;CYP24A1;TMEM161A;STAT5B;RBP4;PRDX3;PCK2;SRR;S100A14;RPS6KA3;ABCG1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.27901864468841026,-0.8770875319441093,0.7090909090909091,0.8446067816470463,1.0,12/33,24.90%,MAGI2;CALM1;DUSP26;DLC1;AGTR2;CDH5;PIN1;MTOR;CALM2;PRKCD;CAMTA1;SMPD1
prerank,gastrulation (GO:0007369),-0.3010496518015158,-0.8756972628227551,0.6,0.8470144556418445,1.0,4/19,20.15%,NPHP3;MEGF8;SMAD2;NR4A3
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.22755610320115066,0.8756351976122371,0.7619047619047619,0.8529549164326363,1.0,31/76,27.96%,IL1A;PSME3;CSF2;IFI6;IL1B;PF4;TNFAIP3;BCL2L1;ICAM1;RELA;GPX1;TNFRSF10B;GSK3B;BRCA1;BMP4;TRAF2;RNF34;EYA1;SERPINE1;TNFRSF10A;MCL1;FASLG;ITGA6;SH3RF1;THBS1;TERT;UNC5B;GSTP1;TGFBR1;CASP8;PARK7
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.31821380678472666,-0.8753327926975392,0.639344262295082,0.8472742401532382,1.0,10/21,27.21%,OSR1;ACTN2;PLN;CASQ2;CAMK2D;GOPC;SLN;CAV3;EPO;NEDD4L
prerank,skeletal system development (GO:0001501),-0.20214225278019476,-0.8753302557908227,0.864406779661017,0.846559240794459,1.0,42/145,24.13%,PKD1;NKX3-2;PTH1R;FGFR1;PRELP;BGLAP;CHRD;EXTL1;MYOC;HOXD3;FGFR2;HAPLN2;BMP3;SOX5;ZBTB16;TRPS1;GLI2;NPR3;BMP1;TLL1;EVC;XYLT1;ANKRD11;DYM;COL13A1;PCSK5;SOX11;MMP16;SUFU;HAPLN4;VKORC1;BMPR1B;AKAP13;SOX6;NCAN;INHA;SPEF2;SH3PXD2B;CREB3L2;ADAMTS4;PKDCC;GDF11
prerank,protein-containing complex assembly (GO:0065003),0.18084596785957624,0.8751844590978334,0.9032258064516129,0.8534730644989,1.0,81/257,25.78%,CLDN1;RUVBL1;MYC;TFAP4;CAPG;TMED2;NIFK;TCF7;PPIH;CDC123;AREG;BLM;FOLR1;PDZD11;CAPZA1;AXIN2;CLDN14;PARD6B;LEF1;SEC13;PML;RBBP5;CTSC;SMARCA4;SOX9;F5;STOML2;TMED10;DHX9;ZW10;HDAC1;FN1;TRAPPC6A;ADAM10;RSPH9;BCL9L;GSK3B;REPS2;TRAF2;MCU;USH1C;LEO1;RAB1A;TFG;CD2AP;NSF;FANCA;TRAPPC9;PREB;CTSZ;SLC2A1;CNIH1;KNTC1;FANCC;CARD10;SLC9A3R1;AXIN1;KLHL12;TRAPPC2L;HES1;TGFA;VIL1;SAMM50;CUL3;ZC3H12A;GEMIN5;LMAN1;PPID;GPAA1;MEN1;TP53;ANKS4B;TSPAN33;TERT;CTNNB1;CREBBP;CD3G;CNIH3;SERPINA1;IL2RB;SEC24A
prerank,acute inflammatory response (GO:0002526),0.2905829028320808,0.8749583300568915,0.6122448979591837,0.853220815228055,1.0,7/20,21.37%,C2CD4A;CEBPB;CTNNBIP1;VNN1;PLSCR1;TNFSF4;C2CD4B
prerank,glycoprotein metabolic process (GO:0009100),0.23963375527841724,0.8749482915516601,0.6415094339622641,0.8524936144168637,1.0,17/52,19.64%,MAN2A1;STT3B;FUT8;ERP44;GCNT1;GANAB;B4GALT7;ST8SIA6;PRKCSH;MANBA;HPSE;AGA;MAN1B1;FBXO6;PCSK6;NGLY1;B4GALT5
prerank,regulation of chemokine production (GO:0032642),-0.26334517128150037,-0.87476177696428,0.6274509803921569,0.847158931762983,1.0,6/41,10.92%,IL6R;TLR9;ELANE;ACKR1;TLR3;TSLP
prerank,positive regulation of protein transport (GO:0051222),-0.24839594632923456,-0.8741912918081217,0.6774193548387096,0.8478656904914711,1.0,24/64,26.85%,VAMP2;APBB3;APBB1;MYOM1;TENM1;CNST;FRMD4A;RUFY3;OAZ2;SYTL4;PCM1;PLA2G1B;CEP290;PCNT;ANKRD1;BCAS3;TTN;CD33;TGFB3;CLN3;EXOC1;TPR;DNM1L;GOLPH3
prerank,negative regulation of neuron death (GO:1901215),-0.2189533452482325,-0.8739164137943782,0.7413793103448276,0.8477536418952868,1.0,16/96,12.29%,NFATC4;NRBP2;GDNF;INPP5A;PTPRZ1;SNCA;CD34;ATF4;NGF;CRLF1;BCL2;LRRK2;CNTF;BHLHB9;NTRK1;MEF2C
prerank,regulation of protein dephosphorylation (GO:0035304),-0.2580367939668944,-0.8735847962912542,0.7068965517241379,0.8477650919395523,1.0,15/38,30.70%,TSC1;CALM1;DLC1;PPP6R2;CDH5;PIN1;CALM2;PRKCD;CAMTA1;SMPD1;PPP6R3;HSP90B1;ARPP19;CNEP1R1;PPP1R15A
prerank,regulation of monocyte differentiation (GO:0045655),0.31813447689173985,0.8729103932675027,0.6976744186046512,0.8566590056417578,1.0,5/15,20.95%,MYC;DCSTAMP;CTNNBIP1;HOXA7;CDK6
prerank,keratan sulfate metabolic process (GO:0042339),0.2666951189253277,0.8718756532237077,0.6190476190476191,0.8582522473941382,1.0,7/33,14.42%,B3GNT4;ACAN;HEXB;GLB1;B3GNT2;B4GALT1;B3GNT3
prerank,glial cell differentiation (GO:0010001),0.2738272475693785,0.8716769998436597,0.6739130434782609,0.8579864831315822,1.0,5/28,7.25%,SOX4;CDK5;GPR157;SHH;SOX9
prerank,fatty acid biosynthetic process (GO:0006633),0.2437865495548008,0.8714470119000955,0.7555555555555555,0.8577111232500026,1.0,22/61,25.57%,HACD3;SCD;TECR;ACOT7;XBP1;LIPG;ASAH2B;MCAT;HACD2;ABHD2;ELOVL1;ELOVL7;ACLY;NDUFAB1;ACSF3;OXSM;LTA4H;ELOVL6;ASAH2;HSD17B8;GPX4;ALOX12
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.30085750088739577,-0.870268306495678,0.6415094339622641,0.8550226075567805,1.0,10/18,31.15%,NPHP3;CCDC39;CCDC40;NEK10;RFX3;SPEF2;ADCY10;AQP4;CFAP53;CABYR
prerank,B cell activation (GO:0042113),0.2160357001520967,0.8692638961519005,0.8780487804878049,0.8615344447507763,1.0,28/82,29.77%,HSPD1;IL11;EPHB2;PHB;CHRNB2;TCF3;JAK3;CD70;CEBPG;TPD52;PTPN2;SLC25A5;RAG1;CD86;MSH2;ZAP70;NFAM1;PTPRJ;CR2;RABL3;CASP8;IL10;IFNE;PIK3CD;ADGRG3;PHB2;RASGRP1;ADAM17
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.2788316649567949,0.8690364620995258,0.6666666666666666,0.8612261871746665,1.0,8/25,16.44%,TRIB3;ADIPOR1;ERLIN1;EIF6;BRCA1;LPGAT1;APOC1;ERLIN2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3008776780957465,-0.868204218127168,0.7272727272727273,0.8589056826243692,1.0,5/23,10.12%,CCBE1;ARNT;RORA;ATF4;FLT4
prerank,regulation of cellular metabolic process (GO:0031323),-0.2568576589270215,-0.8668721117064367,0.6065573770491803,0.8610525574864093,1.0,16/44,28.29%,ACACB;AGPAT1;BCO2;RSPO1;GNB3;PID1;SSH1;PARL;PDK2;BTN2A2;PINK1;PDK4;ABCB11;FLOT1;NCOR2;CYP1B1
prerank,actin filament-based transport (GO:0099515),-0.29644431512945907,-0.8668048787159545,0.6842105263157895,0.8604229759962504,1.0,4/21,11.16%,MYO15A;SUN2;MYO5A;MYO1C
prerank,cellular response to light stimulus (GO:0071482),0.22750502772655384,0.8667000832788656,0.7555555555555555,0.8655519994830998,1.0,19/67,21.47%,MYC;RHNO1;TRIAP1;RUVBL2;AURKB;NOC2L;GNGT1;KDM1A;PTPRK;NPM1;GRK1;MAPK13;CDC25A;POLD1;SDE2;EIF2S1;TMEM161A;BAK1;OPN3
prerank,chloride transmembrane transport (GO:1902476),0.22421440230537693,0.8665091474981571,0.8125,0.8651201611826254,1.0,18/50,28.51%,SLC12A2;GABRP;SLC12A8;GABRD;CLCN3;CLCN1;GABRB1;GLRA2;CFTR;SLC5A1;GABRR1;GABRB2;SLC12A9;ANO9;GABRA3;GABRA4;SLC12A7;APOL1
prerank,regulation of B cell differentiation (GO:0045577),0.30171067251132433,0.8662515020531104,0.7446808510638298,0.8650201870267429,1.0,4/18,9.45%,IL4I1;INHBA;SYK;XBP1
prerank,inorganic anion transmembrane transport (GO:0098661),0.2195180804329542,0.866030589817121,0.782608695652174,0.8647299420054378,1.0,17/65,22.87%,SLC12A2;SLC5A6;GABRP;SLC12A8;GABRD;CLCN3;CLCN1;GABRB1;GLRA2;SLC37A4;CFTR;SLC5A1;SLC37A1;GABRR1;GABRB2;SLC12A9;ANO9
prerank,protein K48-linked ubiquitination (GO:0070936),-0.24170465244416162,-0.8659155121733684,0.7619047619047619,0.8617438005115623,1.0,19/55,23.19%,UBE2G2;UBE2D4;UBE2E1;RNF146;HACE1;RNF216;RNF115;UBE2G1;UBE2E2;RNF152;NHLRC4;UBE2Q2;ARIH2;FBXO38;KLHL3;TTC3;UBE2H;UBR5;ZNRF1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2815678933660809,-0.8658502784855242,0.62,0.8612143807338101,1.0,8/26,20.19%,PLA2G5;PLA2G4B;INPP5F;PLA2G6;PLA2G4C;ENPP2;ENPP6;ABHD16A
prerank,sensory perception of light stimulus (GO:0050953),-0.21895853940231608,-0.8646814452153714,0.7166666666666667,0.8631989095001683,1.0,25/91,22.59%,PRR4;SFRP5;CNGB1;PRPH2;ROM1;MYO9A;CDH23;CRYGN;RD3;GPR179;BBS2;CRYBG3;IMPG2;TULP1;ATXN7;CRYGS;PCDH15;CABP1;KIFC3;EFEMP1;TULP2;RPGR;PDE6C;EYA4;WFS1
prerank,positive regulation of growth (GO:0045927),0.22212198093745217,0.8646638152032496,0.7560975609756098,0.8672142971596751,1.0,20/69,21.39%,CSNK2A3;EXOSC4;NCBP1;PSMD10;DNPH1;ZPR1;TGFB2;CSNK2A1;ADAM10;CXCL16;DDX49;EXOSC2;CIB1;SLC25A33;AGR2;MTPN;FXN;CDC42;BRAT1;RPS6KA1
prerank,lipid catabolic process (GO:0016042),-0.28531019961224274,-0.8633905889627037,0.7058823529411765,0.8654480606349508,1.0,11/24,27.84%,SIRT2;LIPI;PNLIP;ACADL;HSD17B14;PLA2G1B;PNLIPRP3;CES1;LPL;CYP4F12;MT3
prerank,endothelial cell migration (GO:0043542),0.2523252236859037,0.863050051088091,0.72,0.870344541510718,1.0,4/38,4.27%,FAP;S100P;LOXL2;S100A2
prerank,body fluid secretion (GO:0007589),-0.3152395760506034,-0.8627325026397581,0.6190476190476191,0.8662477983490594,1.0,4/15,18.27%,NPR1;VIP;NPPB;ERBB4
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.28675074371310216,0.8625623293592904,0.6904761904761905,0.8706200944800294,1.0,5/17,14.68%,GLE1;IGF1R;GSPT1;OGFOD1;GBA
prerank,positive regulation of exocytosis (GO:0045921),0.258926261169408,0.8625203222669438,0.7111111111111111,0.8699163594179968,1.0,18/34,29.91%,RAB15;RAB3D;ATP13A2;CADPS;SDC1;ATP6AP1;RAB7A;STAM;CFTR;RAB27B;CADPS2;CHMP2A;SDC4;EXPH5;IFNG;RAB5A;SNF8;RAB9A
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.22295839229465178,-0.8624605783846491,0.7142857142857143,0.8661214465224333,1.0,12/67,14.01%,TBC1D1;TBC1D17;RABGAP1;TBC1D10A;TBC1D20;FXR2;GAP43;TBC1D2B;FER;RDX;TBC1D13;RAC1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.22720805644510259,-0.861708809605147,0.6610169491525424,0.867171286068153,1.0,27/79,26.40%,CFLAR;CASP12;NLRP1;MAPT;SNCA;DLC1;NGF;NGFR;CARD8;TNFSF10;PIDD1;FAS;COL4A3;CASP9;APAF1;KHDC1;CRADD;BOK;CASP8AP2;BAD;MUL1;RIPK1;NKX3-1;MTCH1;SMAD3;CASP10;HIP1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.33210695174383487,-0.8611700293356757,0.6727272727272727,0.8676700259323965,1.0,6/16,23.35%,KIT;BCL10;GPRC5B;SIRT1;NR4A3;PLCG2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2797711985642898,-0.8611313830985826,0.7230769230769231,0.8670244059993737,1.0,7/29,15.22%,PLA2G5;PLA2G4B;TMEM86B;PLA2G6;NR1H2;PLA2G4C;PLA2G1B
prerank,proteoglycan biosynthetic process (GO:0030166),-0.27191945856760724,-0.8606260611716644,0.66,0.8674615012311891,1.0,10/31,19.64%,B3GAT1;CHST10;FAM20B;XYLT1;CHST9;CSGALNACT2;CHST12;GAL3ST3;CHST8;BMPR1B
prerank,spindle assembly (GO:0051225),-0.23316673321450007,-0.8604444642867897,0.6226415094339622,0.8671672269378565,1.0,27/78,23.41%,STARD9;FLNA;TUBGCP6;NUMA1;GOLGA8A;CLASP1;ARHGEF10;CLASP2;GOLGA8B;GOLGA8N;MAPRE3;HAUS4;RHOA;TUBGCP5;CEP63;NEK7;HAUS3;MAP9;MAPRE2;CSNK1D;GOLGA8R;CEP192;INO80;SPICE1;GOLGA2;TNKS;AAAS
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.32366268020946526,-0.8597035108449306,0.6785714285714286,0.868097774136852,1.0,6/15,18.07%,DYRK1A;NTRK1;MAPK3;BMX;AATK;EGFR
prerank,regulation of actin filament-based process (GO:0032970),0.22424301571454308,0.8596850129204027,0.8421052631578947,0.8750614033499289,1.0,22/71,20.31%,GRHL3;SIGLEC15;CELSR1;PDGFRB;CNN2;ARHGAP18;ABRACL;OR2A4;ARHGEF19;FZD10;MLST8;EZR;PAK1;BST2;SMIM22;RHOD;ARHGEF5;IQGAP3;F11R;CORO1A;FSCN1;RHOF
prerank,negative regulation of cellular component movement (GO:0051271),-0.3131242753449409,-0.8595245113305152,0.6727272727272727,0.8677502725376931,1.0,4/15,14.53%,TGFBR3;ACTN1;FBLN1;SPOCK3
prerank,positive regulation of response to wounding (GO:1903036),0.26651498107415494,0.859415595825559,0.6875,0.8748633984943983,1.0,11/27,28.28%,CLDN1;ACTG1;MDK;DUOX2;GRN;CLDN4;ARFGEF1;REG3A;ANXA1;CLEC7A;INSL3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.30001007436076543,0.8587439558084157,0.6222222222222222,0.8753928858110753,1.0,5/19,12.19%,TSN;HENMT1;MRPL44;TARBP2;TRIM71
prerank,regulation of nervous system development (GO:0051960),-0.25383581806187877,-0.8580075102823772,0.7272727272727273,0.8703793921213089,1.0,7/39,11.73%,LGI4;NPHP3;ARNTL;PTN;PTPRZ1;SIRT2;HEY1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.23879257169351828,-0.8575696126386169,0.7678571428571429,0.8705539881741726,1.0,26/71,25.44%,BCL2L2;MLLT11;IL6R;MOAP1;P2RX7;NGF;BCL2;TLR3;DAB2IP;DEDD;BAG3;FAS;CASP3;CASP9;DCC;GSK3A;CRADD;BOK;CASP8AP2;IL12A;BAD;HIPK1;RIPK1;GABARAP;TNFRSF1A;SMAD3
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.25684553033354546,0.8566864598235812,0.7027027027027027,0.8794443758364824,1.0,9/25,19.82%,CEMIP;RIPK2;BMP7;PLK1;UBE2K;TGFB1;STOX1;AXIN1;CHI3L1
prerank,negative regulation of RNA splicing (GO:0033119),0.31555384952337684,0.8563023292812516,0.673469387755102,0.8795213777766928,1.0,10/19,24.54%,PTBP3;C1QBP;SRSF9;PTBP1;TMBIM6;SAP18;RPS13;U2AF2;RNPS1;RPS26
prerank,hexose biosynthetic process (GO:0019319),0.2600607363484662,0.8561974253712279,0.7297297297297297,0.8790220684385195,1.0,15/42,23.35%,SORD;GAPDH;GOT2;TPI1;MDH2;GAPDHS;G6PC3;SLC37A4;ALDOC;SLC25A13;RBP4;PCK2;ALDOB;SLC25A1;FBP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.24681662562303439,-0.855814529164195,0.6818181818181818,0.8737221558004331,1.0,9/50,13.02%,IL6R;DEFB124;PTN;ZNF580;MSTN;VEGFB;RARRES2;MAPK1;MAPK3
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.22127716249674248,-0.8554475980347305,0.7258064516129032,0.8738937006501687,1.0,22/69,24.89%,NFATC4;NRBP2;GDNF;PTPRZ1;NGF;CRLF1;BCL2;CNTF;BHLHB9;NTRK1;MEF2C;MAG;NTF3;CLCF1;CCL2;SOD1;LIG4;WFS1;CPEB4;PINK1;TGFB3;CLN3
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.30255860700968396,-0.8553925312628463,0.5918367346938775,0.8732628733496539,1.0,6/15,25.29%,CADM4;ARHGAP24;OGT;ALS2;GABARAP;ARHGAP17
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.28931079924237535,-0.8553461068217666,0.6842105263157895,0.871883468688856,1.0,6/20,20.08%,ARNT;P2RX7;PSEN1;PRKAA2;INSR;INS
prerank,positive regulation of glycolytic process (GO:0045821),-0.28931079924237535,-0.8553461068217666,0.6842105263157895,0.871883468688856,1.0,6/20,20.08%,ARNT;P2RX7;PSEN1;PRKAA2;INSR;INS
prerank,negative regulation of type I interferon production (GO:0032480),-0.2613893202126502,-0.8535596829206699,0.696969696969697,0.8749393664263052,1.0,18/40,33.62%,PTPRS;RNF216;PPM1B;UBA7;NLRX1;PCBP2;HERC5;DHX58;TAX1BP1;PIN1;OTUD5;TRAF3IP1;NLRC3;CACTIN;MAVS;YY1;NPLOC4;SIRPA
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.29311412002227827,0.8534534248262677,0.7317073170731707,0.8844291098476387,1.0,4/19,13.12%,HS6ST2;GLCE;HS2ST1;EXT2
prerank,fatty acid transport (GO:0015908),-0.297420380008812,-0.8532670749425435,0.6122448979591837,0.8748301508310212,1.0,7/19,22.15%,PPARD;SLC27A1;CPT1B;SLC27A6;SLC27A3;CD36;FABP4
prerank,dicarboxylic acid transport (GO:0006835),0.2590191044235026,0.8532517336236274,0.7021276595744681,0.8841246324916017,1.0,9/28,24.51%,FOLR1;SLC19A1;SLC25A22;SLC13A3;ABCC2;SLC25A13;GIPC1;SLC26A8;SLC46A1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.2802173441344201,0.8531429344516035,0.6458333333333334,0.8835531986336139,1.0,6/19,17.28%,PHB;STOML2;MCUR1;MCU;YME1L1;MICU2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.2458841152038188,0.8508727834860601,0.7727272727272727,0.8878231885464261,1.0,4/37,6.15%,FXYD5;GTPBP4;IL1RN;ASS1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.21361762443609703,-0.8508102561684991,0.7741935483870968,0.879724860862993,1.0,26/108,19.33%,GSTM2;GSTM5;CSPG4;PRELP;ST3GAL3;UST;CHST3;CDO1;MAT2A;ST3GAL6;CHST15;GSTA4;B4GAT1;DCN;OGN;GSTM3;DSEL;CHST7;OMD;CHST9;HPGDS;CSGALNACT2;CHST12;GSTT2B;ANGPT1;GSTM4
prerank,gluconeogenesis (GO:0006094),0.2497217262604772,0.8500897317724295,0.6888888888888889,0.8887527196459594,1.0,15/39,25.25%,GAPDH;GOT2;TPI1;MDH2;GAPDHS;G6PC3;SLC37A4;ALDOC;SLC25A13;RBP4;PCK2;ALDOB;SLC25A1;FBP1;PGAM1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2667637794349675,-0.8499980895105209,0.6481481481481481,0.880718739329671,1.0,7/36,13.68%,TRIM39;CSNK2A2;MAP1A;WAC;KLHL40;QRICH2;OGT
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2249461192433696,0.8499688981910426,0.7906976744186046,0.8883071434730411,1.0,21/53,30.90%,IRAK2;MAPKAPK3;UNC93B1;CNPY3;MYD88;FFAR2;IRAK1;MAPKAPK2;TIFA;UBA52;NOD2;HMGB1;LGMN;CTSB;RPS6KA3;TLR7;TRAF6;NOD1;TLR8;UBC;LACC1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.2314820954143339,0.8499562884914963,0.8125,0.887556323256678,1.0,17/55,20.50%,RALA;PMAIP1;VPS35;BBC3;PPIF;BIK;AURKA;GSK3B;ZDHHC6;ZNF205;KDR;MMP9;MCU;PLAUR;BAX;BID;BAK1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2998633226615749,-0.849256456982481,0.6792452830188679,0.8813573865736917,1.0,7/18,22.14%,MAPK7;HSPB1;INS;SIRT1;SOD1;NME5;NOL3
prerank,negative regulation of defense response (GO:0031348),-0.22377499318183527,-0.8490296266358042,0.8333333333333334,0.8811079544752439,1.0,22/78,24.77%,MAPKBP1;MAPK7;GPER1;PPARD;RORA;LRFN5;NR1D1;ELANE;PTGIS;SIRT2;C1QTNF3;PPM1B;TRAFD1;PCBP2;GPS2;FNDC4;DHX58;CDH5;MUL1;PRKCD;TRAF3IP1;TNFRSF1A
prerank,integrated stress response signaling (GO:0140467),0.3486138115677032,0.8490091795132442,0.7073170731707317,0.8889471917875826,1.0,5/15,20.02%,EIF2AK1;CXCL8;IGFBP1;HSPA5;EIF2S1
prerank,receptor catabolic process (GO:0032801),0.25054582124011743,0.8488520113676803,0.6923076923076923,0.8884632115614638,1.0,13/25,28.68%,RNF43;ZNRF3;CLTA;PCSK9;AP2S1;CLTC;AP2B1;TGFB1;MVB12A;LGMN;BECN1;BECN2;KIF16B
prerank,positive regulation of cellular component organization (GO:0051130),-0.2082633781541162,-0.848306785472744,0.8125,0.8819855894757984,1.0,43/108,29.08%,CLIP3;ADD1;RAPGEF3;DCTN1;CLU;FRMPD4;NRXN1;TRABD2B;CALY;SHANK3;TAL1;SNCA;PLEKHM2;AR;CAMK1;TPPP;LGALS3;DAB2IP;RELN;CAMK2B;INSR;ATP10A;ADGRL1;DLL1;BNIP3;CDH5;TIRAP;BCL2L11;CDC42EP2;RHOC;BRK1;TGFB3;SMPD1;MPP7;FNIP1;FLOT1;NEDD4L;ASAP1;PTPN23;ANAPC2;ICE1;BMF;SH3GLB1
prerank,cellular response to oxidative stress (GO:0034599),-0.20131612649695602,-0.8482946554094803,0.7619047619047619,0.8812782523618032,1.0,30/124,20.24%,GPX3;TPM1;ARNTL;PKD2;MAPT;PXN;PDGFRA;ARNT;SNCA;STX2;ATF4;CPEB2;DAPK1;PRKD1;LRRK2;PRKAA2;SIRT2;FER;MAPK1;MAPK3;RAD52;CCS;MAPK8;ANKRD2;WNT16;EGFR;PDK2;PLA2R1;SETX;CAMKK2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3212644300500627,0.8479678216540535,0.7291666666666666,0.8893683590863269,1.0,6/17,27.42%,SYK;NMI;ENPP3;TYROBP;IFNG;IFI35
prerank,positive regulation of protein binding (GO:0032092),0.21282236956650213,0.8479020490584468,0.8333333333333334,0.8887373063576369,1.0,19/55,25.18%,TRIB3;RAN;RIPK2;DERL1;BAMBI;STK4;DTX3L;NMD3;GSK3B;MMP9;BMP4;IDE;CAV1;RPL11;EPB41;MEN1;WNT3A;TERT;PPP2CA
prerank,lipid translocation (GO:0034204),-0.27578673818323435,-0.8478296450533387,0.7192982456140351,0.881419432976932,1.0,7/23,19.55%,ATP8B2;ABCA1;ATP10D;ATP8A2;ATP9B;ATP10A;ATP8B3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.2827152938653256,0.8475921428928377,0.7551020408163265,0.8885889649255807,1.0,9/18,28.45%,POU4F1;LAMTOR5;TGFB1;PAX6;DDRGK1;GTF2B;IFNG;PARK7;TRAF6
prerank,dorsal/ventral pattern formation (GO:0009953),-0.2756290842798152,-0.847173424609746,0.7796610169491526,0.8820773741948399,1.0,12/24,29.60%,BMPR1A;DSCAML1;GLI2;SFRP1;LMX1B;BMPR1B;NBL1;HOXA11;NOG;FBXL15;AIDA;ACVR1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.3034394896538831,0.8470294982729326,0.6744186046511628,0.8888434953437403,1.0,3/15,8.48%,S100A11;PDGFRB;MDK
prerank,telomere capping (GO:0016233),0.3097408845992818,0.8469467583128267,0.6808510638297872,0.888283257962018,1.0,3/15,5.88%,DCLRE1C;DCLRE1B;PRKDC
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.22277680410538264,-0.8464141223083145,0.7321428571428571,0.8832058903932465,1.0,26/72,24.36%,MYH2;PIK3R1;NCK1;PLA2G6;DOCK1;NCKAP1L;MYO1C;MAPK1;MAPK3;ARPC2;ELMO2;RAC1;ELMO1;BAIAP2;WIPF1;WASF2;PLD2;NR4A3;PIK3R2;ACTB;WIPF3;PLCG1;PLCG2;PRKCD;BRK1;ARPC1A
prerank,activin receptor signaling pathway (GO:0032924),0.30926662512985137,0.8461865733175936,0.6666666666666666,0.8892629855721612,1.0,2/17,2.73%,TDGF1;INHBA
prerank,apoptotic cell clearance (GO:0043277),-0.2542747873547353,-0.845809830068575,0.7678571428571429,0.8838987010751278,1.0,15/33,34.26%,XKR4;ADGRB1;ITGB3;MEGF10;RAC1;TXNDC5;RHOBTB1;FCN2;FCN3;XKR8;RARA;GAS6;RHOBTB2;NR1H3;RHOG
prerank,positive regulation of histone modification (GO:0031058),0.24703326093014194,0.8456819251770614,0.6595744680851063,0.889575009563596,1.0,8/33,13.06%,UBE2N;RUVBL2;FOXP3;IL1B;SDR16C5;RPS6KA4;KDM1A;BRCA1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.24351602039839895,0.8455710518281745,0.7428571428571429,0.889015609217081,1.0,17/49,21.47%,TRIB3;PRMT3;GLA;FGF19;KHSRP;PROX1;ERLIN1;ACMSD;BRCA1;APOC1;ERLIN2;PLEK;FYN;CAV1;PGP;ZC3H12A;OPN3
prerank,regulation of hormone secretion (GO:0046883),0.3081132656784106,0.8455368314616456,0.7906976744186046,0.8883105473944773,1.0,4/16,14.03%,OSM;IL11;FFAR2;NMB
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.21387373560753156,-0.8449788817653604,0.8125,0.8848594562087356,1.0,24/99,20.08%,ACACB;BVES;AGPAT1;MAGI2;AGTR1;PPARD;GH1;SNCA;INPP5F;AKR1C1;ECE1;PID1;NR1H2;IFNAR1;CDKN1A;PDGFB;NTF3;CD63;MAPK14;AHI1;INSR;RAMP3;ANGPT1;INS
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.3297812859509615,-0.8447202932133004,0.6956521739130435,0.8847357556996107,1.0,6/15,24.77%,PLA2G6;ORMDL1;SAMD8;SIRT3;PRKCD;TNFRSF1A
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.19052155618131184,-0.8440844385955716,0.9,0.8852689234524417,1.0,75/241,26.37%,HDAC4;CFLAR;MYOCD;FZD4;TRIM52;CRTC3;DDR2;CAPN3;CLU;CAMK2A;SRF;PPARGC1B;TRIM6;TRAF1;JMY;RPS6KA5;PRKCB;TAB2;STK36;TLR9;KIT;AR;TERF2IP;BEX1;PRKD1;PTEN;ALK;EPHA5;FER;CRTC1;NTRK1;ROR1;HDAC5;DVL2;CRTC2;TAB1;RELN;UBE2V1;ERC1;BCL10;PLA2G1B;ESR1;PIDD1;TRIM34;SMO;TP53BP1;IL18R1;UBB;RNF31;CD36;EDA2R;INS;TRIM62;TRIM8;FZD1;MAP3K7;TRIM38;ABRA;LRP6;TIRAP;ARID5B;PLCG2;ATF2;RIPK1;PRKCH;TRIM41;EDA;SMAD3;TSSK4;IL18RAP;HCLS1;RGCC;ESR2;TRAF5;HSPA1A
prerank,histone H2A monoubiquitination (GO:0035518),-0.3286378257232373,-0.8439426434384183,0.6590909090909091,0.8849139534948328,1.0,6/17,24.57%,PCGF3;RING1;SKP1;PCGF6;DDB2;PCGF2
prerank,sphingolipid biosynthetic process (GO:0030148),0.22776632347197304,0.8438754711814936,0.7857142857142857,0.8907617502385419,1.0,24/68,22.53%,SPTLC1;HACD3;CERS6;ALDH3B2;SGPP2;SMPD2;SPTLC2;PNPLA1;CERS2;HACD2;DEGS2;SPNS2;ELOVL1;SGPL1;GBA;ACER2;ELOVL7;FA2H;SPTSSB;ALOXE3;ALDH3B1;B4GALT6;ELOVL6;ASAH2
prerank,endosome organization (GO:0007032),0.23954481736886638,0.8419881256258394,0.6904761904761905,0.8939405876248931,1.0,10/35,19.23%,USP50;PI4K2B;LAPTM4B;SNX10;CLCN3;RAB22A;TMEM9;HOOK1;ARFGEF2;CHMP2B
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.2574482470611342,-0.8417911890455525,0.7543859649122807,0.8882249553817089,1.0,9/39,19.99%,EPN2;KAT2B;RBPJ;MAML1;ZMIZ1;NOTCH4;ENHO;DLL1;TM2D3
prerank,regulation of neuron death (GO:1901214),0.2047945617286482,0.8415913098435989,0.9090909090909091,0.8939253569684122,1.0,33/84,28.52%,GRIN2B;CDK5;SIGMAR1;KIF14;WNT5A;VPS35;NAE1;ATP13A2;TRIM2;PCSK9;GSK3B;SORL1;FOS;DHCR24;TRAF2;GBA;SULT1A3;CTSZ;TNFRSF1B;EGR1;FYN;EIF2S1;NENF;HLA-F;TYROBP;CHRNA7;HTRA2;ITGB2;DDIT4;IFNG;GRM4;PARK7;EGLN3
prerank,visual perception (GO:0007601),0.21121467693587384,0.8404436585239918,0.7727272727272727,0.8954007014981125,1.0,13/90,10.45%,COL1A1;COL11A1;ZIC2;GRM8;GPR143;REEP6;CEP250;CRYBB3;RP2;BEST1;CHRNB2;TH;POU6F2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3145772387075611,-0.8401478981331776,0.6862745098039216,0.8909797265493139,1.0,3/21,9.47%,SASH1;PRKCA;CARD8
prerank,regulation of telomere capping (GO:1904353),-0.2753575515595139,-0.8393049266802143,0.7090909090909091,0.8920044340450672,1.0,9/23,22.60%,MAP3K4;RTEL1;MAPK1;MAPK3;MAP2K7;RAD50;NEK7;SMG6;TNKS
prerank,positive regulation of DNA replication (GO:0045740),0.30094954909342647,0.8392219484432536,0.6545454545454545,0.8970875969247305,1.0,6/16,17.95%,EREG;DNA2;DHX9;ATAD5;CDT1;NPM2
prerank,positive regulation of cholesterol transport (GO:0032376),-0.25816157635382,-0.8382559616986995,0.7454545454545455,0.8935328460637679,1.0,8/30,22.15%,ABCA8;NR1H2;RXRA;ABCA5;GPS2;ABCA3;SIRT1;CES1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.28040020602017635,0.838087427287641,0.6818181818181818,0.8986256594268025,1.0,2/24,4.78%,GNL3L;NAT10
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.20400727594746382,-0.8380827674803304,0.8695652173913043,0.893209746738571,1.0,56/145,28.61%,VAMP2;KCNB1;FLNA;CSNK2A2;TENM1;RAPGEF3;ANK3;MTCL1;PIK3R1;DMAP1;RUFY3;PRNP;CAMK1;BCL2;PSEN1;OAZ2;ABLIM3;PPP3CC;MYO1C;NPEPPS;BAG3;HSPA1L;PCM1;SEC16B;LEPROT;MAPK8;ARIH2;VPS11;CEP290;PCNT;EFCAB7;AKT2;RNF31;FBXW7;GSK3A;BCAS3;PIK3R2;UBR5;BAD;RHOU;BAP1;PRKCD;PINK1;MFF;SMAD3;HCLS1;TPR;UBL4B;YWHAZ;ITGB1BP1;TFDP2;RAB29;MICALL2;SLC51B;ICE1;MIEF2
prerank,negative regulation of blood pressure (GO:0045776),-0.302927738120129,-0.8380108205114464,0.6730769230769231,0.8925903775614666,1.0,4/15,17.45%,NPPA;SCPEP1;NOS1;NPPB
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.28615384531458754,-0.8372612045463428,0.7169811320754716,0.8927547234358436,1.0,7/20,25.36%,DLD;ACAD8;ACAT1;DBT;BCKDHA;ACADSB;ALDH6A1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.28615384531458754,-0.8372612045463428,0.7169811320754716,0.8927547234358436,1.0,7/20,25.36%,DLD;ACAD8;ACAT1;DBT;BCKDHA;ACADSB;ALDH6A1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.2706903137000539,0.8369966585987987,0.74,0.9004525249298405,1.0,5/28,14.32%,HSPD1;IRAK2;MYD88;IRAK1;UBA52
prerank,positive regulation of cellular component movement (GO:0051272),0.27979497184694774,0.8369249681660725,0.6875,0.8997812240863701,1.0,10/26,29.77%,CFAP20;DUOXA2;DUOX2;ACTN4;RPS19;LYN;C1QTNF8;ETS1;TGFBR1;ADAM17
prerank,protein stabilization (GO:0050821),-0.20036396306684684,-0.8360874196116571,0.8055555555555556,0.8944614026731335,1.0,51/165,23.82%,TSC1;TRIM39;CRYAB;ATP1B2;FLNA;ANK2;CLU;MTMR9;PER3;TMEM88;DVL3;PIK3R1;PEX19;CTNND1;CRTAP;ZSWIM7;PARVA;BAG2;PTEN;GPIHBP1;MDM4;OTUD3;USP2;SOX17;USP19;BAG3;EPHA4;CDKN1A;CDC37L1;MORC3;STXBP4;PRKRA;GNAQ;STX12;WIZ;RTN4;RASSF2;FBXW7;SMAD7;GOLGA7;TRIM44;CAMLG;TBRG1;WFS1;PIN1;WDR81;TBL1X;MUL1;PRKCD;PINK1;IFT46
prerank,canonical glycolysis (GO:0061621),0.2725790937748145,0.8360424183890851,0.7391304347826086,0.8999345689373143,1.0,10/23,27.97%,GAPDH;TPI1;GAPDHS;PKLR;PKM;ALDOC;ALDOB;PFKL;PGAM1;GPI
prerank,glucose catabolic process to pyruvate (GO:0061718),0.2725790937748145,0.8360424183890851,0.7391304347826086,0.8999345689373143,1.0,10/23,27.97%,GAPDH;TPI1;GAPDHS;PKLR;PKM;ALDOC;ALDOB;PFKL;PGAM1;GPI
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.26923654608339154,0.8356454858895916,0.7446808510638298,0.9000594538480173,1.0,6/21,16.44%,TRIB3;PRMT3;ERLIN1;BRCA1;APOC1;ERLIN2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.24768190137042906,-0.8353507520165483,0.7419354838709677,0.8954331355535055,1.0,13/38,23.81%,RAP1A;RDX;DAB2IP;TJP1;GFAP;RAPGEF1;ROCK1;VPS11;TIE1;CD36;RAPGEF2;LATS1;PINK1
prerank,eosinophil migration (GO:0072677),0.3025040865077042,0.8353445773711393,0.7209302325581395,0.8990326891931721,1.0,4/15,13.13%,CCL24;CCL4;CCL3;CCL26
prerank,eosinophil chemotaxis (GO:0048245),0.3025040865077042,0.8353445773711393,0.7209302325581395,0.8990326891931721,1.0,4/15,13.13%,CCL24;CCL4;CCL3;CCL26
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.26814149019309685,0.8353116007031635,0.7333333333333333,0.8983564721928062,1.0,7/24,19.31%,IL11;TNFAIP3;ICAM1;SEMA5A;KDR;PAK4;SERPINE1
prerank,establishment of protein localization to membrane (GO:0090150),-0.22902719336735902,-0.8351876798196866,0.7857142857142857,0.8951248469377838,1.0,21/65,22.56%,NACAD;SYNE3;MICALL1;ZDHHC15;REEP1;PARD3;ZDHHC7;MYO1C;TAOK2;GORASP1;VPS37A;BRAF;RTP5;RAB3GAP1;ZDHHC18;EGFR;ZDHHC11;PIKFYVE;GOLGA7;ZDHHC21;RTP1
prerank,response to metal ion (GO:0010038),0.20880982300378742,0.8338089766519505,0.7954545454545454,0.9008076945635366,1.0,27/65,26.59%,IL1A;LOXL2;SLC30A2;TFR2;PPP1CA;ALG2;AQP9;SLC11A2;ATP7B;SLC30A5;KHK;AQP3;GPHN;HOMER1;PLSCR1;FXN;ADAM9;SLC34A1;CAV1;SLC25A13;HAAO;ANXA11;THBS1;PPP2CA;HIF1A;TRPV6;PPP5C
prerank,negative regulation of kinase activity (GO:0033673),-0.2311410441075659,-0.8337653891708701,0.7037037037037037,0.8973349834008719,1.0,15/58,17.14%,MAPT;WWTR1;SNCA;PRKRIP1;DBNDD2;CDKN1C;PRKAG2;PPM1F;HSPB1;INPP5K;TAB1;TRIB2;GNAQ;DUSP19;TSC2
prerank,regulation of interleukin-13 production (GO:0032656),0.29045451634997166,0.8336677021006068,0.7068965517241379,0.9003142814076233,1.0,7/16,32.83%,LEF1;PRKCZ;TNFSF4;IL18;IFNL1;LILRA5;GATA3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.27681731013391103,0.8335864845237487,0.6590909090909091,0.899706138360624,1.0,9/19,28.24%,THY1;EZR;PTPN2;LILRB4;GBP1;DGKZ;PTPRJ;SH2D1A;SLA2
prerank,adenine nucleotide transport (GO:0051503),0.30895229633841764,0.83315563535786,0.6956521739130435,0.8996379860942212,1.0,7/18,17.61%,LRRC8E;SLC35B2;SLC19A1;LRRC8D;SLC25A17;SLC25A24;SLC25A5
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.31925650107949427,0.8327705888614083,0.7391304347826086,0.8995218743643709,1.0,8/17,26.06%,PLA2G7;CXCL10;FPR2;SERPINE1;HMGB1;LGMN;S100A14;CCL1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2218552476504804,-0.8325044852232908,0.7636363636363637,0.8990103442510071,1.0,25/69,24.36%,MYH2;PIK3R1;NCK1;PLA2G6;DOCK1;NCKAP1L;MYO1C;MAPK1;MAPK3;ARPC2;ELMO2;RAC1;ELMO1;BAIAP2;WIPF1;WASF2;PLD2;PIK3R2;ACTB;WIPF3;PLCG1;PLCG2;PRKCD;BRK1;ARPC1A
prerank,positive regulation of ATPase activity (GO:0032781),-0.24214335702141046,-0.8308352806510803,0.7543859649122807,0.9014497050120562,1.0,14/42,23.29%,ATP1B2;TPM1;TNNT3;FXYD2;TOR1AIP1;RYR2;RGN;MYL3;FGF10;GABARAPL2;DNAJB2;MYBPC3;SETMAR;MYL4
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2511011401476174,-0.8307225148599048,0.7192982456140351,0.9009755159773943,1.0,14/36,23.81%,BCO2;MAPT;BCL2;LRRK2;PID1;SLC25A36;PIP5KL1;RNF122;AKT2;UBB;SOD1;ABCD1;BAD;PINK1
prerank,dopamine metabolic process (GO:0042417),0.27495777946936334,0.8306203841972234,0.6923076923076923,0.903210411146449,1.0,5/18,15.35%,TGFB2;TH;DRD2;GCH1;SULT1A3
prerank,cobalamin metabolic process (GO:0009235),-0.2838693156875086,-0.8304704758546709,0.7222222222222222,0.9007449762899762,1.0,5/19,11.86%,CUBN;MTR;CTRB2;CTRC;CTRB1
prerank,piRNA metabolic process (GO:0034587),0.27319281495439407,0.8304573020979532,0.6904761904761905,0.9026882570164751,1.0,2/19,3.84%,HENMT1;PIWIL1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2881227147762432,-0.8303553068645146,0.7049180327868853,0.9002279880473913,1.0,7/21,16.92%,CYP46A1;CYP17A1;CYP11B1;AKR1C1;CYP11A1;AKR1C2;AKR1B1
prerank,dopaminergic neuron differentiation (GO:0071542),0.282070752681325,0.8297498645830188,0.7142857142857143,0.9031548355835587,1.0,4/20,11.00%,WNT2;SHH;MANF;FOXA2
prerank,triglyceride homeostasis (GO:0070328),0.2751128883890296,0.8295554055577133,0.7111111111111111,0.9027677834870962,1.0,8/21,22.74%,DGAT2;SCARB1;XBP1;FITM2;CETP;MLXIPL;HNF4A;PLA2G12B
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.24411033934893572,-0.8295140653554546,0.6545454545454545,0.9013578762961616,1.0,13/41,21.71%,TSC1;FERMT2;MYOC;COL16A1;PPM1F;EFEMP2;RRAS;RAC1;SFRP1;ROCK1;CD36;CCL21;CCL28
prerank,regulation of monocyte chemotaxis (GO:0090025),0.2812897629630834,0.8294247790729465,0.7547169811320755,0.9022186407245413,1.0,13/23,33.36%,PLA2G7;DUSP1;CXCL10;FPR2;LYN;SERPINE1;HMGB1;LGMN;S100A14;CCL1;SLAMF8;CCL5;MOSPD2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.21916993554294137,-0.8293957662406403,0.7678571428571429,0.9008265403798518,1.0,25/70,24.36%,MYH2;PIK3R1;NCK1;PLA2G6;DOCK1;NCKAP1L;MYO1C;MAPK1;MAPK3;ARPC2;ELMO2;RAC1;ELMO1;BAIAP2;WIPF1;WASF2;PLD2;PIK3R2;ACTB;WIPF3;PLCG1;PLCG2;PRKCD;BRK1;ARPC1A
prerank,regulation of cholesterol storage (GO:0010885),-0.30947512120718684,-0.8293827546704757,0.6346153846153846,0.9001419854501798,1.0,5/15,24.39%,PPARD;ABCA1;NR1H2;CES1;LPL
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3069265722729063,-0.8267670573168183,0.8035714285714286,0.9044727856999397,1.0,4/18,14.15%,FGF2;SRF;SLIT2;PIK3R3
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.242361930494923,0.8266872352568899,0.7428571428571429,0.9069507554484528,1.0,9/39,16.48%,SOX4;TNFSF11;TFR2;TM7SF3;DRD2;AIMP1;MCU;AACS;SCT
prerank,ceramide biosynthetic process (GO:0046513),0.23498824219979675,0.8260947044387164,0.7755102040816326,0.9072400193695719,1.0,14/41,22.53%,SPTLC1;CERS6;SMPD2;SPTLC2;PNPLA1;CERS2;DEGS2;ST8SIA6;GBA;FA2H;SPTSSB;ALOXE3;B4GALT6;ASAH2
prerank,vesicle organization (GO:0016050),-0.2475355868351538,-0.8244118860493558,0.7735849056603774,0.9080641692711307,1.0,13/40,19.73%,SNX33;CD34;DNAJC13;CAV2;VPS33B;AKTIP;PI4K2A;VPS11;EPS15;ALS2;HOOK3;PLEKHF1;DNM1
prerank,actin nucleation (GO:0045010),-0.27622579909858475,-0.8242586793552197,0.7551020408163265,0.9076023652375118,1.0,5/20,13.30%,LMOD1;WHAMM;JMY;LMOD2;ARPC2
prerank,lymphocyte differentiation (GO:0030098),0.20884084244893938,0.8235124810684529,0.8444444444444444,0.9117209350961951,1.0,26/81,28.79%,SOX4;IL11;LFNG;TCF3;JAK3;CEBPG;TPD52;GPR89A;CHD7;GPR89B;PTPN2;SLC25A5;RAG1;LCK;JAG2;MSH2;ZAP70;NFAM1;PTPRJ;CR2;RABL3;RHOH;IL10;IFNE;PIK3CD;ADGRG3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.28047557461417355,-0.8232059735740885,0.6842105263157895,0.908925728282249,1.0,9/18,26.49%,IGFBP6;GH1;CILP;IGFBP4;IGFBP5;PHIP;ZFAND2B;NKX3-1;BMP5
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.2882437661347357,-0.8227312650691634,0.7166666666666667,0.9092897105642743,1.0,6/25,17.24%,PLA2G5;PLA2G4B;SLC27A1;PLA2G1B;CDS2;ABCA3
prerank,homologous chromosome segregation (GO:0045143),-0.317704372624246,-0.8227135107837951,0.6666666666666666,0.908623589594224,1.0,5/15,22.01%,PTTG2;FMN2;CENPC;RNF212;ZCWPW1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.22764650173902473,-0.8220302974799751,0.7692307692307693,0.9091404440049482,1.0,18/61,24.77%,DEFB124;MAP3K14;TBKBP1;TAB2;TLR9;TLR3;DAB2IP;TAB1;ERC1;BCL10;TICAM2;ROCK1;UBB;RNF31;MAP3K7;NFKBIL1;RIPK1;TNFRSF1A
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.27577779262235613,0.8219221391540579,0.6808510638297872,0.9141046430482378,1.0,4/19,14.24%,PIK3AP1;NMI;IRAK1;TNIP3
prerank,cellular response to cadmium ion (GO:0071276),-0.2654030971487188,-0.821322097677966,0.7169811320754716,0.9098751750190898,1.0,8/26,27.84%,MAPK1;MAPK3;MT1X;MAPK8;EGFR;MT1M;MT1A;MT3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.2502035553302915,-0.8213101281903322,0.8,0.9091664721560283,1.0,13/29,27.06%,GPR17;LPAR1;GPR20;RAC1;AKAP13;ABRA;LPAR6;ARHGEF3;LPAR4;SYNPO2L;F2RL3;GPR4;F2RL1
prerank,regulation of postsynapse organization (GO:0099175),-0.2655012892299507,-0.8210267560466435,0.71875,0.908990217212531,1.0,12/28,25.81%,ZDHHC15;SHANK3;KIF1A;LRRK2;ABI2;EPHA4;IL1RAPL1;SIPA1L1;PPFIA2;CDKL5;ARC;TANC2
prerank,cellular response to interferon-beta (GO:0035458),0.2905606591381872,0.8200713365332548,0.7619047619047619,0.9169037032401316,1.0,6/18,20.69%,IFITM2;PNPT1;STAT1;UBE2K;MNDA;IFI16
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.2581327793154762,-0.8192569356314406,0.746031746031746,0.9116360141164318,1.0,9/34,15.24%,FGF2;SRF;TEAD1;NGFR;ATOH8;NR3C1;PRL;GATA2;PDGFB
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.22196321780622214,-0.8180833350511625,0.8269230769230769,0.9131149200950097,1.0,18/64,23.64%,CFLAR;FGFR1;PELI3;GPER1;TRAF1;ZMYND11;AR;FEM1B;LGALS3;TNFSF10;BCL10;MADD;FAS;AGTR2;PHIP;NOL3;SCG2;RIPK1
prerank,T cell differentiation (GO:0030217),0.24981570635486824,0.8172292953561318,0.7631578947368421,0.9213076367680665,1.0,18/41,29.77%,SOX4;TCF7;LFNG;SHH;GPR89A;CHD7;GPR89B;PTPN2;RAG1;LCK;JAG2;ZAP70;SPI1;RABL3;ANXA1;RHOH;PIK3CD;ADAM17
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.23944063614616615,0.816337910280095,0.8372093023255814,0.9222399897534409,1.0,8/32,19.31%,IL11;TNFAIP3;MDK;ICAM1;SEMA5A;KDR;PAK4;SERPINE1
prerank,artery morphogenesis (GO:0048844),-0.25137191310154766,-0.8159084107397926,0.7666666666666667,0.9162978368100062,1.0,9/29,21.17%,FOXF1;PKD2;BMPR1A;TBX1;TBX2;ADAMTS9;HEY2;HPGD;SMAD7
prerank,programmed necrotic cell death (GO:0097300),0.2975764835856992,0.815373833664275,0.7435897435897436,0.923351404512906,1.0,6/18,24.80%,PGAM5;PPIF;IPMK;FASLG;MLKL;TICAM1
prerank,regulation of cellular pH (GO:0030641),-0.2601250884914368,-0.8151602954718303,0.6615384615384615,0.9170161551040101,1.0,13/30,30.52%,SLC9A9;ATP1A4;SLC4A7;CA7;SLC4A3;SLC9A5;SLC4A5;CLN3;SLC4A1;SLC4A4;SLC4A10;CA2;SLC9C2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.2158099677925908,0.8146147468693626,0.875,0.9241854085903882,1.0,19/51,29.28%,IL23A;PHB;IL1B;RPS3;NMI;RTKN2;RELA;IRAK1;ACTN4;NOD2;MMP8;CD86;IL12B;IFI35;TLR7;TRAF6;NOD1;PHB2;EIF2AK2
prerank,positive regulation of T cell migration (GO:2000406),0.2780704627971159,0.8145262427541857,0.673469387755102,0.9235561971084411,1.0,7/24,20.78%,WNT5A;CCL20;STK39;ADAM10;CXCL10;TMEM102;CXCL13
prerank,positive regulation of cell growth (GO:0030307),-0.21044977468399997,-0.8144561968486911,0.8793103448275862,0.917581095347294,1.0,26/93,23.84%,NTN1;LGI1;AKAP6;USP47;MAPT;MACF1;ITSN2;RUFY3;L1CAM;NGF;BCL2;KLHL22;SYT2;N6AMT1;SFRP1;DBN1;EGFR;INS;INO80;RIMS1;RPTOR;SYT1;ZNF639;CPNE6;SYT3;CDKL5
prerank,protein hydroxylation (GO:0018126),-0.2970520038711074,-0.8143741604450918,0.7192982456140351,0.916993368193845,1.0,5/15,13.53%,P3H2;VPS33B;HIF1AN;JMJD7;VIPAS39
prerank,sensory perception of pain (GO:0019233),-0.3030503392561813,-0.8137637575887365,0.75,0.9174343855567791,1.0,6/19,16.24%,SCN9A;P2RX7;KCNA2;KCNK4;OPRL1;MRGPRX2
prerank,negative regulation of GTPase activity (GO:0034260),-0.28861465037085055,-0.8137278968561725,0.7090909090909091,0.9167826100878623,1.0,11/23,23.53%,PLXNB3;GPSM1;CPEB2;LRRK2;RDX;DAB2IP;ARL2;KLRK1;BCAS3;FICD;WNK1
prerank,regulation of cholesterol transport (GO:0032374),-0.28432082699951233,-0.813604342732207,0.78,0.9162258100742361,1.0,4/20,15.92%,YJEFN3;ABCA8;NR1H2;ABCA5
prerank,cellular response to fatty acid (GO:0071398),0.2893508257564242,0.8133547929249333,0.6578947368421053,0.9252611304728569,1.0,4/17,10.30%,IRS1;DGAT2;AKR1C4;FFAR2
prerank,regulation of lipid metabolic process (GO:0019216),-0.2138517325386189,-0.8132666688323406,0.9056603773584906,0.9160887073225277,1.0,13/84,9.49%,ACACB;SIN3B;SMARCD3;BBS4;PPARD;NCOA1;RORA;NR1D1;GNB3;NFYB;TNFAIP8L3;C1QTNF2;PRKAG2
prerank,sodium ion import across plasma membrane (GO:0098719),0.28228001297404964,0.8128254787140113,0.8125,0.9253996247225676,1.0,6/18,22.55%,SLC12A2;SLC5A2;SLC9A7;SLC9C1;SLC5A1;SLC9A4
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.3098270618539038,-0.8119821480252639,0.7916666666666666,0.9176618569646057,1.0,6/15,21.82%,RUFY3;KRIT1;KANK1;ROCK1;BCAS3;CDH5
prerank,epithelial to mesenchymal transition (GO:0001837),-0.24735769793107615,-0.8119466535538319,0.7962962962962963,0.9169759054116985,1.0,12/46,17.85%,DDX17;FGFR1;FOXF2;TGFBR3;OLFM1;RBPJ;HEY1;NOTCH4;FAM83D;ROCK1;HEY2;DLG5
prerank,negative regulation of leukocyte activation (GO:0002695),-0.308572175180738,-0.8111497274538069,0.6428571428571429,0.9179191361580273,1.0,2/15,6.28%,GPER1;LRFN5
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.28925183417405875,-0.8108793162855559,0.7962962962962963,0.9178027290424969,1.0,5/17,20.76%,HDAC4;FZD7;HDAC5;GSK3A;SOX6
prerank,tetrapyrrole metabolic process (GO:0033013),-0.2705402995307768,-0.8107696800829229,0.8148148148148148,0.917319677496348,1.0,5/20,11.86%,CUBN;MTR;CTRB2;CTRC;CTRB1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.30730204278744094,-0.8106348451188141,0.7142857142857143,0.9167942613880258,1.0,7/18,22.69%,ATXN3;PIK3R1;RNF185;NCK1;TMEM259;BOK;BCL2L11
prerank,regulation of cytokine production (GO:0001817),0.18602157351804088,0.8100961563073646,0.8787878787878788,0.9296942631167653,1.0,55/146,30.14%,IL1A;EREG;GAPDH;IGF2BP1;FOXP3;CD276;IGF2BP3;BTN1A1;IGF2BP2;IL21;POLA1;CLEC6A;NOS2;MAPKAPK2;BATF;AGPAT2;RPS6KA4;IL17F;AGT;VTCN1;IRF8;ISG15;PLD4;PIK3CG;LYN;TNFRSF1B;TNFSF4;IFI16;SRGN;IL12B;BTNL10;ITK;CD47;CRTAM;NFAM1;PPP1R11;ZBP1;ACE2;FFAR4;ANXA1;IFNG;CASP8;RNF26;IL10;GLMN;HILPDA;BCL6;PIK3CD;NLRP4;IRF3;DTX4;EIF2AK2;BTN3A2;IRF7;CCDC88B
prerank,response to steroid hormone (GO:0048545),-0.25329615201056044,-0.8094205389519875,0.8076923076923077,0.9182445581788339,1.0,7/34,15.42%,ATP1A2;AR;ATP1A3;NR3C1;WBP2;MGARP;TFPI
prerank,regulation of platelet activation (GO:0010543),-0.283509172174769,-0.808900774019788,0.78125,0.9183220072464099,1.0,9/20,27.52%,PDGFRA;PRKCA;CELA2A;PDGFB;C1QTNF1;PDGFA;SELP;PLA2G4A;BLK
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.24329225898329648,0.8088623771660487,0.825,0.9309828333233616,1.0,14/38,24.43%,PMAIP1;TNFAIP3;BCL2L1;ICAM1;GPX1;TNFRSF10B;GSK3B;BRCA1;TRAF2;RNF34;SERPINE1;TNFRSF10A;FASLG;THBS1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.22031133125712343,0.808785079442796,0.8421052631578947,0.930378866771472,1.0,13/54,16.17%,HS6ST2;GLB1;HS3ST1;AGRN;HS2ST1;GALNT5;B3GALT6;B4GALT7;EXT2;SDC1;PXYLP1;CLN6;HPSE
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2664289309192155,-0.808551877143251,0.7692307692307693,0.9182129104995284,1.0,13/25,34.40%,PJA2;TLR9;TLR3;TICAM2;RTN4;TIRAP;F2RL1;FLOT1;NINJ1;TLR2;DDX3X;NR1H3;TLR1
prerank,regulation of phosphate metabolic process (GO:0019220),-0.28697825762308427,-0.8081522687615612,0.723404255319149,0.9181684654909493,1.0,3/16,9.98%,GNB3;PSEN1;SIRT2
prerank,positive regulation of transport (GO:0051050),0.20131032691097023,0.8079722585982789,0.8947368421052632,0.9311358158478542,1.0,11/87,9.10%,CDH3;CALR;LYAR;LMAN2;TFR2;IL1B;IL15RA;SPAG5;SPACA3;PLAA;CYBA
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.2535403713028532,0.8079222595382379,0.7608695652173914,0.9303723405922102,1.0,5/22,11.57%,MGAT5;MASTL;STYXL1;PPP1R1B;GSK3B
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.28660184781080267,-0.8071518059207656,0.7272727272727273,0.9194341821588171,1.0,8/18,24.89%,TMCC2;PSEN1;APH1B;BACE1;PSEN2;NSG1;ADAM19;CLN3
prerank,positive regulation of glucose import (GO:0046326),-0.279387224061037,-0.8069717557643339,0.7368421052631579,0.9190240305144213,1.0,10/24,28.48%,SORBS1;PIK3R1;RHOQ;AKT2;INSR;INS;CLTCL1;OCLN;CAPN10;ARPP19
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2693385413023625,0.8069083917388866,0.8958333333333334,0.9314202651020709,1.0,6/19,20.50%,BCAP31;PML;TMCO1;CCDC47;BAX;BAK1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.27777656046636173,-0.8061288922318458,0.7884615384615384,0.9199368627486614,1.0,7/23,23.41%,FGF2;SRF;SLIT2;PIK3R3;SOX18;CDH5;NR4A1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.2781355985648878,0.8056415558258623,0.7777777777777778,0.9327113204122767,1.0,5/19,17.28%,PDZD8;BCAP31;MCUR1;MCU;MICU2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.21936961365961005,-0.8055087197357733,0.8135593220338984,0.9203126044429472,1.0,16/66,23.51%,CAMK2G;NCAM1;CAMK2A;GBP2;IRF2;MID1;CAMK2B;CAMK2D;TRIM34;TRIM62;TRIM8;IFNGR1;TRIM38;B2M;OAS1;PRKCD
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.25355746773009735,-0.8047567079503486,0.8888888888888888,0.9207519909163658,1.0,10/27,27.06%,GPR17;LPAR1;AGTR1;GPR20;OPRL1;LPAR6;LPAR4;F2RL3;GPR4;F2RL1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.2669938673455731,0.804044084658405,0.673469387755102,0.9345931179691364,1.0,4/20,9.45%,SYK;PRKDC;MDK;XBP1
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.276847463170929,-0.8036934619303903,0.7547169811320755,0.9219608542649557,1.0,6/28,14.60%,PRELP;ST3GAL3;ST3GAL6;B4GAT1;OGN;OMD
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.2561803032277347,0.8034942354900447,0.7307692307692307,0.9347226474427932,1.0,9/29,23.08%,CALR;C1QBP;PLA2G7;CXCL10;FPR2;SERPINE1;HMGB1;LGMN;S100A14
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.27275801021672924,-0.8029570595938536,0.6949152542372882,0.9225265360236166,1.0,4/20,9.42%,TMEM100;FGF2;VEZF1;ATOH8
prerank,positive chemotaxis (GO:0050918),-0.30259556847471,-0.8024965314216527,0.7457627118644068,0.9226142962837077,1.0,8/18,25.02%,PLXNB3;LGALS3;FGF7;FGF10;TSC2;ANGPT1;SCG2;GPNMB
prerank,negative regulation of mitochondrion organization (GO:0010823),0.23751516374073692,0.8024958056917747,0.82,0.9356130081202964,1.0,10/33,19.90%,TRIAP1;PSMD10;BCL2L1;PPIF;GPX1;PRELID1;SLC35F6;SLC25A5;FXN;TMEM14A
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.22820225898464946,-0.8020879404802925,0.7894736842105263,0.9226450042039922,1.0,14/44,24.85%,RBPMS;BMPR1A;SMAD4;BMP3;GDF7;MSTN;GDF5;GDF6;ACVR2A;CSNK2B;INHA;GDF11;TWSG1;TGFB3
prerank,response to tumor necrosis factor (GO:0034612),0.19630629770231356,0.8012729385660597,0.9473684210526315,0.9368398207954087,1.0,31/101,24.63%,TDGF1;CCL24;CXCL8;CCL20;RPS3;CCL22;HYAL3;DHX9;DCSTAMP;CCL4;CCL3;RELA;ADAM10;ADAMTS12;CXCL16;BRCA1;GCH1;CCL26;CIB1;GBA;CCL17;BAG4;ADAM9;CHI3L1;GBP1;ZC3H12A;HYAL2;GBP3;CD58;OCSTAMP;NPNT
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.26605117411211116,0.8009777981075421,0.7659574468085106,0.9365262719685169,1.0,4/20,7.06%,CCND1;PSMD10;PROX1;PSRC1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2713105089488287,0.8008536431715992,0.75,0.9359508401650095,1.0,10/25,26.85%,B3GNT4;B3GNT2;HS2ST1;EXT2;B3GNT3;HAS3;B3GNT8;NDST3;EXT1;HAS2
prerank,regulation of cellular component size (GO:0032535),0.24546578852600004,0.8003236710128678,0.8409090909090909,0.9359663096973946,1.0,11/30,20.99%,PPP1CA;ATP13A2;RAB22A;LAMTOR5;EZR;MTPN;VAV3;SLC9A3R1;MSN;VAV2;LAMTOR4
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.24747648802444172,-0.80027626437073,0.7878787878787878,0.9250500667582747,1.0,11/39,18.07%,BTC;DUSP3;SPRY1;RNF115;DAB2IP;TSG101;ARHGEF7;EPS15L1;CBL;EPS15;EGFR
prerank,myeloid cell development (GO:0061515),-0.2795101492738648,-0.7996496498745118,0.7450980392156863,0.9254837371222702,1.0,11/19,33.96%,KIT;NCKAP1L;THPO;ZNF385A;GATA1;ALAS2;SH2B3;NRROS;ANXA2;TLR2;APP
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.27221673262668156,0.7990372172758,0.7804878048780488,0.9372728915068699,1.0,7/20,20.77%,SAPCD2;BCL2L1;CLTC;MRAP;MRAP2;TGFB1;GBP1
prerank,heme biosynthetic process (GO:0006783),0.2597749655903123,0.7989550954965334,0.782608695652174,0.9365767585323086,1.0,7/20,24.37%,HMBS;TSPO;CPOX;PGRMC1;FXN;ALAS1;ABCB6
prerank,ganglioside metabolic process (GO:0001573),0.2583818447898036,0.7988854220070691,0.7272727272727273,0.9359658604159805,1.0,5/20,14.77%,NEU1;HEXB;ST8SIA6;GM2A;CLN6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3009858431583896,0.7980774729117665,0.7209302325581395,0.9367371952236467,1.0,3/15,7.80%,DDIAS;RPS3;BCL2L1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.23380709243134204,0.7977780319917536,0.8181818181818182,0.936584095685456,1.0,18/33,32.19%,EREG;AREG;AGT;SHKBP1;MMP9;NUP62;PLAUR;AGR2;TGFA;EGF;DOK1;PTK6;EPGN;HIP1R;ADAM17;HBEGF;PDE6G;AKT1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.20635064407855946,-0.7976890982292335,0.9193548387096774,0.9280461283634487,1.0,8/59,10.92%,IL6R;CTF1;GH1;CRLF1;KIT;GHR;CNTF;TSLP
prerank,ERAD pathway (GO:0036503),0.1944911345862892,0.7966757513899615,0.9666666666666667,0.9376331200373899,1.0,23/81,22.28%,STT3B;GET4;UGGT1;DERL1;SEC61B;ERLIN1;FOXRED2;TOR1A;UBE2J1;VCP;ERLIN2;HSPA5;MAN1B1;FBXO6;UBQLN1;FAF2;ERLEC1;OS9;CCDC47;AUP1;DNAJC10;UBXN8;RHBDD2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.28225665622466656,-0.7961532794738464,0.8,0.9300371545009162,1.0,10/24,26.40%,HAP1;GPER1;RBPJ;CCDC88A;CBL;RTN4;AFAP1L2;BCAR3;DGKD;HIP1
prerank,regulation of tissue remodeling (GO:0034103),0.2831385666805767,0.7960455809381765,0.8043478260869565,0.9378984298972057,1.0,6/20,11.97%,IL23A;SYT7;MDK;IL21;RUNX1;SUCO
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.28515986047681363,-0.7959249916641394,0.7758620689655172,0.929650957066858,1.0,6/21,17.52%,MEIS1;MEIS2;ZBTB16;ZFP36L1;ZFP36;HOXA5
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.24796925309432089,-0.7959121335458423,0.7843137254901961,0.928932525106219,1.0,7/29,18.84%,PLA2G5;AGTR1;ITGB3;ABCA1;NR1H2;ABCA5;CD36
prerank,regulation of tumor necrosis factor production (GO:0032680),0.17999759228695839,0.7957708954127515,0.9761904761904762,0.93757732078037,1.0,33/118,27.46%,IL1A;EPHB2;IL23A;WNT5A;SYK;PF4;TNFAIP3;DHX9;CYBA;OAS2;CCL3;TRIM27;IL17A;MAPKAPK2;NOD2;ARFGEF2;OAS3;MMP8;HMGB1;ZC3H12A;IL12B;CD47;CD2;TYROBP;THBS1;CHRNA7;PTPN11;PTPRJ;GSTP1;IL37;IFNG;CLEC7A;IRAK3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.2739065851786305,-0.7953302266976646,0.7192982456140351,0.9292270780521433,1.0,9/19,34.69%,NR1D1;DAB2IP;TICAM2;TIRAP;F2RL1;FLOT1;NINJ1;NR1H3;APPL1
prerank,cell chemotaxis (GO:0060326),-0.20477591103948004,-0.794741586733891,0.8615384615384616,0.9295777411734222,1.0,19/64,23.51%,PLXNB3;LPAR1;AGTR1;PDGFRA;KIT;CCR10;PARVA;ELMO2;ACKR3;PDGFB;DOCK4;AZU1;RAB13;ACKR2;CCL21;CCL28;HGF;NR4A1;PRKCD
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3110161241730584,-0.79407671775371,0.7450980392156863,0.9301186223464688,1.0,8/16,27.06%,NTRK3;VEGFB;NTF3;AZU1;VEGFC;SCG2;CDH13;F2RL1
prerank,stabilization of membrane potential (GO:0030322),-0.28759061146141185,-0.7939543049877553,0.8148148148148148,0.9295785364787887,1.0,5/17,23.43%,KCNK3;KCNK4;KCNK2;KCNK7;KCNK6
prerank,cellular response to interleukin-6 (GO:0071354),-0.2575414030428545,-0.7935354290475738,0.8571428571428571,0.9296036231309297,1.0,6/28,12.00%,IL6R;SMAD4;PTGIS;ST3GAL6;FER;PID1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.29507721596072267,0.7934140413404965,0.8409090909090909,0.9403793278459771,1.0,5/18,16.81%,NCL;NCBP1;DAZAP1;RBM3;TRA2B
prerank,lymphocyte activation involved in immune response (GO:0002285),0.26630459176803256,0.7932571239888154,0.7804878048780488,0.9399173959209667,1.0,23/23,73.40%,MDK;CD244;IFNE;LCP1;CD74;EIF2AK4;CD1C;IFNA1;IFNB1;IFNA8;IFNA14;IFNA7;IFNA4;IFNA10;IFNA17;IFNA16;IFNA2;IFNA6;IFNW1;IFNA21;GPR183;F2RL1;IFNA5
prerank,transcription by RNA polymerase III (GO:0006383),0.26709572848353264,0.7931589544814511,0.7441860465116279,0.9393263465986877,1.0,9/27,21.64%,POLR3K;GTF3A;POLR2K;GTF3C4;POLR3G;CRCP;GTF3C3;GTF3C2;POLR2L
prerank,positive regulation of organelle assembly (GO:1902117),0.22212836068441838,0.7925514748083992,0.8372093023255814,0.9396818346329746,1.0,18/44,27.23%,CAPG;CSF2;G3BP1;SAXO1;SPAG5;GPSM2;SDC1;PLK4;NUP62;CNOT1;STX18;FSCN1;G3BP2;CNOT6;SDC4;RALB;IL5;PIP4K2C
prerank,negative regulation of cell development (GO:0010721),0.23120057187233256,0.7923657997588022,0.8863636363636364,0.9391753298896311,1.0,8/24,24.76%,IL1B;GSK3B;SORL1;PAX6;WNT7A;NOTCH1;WNT3A;DYNLT1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.2252749796255592,-0.7923263186681077,0.8596491228070176,0.9308833639748482,1.0,11/39,21.82%,ATP2B4;PKD2;CLU;CD34;PTGIS;RAC1;INSR;CD36;AGTR2;HBB;KLF2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3019442079498593,-0.7921903624104766,0.7169811320754716,0.9303861961977431,1.0,5/15,19.09%,PLIN5;SLC27A1;NR1H2;FBXW7;CTDNEP1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.20945976245681697,0.7921749633376275,0.7555555555555555,0.9386141422264086,1.0,16/45,26.25%,TDGF1;EREG;AREG;FAM83A;SOX9;GRB7;REPS2;AAMP;TGFB1;TGFA;VIL1;EGF;PTPN11;PIGR;EPGN;IQGAP1
prerank,regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),0.26624483934661647,0.7906879878964269,0.7551020408163265,0.940310138573575,1.0,18/18,73.40%,LIF;IFNG;IFNE;IFNA1;IFNB1;IFNA8;IFNA14;IFNA7;IFNA4;IFNA10;IFNA17;IFNA16;IFNA2;IFNA6;GADD45A;IFNW1;IFNA21;IFNA5
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.23899074066993944,-0.7903193874532608,0.7857142857142857,0.9326909193728868,1.0,15/46,24.90%,RGS2;NPPA;UCHL1;HIPK3;SPRY1;INPP5K;DAB2IP;SPRY3;DUSP19;MAPK8IP1;CDK5RAP3;CAV3;PRKCD;PDCD4;SMPD1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2761525977118563,-0.789985197687582,0.7368421052631579,0.9324673991470239,1.0,11/22,25.76%,USP20;ATXN3;OTUD7A;OTUD3;OTUD7B;USP25;USP34;BAP1;OTUD5;USP8;OTUD4
prerank,response to estrogen (GO:0043627),-0.24497214647215265,-0.7878100146468763,0.8,0.9355821482434815,1.0,10/34,22.50%,CITED2;AR;GSTM3;WBP2;SFRP1;ESR1;ARID5A;CRHBP;BCAS3;CITED4
prerank,regulation of spindle assembly (GO:0090169),0.24325467541514867,0.7876915931950356,0.851063829787234,0.9446457279743602,1.0,12/25,30.50%,SPAG5;CHMP4C;GPSM2;DRG1;PLK1;CHMP5;CHMP2B;CHMP1A;CHMP2A;HNRNPU;CCSAP;CHMP1B
prerank,negative regulation of blood coagulation (GO:0030195),0.2490674312963279,0.7875952598855974,0.8478260869565217,0.9439983060509652,1.0,6/29,11.79%,F12;PLAU;F7;THBD;SERPING1;PROC
prerank,cellular response to acid chemical (GO:0071229),-0.25472954568509165,-0.7874343448481457,0.7419354838709677,0.9355393226262948,1.0,11/26,26.74%,RRAGC;CPEB1;CPEB3;RRAGB;RRAGD;RPTOR;KLF2;CPEB4;MTOR;RRAGA;CAPN2
prerank,modulation by symbiont of entry into host (GO:0052372),0.2772661570640954,0.7868244885611734,0.7297297297297297,0.9444219283769432,1.0,4/19,10.78%,CXCL8;FUCA2;TRIM27;TRIM14
prerank,oligosaccharide biosynthetic process (GO:0009312),0.26736780967905827,0.7863827441125265,0.8444444444444444,0.9443010911981066,1.0,9/23,25.70%,FUT8;FUT1;FUT7;B4GALT1;FUT2;MPDU1;FUT6;FUT4;FUT3
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2633024985770922,-0.7861138090861461,0.8135593220338984,0.9369630011130977,1.0,9/22,22.71%,PRKRIP1;CDKN1C;INPP5K;CDKN1A;ROCK1;CDKN2C;SIRT1;TESK1;INHA
prerank,response to ketone (GO:1901654),-0.2606709745302321,-0.7860104374980191,0.7755102040816326,0.9364424308184659,1.0,16/28,35.20%,TGFBR3;SLIT2;SLIT3;WBP2;CCL21;HSD3B2;NKX3-1;TGFB3;CATSPERG;CATSPER2;YAP1;CSN1S1;CATSPERD;NR1H3;UBE3A;ABCB4
prerank,positive regulation of phagocytosis (GO:0050766),0.22416662874629173,0.7850969219735718,0.875,0.9456077801273579,1.0,7/50,9.10%,CALR;LYAR;LMAN2;IL1B;IL15RA;SPACA3;CYBA
prerank,sensory perception of chemical stimulus (GO:0007606),-0.19559177109243933,-0.7843534810874287,0.9074074074074074,0.9382905911249265,1.0,7/94,19.87%,BBS4;SLC24A4;SYT10;GNAL;CD36;UBR3;BEST2
prerank,neural tube development (GO:0021915),-0.27831559644816944,-0.7834271131968584,0.7543859649122807,0.9391278741224987,1.0,3/16,10.17%,PKD1;PKD2;ZNF358
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.20930009993619783,-0.783324123112946,0.8852459016393442,0.9385508831749838,1.0,22/81,20.98%,FGFR1;SASH1;FGF2;NRP2;ZNF580;ITGB3;PRKCA;RHOB;PRKD1;ATOH8;FLT4;RRAS;ANGPT4;HSPB1;RAC1;GATA2;PDGFB;MAPK14;FGF1;ANGPT1;SIRT1;BCAS3
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.20330413077042161,-0.7825540135019431,0.88,0.9389952675378467,1.0,11/48,16.93%,RBPMS2;IL6R;NDRG4;ELANE;MFN2;APOD;OGN;VIP;IGFBP5;PDGFB;ELN
prerank,aerobic respiration (GO:0009060),0.28440747327326754,0.7807917824154423,0.7608695652173914,0.9513747464871324,1.0,4/20,12.89%,MTFR2;MTFR1;MDH2;UQCRH
prerank,TOR signaling (GO:0031929),0.25111148220849994,0.7805305171379964,0.8297872340425532,0.9510002303161912,1.0,10/25,23.62%,SYAP1;EIF4EBP1;CARD11;RHEBL1;MLST8;NPRL3;TIPRL;RPS6KB2;PRR5;LARP1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.21170962816439814,-0.779011548056597,0.90625,0.9435737184589912,1.0,26/66,27.02%,HAP1;BTC;DUSP3;GPER1;FER;SPRY1;RNF115;DAB2IP;TSG101;ARHGEF7;EPS15L1;CCDC88A;CBL;EPS15;MVB12B;EGFR;AFAP1L2;PTPN12;BCAR3;ERRFI1;RHBDF1;DGKD;ZFYVE28;HIP1;CEACAM1;CDH13
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.2807055838342756,-0.7785723742442032,0.8095238095238095,0.9435250672779979,1.0,3/16,12.21%,OSR1;SPRY1;NOTCH4
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.22235995079191828,0.7785247670532457,0.8863636363636364,0.953326925008656,1.0,16/41,31.57%,CHID1;MYD88;IL17A;NOS2;GBP5;PLD4;LILRB4;NOD2;ADCY7;ZC3H12A;TICAM1;HIF1A;CLEC7A;CD6;IL17D;TNF
prerank,renal system development (GO:0072001),-0.22271683122515085,-0.7777865578091154,0.8095238095238095,0.9441947847626698,1.0,9/55,12.08%,NPHP3;PKD1;FOXF1;MYOCD;AGTR1;PYGO1;TCF21;GLI2;SOX17
prerank,regulation of interferon-alpha production (GO:0032647),0.24754124493016627,0.7777307598395342,0.8571428571428571,0.9536764824145301,1.0,4/25,11.68%,HSPD1;RIPK2;DHX9;STAT1
prerank,regulation of lipid catabolic process (GO:0050994),-0.29022276540799985,-0.7774885647929555,0.8035714285714286,0.9439018402003242,1.0,6/17,21.54%,PDE3B;ALK;BSCL2;RARRES2;INS;ABCD1
prerank,toll-like receptor signaling pathway (GO:0002224),0.18844701049892337,0.7773255933732817,0.9473684210526315,0.9534202090357365,1.0,31/84,31.72%,HSPD1;RIPK2;IRAK2;PIK3AP1;NMI;MAPKAPK3;UNC93B1;CNPY3;MYD88;IRAK1;MAPKAPK2;TNIP3;UBA52;UBE2D1;HMGB1;LGMN;UBE2D2;CTSB;S100A14;RPS6KA3;TICAM1;ITGB2;IRAK3;CASP8;TLR7;TRAF6;TLR8;SCIMP;UBC;IKBKG;IKBKB
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.26644228157928107,-0.7772238917638521,0.8148148148148148,0.9435884514352377,1.0,8/20,24.89%,ZDHHC7;AR;VTI1B;VPS4A;INS;ACTB;STX7;CLN3
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.26738724438892847,0.7770258704558697,0.76,0.9531643588995173,1.0,11/19,37.35%,IL21;RAET1E;HLA-F;IL12B;CRTAM;SLAMF6;NCR3;RASGRP1;PVR;KLRC2;KLRD1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.23484615417445598,0.7769186668959256,0.9285714285714286,0.9525152501677964,1.0,10/25,28.24%,THY1;EZR;PTPN2;LILRB4;GBP1;DGKZ;CD300A;PTPRJ;SH2D1A;SLA2
prerank,regulation of vacuole organization (GO:0044088),0.25499387356097625,0.7767501993488464,0.85,0.9519495420651731,1.0,4/20,16.64%,LAPTM4B;ENO4;TBC1D14;NPRL3
prerank,kidney development (GO:0001822),-0.21546448833996976,-0.7765830790280445,0.9016393442622951,0.94380433507901,1.0,15/68,16.75%,NPHP3;PKD1;KANK2;GDNF;OSR1;AGTR1;PYGO1;TCF21;ZBTB16;GLI2;SOX17;GDF6;CEP290;FGF10;PCSK5
prerank,response to fatty acid (GO:0070542),0.25546392984746297,0.7754641425762349,0.8604651162790697,0.9530117365315032,1.0,4/19,10.30%,IRS1;SCD;SOX9;FFAR2
prerank,steroid hormone biosynthetic process (GO:0120178),0.2379382738086278,0.7749753132876067,0.8695652173913043,0.9529671184032387,1.0,7/28,16.03%,SRD5A1;SRD5A3;DHCR7;FDXR;TSPO;FDX1;MED1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.2901112534130552,0.7741793871154593,0.782608695652174,0.953442712960221,1.0,4/16,16.48%,IRS1;IL1B;ABHD5;SCT
prerank,negative regulation of mRNA processing (GO:0050686),0.28163476768581464,0.7740881505766324,0.7547169811320755,0.9527413358301241,1.0,7/15,23.98%,C1QBP;SRSF9;PTBP1;SAP18;U2AF2;BARD1;RNPS1
prerank,vesicle transport along actin filament (GO:0030050),0.2749407758189675,0.7738754024254385,0.8,0.9522961978594912,1.0,8/19,23.62%,ACTN4;MYO6;FNBP1L;MYO5B;MYO1E;MYO19;MYO1D;MYO1H
prerank,protein import into peroxisome membrane (GO:0045046),0.25222892401272623,0.7733704779890914,0.8490566037735849,0.952261415921756,1.0,4/22,14.02%,PEX13;ACBD5;SLC25A17;PEX16
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.26962099285932717,0.7732353366390364,0.7906976744186046,0.9516809710821031,1.0,3/15,12.62%,XRCC5;NABP2;BRCA2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.2832966375878685,-0.7731166256588177,0.7413793103448276,0.9479133300682289,1.0,4/15,20.46%,PPARD;NR1H2;NR4A3;MLYCD
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.28615766011913857,-0.7724409070406469,0.8333333333333334,0.9482506588322965,1.0,7/17,26.37%,CSNK2A2;HDAC6;FBXW7;GSK3A;CAMKK2;PINK1;DNM1L
prerank,mitochondrial fission (GO:0000266),0.29621208117037773,0.7718108076163371,0.8125,0.9529917566636548,1.0,2/17,2.09%,MTFR2;MTFR1
prerank,response to growth factor (GO:0070848),-0.21969799034771623,-0.7717423631547912,0.9322033898305084,0.9485111141034771,1.0,11/40,20.11%,BMPR1A;MAPK7;HDAC6;NOS1;MAP2K5;SFRP1;PDGFB;ACVR2A;BMPR1B;RPS6KB1;SOX2
prerank,early endosome to late endosome transport (GO:0045022),-0.270597618726232,-0.7705516198345227,0.6949152542372882,0.9494162956027731,1.0,5/20,22.67%,WDR91;AKTIP;PIK3C3;HOOK3;WDR81
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.27763759820440553,0.7704347496254527,0.78,0.9540824662281451,1.0,4/18,14.32%,CXCL8;C1QBP;MDK;MCU
prerank,nucleus organization (GO:0006997),0.21542751297314772,0.7699838117837057,0.8717948717948718,0.9538648770606284,1.0,18/46,25.90%,CEP55;NUP155;NUP93;NUP35;SEH1L;CHMP4C;TOR1A;WDR73;NUP205;RPS19;NDC1;CHMP5;CHMP2B;CHMP1A;SUN3;REEP4;CHMP2A;NUP98
prerank,positive regulation of lipid storage (GO:0010884),0.2689555842926158,0.7697663756525823,0.7727272727272727,0.9532850190822664,1.0,5/20,16.03%,SCARB1;IKBKE;PLIN3;C3;FITM2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.253891863634988,0.7695941317231774,0.8333333333333334,0.9527695152683519,1.0,13/31,31.72%,IKBKE;TNIP3;UBA52;UBE2D1;CD300LF;UBE2D2;TICAM1;CASP8;IRF3;IRF7;UBC;IKBKG;IKBKB
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.22166826991915273,0.7692951653759207,0.8484848484848485,0.9524358688027513,1.0,20/44,29.22%,EREG;VPS25;AREG;GPRC5A;SH3KBP1;PTPN3;RAB7A;PTPN2;STAM;TGFA;CDC42;CBLC;EPN1;EGF;RNF126;PTPRJ;EPGN;ITGA1;SNX6;MVP
prerank,regulation of viral life cycle (GO:1903900),-0.2545427970734896,-0.769264698495624,0.7586206896551724,0.9504933960151547,1.0,8/24,21.58%,TRIM6;TSG101;TRIM34;KPNA6;VPS4A;TRIM62;HS3ST5;TRIM38
prerank,positive regulation of neutrophil migration (GO:1902624),0.27453084850948173,0.7688912968316406,0.8775510204081632,0.9522836350464712,1.0,5/21,15.45%,CXCL8;C1QBP;MDK;MCU;ADAM8
prerank,negative regulation of RNA metabolic process (GO:0051253),0.2649292744471979,0.7684545147814257,0.7962962962962963,0.9521497213859997,1.0,9/19,24.78%,PTBP3;SHQ1;PTBP1;TMBIM6;TGFB1;RPS13;ZC3H12A;RPS26;TERT
prerank,organelle fusion (GO:0048284),-0.27362875970554357,-0.7679673373202883,0.7916666666666666,0.9514996052202318,1.0,10/20,35.03%,MFN2;PLD6;VPS11;SPG7;MFF;MFN1;MIEF2;STX4;CYP26C1;USP30
prerank,regulation of cellular biosynthetic process (GO:0031326),0.23353922735349847,0.7678216302763087,0.8529411764705882,0.9522327150884305,1.0,9/32,18.05%,CXCL8;ADIPOR1;MFSD12;EIF6;FGFR4;C3;FITM2;MED1;TNFRSF1B
prerank,endocardial cushion morphogenesis (GO:0003203),0.2856227604308177,0.7671631532324217,0.75,0.9523426380004595,1.0,7/19,21.82%,TBX20;SOX9;TGFB2;ENG;BMP4;TGFBR2;NOTCH1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.2755095482720673,-0.7671038815521695,0.7555555555555555,0.9513497254506664,1.0,4/15,20.39%,AP3S2;AP3B2;BLOC1S1;SNAPIN
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.2755095482720673,-0.7671038815521695,0.7555555555555555,0.9513497254506664,1.0,4/15,20.39%,AP3S2;AP3B2;BLOC1S1;SNAPIN
prerank,positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),0.2662328920798746,0.7668612076574869,0.9111111111111111,0.9520287216077562,1.0,17/17,73.40%,LIF;IFNG;IFNE;IFNA1;IFNB1;IFNA8;IFNA14;IFNA7;IFNA4;IFNA10;IFNA17;IFNA16;IFNA2;IFNA6;IFNW1;IFNA21;IFNA5
prerank,purine ribonucleotide transport (GO:0015868),0.2990032116795239,0.766394402875795,0.8260869565217391,0.9519404833477975,1.0,6/17,16.29%,LRRC8E;SLC35B2;SLC19A1;LRRC8D;SLC25A17;SLC25A24
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.2621033424704465,-0.765973486271272,0.803921568627451,0.9516077169931345,1.0,7/21,21.95%,CLIP3;ZDHHC15;ZDHHC7;ZDHHC18;ZDHHC11;GOLGA7;ZDHHC21
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.2621033424704465,-0.765973486271272,0.803921568627451,0.9516077169931345,1.0,7/21,21.95%,CLIP3;ZDHHC15;ZDHHC7;ZDHHC18;ZDHHC11;GOLGA7;ZDHHC21
prerank,epithelial cell development (GO:0002064),0.25976182932134356,0.7659458886660371,0.8666666666666667,0.9517713932880723,1.0,11/21,30.93%,WNT7B;POF1B;GRHL2;RAB25;SIX3;SIPA1L3;WNT7A;PDZD7;EXPH5;BFSP1;ROS1
prerank,negative regulation of protein binding (GO:0032091),-0.20189472857371346,-0.7657904430872386,0.9365079365079365,0.951146452903399,1.0,21/67,24.16%,ADRB3;TTBK2;CSNK1E;ADRB2;CAMK1;BAG2;MAP2;LRRK2;CDKN1A;DISC1;PDGFB;ROCK1;MAPK8;CCL23;DNAJB2;B2M;ACTB;GOLGA2;PIN1;PRKCD;ATP2A2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.24886805846281437,0.7655966374658547,0.8461538461538461,0.9514407186974353,1.0,7/21,27.01%,TP73;PML;AEN;IFI16;MSH2;TP53;DDIT4
prerank,blood vessel morphogenesis (GO:0048514),0.19616151904335297,0.7647651402661089,0.9512195121951219,0.9519461718158786,1.0,15/55,21.63%,STRA6;TBX20;SYK;SHH;PROX1;APELA;ENG;KDR;TGFB1;LRP5;ID1;TGFBR2;HES1;CAV1;TNNI3
prerank,melanosome localization (GO:0032400),-0.2558841621310623,-0.7639264881999743,0.8125,0.953188776608936,1.0,6/21,15.91%,BBS4;BBS5;MYO5A;VPS33B;BBS2;BBS7
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.2551569772087715,0.7639009142187246,0.6923076923076923,0.9523520535249292,1.0,8/17,32.19%,DHFR;SCARB1;GCH1;NUS1;TERT;HIF1A;TNF;AKT1
prerank,positive regulation of locomotion (GO:0040017),-0.24713828029933688,-0.7637807295563759,0.9230769230769231,0.9526718986661271,1.0,8/30,20.17%,BVES;NTN1;PPM1F;RARRES2;P2RY12;PDGFB;AKT2;CCL21
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2772139408773362,-0.7625162161647697,0.803921568627451,0.9536084613226792,1.0,5/16,20.46%,PPT2;DIP2A;SCD5;ACAT1;MLYCD
prerank,regulation of phosphatase activity (GO:0010921),-0.24780278390891036,-0.761092273844653,0.8421052631578947,0.9550870977927113,1.0,3/25,11.60%,TSC1;MTMR9;PPP6R2
prerank,development of primary male sexual characteristics (GO:0046546),-0.23387152428136473,-0.7607897187336817,0.8666666666666667,0.9548105606939995,1.0,14/40,27.55%,SOX15;MAMLD1;KIT;AR;KITLG;CSDE1;WNT2B;LHCGR;FGF9;SOX8;ADAM21;GATA1;LHFPL2;FSHR
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.28525918794850136,-0.760633964840652,0.8070175438596491,0.954321493601462,1.0,8/18,31.67%,RTEL1;TINF2;SMG6;TNKS;SLX4;TNKS2;ERCC4;SMG5
prerank,organelle fission (GO:0048285),-0.25473112295916145,-0.7605992525081106,0.7647058823529411,0.9536546942852866,1.0,9/24,27.17%,MTFR1L;PEX19;CORO1C;SEC16B;DNM1;MUL1;MFF;DNM1L;DNM3
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.26799713862307,-0.7594116130608787,0.819672131147541,0.9544978505531616,1.0,4/21,15.22%,PLA2G5;PLA2G4B;OSBPL5;PLA2G1B
prerank,regulation of neurogenesis (GO:0050767),-0.20719247710785818,-0.7590831871056453,0.9322033898305084,0.9542568503496284,1.0,17/60,22.12%,NUMBL;ARNTL;GPER1;BHLHB9;NUMB;HEY1;ZNF335;PCM1;HEY2;SPEN;SERPINF1;SOX11;CCL11;HOOK3;DLL1;LIG4;B2M
prerank,negative regulation of B cell activation (GO:0050869),0.26241826167416704,0.7585661632579663,0.8409090909090909,0.9585969674387592,1.0,9/22,28.33%,INHBA;TNFAIP3;LYN;MNDA;TYROBP;CD300A;FOXJ1;CTLA4;IL10
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2788965298046142,-0.7577620649444894,0.8301886792452831,0.9552695123704913,1.0,4/18,17.08%,IL6R;SMAD4;FER;CBL
prerank,acylglycerol metabolic process (GO:0006639),0.22574127834180588,0.7566433766679248,0.8260869565217391,0.9606908451891956,1.0,9/35,20.10%,DGAT2;ABHD12;GK;PNPLA3;LYPLA2;ABHD2;APOC1;CETP;CAV1
prerank,regulation of glucose metabolic process (GO:0010906),0.23620960474505867,0.7566426311501341,0.8958333333333334,0.9599154692043778,1.0,4/29,7.77%,IRS1;ADIPOR1;PMAIP1;SDHAF3
prerank,regulation of transmembrane transport (GO:0034762),-0.23521889778373195,-0.7554825720209104,0.8148148148148148,0.9577109595926492,1.0,14/33,29.85%,SNCA;PRKCB;BCL2;KCNJ8;KCNJ9;KCNJ1;INS;ACTB;PIM1;KCNJ5;OCLN;NEDD4L;CALHM1;KCNJ12
prerank,response to alcohol (GO:0097305),0.23844976193486828,0.7549365233797081,0.8695652173913043,0.9611189917457649,1.0,5/30,9.42%,GRIN2B;GOT2;CHRNB2;TH;CCL3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.2736543454967709,-0.7549075290286791,0.8518518518518519,0.9577074458996442,1.0,2/18,6.73%,DDX17;CELF4
prerank,pharyngeal system development (GO:0060037),0.2709568187460715,0.7548275469210414,0.8571428571428571,0.9604607588482366,1.0,5/17,19.99%,FOLR1;TGFB2;BMP7;BMP4;HES1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.24823829684786639,-0.7541535659039372,0.8909090909090909,0.9580934368793377,1.0,12/26,31.26%,ADGRB1;SNCA;CD36;INS;PIKFYVE;ABCD1;PLCG2;ABCD2;RAB27A;SLC30A10;SLC5A3;GRIN1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.27009599226853387,-0.7531893442537442,0.8,0.9585266502320177,1.0,8/22,21.46%,CLU;EPHA4;RANBP9;GSAP;CASP3;GSK3A;IFNGR1;LRRTM3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.1945554011562527,-0.7530528625203178,0.9508196721311475,0.9579835083972192,1.0,9/68,10.92%,IL6R;CTF1;GH1;INPP5F;CRLF1;KIT;GHR;CNTF;TSLP
prerank,protein K63-linked ubiquitination (GO:0070534),-0.21298722916816282,-0.7510240143454061,0.8135593220338984,0.9597525006814335,1.0,11/43,17.96%,PELI3;TRAF1;UBE2D4;RNF115;UBE2G1;UBE2E2;RNF152;ZFP91;UBE2V1;ARIH2;HECTD1
prerank,regulation of leukocyte migration (GO:0002685),0.27204388246778993,0.7503764429754592,0.8214285714285714,0.9652266593190132,1.0,7/17,28.02%,ZP3;CD81;HOXA7;TNFSF18;RAC2;ANXA1;RHOH
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.27787862930686263,-0.7497344317304436,0.8367346938775511,0.9606536113386259,1.0,5/17,17.75%,FERMT2;LTBP3;THPO;KAT7;SOX11
prerank,positive regulation of telomere capping (GO:1904355),-0.26252898934898616,-0.7494955066927667,0.8360655737704918,0.9602734904130782,1.0,6/17,16.94%,MAP3K4;RTEL1;MAPK1;MAPK3;MAP2K7;NEK7
prerank,mitotic cytokinetic process (GO:1902410),-0.26627771898604424,-0.7491127645610715,0.88,0.9600844146752665,1.0,6/20,18.28%,KLHDC8B;CHMP3;CNTROB;RHOA;VPS4A;CHMP4A
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.23354837148351903,-0.7489958904302829,0.8928571428571429,0.9595625253661819,1.0,10/34,22.37%,TRIM39;MAP1A;WAC;KLHL40;OPHN1;OGT;GABARAPL2;USP25;ALAD;CAMLG
prerank,regulation of cell size (GO:0008361),0.23914383330666414,0.7475647288267885,0.8867924528301887,0.9679138191805874,1.0,9/23,20.99%,LAMTOR5;EZR;PLEK;MTPN;VAV3;SLC9A3R1;MSN;VAV2;LAMTOR4
prerank,lipid droplet organization (GO:0034389),-0.25898830264657613,-0.7469715542210024,0.8297872340425532,0.9614460608536579,1.0,7/21,18.43%,ZFYVE1;PLIN5;BSCL2;PLA2G4C;CDS2;RAB3GAP1;FITM1
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.22797645090798482,-0.74695260461977,0.9193548387096774,0.960754241890012,1.0,11/36,19.16%,ARNT;TAL1;ZFP36L1;NCKAP1L;BRD1;MAPK11;ZFP36;MAPK14;HOXA5;ACVR2A;ANKRD54
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.2205350395378149,0.7469211061443508,0.875,0.9679474606132334,1.0,6/32,12.46%,CALR;CBFB;RNF6;RUNX1;CARM1;KDM1A
prerank,linoleic acid metabolic process (GO:0043651),-0.2542440708554313,-0.7469151523405215,0.8846153846153846,0.9601041435464926,1.0,1/19,0.50%,GSTM2
prerank,gonad development (GO:0008406),-0.21908340789043698,-0.7468463768166593,0.9107142857142857,0.9595024509745665,1.0,8/48,12.64%,SOX15;MAMLD1;KIT;AR;NR2F2;KITLG;CSDE1;WNT2B
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.26485083609197535,-0.746391845599958,0.8253968253968254,0.9593215563014328,1.0,8/19,24.34%,SLC25A4;CAMK2A;BCL2;BNIP3;SPG7;BAD;MUL1;ARHGAP11B
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.17422431004298367,0.7462921219808587,0.9743589743589743,0.9679988733930887,1.0,42/153,22.85%,RIPK2;UBE2N;TNFSF11;IRAK2;IL1B;WNT5A;CARD14;RPS3;CARD11;RTKN2;DHX9;TRIM27;RIPK4;RHEBL1;MYD88;RELA;IRAK1;TRIM14;RPS6KA4;LAMTOR5;AGT;CIB1;PRKCI;NPM1;PRKCZ;TRAF2;UBA52;NFKB2;ADAM8;NOD2;MTPN;NFKBIA;CAV1;RBCK1;TRIM37;DDRGK1;NFKBIB;PRDX3;TRIM22;TNFSF18;MAP3K13;MTDH
prerank,regulation of sequestering of triglyceride (GO:0010889),0.26372888775184455,0.7458102287800297,0.8936170212765957,0.967880998354409,1.0,4/15,16.03%,ABHD5;PLIN3;PPARG;FITM2
prerank,peptide cross-linking (GO:0018149),0.2386182589896965,0.7457389816295855,0.8837209302325582,0.967176017955217,1.0,11/27,27.67%,FN1;COL3A1;EVPL;PI3;DSP;FCGR3A;THBS1;CSTA;CD3G;ANXA1;TGM6
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2478817636610518,0.7455854532591333,0.9148936170212766,0.9665877538434542,1.0,6/22,19.58%,GTF2H3;RAD23B;DDB1;UBA52;CUL4A;ERCC2
prerank,female gonad development (GO:0008585),0.2604473618241851,0.7449114838706405,0.8163265306122449,0.9664979441849798,1.0,3/21,10.07%,CEBPB;INHBA;NUP107
prerank,regulation of macrophage differentiation (GO:0045649),0.263391918473439,0.7440311091050741,0.88,0.9668077452044879,1.0,2/15,6.76%,INHBA;PF4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.25503299100408383,-0.7439260054474931,0.7758620689655172,0.9615434677936847,1.0,6/21,17.55%,SNX33;TIMP4;TIMP2;TIMP3;ROCK1;PACSIN3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.2734651377567933,0.7436247456872891,0.8571428571428571,0.9666469436894138,1.0,5/21,12.83%,RASSF10;PROX1;MDK;KDM1A;DRD2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.2419875960428993,-0.743347126445815,0.9285714285714286,0.9615033509744617,1.0,12/33,27.15%,CLU;RSPO1;SNAP91;RAC1;CBL;TNK2;CCL21;B2M;SGIP1;HIP1;FLOT1;AAK1
prerank,regulation of centriole replication (GO:0046599),-0.26644610395705265,-0.7428475519687998,0.9019607843137255,0.9612808345197322,1.0,7/18,26.38%,MDM1;KAT2B;KAT2A;CDK5RAP2;SPICE1;CEP295NL;ALMS1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.21816615279265572,-0.7424701668560963,0.9655172413793104,0.9610383877576906,1.0,8/42,15.83%,DOCK3;BTC;DLG4;PRNP;EPHA4;RELN;PDGFB;GPRC5B
prerank,regulation of interleukin-8 production (GO:0032677),0.18322565202687124,0.7419092364789492,0.9210526315789473,0.9679664972460343,1.0,29/78,31.57%,ANXA4;IL1B;SYK;MYD88;RELA;FFAR2;NOS2;LAMTOR5;IL17F;TMSB4X;RAB1A;F2R;NOD2;SERPINE1;CHI3L1;HMGB1;HYAL2;CD2;CD58;ANXA1;CLEC7A;CD244;PARK7;IL10;TLR7;NOD1;TLR8;IL17D;TNF
prerank,monosaccharide transmembrane transport (GO:0015749),0.28893426509561426,0.7407681799087991,0.7027027027027027,0.9686197603099319,1.0,6/16,26.96%,SLC5A2;SLC5A10;SLC50A1;SLC5A1;SLC2A12;SLC45A3
prerank,male gonad development (GO:0008584),-0.22913493012935854,-0.7403840840916145,0.9166666666666666,0.9627531545599026,1.0,7/40,12.64%,SOX15;MAMLD1;KIT;AR;KITLG;CSDE1;WNT2B
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.23692900042377352,0.7402593970306358,0.8958333333333334,0.9684402010431031,1.0,10/27,24.74%,NOTCH3;RITA1;LFNG;CHAC1;NRARP;YTHDF2;DLK2;WWP2;EGF;TSPAN15
prerank,negative regulation of biomineral tissue development (GO:0070168),0.23638249890805135,0.7389625662103076,0.8333333333333334,0.9690036288236322,1.0,5/21,21.82%,SOX9;CCL3;TGFB1;SRGN;NOTCH1
prerank,regulation of defense response to virus (GO:0050688),0.27431212696337925,0.738777424198536,0.8333333333333334,0.9684971682529983,1.0,3/15,8.43%,C1QBP;TNFAIP3;DHX9
prerank,leukotriene metabolic process (GO:0006691),0.23656908676567337,0.7387157269424971,0.84,0.9677796508800218,1.0,7/22,25.57%,DPEP1;MGST2;MAPKAPK2;CYP4F3;LTA4H;CYP4F2;ALOX12
prerank,prostaglandin biosynthetic process (GO:0001516),-0.2571785364735997,-0.7378318839741109,0.8653846153846154,0.9648362526585167,1.0,5/18,25.91%,PTGS1;PTGIS;HPGDS;PTGDS;PLA2G4A
prerank,regulation of cellular amide metabolic process (GO:0034248),0.21210600620626954,0.7378274038413031,0.9069767441860465,0.9681834894519317,1.0,13/31,26.46%,NOLC1;NANOS3;TMED10;EIF4E;METAP1;PKP3;RBM3;MTPN;MAPKAPK5;GEMIN5;CYFIP1;PGAM1;TIGAR
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.25998219749714396,0.7376467314344831,0.8627450980392157,0.9676260056014424,1.0,4/16,13.68%,DCPS;SNRPC;NCBP2;RBM22
prerank,fatty acid oxidation (GO:0019395),-0.20843242852008897,-0.7375899215571482,0.9344262295081968,0.9644637071287644,1.0,14/55,21.90%,ACAD11;ECHDC2;PPARD;ACADVL;ACADL;ECI2;ADH5;CYP4V2;ACAT1;HADHB;ABCD4;CROT;ABCD1;BDH2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.1785648193556444,-0.7371174200223177,0.9852941176470589,0.9643273608081201,1.0,31/117,24.36%,CFLAR;CASP12;GSN;NLRP1;MAPT;GPER1;SNCA;DLC1;NGF;NGFR;DAPK1;CARD8;PPM1F;TNFSF10;SOX7;BCL10;PIDD1;FAS;COL4A3;CASP9;APAF1;KHDC1;CRADD;SIRT1;BOK;CASP8AP2;BAD;MUL1;RIPK1;NKX3-1;MTCH1
prerank,vacuolar acidification (GO:0007035),0.23976558569041684,0.7369483389155634,0.8205128205128205,0.9677475141780245,1.0,6/21,19.14%,GRN;CLN6;TMEM9;PPT1;ATP6AP2;ATP6V0A4
prerank,mesenchyme morphogenesis (GO:0072132),0.2664352493039736,0.7368955079376027,0.7804878048780488,0.9670328673233406,1.0,4/17,10.46%,TBX20;SOX9;TGFB2;ENG
prerank,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.2837877625202584,0.7360089676941187,0.9361702127659575,0.9673305060287101,1.0,5/16,21.69%,CXCL8;HMGA2;APOBEC3F;TOP2A;APOBEC3B
prerank,camera-type eye development (GO:0043010),-0.23744289335885754,-0.7358231209624748,0.9090909090909091,0.9652004092666437,1.0,7/25,19.85%,CACNA1C;SKI;TENM3;CEP290;IFT122;RAB3GAP1;EFEMP1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.2501663633802006,0.7350555619353328,0.8771929824561403,0.9677067444713889,1.0,8/20,24.67%,IL4I1;PRKDC;PRELID1;ZNF683;PRDM1;CRTAM;CD2;XRCC6
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.23479159834907487,0.7341916634360609,0.8461538461538461,0.9679068131527622,1.0,10/24,29.22%,THY1;VPS25;GPRC5A;LILRB4;CAV1;CBLC;HYAL2;PTK6;SNX6;MVP
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2784471445869646,0.7337618990684247,0.8333333333333334,0.9675890303428252,1.0,6/16,22.23%,ATAD5;NPM1;DYRK3;CUL3;DDRGK1;EZH2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2439563838799162,-0.7337168363321256,0.82,0.9669327241914205,1.0,5/29,13.68%,TRIM39;MAP1A;WAC;KLHL40;OGT
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.24861934342573233,-0.733492350471348,0.8035714285714286,0.9665127074769752,1.0,3/19,8.86%,ASPA;DLD;AASS
prerank,positive regulation of histone methylation (GO:0031062),-0.24001006245545384,-0.7333494325913025,0.8888888888888888,0.9660127480472932,1.0,5/25,13.68%,PHF1;SMAD4;KMT2A;FAM47E;OGT
prerank,protein palmitoylation (GO:0018345),0.23622433594919928,0.7314870961501846,0.8775510204081632,0.9693577847938193,1.0,7/28,13.21%,ZDHHC9;ZDHHC5;ZDHHC12;ZDHHC3;ZDHHC24;ZDHHC13;ZDHHC6
prerank,cellular respiration (GO:0045333),-0.21402149122512426,-0.7306864281807122,0.9272727272727272,0.9682102421679105,1.0,8/39,21.02%,MTFR1L;ETFDH;COQ10A;SDHA;BLOC1S1;COX4I2;NR4A3;SIRT3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.23706287176440285,0.7303567947136381,0.9047619047619048,0.9698012988545138,1.0,10/24,23.40%,LAMP3;PML;CSNK2A1;EFNA1;PSMF1;PRKCG;HSP90AB1;RPL11;RPL23;RPS7
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.21978963769728604,-0.7297448935558712,0.9152542372881356,0.9686013186620088,1.0,3/34,5.64%,PER1;DUSP3;ZMYND11
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.20825544358648768,-0.7295619803122938,0.864406779661017,0.968147818058066,1.0,13/52,20.21%,BCO2;AGTR1;PLIN5;SNCA;SIRT2;AKR1C1;PID1;RAC1;CDKN1A;PDGFB;MAPK14;PARL;PIKFYVE
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.23763464113446164,-0.729256750067152,0.864406779661017,0.9677485284799519,1.0,12/28,26.17%,FLNA;PIK3R1;DMAP1;PSEN1;BAG3;EFCAB7;PIK3R2;UBR5;PRKCD;SMAD3;HCLS1;TPR
prerank,pigment granule transport (GO:0051904),-0.24598867202214875,-0.7291874169931529,0.9411764705882353,0.966410309148167,1.0,5/18,15.91%,BBS4;BBS5;MYO5A;BBS2;BBS7
prerank,melanosome transport (GO:0032402),-0.24598867202214875,-0.7291874169931529,0.9411764705882353,0.966410309148167,1.0,5/18,15.91%,BBS4;BBS5;MYO5A;BBS2;BBS7
prerank,anterior/posterior axis specification (GO:0009948),0.24915882602169173,0.7276788227319135,0.9,0.9717492903946732,1.0,6/19,26.43%,TDGF1;SHH;RIPPLY1;CDX2;CDX1;LHX1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.244021959746564,-0.7262583314863639,0.8305084745762712,0.9687782344740036,1.0,11/26,26.37%,ARNT;TAL1;NCKAP1L;BRD1;MAPK11;MAPK14;ACVR2A;ANKRD54;FOXO3;GATA1;HSPA1A
prerank,acetyl-CoA metabolic process (GO:0006084),-0.2744825390161433,-0.7260281275569285,0.86,0.9683396046351705,1.0,4/15,20.46%,ACACB;DIP2A;ACAT1;MLYCD
prerank,organonitrogen compound catabolic process (GO:1901565),-0.19341496996371677,-0.7253701087846449,0.9333333333333333,0.9683084347271642,1.0,12/60,15.51%,PLA2G5;CAPN3;LVRN;ELANE;PLA2G6;NAALADL1;CPQ;NPEPPS;GNPDA2;ADAMTS13;ENPP2;LRSAM1
prerank,regulation of integrin activation (GO:0033623),0.27387651825581394,0.7253138177491822,0.9555555555555556,0.9733969112843447,1.0,3/15,4.48%,FERMT1;KIF14;SKAP1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.1798594029038254,0.7235470263786429,1.0,0.9743080086561582,1.0,19/68,22.28%,STT3B;DERL1;SEC61B;ERLIN1;FOXRED2;EDEM2;UBE2J1;VCP;ERLIN2;HSPA5;MAN1B1;FBXO6;UBQLN1;FAF2;OS9;AUP1;DNAJC10;UBXN8;RHBDD2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.24252054396931308,0.7231752807848284,0.8478260869565217,0.9738557340486622,1.0,5/21,16.56%,IL4I1;TNFAIP3;JAK3;VTCN1;LST1
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.22924582484434525,-0.7222921144879071,0.8983050847457628,0.9708097646478847,1.0,12/29,28.54%,MAPKBP1;CARD8;SIRT2;PPM1B;TRAFD1;PCBP2;DHX58;NFKBIL1;MUL1;TRAF3IP1;NLRC3;CACTIN
prerank,regulation of protein metabolic process (GO:0051246),0.20602340920218218,0.7219827729781533,1.0,0.97419800999982,1.0,10/44,18.64%,ODC1;CHEK2;VPS35;SHH;IL17F;GBA;TMEM9;PLAUR;HSP90AB1;MTPN
prerank,carbohydrate derivative catabolic process (GO:1901136),0.2558893137679685,0.721162873629303,0.85,0.9743131151075145,1.0,8/18,26.20%,STT3B;AOAH;MANBA;FBXO6;NGLY1;DERA;FUCA1;NAGA
prerank,bicarbonate transport (GO:0015701),-0.22974918267593647,-0.7202062474301011,0.9375,0.9722219586799442,1.0,16/33,30.41%,CYB5R1;SLC4A7;AQP1;RHAG;CA7;SLC4A3;SLC26A7;HBB;CA5B;CA1;SLC4A5;SLC4A1;CA3;SLC4A4;SLC4A10;CA2
prerank,contractile actin filament bundle assembly (GO:0030038),-0.2668292648351982,-0.7201947026569224,0.85,0.9708108963306264,1.0,3/15,15.22%,SORBS1;RHOA;PDLIM1
prerank,stress fiber assembly (GO:0043149),-0.2668292648351982,-0.7201947026569224,0.85,0.9708108963306264,1.0,3/15,15.22%,SORBS1;RHOA;PDLIM1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.22327831646763288,0.7185331983560814,0.9215686274509803,0.9762658106073648,1.0,11/24,28.04%,CDK5;TGFB2;CCL3;PCSK9;GRN;BAX;MCL1;TYROBP;CTNNB1;CDK5R1;TFAP2A
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.21693195827389183,0.7183181320756252,0.875,0.9757176865415992,1.0,11/33,23.71%,HACD3;TECR;ACSL6;HACD2;ELOVL1;ACOT4;ELOVL7;SLC27A5;ELOVL6;SLC27A4;CYP4F2
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.2289499950413602,-0.7181962466348604,0.9491525423728814,0.9720140216174066,1.0,4/29,11.28%,TLR9;SYT11;NCKAP1L;C1QTNF3
prerank,negative regulation of proteolysis (GO:0045861),0.2119322663920754,0.717751195883132,0.9736842105263158,0.9755008758306931,1.0,10/38,19.81%,CST4;CDK5;CSTB;TIMP1;EFNA1;CHAC1;PTPN3;TM4SF20;SNX12;CST7
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.20813576506851844,-0.7169459935022219,0.9152542372881356,0.9726244247578962,1.0,14/41,25.97%,MAPK7;GPER1;KRIT1;GATA2;ECSCR;ANGPT1;CCL2;CDH5;PLCG1;SCG2;RAMP2;ANO6;PDCD4;RGCC
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.23421121212988308,0.7161539740929387,0.9444444444444444,0.976231544269418,1.0,3/27,4.65%,RUVBL1;RUVBL2;MRGBP
prerank,receptor internalization (GO:0031623),-0.20766470711690943,-0.7159158468672607,0.9622641509433962,0.972928715521919,1.0,15/47,27.17%,SNX1;SNCA;RAMP1;GRK4;ACKR3;RAMP3;CD36;DNM1;AP2M1;RAB31;CAV3;RAMP2;ADM;CEACAM1;DNM3
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.2467545991799745,0.715196558433153,0.8372093023255814,0.9763359253044378,1.0,9/21,24.89%,PPP1CA;GSK3B;FRAT2;AXIN1;WNT8B;CAV1;WNT3A;FZD2;CTNNB1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.2661407912276592,-0.7148992834788143,0.8103448275862069,0.9732789801100948,1.0,6/18,19.82%,OSR1;KIAA1109;AJAP1;KLF7;MAFG;DLL1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.22223694986034506,-0.7148498078843378,0.9166666666666666,0.9726017385818704,1.0,11/35,23.64%,RNF112;MAPK7;ZNF580;HDAC6;RHOB;AQP1;ANKZF1;SETX;SIRT1;PRKCD;RIPK1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.2562902590601026,-0.7131451132689648,0.9074074074074074,0.9733820993258391,1.0,8/16,27.02%,RBPJ;FER;MVB12B;EGFR;PTPN12;RHBDF1;CEACAM1;CDH13
prerank,regulation of protein transport (GO:0051223),0.21274812616066913,0.7124548634779516,0.9090909090909091,0.977941050682759,1.0,14/28,31.57%,NDFIP2;ATP13A2;RHBDF2;DNAJA1;SNX12;ARFIP1;WWP2;LLGL2;NDFIP1;DNAJC1;LCP1;CHP1;SCFD1;TNF
prerank,positive regulation of protein import (GO:1904591),0.22757843872739378,0.7124326761473025,0.8536585365853658,0.9771943722135854,1.0,11/30,22.02%,RAN;ECT2;ZPR1;JUP;RBM22;ARHGEF5;TGFB1;TRIM28;ZC3H12A;IPO5;HYAL2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.25429558383029155,0.7123962998635234,0.851063829787234,0.9764921706236386,1.0,2/16,4.87%,IRS1;PMAIP1
prerank,leukocyte tethering or rolling (GO:0050901),-0.2486635786970317,-0.7121303931698436,0.9230769230769231,0.9735791044408175,1.0,6/18,26.85%,JAM2;ADD2;ROCK1;MADCAM1;SELP;GOLPH3
prerank,defense response to Gram-positive bacterium (GO:0050830),0.19241443602810165,0.7117877166972646,1.0,0.9762844259698726,1.0,14/58,27.68%,ROMO1;DEFA6;HMGB2;RPL39;MYD88;PGLYRP4;ANG;PGLYRP3;DMBT1;RNASE7;PPP1R11;DEFB4A;GBP4;DEFA1
prerank,protein acylation (GO:0043543),-0.2294108645894587,-0.7110449777780355,0.9,0.9738419398993812,1.0,10/36,21.95%,ZDHHC17;KAT2B;ZDHHC15;ZDHHC7;ING4;KAT2A;GLUL;ZDHHC18;ING5;ZDHHC21
prerank,response to progesterone (GO:0032570),0.2419626906623635,0.709911619683234,0.8936170212765957,0.9770802564349346,1.0,6/20,24.43%,TGFB2;ABHD2;CATSPER1;TGFB1;CAV1;THBS1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.22364474399375708,0.709723785001748,0.9302325581395349,0.9764834881638286,1.0,5/23,17.31%,UGGT1;EDEM2;UBA52;MAN1B1;OS9
prerank,sensory perception of smell (GO:0007608),-0.17667120042135287,-0.7084206299542686,1.0,0.9753398484159788,1.0,3/103,5.99%,BBS4;SLC24A4;SYT10
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2365717486606833,0.7079137762520439,0.9230769230769231,0.9773988186661351,1.0,11/22,37.35%,IL21;RAET1E;HLA-F;CRTAM;SLAMF6;NCR3;RASGRP1;PVR;RAET1G;KLRC2;KLRD1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.2153483898021205,-0.706477544559489,0.8928571428571429,0.9764394824256112,1.0,9/36,20.37%,TRIM39;CSNK2A2;TRAF1;BCL2;DAB2IP;MADD;FAS;CRADD;ING5
prerank,oligosaccharide metabolic process (GO:0009311),0.2021203227974317,0.706292344513383,0.9387755102040817,0.9780883835441563,1.0,17/49,26.20%,NEU1;GLA;FUT8;FUT1;ST8SIA6;FUT7;B4GALT1;FUT2;MANBA;MAN1B1;MPDU1;AMY1A;AMY1C;FUT6;FUT4;FUT3;NAGA
prerank,morphogenesis of an epithelium (GO:0002009),-0.23694884795451776,-0.7043062357566582,0.9310344827586207,0.9777882260280796,1.0,4/27,7.25%,VCL;LAMA5;FGFR2;FLG2
prerank,regulation of mitochondrial fission (GO:0090140),-0.2440904510562555,-0.7032052678028059,0.8392857142857143,0.9779615753069365,1.0,12/22,29.86%,MAPT;LRRK2;DCN;DDHD1;BNIP3;MUL1;PINK1;MFF;DNM1L;MIEF2;SPIRE1;RALBP1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.25571270473748214,0.7023855490691351,0.9183673469387755,0.9806823029604592,1.0,4/20,14.32%,CXCL8;C1QBP;MDK;MCU
prerank,regulation of B cell proliferation (GO:0030888),0.1893058623520564,0.70127837941786,0.975,0.9807910331694144,1.0,15/46,29.29%,EPHB2;CHRNB2;IL21;CD81;CD320;LYN;VAV3;MNDA;TYROBP;TNFSF13B;CD300A;TNFRSF4;CTLA4;IL10;AHR
prerank,regulation of lymphocyte activation (GO:0051249),0.2630566119826698,0.7010950473737919,0.8636363636363636,0.9801076163443274,1.0,8/15,38.65%,LCK;SIT1;CRTAM;CLEC7A;CCL5;DCAF15;IKZF3;CD4
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.22811739493288266,0.7001412230064707,0.9347826086956522,0.9800703930959214,1.0,10/22,30.18%,HNF1A;MED14;SUB1;MED1;MED30;PAXIP1;MED13;FOSL1;MED4;HNF1B
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.25240262561596316,-0.69953457814486,0.7924528301886793,0.9806445879307035,1.0,7/18,23.81%,MAPK7;HSPB1;INS;SIRT1;NME5;NOL3;PINK1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.2209257701628541,0.6983713934332941,0.9545454545454546,0.9807724081763598,1.0,10/29,21.39%,CBFB;RUNX1;FOXH1;CARM1;BRCA1;PAK1;CNOT1;AXIN1;UFM1;DDRGK1
prerank,glial cell development (GO:0021782),0.22440349575796625,0.695497867119094,0.9375,0.9821518257880588,1.0,5/25,16.00%,SOX4;MDK;ZNF488;NSUN5;MYRF
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.24098570152590953,0.6951347066791194,0.95,0.9817440892699552,1.0,6/16,20.10%,STK39;PPIF;MMP9;COMMD1;SLC43A2;CAV1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.1976187044304831,0.6951269445908825,0.9761904761904762,0.9809853998655735,1.0,18/46,27.40%,PDGFRB;ROMO1;SYK;CYBA;AGT;FPR2;DCXR;TGFB1;MMP8;TGFBR2;ZC3H12A;TP53;TYROBP;THBS1;GSTP1;ACE2;ITGB2;CLEC7A
prerank,ear morphogenesis (GO:0042471),-0.23581737098770184,-0.6926298787677843,0.8928571428571429,0.9853052179787292,1.0,4/23,9.31%,OSR1;FGFR2;TBX1;TMIE
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.20795783294489115,-0.6925562703300795,0.9310344827586207,0.9846110483845504,1.0,5/31,12.26%,GH1;KIT;GHR;TSLP;PRL
prerank,regulation of transferase activity (GO:0051338),0.2536881808644566,0.6916062750139265,0.9333333333333333,0.9831411977991782,1.0,5/17,19.59%,NABP2;PARP4;NLRC5;FEM1A;SPTSSB
prerank,regulation of intracellular pH (GO:0051453),0.2018714761265814,0.6907677690692853,0.926829268292683,0.9830504343714622,1.0,9/35,19.34%,TM9SF4;NOX1;TMEM165;GPR89A;SLC9B1;SLC9A7;GPR89B;SLC9C1;CFTR
prerank,B cell differentiation (GO:0030183),0.19078636267691973,0.6906373890571522,0.9736842105263158,0.9823866016200368,1.0,18/59,29.77%,IL11;TCF3;JAK3;CEBPG;TPD52;IRF2BP2;PTPN2;SLC25A5;RAG1;MSH2;NFAM1;PTPRJ;CR2;RABL3;IL10;IFNE;ADGRG3;ADAM17
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.22929287103299956,-0.6901623808012542,0.8923076923076924,0.9857650338019395,1.0,11/27,27.41%,PTEN;SPRY1;DAB2IP;SFRP1;IL17RD;FUZ;VASN;SMAD7;SDHAF2;BMP5;LDLRAD4
prerank,"wound healing, spreading of cells (GO:0044319)",0.23289998124449343,0.690054270236602,0.9130434782608695,0.9820400962592909,1.0,6/21,14.96%,CD44;DDR1;TOR1A;ITGA5;PDCD10;MMP12
prerank,establishment of spindle localization (GO:0051293),0.25900866009855966,0.6885851977708373,0.8695652173913043,0.9822920777081207,1.0,8/15,29.76%,KPNB1;ESPL1;CFL1;LLGL2;MAP4;KIF25;OOEP;ZBED3
prerank,response to copper ion (GO:0046688),0.24000904232366746,0.6883263531950299,0.9285714285714286,0.981749858899696,1.0,2/21,2.74%,IL1A;LOXL2
prerank,regulation of B cell activation (GO:0050864),0.21799204674162898,0.6882805296046408,0.9347826086956522,0.981037892463456,1.0,13/27,37.58%,IL4I1;TNFAIP3;SH3KBP1;NOD2;TNFSF4;FOXJ1;IL10;AHR;SLAMF8;SAMSN1;BANK1;LAPTM5;IKZF3
prerank,endocytic recycling (GO:0032456),-0.2026352263314214,-0.6872719734878618,0.8888888888888888,0.9871735482575202,1.0,10/45,19.20%,VPS39;EHD2;MICALL1;SNX27;KIAA1109;CCDC93;RAB11FIP3;RAB13;EPS15;SNX31
prerank,mesoderm formation (GO:0001707),0.23746604932873233,0.6868512340181357,0.8888888888888888,0.9812133604820376,1.0,4/19,14.12%,TBX20;CRB2;HMGA2;ITGA2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.1929382479663964,-0.6834561726594595,0.9836065573770492,0.9890723524476153,1.0,15/53,27.06%,CLIP3;CFLAR;PELI3;TRAF1;CARD8;MADD;GPS2;RNF31;TAX1BP1;HIPK1;SPPL2B;RIPK1;TNFRSF1A;HSPA1A;F2RL1
prerank,necroptotic process (GO:0070266),0.25383052098584924,0.6830951065337545,0.8571428571428571,0.9831002685490324,1.0,5/16,24.80%,PGAM5;IPMK;FASLG;MLKL;TICAM1
prerank,endocrine system development (GO:0035270),0.23396979297018014,0.681634246460445,0.8974358974358975,0.9833845085413799,1.0,6/23,20.05%,STRA6;MDK;SIX1;WNT11;SIX3;PAX8
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.20415344727299864,0.6806634512035907,0.9736842105263158,0.9832006525499356,1.0,6/27,17.47%,AJUBA;DHX9;EIF4E2;BMP4;MYCN;TGFB1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2112446111702977,-0.680554692703767,0.921875,0.990109156380923,1.0,11/36,23.97%,JMY;ZNF385B;CDIP1;PHLDA3;RRP8;PDK2;SIRT1;BOK;USP28;HIPK1;TMEM109
prerank,protein localization to cell-cell junction (GO:0150105),0.25408212315868667,0.6802863893483105,0.8536585365853658,0.9827282003407228,1.0,6/15,23.97%,ACTG1;LSR;PAK2;DSP;F11R;SCRIB
prerank,histone H2A ubiquitination (GO:0033522),0.2506961327610325,0.6790479478196378,0.9302325581395349,0.9828592543016753,1.0,7/17,25.68%,RNF2;DTX3L;DDB1;UBE2A;TRIM37;PCGF1;RNF8
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.26161087431811936,0.6786552452905189,0.9347826086956522,0.9824047523316118,1.0,4/17,13.27%,CSF2;PF4;PLA2G3;AGT
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.24342831018495048,0.6784749310002784,0.8666666666666667,0.981806836929727,1.0,4/17,24.63%,C1QBP;OASL;ZCCHC3;TRIM15
prerank,response to gamma radiation (GO:0010332),0.21770485815091462,0.67832319512858,0.9555555555555556,0.9811420706806987,1.0,8/23,26.45%,MYC;XRCC5;KDM1A;MEN1;TP53;XRCC6;FANCD2;ATR
prerank,apoptotic nuclear changes (GO:0030262),-0.2406703336980493,-0.6777438981250745,0.9298245614035088,0.9913738919484726,1.0,9/22,26.27%,GPER1;ACIN1;DICER1;CASP3;CDK5RAP3;CECR2;EXOG;DNASE1L3;KPNA1
prerank,monocarboxylic acid transport (GO:0015718),-0.1886181269442016,-0.6735071879245781,0.96875,0.9934293726288007,1.0,22/54,30.00%,SLC16A12;NCOA1;AKR1C1;SLC27A1;RXRA;SLC16A2;SLC10A4;SLCO2A1;CD36;SLC51A;ABCG2;SLC16A7;SLC16A8;ABCB11;CEACAM1;ABCC4;SLC10A6;NR1H4;SLC6A8;SLC51B;SLC16A11;STARD5
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2319856238920049,0.6733921900400557,0.9318181818181818,0.9832714388372227,1.0,5/23,15.66%,COPS5;RAD23B;DDB1;UBA52;CUL4A
prerank,protein localization to chromosome (GO:0034502),-0.2149998106035224,-0.6732940723998497,0.9444444444444444,0.9928441418242333,1.0,9/29,24.09%,IFFO1;TERF2IP;FAM47E;TINF2;ESR1;PARP3;TNKS;TPP1;CHMP7
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.23891662258916418,-0.6732179801095088,0.9259259259259259,0.9921747176829336,1.0,5/18,22.85%,PTN;PTPRZ1;DICER1;CLCF1;ID2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.24203189516528462,0.6731967476204017,0.8958333333333334,0.9826488573869304,1.0,3/16,9.23%,PAH;SMOX;TH
prerank,defense response to fungus (GO:0050832),0.21451054805257067,0.6725646020034692,0.8648648648648649,0.9822723064087917,1.0,10/23,38.49%,GAPDH;CLEC6A;RNASE7;IL36RN;CLEC7A;CLEC4D;CARD9;CX3CR1;LTF;FAM3A
prerank,stem cell development (GO:0048864),0.2257430140286241,0.6723203269872439,0.9411764705882353,0.9816598776224258,1.0,5/17,20.23%,NOLC1;SHH;KBTBD8;KLHL12;WNT7A
prerank,lymphocyte proliferation (GO:0046651),-0.1951021571960696,-0.6713237101962136,1.0,0.9926761943672697,1.0,4/37,12.29%,LMBR1L;PPP3CB;BCL2;MEF2C
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.22406016239614768,-0.6712835263598869,0.9344262295081968,0.9919947815035551,1.0,10/24,26.37%,MLLT11;GPER1;MOAP1;TNFSF10;BNIP3;BCL2L11;BAD;PINK1;MFF;DNM1L
prerank,negative regulation of transferase activity (GO:0051348),-0.2129205973073294,-0.6711255369425277,0.9454545454545454,0.9913730796124348,1.0,8/29,21.17%,MAPT;CDKN1C;CERS1;INPP5K;ZFP36;GSK3A;EIF4A2;SMAD7
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.2404653297721152,-0.671002779192212,0.9607843137254902,0.9907718288698656,1.0,6/20,30.13%,CFLAR;OGT;NUPR1;RIPK1;FLOT1;BIRC2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.22459181980491655,0.670418553229778,0.926829268292683,0.9820103413346005,1.0,14/30,35.88%,IKBKE;UBA52;UBE2D1;CD300LF;UBE2D2;TICAM1;CASP8;IRF3;IRF7;UBC;IKBKG;IKBKB;TLR4;TRAF3
prerank,positive regulation of B cell proliferation (GO:0030890),0.2019518195582013,0.669622901221368,0.9565217391304348,0.9816519976354338,1.0,5/30,14.07%,EPHB2;CHRNB2;IL21;CD81;CD320
prerank,establishment of melanosome localization (GO:0032401),0.23734956215582645,0.667849217291408,0.9387755102040817,0.982027211437034,1.0,7/19,21.16%,GPR143;MREG;RAB11A;BLOC1S3;SHROOM2;RAB27B;RAB17
prerank,pulmonary valve development (GO:0003177),0.23559748824713622,0.6669745884823635,0.9787234042553191,0.9816273034677191,1.0,6/18,21.82%,STRA6;TGFB2;ROBO2;BMP4;TNFRSF1B;NOTCH1
prerank,response to amino acid (GO:0043200),-0.2092892916549314,-0.6667640334868611,0.8813559322033898,0.9928566087096389,1.0,11/29,26.74%,RRAGC;CPEB1;GLRB;CPEB3;RRAGB;RRAGD;RPTOR;CPEB4;MTOR;RRAGA;CAPN2
prerank,regulation of vasculature development (GO:1901342),-0.226347486775193,-0.6652562318927132,0.9508196721311475,0.9929780772207022,1.0,10/26,30.19%,FGF2;EGLN1;SFRP1;ADGRA2;KRT1;HMOX1;GPNMB;BMPER;LEP;PROK1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.23625359142959518,0.6650564257908891,0.9166666666666666,0.9819178404049235,1.0,8/18,30.32%,DCUN1D5;UBQLN1;HSP90AB1;EGR1;HSP90AA1;HIF1A;TGFBR1;ITCH
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.23553913803843785,-0.6640113988566955,0.9074074074074074,0.9930473079262447,1.0,6/20,22.59%,MAPK7;MAP2K5;PDGFB;MAPK8;KLF2;WFS1
prerank,aminoglycan catabolic process (GO:0006026),-0.20594212836743642,-0.6576012245752402,0.9423076923076923,0.9958934515739706,1.0,9/31,23.55%,HPSE2;IDS;SDC3;SDC2;HSPG2;GPC1;HGSNAT;GPC6;SGSH
prerank,ERBB signaling pathway (GO:0038127),-0.18823462550433304,-0.6567105162715967,0.9821428571428571,0.9957395529308201,1.0,17/64,22.76%,NRG2;GAB1;BTC;PIK3R1;RPS6KA5;PRKCA;PLCE1;MAPK1;BRAF;SOS1;CBL;EGFR;ERBB4;EFEMP1;SHC3;PTPN12;PLCG1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.250238722272143,-0.6564022987732784,0.9365079365079365,0.9952286847850981,1.0,2/18,4.21%,PLA2G5;PLA2G4B
prerank,macromolecule catabolic process (GO:0009057),-0.1949039574731501,-0.6562548053830277,0.9482758620689655,0.9946406635916173,1.0,11/28,29.08%,CAPN3;ELANE;UVRAG;LRSAM1;MTOR;TPP1;SNX25;CLN8;SMURF1;CTRL;SH3GLB1
prerank,B cell receptor signaling pathway (GO:0050853),-0.20083352812025074,-0.6561261553416848,0.9333333333333333,0.9939756531572732,1.0,5/33,14.38%,PRKCB;BCL2;NCKAP1L;MEF2C;BMX
prerank,mesenchymal cell development (GO:0014031),-0.2324964076817663,-0.6554242973828053,0.9782608695652174,0.9935837661033484,1.0,7/19,24.28%,TAPT1;CDH2;HEY2;SOX11;SOX8;FAM172A;SNAI2
prerank,bile acid and bile salt transport (GO:0015721),-0.21236700834530509,-0.6553527728685061,0.9482758620689655,0.992907490612516,1.0,12/25,30.00%,NCOA1;AKR1C1;RXRA;SLC10A4;SLC51A;ABCB11;CEACAM1;ABCC4;SLC10A6;NR1H4;SLC51B;STARD5
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.19320477661232102,0.6542285750770059,1.0,0.9870331485818603,1.0,14/32,33.12%,OCIAD2;PRLR;F2R;HES1;CRLF3;NOTCH1;IL10;PIBF1;IL10RA;IFNL1;IL26;CCL5;TNF;OCIAD1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.22183055394313045,-0.6541886992961569,1.0,0.9928404808670994,1.0,7/23,19.44%,LRAT;CUBN;CYP11A1;CYP1A1;RLBP1;VKORC1;PIAS4
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.21946919394616898,0.653134535057592,0.9454545454545454,0.9867563582225508,1.0,10/24,26.91%,ACOT7;ASAH2B;ALOXE3;LTA4H;ELOVL6;ASAH2;GPX4;ALOX12;GSTP1;ALOX12B
prerank,protein kinase B signaling (GO:0043491),-0.2274768945033334,-0.6514999481278876,0.9423076923076923,0.9936271861933033,1.0,8/24,24.08%,PTEN;ZFP36L1;SIRT2;PIK3R3;TSC2;SETX;CCL2;NKX3-1
prerank,synaptonemal complex organization (GO:0070193),0.2332663072349396,0.6513701281350627,1.0,0.9860782243414993,1.0,5/15,26.23%,P3H4;TRIP13;SYCE3;HORMAD1;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.2332663072349396,0.6513701281350627,1.0,0.9860782243414993,1.0,5/15,26.23%,P3H4;TRIP13;SYCE3;HORMAD1;RAD21
prerank,embryonic axis specification (GO:0000578),0.2386828577083919,0.6490813074299217,0.8974358974358975,0.9863894450473222,1.0,1/16,0.88%,TDGF1
prerank,regulation of platelet aggregation (GO:0090330),-0.2317855765696899,-0.6484078173788482,0.8833333333333333,0.9946066497625713,1.0,8/18,29.16%,PRKCA;PRKG1;CELA2A;PRKCD;C1QTNF1;CEACAM1;BLK;SH2B3
prerank,apoptotic DNA fragmentation (GO:0006309),0.24639248815140252,0.6473405300335319,0.8863636363636364,0.9863568386216042,1.0,7/15,28.47%,HMGB2;KPNB1;ENDOG;DNASE2;HMGB1;DFFA;FOXL2
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.21886690355775182,-0.6458099705427428,0.9298245614035088,0.9950229122993104,1.0,4/21,16.18%,GNB3;ACADVL;ACADL;FMO5
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.2072922412550881,0.6456831933416424,0.9318181818181818,0.9863661226470194,1.0,6/22,20.16%,HMBS;TSPO;CPOX;PGRMC1;FXN;ALAS1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.24181896597396602,0.6456740005538135,0.9459459459459459,0.9856228173548964,1.0,4/15,18.64%,SMAD1;FUT1;ITGA5;PKM
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.2393382040107328,0.6442155867566429,0.9285714285714286,0.9855908618681616,1.0,5/15,26.45%,PMAIP1;MSX1;SPRED2;SPRED1;ATR
prerank,response to cadmium ion (GO:0046686),-0.2094617916781384,-0.6420076809601896,1.0,0.9961032639904501,1.0,8/28,27.84%,MAPK1;MAPK3;MT1X;MAPK8;EGFR;MT1M;MT1A;MT3
prerank,diacylglycerol metabolic process (GO:0046339),-0.21994891129660923,-0.6419933362804782,0.9444444444444444,0.9954022764718079,1.0,8/22,26.43%,DGKE;DGKG;PLCE1;DGKB;DGKI;DGKD;PNPLA2;DGKA
prerank,regulation of lipid storage (GO:0010883),-0.2207625415605314,-0.6395515220850471,0.9285714285714286,0.995810657221653,1.0,6/20,20.12%,PLIN5;ITGB3;FTO;FBXW7;VSTM2A;SIRT1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.21385024192362845,-0.6390579421862342,0.9411764705882353,0.9952911680922136,1.0,6/29,12.91%,MOAP1;NGF;BCL2;DAB2IP;DEDD;BAG3
prerank,snRNA metabolic process (GO:0016073),0.24198217198342326,0.6387663653949072,0.9565217391304348,0.9873039715963665,1.0,1/15,1.01%,INTS7
prerank,peptide catabolic process (GO:0043171),0.22677141608091375,0.6370999710508446,0.8936170212765957,0.9872791432237686,1.0,8/24,21.98%,DPEP1;CTSH;CHAC2;CHAC1;XPNPEP1;IDE;ERAP1;LTA4H
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.22000631627472564,0.6361333708602959,1.0,0.9869208794296346,1.0,7/22,24.67%,VPS25;TOM1L1;PLAA;VPS37B;STAM;MVB12A;RNF126
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.22838471166030572,0.6354811820250259,0.9777777777777777,0.9863215673476259,1.0,8/21,24.20%,HMGB2;KPNB1;DNASE1L1;ENDOG;DNASE2;REXO4;HMGB1;DFFA
prerank,regulation of transforming growth factor beta production (GO:0071634),0.23566775615046986,0.6353451071909144,0.9615384615384616,0.9856482356696172,1.0,3/18,9.92%,CD46;TGFB2;FN1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.22652729363784896,-0.6333395482020044,0.9074074074074074,0.9970504101778029,1.0,8/21,27.78%,CLU;LRRK2;NR1H2;USP25;WFS1;CREB3;HSPA1A;UBXN1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.17199789887356148,-0.6331316077334893,1.0,0.9964086003319204,1.0,7/52,15.68%,GSTM2;PTGS1;PLA2G4B;FADS3;EPHX1;PLA2G4C;SCD5
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.24220067540006918,-0.6328327301577175,0.9298245614035088,0.9958448027296694,1.0,4/15,21.48%,TLR9;TLR3;USP15;DHX58
prerank,receptor metabolic process (GO:0043112),-0.1715777959871992,-0.6305965436172869,0.9833333333333333,0.9961615414031152,1.0,19/54,29.08%,SNX1;SNCA;RAMP1;UVRAG;GRK4;ACKR3;RAMP3;CD36;DNM1;AP2M1;NSG1;RAB31;RAMP2;ADM;SNX25;DNM3;SMURF1;RAB11B;SH3GLB1
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.24289205422960192,-0.6266223028711315,0.9803921568627451,0.99714520524016,1.0,8/17,31.15%,SIRT1;CES1;BMP5;NR1H4;STAR;CYP7A1;CGA;NR0B1
prerank,regulation of leukocyte activation (GO:0002694),-0.25575649928865407,-0.6258699887833197,0.9830508474576272,0.9968065138803409,1.0,2/16,7.19%,GPER1;PJA2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.21178981137478806,-0.6257394895213122,0.9310344827586207,0.9961478945838254,1.0,7/21,24.13%,PLIN5;HDAC6;SIRT2;INS;ABCD1;PINK1;ABCD2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.2166791616362381,-0.6251765403060106,0.9661016949152542,0.9956374775454533,1.0,6/17,27.46%,APOD;ABCD1;CUEDC2;PDCD4;ABCD2;NLRC3
prerank,regulation of interferon-beta production (GO:0032648),0.16856103739494183,0.6233880540656008,0.9777777777777777,0.989451035019456,1.0,15/47,30.20%,RIPK2;POLR3C;DHX9;POLR3B;OAS2;ISG15;POLR3G;OAS3;HSP90AA1;POLR3A;PTPN11;TLR7;IRF3;IRF7;TLR8
prerank,"phototransduction, visible light (GO:0007603)",-0.23247917299809967,-0.6233195955484465,0.9565217391304348,0.9957164890024136,1.0,5/15,23.56%,CNGB1;GNAQ;PDE6B;GNA11;RHO
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.16754630622734715,-0.6156958250936329,1.0,0.9978160892636723,1.0,7/67,12.43%,IL6R;ADGRB1;TLR9;ELANE;OPTN;RARRES2;AQP1
prerank,response to exogenous dsRNA (GO:0043330),0.17857399292540926,0.6154684732067606,1.0,0.9914361563887605,1.0,8/32,28.45%,DHX9;SLC3A2;CAV1;ZCCHC3;TICAM1;RALB;IRAK3;IFNE
prerank,negative regulation of phagocytosis (GO:0050765),-0.21949586421573553,-0.6149041472243236,0.9423076923076923,0.997458940520899,1.0,9/15,36.65%,SYT11;DYSF;PRTN3;SNX3;TLR2;SIRPA;APPL1;FCGR2B;ADIPOQ
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.19655371273196232,0.610143178672671,1.0,0.9922887420303014,1.0,7/24,26.23%,P3H4;TRIP13;RNF212B;SYCE3;HORMAD1;FANCD2;RAD21
prerank,negative regulation of immune effector process (GO:0002698),0.24123796293476332,0.6086250469702464,0.9512195121951219,0.99186194386324,1.0,10/16,36.09%,CD55;GRN;RPS19;CD47;ENPP3;CD300A;IFNL1;SLAMF8;HAVCR2;LILRB1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.23093835032257806,-0.6065393365288675,0.9649122807017544,0.9993053577639325,1.0,4/16,19.09%,PLIN5;SLC27A1;NR1H2;CTDNEP1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.2176156503791448,-0.6059200987173806,0.9565217391304348,0.9987562316044939,1.0,15/15,78.26%,MICA;CLEC12B;CEACAM1;LGALS9;FCGR2B;KLRC1;KIR2DL4;HLA-G;HLA-E;PTPRC;KLRD1;LILRB1;ARRB2;CX3CR1;HLA-F
prerank,acylglycerol homeostasis (GO:0055090),0.20788892436785134,0.605482260062596,0.9607843137254902,0.9919914282343257,1.0,5/15,22.74%,SCARB1;CETP;MLXIPL;HNF4A;PLA2G12B
prerank,response to acidic pH (GO:0010447),-0.23091193964873163,-0.60496398445802,0.96,0.9983672901481979,1.0,5/15,28.28%,TRPV1;RAB11FIP5;CTSS;GPR4;RAB11B
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.1871110478406635,-0.6021215761199138,0.9830508474576272,0.998597010783259,1.0,5/35,15.24%,AGPAT1;C1QTNF4;TRIM6;TSLP;TICAM2
prerank,protein targeting to lysosome (GO:0006622),-0.20468349622172388,-0.5967866508271744,0.967741935483871,0.9993613203250734,1.0,3/20,16.94%,CLU;GGA3;VPS4A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.20104856462443502,-0.5961628495682257,1.0,0.9988009535884047,1.0,9/26,26.57%,PKD2;CLU;INSR;CD36;AGTR2;HBB;KLF2;SMAD3;NOS1AP
prerank,peroxisome organization (GO:0007031),0.1941188806435114,0.5835890378358785,0.9622641509433962,0.9960736225006804,1.0,4/24,14.86%,PEX7;PEX10;PEX16;ACOT8
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.19780987552925627,-0.5830171678618917,0.9782608695652174,1.0,1.0,9/27,26.57%,PKD2;CLU;INSR;CD36;AGTR2;HBB;KLF2;SMAD3;NOS1AP
prerank,regulation of stem cell proliferation (GO:0072091),-0.20753133275530644,-0.5814012899826543,0.9622641509433962,1.0,1.0,4/17,17.75%,ZFP36L1;FBLN1;AGO3;SOX11
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.20153323385137487,-0.580733424379384,0.9629629629629629,1.0,1.0,3/24,9.21%,MAPK7;ATF4;RBPJ
prerank,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.2176156503791448,-0.5798020613449337,1.0,0.9995434773416771,1.0,15/15,78.26%,MICA;CLEC12B;CEACAM1;LGALS9;KLRC1;KIR2DL4;HLA-A;HLA-G;HLA-E;HLA-B;KLRD1;LILRB1;ARRB2;SERPINB9;HLA-F
prerank,regulation of lymphocyte proliferation (GO:0050670),0.20365717558159566,0.5792661891671577,0.9787234042553191,0.9962494555158273,1.0,6/19,22.40%,TNFSF9;LST1;TNFRSF1B;IL12B;TNFSF8;TNFSF18
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.19038654380899397,-0.5743450177299176,1.0,0.99987273538481,1.0,10/26,27.64%,CNRIP1;TSG101;ZGPAT;CRHBP;CBL;RAMP3;ERRFI1;ZFYVE28;CLEC12B;SLC6A9
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.19942895888016435,0.5732364642960881,0.9743589743589743,0.9965077727850173,1.0,7/18,26.54%,BMP4;MYCN;TGFB1;ZC3H12A;TP53;TERT;LIN28A
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.19969570182024685,-0.5723522271687387,1.0,0.9996565450410396,1.0,6/19,26.85%,JAM2;ADD2;ROCK1;MADCAM1;SELP;GOLPH3
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.21988415217852209,0.5716867077366864,0.975,0.9960380785186487,1.0,6/15,32.01%,ACOXL;ACOT8;HSD17B4;EHHADH;DECR2;ACOX1
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.18564437241835952,-0.5696361158237202,0.9682539682539683,0.9994533190054761,1.0,7/26,21.12%,SLC12A4;KCNH2;SCNN1B;SCNN1G;ATP6V1B1;PDK2;SLC26A4
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.18617568437092533,-0.5657650306127513,1.0,0.999516165408528,1.0,7/35,19.05%,PPT2;HMGCLL1;ACSS3;SCD5;PAM;HPGD;ACAT1
prerank,positive regulation of chemokine production (GO:0032722),0.15903270363893618,0.5640780412717004,1.0,0.9963705294349654,1.0,18/52,30.19%,IL1B;WNT5A;SYK;FFAR2;IL17A;IL17F;EGR1;OAS3;TNFSF4;HMGB1;HIF1A;IFNG;CLEC7A;IL18;TLR7;EIF2AK2;ADAM17;AIRE
prerank,global genome nucleotide-excision repair (GO:0070911),-0.19846177185426844,-0.5607378064490679,1.0,0.9996105451037907,1.0,11/26,30.06%,XPA;ERCC3;UBB;GTF2H4;XPC;DDB2;CHD1L;USP45;ERCC1;ERCC4;RNF111
prerank,response to zinc ion (GO:0010043),0.18482117772877169,0.5579987305089961,1.0,0.9967189979913921,1.0,7/28,23.94%,SLC30A2;ATP13A2;SLC30A5;KHK;GLRA2;HAAO;MT1F
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.1955284282963213,0.5554231848290225,0.9795918367346939,0.9963821949805749,1.0,5/21,21.52%,IL1B;C3;HSP90AB1;SUGT1;ENTPD1
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.208098070463833,-0.5540213432958806,0.9516129032258065,0.9998375071853509,1.0,4/18,14.63%,SKI;DAB2IP;MORC3;SFRP1
prerank,phosphate ion transport (GO:0006817),0.19682071875639212,0.5514949291654062,1.0,0.9961777950062698,1.0,8/17,36.22%,SLC37A4;SLC34A1;SLC37A1;SLC34A3;SLC17A1;SLC25A10;SLC34A2;SLC37A3
prerank,lipid modification (GO:0030258),-0.18170177450092026,-0.5488061261186293,0.98,0.9998304906797384,1.0,8/28,26.43%,DGKE;DGKG;CYP1A1;DGKB;DGKI;DGKD;PORCN;DGKA
prerank,regulation of mast cell degranulation (GO:0043304),-0.1996193128214829,-0.5487625576872163,0.9411764705882353,0.9991482131287496,1.0,2/15,10.39%,FES;FER
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.19631678190108487,-0.5457844837526199,1.0,0.9987822045986122,1.0,3/17,14.07%,SEMA4C;TAOK2;MID1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.19914784866783306,-0.5405060432641283,0.9795918367346939,0.9988200441855795,1.0,3/15,16.85%,PELI3;CARD8;GPS2
prerank,B cell proliferation (GO:0042100),0.16160737766171612,0.536963243712493,1.0,0.997052849199857,1.0,2/31,10.97%,HSPD1;CD70
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.19036058638147138,-0.5300058937172322,1.0,0.9992105157814022,1.0,6/20,23.93%,RHOQ;NUMB;PID1;TMBIM1;AP2M1;PKDCC
prerank,NAD biosynthetic process (GO:0009435),0.1765708257628697,0.5289716812514058,0.975609756097561,0.9970540469796213,1.0,7/18,31.16%,QPRT;KYNU;NAPRT;HAAO;NAMPT;NMNAT1;RNLS
prerank,response to cholesterol (GO:0070723),0.17533545752367274,0.5281922082579896,1.0,0.9963807455664133,1.0,19/19,82.48%,CCL3;TGFB1;TGFBR2;TGFBR1;CCR5;PTCH1;GPLD1;GRAMD1A;GRAMD1C;GRAMD1B;MLC1;PMVK;ABCA2;CYP7A1;OSBPL7;CES1;LRP6;SMAD2;SMO
prerank,mitochondrial fusion (GO:0008053),-0.1959566444108147,-0.5208928047150004,1.0,0.9994053493077518,1.0,6/16,28.61%,MFN2;PLD6;SPG7;MFF;MFN1;MIEF2
prerank,regulation of T cell migration (GO:2000404),-0.18713468826657959,-0.5149878763671953,0.98,0.9991848226518433,1.0,4/19,21.55%,APOD;RHOA;CCL21;TNFRSF14
prerank,cellular response to zinc ion (GO:0071294),-0.1843294968563033,-0.5065007806999092,1.0,0.9989834534124256,1.0,5/17,27.84%,MT1X;ZNF658;MT1M;MT1A;MT3
prerank,leukotriene biosynthetic process (GO:0019370),-0.1875477603117573,-0.49568346487055803,1.0,0.9987383955725768,1.0,5/15,27.48%,PLA2G5;PLA2G1B;PLA2G4A;GGT5;GGT7
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.12541565326168796,-0.41417488403637903,1.0,0.9998493673428399,1.0,6/29,26.46%,MICA;CADM1;KLRK1;IL12A;PIK3R6;CLEC12B
